data_1sjg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sjg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.5 t . . . . . 0 C--O 1.243 0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.8 m-85 -90.11 105.62 17.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.177 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -106.3 146.23 30.65 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -76.09 116.78 17.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -98.55 -30.89 3.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.523 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.0 p -167.35 -171.73 1.78 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.082 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 56.7 p -130.5 152.8 49.48 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.588 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.7 mt -67.9 -15.36 63.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.858 0.837 . . . . 0.0 109.325 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.4 -23.58 63.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.047 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -83.6 -64.55 1.15 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.7 pt -103.16 134.57 43.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.48 1.133 . . . . 0.0 113.604 -174.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 30.6 m95 -93.1 170.02 9.96 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.179 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.5 118.3 6.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.36 56.88 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -112.22 151.28 29.76 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.859 0.362 . . . . 0.0 110.539 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.506 ' SD ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -148.39 146.61 28.56 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 178.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.6 pt-20 -158.36 156.77 31.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.514 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.9 t -94.19 141.7 28.25 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.064 0.459 . . . . 0.0 110.039 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -131.57 155.63 47.15 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.45 138.34 35.81 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -82.86 173.7 11.6 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -66.39 -15.48 63.33 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.155 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -93.59 -13.9 27.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.222 0.534 . . . . 0.0 110.204 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 -3.4 38.78 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.671 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 m -76.89 133.09 39.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.81 123.01 42.77 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.99 0.9 . . . . 0.0 109.149 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -122.62 143.83 34.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.449 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.506 HD23 ' SD ' ' A' ' 17' ' ' MET . 2.8 tm? -94.24 120.48 34.54 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 30' ' ' ILE . 2.0 mp -104.4 113.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 7.7 p -112.84 128.53 69.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.123 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.9 t30 -111.06 102.3 10.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 169.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.4 p -103.64 157.81 16.8 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.885 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -33.67 58.71 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.403 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -94.69 -46.14 7.05 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -97.28 -4.74 38.19 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.976 -0.453 . . . . 0.0 111.468 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.52 -163.12 48.09 Favored Glycine 0 C--O 1.248 0.995 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -93.36 118.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-O 121.716 0.77 . . . . 0.0 109.352 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -129.99 146.69 51.69 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.896 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.86 112.6 16.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.457 ' HB2' HD12 ' A' ' 86' ' ' LEU . 5.1 p90 -138.95 163.33 32.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -51.52 137.13 24.92 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.53 0.519 . . . . 0.0 110.377 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -111.66 -37.89 5.05 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -84.1 79.92 9.35 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -167.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -100.72 -28.41 0.23 Allowed Pre-proline 0 C--O 1.174 -2.921 0 CA-C-O 116.748 -1.596 . . . . 0.0 110.786 167.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 10.2 Cg_endo -50.06 105.44 0.1 OUTLIER 'Trans proline' 1 C--N 1.424 4.547 0 CA-C-N 122.683 1.994 . . . . 0.0 112.288 -177.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 68.0 m80 -82.61 9.46 9.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.032 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.74 116.9 20.93 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 103.358 -2.83 . . . . 0.0 103.358 170.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.78 111.7 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -173.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 tp -155.27 163.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.14 100.25 9.99 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.066 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.64 -32.83 65.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.624 1.169 . . . . 0.0 112.897 -173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 31.8 p -72.36 -22.48 61.14 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.495 0.664 . . . . 0.0 111.517 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -103.64 12.65 34.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.17 -103.08 2.85 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.817 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.548 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 22.6 t -144.74 145.42 31.68 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 123.372 1.558 . . . . 0.0 114.26 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -131.82 114.43 14.69 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 110.874 -2.875 . . . . 0.0 104.389 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -116.59 103.29 10.24 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.069 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.28 -72.77 0.43 Allowed Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.239 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.24 3.11 0.54 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.68 124.68 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.488 0.661 . . . . 0.0 109.363 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.66 139.13 18.82 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.548 ' OG1' ' HB3' ' A' ' 56' ' ' SER . 35.8 m -80.78 115.39 20.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.556 1.169 . . . . 0.0 112.873 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 37.1 t -93.06 141.07 28.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 173.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -118.76 -42.53 2.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 117.237 -1.785 . . . . 0.0 114.691 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . . . -93.45 -6.33 47.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.222 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 72.9 m80 -116.75 -174.21 2.53 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.425 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.76 73.56 4.33 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . 0.343 17.9 p-90 35.94 -31.91 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 131.095 3.758 . . . . 0.0 120.841 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -102.19 127.29 49.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 86' ' ' LEU . 37.1 t80 -135.33 136.15 41.33 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 171.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -123.59 133.32 53.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 117.773 -1.571 . . . . 0.0 114.16 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.17 -42.43 72.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.921 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.18 98.52 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.58 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -80.46 -27.46 37.88 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.21 26.7 73.88 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -157.56 154.91 29.3 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.02 137.49 23.16 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.54 -41.83 20.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -160.68 113.96 1.35 Allowed Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.44 -179.54 25.0 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.963 4.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.44 -19.51 29.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.838 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.35 -33.33 74.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.423 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.5 p -90.69 142.44 27.75 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-O 122.112 0.958 . . . . 0.0 112.078 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.676 ' SG ' ' HB3' ' A' ' 108' ' ' ASN . 1.6 p -139.38 159.83 41.25 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.275 -1.329 . . . . 0.0 111.399 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 41' ' ' TYR . 34.4 tp -111.61 129.83 55.95 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.046 0.45 . . . . 0.0 110.997 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.48 ' HB3' HD21 ' A' ' 108' ' ' ASN . . . -110.8 111.62 22.9 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.06 148.73 22.71 Favored 'General case' 0 N--CA 1.421 -1.894 0 O-C-N 123.618 0.574 . . . . 0.0 110.499 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 101' ' ' SER . 97.6 m-85 -108.7 149.8 39.94 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.624 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.8 121.83 9.29 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.7 2.267 . . . . 0.0 110.755 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.69 138.32 32.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.865 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 119.07 35.43 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.12 120.24 59.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.289 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 94' ' ' LYS 0.282 0.0 OUTLIER -126.54 145.72 50.41 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.946 174.985 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -25.29 -45.75 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 119.763 2.665 . . . . 0.0 119.763 -171.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' SER . 26.6 m-20 -116.46 -13.59 10.96 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 117.808 0.804 . . . . 0.0 111.795 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -121.62 148.9 43.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.612 0.72 . . . . 0.0 112.887 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -126.14 111.57 27.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.309 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -108.98 144.29 37.15 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.781 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 8.8 p -140.32 145.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 2' ' ' SER . 38.5 t -87.84 114.21 24.24 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -134.36 15.87 3.75 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.416 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -108.36 118.19 36.11 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.265 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 -3.82 86.73 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.175 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.6 mt -90.39 130.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 120.778 0.323 . . . . 0.0 110.444 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.6 tp -78.48 119.98 79.33 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.103 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.11 145.93 62.55 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.842 2.361 . . . . 0.0 111.052 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.676 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 30.9 m-80 -88.91 179.14 6.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.853 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 11.0 mptt -67.8 101.38 1.06 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.74 1.257 . . . . 0.0 112.582 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.262 -3.239 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 -178.58 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.433 -1.282 0 CA-C-O 120.675 0.274 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.515 ' CE1' ' HG3' ' A' ' 92' ' ' GLU . 96.4 m-85 58.28 97.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.3 150.26 50.15 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.106 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 88.4 tttt -68.72 137.83 54.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.013 0.435 . . . . 0.0 111.602 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.446 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -127.25 -40.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' A' ' 6' ' ' ILE . 19.8 p -155.08 -172.11 4.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.305 0.574 . . . . 0.0 112.122 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p -131.45 150.01 52.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.646 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.511 ' O ' HD21 ' A' ' 9' ' ' LEU . 5.7 tt -69.65 -25.66 64.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.05 -24.93 68.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.977 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.38 -55.11 3.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.683 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 40.4 pt -100.82 110.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 122.541 1.162 . . . . 0.0 111.085 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -83.75 170.15 14.49 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.749 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -56.89 118.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.012 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 -2.27 61.25 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.64 142.3 34.56 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.464 ' HE2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -141.97 142.11 32.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.189 -176.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -148.16 133.8 18.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.232 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 89.4 m -79.03 123.08 26.97 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -119.23 155.04 32.44 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.508 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -102.65 134.66 45.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.819 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -83.55 167.36 17.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -63.14 -13.31 35.29 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -88.48 -12.27 43.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.25 30.87 11.45 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -97.62 133.59 41.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.64 126.83 35.78 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.176 0.512 . . . . 0.0 110.068 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' THR . 42.0 t -131.67 140.15 48.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -97.34 108.13 20.79 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -99.36 115.85 41.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.37 125.11 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.418 ' ND2' ' HG ' ' A' ' 9' ' ' LEU . 42.5 t30 -97.26 105.08 17.16 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.306 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -101.4 148.58 25.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -76.64 -50.72 13.06 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.505 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.54 -38.5 14.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.81 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -79.72 -9.66 59.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.65 169.51 38.52 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.337 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -76.01 122.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.47 142.95 50.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.57 137.5 49.33 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 96.4 m-85 -130.35 149.77 51.88 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.535 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 33.7 tt0 -52.02 136.31 29.39 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.86 19.61 18.91 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.65 0.738 . . . . 0.0 110.511 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.2 mmm -78.55 87.5 4.52 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 52' ' ' LEU . 9.1 p -115.89 94.09 40.07 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 165.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.47 42.25 1.2 Allowed 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.993 2.462 . . . . 0.0 113.89 -170.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -96.26 -67.0 0.87 Allowed 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.884 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -161.7 -35.62 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.009 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -99.74 100.65 11.64 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.873 0.844 . . . . 0.0 110.913 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.4 tp -92.51 0.49 9.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 122.734 1.254 . . . . 0.0 108.565 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.26 41.85 1.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.369 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.555 HD12 ' SG ' ' A' ' 45' ' ' CYS . 4.5 mp -56.66 -32.55 65.49 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.414 0.686 . . . . 0.0 111.248 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.637 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 80.7 p -72.23 -28.05 62.92 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.609 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -99.73 17.5 20.49 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 64' ' ' CYS . . . -86.68 -109.21 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 t -149.67 148.77 29.68 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.131 0.967 . . . . 0.0 111.883 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -129.89 121.11 26.02 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.109 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 44.2 mt-10 -115.4 168.13 10.26 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.35 64.48 2.47 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 120.802 -0.714 . . . . 0.0 113.128 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.09 -12.7 3.08 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 70.6 t -123.5 131.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 120.778 0.323 . . . . 0.0 110.382 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mm -111.47 135.58 50.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.0 m -128.06 129.16 46.2 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 43.1 t -63.85 -72.11 0.15 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 25.8 ttt180 161.05 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.65 1.58 . . . . 0.0 107.263 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.59 11.85 7.02 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.552 1.167 . . . . 0.0 108.668 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -146.57 145.61 30.17 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 127.464 2.306 . . . . 0.0 107.473 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.426 ' HB3' ' H ' ' A' ' 64' ' ' CYS . 43.3 tp 58.15 82.74 0.13 Allowed 'General case' 0 C--N 1.32 -0.677 0 O-C-N 124.965 1.416 . . . . 0.0 109.68 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -74.55 -45.76 43.39 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.421 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 p -133.69 129.11 36.33 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.665 0.745 . . . . 0.0 111.275 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 74.1 t80 -135.1 138.62 43.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -103.85 112.8 25.92 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.461 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.13 -22.26 66.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.58 1.152 . . . . 0.0 111.502 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 16.79 57.31 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.954 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.1 m -148.78 -47.98 0.15 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.201 -0.587 . . . . 0.0 111.14 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.46 -3.62 34.76 Favored Glycine 0 C--O 1.211 -1.337 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.794 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -104.17 147.5 27.38 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.997 -0.707 . . . . 0.0 110.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.48 133.71 11.95 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.2 mp -82.09 -43.15 19.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 27.2 t-20 -140.31 113.02 7.34 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.032 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 96.8 Cg_endo -85.68 163.86 57.51 Favored 'Cis proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.26 -1.558 . . . . 0.0 111.468 -1.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -82.5 -11.73 58.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.128 0.966 . . . . 0.0 108.463 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.08 -26.21 25.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.212 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 73.3 m -139.47 158.17 44.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.087 0.946 . . . . 0.0 111.631 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.2 m -153.06 169.09 23.78 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.502 HD22 ' O ' ' A' ' 42' ' ' GLN . 51.2 mt -126.79 163.92 22.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.601 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -118.32 153.66 33.61 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.21 131.8 47.45 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.301 1.0 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 100' ' ' VAL . 1.7 t80 -126.44 106.54 23.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.79 125.13 16.14 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.844 3.03 . . . . 0.0 113.751 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.06 145.19 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.766 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' A' ' 3' ' ' PHE . 42.1 mt-10 -127.78 134.24 49.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.317 0.647 . . . . 0.0 110.345 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.1 117.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.456 ' HE2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -127.79 108.91 11.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.251 178.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 55.92 54.68 33.53 Favored Glycine 0 CA--C 1.5 -0.865 0 C-N-CA 121.361 -0.447 . . . . 0.0 113.026 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 72.23 -6.4 1.55 Allowed 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 125.141 1.377 . . . . 0.0 113.842 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -100.89 138.86 37.37 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -126.37 125.51 67.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 5' ' ' LYS . 3.2 m-85 -112.83 141.63 46.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.738 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 89' ' ' TYR . 27.0 m -129.8 143.23 41.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.115 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.411 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 26.7 t -116.23 129.69 56.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.578 0.228 . . . . 0.0 111.32 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.479 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 2.9 m -86.38 -15.15 41.28 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -88.6 123.58 33.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.36 23.23 8.56 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 64.1 mt -100.12 129.44 50.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.977 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 2.8 tm? -106.44 102.12 39.22 Favored Pre-proline 0 N--CA 1.426 -1.655 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.02 132.68 23.41 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.276 1.984 . . . . 0.0 110.002 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.601 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 18.6 t30 -115.08 115.68 27.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.623 -172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 8.7 tmtt? 64.1 -53.32 0.26 Allowed 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 127.534 2.334 . . . . 0.0 111.239 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.535 ' HB1' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 C--N 1.284 -2.27 0 C-N-CA 124.23 1.012 . . . . 0.0 109.113 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 68.7 103.41 0.05 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.925 0.869 . . . . 0.0 111.382 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.25 143.16 37.46 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.539 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -69.41 119.28 13.43 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.506 0.722 . . . . 0.0 109.504 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -115.97 -47.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.471 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.3 p -157.57 -168.08 2.46 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-O 121.452 0.644 . . . . 0.0 112.096 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.2 p -129.56 152.36 49.17 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.402 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 9' ' ' LEU . 1.6 tm? -67.23 -16.2 64.15 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.46 -29.9 70.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.786 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.82 -60.35 2.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.038 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -111.56 118.17 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 122.356 1.074 . . . . 0.0 113.227 -176.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -99.15 171.83 7.76 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.237 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.487 ' CG2' ' HA ' ' A' ' 34' ' ' GLU . 7.2 p -51.11 111.73 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 CA-C-O 121.567 0.699 . . . . 0.0 111.443 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.75 7.68 56.41 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.38 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -109.45 151.59 26.5 Favored 'General case' 0 C--O 1.246 0.914 0 O-C-N 122.37 -0.488 . . . . 0.0 110.219 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.563 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -150.46 137.48 19.3 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.1 mt-10 -149.66 153.48 37.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.0 t -92.87 138.15 31.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.236 0.541 . . . . 0.0 110.565 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 148.82 52.43 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 42.6 tt0 -98.22 146.0 26.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.939 0.399 . . . . 0.0 111.544 -171.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -83.26 178.72 7.95 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 m -70.57 -11.9 61.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.46 0.648 . . . . 0.0 110.592 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -91.49 -14.36 30.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.044 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.08 15.57 51.21 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.501 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.1 m -97.34 128.4 44.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.381 -0.482 . . . . 0.0 109.844 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 40.3 mt-10 -90.05 128.07 36.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.445 0.64 . . . . 0.0 111.036 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' THR . 94.3 t -117.99 141.54 36.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.53 -175.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.5 117.11 29.79 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.2 mp -100.11 112.79 33.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.59 130.55 68.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.75 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -105.52 106.91 17.63 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 t -79.36 146.49 32.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 124.451 1.1 . . . . 0.0 110.769 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.487 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 mp0 -53.94 -50.19 67.0 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.365 1.066 . . . . 0.0 111.904 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -110.4 -36.87 5.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.589 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -79.96 -28.51 39.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.482 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.78 -149.97 17.39 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.881 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -86.39 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.712 0.768 . . . . 0.0 111.652 -171.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -129.26 130.0 45.65 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.316 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.54 111.5 15.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.032 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.499 ' HH ' ' CD1' ' A' ' 62' ' ' ILE . 20.7 p90 -144.56 154.52 42.95 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.53 137.06 19.97 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.644 0.59 . . . . 0.0 109.652 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.87 -54.03 9.85 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.406 ' HE2' ' HB2' ' A' ' 27' ' ' GLU . 1.7 pmm? -88.27 160.94 17.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.777 -172.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.638 ' SG ' ' HA ' ' A' ' 64' ' ' CYS . 13.5 p -89.62 86.44 0.17 Allowed Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -1.44 42.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.95 1 C-N-CA 128.156 5.904 . . . . 0.0 119.476 -162.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -149.71 129.93 13.67 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 68.31 123.7 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 114.796 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.77 103.27 14.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.304 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tp -153.07 154.68 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.36 80.51 4.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.198 0.999 . . . . 0.0 110.233 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' H ' HD11 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -73.22 -19.17 61.14 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.679 -176.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 30.5 p -56.31 -19.72 15.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -84.42 -9.67 58.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.378 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.13 75.41 0.28 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.402 ' H ' ' HE2' ' A' ' 17' ' ' MET . 18.1 m -130.76 -73.29 0.55 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.311 0.577 . . . . 0.0 110.841 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 64.8 t80 -91.26 112.74 24.78 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.332 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -118.89 104.05 10.17 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.21 -73.11 0.41 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-O 121.28 0.378 . . . . 0.0 112.643 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.73 12.3 0.46 Allowed Glycine 0 C--N 1.301 -1.4 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.66 134.48 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 40.0 mm -100.15 139.41 21.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 m -83.56 115.08 21.95 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 111.72 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.638 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 5.6 t -81.02 119.33 23.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.424 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -60.57 -60.24 4.12 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.94 -39.05 4.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 10.6 m80 -58.09 -45.6 86.92 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -157.56 -95.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.416 ' CD1' HG23 ' A' ' 70' ' ' THR . 18.4 p90 172.96 -16.46 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 124.387 1.075 . . . . 0.0 110.376 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 69' ' ' TRP . 35.1 p -101.78 128.82 47.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.158 0.504 . . . . 0.0 111.802 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.621 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 43.7 t80 -137.5 138.98 40.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 171.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.02 111.15 22.15 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.05 -33.38 63.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 111.713 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.73 88.69 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -94.99 -28.48 15.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.309 0.576 . . . . 0.0 109.612 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.72 18.83 64.9 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -136.54 137.6 40.42 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.82 137.73 20.48 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.398 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.84 -44.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -154.04 109.2 2.48 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.1 148.85 91.95 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.167 -1.597 . . . . 0.0 113.213 3.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 14.2 t70 -86.2 -24.69 26.0 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.869 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.91 -37.83 86.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.0 m -94.72 151.32 19.37 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 123.077 1.418 . . . . 0.0 112.715 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.73 140.04 20.4 Favored 'General case' 0 C--N 1.262 -3.232 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.681 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.621 HD12 ' CZ ' ' A' ' 71' ' ' PHE . 7.6 mp -110.97 100.98 9.58 Favored 'General case' 0 C--N 1.259 -3.368 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.617 -175.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.26 127.73 33.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.604 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.2 160.77 25.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 124.003 0.814 . . . . 0.0 110.014 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.12 148.41 43.56 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.94 121.16 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.017 1.812 . . . . 0.0 109.248 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.11 133.67 68.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.426 0.632 . . . . 0.0 111.765 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.459 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 47.3 mt-10 -122.76 135.05 54.44 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.15 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.98 120.82 63.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.115 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -121.66 91.33 3.49 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.93 -99.19 0.18 Allowed Glycine 0 N--CA 1.437 -1.271 0 O-C-N 123.793 0.683 . . . . 0.0 113.869 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -90.55 -18.55 25.05 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.828 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -110.91 147.47 34.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.6 mt -127.32 129.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.577 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -119.22 136.9 53.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.68 137.53 55.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -97.35 114.69 26.52 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.012 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.5 m -100.27 -40.53 7.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -53.86 111.0 0.66 Allowed 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.686 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.82 -25.28 9.64 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.343 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -103.73 133.16 48.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 120.939 0.4 . . . . 0.0 110.119 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.89 124.05 55.71 Favored Pre-proline 0 N--CA 1.403 -2.799 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.464 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 149.29 85.78 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 121.865 1.71 . . . . 0.0 108.712 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -91.49 113.54 25.83 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm 49.66 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 124.71 1.256 . . . . 0.0 110.241 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 125.856 1.662 . . . . 0.0 111.299 176.469 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 39.9 t . . . . . 0 N--CA 1.428 -1.568 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 81.0 m-85 -80.15 97.9 7.08 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.157 0.503 . . . . 0.0 109.701 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -106.23 143.75 33.91 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -75.0 124.05 26.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -83.18 -54.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.8 m -171.98 -173.79 1.19 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 126.001 1.72 . . . . 0.0 108.052 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 15.5 p -101.11 151.47 21.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.13 -17.85 43.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.257 1.027 . . . . 0.0 108.971 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.86 -25.74 68.3 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.164 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -93.11 -43.8 8.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.303 0.573 . . . . 0.0 109.824 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 tp -100.28 117.21 45.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.984 0.897 . . . . 0.0 111.868 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -105.86 168.97 8.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.298 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.58 123.68 26.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.143 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.72 65.29 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -104.01 162.13 13.4 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.04 0.447 . . . . 0.0 110.377 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 53' ' ' SER . 26.7 ptt? -150.15 136.84 19.16 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.3 tp10 -147.39 152.93 38.97 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.622 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 97.2 m -97.33 129.19 44.63 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.85 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -139.74 157.97 44.87 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -108.01 143.78 36.23 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.159 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 p -83.07 168.61 16.75 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -68.18 -18.62 64.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.442 0.639 . . . . 0.0 109.664 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.44 -13.33 52.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.84 14.26 37.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.201 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 m -97.37 126.39 42.58 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.2 123.69 33.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.47 146.01 33.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.7 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.53 111.92 24.42 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 30' ' ' ILE . 2.4 mp -95.95 119.22 43.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 7.6 p -110.08 123.82 66.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -114.51 104.15 11.74 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.376 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 36' ' ' HIS . 58.9 p -102.32 148.77 25.06 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.13 -37.96 66.46 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.315 0.578 . . . . 0.0 110.27 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -86.13 -30.2 22.7 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.811 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.439 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 12.0 m170 -106.84 -23.58 12.34 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.82 -170.96 17.56 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.448 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.25 121.45 48.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.495 0.664 . . . . 0.0 111.459 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -117.77 148.15 42.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.195 177.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.18 113.19 17.99 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -131.72 163.6 27.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -50.71 138.14 18.82 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.707 0.63 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.09 8.74 32.38 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.2 tpt -75.57 88.4 2.7 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.217 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 48' ' ' GLN . 44.8 t -159.25 85.57 2.25 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.918 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.62 5.62 6.28 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.315 2.01 . . . . 0.0 108.947 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.408 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 17.9 t-160 -86.51 -18.91 30.38 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.74 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.702 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 53.6 tt0 -69.24 147.06 51.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.421 -1.263 . . . . 0.0 113.383 -171.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.16 100.05 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.046 1.738 . . . . 0.0 112.953 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mm 63.75 -79.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 125.049 1.339 . . . . 0.0 114.017 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -118.65 119.99 36.12 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -174.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 52' ' ' LEU . 1.9 pt? -63.93 -49.08 74.0 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 77.4 p -73.74 -31.34 63.31 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.499 0.666 . . . . 0.0 112.446 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.42 ' H ' HD12 ' A' ' 51' ' ' LEU . 43.4 mt-10 -95.11 22.06 7.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.78 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.0 -95.41 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.655 0.597 . . . . 0.0 113.373 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.7 m -155.53 127.5 7.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.899 0.857 . . . . 0.0 111.903 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -130.44 120.62 24.47 Favored 'General case' 0 C--N 1.261 -3.273 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.707 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 45.9 mt-10 -110.21 168.17 9.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -37.01 -58.45 1.22 Allowed Glycine 0 N--CA 1.48 1.575 0 O-C-N 124.236 0.96 . . . . 0.0 114.782 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.26 24.59 4.7 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.771 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 64.5 t -124.15 122.07 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 120.944 0.402 . . . . 0.0 110.484 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.648 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 47.8 mm -95.72 138.08 22.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 m -127.22 115.69 19.45 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.18 -1.408 . . . . 0.0 111.112 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.1 t -64.86 -21.78 66.87 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.505 ' H ' HD13 ' A' ' 68' ' ' LEU 0.343 71.6 ttt180 46.39 80.95 0.04 OUTLIER 'General case' 0 C--O 1.248 1.009 0 C-N-CA 129.505 3.122 . . . . 0.0 117.792 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 174.02 -45.4 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 125.352 1.657 . . . . 0.0 109.464 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.408 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.7 p-80 -123.31 8.84 9.11 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -119.82 162.75 18.57 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.547 -1.261 . . . . 0.0 112.759 -177.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -96.71 -69.45 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 p -135.01 141.96 46.32 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 121.497 0.665 . . . . 0.0 111.686 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.648 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 21.3 t80 -135.45 138.29 43.04 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -98.81 127.22 44.68 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 39' ' ' LYS . 5.7 t70 -62.2 -56.59 17.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.157 0.983 . . . . 0.0 113.446 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.33 -50.43 62.42 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.202 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.2 m -81.17 -32.51 33.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.165 0.507 . . . . 0.0 110.402 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.97 71.65 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.61 ' HA ' ' SG ' ' A' ' 85' ' ' CYS . 14.2 t-80 -102.65 138.61 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.543 1.137 . . . . 0.0 109.567 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.1 140.79 15.66 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.8 -48.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -149.17 112.18 3.52 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.052 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.8 160.68 94.73 Favored 'Cis proline' 0 C--O 1.241 0.663 0 C-N-CA 123.127 -1.614 . . . . 0.0 111.817 -0.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.38 -40.88 66.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.742 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -89.44 26.28 1.73 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.194 0.521 . . . . 0.0 111.719 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.405 ' O ' ' HE2' ' A' ' 71' ' ' PHE . 18.5 t -101.27 6.22 42.79 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.581 0.705 . . . . 0.0 109.428 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 38.0 m -51.53 155.91 1.43 Allowed 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.127 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 pp -101.53 -177.86 3.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.27 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.58 113.55 15.59 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.5 120.33 32.87 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.638 0.733 . . . . 0.0 110.904 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -91.61 129.65 41.92 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.21 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.49 120.89 8.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.693 2.929 . . . . 0.0 112.04 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.01 131.74 56.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.233 0.54 . . . . 0.0 111.114 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -109.38 110.56 21.74 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.2 115.81 50.72 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.49 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -126.01 147.02 49.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -38.91 124.45 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.602 0.564 . . . . 0.0 113.628 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 8' ' ' SER . 19.5 m-20 78.92 -19.53 0.44 Allowed 'General case' 0 C--O 1.2 -1.535 0 C-N-CA 126.281 1.832 . . . . 0.0 114.928 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 34.4 t70 -145.77 143.64 29.82 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.673 1.579 . . . . 0.0 114.266 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.94 127.15 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.38 151.3 38.72 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.364 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.87 144.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 121.388 0.613 . . . . 0.0 111.627 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.46 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 37.3 t -95.28 124.85 39.54 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.094 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -111.07 15.41 21.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 63.8 tttp -66.35 110.18 2.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.789 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.53 7.11 78.5 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.256 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.04 108.8 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.22 155.66 38.63 Favored Pre-proline 0 N--CA 1.411 -2.412 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 138.19 53.63 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.918 1.745 . . . . 0.0 109.632 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.12 169.8 17.62 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -52.65 -23.1 5.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.061 1.344 . . . . 0.0 113.782 -171.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.286 -2.164 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.96 178.79 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 24.6 m . . . . . 0 CA--C 1.554 1.113 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 77.1 m-85 -95.65 107.54 19.75 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -114.12 150.31 34.29 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.04 117.72 9.48 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 tp -111.33 -39.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.945 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.5 m -147.94 172.26 14.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.363 0.601 . . . . 0.0 110.717 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 27.2 m -118.86 152.38 36.36 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 170.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.57 -17.15 12.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.524 0.678 . . . . 0.0 112.398 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.69 -22.15 54.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.92 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.54 -35.73 24.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.888 0.852 . . . . 0.0 109.305 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.2 tp -125.07 113.95 38.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.165 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -104.28 168.39 9.13 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.829 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 122.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.308 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.88 65.36 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -103.84 159.91 15.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 121.405 0.621 . . . . 0.0 112.07 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 26.8 ptt? -151.35 140.89 21.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.07 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 43.8 tt0 -154.53 155.04 34.1 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.831 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 85.1 m -90.39 132.01 35.84 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.634 0.731 . . . . 0.0 110.677 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -128.37 153.49 47.0 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.11 137.44 45.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.565 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 p -83.89 -178.33 6.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.611 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -70.24 -30.75 67.88 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.69 -13.01 57.15 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.46 20.28 13.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.222 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.9 m -87.14 123.67 32.43 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.57 123.01 33.88 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.9 t -133.09 146.0 33.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 120.778 0.323 . . . . 0.0 110.269 -174.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.427 HD23 ' CE1' ' A' ' 41' ' ' TYR . 66.3 tp -96.17 114.81 26.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.1 mp -96.53 116.76 39.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.84 128.64 69.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -110.91 107.14 16.5 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -96.62 149.39 21.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.856 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -50.3 49.55 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -89.1 -37.57 14.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.898 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -94.35 1.42 55.88 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 -161.51 54.24 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.704 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.2 t -89.22 122.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -122.31 136.44 54.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.37 127.31 47.39 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.427 ' CE1' HD23 ' A' ' 29' ' ' LEU . 40.3 p90 -143.68 163.7 32.53 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.393 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -44.3 137.38 3.58 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.897 0.748 . . . . 0.0 110.101 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.78 -36.03 7.17 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.32 121.54 29.04 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.931 -0.707 . . . . 0.0 112.309 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.3 t -97.11 118.66 64.5 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -90.78 10.55 2.84 Favored 'Trans proline' 0 CA--C 1.502 -1.114 0 C-N-CA 123.129 2.553 . . . . 0.0 111.151 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.02 -56.06 6.3 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -140.95 -63.89 0.46 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -125.6 157.86 36.11 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.402 HG13 ' CD2' ' A' ' 51' ' ' LEU . 38.1 pt -108.42 -161.57 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.039 0.936 . . . . 0.0 109.336 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.402 ' CD2' HG13 ' A' ' 50' ' ' ILE . 4.3 mm? 74.6 29.01 1.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.884 0.85 . . . . 0.0 110.587 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 64' ' ' CYS . 53.8 tp -59.08 -29.69 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.478 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 51.0 p -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.279 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -109.95 22.47 15.59 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.89 -129.38 1.37 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 t -137.26 151.99 49.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.148 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -129.87 129.25 43.7 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.87 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.48 169.48 9.13 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.25 -46.62 5.43 Favored Glycine 0 N--CA 1.476 1.305 0 O-C-N 123.964 0.79 . . . . 0.0 114.239 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.58 14.95 3.4 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.786 -1.197 . . . . 0.0 113.073 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.93 140.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.564 ' HB ' ' CB ' ' A' ' 71' ' ' PHE . 29.3 mm -112.27 140.34 32.47 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.639 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 68' ' ' LEU . 49.9 m -100.47 117.55 34.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.823 -0.548 . . . . 0.0 110.674 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.43 ' HA ' HD13 ' A' ' 52' ' ' LEU . 43.0 t -66.25 135.72 54.85 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -49.82 107.0 0.13 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.082 0.553 . . . . 0.0 111.917 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.26 13.94 9.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.472 1.109 . . . . 0.0 113.177 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -129.53 98.12 4.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.628 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 63' ' ' THR . 4.4 mm? 64.95 -170.34 0.19 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -128.66 11.61 6.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.645 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -120.05 130.8 54.86 Favored 'General case' 0 C--O 1.167 -3.271 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.564 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 45.4 t80 -139.74 159.43 42.19 Favored 'General case' 0 CA--C 1.469 -2.142 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 166.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.493 ' ND2' ' HB ' ' A' ' 75' ' ' THR . 51.0 t30 -115.73 99.08 7.05 Favored 'General case' 0 N--CA 1.391 -3.398 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.024 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.46 -60.16 3.45 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.775 -173.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.48 32.71 4.62 Favored Glycine 0 C--N 1.304 -1.213 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.777 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.493 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 26.0 m -151.4 -38.62 0.12 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.282 0.541 . . . . 0.0 111.318 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.76 -55.84 0.52 Allowed Glycine 0 C--O 1.223 -0.575 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.829 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 85' ' ' CYS . 16.2 p80 -85.1 135.24 34.07 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 72' ' ' ASN . . . 157.14 38.0 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.385 0 N-CA-C 119.815 2.686 . . . . 0.0 119.815 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.725 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 mp -107.11 -56.11 5.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 116.901 -1.92 . . . . 0.0 111.775 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 24.6 t-20 159.34 105.49 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.389 1.476 . . . . 0.0 107.909 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 5.7 Cg_exo -78.83 -170.86 9.15 Favored 'Cis proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.812 -1.745 . . . . 0.0 110.909 1.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 7.0 m-20 -61.15 -18.17 56.69 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.72 -32.8 70.87 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.062 1.345 . . . . 0.0 113.121 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.725 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 17.9 p -81.74 133.12 35.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.124 -1.031 . . . . 0.0 112.311 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' A' ' 109' ' ' LYS . 12.9 p -142.02 170.1 16.35 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.603 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -146.13 125.83 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.576 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB3' ' H ' ' A' ' 108' ' ' ASN . . . -60.25 129.0 39.5 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -96.26 131.17 43.03 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.789 0.681 . . . . 0.0 109.556 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 101' ' ' SER . 47.4 m-85 -116.08 138.56 24.24 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -59.97 135.12 60.86 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 C-N-CA 123.15 2.566 . . . . 0.0 112.037 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.87 130.78 74.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -109.92 112.7 24.89 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.88 106.73 21.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 122.07 0.938 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.438 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -129.64 117.32 20.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.342 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.16 -115.14 7.63 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.302 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' A' ' 8' ' ' SER . 7.1 m-20 -95.76 -10.78 28.23 Favored 'General case' 0 C--O 1.195 -1.791 0 O-C-N 123.64 0.259 . . . . 0.0 110.784 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -104.21 138.66 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.2 mt -124.74 115.33 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.463 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -109.52 145.08 36.89 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.881 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 60.2 t -134.11 145.56 32.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 32.8 t -87.86 113.69 23.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 t -126.2 -11.34 6.41 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.203 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' SER . 59.1 tttp -122.87 126.42 47.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.38 -39.86 2.46 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.2 mt -102.07 106.21 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tt -85.79 130.42 50.78 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -42.08 128.78 4.27 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 124.056 3.17 . . . . 0.0 112.02 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.608 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -94.22 116.69 29.12 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.983 0.421 . . . . 0.0 111.04 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.539 ' HD3' ' SG ' ' A' ' 85' ' ' CYS . 89.0 tttt 57.0 -169.16 0.1 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.282 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.461 ' H ' ' HG2' ' A' ' 109' ' ' LYS . . . . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 101' ' ' SER . 57.5 m . . . . . 0 N--CA 1.437 -1.089 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -88.56 131.77 34.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.007 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.67 149.17 38.52 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' A' ' 5' ' ' LYS . 6.7 ttpm? -68.7 127.1 31.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 7' ' ' CYS . 7.6 tp -83.75 -50.31 15.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.448 ' N ' HG23 ' A' ' 6' ' ' ILE . 95.7 m -164.64 -175.24 3.74 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 125.094 1.357 . . . . 0.0 108.416 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.9 m -111.16 154.98 23.58 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.07 -16.41 7.31 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.429 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 5.1 p-10 -79.99 -20.2 46.02 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.657 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.05 -54.56 4.76 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.0 tp -108.05 110.54 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.071 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.432 ' HB2' ' CG ' ' A' ' 16' ' ' GLU . 20.8 m95 -86.37 163.03 17.88 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.227 -1.352 . . . . 0.0 111.163 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.65 121.88 26.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.235 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.5 59.81 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 13' ' ' TRP . 24.4 mm-40 -107.66 162.42 13.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.937 0.399 . . . . 0.0 110.964 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.648 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 26.1 ptt? -144.3 135.57 25.49 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.179 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' SER 0.319 10.1 pt-20 -157.18 155.12 30.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 71.9 m -83.52 127.05 33.42 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.681 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -126.81 150.5 49.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -97.55 143.81 27.87 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.534 0.683 . . . . 0.0 111.457 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -83.55 176.98 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.518 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -74.39 -8.78 57.42 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.2 0.524 . . . . 0.0 111.241 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.9 -6.16 51.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.405 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.81 17.67 57.7 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.019 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 m -94.47 127.32 40.3 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.24 124.29 34.25 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.652 0.739 . . . . 0.0 110.602 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' THR . 48.7 t -125.42 146.5 31.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.93 -175.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.4 tp -89.35 111.21 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.81 114.21 31.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.78 123.72 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.9 t30 -106.46 104.7 14.45 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.578 ' CB ' ' HB3' ' A' ' 36' ' ' HIS . 19.6 m -100.33 157.34 16.69 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.1 -51.41 13.54 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -108.55 -25.21 11.02 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.954 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.578 ' HB3' ' CB ' ' A' ' 33' ' ' SER . 43.6 t-80 -79.17 -7.61 58.35 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.785 0.803 . . . . 0.0 109.166 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.73 173.19 17.77 Favored Glycine 0 CA--C 1.5 -0.86 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.591 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.432 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 7.1 p -84.64 117.58 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.27 176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -130.07 149.14 51.92 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.319 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 89' ' ' TYR . . . -123.71 132.35 53.81 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.6 154.84 51.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.414 ' OE1' ' HB3' ' A' ' 107' ' ' PRO . 26.6 mm-40 -53.98 137.02 40.41 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.567 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.563 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -101.13 -11.35 19.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.873 0.844 . . . . 0.0 109.739 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.455 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 11.9 mmt -93.98 108.77 20.55 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.054 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 47' ' ' HIS . 24.0 p -105.79 172.57 3.86 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 110' ' ' ALA . 73.2 Cg_endo -76.15 21.78 0.52 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 121.89 1.727 . . . . 0.0 111.605 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' A' ' 45' ' ' CYS . 32.0 m80 -144.45 135.35 25.04 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 125.336 1.454 . . . . 0.0 107.649 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 60.11 -172.11 0.13 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.512 0.672 . . . . 0.0 112.394 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.66 -48.88 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.3 pt -94.66 178.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp 79.67 -25.88 0.18 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.463 1.105 . . . . 0.0 112.368 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 43' ' ' ALA . 4.0 mm? -56.8 -40.89 76.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.52 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 90.5 p -80.31 -15.6 56.53 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.369 0.604 . . . . 0.0 110.888 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -92.0 -9.13 44.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.949 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 126.65 0.89 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.589 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.7 t 178.28 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.648 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 66.3 t80 -91.85 113.11 25.29 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.109 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -115.91 105.34 12.56 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.452 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 -69.24 1.69 Allowed Glycine 0 C--O 1.241 0.567 0 O-C-N 123.215 0.322 . . . . 0.0 112.313 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.68 26.39 0.16 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.62 133.8 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 42.9 mm -96.51 117.16 40.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.003 0.906 . . . . 0.0 109.525 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.7 m -102.0 121.33 41.95 Favored 'General case' 0 C--N 1.259 -3.333 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.194 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.24 -177.02 3.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.374 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.499 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 2.8 mmp_? -119.33 -42.44 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.165 -1.014 . . . . 0.0 113.153 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 47' ' ' HIS . . . -98.17 -20.57 17.21 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.606 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -116.51 137.33 52.26 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 117.969 -1.493 . . . . 0.0 109.314 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 68' ' ' LEU . 2.9 tm? -63.26 -36.47 83.76 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 124.28 1.032 . . . . 0.0 113.119 -170.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -62.26 174.36 0.95 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -103.37 161.22 14.02 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.644 0.735 . . . . 0.0 112.6 -169.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.516 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 48.7 t80 -132.43 141.41 48.83 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.24 119.8 31.25 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -73.47 -22.31 60.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.48 -54.49 10.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.6 m -73.9 -34.65 64.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.844 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.8 -4.26 49.73 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.751 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -125.27 161.74 26.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 122.84 0.456 . . . . 0.0 110.381 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -77.98 144.07 28.28 Favored Glycine 0 N--CA 1.416 -2.65 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.83 -30.68 29.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HA ' ' C ' ' A' ' 81' ' ' PRO . 27.4 t-20 -143.61 125.83 8.53 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.356 172.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 80' ' ' ASN . 22.0 Cg_exo -67.37 -63.79 0.03 OUTLIER 'Cis proline' 0 C--N 1.354 0.824 0 C-N-CA 123.847 -1.314 . . . . 0.0 113.783 0.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 21.4 t70 164.91 -35.06 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 125.122 1.369 . . . . 0.0 109.569 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.16 -26.91 69.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.845 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.31 142.36 39.46 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 121.744 0.783 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.33 150.93 31.09 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.834 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 86' ' ' LEU . 1.6 pt? -114.44 141.34 47.8 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.267 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 108' ' ' ASN . . . -88.12 124.05 33.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.379 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -96.74 110.85 23.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 33.9 m-85 -79.24 139.79 56.44 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.662 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.27 120.22 7.4 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.227 1.952 . . . . 0.0 109.114 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 38' ' ' VAL . 20.9 t -132.38 140.84 46.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -136.37 150.32 48.76 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.977 0.418 . . . . 0.0 110.982 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.02 117.28 55.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.283 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.427 ' HZ3' ' HB2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -125.94 100.73 6.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.603 0.716 . . . . 0.0 110.243 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.94 -112.16 3.95 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.083 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 8' ' ' SER . 19.5 m-20 -102.24 -1.82 30.42 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.729 -0.235 . . . . 0.0 111.115 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.427 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 26.1 m-20 -121.82 155.85 34.47 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.84 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.1 mt -127.58 129.04 70.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -112.72 143.14 44.45 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.926 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 6' ' ' ILE . 5.9 p -132.85 143.39 39.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.806 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 2' ' ' SER . 33.5 t -91.58 113.94 26.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.0 p -109.99 -41.25 4.52 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.339 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -70.65 112.17 6.68 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.136 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.3 -27.32 7.03 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.5 mm -99.78 117.73 45.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 tt -99.27 136.38 20.48 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.414 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 50.5 Cg_exo -55.72 127.78 27.58 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.309 2.006 . . . . 0.0 111.534 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.408 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 33.9 t-20 -84.45 177.33 8.17 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.462 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -74.27 60.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 124.248 1.019 . . . . 0.0 113.354 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 46' ' ' PRO . . . . . . . . 0 C--N 1.273 -2.748 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 74.17 96.77 0.07 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -166.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -119.79 150.06 41.02 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.99 109.51 5.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -92.04 -40.91 12.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.853 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . 63.7 m -155.09 175.85 13.3 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.473 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 m -120.88 154.79 35.37 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.21 -25.28 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.203 0.525 . . . . 0.0 111.062 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.49 -20.61 62.84 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.258 0.551 . . . . 0.0 110.777 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 17.4 m-20 -88.51 -36.88 16.17 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.938 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 tp -130.71 116.14 33.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.158 0.98 . . . . 0.0 111.736 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -104.72 167.15 9.91 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.029 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.57 130.47 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.245 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 10.09 70.61 Favored Glycine 0 C--N 1.309 -0.942 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.61 147.68 48.34 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 120.814 0.34 . . . . 0.0 111.108 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.8 mtp -130.74 133.74 46.29 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 33.4 mt-10 -146.17 140.43 26.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.861 0.363 . . . . 0.0 111.349 172.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.1 m -73.78 132.48 42.65 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -128.4 162.22 27.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -106.18 137.06 44.78 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.413 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -83.54 171.87 12.93 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 m -67.8 -17.99 64.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.056 0.455 . . . . 0.0 111.729 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.56 4.8 51.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.8 29.36 35.29 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.597 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -98.68 136.72 38.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.386 -0.479 . . . . 0.0 110.177 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.49 124.94 34.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 41' ' ' TYR . 97.3 t -133.6 147.01 31.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -96.41 117.21 30.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -100.78 116.97 45.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.3 122.83 68.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' OD1' ' HB ' ' A' ' 38' ' ' VAL . 49.3 t30 -113.87 106.8 14.88 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.432 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -99.99 150.78 22.08 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -51.38 12.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.58 -45.86 12.13 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -79.01 -12.95 60.04 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.025 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -175.75 50.83 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.139 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' OD1' ' A' ' 32' ' ' ASN . 6.6 p -105.4 125.26 60.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.524 0.678 . . . . 0.0 111.115 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -129.92 150.98 50.96 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.595 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.07 128.44 49.33 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' O ' HG12 ' A' ' 28' ' ' VAL . 2.6 m-85 -131.08 163.08 28.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HB2' HD13 ' A' ' 86' ' ' LEU . 15.7 mm100 -53.12 138.95 30.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.19 -28.24 1.2 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 -169.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.492 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -162.28 -178.15 6.15 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -169.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.466 ' SG ' ' OG1' ' A' ' 70' ' ' THR . 86.9 m -87.02 163.75 39.16 Favored Pre-proline 0 C--N 1.361 1.091 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 169.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.58 24.31 0.17 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.276 1.984 . . . . 0.0 113.037 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.461 ' H ' ' C ' ' A' ' 45' ' ' CYS . 32.2 m170 -111.96 -52.25 2.8 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 63.33 108.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.485 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 55.0 mm-40 -124.5 170.74 10.59 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 165.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 pt -87.18 167.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 118.429 0.559 . . . . 0.0 111.092 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.7 mt 70.73 28.84 3.35 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.533 1.133 . . . . 0.0 111.449 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.557 ' H ' HD21 ' A' ' 52' ' ' LEU . 1.7 pt? -75.24 -42.17 55.84 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.587 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 96.1 p -72.93 -21.97 60.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.924 0.869 . . . . 0.0 109.503 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.66 15.86 5.26 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.293 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.2 -124.93 1.93 Allowed Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.4 m -142.79 157.09 44.97 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-O 122.167 0.984 . . . . 0.0 113.009 -174.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.06 116.79 19.84 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.27 -1.787 . . . . 0.0 108.222 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -115.15 104.55 11.96 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.87 -74.87 0.46 Allowed Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.648 0.582 . . . . 0.0 111.905 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.0 0.51 0.34 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.69 143.33 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.531 HD11 ' N ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -117.89 117.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.389 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.5 m -108.86 132.15 54.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.255 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.658 ' HB3' ' N ' ' A' ' 69' ' ' TRP . 1.7 p -85.02 -13.91 49.02 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 64.47 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.973 0.909 . . . . 0.0 112.649 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.49 27.74 8.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 109.775 -175.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.599 ' C ' HD12 ' A' ' 68' ' ' LEU 0.276 96.2 m-70 84.01 97.24 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 67' ' ' HIS . 7.2 mp -149.51 -80.04 0.13 Allowed 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 127.906 2.482 . . . . 0.0 108.954 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.658 ' N ' ' HB3' ' A' ' 64' ' ' CYS . 0.9 OUTLIER -146.8 135.22 21.89 Favored 'General case' 0 CA--C 1.594 2.641 0 O-C-N 121.955 -0.466 . . . . 0.0 111.221 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -139.69 132.4 29.0 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.541 -0.725 . . . . 0.0 112.721 174.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.416 ' H ' HG12 ' A' ' 62' ' ' ILE . 75.2 t80 -138.15 150.43 46.8 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.353 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.502 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . 45.8 t-20 -105.98 100.46 10.01 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.01 -36.71 50.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.13 -3.3 60.38 Favored Glycine 0 C--N 1.311 -0.832 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.857 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.3 m -139.74 -14.55 1.07 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.089 0.944 . . . . 0.0 112.98 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.49 -59.17 4.99 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.499 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 42.0 m80 -63.44 102.29 0.4 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.584 ' O ' ' HB ' ' A' ' 70' ' ' THR . . . -161.06 19.06 0.2 Allowed Glycine 0 CA--C 1.469 -2.823 0 C-N-CA 119.985 -1.102 . . . . 0.0 114.284 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.5 mp -98.77 -12.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.106 0 CA-C-N 115.126 -0.537 . . . . 0.0 111.131 -169.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 77.28 115.06 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.721 0 C-N-CA 125.293 1.437 . . . . 0.0 112.111 178.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 83' ' ' ASP . 14.1 Cg_exo -71.35 -174.14 10.74 Favored 'Cis proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.039 -1.65 . . . . 0.0 112.012 -0.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 77' ' ' HIS . 9.2 p-10 -68.99 2.76 2.43 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.714 0.769 . . . . 0.0 111.248 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 81' ' ' PRO . 16.9 t70 -80.55 -21.14 42.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.965 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.519 ' SG ' ' HE2' ' A' ' 109' ' ' LYS . 37.3 m -102.42 141.38 35.34 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.424 0.631 . . . . 0.0 111.507 -172.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.3 p -122.15 178.09 5.07 Favored 'General case' 0 C--N 1.273 -2.754 0 C-N-CA 125.176 1.391 . . . . 0.0 109.899 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 42' ' ' GLN . 52.1 tp -141.25 156.28 45.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.37 124.28 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.902 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.68 125.09 38.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 98.6 m-85 -100.27 132.36 22.69 Favored Pre-proline 0 C--N 1.28 -2.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.917 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.5 120.78 8.16 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.109 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 100' ' ' VAL . 45.1 t -109.47 134.47 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.3 131.98 56.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -108.41 118.1 55.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.781 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.76 91.57 3.37 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.59 -107.3 1.33 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.77 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -101.87 -0.97 33.15 Favored 'General case' 0 C--O 1.193 -1.872 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.332 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -106.52 139.51 40.87 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.441 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.5 mm -127.06 122.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.204 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -118.82 142.78 47.41 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.962 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 91' ' ' VAL . 39.2 t -134.31 139.14 48.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 t -95.31 114.29 26.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 24.5 p -118.52 -47.01 2.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.668 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -78.48 105.02 9.46 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.558 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.44 -35.57 1.72 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -96.19 128.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.21 133.09 72.22 Favored Pre-proline 0 N--CA 1.417 -2.076 0 CA-C-O 120.671 0.272 . . . . 0.0 111.722 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.471 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 18.4 Cg_endo -61.22 134.72 53.95 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.307 2.671 . . . . 0.0 111.135 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.57 123.52 47.69 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.519 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 52.0 tptt 58.88 178.87 0.07 Allowed 'General case' 0 CA--C 1.568 1.662 0 O-C-N 125.467 1.729 . . . . 0.0 111.349 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 109' ' ' LYS . . . . . . . . 0 CA--C 1.514 -0.414 0 C-N-CA 125.185 1.394 . . . . 0.0 114.217 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 68.54 84.79 0.15 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.06 0.85 . . . . 0.0 109.846 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.74 144.09 40.23 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.181 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.13 119.27 20.59 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.313 0.578 . . . . 0.0 110.933 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.6 -44.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.747 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.95 -172.83 4.07 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.492 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.3 m -118.89 152.65 35.9 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.189 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' HD21 ' A' ' 9' ' ' LEU . 6.5 tt -61.46 -22.06 64.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.292 0.637 . . . . 0.0 110.372 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 2.5 p-10 -77.27 -11.19 59.8 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.705 -0.622 . . . . 0.0 109.81 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -84.68 -45.04 12.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.8 pt -114.37 109.84 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 122.468 1.127 . . . . 0.0 109.777 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -75.25 170.43 16.07 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.747 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.59 115.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.173 0.511 . . . . 0.0 110.672 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.13 10.79 59.33 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.213 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.13 149.52 24.19 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -150.5 142.09 23.55 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.607 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 pt-20 -155.01 144.78 21.52 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.205 0.526 . . . . 0.0 112.291 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 90.1 m -79.96 138.85 37.17 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.588 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -129.65 162.33 28.56 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.32 134.93 54.36 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.079 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -83.15 168.46 16.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.0 m -68.0 -17.27 64.37 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.043 0.449 . . . . 0.0 110.767 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.52 -12.83 59.85 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.321 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.42 37.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.0 m -96.13 131.58 42.42 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 122.181 0.193 . . . . 0.0 111.088 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.94 124.45 36.06 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.541 0.686 . . . . 0.0 109.353 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' THR . 58.1 t -125.84 136.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.403 ' CD2' ' HB2' ' A' ' 17' ' ' MET . 1.3 tt -95.56 112.21 23.97 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 18' ' ' GLU . 9.9 tp -95.8 117.22 39.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.52 125.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -113.13 104.58 12.5 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.138 174.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -102.0 158.54 16.07 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.432 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -75.54 -50.72 14.79 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.641 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.69 -46.46 17.07 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -84.44 -11.32 56.42 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.605 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.72 -157.44 34.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.967 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.65 123.22 53.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 16.7 tppt? -128.59 145.34 51.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.39 113.94 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.555 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.456 ' CZ ' HD12 ' A' ' 62' ' ' ILE . 22.5 m-85 -116.32 147.72 41.28 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.416 ' CG ' HD22 ' A' ' 86' ' ' LEU . 11.3 pt20 -64.36 138.71 58.57 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.99 -68.37 0.69 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.489 0.661 . . . . 0.0 111.043 -175.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.486 ' CE ' ' HA ' ' A' ' 44' ' ' MET 0.265 0.1 OUTLIER 62.73 -100.21 0.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -178.86 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.4 t 49.56 96.36 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.824 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.58 36.96 0.48 Allowed 'Trans proline' 0 N--CA 1.48 0.69 0 C-N-CA 123.099 2.532 . . . . 0.0 112.149 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.469 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 37.2 m80 -150.39 -179.77 7.48 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 123.936 0.894 . . . . 0.0 109.578 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.7 pt20 62.78 142.33 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.523 2.329 . . . . 0.0 114.505 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.21 85.36 2.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 tp 169.83 167.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.48 138.04 36.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.928 0.394 . . . . 0.0 111.529 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.491 ' O ' HD21 ' A' ' 52' ' ' LEU . 4.1 tt -67.07 -32.47 73.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.5 p -63.7 -14.02 48.44 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.314 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -100.68 13.27 35.36 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.702 0.763 . . . . 0.0 109.267 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.76 -109.91 0.64 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.414 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 20.8 p -155.78 146.8 22.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -125.83 116.67 21.93 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.911 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 2.4 mp0 -99.37 170.12 8.86 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.24 67.45 0.37 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 -1.51 21.56 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.5 t -124.02 136.64 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.456 HD12 ' CZ ' ' A' ' 41' ' ' TYR . 52.2 mt -119.57 129.99 74.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.414 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 53.8 m -110.5 123.66 50.34 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.4 p -57.75 -30.6 65.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 169.24 -48.57 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.241 1.816 . . . . 0.0 107.501 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.69 -87.41 0.09 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.559 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 52.87 -85.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.161 1.384 . . . . 0.0 111.489 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.6 tp -174.16 -60.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.32 0.648 . . . . 0.0 109.47 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -99.11 -176.47 3.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.341 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 65.9 p -135.05 165.33 25.62 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.57 0.748 . . . . 0.0 111.316 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -103.22 147.75 26.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -118.22 126.12 51.54 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.997 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.71 -56.69 16.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.245 1.018 . . . . 0.0 111.243 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.49 50.02 4.27 Favored Glycine 0 CA--C 1.509 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.673 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.2 m -152.95 -44.83 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.24 -34.51 3.78 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . 21.3 t-80 -90.32 146.29 24.31 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.61 140.58 14.92 Favored Glycine 0 CA--C 1.483 -1.925 0 C-N-CA 118.705 -1.712 . . . . 0.0 112.391 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 70' ' ' THR . 2.0 mp -73.52 -31.41 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -109.97 129.4 23.97 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.632 169.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.37 -41.73 0.95 Allowed 'Cis proline' 0 CA--C 1.498 -1.283 0 C-N-CA 123.658 -1.393 . . . . 0.0 110.456 -4.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.3 t70 152.54 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.445 2.298 . . . . 0.0 107.326 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.45 -21.01 49.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.001 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.0 m -96.09 150.57 20.35 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-O 122.893 1.33 . . . . 0.0 112.721 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 77' ' ' HIS . 1.7 p -140.0 148.62 42.13 Favored 'General case' 0 C--N 1.253 -3.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 106.904 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.416 HD22 ' CG ' ' A' ' 42' ' ' GLN . 51.2 mt -112.83 175.94 5.23 Favored 'General case' 0 C--N 1.266 -3.043 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.022 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.36 142.99 51.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.187 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.05 118.26 35.41 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.448 ' HH ' ' HA ' ' A' ' 107' ' ' PRO . 89.6 m-85 -89.81 148.07 39.0 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.754 -175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 101' ' ' SER . 11.9 Cg_exo -68.04 119.73 6.73 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.508 1.472 . . . . 0.0 111.002 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.6 p -127.95 134.84 64.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.128 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -127.32 126.51 42.7 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.497 0.665 . . . . 0.0 109.952 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.7 124.5 68.5 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.502 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.541 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.81 96.97 4.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.492 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.43 -104.87 1.52 Allowed Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.05 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 8' ' ' SER . 21.8 m-20 -109.37 4.11 22.19 Favored 'General case' 0 C--O 1.19 -2.027 0 CA-C-N 115.525 -0.337 . . . . 0.0 110.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.64 139.59 43.21 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 120.63 0.252 . . . . 0.0 111.155 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -127.1 119.64 53.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.495 0.664 . . . . 0.0 111.303 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -112.58 137.87 50.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.755 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.4 m -127.33 148.53 32.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.492 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 32.2 t -127.77 146.6 50.54 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.5 m -125.74 2.06 7.47 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -91.33 130.78 37.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.458 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.16 -45.8 1.26 Allowed Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.9 mt -108.05 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.6 tp -82.46 139.09 44.47 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.968 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.448 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 96.0 Cg_exo -50.61 128.99 25.41 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 122.547 2.165 . . . . 0.0 111.014 174.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -86.99 143.57 27.28 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.687 -173.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.43 -76.09 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.08 2.552 . . . . 0.0 113.768 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.424 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.075 -176.555 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.223 -0.318 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.85 148.04 35.73 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -142.46 144.84 33.21 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -73.16 129.54 38.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.241 0.543 . . . . 0.0 110.758 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.527 HG21 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -100.43 -42.61 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.044 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.527 ' SG ' HG21 ' A' ' 6' ' ' ILE . 7.7 p -165.76 -176.69 3.97 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.22 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 14.9 m -123.57 150.42 44.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.296 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.522 ' O ' HD21 ' A' ' 9' ' ' LEU . 6.4 tt -60.1 -24.62 64.79 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.222 1.409 . . . . 0.0 110.287 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.28 -23.49 64.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.21 -45.4 4.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.342 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 5.6 tp -100.68 110.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 122.298 1.047 . . . . 0.0 111.972 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -101.64 162.84 12.6 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.249 -1.342 . . . . 0.0 113.073 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.27 124.23 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.714 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.39 64.15 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -119.75 158.24 26.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -151.21 148.62 28.45 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.784 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.8 pt-20 -156.52 151.25 25.86 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.111 171.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -73.0 133.32 44.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.389 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -130.35 154.23 47.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -104.87 142.65 34.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.7 p -83.41 179.17 7.74 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -76.05 -17.65 59.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.169 0.509 . . . . 0.0 110.683 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.37 -12.49 49.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.607 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.15 21.73 19.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -95.81 120.59 36.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.02 122.61 33.82 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.153 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.8 142.6 42.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.125 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.5 tt -93.93 114.28 26.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.35 112.95 28.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.9 t -110.35 124.75 67.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.527 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -100.13 107.19 19.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -98.29 148.83 23.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.7 -36.71 65.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -111.15 -38.09 5.14 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.153 0.501 . . . . 0.0 111.082 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -81.97 -3.51 54.55 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.321 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.74 -178.67 47.95 Favored Glycine 0 CA--C 1.51 -0.281 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.671 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -78.2 129.55 37.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -129.32 141.77 51.0 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.52 115.1 20.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.765 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 47.7 p90 -143.62 157.32 44.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -50.25 138.03 17.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -106.86 -78.17 0.59 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.584 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.6 tpt 53.26 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.478 ' SG ' ' HG ' ' A' ' 52' ' ' LEU . 69.2 m 55.49 84.77 0.2 Allowed Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 121.119 0.485 . . . . 0.0 112.237 -168.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -90.87 21.13 0.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.93 1.753 . . . . 0.0 110.867 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -103.68 -78.6 0.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.05 -39.29 7.36 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 69.42 -89.42 0.03 OUTLIER 'General case' 0 C--O 1.243 0.745 0 O-C-N 124.465 1.103 . . . . 0.0 112.918 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.0 mt 58.24 -81.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 124.799 1.24 . . . . 0.0 109.212 -171.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -167.03 92.06 0.42 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 128.158 2.583 . . . . 0.0 104.306 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -67.21 -21.82 65.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.419 0.628 . . . . 0.0 111.828 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.59 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 10.6 p -75.58 -10.67 59.64 Favored 'General case' 0 N--CA 1.414 -2.225 0 C-N-CA 124.805 1.242 . . . . 0.0 111.434 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -94.78 11.0 33.0 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.48 -128.18 1.39 Allowed Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.938 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -150.85 156.99 42.36 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.932 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -130.37 128.99 42.52 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.756 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -115.65 158.13 23.19 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.84 -30.31 21.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.119 0.407 . . . . 0.0 114.119 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.57 -4.08 5.86 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.163 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 61.7 t -124.04 125.0 70.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-N 117.343 0.572 . . . . 0.0 110.717 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 46.6 mt -103.17 136.09 37.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 69' ' ' TRP . 99.3 m -117.51 116.02 26.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.31 144.49 57.11 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -50.98 -55.23 18.34 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.815 0.697 . . . . 0.0 109.639 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.6 91.66 2.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.274 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -167.94 -76.37 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 69' ' ' TRP . 5.2 tt -144.56 143.63 30.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.47 ' HA ' HG23 ' A' ' 63' ' ' THR . 40.8 p90 -89.82 -19.57 24.51 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -169.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.2 p -103.93 126.32 50.97 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.719 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 90.7 t80 -138.71 144.73 39.67 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -99.08 104.81 16.85 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 118.466 0.575 . . . . 0.0 111.146 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.38 -39.54 94.81 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.378 0.671 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.4 94.42 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.731 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 m -80.11 -35.41 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.864 0.364 . . . . 0.0 111.32 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.61 3.61 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 85' ' ' CYS . 14.8 t-80 -92.71 132.53 36.84 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 173.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.69 146.41 22.34 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.98 -36.26 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 47.7 t30 -164.24 110.79 0.9 Allowed Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.38 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 2.5 Cg_endo -87.97 172.11 32.48 Favored 'Cis proline' 0 CA--C 1.554 1.502 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.222 1.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.92 -11.39 28.73 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.29 12.92 34.87 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.987 0.898 . . . . 0.0 110.881 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.586 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 77.7 m -112.81 9.46 19.02 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.231 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 57.5 m -58.3 156.3 10.23 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.678 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 2.8 pp -117.85 169.09 9.9 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.207 -174.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 108' ' ' ASN . . . -130.88 122.18 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.89 127.36 32.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.172 0.51 . . . . 0.0 112.015 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.9 143.45 26.74 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.394 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.78 127.64 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.183 1.922 . . . . 0.0 110.53 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.78 143.74 39.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.04 138.08 52.43 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 120.938 0.399 . . . . 0.0 110.551 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.38 126.25 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.287 1.041 . . . . 0.0 111.474 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -119.52 146.92 45.03 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.41 100.66 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' A' ' 8' ' ' SER . 38.1 t70 84.86 -33.46 0.06 Allowed 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 126.797 2.039 . . . . 0.0 114.476 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -99.37 131.2 45.55 Favored 'General case' 0 C--N 1.282 -2.353 0 O-C-N 120.639 -1.288 . . . . 0.0 111.206 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.15 123.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.837 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -112.74 145.61 40.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.985 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.4 144.51 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.4 t -105.1 115.22 29.9 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.4 m -106.44 -33.54 7.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.428 0.633 . . . . 0.0 109.486 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.513 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.3 tpmt? -74.02 107.98 6.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.666 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.29 -4.04 8.9 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.9 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.2 mm -119.17 140.69 42.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.44 120.79 55.29 Favored Pre-proline 0 N--CA 1.42 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.91 133.08 53.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.726 2.284 . . . . 0.0 111.996 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.413 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 51.2 t30 -89.53 176.24 6.97 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.571 -176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.31 104.65 0.52 Allowed 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.198 0.999 . . . . 0.0 111.679 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.318 0 CA-C-N 112.278 -2.237 . . . . 0.0 105.649 -176.47 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.408 ' OG ' ' HE3' ' A' ' 103' ' ' LYS . 31.3 t . . . . . 0 N--CA 1.413 -2.301 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.486 ' H ' ' HA ' ' A' ' 101' ' ' SER . 96.7 m-85 72.46 93.53 0.08 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.425 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 8.4 tp10 -106.81 138.27 43.29 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 4.1 tmmm? -80.94 105.14 11.93 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -85.94 -49.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.826 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.061 -176.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.5 m -145.65 177.58 8.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.709 0.766 . . . . 0.0 111.317 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.7 p -110.56 152.76 26.02 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.051 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.38 -20.04 58.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.014 0.911 . . . . 0.0 109.918 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.35 -20.88 58.77 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.363 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.22 -32.09 12.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.232 0.539 . . . . 0.0 110.556 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 16' ' ' GLU . 3.2 tp -124.11 111.87 30.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.921 0.867 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -105.06 163.96 12.17 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.406 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.57 124.98 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.422 0.63 . . . . 0.0 111.32 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.37 59.8 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.542 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' HB3' HD12 ' A' ' 12' ' ' ILE . 8.8 tp10 -103.76 152.16 22.18 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.75 139.1 20.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 120.883 0.373 . . . . 0.0 110.156 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.0 tt0 -158.05 155.22 28.91 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.2 t -89.16 132.61 34.75 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.027 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.34 151.7 42.22 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.05 133.78 47.59 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -83.01 178.79 7.99 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -69.11 -21.53 64.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.463 0.649 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.94 -13.36 58.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.696 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.01 23.06 33.61 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -92.85 115.6 28.26 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.99 123.75 34.16 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 40' ' ' ALA . 46.6 t -130.64 144.53 37.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.503 ' N ' ' HB2' ' A' ' 43' ' ' ALA . 62.2 tp -88.32 111.86 22.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.09 118.65 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.36 125.19 74.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.849 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 46.6 t-20 -92.32 106.99 18.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.0 m -99.02 152.96 19.24 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.8 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.51 -50.28 16.15 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.07 -22.19 18.67 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -99.23 -4.27 32.38 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.128 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.89 -170.67 51.42 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.908 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 46.2 t -80.55 120.74 32.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.06 150.74 50.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.147 0.498 . . . . 0.0 110.802 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -124.74 131.69 53.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 59.8 m-85 -130.21 162.21 29.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 119.562 -0.256 . . . . 0.0 110.478 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.549 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -50.18 136.31 19.73 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -118.05 -11.51 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.469 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 47.3 tpp -69.2 108.91 3.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 47' ' ' HIS . 17.4 t -108.69 107.27 59.95 Favored Pre-proline 0 N--CA 1.413 -2.29 0 CA-C-O 121.233 0.54 . . . . 0.0 111.452 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -96.87 17.08 0.65 Allowed 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.677 2.251 . . . . 0.0 109.422 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.582 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 16.5 t-160 -94.71 -38.9 10.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.44 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 178.57 110.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.28 1.832 . . . . 0.0 107.704 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -155.94 134.71 11.86 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.127 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -114.57 -63.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 162.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.47 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 68.9 mt -154.06 110.82 3.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 165.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -68.59 -25.35 64.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.918 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 47.7 p -62.57 -19.65 63.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -170.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp0 -84.88 -9.16 58.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.105 0.479 . . . . 0.0 110.818 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.57 81.07 0.27 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 63' ' ' THR . 66.9 m -143.26 -33.76 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -129.0 113.49 15.23 Favored 'General case' 0 C--N 1.264 -3.114 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.348 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -116.97 112.26 20.75 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.227 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 -73.8 1.04 Allowed Glycine 0 CA--C 1.5 -0.871 0 O-C-N 123.582 0.551 . . . . 0.0 111.938 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.26 13.64 0.15 Allowed Glycine 0 C--N 1.298 -1.56 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.74 143.6 23.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 O-C-N 122.531 -0.394 . . . . 0.0 110.273 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' SER . 48.4 mm -89.92 133.41 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.634 0.73 . . . . 0.0 111.934 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' A' ' 56' ' ' SER . 32.4 m -128.29 152.27 48.32 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 124.327 1.051 . . . . 0.0 108.253 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.1 t -119.82 89.03 3.05 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.453 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HA ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 tpm_? 54.64 21.31 3.36 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.093 0.957 . . . . 0.0 111.001 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.8 100.18 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 111.894 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.407 ' O ' ' HB2' ' A' ' 68' ' ' LEU 0.271 1.5 p-80 -107.69 -13.06 15.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 1.7 tm? 171.36 -63.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 28.7 t-105 -141.05 -155.57 0.6 Allowed 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.507 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 28.3 p -101.3 163.54 12.23 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -171.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -110.49 148.05 32.87 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -111.56 108.07 17.45 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -76.8 -29.79 56.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.983 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.04 73.22 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.9 m -90.52 -52.0 5.12 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.18 -42.16 1.46 Allowed Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.386 -0.912 . . . . 0.0 112.398 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -87.94 158.81 18.57 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 120.828 0.347 . . . . 0.0 110.611 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.75 157.26 52.23 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.874 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 70' ' ' THR . 69.5 mt -84.6 -51.42 13.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 117.635 0.718 . . . . 0.0 109.478 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 63.7 t30 -160.73 108.47 1.31 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.122 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.57 -174.86 15.08 Favored 'Cis proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.539 -1.859 . . . . 0.0 110.278 -3.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.82 -43.57 58.37 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . 0.326 4.4 p30 38.76 31.53 0.04 OUTLIER 'General case' 0 C--N 1.369 1.424 0 C-N-CA 127.106 2.162 . . . . 0.0 113.828 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 64.5 m 79.13 148.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.654 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.7 p -72.9 172.68 10.43 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.224 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 pp -96.86 -171.1 2.17 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.633 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -130.18 119.24 22.64 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.27 134.02 38.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.005 0.431 . . . . 0.0 110.941 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 12.0 m-85 -102.9 145.67 31.0 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 123.616 0.766 . . . . 0.0 109.535 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.99 120.29 6.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.51 2.14 . . . . 0.0 110.413 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.01 141.0 42.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.53 137.57 53.94 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.83 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.518 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -125.22 99.13 5.94 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.37 5.47 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.674 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.19 -10.05 34.35 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.216 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -109.68 143.13 39.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 59.5 mt -122.37 120.47 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.953 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 26.9 m-85 -113.58 149.47 34.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.249 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 7.4 p -135.45 138.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.486 ' HA ' ' H ' ' A' ' 3' ' ' PHE . 35.3 t -97.99 133.58 42.27 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.826 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -122.3 16.37 10.6 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.157 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HE3' ' OG ' ' A' ' 2' ' ' SER . 37.7 ttmt -58.47 -76.31 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.748 0.785 . . . . 0.0 112.839 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.42 20.79 45.39 Favored Glycine 0 C--N 1.263 -3.528 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.04 120.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.502 0.668 . . . . 0.0 111.693 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 tp -110.07 124.01 34.58 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -65.67 137.75 51.21 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -80.03 175.78 10.33 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HB2' ' HZ3' ' A' ' 109' ' ' LYS . 4.7 ttmp? -57.15 138.55 54.42 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 p . . . . . 0 N--CA 1.429 -1.525 0 CA-C-O 121.327 0.584 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 99.4 m-85 -90.81 125.47 35.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.889 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -112.72 144.98 41.32 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 37.5 ttpt -87.07 128.08 35.11 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.842 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.485 HG12 ' CD1' ' A' ' 20' ' ' PHE . 6.5 tp -115.16 -45.05 4.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.227 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.7 p -139.71 -173.47 3.64 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.573 0.701 . . . . 0.0 111.915 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -129.61 150.12 51.08 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.558 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -72.61 -22.91 60.89 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.72 -21.76 65.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.457 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.59 -49.97 5.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.193 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.4 pt -110.85 116.88 53.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-O 122.135 0.969 . . . . 0.0 111.107 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -90.36 169.24 11.25 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.758 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.19 117.79 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.353 0.597 . . . . 0.0 110.844 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.46 62.15 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -103.1 140.47 37.28 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.281 0.632 . . . . 0.0 110.188 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.413 ' SD ' HD23 ' A' ' 29' ' ' LEU . 26.9 ptt? -151.03 156.3 40.82 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.874 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -157.5 156.58 32.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.593 0.558 . . . . 0.0 109.517 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.2 t -88.87 137.09 32.63 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 121.218 0.532 . . . . 0.0 110.051 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.485 ' CD1' HG12 ' A' ' 6' ' ' ILE . 52.4 p90 -119.94 156.41 30.86 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 22' ' ' THR . 44.7 tt0 -100.35 135.31 41.98 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 77.7 p -82.58 171.29 14.23 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -73.36 -15.49 61.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.68 0.752 . . . . 0.0 109.252 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -84.55 -12.59 53.83 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.6 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.99 36.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.827 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 84.8 m -97.08 137.43 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.142 -0.622 . . . . 0.0 111.989 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -88.85 126.55 35.41 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.499 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 19' ' ' THR . 60.6 t -130.25 137.7 55.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.186 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.413 HD23 ' SD ' ' A' ' 17' ' ' MET . 45.5 tp -87.28 114.65 24.08 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.409 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 10.0 tp -97.74 112.7 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 8.2 p -114.12 127.9 71.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.5 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.443 ' ND2' ' HG ' ' A' ' 9' ' ' LEU . 51.2 t-20 -95.45 104.15 16.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 36' ' ' HIS . 21.5 m -102.77 150.79 23.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.197 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -76.46 -50.27 14.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.242 0.544 . . . . 0.0 110.591 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.68 -46.7 16.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.921 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.425 ' HB2' ' CB ' ' A' ' 33' ' ' SER . 50.8 m80 -79.11 -21.19 47.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.923 0.392 . . . . 0.0 111.185 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.72 -168.68 47.88 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 45.7 t -81.49 120.02 32.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.722 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -118.63 149.33 41.56 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.602 0.761 . . . . 0.0 111.201 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.91 112.69 16.91 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.458 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 88' ' ' GLU . 49.7 m-85 -125.57 159.84 31.08 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.422 ' O ' HD13 ' A' ' 86' ' ' LEU . 35.4 tt0 -53.77 138.33 35.87 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.92 -12.39 59.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -167.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.409 ' HB3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.8 166.79 31.15 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.152 -1.419 . . . . 0.0 114.086 -175.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.9 m -88.79 166.52 22.06 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.07 31.41 0.52 Allowed 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 121.73 1.62 . . . . 0.0 112.723 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.491 ' CE1' ' HG3' ' A' ' 81' ' ' PRO . 14.1 m170 -120.34 -75.34 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.191 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.455 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 15.5 mm100 -93.96 -177.62 4.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 0.0 112.622 -174.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.32 163.24 28.04 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.114 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 44' ' ' MET . 29.8 mt -74.94 87.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.44 0.638 . . . . 0.0 110.438 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 85.0 mt -106.39 1.49 25.73 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.516 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.8 tt -76.23 -41.72 48.32 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.925 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -67.75 -7.39 26.92 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.48 -9.19 50.99 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.24 115.37 1.33 Allowed Glycine 0 CA--C 1.495 -1.167 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 63' ' ' THR . 72.0 m -161.41 -25.02 0.05 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.907 0.861 . . . . 0.0 110.867 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 94.5 t80 -89.05 115.53 26.66 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.181 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -116.15 104.5 11.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.681 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.91 -72.85 0.53 Allowed Glycine 0 C--N 1.316 -0.53 0 O-C-N 123.899 0.749 . . . . 0.0 113.504 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.16 17.43 1.18 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 62.9 t -123.11 132.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -98.1 129.17 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 36.3 m -106.74 151.79 24.67 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' A' ' 66' ' ' ALA . 8.0 t -75.15 -40.31 59.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.22 172.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.46 ' H ' HG23 ' A' ' 63' ' ' THR . 1.1 tmt_? 75.93 -21.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.495 1.118 . . . . 0.0 110.939 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . -96.56 -23.45 16.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.927 173.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.455 ' CE1' ' HG2' ' A' ' 48' ' ' GLN . 22.3 m170 -146.88 152.46 38.74 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.305 0.642 . . . . 0.0 112.069 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 69' ' ' TRP 0.278 2.2 tm? 36.94 -107.21 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.85 2.46 . . . . 0.0 113.602 175.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 63' ' ' THR . 94.9 m95 -163.7 -51.36 0.03 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.6 p -107.71 130.64 54.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -160.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -134.1 137.49 44.63 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -122.98 114.84 20.96 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.961 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.64 -29.67 70.28 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.11 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.91 -3.6 74.74 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.894 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.4 m -124.22 1.26 8.47 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.666 0.746 . . . . 0.0 109.66 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -49.06 1.08 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.536 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 25.8 p80 -88.84 160.91 17.01 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.219 0.533 . . . . 0.0 111.719 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.13 169.99 35.49 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.923 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.61 -31.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 3.2 p-10 -127.27 101.92 24.5 Favored Pre-proline 0 N--CA 1.42 -1.939 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.883 173.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.508 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 22.7 Cg_endo -89.62 155.23 31.62 Favored 'Cis proline' 0 C--N 1.362 1.282 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.864 -4.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.9 p-10 -74.4 -19.26 60.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.83 -22.07 24.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.248 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.508 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 65.3 m -95.82 150.91 19.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-O 121.79 0.805 . . . . 0.0 110.577 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 77' ' ' HIS . 17.6 p -142.08 167.85 21.14 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.941 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 42' ' ' GLN . 81.2 mt -120.98 129.18 53.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.87 136.51 32.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -104.42 158.52 16.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.277 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.438 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 19.1 p90 -135.39 157.73 75.95 Favored Pre-proline 0 C--N 1.273 -2.751 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.508 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 89' ' ' TYR . 37.5 Cg_endo -61.27 138.58 78.11 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 122.545 2.163 . . . . 0.0 114.03 -174.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.14 128.99 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.54 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -109.98 131.66 54.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.99 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.1 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -122.75 91.34 3.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.95 -112.11 4.68 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.573 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.26 -5.44 33.13 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.714 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -103.21 137.05 41.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -127.61 123.4 61.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 5.0 m-85 -112.01 142.08 44.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.834 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.96 154.71 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 89' ' ' TYR . 28.3 t -127.9 114.6 17.39 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.345 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -108.76 -8.05 15.44 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.63 102.51 5.36 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.72 -29.28 4.99 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.6 mt -120.63 108.35 22.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.447 0.641 . . . . 0.0 110.319 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -89.08 147.92 39.73 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.78 140.96 43.87 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.059 1.84 . . . . 0.0 112.298 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -88.31 133.05 34.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.3 -176.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.405 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 125.255 1.422 . . . . 0.0 113.069 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 p . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 73.54 108.21 0.07 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 -168.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -106.57 137.36 44.72 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -73.84 121.32 20.71 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.876 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tp -97.51 -48.52 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.357 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.7 m -159.23 -174.55 4.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.386 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -129.77 152.67 49.01 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 12' ' ' ILE . 27.5 tp -56.66 -21.22 25.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.184 1.393 . . . . 0.0 110.624 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.76 -30.97 71.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.261 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -100.18 -40.87 7.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.388 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.476 ' O ' HD13 ' A' ' 9' ' ' LEU . 3.4 tp -104.96 115.43 46.83 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-O 121.533 0.682 . . . . 0.0 110.934 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -102.99 164.75 11.43 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.469 -172.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.67 127.57 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.491 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.64 -0.81 68.1 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.92 154.13 29.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -146.15 131.06 18.14 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.727 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 44.1 mt-10 -144.22 150.52 38.09 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 93.7 m -74.42 130.97 40.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.993 0.425 . . . . 0.0 111.124 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -140.71 149.8 42.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.25 146.88 34.87 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.642 0.258 . . . . 0.0 110.359 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -83.72 165.29 19.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.9 m -65.59 -14.03 60.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.89 -12.48 41.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.444 0.64 . . . . 0.0 110.137 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.75 23.41 13.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.902 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -97.09 127.92 43.53 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -88.07 123.28 32.6 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.09 143.75 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.378 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 60.0 tp -93.01 112.86 24.96 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' MET . 49.6 mm -94.73 112.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.66 124.75 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 54.0 t30 -103.83 104.93 14.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 14.0 m -83.77 143.21 30.13 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.454 -172.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -47.08 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -83.14 -44.13 15.42 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -101.88 2.92 38.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 86.73 -176.95 48.09 Favored Glycine 0 C--O 1.201 -1.937 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.931 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 9.3 p -72.39 134.65 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 118.274 1.037 . . . . 0.0 111.553 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -125.7 139.01 53.9 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.774 0.83 . . . . 0.0 110.501 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.06 115.25 20.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' OH ' HG12 ' A' ' 62' ' ' ILE . 18.6 p90 -143.27 165.11 28.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.082 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -41.19 137.4 1.37 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.756 0.66 . . . . 0.0 111.818 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -71.29 -46.77 60.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.287 0.565 . . . . 0.0 112.524 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 69.8 mtm -94.25 147.07 23.55 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.17 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.439 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 28.9 p -94.82 161.87 27.18 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.777 0.673 . . . . 0.0 111.258 -175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 57.0 Cg_endo -71.2 -4.75 15.54 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.499 2.132 . . . . 0.0 111.914 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -88.74 -96.9 0.09 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -179.3 104.59 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 117.911 0.323 . . . . 0.0 110.579 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 6.5 tp10 -171.97 145.8 1.9 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 111.375 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.8 pt -118.58 141.67 37.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 tp 65.77 24.03 11.45 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.672 1.225 . . . . 0.0 109.129 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' H ' HD21 ' A' ' 52' ' ' LEU . 2.2 pt? -62.04 -20.54 64.06 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.141 -1.391 . . . . 0.0 111.289 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 36.0 p -56.92 -32.53 66.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 125.965 1.706 . . . . 0.0 113.832 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -100.66 23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.989 -0.445 . . . . 0.0 110.962 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.75 -83.61 0.04 OUTLIER Glycine 0 C--N 1.346 1.113 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.421 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 19.0 p -173.49 146.89 1.4 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -129.75 115.62 17.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.98 105.8 12.72 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.489 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.89 0.44 Allowed Glycine 0 N--CA 1.462 0.429 0 O-C-N 123.489 0.493 . . . . 0.0 114.206 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' A' ' 73' ' ' ASP . . . -153.21 17.95 0.7 Allowed Glycine 0 C--N 1.301 -1.366 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.1 t -125.12 124.92 68.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.789 0.436 . . . . 0.0 110.05 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.403 HG12 ' OH ' ' A' ' 41' ' ' TYR . 2.0 pp -92.76 140.26 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.421 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 89.9 m -116.44 127.05 54.25 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.19 156.31 39.71 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' O ' ' HD3' ' A' ' 65' ' ' ARG . 1.8 tmt_? -73.34 -33.08 64.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.783 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.473 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . . . -83.08 -72.32 0.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.308 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.484 ' CD2' ' HB2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -82.66 110.26 17.56 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.132 175.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.08 84.83 7.57 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.356 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.484 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 86.9 m95 -144.3 -166.55 2.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 p -101.66 136.65 41.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 121.955 0.883 . . . . 0.0 112.268 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 47.4 t80 -134.06 143.19 47.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.99 111.87 19.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.348 0.594 . . . . 0.0 111.33 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.552 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 16.3 t70 -71.41 -11.81 61.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.418 1.487 . . . . 0.0 112.012 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.51 -33.76 6.06 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.717 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.6 p -107.24 -26.14 11.19 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.436 0.618 . . . . 0.0 112.638 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.87 65.32 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -106.76 146.39 30.91 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -76.64 153.25 42.17 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.517 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.95 -49.25 12.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -146.55 111.71 4.26 Favored Pre-proline 0 N--CA 1.436 -1.153 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.415 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.74 141.61 64.64 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.962 -1.683 . . . . 0.0 111.004 -1.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.1 p30 -74.66 -12.48 60.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.407 0.622 . . . . 0.0 109.627 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.87 -28.53 68.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.736 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 36.9 m -92.72 152.15 19.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-O 121.563 0.696 . . . . 0.0 111.002 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.454 ' C ' HD12 ' A' ' 86' ' ' LEU . 5.9 p -163.27 156.13 18.75 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.045 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.466 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 7.3 mp -129.45 135.16 48.31 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.289 1.436 . . . . 0.0 107.868 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.9 123.92 29.85 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.726 0.411 . . . . 0.0 109.972 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -86.64 143.94 27.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.086 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 101' ' ' SER . 46.2 m-85 -102.37 143.32 26.37 Favored Pre-proline 0 N--CA 1.428 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.04 123.01 12.56 Favored 'Trans proline' 0 C--O 1.253 1.242 0 C-N-CA 122.329 2.019 . . . . 0.0 110.264 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.87 132.96 70.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -112.57 117.21 31.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.447 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.56 107.56 23.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 122.026 0.917 . . . . 0.0 109.69 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.559 ' HZ2' ' HB3' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -127.69 118.16 23.3 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.43 -119.93 9.75 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.96 -4.45 16.71 Favored 'General case' 0 C--O 1.17 -3.086 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.559 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 17.0 t70 -100.03 139.28 35.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.697 -0.627 . . . . 0.0 110.089 -170.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.2 mt -127.63 119.12 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -102.72 146.23 28.52 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.71 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.63 137.23 54.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 20.4 t -107.35 113.26 26.52 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.446 -1.702 . . . . 0.0 109.296 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.4 p -95.96 -36.43 11.07 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.93 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -66.3 113.26 4.47 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.112 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.26 -36.14 2.78 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 105' ' ' ILE . 2.7 mp -100.89 120.82 50.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 tt -79.92 124.1 83.35 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.96 145.58 40.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.006 2.471 . . . . 0.0 111.994 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -80.43 177.61 8.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.69 -11.89 2.5 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.464 ' CB ' ' HG ' ' A' ' 86' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.472 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.996 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 67.22 100.25 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.464 -169.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -106.9 130.53 54.55 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.815 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -70.17 115.64 9.6 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.62 -59.59 3.06 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.194 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.6 m -152.21 -177.29 6.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.353 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 8.7 p -101.02 153.52 19.47 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.588 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.43 -17.52 21.33 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.847 0.832 . . . . 0.0 110.673 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.4 -10.84 58.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.583 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -97.7 -41.46 8.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.687 -0.633 . . . . 0.0 109.358 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.3 tp -109.95 114.13 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.415 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -101.05 166.96 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.503 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.44 128.83 35.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.496 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.89 66.7 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -103.87 144.14 31.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.172 -0.514 . . . . 0.0 110.127 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.4 134.0 39.24 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.573 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 9.2 pt-20 -157.63 156.21 31.41 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 15.1 t -90.51 137.7 32.14 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 77.3 m-85 -126.41 155.94 41.37 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -113.95 141.49 47.32 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -83.18 172.76 12.3 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -68.86 -20.17 64.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.131 0.491 . . . . 0.0 110.424 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.97 -12.25 55.6 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 109.526 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.95 14.82 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.109 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.5 m -92.19 124.31 36.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.77 128.97 35.64 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' THR . 40.0 t -133.03 141.2 45.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 53' ' ' SER . 0.7 OUTLIER -94.18 116.43 28.83 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -177.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.58 122.83 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 122.327 0.251 . . . . 0.0 110.355 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.99 123.61 70.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 50.7 t30 -103.12 106.41 16.92 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.837 173.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -98.81 148.67 23.67 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.511 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.95 -48.85 77.1 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 122.957 0.503 . . . . 0.0 111.8 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.26 -40.33 8.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.95 0.405 . . . . 0.0 111.979 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -79.69 -11.42 59.85 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -167.33 42.47 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.042 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 6.7 p -99.05 118.05 45.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.535 0.683 . . . . 0.0 109.333 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -131.98 151.16 51.9 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.162 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.05 143.27 45.7 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.569 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 63.9 m-85 -133.28 157.6 45.04 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -59.11 139.22 57.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.187 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.21 -7.29 58.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.336 0.589 . . . . 0.0 110.252 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -92.79 99.76 12.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.618 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.528 ' C ' ' H ' ' A' ' 47' ' ' HIS . 59.0 m -76.71 158.8 80.33 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.92 20.78 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.718 1.612 . . . . 0.0 108.883 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.61 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 36.9 m80 -120.1 -175.12 2.92 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.778 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -65.98 103.72 0.99 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.265 0.353 . . . . 0.0 111.039 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.73 156.6 22.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.633 0.73 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.586 HG13 ' H ' ' A' ' 51' ' ' LEU . 9.8 tp -179.99 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 -174.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.586 ' H ' HG13 ' A' ' 50' ' ' ILE . 2.9 mm? -78.01 91.68 4.27 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 121.118 1.781 . . . . 0.0 109.738 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.575 HD21 ' O ' ' A' ' 50' ' ' ILE . 2.0 mm? -73.36 -20.98 60.64 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.776 1.274 . . . . 0.0 108.156 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.573 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 60.0 p -63.4 -19.49 64.72 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.921 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.62 12.24 36.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.742 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 -108.41 0.03 OUTLIER Glycine 0 C--O 1.241 0.566 0 O-C-N 123.324 0.39 . . . . 0.0 113.033 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.3 t -146.14 154.07 41.39 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.915 0.864 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -128.78 114.63 16.81 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.153 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 42.4 mt-10 -118.14 169.9 9.31 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.27 74.39 0.14 Allowed Glycine 0 C--N 1.309 -0.932 0 O-C-N 123.309 0.381 . . . . 0.0 113.799 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.18 38.68 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.7 t -123.96 119.27 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.526 ' HB ' ' CZ ' ' A' ' 71' ' ' PHE . 42.6 mm -112.58 138.26 42.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.4 m -118.08 115.72 25.41 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -72.71 0.41 Allowed 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.887 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -149.02 -63.42 0.23 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.597 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.36 27.96 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 13.5 p-80 162.32 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.931 2.092 . . . . 0.0 107.575 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.6 tp 172.59 -71.7 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.569 1.548 . . . . 0.0 108.983 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -176.92 -49.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.059 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p -103.53 136.48 43.17 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -169.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.526 ' CZ ' ' HB ' ' A' ' 62' ' ' ILE . 22.5 p90 -135.16 142.7 46.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 159.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -86.84 122.87 31.32 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.322 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.25 -38.41 90.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.793 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.18 26.58 3.83 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.002 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -155.33 -51.28 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.819 0.31 . . . . 0.0 110.816 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.64 40.05 Favored Glycine 0 C--O 1.218 -0.844 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -85.75 139.16 31.57 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 108.887 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.53 140.34 35.02 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.416 ' H ' ' HA ' ' A' ' 71' ' ' PHE . 60.0 mt -81.16 -51.65 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -150.23 113.88 3.32 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -81.3 179.25 28.66 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.858 -1.726 . . . . 0.0 111.412 -3.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -95.93 12.23 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.4 ' O ' ' HE3' ' A' ' 109' ' ' LYS . 34.8 t70 -67.73 -14.66 63.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.397 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.41 ' C ' ' HG ' ' A' ' 85' ' ' CYS . 23.6 p -136.89 152.21 49.97 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.543 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.41 ' HG ' ' C ' ' A' ' 84' ' ' CYS . 31.1 m -152.17 146.11 25.22 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 mp -102.79 153.67 19.94 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-O 120.984 0.421 . . . . 0.0 110.784 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -88.19 119.54 28.69 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.738 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.48 129.98 34.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.732 0.645 . . . . 0.0 109.537 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.11 136.25 20.12 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.37 124.3 11.5 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.548 2.165 . . . . 0.0 112.304 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.86 138.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.58 135.82 54.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.416 ' C ' ' HE2' ' A' ' 94' ' ' LYS . 58.7 t -106.21 122.52 60.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -167.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HD3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -111.36 146.35 37.28 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 173.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.71 -35.6 17.16 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 115.61 1.004 . . . . 0.0 115.61 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' SER . 25.4 t70 -113.7 -22.7 10.1 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.778 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -114.87 147.65 39.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.136 0.969 . . . . 0.0 113.422 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.71 118.16 54.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.788 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.616 ' CD1' ' HD3' ' A' ' 94' ' ' LYS . 4.5 m-85 -112.2 144.11 42.14 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.96 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.78 141.31 39.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 t -104.15 128.17 51.8 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.518 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.2 p -120.56 5.55 10.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -74.99 118.39 17.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.734 -174.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.03 16.09 79.64 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.142 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.26 119.51 57.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.255 0.55 . . . . 0.0 110.957 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.88 142.68 36.82 Favored Pre-proline 0 N--CA 1.411 -2.387 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.363 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.38 150.08 88.93 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.468 2.112 . . . . 0.0 111.166 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.591 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 34.9 t-20 -81.41 -179.77 7.51 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 83' ' ' ASP . 39.2 ttpt -62.42 93.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.41 1.1 . . . . 0.0 111.521 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.267 -3.019 0 C-N-CA 128.274 2.63 . . . . 0.0 104.471 -174.749 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.427 -1.588 0 CA-C-O 121.126 0.489 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -156.95 97.81 1.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 125.979 1.712 . . . . 0.0 107.252 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.87 133.47 52.18 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.41 127.39 32.11 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.22 -40.94 5.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.721 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.9 p -160.34 -170.88 2.96 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.768 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 7.2 m -120.15 153.07 36.74 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.348 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -61.58 -21.4 64.28 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.846 0.831 . . . . 0.0 108.924 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.86 -29.63 69.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.266 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.96 -47.55 65.35 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.607 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.83 112.27 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.734 1.254 . . . . 0.0 113.529 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -79.16 170.54 16.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.786 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.34 118.79 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 CA-C-O 121.602 0.715 . . . . 0.0 110.451 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.97 56.9 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.682 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -103.22 150.45 23.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.8 ptt? -150.12 137.92 20.06 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 34.7 mt-10 -144.2 155.11 43.75 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 m -91.42 123.97 35.25 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.01 154.32 34.72 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -113.54 137.35 51.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -83.0 173.3 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 m -71.94 -9.35 58.23 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.159 0.505 . . . . 0.0 111.669 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.74 -4.74 46.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.36 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.17 44.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.628 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.9 m -89.86 114.79 26.61 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -91.58 123.83 35.28 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -136.49 142.49 38.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.027 -172.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.459 ' N ' ' HB2' ' A' ' 43' ' ' ALA . 32.9 tp -83.61 117.62 23.28 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -107.87 113.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.87 137.31 43.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.711 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -109.97 107.8 17.82 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.3 t -99.2 148.51 24.03 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.031 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -36.16 62.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.24 -46.75 6.62 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.793 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -88.51 -7.01 57.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.73 -164.9 52.22 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.202 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.8 t -82.82 128.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -127.9 141.52 51.53 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.483 0.713 . . . . 0.0 111.197 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.07 121.26 33.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CD1' HD21 ' A' ' 86' ' ' LEU . 53.6 m-85 -133.04 152.1 51.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -48.96 138.06 12.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -141.17 19.12 2.26 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -172.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 86.3 mtp -68.97 -30.56 69.01 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.811 ' SG ' ' N ' ' A' ' 65' ' ' ARG . 3.5 t -76.48 124.09 87.88 Favored Pre-proline 0 CA--C 1.619 3.603 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.662 ' C ' ' HA ' ' A' ' 65' ' ' ARG . 12.6 Cg_endo -108.71 104.83 0.02 OUTLIER 'Trans proline' 2 C--N 1.421 4.375 0 C-N-CA 123.922 3.081 . . . . 0.0 113.145 163.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.86 ' CE1' ' H ' ' A' ' 67' ' ' HIS . 6.4 t60 -81.26 -25.8 36.3 Favored 'General case' 0 N--CA 1.523 3.212 0 O-C-N 121.363 -0.835 . . . . 0.0 109.882 -173.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -105.32 111.94 24.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.306 10.9 pt-20 -74.14 83.46 1.82 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.791 1.282 . . . . 0.0 114.256 -174.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.563 HG12 ' H ' ' A' ' 51' ' ' LEU . 15.1 tt -152.74 -159.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 102.388 -3.189 . . . . 0.0 102.388 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.563 ' H ' HG12 ' A' ' 50' ' ' ILE . 84.9 mt -64.06 122.55 16.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 120.752 1.615 . . . . 0.0 109.301 175.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 43' ' ' ALA . 1.4 pt? -56.0 -44.76 78.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.409 1.084 . . . . 0.0 113.713 -172.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 38.2 p -63.54 -24.26 67.73 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.422 0.689 . . . . 0.0 112.516 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -84.31 3.16 36.89 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -139.85 36.64 1.8 Allowed Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.737 -1.22 . . . . 0.0 113.066 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.3 m -107.14 -80.39 0.57 Allowed 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.351 0.596 . . . . 0.0 111.425 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.557 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 80.7 t80 -90.39 112.73 24.44 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-O 121.84 0.829 . . . . 0.0 110.684 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.51 105.41 11.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.524 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.08 -77.28 0.56 Allowed Glycine 0 N--CA 1.45 -0.395 0 O-C-N 123.384 0.427 . . . . 0.0 112.424 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.22 6.56 0.82 Allowed Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.66 135.16 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 69.1 mt -105.68 129.95 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 121.347 0.594 . . . . 0.0 109.763 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 9.1 m -111.2 152.5 27.01 Favored 'General case' 0 N--CA 1.38 -3.951 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 1.555 ' CA ' ' CB ' ' A' ' 64' ' ' CYS 0.473 15.0 p -118.32 -112.49 0.34 Allowed 'General case' 2 CA--C 1.789 10.154 0 C-N-CA 128.179 2.591 . . . . 0.0 106.829 179.1 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.857 ' HA ' ' N ' ' A' ' 47' ' ' HIS . 37.2 ttm105 -122.29 -161.89 0.96 Allowed 'General case' 3 N--CA 1.652 9.667 1 C-N-CA 137.532 6.333 . . . . 0.0 107.513 170.359 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.638 ' H ' ' HG2' ' A' ' 65' ' ' ARG . . . -55.95 100.38 0.04 OUTLIER 'General case' 2 N--CA 1.557 4.891 1 N-CA-C 122.168 4.136 . . . . 0.0 122.168 -166.922 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.86 ' H ' ' CE1' ' A' ' 47' ' ' HIS 0.373 53.7 m80 -96.1 -170.47 2.12 Favored 'General case' 1 N--CA 1.543 4.186 0 C-N-CA 129.863 3.265 . . . . 0.0 106.597 170.21 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -145.06 8.94 1.25 Allowed 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.66 ' H ' ' HB3' ' A' ' 67' ' ' HIS . 28.8 m-90 -146.32 -159.96 1.09 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.7 2.0 . . . . 0.0 107.822 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -124.26 161.98 24.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.477 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 11.8 t80 -119.48 142.47 48.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -119.33 140.61 50.04 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.656 -1.218 . . . . 0.0 114.214 -172.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.444 ' HB2' HG13 ' A' ' 62' ' ' ILE . 7.0 t70 -75.28 -53.91 7.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.647 1.179 . . . . 0.0 112.463 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.54 95.73 Favored Glycine 0 CA--C 1.503 -0.658 0 O-C-N 123.702 0.626 . . . . 0.0 112.789 -175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -79.46 -30.86 42.34 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.84 93.37 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 78' ' ' GLY . 12.1 t60 -160.03 150.52 18.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -174.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.448 ' O ' ' HD2' ' A' ' 77' ' ' HIS . . . -77.88 133.75 13.47 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 119.225 -1.465 . . . . 0.0 110.251 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.89 -37.51 54.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -146.81 119.98 4.98 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.87 154.63 54.85 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.62 -1.408 . . . . 0.0 112.895 0.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.12 -15.68 57.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.942 0.877 . . . . 0.0 109.235 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.9 -32.87 61.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.218 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 109' ' ' LYS . 71.9 m -134.4 161.43 35.02 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 122.229 1.014 . . . . 0.0 112.317 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.5 p -138.21 -171.88 3.14 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.597 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.0 pp -97.41 145.71 25.9 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.983 0.42 . . . . 0.0 111.226 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.24 113.74 26.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.43 118.51 22.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 O-C-N 123.452 0.47 . . . . 0.0 109.779 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -90.74 124.47 62.19 Favored Pre-proline 0 C--N 1.278 -2.536 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -60.2 120.05 7.6 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.966 1.778 . . . . 0.0 110.45 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.37 130.31 72.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.411 0.624 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.519 ' HG2' ' HD2' ' A' ' 94' ' ' LYS . 35.7 tt0 -115.42 131.51 56.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.161 -174.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.28 117.34 55.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.001 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.554 ' HE2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -125.96 98.5 5.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.21 -107.07 2.12 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' SER . 31.2 t70 -109.98 -5.24 15.51 Favored 'General case' 0 C--O 1.177 -2.758 0 CA-C-O 121.051 0.453 . . . . 0.0 109.962 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.64 133.18 44.35 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.294 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.7 mt -123.88 119.54 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.875 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.554 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 10.9 m-85 -112.68 144.49 42.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.098 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.55 142.32 39.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.42 0.629 . . . . 0.0 111.098 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.447 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t -106.71 128.97 54.65 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.113 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -120.84 -8.32 9.43 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.252 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -78.01 121.83 24.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.07 -32.52 6.63 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.569 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.4 HD13 ' HD3' ' A' ' 90' ' ' PRO . 73.1 mt -120.14 108.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.504 0.668 . . . . 0.0 109.963 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -94.02 155.06 40.55 Favored Pre-proline 0 N--CA 1.41 -2.459 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.339 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.59 144.1 99.51 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.448 2.098 . . . . 0.0 109.86 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -79.58 166.03 22.32 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 52.8 mtmt -38.04 -51.26 1.38 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.472 1.509 . . . . 0.0 115.073 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.413 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . . . . . . . . 0 C--N 1.285 -2.225 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -175.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' SER . 46.5 t . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -79.89 115.72 19.63 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 170.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.29 144.97 49.68 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -74.08 125.43 28.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.101 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.405 HG21 ' N ' ' A' ' 7' ' ' CYS . 9.2 tp -106.68 -42.25 6.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.488 178.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' N ' HG21 ' A' ' 6' ' ' ILE . 71.3 m -148.08 -179.32 6.83 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.338 -173.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 12' ' ' ILE . 13.2 p -130.69 152.7 49.77 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 125.211 1.405 . . . . 0.0 108.881 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 9' ' ' LEU . 2.8 tm? -56.41 -23.76 40.5 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.12 -30.33 71.4 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.668 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.8 -8.39 13.19 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 8' ' ' SER . 3.7 tp -127.65 110.4 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 0.0 110.081 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.37 164.63 11.57 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.513 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.48 124.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.065 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.09 -8.17 62.83 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -102.81 153.25 20.36 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.447 0.641 . . . . 0.0 111.142 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -149.55 137.72 20.57 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.121 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 20' ' ' PHE . 12.0 pt-20 -157.41 155.36 30.35 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.402 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -93.81 141.36 28.59 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 112.047 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.77 148.75 52.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.491 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.73 139.72 37.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -83.56 168.37 16.46 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 m -70.05 -12.4 61.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.084 0.469 . . . . 0.0 110.845 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -90.22 -2.9 58.09 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.374 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.41 12.91 60.69 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.392 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -87.01 123.34 32.0 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.35 123.6 33.68 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.16 135.64 60.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.446 0.641 . . . . 0.0 110.892 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -89.53 113.97 25.44 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 124.454 1.101 . . . . 0.0 109.277 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.19 113.6 30.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.44 124.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 43.5 t30 -108.17 104.57 14.01 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.766 -1.173 . . . . 0.0 108.323 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 t -101.36 149.26 24.23 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.506 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -77.46 -32.32 54.38 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.292 0.568 . . . . 0.0 109.576 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -93.43 -47.13 7.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.699 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -83.28 -19.96 35.34 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.781 0.324 . . . . 0.0 111.309 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.37 -174.29 48.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -87.52 118.15 32.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.679 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -131.68 157.74 42.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.007 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 89' ' ' TYR . . . -124.7 134.96 52.67 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 73' ' ' ASP . 69.2 m-85 -134.11 163.63 29.14 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 10.2 pt20 -66.57 144.23 56.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.77 8.19 33.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.43 0.633 . . . . 0.0 111.305 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.2 tpp -99.4 143.37 29.74 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.876 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.493 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -116.76 152.73 48.82 Favored Pre-proline 0 N--CA 1.426 -1.663 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.925 177.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.72 -39.39 13.51 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 123.564 2.843 . . . . 0.0 112.558 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.491 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 8.8 m80 -64.77 -86.14 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 168.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -153.22 173.85 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.74 129.82 36.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.402 ' O ' HG12 ' A' ' 50' ' ' ILE . 13.0 tt -156.74 24.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 122.82 1.295 . . . . 0.0 108.714 -174.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt 69.31 84.38 0.15 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 113.524 -1.671 . . . . 0.0 113.687 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.2 mp -70.14 -30.65 67.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.456 1.122 . . . . 0.0 108.26 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 11.6 p -61.41 -29.81 70.17 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.975 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -98.69 2.65 47.34 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 65' ' ' ARG . . . 164.71 91.94 0.08 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 118.297 -1.906 . . . . 0.0 115.241 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -157.27 -62.02 0.09 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.569 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 41.2 t80 -90.48 114.05 26.14 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.39 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -118.41 114.36 22.78 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.465 173.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.03 -70.64 1.21 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.359 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.78 -17.74 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.654 -0.273 . . . . 0.0 112.765 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.66 141.79 15.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 117.072 0.436 . . . . 0.0 109.961 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 57.5 mt -111.3 123.76 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 94.9 m -92.85 143.96 25.76 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 3.7 t -76.29 -85.44 0.05 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 116.2 -2.2 . . . . 0.0 107.74 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 23.9 tpt180 -178.81 -34.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.065 0.848 . . . . 0.0 112.522 164.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.63 -39.62 8.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.491 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 6.6 p-80 -84.92 178.73 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.431 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -53.41 -70.61 0.09 Allowed 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.494 ' O ' ' HA ' ' A' ' 63' ' ' THR 0.255 98.0 m95 -129.18 -93.71 0.43 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -173.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 32.6 p -101.6 146.17 28.05 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 117.333 2.345 . . . . 0.0 117.333 -160.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 45.8 t80 -135.96 143.08 44.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 168.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -119.11 128.17 54.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 120.507 1.503 . . . . 0.0 113.685 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 10.5 p-10 -79.44 -40.68 29.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.943 -175.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.02 47.24 2.22 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 121.141 0.301 . . . . 0.0 112.91 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -163.46 -45.34 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 85' ' ' CYS . . . 104.86 -65.36 0.3 Allowed Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 84' ' ' CYS . 44.1 m80 -73.73 132.47 42.69 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -82.97 177.14 53.3 Favored Glycine 0 C--N 1.299 -1.508 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.976 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.435 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.4 mp -84.39 -34.99 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 23.7 t-20 -142.73 109.86 5.63 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.0 Cg_exo -80.08 147.83 77.36 Favored 'Cis proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.429 -3.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.664 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.6 p30 -77.61 -21.75 51.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.93 -8.38 58.78 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.913 0.387 . . . . 0.0 110.377 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 67.8 m -103.62 152.4 21.81 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 121.605 0.717 . . . . 0.0 111.842 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 4.3 p -132.0 178.77 6.53 Favored 'General case' 0 C--N 1.273 -2.743 0 C-N-CA 125.496 1.518 . . . . 0.0 110.139 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -131.32 35.75 3.86 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.539 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . . . 46.3 102.46 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.849 1.26 . . . . 0.0 114.398 -177.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.99 112.25 23.6 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 110.941 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 93.6 m-85 -102.51 130.64 23.63 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.468 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -72.16 139.47 32.5 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.053 1.835 . . . . 0.0 111.271 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.58 140.07 49.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.685 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -130.43 137.24 49.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 110.537 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.26 129.22 64.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.795 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HE3' ' CB ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -125.3 95.24 4.4 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.49 4.07 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.519 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -101.93 -2.87 28.84 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.544 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.455 ' CB ' ' HE3' ' A' ' 94' ' ' LYS . 20.7 m-20 -111.75 148.91 32.49 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.3 mt -126.39 131.99 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -99.49 148.48 24.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.538 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.67 137.31 52.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 2' ' ' SER . 43.7 t -90.58 113.73 25.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.8 p -138.29 -26.46 0.91 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.236 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -74.44 99.51 3.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.401 0.62 . . . . 0.0 109.725 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.92 -8.21 16.64 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.837 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.11 115.64 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.999 0.428 . . . . 0.0 110.456 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.83 144.29 31.41 Favored Pre-proline 0 N--CA 1.412 -2.351 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.76 128.58 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.96 1.773 . . . . 0.0 111.141 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.3 p-10 -85.28 122.0 28.82 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.136 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.5 tptt 67.72 160.93 0.17 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.92 1.387 . . . . 0.0 111.029 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 124.919 1.288 . . . . 0.0 112.64 176.162 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 101' ' ' SER . 22.7 t . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 68.2 m-85 -75.51 97.79 3.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -107.13 144.95 33.11 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -77.28 124.28 27.64 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -98.21 -45.92 12.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.734 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.1 p -157.79 -172.18 3.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.372 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -125.74 152.7 45.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.597 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.516 ' O ' HD21 ' A' ' 9' ' ' LEU . 5.5 tt -61.57 -26.03 67.7 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.26 -10.76 56.91 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.918 -0.489 . . . . 0.0 111.378 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -93.76 -53.4 4.04 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.2 pt -111.4 110.86 33.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 122.462 1.125 . . . . 0.0 111.757 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.97 170.23 16.96 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.251 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 34' ' ' GLU . 7.1 p -57.71 112.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-O 121.874 0.845 . . . . 0.0 111.276 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.21 58.95 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.558 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -102.83 152.48 21.22 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.168 0.508 . . . . 0.0 111.072 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.44 ' HB3' HG23 ' A' ' 31' ' ' VAL . 25.3 ptt? -149.95 145.23 26.36 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.895 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.8 pt-20 -157.8 154.73 28.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 73.5 m -71.99 130.26 40.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.017 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -128.09 157.01 41.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -106.24 135.68 47.29 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -83.39 173.71 11.29 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 m -73.89 -12.24 60.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.493 0.663 . . . . 0.0 110.993 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.2 -12.22 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.659 0.742 . . . . 0.0 109.111 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 20.71 24.91 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.629 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.9 m -91.34 130.27 37.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -88.04 124.39 33.7 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.8 t -138.7 145.68 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.407 HD23 ' HB2' ' A' ' 17' ' ' MET . 5.7 tt -97.3 112.32 24.18 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mm -97.6 119.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.456 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 10.1 p -116.52 134.1 61.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.411 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -108.86 104.31 13.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.3 m -101.19 143.9 30.72 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -76.57 -51.31 11.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.3 -46.58 22.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.317 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -92.75 2.62 56.64 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.199 0.523 . . . . 0.0 111.361 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.92 177.06 35.3 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.719 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.2 125.63 39.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 9.8 mmpt? -127.81 145.19 51.01 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.123 0.569 . . . . 0.0 109.97 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -125.56 112.13 15.83 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.467 ' HH ' HD13 ' A' ' 62' ' ' ILE . 13.9 p90 -137.53 140.94 41.39 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 119.553 -0.26 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 86' ' ' LEU . 38.3 mt-30 -42.91 137.36 2.38 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.938 0.774 . . . . 0.0 111.953 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -102.46 78.7 1.75 Allowed 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.467 0.651 . . . . 0.0 110.157 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.408 ' HB2' ' HB2' ' A' ' 110' ' ' ALA 0.286 10.9 mmt -123.75 135.7 53.99 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.87 90.67 0.47 Allowed Pre-proline 0 C--N 1.311 -1.067 0 C-N-CA 127.594 2.357 . . . . 0.0 107.873 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -85.33 27.76 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.54 2.16 . . . . 0.0 111.063 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -85.18 -52.95 5.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.15 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -138.0 -72.02 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -98.83 115.69 29.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.31 -28.86 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.185 0.928 . . . . 0.0 110.515 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.7 mt -79.02 98.13 6.35 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.429 ' O ' HD21 ' A' ' 52' ' ' LEU . 3.2 tt -56.95 -28.9 62.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.53 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 67.5 p -58.04 -21.72 46.65 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.713 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -88.59 8.71 27.0 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.968 0.413 . . . . 0.0 112.009 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.49 -124.57 1.21 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 173.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.6 t -157.29 150.04 23.29 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 110.263 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.441 ' CD1' HD11 ' A' ' 62' ' ' ILE . 6.8 t80 -130.89 115.91 17.18 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.293 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -116.15 104.15 11.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.02 -73.89 0.13 Allowed Glycine 0 CA--C 1.52 0.364 0 O-C-N 123.715 0.634 . . . . 0.0 112.845 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.68 25.09 1.19 Allowed Glycine 0 C--N 1.295 -1.7 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.52 120.99 62.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.467 HD13 ' HH ' ' A' ' 41' ' ' TYR . 35.4 mm -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 m -127.2 129.05 47.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -155.2 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.045 0 C-N-CA 123.442 0.697 . . . . 0.0 111.411 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -113.1 95.09 5.2 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.762 -0.586 . . . . 0.0 110.654 -169.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.69 21.81 10.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -97.72 -17.02 19.66 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.21 -48.69 0.69 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -74.4 177.24 6.07 Favored 'General case' 0 CA--C 1.577 2.017 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.766 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -103.08 156.92 17.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -166.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CZ ' ' HG ' ' A' ' 86' ' ' LEU . 6.3 t80 -134.07 146.26 50.15 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -118.57 112.84 20.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.905 0.775 . . . . 0.0 112.976 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.59 -34.36 58.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.515 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.84 -40.16 89.33 Favored Glycine 0 CA--C 1.508 -0.369 0 O-C-N 123.342 0.402 . . . . 0.0 113.486 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -101.1 -12.75 18.56 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.644 0.735 . . . . 0.0 109.41 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.35 38.68 38.19 Favored Glycine 0 C--O 1.219 -0.821 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.777 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -140.74 141.32 34.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -85.73 139.75 17.42 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.922 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.63 -35.97 17.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -141.47 137.47 16.52 Favored Pre-proline 0 N--CA 1.417 -2.114 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -66.76 -13.56 8.08 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 CA-C-N 119.383 0.815 . . . . 0.0 113.44 -0.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.575 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 11.2 t70 90.14 -39.35 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 126.928 2.091 . . . . 0.0 110.0 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -56.46 -34.28 66.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.325 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 51.6 m -93.7 141.84 28.03 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.853 0.835 . . . . 0.0 108.885 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.3 m -144.52 166.6 24.69 Favored 'General case' 0 C--N 1.254 -3.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.466 ' HG ' ' CZ ' ' A' ' 71' ' ' PHE . 72.5 mt -128.98 179.69 5.6 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -175.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.92 117.62 17.9 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -85.66 101.22 12.55 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -81.11 141.87 50.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.415 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -58.37 118.55 5.45 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.764 1.643 . . . . 0.0 110.537 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.0 p -133.5 137.79 52.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -133.64 140.19 46.94 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.365 0.602 . . . . 0.0 111.062 -176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.8 127.97 57.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.43 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.53 91.3 3.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.37 -106.0 1.22 Allowed Glycine 0 C--N 1.3 -1.439 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.418 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.9 -10.86 22.27 Favored 'General case' 0 C--O 1.186 -2.283 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.16 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.87 140.36 35.27 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.774 0.321 . . . . 0.0 111.406 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.7 mt -127.14 122.06 59.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.831 0.825 . . . . 0.0 111.664 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 39.7 m-85 -115.12 144.41 43.7 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.937 -176.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.54 145.37 29.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.04 0.448 . . . . 0.0 110.911 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 2' ' ' SER . 51.5 m -111.45 116.26 30.6 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.441 ' HA ' ' CG2' ' A' ' 105' ' ' ILE . 10.0 t -134.26 -10.66 2.54 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.913 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -85.44 97.11 9.83 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.857 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.86 -32.85 2.47 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 102' ' ' THR . 13.3 tt -86.83 136.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.21 123.53 79.32 Favored Pre-proline 0 N--CA 1.426 -1.672 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 23.0 Cg_exo -68.25 129.7 19.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.605 2.87 . . . . 0.0 108.511 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -81.16 174.39 11.61 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.659 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -52.81 104.6 0.09 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.813 1.292 . . . . 0.0 114.158 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.279 -2.492 0 CA-C-N 111.237 -2.711 . . . . 0.0 104.406 -174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 101' ' ' SER . 49.3 m . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.439 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 95.6 m-85 -86.09 124.82 32.94 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -120.23 145.1 47.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 118.24 23.38 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -118.23 -40.72 2.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.379 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 p -146.27 -175.15 4.65 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.577 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.57 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.6 m -131.57 150.6 52.09 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.221 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -71.47 -25.26 62.21 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 96' ' ' ASP . 23.8 t70 -72.19 -17.68 61.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.316 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.25 -53.43 4.7 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 12' ' ' ILE . 43.3 pt -108.37 110.13 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 122.433 1.111 . . . . 0.0 110.523 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.481 ' HB2' ' OE2' ' A' ' 16' ' ' GLU . 37.3 m95 -80.38 170.07 16.88 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.119 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.43 127.13 14.99 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.036 0.446 . . . . 0.0 110.015 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.65 -1.72 79.13 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' OE2' ' HB2' ' A' ' 13' ' ' TRP . 44.8 mt-10 -110.34 149.94 29.5 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.38 0.61 . . . . 0.0 112.239 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.408 ' HE2' ' H ' ' A' ' 56' ' ' SER . 20.3 ptt? -150.39 152.2 33.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.485 -171.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -157.24 151.91 25.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 123.613 0.571 . . . . 0.0 109.472 177.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 99.1 m -89.49 121.01 31.31 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 97.6 m-85 -119.2 155.77 31.08 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.88 143.42 39.8 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.1 p -83.06 165.76 19.32 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 m -67.0 -13.13 61.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.142 0.496 . . . . 0.0 111.213 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.85 -13.11 49.01 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 109.489 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 22.39 16.42 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.794 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.545 ' CG2' HE22 ' A' ' 42' ' ' GLN . 31.5 m -97.72 130.03 44.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.764 -0.257 . . . . 0.0 111.168 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.64 126.85 35.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.571 0.701 . . . . 0.0 111.589 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.19 148.78 27.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.8 tp -100.29 111.1 23.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.94 117.45 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.05 125.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.839 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -88.09 104.22 16.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -101.59 145.75 28.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.144 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.82 -48.98 19.37 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.483 0.659 . . . . 0.0 109.574 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.29 -41.33 61.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.723 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -100.78 2.48 41.27 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.77 -170.68 46.1 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.1 t -78.43 119.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.09 144.77 44.29 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.655 0.264 . . . . 0.0 110.914 -176.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.97 119.99 31.18 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 2.0 p90 -143.23 140.19 30.58 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.394 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.545 HE22 ' CG2' ' A' ' 26' ' ' THR . 14.7 mm100 -44.66 138.21 3.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.25 59.21 4.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.425 1.107 . . . . 0.0 109.877 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.559 ' HE1' ' HA ' ' A' ' 44' ' ' MET . 19.0 mmt -66.07 94.1 0.23 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 113.618 -1.628 . . . . 0.0 114.262 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 m -166.47 93.84 0.76 Allowed Pre-proline 0 C--N 1.31 -1.148 0 C-N-CA 125.445 1.498 . . . . 0.0 110.403 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.98 30.27 0.47 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.206 2.604 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 30.38 3.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -47.91 124.02 6.89 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.244 2.218 . . . . 0.0 114.817 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 41.7 mm-40 -92.55 -62.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 173.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 tp -151.16 172.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 110.71 2.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 118.985 0.811 . . . . 0.0 109.67 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.16 -20.01 63.66 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.893 1.277 . . . . 0.0 112.409 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.596 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 59.3 p -55.0 -21.86 13.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -166.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.46 8.59 44.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.36 0.6 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.68 81.3 0.12 Allowed Glycine 0 C--N 1.318 -0.426 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 62' ' ' ILE . 66.3 m -138.53 -77.86 0.36 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -90.23 114.23 26.2 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.508 -169.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.4 105.24 11.93 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.657 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.85 -64.07 1.55 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 123.207 0.317 . . . . 0.0 113.028 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.1 -2.62 0.06 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.88 140.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 71' ' ' PHE . 36.4 mt -113.4 121.06 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 0.0 112.044 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.4 m -92.94 148.46 21.99 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 125.67 1.588 . . . . 0.0 110.432 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.566 ' C ' ' H ' ' A' ' 66' ' ' ALA . 44.6 t -156.21 34.7 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 72.32 -22.91 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.694 1.198 . . . . 0.0 109.83 -170.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.566 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . 71.17 100.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 125.367 1.467 . . . . 0.0 111.576 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 49' ' ' GLU . 52.7 m80 -99.83 -0.17 40.27 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.499 174.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -147.55 -55.1 0.22 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.016 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -170.62 -143.78 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.511 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 32.8 p -134.39 167.68 20.3 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.363 1.465 . . . . 0.0 108.981 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.508 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 54.2 m-85 -98.69 138.39 35.93 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -107.46 112.54 25.37 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 173.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.405 4.6 p-10 52.77 63.19 2.33 Favored 'General case' 0 CA--C 1.476 -1.883 0 CA-C-O 123.333 1.539 . . . . 0.0 111.342 -167.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' HA3' HD13 ' A' ' 62' ' ' ILE . . . -73.26 64.47 1.67 Allowed Glycine 0 CA--C 1.474 -2.491 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.257 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.2 m -139.85 -46.64 0.44 Allowed 'General case' 1 C--N 1.242 -4.09 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.96 -3.53 6.3 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 119.171 -1.49 . . . . 0.0 113.399 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -144.12 142.95 30.89 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.326 0.563 . . . . 0.0 110.801 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.45 129.05 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.699 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 70' ' ' THR . 51.1 mt -88.3 -22.93 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 173.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -143.8 113.44 5.44 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.895 168.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -76.11 129.16 18.08 Favored 'Cis proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.706 -1.789 . . . . 0.0 110.914 -2.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.21 -11.84 59.96 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.739 0.78 . . . . 0.0 109.886 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.84 -19.78 61.25 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.712 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 79.3 m -155.11 161.67 41.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 122.327 1.06 . . . . 0.0 113.196 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 p -94.06 -167.56 1.7 Allowed 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 84.6 mt -117.38 142.72 46.77 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.843 177.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.22 86.38 5.01 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.569 176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 123.58 24.57 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.105 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.507 ' CD2' HG23 ' A' ' 105' ' ' ILE 0.251 5.4 p90 -124.08 160.32 52.69 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.58 133.67 43.77 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.68 2.92 . . . . 0.0 115.012 -172.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.3 t -116.3 143.56 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-N 113.713 -1.585 . . . . 0.0 107.498 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.9 132.38 47.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.52 130.49 48.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.63 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -125.04 90.6 3.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 176.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.64 -113.55 5.96 Favored Glycine 0 C--N 1.31 -0.889 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.604 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.2 m-20 -91.93 -8.2 46.96 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 123.365 0.666 . . . . 0.0 110.671 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -111.65 157.61 20.24 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.2 mm -126.93 135.93 62.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 16.6 m-85 -106.54 145.99 31.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 167.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.32 151.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 2' ' ' SER . 20.8 m -87.47 113.08 22.85 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.1 p -124.51 -38.28 2.42 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.4 tpmt? -107.32 91.19 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.07 -39.08 0.73 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.617 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 28.1 mm -85.49 143.25 11.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 170.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.0 tp -96.86 100.75 7.9 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.451 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 105' ' ' ILE . 2.9 Cg_exo -78.41 136.98 14.49 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 123.084 2.523 . . . . 0.0 109.872 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -80.53 117.01 20.87 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.252 0.548 . . . . 0.0 110.385 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.436 ' O ' ' HE2' ' A' ' 44' ' ' MET . 40.8 ttmt -71.83 -24.13 61.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.704 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HA ' ' SD ' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.301 -1.504 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.912 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 CA--C 1.506 -0.726 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 52.46 87.82 0.03 OUTLIER 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.151 0.977 . . . . 0.0 111.342 -174.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -105.3 142.48 34.99 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -65.8 117.52 8.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.278 0.561 . . . . 0.0 110.128 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 tt -104.3 -56.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.57 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.846 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.3 m -157.92 -177.14 6.35 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 123.058 0.543 . . . . 0.0 111.064 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 p -103.62 150.17 24.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.488 ' O ' HD22 ' A' ' 9' ' ' LEU . 5.0 tt -72.85 -24.77 60.92 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.4 -25.97 68.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.215 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.54 -48.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.6 pt -100.91 110.79 28.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 CA-C-O 122.802 1.287 . . . . 0.0 112.27 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -79.2 169.78 17.63 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 113.514 -1.676 . . . . 0.0 112.227 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.1 116.71 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.703 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.34 2.12 59.08 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.383 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -104.18 145.04 30.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.21 0.528 . . . . 0.0 110.679 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -142.36 143.73 32.85 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 tp10 -152.86 149.76 28.62 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 69.5 m -89.08 123.06 33.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.001 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -127.57 162.51 26.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.765 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -102.0 141.54 34.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -83.97 170.59 13.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -64.02 -13.68 48.5 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.758 0.423 . . . . 0.0 111.66 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.52 -13.24 24.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.283 0.563 . . . . 0.0 110.373 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.2 18.58 23.82 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.978 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -97.09 139.12 33.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -89.65 135.45 33.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 19' ' ' THR . 99.2 t -134.94 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -104.08 110.29 22.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.4 mp -101.3 123.19 54.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -111.96 125.58 69.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -101.86 102.01 12.54 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 117.941 -1.504 . . . . 0.0 108.456 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.9 m -103.6 139.08 39.38 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.64 -38.62 54.36 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.412 0.625 . . . . 0.0 109.706 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -92.93 -46.89 7.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.68 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -79.74 -12.3 59.8 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.111 0.481 . . . . 0.0 110.41 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.76 159.13 31.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.988 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.464 HG11 ' HB ' ' A' ' 93' ' ' VAL . 7.2 p -72.94 124.01 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -127.06 138.59 53.24 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.24 0.543 . . . . 0.0 112.38 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.7 112.33 16.62 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.015 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -136.82 147.08 46.37 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.676 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -47.33 137.79 8.02 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.896 0.855 . . . . 0.0 113.02 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -83.99 101.09 11.48 Favored 'General case' 0 N--CA 1.396 -3.141 0 CA-C-N 114.474 -1.239 . . . . 0.0 113.198 -172.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 26.1 ptt? 64.07 179.42 0.17 Allowed 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 111.32 -2.673 . . . . 0.0 116.306 163.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.61 116.64 66.83 Favored Pre-proline 0 N--CA 1.416 -2.169 0 CA-C-N 112.238 -2.256 . . . . 0.0 107.202 171.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -85.8 37.26 0.55 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 122.742 2.295 . . . . 0.0 113.347 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -85.13 -59.69 2.26 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.15 115.11 29.71 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.603 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -75.13 82.97 2.32 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 122.359 1.076 . . . . 0.0 111.164 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.0 tt -71.99 -37.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.93 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 60.61 69.49 0.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.428 HD23 ' SD ' ' A' ' 44' ' ' MET . 1.5 pt? -77.5 -19.33 56.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.323 -2.217 . . . . 0.0 114.074 -169.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.478 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.9 p -54.88 -23.12 17.11 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -163.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.49 -9.24 58.53 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 119.083 0.856 . . . . 0.0 110.182 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.6 83.18 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.428 ' OG ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 m -125.31 -57.68 1.47 Allowed 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 122.411 1.1 . . . . 0.0 109.107 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -91.21 113.52 25.81 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.403 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.36 105.52 11.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 -53.82 2.1 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.606 -0.331 . . . . 0.0 113.585 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.55 -12.28 0.02 OUTLIER Glycine 0 C--N 1.306 -1.107 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.7 141.55 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 51.5 mm -106.83 128.35 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 123.956 0.902 . . . . 0.0 108.954 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.4 m -85.74 125.25 33.08 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 5.4 t -105.79 155.57 19.16 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.39 117.77 29.96 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.303 0.241 . . . . 0.0 110.957 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.05 -38.34 0.39 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 36.0 m170 -71.2 114.71 9.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 118.266 0.485 . . . . 0.0 111.38 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB3' ' CG ' ' A' ' 80' ' ' ASN . 2.1 tm? 49.24 -97.49 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.438 1.495 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -166.98 -44.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 p -138.34 134.93 34.85 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -160.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.406 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 48.3 t80 -116.23 138.53 51.21 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 101.868 -3.382 . . . . 0.0 101.868 168.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -123.35 117.34 24.99 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.873 1.67 . . . . 0.0 115.156 -168.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.48 -33.46 42.23 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.256 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -48.47 -54.58 12.74 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.757 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.7 m -88.94 -36.78 15.7 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.087 0.47 . . . . 0.0 110.223 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.509 ' O ' HD13 ' A' ' 86' ' ' LEU . . . 114.37 -33.55 5.35 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.471 ' HD2' ' SG ' ' A' ' 85' ' ' CYS . 29.8 t-80 -82.72 137.97 34.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.79 144.22 17.17 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.92 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.56 -42.42 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.473 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 3.5 p-10 -135.32 118.89 12.97 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.11 131.76 21.39 Favored 'Cis proline' 0 C--O 1.243 0.757 0 C-N-CA 123.797 -1.335 . . . . 0.0 111.397 -1.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.0 p30 -71.5 -12.69 61.51 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.059 0.457 . . . . 0.0 111.101 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.41 -17.53 62.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.39 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 25.5 p -138.58 178.78 6.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 111.951 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.471 ' SG ' ' HD2' ' A' ' 77' ' ' HIS . 62.3 m -133.61 176.12 8.83 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 76' ' ' GLY 0.313 0.0 OUTLIER -101.02 127.06 47.7 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.646 175.466 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.83 114.2 10.71 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -87.32 116.89 25.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 101' ' ' SER . 65.4 m-85 -95.69 152.54 39.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD3' HD11 ' A' ' 105' ' ' ILE . 14.2 Cg_exo -70.76 120.55 7.16 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.186 1.924 . . . . 0.0 110.058 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.74 138.27 52.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.468 0.652 . . . . 0.0 110.667 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -115.24 132.06 56.73 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.464 ' HB ' HG11 ' A' ' 38' ' ' VAL . 8.8 p -106.57 122.21 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.324 -175.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -125.89 143.93 50.88 Favored 'General case' 0 N--CA 1.394 -3.234 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.312 176.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -33.62 -53.75 0.63 Allowed Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 117.531 1.772 . . . . 0.0 117.531 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.56 -0.73 13.58 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.457 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 9.3 m-20 -146.89 134.82 21.37 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.67 129.77 73.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-O 121.354 0.597 . . . . 0.0 111.088 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -113.73 141.49 47.2 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.027 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.76 147.94 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 120.946 0.403 . . . . 0.0 111.082 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.428 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 51.3 m -104.79 115.22 29.93 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.969 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -101.01 -18.43 16.28 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -81.73 108.38 15.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.147 176.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.55 -34.32 2.43 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.445 HD11 ' HD3' ' A' ' 90' ' ' PRO . 33.7 mt -119.02 127.64 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.06 128.07 61.69 Favored Pre-proline 0 N--CA 1.404 -2.732 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.09 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.42 148.87 91.87 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.36 2.04 . . . . 0.0 110.362 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -80.18 166.88 21.0 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -78.56 74.14 5.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.975 1.369 . . . . 0.0 114.139 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.26 -3.291 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.87 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.6 m . . . . . 0 C--O 1.243 0.727 0 CA-C-O 119.82 -0.133 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.515 ' CD2' ' HB2' ' A' ' 101' ' ' SER . 92.2 m-85 -76.07 97.72 4.14 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.76 143.81 35.79 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 120.908 0.385 . . . . 0.0 110.284 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 86.1 tttt -79.54 123.66 27.78 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.415 HG21 ' SG ' ' A' ' 7' ' ' CYS . 39.7 mm -94.87 -53.55 8.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.333 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' HG21 ' A' ' 6' ' ' ILE . 93.4 m -158.31 -172.56 3.93 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.465 0.65 . . . . 0.0 111.921 -173.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 41.2 t -104.74 153.22 21.57 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.959 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.518 ' O ' HD22 ' A' ' 9' ' ' LEU . 6.4 tt -61.73 -21.8 64.82 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.99 -19.6 66.08 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.186 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -94.98 -42.95 8.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.6 tp -114.49 110.83 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.056 0.931 . . . . 0.0 112.65 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -102.59 169.04 8.89 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.327 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.42 124.76 27.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.684 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.52 66.0 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -105.14 153.27 21.75 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.083 -0.559 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.411 ' HE2' ' O ' ' A' ' 52' ' ' LEU . 23.5 ptt? -151.27 143.92 24.34 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.512 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.01 155.44 31.25 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.3 m -73.38 136.21 44.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.064 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -135.33 160.5 38.22 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.11 136.98 44.83 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.9 p -84.62 175.64 9.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.9 m -66.12 -20.72 66.24 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.046 0.45 . . . . 0.0 111.368 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.44 5.12 52.42 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.588 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.05 33.67 54.17 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.104 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 m -97.98 134.95 40.39 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.68 122.67 33.01 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.13 141.98 45.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.215 0.531 . . . . 0.0 110.267 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 53.5 tp -100.04 111.91 24.21 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 124.512 1.125 . . . . 0.0 108.191 177.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.7 114.33 32.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.39 124.55 64.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.3 t30 -109.31 106.46 16.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.5 m -98.37 157.3 16.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.686 0.755 . . . . 0.0 112.518 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -75.26 -48.96 20.88 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.543 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.12 -33.77 10.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -91.45 3.28 55.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.15 -166.37 41.23 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.392 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 10.6 p -90.92 128.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -132.3 158.16 42.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.336 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.31 128.02 48.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 39' ' ' LYS . 95.0 m-85 -134.97 163.56 29.59 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -55.38 138.93 44.72 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.206 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.47 -39.3 74.32 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.493 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 66.6 mtt -103.19 120.61 41.03 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.8 p -70.7 171.88 7.34 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 123.362 0.413 . . . . 0.0 110.429 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.476 ' N ' ' HA ' ' A' ' 110' ' ' ALA . 31.8 Cg_exo -60.62 -18.84 57.26 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.672 2.248 . . . . 0.0 111.661 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -100.01 -22.69 15.14 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.369 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.548 ' HG3' ' H ' ' A' ' 49' ' ' GLU 0.375 11.8 pt20 47.9 -102.98 0.09 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.02 0.928 . . . . 0.0 113.433 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 44.4 mt-10 58.5 -75.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.796 1.238 . . . . 0.0 113.505 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -109.27 141.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.62 99.34 5.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.942 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.474 HD22 ' H ' ' A' ' 52' ' ' LEU . 1.5 pt? -60.33 -24.97 65.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.3 p -63.58 -27.82 69.51 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 123.982 0.913 . . . . 0.0 110.305 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -113.84 21.19 15.17 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.37 -110.47 2.62 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.8 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 m -148.27 157.84 43.73 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.546 0.689 . . . . 0.0 111.495 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -125.24 127.47 46.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.327 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -114.96 163.88 14.95 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.26 -34.85 48.6 Favored Glycine 0 C--N 1.317 -0.479 0 CA-C-N 118.535 0.607 . . . . 0.0 113.288 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.06 7.14 5.11 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.527 -1.32 . . . . 0.0 113.058 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.3 t -124.79 125.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 122.002 -0.705 . . . . 0.0 111.43 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.469 ' HB ' ' CD2' ' A' ' 71' ' ' PHE . 51.4 mm -89.99 130.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.3 m -91.93 113.73 26.08 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.059 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.435 ' C ' ' H ' ' A' ' 66' ' ' ALA . 39.8 m -87.02 -45.55 10.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.786 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.517 ' O ' ' HD3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER 71.76 -36.28 0.35 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.71 1.204 . . . . 0.0 110.822 -177.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . -56.16 -61.06 2.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -75.8 -19.29 59.08 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.134 -1.426 . . . . 0.0 112.079 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.0 tp 179.87 -77.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 73.7 t90 177.32 -27.69 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.503 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.4 ' HB ' HD12 ' A' ' 79' ' ' ILE . 34.1 p -100.77 140.58 34.84 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CD2' ' HB ' ' A' ' 62' ' ' ILE . 42.7 t80 -134.39 139.93 45.94 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 126.311 1.844 . . . . 0.0 107.107 173.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -106.47 113.03 26.31 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.955 0.407 . . . . 0.0 110.704 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.94 -50.91 72.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -42.7 -45.32 5.67 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.574 ' HB ' ' CD2' ' A' ' 77' ' ' HIS . 10.7 m -116.31 12.17 15.26 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 122.123 -0.634 . . . . 0.0 110.634 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.56 51.42 52.15 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.396 -0.431 . . . . 0.0 112.258 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.574 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -146.46 157.24 43.73 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.56 173.79 54.9 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 119.346 -1.406 . . . . 0.0 109.998 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.8 mp -87.71 -27.77 5.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.07 107.13 2.82 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.558 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.87 158.07 98.36 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.123 -1.615 . . . . 0.0 111.175 -2.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.2 p-10 -104.22 -4.61 22.83 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -173.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.49 -55.44 18.92 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.236 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 85.9 m -167.46 170.63 11.16 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.619 0.768 . . . . 0.0 109.895 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.571 ' CB ' ' HA ' ' A' ' 77' ' ' HIS . 42.1 t -145.39 -79.42 0.18 Allowed 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.312 1.053 . . . . 0.0 110.756 169.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HG ' ' SG ' ' A' ' 85' ' ' CYS . 87.5 mt -114.0 167.14 10.92 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.824 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -97.51 137.7 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -95.67 113.88 25.57 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -106.03 142.74 25.47 Favored Pre-proline 0 C--O 1.245 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.048 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.89 131.97 32.99 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.963 2.442 . . . . 0.0 111.074 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.15 146.78 31.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.508 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 50.6 mt-10 -131.74 132.61 43.99 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.28 118.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.202 0.525 . . . . 0.0 110.427 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -120.7 91.97 3.66 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.34 -99.52 0.52 Allowed Glycine 0 CA--C 1.498 -0.989 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.583 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 8' ' ' SER . 10.6 m-20 -104.85 -9.78 17.79 Favored 'General case' 0 C--O 1.174 -2.886 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.956 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.8 128.39 45.9 Favored 'General case' 0 C--N 1.273 -2.722 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.551 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -119.73 121.9 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.409 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 20.3 m-85 -114.08 142.37 46.28 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.251 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.56 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 2' ' ' SER . 32.1 t -105.45 120.03 40.58 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.163 0.506 . . . . 0.0 110.074 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.2 t -102.49 12.75 36.03 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.784 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -100.82 144.33 29.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 -41.66 2.65 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.43 136.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.26 140.75 23.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.23 138.78 28.76 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.073 2.515 . . . . 0.0 113.688 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -80.86 -177.34 6.32 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -14.74 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 124.118 0.967 . . . . 0.0 112.8 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.314 -0.946 0 C-N-CA 125.453 1.501 . . . . 0.0 111.242 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -59.54 102.88 0.16 Allowed 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.302 0.572 . . . . 0.0 110.049 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -117.71 150.28 39.34 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.659 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.38 115.29 17.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.291 0.567 . . . . 0.0 110.083 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 tp -96.4 -35.28 5.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.791 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.9 p -162.3 -166.58 1.42 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.981 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.697 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.2 m -127.96 149.1 50.49 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.147 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.95 -34.72 78.62 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 123.495 0.718 . . . . 0.0 109.395 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.45 -23.08 66.83 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.36 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.45 -46.47 12.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.572 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.0 pt -100.65 114.75 40.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.353 1.073 . . . . 0.0 112.124 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 15.0 m95 -82.25 168.52 17.53 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.196 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.08 122.06 11.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.67 0.748 . . . . 0.0 110.001 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 57' ' ' TYR . . . 94.18 1.11 65.05 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.223 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 24.2 mm-40 -102.69 137.83 40.4 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.3 0.572 . . . . 0.0 109.747 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.408 ' CB ' HG22 ' A' ' 31' ' ' VAL . 23.1 ptm -137.23 143.14 42.11 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.902 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 12.2 tp10 -156.54 154.66 30.65 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 176.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.636 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 89.1 m -100.93 130.94 47.0 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.19 0.519 . . . . 0.0 109.912 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -123.11 152.19 41.33 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.08 138.47 51.6 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.18 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.2 p -83.92 172.71 11.84 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 p -64.43 -26.54 68.49 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.177 0.591 . . . . 0.0 110.944 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.55 -12.22 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.212 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.52 18.07 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.443 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.6 m -90.28 117.0 28.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.72 123.72 33.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' THR . 62.1 t -127.33 137.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.163 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 29' ' ' LEU . 4.3 pp -93.3 123.3 36.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -109.44 114.55 47.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' CB ' ' A' ' 17' ' ' MET . 46.6 t -119.19 125.84 74.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.355 -177.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -87.82 106.21 17.92 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 22.8 m -99.53 149.35 23.33 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -75.28 -50.04 17.34 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.177 0.513 . . . . 0.0 111.063 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.7 -45.04 9.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.803 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.4 ' NE2' ' HE3' ' A' ' 39' ' ' LYS . 21.3 t-160 -84.25 -15.02 48.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.86 0.362 . . . . 0.0 111.949 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 85.59 -171.5 45.48 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.003 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.72 123.35 34.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HE3' ' NE2' ' A' ' 36' ' ' HIS . 74.3 mmtt -128.25 150.44 50.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.23 119.24 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.329 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -128.69 158.61 38.11 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -60.19 138.23 57.96 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HB1' ' N ' ' A' ' 29' ' ' LEU . . . -106.35 -5.75 18.83 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.01 17.49 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.3 m -80.45 111.79 25.7 Favored Pre-proline 0 N--CA 1.443 -0.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 168.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.07 39.05 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.626 2.218 . . . . 0.0 111.845 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -102.25 -77.03 0.56 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -170.15 131.78 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 43.1 mt-10 64.54 86.44 0.13 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.778 0.799 . . . . 0.0 112.164 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tt -93.88 106.46 18.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.729 0.776 . . . . 0.0 111.836 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HB3' ' HG2' ' A' ' 65' ' ' ARG . 36.1 tp -154.38 48.92 0.61 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.451 ' C ' HD12 ' A' ' 52' ' ' LEU . 1.6 tm? -56.16 -38.78 71.36 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.276 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.636 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 94.0 p -68.56 -29.47 68.02 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.382 0.611 . . . . 0.0 112.331 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -83.87 17.15 2.46 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 124.265 1.026 . . . . 0.0 110.815 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.01 -125.01 1.15 Allowed Glycine 0 N--CA 1.412 -2.914 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.4 m -152.69 151.46 30.57 Favored 'General case' 0 N--CA 1.424 -1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.905 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.519 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 20.8 t80 -120.75 116.25 24.87 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.162 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -117.18 170.82 8.37 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 69.61 0.04 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.01 1.75 39.08 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.14 127.21 72.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.8 mm -122.72 132.94 70.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.39 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.4 m -101.76 137.39 40.12 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 25.9 p -78.09 -73.86 0.29 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.558 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HG2' ' HB3' ' A' ' 51' ' ' LEU . 29.7 tpt180 174.72 -69.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 49' ' ' GLU . . . -66.51 -57.96 6.23 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' A' ' 69' ' ' TRP . 8.6 m170 -70.59 116.11 10.53 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.836 167.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.93 17.63 3.39 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.53 1.157 . . . . 0.0 108.603 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.443 ' H ' ' C ' ' A' ' 67' ' ' HIS . 87.7 m95 -93.47 177.41 6.04 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.164 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -129.8 140.81 50.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 53.5 p90 -105.67 154.02 21.02 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -93.7 116.57 29.07 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.983 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.46 -30.49 67.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.159 0.584 . . . . 0.0 111.3 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.77 31.51 4.25 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.3 m -156.7 -44.2 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.784 0.834 . . . . 0.0 109.305 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.59 -9.72 66.65 Favored Glycine 0 C--O 1.215 -1.049 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.911 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.12 148.29 28.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.474 ' HA2' ' CB ' ' A' ' 71' ' ' PHE . . . -72.56 137.73 25.08 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.645 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.41 -43.72 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -160.84 124.31 1.93 Allowed Pre-proline 0 N--CA 1.425 -1.721 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD2' ' SG ' ' A' ' 84' ' ' CYS . 12.7 Cg_exo -71.92 166.21 79.85 Favored 'Cis proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.79 0.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.41 -11.54 34.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.18 -10.75 59.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.503 ' SG ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 p -110.32 133.98 52.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 122.334 1.064 . . . . 0.0 111.96 176.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.52 157.69 43.3 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.3 mt -131.75 179.47 6.05 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -141.07 139.66 34.08 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.25 104.09 16.49 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.235 0.541 . . . . 0.0 109.933 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -89.96 163.51 31.88 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.88 119.57 6.81 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.656 2.237 . . . . 0.0 114.018 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 p -129.9 127.47 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.629 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.459 0.647 . . . . 0.0 110.028 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.83 129.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.062 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -122.61 146.85 47.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.07 101.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.07 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.741 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.697 ' O ' ' HB3' ' A' ' 8' ' ' SER . 8.0 m-20 76.27 -13.82 0.87 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.28 2.232 . . . . 0.0 114.716 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -120.62 155.46 33.72 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-N 119.965 1.257 . . . . 0.0 110.849 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . 0.251 45.8 mt -131.26 133.92 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -119.44 144.38 46.98 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.495 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.52 144.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -132.39 118.09 18.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -92.92 6.08 49.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.156 0.503 . . . . 0.0 109.96 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -72.13 109.76 6.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.719 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.02 25.4 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.62 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.8 119.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 110.031 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 148.05 34.03 Favored Pre-proline 0 N--CA 1.409 -2.496 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.83 134.13 57.61 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.887 2.391 . . . . 0.0 111.251 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 54.3 t30 -79.91 157.29 26.95 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.1 106.01 0.24 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.826 0 CA-C-N 111.614 -2.539 . . . . 0.0 106.34 -179.402 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 C--O 1.237 0.436 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.509 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.5 t -92.35 -54.01 3.98 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.8 m-85 -90.11 105.62 17.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.177 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -106.3 146.23 30.65 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -76.09 116.78 17.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -98.55 -30.89 3.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.523 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.0 p -167.35 -171.73 1.78 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.082 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 56.7 p -130.5 152.8 49.48 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.588 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.7 mt -67.9 -15.36 63.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.858 0.837 . . . . 0.0 109.325 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.4 -23.58 63.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.047 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -83.6 -64.55 1.15 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.7 pt -103.16 134.57 43.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.48 1.133 . . . . 0.0 113.604 -174.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 30.6 m95 -93.1 170.02 9.96 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.179 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.5 118.3 6.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.36 56.88 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -112.22 151.28 29.76 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.859 0.362 . . . . 0.0 110.539 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.506 ' SD ' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -148.39 146.61 28.56 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 178.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.6 pt-20 -158.36 156.77 31.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.514 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.9 t -94.19 141.7 28.25 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.064 0.459 . . . . 0.0 110.039 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -131.57 155.63 47.15 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.45 138.34 35.81 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -82.86 173.7 11.6 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -66.39 -15.48 63.33 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.155 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -93.59 -13.9 27.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.222 0.534 . . . . 0.0 110.204 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 -3.4 38.78 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.671 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 m -76.89 133.09 39.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.81 123.01 42.77 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.99 0.9 . . . . 0.0 109.149 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -122.62 143.83 34.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.449 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.506 HD23 ' SD ' ' A' ' 17' ' ' MET . 2.8 tm? -94.24 120.48 34.54 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 30' ' ' ILE . 2.0 mp -104.4 113.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 7.7 p -112.84 128.53 69.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.123 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.9 t30 -111.06 102.3 10.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 169.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.4 p -103.64 157.81 16.8 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.885 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.46 -33.67 58.71 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.403 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -94.69 -46.14 7.05 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -97.28 -4.74 38.19 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.976 -0.453 . . . . 0.0 111.468 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.52 -163.12 48.09 Favored Glycine 0 C--O 1.248 0.995 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -93.36 118.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-O 121.716 0.77 . . . . 0.0 109.352 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -129.99 146.69 51.69 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.896 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.86 112.6 16.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.457 ' HB2' HD12 ' A' ' 86' ' ' LEU . 5.1 p90 -138.95 163.33 32.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -51.52 137.13 24.92 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.53 0.519 . . . . 0.0 110.377 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -111.66 -37.89 5.05 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -84.1 79.92 9.35 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -167.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -100.72 -28.41 0.23 Allowed Pre-proline 0 C--O 1.174 -2.921 0 CA-C-O 116.748 -1.596 . . . . 0.0 110.786 167.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 10.2 Cg_endo -50.06 105.44 0.1 OUTLIER 'Trans proline' 1 C--N 1.424 4.547 0 CA-C-N 122.683 1.994 . . . . 0.0 112.288 -177.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.443 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 68.0 m80 -82.61 9.46 9.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.032 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.74 116.9 20.93 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 103.358 -2.83 . . . . 0.0 103.358 170.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.78 111.7 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -173.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 tp -155.27 163.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.14 100.25 9.99 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.066 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.64 -32.83 65.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.624 1.169 . . . . 0.0 112.897 -173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 31.8 p -72.36 -22.48 61.14 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.495 0.664 . . . . 0.0 111.517 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -103.64 12.65 34.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.17 -103.08 2.85 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.817 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.548 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 22.6 t -144.74 145.42 31.68 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 123.372 1.558 . . . . 0.0 114.26 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -131.82 114.43 14.69 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 110.874 -2.875 . . . . 0.0 104.389 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -116.59 103.29 10.24 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.069 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.28 -72.77 0.43 Allowed Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.239 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.24 3.11 0.54 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.68 124.68 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.488 0.661 . . . . 0.0 109.363 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 67.6 mt -93.66 139.13 18.82 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.548 ' OG1' ' HB3' ' A' ' 56' ' ' SER . 35.8 m -80.78 115.39 20.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.556 1.169 . . . . 0.0 112.873 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 37.1 t -93.06 141.07 28.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 173.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -118.76 -42.53 2.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 117.237 -1.785 . . . . 0.0 114.691 -168.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 47' ' ' HIS . . . -93.45 -6.33 47.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.222 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 72.9 m80 -116.75 -174.21 2.53 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.425 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -77.76 73.56 4.33 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . 0.343 17.9 p-90 35.94 -31.91 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 131.095 3.758 . . . . 0.0 120.841 172.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -102.19 127.29 49.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.417 ' CE2' HD13 ' A' ' 86' ' ' LEU . 37.1 t80 -135.33 136.15 41.33 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 171.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -123.59 133.32 53.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 117.773 -1.571 . . . . 0.0 114.16 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.17 -42.43 72.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.921 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.18 98.52 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.58 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -80.46 -27.46 37.88 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.21 26.7 73.88 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 16.9 t-160 -157.56 154.91 29.3 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.02 137.49 23.16 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.54 -41.83 20.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -160.68 113.96 1.35 Allowed Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.44 -179.54 25.0 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.963 4.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.44 -19.51 29.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.838 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.35 -33.33 74.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.423 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.5 p -90.69 142.44 27.75 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-O 122.112 0.958 . . . . 0.0 112.078 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.676 ' SG ' ' HB3' ' A' ' 108' ' ' ASN . 1.6 p -139.38 159.83 41.25 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.275 -1.329 . . . . 0.0 111.399 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.457 HD12 ' HB2' ' A' ' 41' ' ' TYR . 34.4 tp -111.61 129.83 55.95 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.046 0.45 . . . . 0.0 110.997 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.48 ' HB3' HD21 ' A' ' 108' ' ' ASN . . . -110.8 111.62 22.9 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.06 148.73 22.71 Favored 'General case' 0 N--CA 1.421 -1.894 0 O-C-N 123.618 0.574 . . . . 0.0 110.499 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 101' ' ' SER . 97.6 m-85 -108.7 149.8 39.94 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.624 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.8 121.83 9.29 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.7 2.267 . . . . 0.0 110.755 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.69 138.32 32.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.865 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 119.07 35.43 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.12 120.24 59.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.289 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.428 ' HD2' ' N ' ' A' ' 94' ' ' LYS 0.282 0.0 OUTLIER -126.54 145.72 50.41 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.946 174.985 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -25.29 -45.75 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 119.763 2.665 . . . . 0.0 119.763 -171.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' SER . 26.6 m-20 -116.46 -13.59 10.96 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 117.808 0.804 . . . . 0.0 111.795 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -121.62 148.9 43.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.612 0.72 . . . . 0.0 112.887 -169.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -126.14 111.57 27.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.309 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -108.98 144.29 37.15 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.781 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 8.8 p -140.32 145.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 2' ' ' SER . 38.5 t -87.84 114.21 24.24 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -134.36 15.87 3.75 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.416 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -108.36 118.19 36.11 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.265 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 -3.82 86.73 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.175 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.6 mt -90.39 130.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 120.778 0.323 . . . . 0.0 110.444 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.6 tp -78.48 119.98 79.33 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.103 -175.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.11 145.93 62.55 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.842 2.361 . . . . 0.0 111.052 172.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.676 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 30.9 m-80 -88.91 179.14 6.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.853 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.49 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 11.0 mptt -67.8 101.38 1.06 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.74 1.257 . . . . 0.0 112.582 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 178.24 -63.78 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.239 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.401 ' CG ' ' H ' ' A' ' 112' ' ' SER . 23.0 t-80 56.23 -164.95 0.14 Allowed 'General case' 0 CA--C 1.562 1.409 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.918 169.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.401 ' H ' ' CG ' ' A' ' 111' ' ' HIS . 37.7 m . . . . . 0 N--CA 1.428 -1.561 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.43 ' S1 ' ' HA ' ' A' ' 46' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 C--O 1.24 0.602 0 CA-C-O 120.777 0.322 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -102.2 101.05 11.32 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.675 0.274 . . . . 0.0 111.265 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.515 ' CE1' ' HG3' ' A' ' 92' ' ' GLU . 96.4 m-85 58.28 97.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.3 150.26 50.15 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.106 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 88.4 tttt -68.72 137.83 54.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.013 0.435 . . . . 0.0 111.602 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.446 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -127.25 -40.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.446 ' SG ' HG23 ' A' ' 6' ' ' ILE . 19.8 p -155.08 -172.11 4.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.305 0.574 . . . . 0.0 112.122 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p -131.45 150.01 52.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.646 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.511 ' O ' HD21 ' A' ' 9' ' ' LEU . 5.7 tt -69.65 -25.66 64.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.05 -24.93 68.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.977 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.38 -55.11 3.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.683 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 40.4 pt -100.82 110.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 122.541 1.162 . . . . 0.0 111.085 177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -83.75 170.15 14.49 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.749 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -56.89 118.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.012 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 -2.27 61.25 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.64 142.3 34.56 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.464 ' HE2' ' O ' ' A' ' 53' ' ' SER . 0.0 OUTLIER -141.97 142.11 32.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.189 -176.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -148.16 133.8 18.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.232 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 89.4 m -79.03 123.08 26.97 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -119.23 155.04 32.44 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.508 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -102.65 134.66 45.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.819 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -83.55 167.36 17.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -63.14 -13.31 35.29 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -88.48 -12.27 43.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.25 30.87 11.45 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -97.62 133.59 41.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.64 126.83 35.78 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.176 0.512 . . . . 0.0 110.068 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' THR . 42.0 t -131.67 140.15 48.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -97.34 108.13 20.79 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -99.36 115.85 41.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.37 125.11 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.418 ' ND2' ' HG ' ' A' ' 9' ' ' LEU . 42.5 t30 -97.26 105.08 17.16 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.306 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -101.4 148.58 25.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -76.64 -50.72 13.06 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.505 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.54 -38.5 14.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.81 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -79.72 -9.66 59.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.65 169.51 38.52 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.337 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -76.01 122.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.47 142.95 50.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.57 137.5 49.33 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 96.4 m-85 -130.35 149.77 51.88 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.535 ' OE1' ' HB1' ' A' ' 110' ' ' ALA . 33.7 tt0 -52.02 136.31 29.39 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.86 19.61 18.91 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.65 0.738 . . . . 0.0 110.511 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.2 mmm -78.55 87.5 4.52 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.555 ' SG ' HD12 ' A' ' 52' ' ' LEU . 9.1 p -115.89 94.09 40.07 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 165.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.47 42.25 1.2 Allowed 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.993 2.462 . . . . 0.0 113.89 -170.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.636 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 19.5 m80 -96.26 -67.0 0.87 Allowed 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.884 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -161.7 -35.62 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.009 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.431 ' N ' ' S1 ' ' A' ' 113' ' ' FES . 2.7 mp0 -99.74 100.65 11.64 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.873 0.844 . . . . 0.0 110.913 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.4 tp -92.51 0.49 9.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 122.734 1.254 . . . . 0.0 108.565 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.26 41.85 1.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.369 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.555 HD12 ' SG ' ' A' ' 45' ' ' CYS . 4.5 mp -56.66 -32.55 65.49 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.414 0.686 . . . . 0.0 111.248 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.637 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 80.7 p -72.23 -28.05 62.92 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.609 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -99.73 17.5 20.49 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 64' ' ' CYS . . . -86.68 -109.21 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 t -149.67 148.77 29.68 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.131 0.967 . . . . 0.0 111.883 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -129.89 121.11 26.02 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.109 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 44.2 mt-10 -115.4 168.13 10.26 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.35 64.48 2.47 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 120.802 -0.714 . . . . 0.0 113.128 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.09 -12.7 3.08 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 70.6 t -123.5 131.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 120.778 0.323 . . . . 0.0 110.382 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mm -111.47 135.58 50.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.0 m -128.06 129.16 46.2 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 43.1 t -63.85 -72.11 0.15 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 25.8 ttt180 161.05 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.65 1.58 . . . . 0.0 107.263 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.59 11.85 7.02 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.552 1.167 . . . . 0.0 108.668 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.826 ' HB3' ' S2 ' ' A' ' 113' ' ' FES . 8.9 m-70 -146.57 145.61 30.17 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 127.464 2.306 . . . . 0.0 107.473 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.426 ' HB3' ' H ' ' A' ' 64' ' ' CYS . 43.3 tp 58.15 82.74 0.13 Allowed 'General case' 0 C--N 1.32 -0.677 0 O-C-N 124.965 1.416 . . . . 0.0 109.68 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -74.55 -45.76 43.39 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.421 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 p -133.69 129.11 36.33 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.665 0.745 . . . . 0.0 111.275 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 74.1 t80 -135.1 138.62 43.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -103.85 112.8 25.92 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.461 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.13 -22.26 66.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.58 1.152 . . . . 0.0 111.502 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 16.79 57.31 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.954 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.1 m -148.78 -47.98 0.15 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.201 -0.587 . . . . 0.0 111.14 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.46 -3.62 34.76 Favored Glycine 0 C--O 1.211 -1.337 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.794 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -104.17 147.5 27.38 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.997 -0.707 . . . . 0.0 110.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.48 133.71 11.95 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.2 mp -82.09 -43.15 19.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 27.2 t-20 -140.31 113.02 7.34 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.032 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 96.8 Cg_endo -85.68 163.86 57.51 Favored 'Cis proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.26 -1.558 . . . . 0.0 111.468 -1.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -82.5 -11.73 58.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.128 0.966 . . . . 0.0 108.463 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.08 -26.21 25.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.212 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 73.3 m -139.47 158.17 44.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.087 0.946 . . . . 0.0 111.631 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.2 m -153.06 169.09 23.78 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.502 HD22 ' O ' ' A' ' 42' ' ' GLN . 51.2 mt -126.79 163.92 22.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.601 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -118.32 153.66 33.61 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.21 131.8 47.45 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.301 1.0 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.497 ' CE1' ' HB ' ' A' ' 100' ' ' VAL . 1.7 t80 -126.44 106.54 23.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.79 125.13 16.14 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.844 3.03 . . . . 0.0 113.751 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.06 145.19 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.766 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.515 ' HG3' ' CE1' ' A' ' 3' ' ' PHE . 42.1 mt-10 -127.78 134.24 49.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.317 0.647 . . . . 0.0 110.345 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.1 117.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.456 ' HE2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -127.79 108.91 11.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.251 178.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 55.92 54.68 33.53 Favored Glycine 0 CA--C 1.5 -0.865 0 C-N-CA 121.361 -0.447 . . . . 0.0 113.026 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 72.23 -6.4 1.55 Allowed 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 125.141 1.377 . . . . 0.0 113.842 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -100.89 138.86 37.37 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -126.37 125.51 67.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.505 ' CE1' ' HB2' ' A' ' 5' ' ' LYS . 3.2 m-85 -112.83 141.63 46.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.738 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 89' ' ' TYR . 27.0 m -129.8 143.23 41.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.115 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.411 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 26.7 t -116.23 129.69 56.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.578 0.228 . . . . 0.0 111.32 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.479 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 2.9 m -86.38 -15.15 41.28 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -88.6 123.58 33.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.36 23.23 8.56 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 64.1 mt -100.12 129.44 50.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.977 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 87' ' ' ALA . 2.8 tm? -106.44 102.12 39.22 Favored Pre-proline 0 N--CA 1.426 -1.655 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 172.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.02 132.68 23.41 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.276 1.984 . . . . 0.0 110.002 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.601 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 18.6 t30 -115.08 115.68 27.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.623 -172.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 8.7 tmtt? 64.1 -53.32 0.26 Allowed 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 127.534 2.334 . . . . 0.0 111.239 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.535 ' HB1' ' OE1' ' A' ' 42' ' ' GLN . . . -86.59 -156.8 0.33 Allowed 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 124.23 1.012 . . . . 0.0 109.113 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -158.8 157.67 32.06 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.497 -0.752 . . . . 0.0 111.853 -171.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.299 -1.629 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.09 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.826 ' S2 ' ' HB3' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 CA--C 1.512 -0.511 0 CA-C-O 120.824 0.345 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m -115.44 132.28 56.67 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 68.7 103.41 0.05 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.925 0.869 . . . . 0.0 111.382 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.25 143.16 37.46 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.539 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -69.41 119.28 13.43 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.506 0.722 . . . . 0.0 109.504 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -115.97 -47.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.471 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.3 p -157.57 -168.08 2.46 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-O 121.452 0.644 . . . . 0.0 112.096 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.2 p -129.56 152.36 49.17 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.402 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 9' ' ' LEU . 1.6 tm? -67.23 -16.2 64.15 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.46 -29.9 70.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.786 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.82 -60.35 2.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.038 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -111.56 118.17 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 122.356 1.074 . . . . 0.0 113.227 -176.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -99.15 171.83 7.76 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.237 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.487 ' CG2' ' HA ' ' A' ' 34' ' ' GLU . 7.2 p -51.11 111.73 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 CA-C-O 121.567 0.699 . . . . 0.0 111.443 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.75 7.68 56.41 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.38 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -109.45 151.59 26.5 Favored 'General case' 0 C--O 1.246 0.914 0 O-C-N 122.37 -0.488 . . . . 0.0 110.219 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.563 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -150.46 137.48 19.3 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.537 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.1 mt-10 -149.66 153.48 37.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.0 t -92.87 138.15 31.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.236 0.541 . . . . 0.0 110.565 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 148.82 52.43 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 42.6 tt0 -98.22 146.0 26.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.939 0.399 . . . . 0.0 111.544 -171.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -83.26 178.72 7.95 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 m -70.57 -11.9 61.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.46 0.648 . . . . 0.0 110.592 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -91.49 -14.36 30.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.044 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.08 15.57 51.21 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.501 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.1 m -97.34 128.4 44.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.381 -0.482 . . . . 0.0 109.844 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 40.3 mt-10 -90.05 128.07 36.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.445 0.64 . . . . 0.0 111.036 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' THR . 94.3 t -117.99 141.54 36.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.53 -175.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.5 117.11 29.79 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.2 mp -100.11 112.79 33.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.59 130.55 68.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.75 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -105.52 106.91 17.63 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 t -79.36 146.49 32.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 124.451 1.1 . . . . 0.0 110.769 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.487 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 mp0 -53.94 -50.19 67.0 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.365 1.066 . . . . 0.0 111.904 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -110.4 -36.87 5.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.589 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -79.96 -28.51 39.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.482 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.78 -149.97 17.39 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.881 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -86.39 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.712 0.768 . . . . 0.0 111.652 -171.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -129.26 130.0 45.65 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.316 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.54 111.5 15.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.032 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.499 ' HH ' ' CD1' ' A' ' 62' ' ' ILE . 20.7 p90 -144.56 154.52 42.95 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.53 137.06 19.97 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.644 0.59 . . . . 0.0 109.652 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.87 -54.03 9.85 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.406 ' HE2' ' HB2' ' A' ' 27' ' ' GLU . 1.7 pmm? -88.27 160.94 17.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.777 -172.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.638 ' SG ' ' HA ' ' A' ' 64' ' ' CYS . 13.5 p -89.62 86.44 0.17 Allowed Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -1.44 42.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.95 1 C-N-CA 128.156 5.904 . . . . 0.0 119.476 -162.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -149.71 129.93 13.67 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 68.31 123.7 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 114.796 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -85.77 103.27 14.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.304 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tp -153.07 154.68 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.36 80.51 4.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.198 0.999 . . . . 0.0 110.233 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' H ' HD11 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -73.22 -19.17 61.14 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.679 -176.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 30.5 p -56.31 -19.72 15.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -84.42 -9.67 58.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.378 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.13 75.41 0.28 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.402 ' H ' ' HE2' ' A' ' 17' ' ' MET . 18.1 m -130.76 -73.29 0.55 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.311 0.577 . . . . 0.0 110.841 -177.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 64.8 t80 -91.26 112.74 24.78 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.332 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -118.89 104.05 10.17 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.21 -73.11 0.41 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-O 121.28 0.378 . . . . 0.0 112.643 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.73 12.3 0.46 Allowed Glycine 0 C--N 1.301 -1.4 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.66 134.48 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 40.0 mm -100.15 139.41 21.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 m -83.56 115.08 21.95 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 111.72 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.638 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 5.6 t -81.02 119.33 23.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.424 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -60.57 -60.24 4.12 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.94 -39.05 4.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.503 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 10.6 m80 -58.09 -45.6 86.92 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -157.56 -95.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.416 ' CD1' HG23 ' A' ' 70' ' ' THR . 18.4 p90 172.96 -16.46 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 124.387 1.075 . . . . 0.0 110.376 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 69' ' ' TRP . 35.1 p -101.78 128.82 47.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.158 0.504 . . . . 0.0 111.802 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.621 ' CZ ' HD12 ' A' ' 86' ' ' LEU . 43.7 t80 -137.5 138.98 40.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 171.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.02 111.15 22.15 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.05 -33.38 63.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 111.713 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.73 88.69 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -94.99 -28.48 15.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.309 0.576 . . . . 0.0 109.612 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.72 18.83 64.9 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -136.54 137.6 40.42 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.82 137.73 20.48 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.398 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.84 -44.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -154.04 109.2 2.48 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.1 148.85 91.95 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.167 -1.597 . . . . 0.0 113.213 3.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 14.2 t70 -86.2 -24.69 26.0 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.869 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.91 -37.83 86.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.0 m -94.72 151.32 19.37 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 123.077 1.418 . . . . 0.0 112.715 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.73 140.04 20.4 Favored 'General case' 0 C--N 1.262 -3.232 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.681 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.621 HD12 ' CZ ' ' A' ' 71' ' ' PHE . 7.6 mp -110.97 100.98 9.58 Favored 'General case' 0 C--N 1.259 -3.368 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.617 -175.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.26 127.73 33.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.604 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.2 160.77 25.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 124.003 0.814 . . . . 0.0 110.014 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.12 148.41 43.56 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -62.94 121.16 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.017 1.812 . . . . 0.0 109.248 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.11 133.67 68.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.426 0.632 . . . . 0.0 111.765 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.459 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 47.3 mt-10 -122.76 135.05 54.44 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.15 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.98 120.82 63.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.115 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -121.66 91.33 3.49 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.93 -99.19 0.18 Allowed Glycine 0 N--CA 1.437 -1.271 0 O-C-N 123.793 0.683 . . . . 0.0 113.869 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -90.55 -18.55 25.05 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.828 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -110.91 147.47 34.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 78.6 mt -127.32 129.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.577 176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -119.22 136.9 53.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.68 137.53 55.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -97.35 114.69 26.52 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.012 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.5 m -100.27 -40.53 7.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -53.86 111.0 0.66 Allowed 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.686 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.82 -25.28 9.64 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.343 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -103.73 133.16 48.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 120.939 0.4 . . . . 0.0 110.119 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.89 124.05 55.71 Favored Pre-proline 0 N--CA 1.403 -2.799 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.464 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 149.29 85.78 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 121.865 1.71 . . . . 0.0 108.712 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -91.49 113.54 25.83 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm 49.66 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 124.71 1.256 . . . . 0.0 110.241 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 44.99 -156.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.856 1.662 . . . . 0.0 111.299 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.5 t60 69.22 116.33 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.759 0.823 . . . . 0.0 110.3 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 C--O 1.246 0.871 0 C-N-CA 124.036 0.934 . . . . 0.0 111.266 -174.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' FES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.6 ttm . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 121.204 0.526 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 39.9 t -148.7 -145.93 0.18 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.46 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 81.0 m-85 -80.15 97.9 7.08 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.157 0.503 . . . . 0.0 109.701 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -106.23 143.75 33.91 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -75.0 124.05 26.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -83.18 -54.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.8 m -171.98 -173.79 1.19 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 126.001 1.72 . . . . 0.0 108.052 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 15.5 p -101.11 151.47 21.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.13 -17.85 43.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.257 1.027 . . . . 0.0 108.971 175.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.86 -25.74 68.3 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.164 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -93.11 -43.8 8.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.303 0.573 . . . . 0.0 109.824 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 tp -100.28 117.21 45.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.984 0.897 . . . . 0.0 111.868 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -105.86 168.97 8.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.298 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.58 123.68 26.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.143 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.72 65.29 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -104.01 162.13 13.4 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.04 0.447 . . . . 0.0 110.377 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 53' ' ' SER . 26.7 ptt? -150.15 136.84 19.16 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.56 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.3 tp10 -147.39 152.93 38.97 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.622 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 97.2 m -97.33 129.19 44.63 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.85 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -139.74 157.97 44.87 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -108.01 143.78 36.23 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.159 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 p -83.07 168.61 16.75 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -68.18 -18.62 64.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.442 0.639 . . . . 0.0 109.664 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.44 -13.33 52.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.84 14.26 37.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.201 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 m -97.37 126.39 42.58 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -89.2 123.69 33.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.47 146.01 33.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.7 -171.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.53 111.92 24.42 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 30' ' ' ILE . 2.4 mp -95.95 119.22 43.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 7.6 p -110.08 123.82 66.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -114.51 104.15 11.74 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.376 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 36' ' ' HIS . 58.9 p -102.32 148.77 25.06 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.13 -37.96 66.46 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.315 0.578 . . . . 0.0 110.27 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -86.13 -30.2 22.7 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.811 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.439 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 12.0 m170 -106.84 -23.58 12.34 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.82 -170.96 17.56 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.448 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -98.25 121.45 48.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.495 0.664 . . . . 0.0 111.459 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.421 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -117.77 148.15 42.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.195 177.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.18 113.19 17.99 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -131.72 163.6 27.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -50.71 138.14 18.82 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.707 0.63 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.09 8.74 32.38 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.2 tpt -75.57 88.4 2.7 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.217 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.702 ' SG ' ' HB2' ' A' ' 48' ' ' GLN . 44.8 t -159.25 85.57 2.25 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.918 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.62 5.62 6.28 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.315 2.01 . . . . 0.0 108.947 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.408 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 17.9 t-160 -86.51 -18.91 30.38 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.74 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.702 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 53.6 tt0 -69.24 147.06 51.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.421 -1.263 . . . . 0.0 113.383 -171.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.16 100.05 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.046 1.738 . . . . 0.0 112.953 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mm 63.75 -79.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 125.049 1.339 . . . . 0.0 114.017 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.42 HD12 ' H ' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -118.65 119.99 36.12 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -174.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.4 HD22 ' H ' ' A' ' 52' ' ' LEU . 1.9 pt? -63.93 -49.08 74.0 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 77.4 p -73.74 -31.34 63.31 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.499 0.666 . . . . 0.0 112.446 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.42 ' H ' HD12 ' A' ' 51' ' ' LEU . 43.4 mt-10 -95.11 22.06 7.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.78 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.0 -95.41 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.655 0.597 . . . . 0.0 113.373 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.7 m -155.53 127.5 7.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.899 0.857 . . . . 0.0 111.903 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -130.44 120.62 24.47 Favored 'General case' 0 C--N 1.261 -3.273 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.707 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.509 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 45.9 mt-10 -110.21 168.17 9.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -37.01 -58.45 1.22 Allowed Glycine 0 N--CA 1.48 1.575 0 O-C-N 124.236 0.96 . . . . 0.0 114.782 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.26 24.59 4.7 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.771 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 64.5 t -124.15 122.07 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 120.944 0.402 . . . . 0.0 110.484 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.648 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 47.8 mm -95.72 138.08 22.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 m -127.22 115.69 19.45 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.18 -1.408 . . . . 0.0 111.112 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 4.1 t -64.86 -21.78 66.87 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.505 ' H ' HD13 ' A' ' 68' ' ' LEU 0.343 71.6 ttt180 46.39 80.95 0.04 OUTLIER 'General case' 0 C--O 1.248 1.009 0 C-N-CA 129.505 3.122 . . . . 0.0 117.792 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.661 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . . . 174.02 -45.4 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 125.352 1.657 . . . . 0.0 109.464 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.408 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 4.7 p-80 -123.31 8.84 9.11 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -119.82 162.75 18.57 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.547 -1.261 . . . . 0.0 112.759 -177.066 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 75.6 t-105 -96.71 -69.45 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 p -135.01 141.96 46.32 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 121.497 0.665 . . . . 0.0 111.686 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.648 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 21.3 t80 -135.45 138.29 43.04 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -98.81 127.22 44.68 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.411 ' CG ' ' HZ3' ' A' ' 39' ' ' LYS . 5.7 t70 -62.2 -56.59 17.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.157 0.983 . . . . 0.0 113.446 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.33 -50.43 62.42 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.202 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.2 m -81.17 -32.51 33.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.165 0.507 . . . . 0.0 110.402 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.97 71.65 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.61 ' HA ' ' SG ' ' A' ' 85' ' ' CYS . 14.2 t-80 -102.65 138.61 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.543 1.137 . . . . 0.0 109.567 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.1 140.79 15.66 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.8 -48.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -149.17 112.18 3.52 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.052 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -76.8 160.68 94.73 Favored 'Cis proline' 0 C--O 1.241 0.663 0 C-N-CA 123.127 -1.614 . . . . 0.0 111.817 -0.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.38 -40.88 66.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.742 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -89.44 26.28 1.73 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.194 0.521 . . . . 0.0 111.719 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.405 ' O ' ' HE2' ' A' ' 71' ' ' PHE . 18.5 t -101.27 6.22 42.79 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.581 0.705 . . . . 0.0 109.428 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 38.0 m -51.53 155.91 1.43 Allowed 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.127 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 pp -101.53 -177.86 3.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.27 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.58 113.55 15.59 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.5 120.33 32.87 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.638 0.733 . . . . 0.0 110.904 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -91.61 129.65 41.92 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.21 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.49 120.89 8.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.693 2.929 . . . . 0.0 112.04 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.01 131.74 56.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.233 0.54 . . . . 0.0 111.114 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -109.38 110.56 21.74 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.2 115.81 50.72 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.49 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -126.01 147.02 49.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -38.91 124.45 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.602 0.564 . . . . 0.0 113.628 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 8' ' ' SER . 19.5 m-20 78.92 -19.53 0.44 Allowed 'General case' 0 C--O 1.2 -1.535 0 C-N-CA 126.281 1.832 . . . . 0.0 114.928 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 34.4 t70 -145.77 143.64 29.82 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.673 1.579 . . . . 0.0 114.266 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.94 127.15 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.38 151.3 38.72 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.364 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.87 144.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 121.388 0.613 . . . . 0.0 111.627 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.46 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 37.3 t -95.28 124.85 39.54 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.094 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -111.07 15.41 21.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 63.8 tttp -66.35 110.18 2.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.789 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.53 7.11 78.5 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.256 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.04 108.8 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.22 155.66 38.63 Favored Pre-proline 0 N--CA 1.411 -2.412 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 138.19 53.63 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.918 1.745 . . . . 0.0 109.632 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.12 169.8 17.62 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -52.65 -23.1 5.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.061 1.344 . . . . 0.0 113.782 -171.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.0 -16.21 63.18 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.96 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -64.31 97.98 0.21 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.731 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 124.052 0.941 . . . . 0.0 110.577 177.122 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.661 ' S1 ' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 119.723 -0.179 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 24.6 m 60.63 -87.95 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.825 0.85 . . . . 0.0 111.929 -176.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 77.1 m-85 -95.65 107.54 19.75 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -114.12 150.31 34.29 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.04 117.72 9.48 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 tp -111.33 -39.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.945 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.5 m -147.94 172.26 14.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.363 0.601 . . . . 0.0 110.717 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.538 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 27.2 m -118.86 152.38 36.36 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 170.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.57 -17.15 12.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.524 0.678 . . . . 0.0 112.398 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.69 -22.15 54.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.92 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.54 -35.73 24.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.888 0.852 . . . . 0.0 109.305 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.2 tp -125.07 113.95 38.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.165 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -104.28 168.39 9.13 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.829 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 122.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.308 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.88 65.36 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -103.84 159.91 15.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 121.405 0.621 . . . . 0.0 112.07 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 26.8 ptt? -151.35 140.89 21.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.07 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 43.8 tt0 -154.53 155.04 34.1 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.831 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 85.1 m -90.39 132.01 35.84 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.634 0.731 . . . . 0.0 110.677 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -128.37 153.49 47.0 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.11 137.44 45.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.565 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 p -83.89 -178.33 6.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.611 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -70.24 -30.75 67.88 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.69 -13.01 57.15 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.46 20.28 13.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.222 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.9 m -87.14 123.67 32.43 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.57 123.01 33.88 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.9 t -133.09 146.0 33.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 120.778 0.323 . . . . 0.0 110.269 -174.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.427 HD23 ' CE1' ' A' ' 41' ' ' TYR . 66.3 tp -96.17 114.81 26.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.1 mp -96.53 116.76 39.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 43.5 t -112.84 128.64 69.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -110.91 107.14 16.5 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -96.62 149.39 21.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.856 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -50.3 49.55 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -89.1 -37.57 14.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.898 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -94.35 1.42 55.88 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 -161.51 54.24 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.704 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.2 t -89.22 122.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -122.31 136.44 54.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.37 127.31 47.39 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.427 ' CE1' HD23 ' A' ' 29' ' ' LEU . 40.3 p90 -143.68 163.7 32.53 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.393 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' A' ' 111' ' ' HIS . 6.1 tp-100 -44.3 137.38 3.58 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.897 0.748 . . . . 0.0 110.101 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.78 -36.03 7.17 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.481 ' HB3' ' H ' ' A' ' 112' ' ' SER . 0.6 OUTLIER -86.32 121.54 29.04 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.931 -0.707 . . . . 0.0 112.309 -177.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.3 t -97.11 118.66 64.5 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 112' ' ' SER . 41.7 Cg_endo -90.78 10.55 2.84 Favored 'Trans proline' 0 CA--C 1.502 -1.114 0 C-N-CA 123.129 2.553 . . . . 0.0 111.151 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.657 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 11.3 t-160 -72.02 -56.06 6.3 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -140.95 -63.89 0.46 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -125.6 157.86 36.11 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.402 HG13 ' CD2' ' A' ' 51' ' ' LEU . 38.1 pt -108.42 -161.57 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.039 0.936 . . . . 0.0 109.336 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.402 ' CD2' HG13 ' A' ' 50' ' ' ILE . 4.3 mm? 74.6 29.01 1.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.884 0.85 . . . . 0.0 110.587 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 64' ' ' CYS . 53.8 tp -59.08 -29.69 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.478 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 51.0 p -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.279 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -109.95 22.47 15.59 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.89 -129.38 1.37 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 t -137.26 151.99 49.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.148 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -129.87 129.25 43.7 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.87 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.48 169.48 9.13 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.25 -46.62 5.43 Favored Glycine 0 N--CA 1.476 1.305 0 O-C-N 123.964 0.79 . . . . 0.0 114.239 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.58 14.95 3.4 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.786 -1.197 . . . . 0.0 113.073 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.93 140.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.564 ' HB ' ' CB ' ' A' ' 71' ' ' PHE . 29.3 mm -112.27 140.34 32.47 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.639 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 68' ' ' LEU . 49.9 m -100.47 117.55 34.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.823 -0.548 . . . . 0.0 110.674 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.43 ' HA ' HD13 ' A' ' 52' ' ' LEU . 43.0 t -66.25 135.72 54.85 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -49.82 107.0 0.13 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.082 0.553 . . . . 0.0 111.917 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.26 13.94 9.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.472 1.109 . . . . 0.0 113.177 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -129.53 98.12 4.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.628 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.402 ' O ' HG22 ' A' ' 63' ' ' THR . 4.4 mm? 64.95 -170.34 0.19 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -128.66 11.61 6.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.645 -176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.65 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -120.05 130.8 54.86 Favored 'General case' 0 C--O 1.167 -3.271 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.564 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 45.4 t80 -139.74 159.43 42.19 Favored 'General case' 0 CA--C 1.469 -2.142 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 166.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.493 ' ND2' ' HB ' ' A' ' 75' ' ' THR . 51.0 t30 -115.73 99.08 7.05 Favored 'General case' 0 N--CA 1.391 -3.398 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.024 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.46 -60.16 3.45 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.775 -173.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.48 32.71 4.62 Favored Glycine 0 C--N 1.304 -1.213 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.777 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.493 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 26.0 m -151.4 -38.62 0.12 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.282 0.541 . . . . 0.0 111.318 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.76 -55.84 0.52 Allowed Glycine 0 C--O 1.223 -0.575 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.829 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 85' ' ' CYS . 16.2 p80 -85.1 135.24 34.07 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' HA3' ' CB ' ' A' ' 72' ' ' ASN . . . 157.14 38.0 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.385 0 N-CA-C 119.815 2.686 . . . . 0.0 119.815 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.725 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 mp -107.11 -56.11 5.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 116.901 -1.92 . . . . 0.0 111.775 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 24.6 t-20 159.34 105.49 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.389 1.476 . . . . 0.0 107.909 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 5.7 Cg_exo -78.83 -170.86 9.15 Favored 'Cis proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.812 -1.745 . . . . 0.0 110.909 1.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 7.0 m-20 -61.15 -18.17 56.69 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.72 -32.8 70.87 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.062 1.345 . . . . 0.0 113.121 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.725 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 17.9 p -81.74 133.12 35.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.124 -1.031 . . . . 0.0 112.311 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' A' ' 109' ' ' LYS . 12.9 p -142.02 170.1 16.35 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.603 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -146.13 125.83 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.576 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.608 ' HB3' ' H ' ' A' ' 108' ' ' ASN . . . -60.25 129.0 39.5 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -96.26 131.17 43.03 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.789 0.681 . . . . 0.0 109.556 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 101' ' ' SER . 47.4 m-85 -116.08 138.56 24.24 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -59.97 135.12 60.86 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 C-N-CA 123.15 2.566 . . . . 0.0 112.037 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.87 130.78 74.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -109.92 112.7 24.89 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.88 106.73 21.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 122.07 0.938 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.438 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -129.64 117.32 20.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.342 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.16 -115.14 7.63 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.302 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.538 ' O ' ' HA ' ' A' ' 8' ' ' SER . 7.1 m-20 -95.76 -10.78 28.23 Favored 'General case' 0 C--O 1.195 -1.791 0 O-C-N 123.64 0.259 . . . . 0.0 110.784 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -104.21 138.66 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.2 mt -124.74 115.33 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.463 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -109.52 145.08 36.89 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.881 176.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 60.2 t -134.11 145.56 32.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 32.8 t -87.86 113.69 23.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 t -126.2 -11.34 6.41 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.203 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 2' ' ' SER . 59.1 tttp -122.87 126.42 47.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.38 -39.86 2.46 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.2 mt -102.07 106.21 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.5 tt -85.79 130.42 50.78 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -42.08 128.78 4.27 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 124.056 3.17 . . . . 0.0 112.02 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.608 ' H ' ' HB3' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -94.22 116.69 29.12 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.983 0.421 . . . . 0.0 111.04 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.539 ' HD3' ' SG ' ' A' ' 85' ' ' CYS . 89.0 tttt 57.0 -169.16 0.1 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.282 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.461 ' H ' ' HG2' ' A' ' 109' ' ' LYS . . . 65.4 -167.53 0.22 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.403 ' HB2' ' NE2' ' A' ' 42' ' ' GLN . 51.0 t-80 74.12 116.09 0.06 Allowed 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 126.185 1.794 . . . . 0.0 111.345 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.481 ' H ' ' HB3' ' A' ' 44' ' ' MET . 15.8 t . . . . . 0 C--N 1.3 -1.557 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.657 ' S1 ' ' HB3' ' A' ' 47' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ptp . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 121.31 0.576 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 101' ' ' SER . 57.5 m -159.13 -60.49 0.07 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -88.56 131.77 34.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.007 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.67 149.17 38.52 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HB3' ' HZ3' ' A' ' 5' ' ' LYS . 6.7 ttpm? -68.7 127.1 31.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.448 HG23 ' N ' ' A' ' 7' ' ' CYS . 7.6 tp -83.75 -50.31 15.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' N ' HG23 ' A' ' 6' ' ' ILE . 95.7 m -164.64 -175.24 3.74 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 125.094 1.357 . . . . 0.0 108.416 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.9 m -111.16 154.98 23.58 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.07 -16.41 7.31 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.429 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 5.1 p-10 -79.99 -20.2 46.02 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.657 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.05 -54.56 4.76 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 4.0 tp -108.05 110.54 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.071 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.432 ' HB2' ' CG ' ' A' ' 16' ' ' GLU . 20.8 m95 -86.37 163.03 17.88 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.227 -1.352 . . . . 0.0 111.163 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.65 121.88 26.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.235 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.5 59.81 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.432 ' CG ' ' HB2' ' A' ' 13' ' ' TRP . 24.4 mm-40 -107.66 162.42 13.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.937 0.399 . . . . 0.0 110.964 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.648 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 26.1 ptt? -144.3 135.57 25.49 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.179 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' SER 0.319 10.1 pt-20 -157.18 155.12 30.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.509 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 71.9 m -83.52 127.05 33.42 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.681 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -126.81 150.5 49.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -97.55 143.81 27.87 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.534 0.683 . . . . 0.0 111.457 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -83.55 176.98 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.518 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -74.39 -8.78 57.42 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.2 0.524 . . . . 0.0 111.241 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.9 -6.16 51.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.405 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.81 17.67 57.7 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.019 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 m -94.47 127.32 40.3 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.24 124.29 34.25 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.652 0.739 . . . . 0.0 110.602 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' THR . 48.7 t -125.42 146.5 31.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.93 -175.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 65.4 tp -89.35 111.21 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.81 114.21 31.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.78 123.72 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.9 t30 -106.46 104.7 14.45 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.578 ' CB ' ' HB3' ' A' ' 36' ' ' HIS . 19.6 m -100.33 157.34 16.69 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.1 -51.41 13.54 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -108.55 -25.21 11.02 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.954 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.578 ' HB3' ' CB ' ' A' ' 33' ' ' SER . 43.6 t-80 -79.17 -7.61 58.35 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.785 0.803 . . . . 0.0 109.166 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.73 173.19 17.77 Favored Glycine 0 CA--C 1.5 -0.86 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.591 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.432 ' O ' ' HB ' ' A' ' 91' ' ' VAL . 7.1 p -84.64 117.58 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.27 176.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -130.07 149.14 51.92 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.319 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.436 ' HB1' ' HB2' ' A' ' 89' ' ' TYR . . . -123.71 132.35 53.81 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.6 154.84 51.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.414 ' OE1' ' HB3' ' A' ' 107' ' ' PRO . 26.6 mm-40 -53.98 137.02 40.41 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.567 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.563 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -101.13 -11.35 19.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.873 0.844 . . . . 0.0 109.739 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.455 ' HA ' ' HE3' ' A' ' 44' ' ' MET . 11.9 mmt -93.98 108.77 20.55 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.054 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.501 ' C ' ' H ' ' A' ' 47' ' ' HIS . 24.0 p -105.79 172.57 3.86 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.819 ' HD2' ' S2 ' ' A' ' 113' ' ' FES . 73.2 Cg_endo -76.15 21.78 0.52 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 121.89 1.727 . . . . 0.0 111.605 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' A' ' 45' ' ' CYS . 32.0 m80 -144.45 135.35 25.04 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 125.336 1.454 . . . . 0.0 107.649 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 60.11 -172.11 0.13 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.512 0.672 . . . . 0.0 112.394 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.66 -48.88 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.3 pt -94.66 178.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp 79.67 -25.88 0.18 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.463 1.105 . . . . 0.0 112.368 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 43' ' ' ALA . 4.0 mm? -56.8 -40.89 76.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.52 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 90.5 p -80.31 -15.6 56.53 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.369 0.604 . . . . 0.0 110.888 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -92.0 -9.13 44.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.949 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 126.65 0.89 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.589 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.7 t 178.28 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.648 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 66.3 t80 -91.85 113.11 25.29 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.109 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -115.91 105.34 12.56 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.452 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 -69.24 1.69 Allowed Glycine 0 C--O 1.241 0.567 0 O-C-N 123.215 0.322 . . . . 0.0 112.313 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.68 26.39 0.16 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.62 133.8 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 42.9 mm -96.51 117.16 40.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.003 0.906 . . . . 0.0 109.525 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.7 m -102.0 121.33 41.95 Favored 'General case' 0 C--N 1.259 -3.333 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.194 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.977 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 1.2 m -75.24 -177.02 3.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.374 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.499 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 2.8 mmp_? -119.33 -42.44 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.165 -1.014 . . . . 0.0 113.153 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' HB3' ' A' ' 47' ' ' HIS . . . -98.17 -20.57 17.21 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.606 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -116.51 137.33 52.26 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 117.969 -1.493 . . . . 0.0 109.314 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.445 HD12 ' O ' ' A' ' 68' ' ' LEU . 2.9 tm? -63.26 -36.47 83.76 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 124.28 1.032 . . . . 0.0 113.119 -170.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 13.5 m-90 -62.26 174.36 0.95 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -175.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -103.37 161.22 14.02 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.644 0.735 . . . . 0.0 112.6 -169.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.516 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 48.7 t80 -132.43 141.41 48.83 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.24 119.8 31.25 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -73.47 -22.31 60.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.48 -54.49 10.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.6 m -73.9 -34.65 64.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.844 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.8 -4.26 49.73 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.751 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -125.27 161.74 26.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 122.84 0.456 . . . . 0.0 110.381 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -77.98 144.07 28.28 Favored Glycine 0 N--CA 1.416 -2.65 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.83 -30.68 29.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.442 ' HA ' ' C ' ' A' ' 81' ' ' PRO . 27.4 t-20 -143.61 125.83 8.53 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.356 172.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 80' ' ' ASN . 22.0 Cg_exo -67.37 -63.79 0.03 OUTLIER 'Cis proline' 0 C--N 1.354 0.824 0 C-N-CA 123.847 -1.314 . . . . 0.0 113.783 0.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 21.4 t70 164.91 -35.06 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 125.122 1.369 . . . . 0.0 109.569 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.16 -26.91 69.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.845 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.31 142.36 39.46 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 121.744 0.783 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.33 150.93 31.09 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.834 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 86' ' ' LEU . 1.6 pt? -114.44 141.34 47.8 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.267 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.408 ' HB1' ' HB2' ' A' ' 108' ' ' ASN . . . -88.12 124.05 33.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.379 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -96.74 110.85 23.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 33.9 m-85 -79.24 139.79 56.44 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.662 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.27 120.22 7.4 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.227 1.952 . . . . 0.0 109.114 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 38' ' ' VAL . 20.9 t -132.38 140.84 46.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -136.37 150.32 48.76 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.977 0.418 . . . . 0.0 110.982 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.02 117.28 55.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.283 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.427 ' HZ3' ' HB2' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -125.94 100.73 6.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.603 0.716 . . . . 0.0 110.243 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.94 -112.16 3.95 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.083 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.502 ' O ' ' HB3' ' A' ' 8' ' ' SER . 19.5 m-20 -102.24 -1.82 30.42 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.729 -0.235 . . . . 0.0 111.115 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.427 ' HB2' ' HZ3' ' A' ' 94' ' ' LYS . 26.1 m-20 -121.82 155.85 34.47 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.84 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 75.1 mt -127.58 129.04 70.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -112.72 143.14 44.45 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.926 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.409 ' CG1' ' HB ' ' A' ' 6' ' ' ILE . 5.9 p -132.85 143.39 39.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.806 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 2' ' ' SER . 33.5 t -91.58 113.94 26.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.0 p -109.99 -41.25 4.52 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.339 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -70.65 112.17 6.68 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.136 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.3 -27.32 7.03 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.5 mm -99.78 117.73 45.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 tt -99.27 136.38 20.48 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.414 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 50.5 Cg_exo -55.72 127.78 27.58 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.309 2.006 . . . . 0.0 111.534 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.408 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 33.9 t-20 -84.45 177.33 8.17 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.462 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -74.27 60.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 124.248 1.019 . . . . 0.0 113.354 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 46' ' ' PRO . . . -84.98 -20.08 31.08 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 26.9 p80 -141.65 155.74 45.69 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--N 1.287 -2.121 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.371 178.547 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.977 ' S1 ' ' HB3' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 m 55.77 91.42 0.03 OUTLIER 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -170.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 74.17 96.77 0.07 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -166.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -119.79 150.06 41.02 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.99 109.51 5.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -92.04 -40.91 12.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.853 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . 63.7 m -155.09 175.85 13.3 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.473 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 m -120.88 154.79 35.37 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.21 -25.28 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.203 0.525 . . . . 0.0 111.062 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.49 -20.61 62.84 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.258 0.551 . . . . 0.0 110.777 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 17.4 m-20 -88.51 -36.88 16.17 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.938 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 tp -130.71 116.14 33.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.158 0.98 . . . . 0.0 111.736 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -104.72 167.15 9.91 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.029 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.57 130.47 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.245 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 10.09 70.61 Favored Glycine 0 C--N 1.309 -0.942 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.61 147.68 48.34 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 120.814 0.34 . . . . 0.0 111.108 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.8 mtp -130.74 133.74 46.29 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 33.4 mt-10 -146.17 140.43 26.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.861 0.363 . . . . 0.0 111.349 172.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.1 m -73.78 132.48 42.65 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -128.4 162.22 27.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -106.18 137.06 44.78 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.413 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -83.54 171.87 12.93 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 m -67.8 -17.99 64.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.056 0.455 . . . . 0.0 111.729 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.56 4.8 51.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.8 29.36 35.29 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.597 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -98.68 136.72 38.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.386 -0.479 . . . . 0.0 110.177 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.49 124.94 34.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 41' ' ' TYR . 97.3 t -133.6 147.01 31.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.467 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -96.41 117.21 30.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -100.78 116.97 45.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.3 122.83 68.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' OD1' ' HB ' ' A' ' 38' ' ' VAL . 49.3 t30 -113.87 106.8 14.88 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.432 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -99.99 150.78 22.08 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -51.38 12.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.58 -45.86 12.13 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -79.01 -12.95 60.04 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.025 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -175.75 50.83 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.139 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.443 ' HB ' ' OD1' ' A' ' 32' ' ' ASN . 6.6 p -105.4 125.26 60.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.524 0.678 . . . . 0.0 111.115 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -129.92 150.98 50.96 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.595 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.07 128.44 49.33 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' O ' HG12 ' A' ' 28' ' ' VAL . 2.6 m-85 -131.08 163.08 28.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HB2' HD13 ' A' ' 86' ' ' LEU . 15.7 mm100 -53.12 138.95 30.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.19 -28.24 1.2 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 -169.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.492 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -162.28 -178.15 6.15 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -169.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.573 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 86.9 m -87.02 163.75 39.16 Favored Pre-proline 0 C--N 1.361 1.091 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 169.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.58 24.31 0.17 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.276 1.984 . . . . 0.0 113.037 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.468 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 32.2 m170 -111.96 -52.25 2.8 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 63.33 108.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 55.0 mm-40 -124.5 170.74 10.59 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 165.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 pt -87.18 167.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 118.429 0.559 . . . . 0.0 111.092 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.7 mt 70.73 28.84 3.35 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.533 1.133 . . . . 0.0 111.449 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.557 ' H ' HD21 ' A' ' 52' ' ' LEU . 1.7 pt? -75.24 -42.17 55.84 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.587 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 96.1 p -72.93 -21.97 60.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.924 0.869 . . . . 0.0 109.503 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.66 15.86 5.26 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.293 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.2 -124.93 1.93 Allowed Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.4 m -142.79 157.09 44.97 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-O 122.167 0.984 . . . . 0.0 113.009 -174.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.06 116.79 19.84 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.27 -1.787 . . . . 0.0 108.222 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -115.15 104.55 11.96 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.87 -74.87 0.46 Allowed Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.648 0.582 . . . . 0.0 111.905 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.0 0.51 0.34 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.69 143.33 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.531 HD11 ' N ' ' A' ' 62' ' ' ILE . 0.1 OUTLIER -117.89 117.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.389 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.5 m -108.86 132.15 54.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.255 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.658 ' HB3' ' N ' ' A' ' 69' ' ' TRP . 1.7 p -85.02 -13.91 49.02 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 64.47 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.973 0.909 . . . . 0.0 112.649 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.49 27.74 8.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 109.775 -175.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.657 ' HA ' ' S1 ' ' A' ' 113' ' ' FES 0.276 96.2 m-70 84.01 97.24 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.599 HD12 ' C ' ' A' ' 67' ' ' HIS . 7.2 mp -149.51 -80.04 0.13 Allowed 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 127.906 2.482 . . . . 0.0 108.954 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.658 ' N ' ' HB3' ' A' ' 64' ' ' CYS . 0.9 OUTLIER -146.8 135.22 21.89 Favored 'General case' 0 CA--C 1.594 2.641 0 O-C-N 121.955 -0.466 . . . . 0.0 111.221 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.584 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -139.69 132.4 29.0 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.541 -0.725 . . . . 0.0 112.721 174.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.416 ' H ' HG12 ' A' ' 62' ' ' ILE . 75.2 t80 -138.15 150.43 46.8 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.353 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.502 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . 45.8 t-20 -105.98 100.46 10.01 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.01 -36.71 50.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.13 -3.3 60.38 Favored Glycine 0 C--N 1.311 -0.832 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.857 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.3 m -139.74 -14.55 1.07 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.089 0.944 . . . . 0.0 112.98 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.49 -59.17 4.99 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.499 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 42.0 m80 -63.44 102.29 0.4 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.584 ' O ' ' HB ' ' A' ' 70' ' ' THR . . . -161.06 19.06 0.2 Allowed Glycine 0 CA--C 1.469 -2.823 0 C-N-CA 119.985 -1.102 . . . . 0.0 114.284 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.478 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.5 mp -98.77 -12.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.106 0 CA-C-N 115.126 -0.537 . . . . 0.0 111.131 -169.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.573 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 73.7 m-20 77.28 115.06 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.721 0 C-N-CA 125.293 1.437 . . . . 0.0 112.111 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 83' ' ' ASP . 14.1 Cg_exo -71.35 -174.14 10.74 Favored 'Cis proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.039 -1.65 . . . . 0.0 112.012 -0.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.499 ' O ' ' HB3' ' A' ' 77' ' ' HIS . 9.2 p-10 -68.99 2.76 2.43 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.714 0.769 . . . . 0.0 111.248 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 81' ' ' PRO . 16.9 t70 -80.55 -21.14 42.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.965 174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.519 ' SG ' ' HE2' ' A' ' 109' ' ' LYS . 37.3 m -102.42 141.38 35.34 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.424 0.631 . . . . 0.0 111.507 -172.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.3 p -122.15 178.09 5.07 Favored 'General case' 0 C--N 1.273 -2.754 0 C-N-CA 125.176 1.391 . . . . 0.0 109.899 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 42' ' ' GLN . 52.1 tp -141.25 156.28 45.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.37 124.28 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.902 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.68 125.09 38.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 98.6 m-85 -100.27 132.36 22.69 Favored Pre-proline 0 C--N 1.28 -2.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.917 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.5 120.78 8.16 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.109 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.416 HG12 HG23 ' A' ' 100' ' ' VAL . 45.1 t -109.47 134.47 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.3 131.98 56.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -108.41 118.1 55.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.781 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.76 91.57 3.37 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.59 -107.3 1.33 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.77 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -101.87 -0.97 33.15 Favored 'General case' 0 C--O 1.193 -1.872 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.332 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -106.52 139.51 40.87 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.441 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.5 mm -127.06 122.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.204 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -118.82 142.78 47.41 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.962 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.416 HG23 HG12 ' A' ' 91' ' ' VAL . 39.2 t -134.31 139.14 48.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 t -95.31 114.29 26.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.507 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 24.5 p -118.52 -47.01 2.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.668 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -78.48 105.02 9.46 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.558 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.44 -35.57 1.72 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -96.19 128.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.21 133.09 72.22 Favored Pre-proline 0 N--CA 1.417 -2.076 0 CA-C-O 120.671 0.272 . . . . 0.0 111.722 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.471 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 18.4 Cg_endo -61.22 134.72 53.95 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.307 2.671 . . . . 0.0 111.135 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.57 123.52 47.69 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.519 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 52.0 tptt 58.88 178.87 0.07 Allowed 'General case' 0 CA--C 1.568 1.662 0 O-C-N 125.467 1.729 . . . . 0.0 111.349 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.449 ' N ' ' HG3' ' A' ' 109' ' ' LYS . . . 65.6 -78.1 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.185 1.394 . . . . 0.0 114.217 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -133.54 105.33 6.83 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 C--N 1.282 -2.344 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.659 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.657 ' S1 ' ' HA ' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -136.8 130.51 31.99 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 68.54 84.79 0.15 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.06 0.85 . . . . 0.0 109.846 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.74 144.09 40.23 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.181 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.13 119.27 20.59 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.313 0.578 . . . . 0.0 110.933 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.6 -44.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.747 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.95 -172.83 4.07 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.492 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.3 m -118.89 152.65 35.9 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.189 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.531 ' O ' HD21 ' A' ' 9' ' ' LEU . 6.5 tt -61.46 -22.06 64.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.292 0.637 . . . . 0.0 110.372 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.492 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 2.5 p-10 -77.27 -11.19 59.8 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.705 -0.622 . . . . 0.0 109.81 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -84.68 -45.04 12.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.8 pt -114.37 109.84 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 122.468 1.127 . . . . 0.0 109.777 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -75.25 170.43 16.07 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.747 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.59 115.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.173 0.511 . . . . 0.0 110.672 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.13 10.79 59.33 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.213 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.13 149.52 24.19 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -150.5 142.09 23.55 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.607 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 pt-20 -155.01 144.78 21.52 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.205 0.526 . . . . 0.0 112.291 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 90.1 m -79.96 138.85 37.17 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.588 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -129.65 162.33 28.56 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.32 134.93 54.36 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.079 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -83.15 168.46 16.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.0 m -68.0 -17.27 64.37 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.043 0.449 . . . . 0.0 110.767 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.52 -12.83 59.85 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.321 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.42 37.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.472 ' HA ' ' HG ' ' A' ' 112' ' ' SER . 76.0 m -96.13 131.58 42.42 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 122.181 0.193 . . . . 0.0 111.088 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.94 124.45 36.06 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.541 0.686 . . . . 0.0 109.353 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 19' ' ' THR . 58.1 t -125.84 136.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.403 ' CD2' ' HB2' ' A' ' 17' ' ' MET . 1.3 tt -95.56 112.21 23.97 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 18' ' ' GLU . 9.9 tp -95.8 117.22 39.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.52 125.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -113.13 104.58 12.5 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.138 174.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -102.0 158.54 16.07 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.432 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -75.54 -50.72 14.79 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.641 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.69 -46.46 17.07 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -84.44 -11.32 56.42 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.605 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.72 -157.44 34.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.967 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.65 123.22 53.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 16.7 tppt? -128.59 145.34 51.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.39 113.94 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.555 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.456 ' CZ ' HD12 ' A' ' 62' ' ' ILE . 22.5 m-85 -116.32 147.72 41.28 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.416 ' CG ' HD22 ' A' ' 86' ' ' LEU . 11.3 pt20 -64.36 138.71 58.57 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.99 -68.37 0.69 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.489 0.661 . . . . 0.0 111.043 -175.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.486 ' CE ' ' HA ' ' A' ' 44' ' ' MET 0.265 0.1 OUTLIER 62.73 -100.21 0.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -178.86 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.4 t 49.56 96.36 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.824 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.444 ' HD2' ' S2 ' ' A' ' 113' ' ' FES . 71.6 Cg_endo -75.58 36.96 0.48 Allowed 'Trans proline' 0 N--CA 1.48 0.69 0 C-N-CA 123.099 2.532 . . . . 0.0 112.149 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.469 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 37.2 m80 -150.39 -179.77 7.48 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 123.936 0.894 . . . . 0.0 109.578 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.7 pt20 62.78 142.33 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.523 2.329 . . . . 0.0 114.505 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.21 85.36 2.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 tp 169.83 167.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.48 138.04 36.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.928 0.394 . . . . 0.0 111.529 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.491 ' O ' HD21 ' A' ' 52' ' ' LEU . 4.1 tt -67.07 -32.47 73.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.5 p -63.7 -14.02 48.44 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.314 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -100.68 13.27 35.36 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.702 0.763 . . . . 0.0 109.267 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.76 -109.91 0.64 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.414 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 20.8 p -155.78 146.8 22.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -125.83 116.67 21.93 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.911 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 2.4 mp0 -99.37 170.12 8.86 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.24 67.45 0.37 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 -1.51 21.56 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.5 t -124.02 136.64 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.456 HD12 ' CZ ' ' A' ' 41' ' ' TYR . 52.2 mt -119.57 129.99 74.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 53.8 m -110.5 123.66 50.34 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 10.4 p -57.75 -30.6 65.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 169.24 -48.57 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.241 1.816 . . . . 0.0 107.501 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.69 -87.41 0.09 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.559 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.683 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 3.6 t-160 52.87 -85.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.161 1.384 . . . . 0.0 111.489 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.6 tp -174.16 -60.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.32 0.648 . . . . 0.0 109.47 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -99.11 -176.47 3.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.341 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 65.9 p -135.05 165.33 25.62 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.57 0.748 . . . . 0.0 111.316 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -103.22 147.75 26.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -118.22 126.12 51.54 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.997 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.71 -56.69 16.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.245 1.018 . . . . 0.0 111.243 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.49 50.02 4.27 Favored Glycine 0 CA--C 1.509 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.673 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.2 m -152.95 -44.83 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.24 -34.51 3.78 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.426 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . 21.3 t-80 -90.32 146.29 24.31 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.61 140.58 14.92 Favored Glycine 0 CA--C 1.483 -1.925 0 C-N-CA 118.705 -1.712 . . . . 0.0 112.391 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.419 ' HB ' ' O ' ' A' ' 70' ' ' THR . 2.0 mp -73.52 -31.41 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -109.97 129.4 23.97 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.632 169.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.37 -41.73 0.95 Allowed 'Cis proline' 0 CA--C 1.498 -1.283 0 C-N-CA 123.658 -1.393 . . . . 0.0 110.456 -4.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.3 t70 152.54 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.445 2.298 . . . . 0.0 107.326 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.45 -21.01 49.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.001 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.0 m -96.09 150.57 20.35 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-O 122.893 1.33 . . . . 0.0 112.721 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.426 ' HB3' ' HA ' ' A' ' 77' ' ' HIS . 1.7 p -140.0 148.62 42.13 Favored 'General case' 0 C--N 1.253 -3.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 106.904 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.416 HD22 ' CG ' ' A' ' 42' ' ' GLN . 51.2 mt -112.83 175.94 5.23 Favored 'General case' 0 C--N 1.266 -3.043 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.022 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.36 142.99 51.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.187 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.05 118.26 35.41 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.448 ' HH ' ' HA ' ' A' ' 107' ' ' PRO . 89.6 m-85 -89.81 148.07 39.0 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.754 -175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 101' ' ' SER . 11.9 Cg_exo -68.04 119.73 6.73 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.508 1.472 . . . . 0.0 111.002 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.6 p -127.95 134.84 64.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.128 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -127.32 126.51 42.7 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.497 0.665 . . . . 0.0 109.952 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.7 124.5 68.5 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.502 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.541 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.81 96.97 4.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.492 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.43 -104.87 1.52 Allowed Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.05 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 8' ' ' SER . 21.8 m-20 -109.37 4.11 22.19 Favored 'General case' 0 C--O 1.19 -2.027 0 CA-C-N 115.525 -0.337 . . . . 0.0 110.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.64 139.59 43.21 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 120.63 0.252 . . . . 0.0 111.155 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -127.1 119.64 53.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.495 0.664 . . . . 0.0 111.303 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -112.58 137.87 50.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.755 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.4 m -127.33 148.53 32.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.492 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 32.2 t -127.77 146.6 50.54 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.5 m -125.74 2.06 7.47 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -91.33 130.78 37.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.458 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.16 -45.8 1.26 Allowed Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.9 mt -108.05 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 33.6 tp -82.46 139.09 44.47 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.968 -177.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.448 ' HA ' ' HH ' ' A' ' 89' ' ' TYR . 96.0 Cg_exo -50.61 128.99 25.41 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 122.547 2.165 . . . . 0.0 111.014 174.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -86.99 143.57 27.28 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.687 -173.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.43 -76.09 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.08 2.552 . . . . 0.0 113.768 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.86 -61.62 2.28 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.075 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 61.02 92.38 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.202 0.939 . . . . 0.0 112.551 175.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.472 ' HG ' ' HA ' ' A' ' 26' ' ' THR . 35.0 p . . . . . 0 C--N 1.288 -2.101 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.683 ' S1 ' ' HB2' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -57.93 -51.33 70.06 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.85 148.04 35.73 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -142.46 144.84 33.21 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -73.16 129.54 38.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.241 0.543 . . . . 0.0 110.758 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.527 HG21 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -100.43 -42.61 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.044 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.527 ' SG ' HG21 ' A' ' 6' ' ' ILE . 7.7 p -165.76 -176.69 3.97 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.22 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 14.9 m -123.57 150.42 44.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.296 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.522 ' O ' HD21 ' A' ' 9' ' ' LEU . 6.4 tt -60.1 -24.62 64.79 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.222 1.409 . . . . 0.0 110.287 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.28 -23.49 64.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.21 -45.4 4.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.342 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 5.6 tp -100.68 110.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 122.298 1.047 . . . . 0.0 111.972 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -101.64 162.84 12.6 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.249 -1.342 . . . . 0.0 113.073 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.27 124.23 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.714 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.39 64.15 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -119.75 158.24 26.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -151.21 148.62 28.45 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.784 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.59 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.8 pt-20 -156.52 151.25 25.86 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.111 171.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -73.0 133.32 44.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.389 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -130.35 154.23 47.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -104.87 142.65 34.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.7 p -83.41 179.17 7.74 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -76.05 -17.65 59.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.169 0.509 . . . . 0.0 110.683 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.37 -12.49 49.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.607 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.15 21.73 19.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -95.81 120.59 36.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.02 122.61 33.82 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.153 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.8 142.6 42.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.125 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.5 tt -93.93 114.28 26.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.35 112.95 28.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.9 t -110.35 124.75 67.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.527 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -100.13 107.19 19.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -98.29 148.83 23.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.7 -36.71 65.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -111.15 -38.09 5.14 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.153 0.501 . . . . 0.0 111.082 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -81.97 -3.51 54.55 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.321 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.74 -178.67 47.95 Favored Glycine 0 CA--C 1.51 -0.281 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.671 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -78.2 129.55 37.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -129.32 141.77 51.0 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.52 115.1 20.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.765 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 47.7 p90 -143.62 157.32 44.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -50.25 138.03 17.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -106.86 -78.17 0.59 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.584 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.498 ' SD ' ' HD2' ' A' ' 111' ' ' HIS . 15.6 tpt 53.26 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.612 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 69.2 m 55.49 84.77 0.2 Allowed Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 121.119 0.485 . . . . 0.0 112.237 -168.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -90.87 21.13 0.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.93 1.753 . . . . 0.0 110.867 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.506 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 8.8 m80 -103.68 -78.6 0.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.05 -39.29 7.36 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 69.42 -89.42 0.03 OUTLIER 'General case' 0 C--O 1.243 0.745 0 O-C-N 124.465 1.103 . . . . 0.0 112.918 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.0 mt 58.24 -81.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 124.799 1.24 . . . . 0.0 109.212 -171.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -167.03 92.06 0.42 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 128.158 2.583 . . . . 0.0 104.306 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' HG ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -67.21 -21.82 65.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.419 0.628 . . . . 0.0 111.828 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.59 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 10.6 p -75.58 -10.67 59.64 Favored 'General case' 0 N--CA 1.414 -2.225 0 C-N-CA 124.805 1.242 . . . . 0.0 111.434 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -94.78 11.0 33.0 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.48 -128.18 1.39 Allowed Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.938 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -150.85 156.99 42.36 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.932 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -130.37 128.99 42.52 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.756 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -115.65 158.13 23.19 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 175.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.84 -30.31 21.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.119 0.407 . . . . 0.0 114.119 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.57 -4.08 5.86 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.163 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 61.7 t -124.04 125.0 70.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-N 117.343 0.572 . . . . 0.0 110.717 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.418 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 46.6 mt -103.17 136.09 37.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.47 HG23 ' HA ' ' A' ' 69' ' ' TRP . 99.3 m -117.51 116.02 26.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.31 144.49 57.11 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -50.98 -55.23 18.34 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.815 0.697 . . . . 0.0 109.639 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.6 91.66 2.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.274 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -167.94 -76.37 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 69' ' ' TRP . 5.2 tt -144.56 143.63 30.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.47 ' HA ' HG23 ' A' ' 63' ' ' THR . 40.8 p90 -89.82 -19.57 24.51 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -169.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 41.2 p -103.93 126.32 50.97 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.719 -177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 90.7 t80 -138.71 144.73 39.67 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -99.08 104.81 16.85 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 118.466 0.575 . . . . 0.0 111.146 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.38 -39.54 94.81 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.378 0.671 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.4 94.42 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.731 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 m -80.11 -35.41 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.864 0.364 . . . . 0.0 111.32 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.61 3.61 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 85' ' ' CYS . 14.8 t-80 -92.71 132.53 36.84 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 173.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.69 146.41 22.34 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.98 -36.26 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.402 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 47.7 t30 -164.24 110.79 0.9 Allowed Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.38 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.586 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 2.5 Cg_endo -87.97 172.11 32.48 Favored 'Cis proline' 0 CA--C 1.554 1.502 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.222 1.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.92 -11.39 28.73 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.29 12.92 34.87 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.987 0.898 . . . . 0.0 110.881 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.586 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 77.7 m -112.81 9.46 19.02 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.231 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 57.5 m -58.3 156.3 10.23 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.678 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 2.8 pp -117.85 169.09 9.9 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.207 -174.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 108' ' ' ASN . . . -130.88 122.18 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.89 127.36 32.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.172 0.51 . . . . 0.0 112.015 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.9 143.45 26.74 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.394 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.78 127.64 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.183 1.922 . . . . 0.0 110.53 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.78 143.74 39.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.04 138.08 52.43 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 120.938 0.399 . . . . 0.0 110.551 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.38 126.25 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.287 1.041 . . . . 0.0 111.474 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -119.52 146.92 45.03 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.41 100.66 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.575 ' O ' ' HA ' ' A' ' 8' ' ' SER . 38.1 t70 84.86 -33.46 0.06 Allowed 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 126.797 2.039 . . . . 0.0 114.476 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -99.37 131.2 45.55 Favored 'General case' 0 C--N 1.282 -2.353 0 O-C-N 120.639 -1.288 . . . . 0.0 111.206 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.15 123.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.837 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -112.74 145.61 40.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.985 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.4 144.51 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.4 t -105.1 115.22 29.9 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.4 m -106.44 -33.54 7.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.428 0.633 . . . . 0.0 109.486 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.513 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.3 tpmt? -74.02 107.98 6.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.666 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.29 -4.04 8.9 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.9 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.2 mm -119.17 140.69 42.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.44 120.79 55.29 Favored Pre-proline 0 N--CA 1.42 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.91 133.08 53.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.726 2.284 . . . . 0.0 111.996 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.413 ' CB ' ' HB3' ' A' ' 87' ' ' ALA . 51.2 t30 -89.53 176.24 6.97 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.571 -176.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.31 104.65 0.52 Allowed 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.198 0.999 . . . . 0.0 111.679 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -176.13 -38.64 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 112.278 -2.237 . . . . 0.0 105.649 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.498 ' HD2' ' SD ' ' A' ' 44' ' ' MET . 54.7 t-80 -129.32 92.87 3.44 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.308 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.167 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.612 ' S1 ' ' HB3' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 CA--C 1.502 -0.879 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.408 ' OG ' ' HE3' ' A' ' 103' ' ' LYS . 31.3 t -75.38 111.39 10.6 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.486 ' H ' ' HA ' ' A' ' 101' ' ' SER . 96.7 m-85 72.46 93.53 0.08 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.425 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 8.4 tp10 -106.81 138.27 43.29 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 4.1 tmmm? -80.94 105.14 11.93 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -85.94 -49.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.826 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.061 -176.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.5 m -145.65 177.58 8.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.709 0.766 . . . . 0.0 111.317 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.7 p -110.56 152.76 26.02 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.051 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.38 -20.04 58.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.014 0.911 . . . . 0.0 109.918 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.35 -20.88 58.77 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.363 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.22 -32.09 12.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.232 0.539 . . . . 0.0 110.556 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 16' ' ' GLU . 3.2 tp -124.11 111.87 30.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.921 0.867 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -105.06 163.96 12.17 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.406 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.57 124.98 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.422 0.63 . . . . 0.0 111.32 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.37 59.8 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.542 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' HB3' HD12 ' A' ' 12' ' ' ILE . 8.8 tp10 -103.76 152.16 22.18 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.75 139.1 20.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 120.883 0.373 . . . . 0.0 110.156 177.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.0 tt0 -158.05 155.22 28.91 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.2 t -89.16 132.61 34.75 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.027 175.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.34 151.7 42.22 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.05 133.78 47.59 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -83.01 178.79 7.99 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -69.11 -21.53 64.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.463 0.649 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.94 -13.36 58.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.696 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.01 23.06 33.61 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -92.85 115.6 28.26 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.99 123.75 34.16 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 40' ' ' ALA . 46.6 t -130.64 144.53 37.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.503 ' N ' ' HB2' ' A' ' 43' ' ' ALA . 62.2 tp -88.32 111.86 22.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.09 118.65 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -119.36 125.19 74.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.849 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 46.6 t-20 -92.32 106.99 18.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.0 m -99.02 152.96 19.24 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.8 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.51 -50.28 16.15 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.07 -22.19 18.67 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -99.23 -4.27 32.38 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.128 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.89 -170.67 51.42 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.908 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 46.2 t -80.55 120.74 32.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.06 150.74 50.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.147 0.498 . . . . 0.0 110.802 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.411 ' HB3' ' CG1' ' A' ' 28' ' ' VAL . . . -124.74 131.69 53.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.527 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 59.8 m-85 -130.21 162.21 29.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 119.562 -0.256 . . . . 0.0 110.478 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.549 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -50.18 136.31 19.73 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.503 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -118.05 -11.51 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.469 ' O ' ' HB3' ' A' ' 110' ' ' ALA . 47.3 tpp -69.2 108.91 3.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 47' ' ' HIS . 17.4 t -108.69 107.27 59.95 Favored Pre-proline 0 N--CA 1.413 -2.29 0 CA-C-O 121.233 0.54 . . . . 0.0 111.452 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -96.87 17.08 0.65 Allowed 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.677 2.251 . . . . 0.0 109.422 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.582 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 16.5 t-160 -94.71 -38.9 10.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.44 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.639 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 20.4 tt0 178.57 110.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.28 1.832 . . . . 0.0 107.704 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -155.94 134.71 11.86 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.127 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -114.57 -63.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 162.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.47 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 68.9 mt -154.06 110.82 3.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 165.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -68.59 -25.35 64.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.918 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.524 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 47.7 p -62.57 -19.65 63.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -170.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.47 ' OE1' ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp0 -84.88 -9.16 58.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.105 0.479 . . . . 0.0 110.818 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.57 81.07 0.27 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 63' ' ' THR . 66.9 m -143.26 -33.76 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -129.0 113.49 15.23 Favored 'General case' 0 C--N 1.264 -3.114 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.348 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -116.97 112.26 20.75 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.227 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 -73.8 1.04 Allowed Glycine 0 CA--C 1.5 -0.871 0 O-C-N 123.582 0.551 . . . . 0.0 111.938 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.26 13.64 0.15 Allowed Glycine 0 C--N 1.298 -1.56 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 177.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.74 143.6 23.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 O-C-N 122.531 -0.394 . . . . 0.0 110.273 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' SER . 48.4 mm -89.92 133.41 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.634 0.73 . . . . 0.0 111.934 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' A' ' 56' ' ' SER . 32.4 m -128.29 152.27 48.32 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 124.327 1.051 . . . . 0.0 108.253 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.1 t -119.82 89.03 3.05 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.453 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.433 ' HA ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 tpm_? 54.64 21.31 3.36 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.093 0.957 . . . . 0.0 111.001 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 62.8 100.18 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 111.894 -176.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.55 ' HB3' ' S1 ' ' A' ' 113' ' ' FES 0.271 1.5 p-80 -107.69 -13.06 15.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 1.7 tm? 171.36 -63.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 28.7 t-105 -141.05 -155.57 0.6 Allowed 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.507 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 28.3 p -101.3 163.54 12.23 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -171.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -110.49 148.05 32.87 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -111.56 108.07 17.45 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -76.8 -29.79 56.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.983 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.04 73.22 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.9 m -90.52 -52.0 5.12 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.18 -42.16 1.46 Allowed Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.386 -0.912 . . . . 0.0 112.398 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -87.94 158.81 18.57 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 120.828 0.347 . . . . 0.0 110.611 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.75 157.26 52.23 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.874 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.507 ' HB ' ' O ' ' A' ' 70' ' ' THR . 69.5 mt -84.6 -51.42 13.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 117.635 0.718 . . . . 0.0 109.478 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 63.7 t30 -160.73 108.47 1.31 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.122 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -75.57 -174.86 15.08 Favored 'Cis proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.539 -1.859 . . . . 0.0 110.278 -3.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.82 -43.57 58.37 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . 0.326 4.4 p30 38.76 31.53 0.04 OUTLIER 'General case' 0 C--N 1.369 1.424 0 C-N-CA 127.106 2.162 . . . . 0.0 113.828 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 64.5 m 79.13 148.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.654 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.7 p -72.9 172.68 10.43 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.224 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 pp -96.86 -171.1 2.17 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.633 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.527 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -130.18 119.24 22.64 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.27 134.02 38.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.005 0.431 . . . . 0.0 110.941 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 12.0 m-85 -102.9 145.67 31.0 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 123.616 0.766 . . . . 0.0 109.535 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.99 120.29 6.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.51 2.14 . . . . 0.0 110.413 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.01 141.0 42.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.53 137.57 53.94 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.83 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.518 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -125.22 99.13 5.94 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.37 5.47 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.674 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.19 -10.05 34.35 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.216 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -109.68 143.13 39.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 59.5 mt -122.37 120.47 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.953 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 26.9 m-85 -113.58 149.47 34.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.249 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 7.4 p -135.45 138.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.486 ' HA ' ' H ' ' A' ' 3' ' ' PHE . 35.3 t -97.99 133.58 42.27 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.826 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -122.3 16.37 10.6 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.157 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HE3' ' OG ' ' A' ' 2' ' ' SER . 37.7 ttmt -58.47 -76.31 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.748 0.785 . . . . 0.0 112.839 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.42 20.79 45.39 Favored Glycine 0 C--N 1.263 -3.528 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.04 120.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.502 0.668 . . . . 0.0 111.693 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 tp -110.07 124.01 34.58 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -65.67 137.75 51.21 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -80.03 175.78 10.33 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.492 ' HB2' ' HZ3' ' A' ' 109' ' ' LYS . 4.7 ttmp? -57.15 138.55 54.42 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 44' ' ' MET . . . -71.26 83.35 0.75 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.528 ' NE2' ' S2 ' ' A' ' 113' ' ' FES . 81.3 m-70 56.42 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.348 -1.297 . . . . 0.0 112.913 -172.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 C--N 1.292 -1.893 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.823 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.639 ' S1 ' ' HB3' ' A' ' 48' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 p -79.34 106.05 11.1 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.327 0.584 . . . . 0.0 110.766 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 99.4 m-85 -90.81 125.47 35.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.889 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -112.72 144.98 41.32 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 37.5 ttpt -87.07 128.08 35.11 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.842 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.485 HG12 ' CD1' ' A' ' 20' ' ' PHE . 6.5 tp -115.16 -45.05 4.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.227 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.7 p -139.71 -173.47 3.64 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.573 0.701 . . . . 0.0 111.915 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -129.61 150.12 51.08 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.558 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -72.61 -22.91 60.89 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.72 -21.76 65.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.457 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.59 -49.97 5.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.193 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.4 pt -110.85 116.88 53.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-O 122.135 0.969 . . . . 0.0 111.107 176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -90.36 169.24 11.25 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.758 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.19 117.79 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.353 0.597 . . . . 0.0 110.844 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.46 62.15 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -103.1 140.47 37.28 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.281 0.632 . . . . 0.0 110.188 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.413 ' SD ' HD23 ' A' ' 29' ' ' LEU . 26.9 ptt? -151.03 156.3 40.82 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.874 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -157.5 156.58 32.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.593 0.558 . . . . 0.0 109.517 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.2 t -88.87 137.09 32.63 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 121.218 0.532 . . . . 0.0 110.051 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.485 ' CD1' HG12 ' A' ' 6' ' ' ILE . 52.4 p90 -119.94 156.41 30.86 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 22' ' ' THR . 44.7 tt0 -100.35 135.31 41.98 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.402 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 77.7 p -82.58 171.29 14.23 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -73.36 -15.49 61.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.68 0.752 . . . . 0.0 109.252 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -84.55 -12.59 53.83 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.6 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.99 36.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.827 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 84.8 m -97.08 137.43 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.142 -0.622 . . . . 0.0 111.989 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -88.85 126.55 35.41 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.499 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 19' ' ' THR . 60.6 t -130.25 137.7 55.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.186 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.413 HD23 ' SD ' ' A' ' 17' ' ' MET . 45.5 tp -87.28 114.65 24.08 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.409 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 10.0 tp -97.74 112.7 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 8.2 p -114.12 127.9 71.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.5 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.443 ' ND2' ' HG ' ' A' ' 9' ' ' LEU . 51.2 t-20 -95.45 104.15 16.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.425 ' CB ' ' HB2' ' A' ' 36' ' ' HIS . 21.5 m -102.77 150.79 23.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.197 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -76.46 -50.27 14.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.242 0.544 . . . . 0.0 110.591 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.68 -46.7 16.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.921 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.425 ' HB2' ' CB ' ' A' ' 33' ' ' SER . 50.8 m80 -79.11 -21.19 47.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.923 0.392 . . . . 0.0 111.185 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.72 -168.68 47.88 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 45.7 t -81.49 120.02 32.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.722 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -118.63 149.33 41.56 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.602 0.761 . . . . 0.0 111.201 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.91 112.69 16.91 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.458 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 88' ' ' GLU . 49.7 m-85 -125.57 159.84 31.08 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.422 ' O ' HD13 ' A' ' 86' ' ' LEU . 35.4 tt0 -53.77 138.33 35.87 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -79.92 -12.39 59.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -167.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.409 ' HB3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.8 166.79 31.15 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.152 -1.419 . . . . 0.0 114.086 -175.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.712 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 18.9 m -88.79 166.52 22.06 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.07 31.41 0.52 Allowed 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 121.73 1.62 . . . . 0.0 112.723 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.672 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 14.1 m170 -120.34 -75.34 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.191 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.455 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 15.5 mm100 -93.96 -177.62 4.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 0.0 112.622 -174.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.32 163.24 28.04 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.114 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 44' ' ' MET . 29.8 mt -74.94 87.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.44 0.638 . . . . 0.0 110.438 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 85.0 mt -106.39 1.49 25.73 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.516 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.8 tt -76.23 -41.72 48.32 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.925 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -67.75 -7.39 26.92 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.48 -9.19 50.99 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.24 115.37 1.33 Allowed Glycine 0 CA--C 1.495 -1.167 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' A' ' 63' ' ' THR . 72.0 m -161.41 -25.02 0.05 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.907 0.861 . . . . 0.0 110.867 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 94.5 t80 -89.05 115.53 26.66 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.181 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -116.15 104.5 11.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.681 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.91 -72.85 0.53 Allowed Glycine 0 C--N 1.316 -0.53 0 O-C-N 123.899 0.749 . . . . 0.0 113.504 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.16 17.43 1.18 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 62.9 t -123.11 132.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -98.1 129.17 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 36.3 m -106.74 151.79 24.67 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.455 ' C ' ' H ' ' A' ' 66' ' ' ALA . 8.0 t -75.15 -40.31 59.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.22 172.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.46 ' H ' HG23 ' A' ' 63' ' ' THR . 1.1 tmt_? 75.93 -21.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.495 1.118 . . . . 0.0 110.939 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . -96.56 -23.45 16.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.927 173.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.791 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 22.3 m170 -146.88 152.46 38.74 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.305 0.642 . . . . 0.0 112.069 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.422 HD13 ' N ' ' A' ' 69' ' ' TRP 0.278 2.2 tm? 36.94 -107.21 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.85 2.46 . . . . 0.0 113.602 175.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 63' ' ' THR . 94.9 m95 -163.7 -51.36 0.03 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.6 p -107.71 130.64 54.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -160.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -134.1 137.49 44.63 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -122.98 114.84 20.96 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.961 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.64 -29.67 70.28 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.11 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.91 -3.6 74.74 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.894 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.4 m -124.22 1.26 8.47 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.666 0.746 . . . . 0.0 109.66 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -49.06 1.08 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.536 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 25.8 p80 -88.84 160.91 17.01 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.219 0.533 . . . . 0.0 111.719 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.13 169.99 35.49 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.923 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.61 -31.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 3.2 p-10 -127.27 101.92 24.5 Favored Pre-proline 0 N--CA 1.42 -1.939 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.883 173.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.508 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 22.7 Cg_endo -89.62 155.23 31.62 Favored 'Cis proline' 0 C--N 1.362 1.282 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.864 -4.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.9 p-10 -74.4 -19.26 60.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.83 -22.07 24.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.248 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.508 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 65.3 m -95.82 150.91 19.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-O 121.79 0.805 . . . . 0.0 110.577 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 77' ' ' HIS . 17.6 p -142.08 167.85 21.14 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.941 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 42' ' ' GLN . 81.2 mt -120.98 129.18 53.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -88.87 136.51 32.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -104.42 158.52 16.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.277 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.438 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 19.1 p90 -135.39 157.73 75.95 Favored Pre-proline 0 C--N 1.273 -2.751 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.508 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.438 ' HD2' ' HB2' ' A' ' 89' ' ' TYR . 37.5 Cg_endo -61.27 138.58 78.11 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 122.545 2.163 . . . . 0.0 114.03 -174.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.14 128.99 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.54 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -109.98 131.66 54.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.99 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.1 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -122.75 91.34 3.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.95 -112.11 4.68 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.573 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.26 -5.44 33.13 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.714 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -103.21 137.05 41.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -127.61 123.4 61.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 5.0 m-85 -112.01 142.08 44.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.834 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.96 154.71 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 89' ' ' TYR . 28.3 t -127.9 114.6 17.39 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.345 178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -108.76 -8.05 15.44 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.63 102.51 5.36 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.72 -29.28 4.99 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.6 mt -120.63 108.35 22.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.447 0.641 . . . . 0.0 110.319 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -89.08 147.92 39.73 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.78 140.96 43.87 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.059 1.84 . . . . 0.0 112.298 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -88.31 133.05 34.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.3 -176.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.405 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . 57.53 -82.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.255 1.422 . . . . 0.0 113.069 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -138.18 103.28 4.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.422 -1.842 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.145 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.791 ' S2 ' ' HB2' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 CA--C 1.515 -0.382 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 p -95.18 -52.92 3.99 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -171.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 73.54 108.21 0.07 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 -168.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -106.57 137.36 44.72 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -73.84 121.32 20.71 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.876 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tp -97.51 -48.52 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.357 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.7 m -159.23 -174.55 4.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.386 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -129.77 152.67 49.01 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 12' ' ' ILE . 27.5 tp -56.66 -21.22 25.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.184 1.393 . . . . 0.0 110.624 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.76 -30.97 71.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.261 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -100.18 -40.87 7.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.388 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.476 ' O ' HD13 ' A' ' 9' ' ' LEU . 3.4 tp -104.96 115.43 46.83 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-O 121.533 0.682 . . . . 0.0 110.934 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -102.99 164.75 11.43 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.469 -172.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.67 127.57 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.491 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.64 -0.81 68.1 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.92 154.13 29.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.507 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -146.15 131.06 18.14 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.727 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 44.1 mt-10 -144.22 150.52 38.09 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.478 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 93.7 m -74.42 130.97 40.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.993 0.425 . . . . 0.0 111.124 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -140.71 149.8 42.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.25 146.88 34.87 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.642 0.258 . . . . 0.0 110.359 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -83.72 165.29 19.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.9 m -65.59 -14.03 60.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.89 -12.48 41.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.444 0.64 . . . . 0.0 110.137 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.75 23.41 13.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.902 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -97.09 127.92 43.53 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -88.07 123.28 32.6 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.09 143.75 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.378 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 60.0 tp -93.01 112.86 24.96 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' MET . 49.6 mm -94.73 112.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.9 t -112.66 124.75 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 54.0 t30 -103.83 104.93 14.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 14.0 m -83.77 143.21 30.13 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.454 -172.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -47.08 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -83.14 -44.13 15.42 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -101.88 2.92 38.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 86.73 -176.95 48.09 Favored Glycine 0 C--O 1.201 -1.937 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.931 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 9.3 p -72.39 134.65 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 118.274 1.037 . . . . 0.0 111.553 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -125.7 139.01 53.9 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.774 0.83 . . . . 0.0 110.501 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.06 115.25 20.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' OH ' HG12 ' A' ' 62' ' ' ILE . 18.6 p90 -143.27 165.11 28.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.082 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -41.19 137.4 1.37 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.756 0.66 . . . . 0.0 111.818 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -71.29 -46.77 60.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.287 0.565 . . . . 0.0 112.524 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 69.8 mtm -94.25 147.07 23.55 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.17 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 28.9 p -94.82 161.87 27.18 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.777 0.673 . . . . 0.0 111.258 -175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 57.0 Cg_endo -71.2 -4.75 15.54 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.499 2.132 . . . . 0.0 111.914 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.44 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 36.3 m80 -88.74 -96.9 0.09 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -179.3 104.59 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 117.911 0.323 . . . . 0.0 110.579 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 6.5 tp10 -171.97 145.8 1.9 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 111.375 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.8 pt -118.58 141.67 37.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 tp 65.77 24.03 11.45 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.672 1.225 . . . . 0.0 109.129 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' H ' HD21 ' A' ' 52' ' ' LEU . 2.2 pt? -62.04 -20.54 64.06 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.141 -1.391 . . . . 0.0 111.289 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 36.0 p -56.92 -32.53 66.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 125.965 1.706 . . . . 0.0 113.832 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -100.66 23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.989 -0.445 . . . . 0.0 110.962 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.75 -83.61 0.04 OUTLIER Glycine 0 C--N 1.346 1.113 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.421 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 19.0 p -173.49 146.89 1.4 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -129.75 115.62 17.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.98 105.8 12.72 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.489 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.89 0.44 Allowed Glycine 0 N--CA 1.462 0.429 0 O-C-N 123.489 0.493 . . . . 0.0 114.206 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.552 ' O ' ' HB3' ' A' ' 73' ' ' ASP . . . -153.21 17.95 0.7 Allowed Glycine 0 C--N 1.301 -1.366 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.1 t -125.12 124.92 68.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.789 0.436 . . . . 0.0 110.05 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.403 HG12 ' OH ' ' A' ' 41' ' ' TYR . 2.0 pp -92.76 140.26 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.421 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 89.9 m -116.44 127.05 54.25 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.19 156.31 39.71 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' O ' ' HD3' ' A' ' 65' ' ' ARG . 1.8 tmt_? -73.34 -33.08 64.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.783 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.67 ' HB1' ' S1 ' ' A' ' 113' ' ' FES . . . -83.08 -72.32 0.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.308 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.484 ' CD2' ' HB2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -82.66 110.26 17.56 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.132 175.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.08 84.83 7.57 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.356 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.484 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 86.9 m95 -144.3 -166.55 2.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 p -101.66 136.65 41.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 121.955 0.883 . . . . 0.0 112.268 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 47.4 t80 -134.06 143.19 47.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.99 111.87 19.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.348 0.594 . . . . 0.0 111.33 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.552 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 16.3 t70 -71.41 -11.81 61.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.418 1.487 . . . . 0.0 112.012 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.51 -33.76 6.06 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.717 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.6 p -107.24 -26.14 11.19 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.436 0.618 . . . . 0.0 112.638 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.87 65.32 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -106.76 146.39 30.91 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -76.64 153.25 42.17 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.517 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.95 -49.25 12.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -146.55 111.71 4.26 Favored Pre-proline 0 N--CA 1.436 -1.153 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.415 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.74 141.61 64.64 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.962 -1.683 . . . . 0.0 111.004 -1.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.1 p30 -74.66 -12.48 60.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.407 0.622 . . . . 0.0 109.627 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.87 -28.53 68.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.736 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 36.9 m -92.72 152.15 19.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-O 121.563 0.696 . . . . 0.0 111.002 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.454 ' C ' HD12 ' A' ' 86' ' ' LEU . 5.9 p -163.27 156.13 18.75 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.045 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.466 HD11 ' CZ ' ' A' ' 71' ' ' PHE . 7.3 mp -129.45 135.16 48.31 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.289 1.436 . . . . 0.0 107.868 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.9 123.92 29.85 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.726 0.411 . . . . 0.0 109.972 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -86.64 143.94 27.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.086 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 101' ' ' SER . 46.2 m-85 -102.37 143.32 26.37 Favored Pre-proline 0 N--CA 1.428 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.04 123.01 12.56 Favored 'Trans proline' 0 C--O 1.253 1.242 0 C-N-CA 122.329 2.019 . . . . 0.0 110.264 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.87 132.96 70.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -112.57 117.21 31.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.447 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.56 107.56 23.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 122.026 0.917 . . . . 0.0 109.69 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.559 ' HZ2' ' HB3' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -127.69 118.16 23.3 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.43 -119.93 9.75 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.96 -4.45 16.71 Favored 'General case' 0 C--O 1.17 -3.086 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.559 ' HB3' ' HZ2' ' A' ' 94' ' ' LYS . 17.0 t70 -100.03 139.28 35.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.697 -0.627 . . . . 0.0 110.089 -170.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.2 mt -127.63 119.12 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -102.72 146.23 28.52 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.71 172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.63 137.23 54.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 20.4 t -107.35 113.26 26.52 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.446 -1.702 . . . . 0.0 109.296 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.4 p -95.96 -36.43 11.07 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.93 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -66.3 113.26 4.47 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.112 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.26 -36.14 2.78 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.407 HD11 ' N ' ' A' ' 105' ' ' ILE . 2.7 mp -100.89 120.82 50.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 tt -79.92 124.1 83.35 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.96 145.58 40.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.006 2.471 . . . . 0.0 111.994 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -80.43 177.61 8.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.69 -11.89 2.5 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.464 ' CB ' ' HG ' ' A' ' 86' ' ' LEU . . . -57.37 -36.19 70.91 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.996 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -108.64 102.83 11.85 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.863 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.704 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.67 ' S1 ' ' HB1' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m 59.24 84.76 0.11 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.404 0.682 . . . . 0.0 109.232 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 67.22 100.25 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.464 -169.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -106.9 130.53 54.55 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.815 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -70.17 115.64 9.6 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.62 -59.59 3.06 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.194 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.6 m -152.21 -177.29 6.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.353 -175.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 8.7 p -101.02 153.52 19.47 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.588 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.43 -17.52 21.33 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.847 0.832 . . . . 0.0 110.673 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.4 -10.84 58.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.583 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -97.7 -41.46 8.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.687 -0.633 . . . . 0.0 109.358 177.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.3 tp -109.95 114.13 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.415 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -101.05 166.96 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.503 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.44 128.83 35.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.496 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.89 66.7 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -103.87 144.14 31.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.172 -0.514 . . . . 0.0 110.127 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.4 134.0 39.24 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.573 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 9.2 pt-20 -157.63 156.21 31.41 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 15.1 t -90.51 137.7 32.14 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.404 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 77.3 m-85 -126.41 155.94 41.37 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -113.95 141.49 47.32 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -83.18 172.76 12.3 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -68.86 -20.17 64.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.131 0.491 . . . . 0.0 110.424 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.97 -12.25 55.6 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 109.526 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.95 14.82 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.109 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.5 m -92.19 124.31 36.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.77 128.97 35.64 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 19' ' ' THR . 40.0 t -133.03 141.2 45.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.412 HD21 ' HA ' ' A' ' 53' ' ' SER . 0.7 OUTLIER -94.18 116.43 28.83 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -177.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.58 122.83 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 122.327 0.251 . . . . 0.0 110.355 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.99 123.61 70.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 50.7 t30 -103.12 106.41 16.92 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.837 173.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -98.81 148.67 23.67 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.511 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.95 -48.85 77.1 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 122.957 0.503 . . . . 0.0 111.8 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.26 -40.33 8.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.95 0.405 . . . . 0.0 111.979 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -79.69 -11.42 59.85 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -167.33 42.47 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.042 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 6.7 p -99.05 118.05 45.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.535 0.683 . . . . 0.0 109.333 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -131.98 151.16 51.9 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.162 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.05 143.27 45.7 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.569 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 63.9 m-85 -133.28 157.6 45.04 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -59.11 139.22 57.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.187 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.21 -7.29 58.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.336 0.589 . . . . 0.0 110.252 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -92.79 99.76 12.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.618 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.528 ' C ' ' H ' ' A' ' 47' ' ' HIS . 59.0 m -76.71 158.8 80.33 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.484 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 92.8 Cg_endo -82.92 20.78 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.718 1.612 . . . . 0.0 108.883 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.61 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 36.9 m80 -120.1 -175.12 2.92 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.778 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -65.98 103.72 0.99 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.265 0.353 . . . . 0.0 111.039 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.73 156.6 22.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.633 0.73 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.586 HG13 ' H ' ' A' ' 51' ' ' LEU . 9.8 tp -179.99 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 -174.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.586 ' H ' HG13 ' A' ' 50' ' ' ILE . 2.9 mm? -78.01 91.68 4.27 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 121.118 1.781 . . . . 0.0 109.738 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.575 HD21 ' O ' ' A' ' 50' ' ' ILE . 2.0 mm? -73.36 -20.98 60.64 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.776 1.274 . . . . 0.0 108.156 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.573 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 60.0 p -63.4 -19.49 64.72 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.921 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.62 12.24 36.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.742 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 -108.41 0.03 OUTLIER Glycine 0 C--O 1.241 0.566 0 O-C-N 123.324 0.39 . . . . 0.0 113.033 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.3 t -146.14 154.07 41.39 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.915 0.864 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -128.78 114.63 16.81 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.153 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.433 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 42.4 mt-10 -118.14 169.9 9.31 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.27 74.39 0.14 Allowed Glycine 0 C--N 1.309 -0.932 0 O-C-N 123.309 0.381 . . . . 0.0 113.799 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.18 38.68 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.7 t -123.96 119.27 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.526 ' HB ' ' CZ ' ' A' ' 71' ' ' PHE . 42.6 mm -112.58 138.26 42.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.4 m -118.08 115.72 25.41 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -72.71 0.41 Allowed 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.887 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -149.02 -63.42 0.23 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.597 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' N ' ' S1 ' ' A' ' 113' ' ' FES . . . -144.66 139.36 27.96 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.61 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 13.5 p-80 162.32 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.931 2.092 . . . . 0.0 107.575 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.6 tp 172.59 -71.7 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.569 1.548 . . . . 0.0 108.983 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -176.92 -49.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.059 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p -103.53 136.48 43.17 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -169.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.526 ' CZ ' ' HB ' ' A' ' 62' ' ' ILE . 22.5 p90 -135.16 142.7 46.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 159.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -86.84 122.87 31.32 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.322 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.25 -38.41 90.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.793 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.18 26.58 3.83 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.002 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -155.33 -51.28 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.819 0.31 . . . . 0.0 110.816 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.64 40.05 Favored Glycine 0 C--O 1.218 -0.844 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -85.75 139.16 31.57 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 108.887 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.53 140.34 35.02 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 176.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.416 ' H ' ' HA ' ' A' ' 71' ' ' PHE . 60.0 mt -81.16 -51.65 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -150.23 113.88 3.32 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -81.3 179.25 28.66 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.858 -1.726 . . . . 0.0 111.412 -3.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -95.93 12.23 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.4 ' O ' ' HE3' ' A' ' 109' ' ' LYS . 34.8 t70 -67.73 -14.66 63.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.397 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.413 ' SG ' ' S2 ' ' A' ' 113' ' ' FES . 23.6 p -136.89 152.21 49.97 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.543 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.41 ' HG ' ' C ' ' A' ' 84' ' ' CYS . 31.1 m -152.17 146.11 25.22 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 mp -102.79 153.67 19.94 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-O 120.984 0.421 . . . . 0.0 110.784 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -88.19 119.54 28.69 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.738 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.48 129.98 34.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.732 0.645 . . . . 0.0 109.537 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.11 136.25 20.12 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -68.37 124.3 11.5 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.548 2.165 . . . . 0.0 112.304 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.86 138.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -119.58 135.82 54.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.416 ' C ' ' HE2' ' A' ' 94' ' ' LYS . 58.7 t -106.21 122.52 60.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -167.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.616 ' HD3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -111.36 146.35 37.28 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 173.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.71 -35.6 17.16 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 115.61 1.004 . . . . 0.0 115.61 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 8' ' ' SER . 25.4 t70 -113.7 -22.7 10.1 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.778 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -114.87 147.65 39.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.136 0.969 . . . . 0.0 113.422 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.7 mt -121.71 118.16 54.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.788 176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.616 ' CD1' ' HD3' ' A' ' 94' ' ' LYS . 4.5 m-85 -112.2 144.11 42.14 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.96 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.78 141.31 39.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.4 t -104.15 128.17 51.8 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.518 -177.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.2 p -120.56 5.55 10.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -74.99 118.39 17.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.734 -174.86 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.03 16.09 79.64 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.142 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.26 119.51 57.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.255 0.55 . . . . 0.0 110.957 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.88 142.68 36.82 Favored Pre-proline 0 N--CA 1.411 -2.387 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.363 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.38 150.08 88.93 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.468 2.112 . . . . 0.0 111.166 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.591 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 34.9 t-20 -81.41 -179.77 7.51 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.4 ' HE3' ' O ' ' A' ' 83' ' ' ASP . 39.2 ttpt -62.42 93.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.41 1.1 . . . . 0.0 111.521 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 174.44 -149.46 0.01 OUTLIER 'General case' 0 C--N 1.267 -3.019 0 C-N-CA 128.274 2.63 . . . . 0.0 104.471 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 51.66 88.15 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.898 0.772 . . . . 0.0 112.32 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.484 ' OG ' ' HA ' ' A' ' 46' ' ' PRO . 24.7 p . . . . . 0 C--N 1.298 -1.67 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.676 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.456 ' S1 ' ' N ' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 120.631 0.253 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -80.06 85.17 5.67 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.126 0.489 . . . . 0.0 109.95 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -156.95 97.81 1.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 125.979 1.712 . . . . 0.0 107.252 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.87 133.47 52.18 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.41 127.39 32.11 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.22 -40.94 5.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.721 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.9 p -160.34 -170.88 2.96 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.768 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 7.2 m -120.15 153.07 36.74 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.348 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -61.58 -21.4 64.28 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.846 0.831 . . . . 0.0 108.924 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.86 -29.63 69.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.266 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.96 -47.55 65.35 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.607 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.83 112.27 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.734 1.254 . . . . 0.0 113.529 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -79.16 170.54 16.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.786 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.34 118.79 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 CA-C-O 121.602 0.715 . . . . 0.0 110.451 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.97 56.9 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.682 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -103.22 150.45 23.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.8 ptt? -150.12 137.92 20.06 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.582 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 34.7 mt-10 -144.2 155.11 43.75 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 m -91.42 123.97 35.25 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.01 154.32 34.72 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -113.54 137.35 51.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -83.0 173.3 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 m -71.94 -9.35 58.23 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.159 0.505 . . . . 0.0 111.669 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.74 -4.74 46.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.36 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.17 44.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.628 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.9 m -89.86 114.79 26.61 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -91.58 123.83 35.28 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.7 t -136.49 142.49 38.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.027 -172.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.459 ' N ' ' HB2' ' A' ' 43' ' ' ALA . 32.9 tp -83.61 117.62 23.28 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -107.87 113.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.87 137.31 43.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.711 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -109.97 107.8 17.82 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.3 t -99.2 148.51 24.03 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.031 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -36.16 62.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.24 -46.75 6.62 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.793 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -88.51 -7.01 57.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.73 -164.9 52.22 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.202 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.8 t -82.82 128.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -127.9 141.52 51.53 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.483 0.713 . . . . 0.0 111.197 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.07 121.26 33.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.913 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.426 ' CD1' HD21 ' A' ' 86' ' ' LEU . 53.6 m-85 -133.04 152.1 51.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 111' ' ' HIS . 47.7 mt-30 -48.96 138.06 12.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.612 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -141.17 19.12 2.26 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -172.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 86.3 mtp -68.97 -30.56 69.01 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.811 ' SG ' ' N ' ' A' ' 65' ' ' ARG . 3.5 t -76.48 124.09 87.88 Favored Pre-proline 0 CA--C 1.619 3.603 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.662 ' C ' ' HA ' ' A' ' 65' ' ' ARG . 12.6 Cg_endo -108.71 104.83 0.02 OUTLIER 'Trans proline' 2 C--N 1.421 4.375 0 C-N-CA 123.922 3.081 . . . . 0.0 113.145 163.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.86 ' CE1' ' H ' ' A' ' 67' ' ' HIS . 6.4 t60 -81.26 -25.8 36.3 Favored 'General case' 0 N--CA 1.523 3.212 0 O-C-N 121.363 -0.835 . . . . 0.0 109.882 -173.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -105.32 111.94 24.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.306 10.9 pt-20 -74.14 83.46 1.82 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.791 1.282 . . . . 0.0 114.256 -174.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.563 HG12 ' H ' ' A' ' 51' ' ' LEU . 15.1 tt -152.74 -159.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 102.388 -3.189 . . . . 0.0 102.388 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.563 ' H ' HG12 ' A' ' 50' ' ' ILE . 84.9 mt -64.06 122.55 16.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 120.752 1.615 . . . . 0.0 109.301 175.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 43' ' ' ALA . 1.4 pt? -56.0 -44.76 78.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.409 1.084 . . . . 0.0 113.713 -172.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 38.2 p -63.54 -24.26 67.73 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.422 0.689 . . . . 0.0 112.516 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -84.31 3.16 36.89 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -139.85 36.64 1.8 Allowed Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.737 -1.22 . . . . 0.0 113.066 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.3 m -107.14 -80.39 0.57 Allowed 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.351 0.596 . . . . 0.0 111.425 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.557 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 80.7 t80 -90.39 112.73 24.44 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-O 121.84 0.829 . . . . 0.0 110.684 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.51 105.41 11.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.524 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.08 -77.28 0.56 Allowed Glycine 0 N--CA 1.45 -0.395 0 O-C-N 123.384 0.427 . . . . 0.0 112.424 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.22 6.56 0.82 Allowed Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.66 135.16 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.477 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 69.1 mt -105.68 129.95 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 121.347 0.594 . . . . 0.0 109.763 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 9.1 m -111.2 152.5 27.01 Favored 'General case' 0 N--CA 1.38 -3.951 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 1.555 ' CA ' ' CB ' ' A' ' 64' ' ' CYS 0.473 15.0 p -118.32 -112.49 0.34 Allowed 'General case' 2 CA--C 1.789 10.154 0 C-N-CA 128.179 2.591 . . . . 0.0 106.829 179.1 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.857 ' HA ' ' N ' ' A' ' 47' ' ' HIS . 37.2 ttm105 -122.29 -161.89 0.96 Allowed 'General case' 3 N--CA 1.652 9.667 1 C-N-CA 137.532 6.333 . . . . 0.0 107.513 170.359 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.638 ' H ' ' HG2' ' A' ' 65' ' ' ARG . . . -55.95 100.38 0.04 OUTLIER 'General case' 2 N--CA 1.557 4.891 1 N-CA-C 122.168 4.136 . . . . 0.0 122.168 -166.922 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.86 ' H ' ' CE1' ' A' ' 47' ' ' HIS 0.373 53.7 m80 -96.1 -170.47 2.12 Favored 'General case' 1 N--CA 1.543 4.186 0 C-N-CA 129.863 3.265 . . . . 0.0 106.597 170.21 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -145.06 8.94 1.25 Allowed 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.66 ' H ' ' HB3' ' A' ' 67' ' ' HIS . 28.8 m-90 -146.32 -159.96 1.09 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.7 2.0 . . . . 0.0 107.822 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -124.26 161.98 24.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.477 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 11.8 t80 -119.48 142.47 48.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -119.33 140.61 50.04 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.656 -1.218 . . . . 0.0 114.214 -172.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.444 ' HB2' HG13 ' A' ' 62' ' ' ILE . 7.0 t70 -75.28 -53.91 7.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.647 1.179 . . . . 0.0 112.463 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.54 95.73 Favored Glycine 0 CA--C 1.503 -0.658 0 O-C-N 123.702 0.626 . . . . 0.0 112.789 -175.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -79.46 -30.86 42.34 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 66.8 41.84 93.37 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 78' ' ' GLY . 12.1 t60 -160.03 150.52 18.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -174.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.448 ' O ' ' HD2' ' A' ' 77' ' ' HIS . . . -77.88 133.75 13.47 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 119.225 -1.465 . . . . 0.0 110.251 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.89 -37.51 54.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -146.81 119.98 4.98 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.87 154.63 54.85 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.62 -1.408 . . . . 0.0 112.895 0.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.12 -15.68 57.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.942 0.877 . . . . 0.0 109.235 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.9 -32.87 61.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.218 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 109' ' ' LYS . 71.9 m -134.4 161.43 35.02 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 122.229 1.014 . . . . 0.0 112.317 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.5 p -138.21 -171.88 3.14 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.597 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 86' ' ' LEU . 2.0 pp -97.41 145.71 25.9 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.983 0.42 . . . . 0.0 111.226 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.24 113.74 26.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.43 118.51 22.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 O-C-N 123.452 0.47 . . . . 0.0 109.779 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -90.74 124.47 62.19 Favored Pre-proline 0 C--N 1.278 -2.536 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -60.2 120.05 7.6 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.966 1.778 . . . . 0.0 110.45 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.37 130.31 72.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.411 0.624 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.519 ' HG2' ' HD2' ' A' ' 94' ' ' LYS . 35.7 tt0 -115.42 131.51 56.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.161 -174.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.28 117.34 55.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.001 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.554 ' HE2' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -125.96 98.5 5.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.21 -107.07 2.12 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 8' ' ' SER . 31.2 t70 -109.98 -5.24 15.51 Favored 'General case' 0 C--O 1.177 -2.758 0 CA-C-O 121.051 0.453 . . . . 0.0 109.962 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.64 133.18 44.35 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.294 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.7 mt -123.88 119.54 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.875 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.554 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 10.9 m-85 -112.68 144.49 42.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.098 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.55 142.32 39.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.42 0.629 . . . . 0.0 111.098 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.447 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t -106.71 128.97 54.65 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.113 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -120.84 -8.32 9.43 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.252 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -78.01 121.83 24.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.07 -32.52 6.63 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.569 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.4 HD13 ' HD3' ' A' ' 90' ' ' PRO . 73.1 mt -120.14 108.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.504 0.668 . . . . 0.0 109.963 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -94.02 155.06 40.55 Favored Pre-proline 0 N--CA 1.41 -2.459 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.339 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.59 144.1 99.51 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.448 2.098 . . . . 0.0 109.86 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -79.58 166.03 22.32 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.476 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 52.8 mtmt -38.04 -51.26 1.38 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.472 1.509 . . . . 0.0 115.073 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' A' ' 112' ' ' SER . . . -63.87 -32.75 74.37 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -175.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.433 ' HA ' ' NE2' ' A' ' 42' ' ' GLN . 79.3 m-70 75.91 -36.52 0.29 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.51 1.124 . . . . 0.0 110.554 -174.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.557 ' C ' ' HB2' ' A' ' 45' ' ' CYS . 32.5 p . . . . . 0 N--CA 1.429 -1.523 0 O-C-N 125.332 1.645 . . . . 0.0 110.713 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.76 ' S1 ' ' N ' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 CA--C 1.501 -0.933 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' SER . 46.5 t 67.01 -69.7 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -167.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -79.89 115.72 19.63 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 170.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.29 144.97 49.68 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -74.08 125.43 28.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.101 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.405 HG21 ' N ' ' A' ' 7' ' ' CYS . 9.2 tp -106.68 -42.25 6.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.488 178.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' N ' HG21 ' A' ' 6' ' ' ILE . 71.3 m -148.08 -179.32 6.83 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.338 -173.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 12' ' ' ILE . 13.2 p -130.69 152.7 49.77 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 125.211 1.405 . . . . 0.0 108.881 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 9' ' ' LEU . 2.8 tm? -56.41 -23.76 40.5 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.12 -30.33 71.4 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.668 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.8 -8.39 13.19 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 8' ' ' SER . 3.7 tp -127.65 110.4 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 0.0 110.081 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.37 164.63 11.57 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.513 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.48 124.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.065 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.09 -8.17 62.83 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -102.81 153.25 20.36 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.447 0.641 . . . . 0.0 111.142 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -149.55 137.72 20.57 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.121 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' HG3' ' CE2' ' A' ' 20' ' ' PHE . 12.0 pt-20 -157.41 155.36 30.35 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.402 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -93.81 141.36 28.59 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 112.047 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.77 148.75 52.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.491 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.73 139.72 37.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -83.56 168.37 16.46 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 m -70.05 -12.4 61.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.084 0.469 . . . . 0.0 110.845 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -90.22 -2.9 58.09 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.374 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.41 12.91 60.69 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.392 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -87.01 123.34 32.0 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.35 123.6 33.68 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.16 135.64 60.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.446 0.641 . . . . 0.0 110.892 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -89.53 113.97 25.44 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 124.454 1.101 . . . . 0.0 109.277 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.19 113.6 30.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.44 124.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 43.5 t30 -108.17 104.57 14.01 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.766 -1.173 . . . . 0.0 108.323 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.0 t -101.36 149.26 24.23 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.506 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -77.46 -32.32 54.38 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.292 0.568 . . . . 0.0 109.576 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -93.43 -47.13 7.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.699 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -83.28 -19.96 35.34 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.781 0.324 . . . . 0.0 111.309 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.37 -174.29 48.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -87.52 118.15 32.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.679 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -131.68 157.74 42.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.007 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' HB1' ' HB2' ' A' ' 89' ' ' TYR . . . -124.7 134.96 52.67 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.624 ' CZ ' ' HB2' ' A' ' 73' ' ' ASP . 69.2 m-85 -134.11 163.63 29.14 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 10.2 pt20 -66.57 144.23 56.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.77 8.19 33.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.43 0.633 . . . . 0.0 111.305 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.2 tpp -99.4 143.37 29.74 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.876 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.481 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -116.76 152.73 48.82 Favored Pre-proline 0 N--CA 1.426 -1.663 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.925 177.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.403 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 80.9 Cg_exo -44.72 -39.39 13.51 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 123.564 2.843 . . . . 0.0 112.558 178.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.491 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 8.8 m80 -64.77 -86.14 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 168.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -153.22 173.85 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.74 129.82 36.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.402 ' O ' HG12 ' A' ' 50' ' ' ILE . 13.0 tt -156.74 24.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 122.82 1.295 . . . . 0.0 108.714 -174.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt 69.31 84.38 0.15 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 113.524 -1.671 . . . . 0.0 113.687 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.2 mp -70.14 -30.65 67.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.456 1.122 . . . . 0.0 108.26 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 11.6 p -61.41 -29.81 70.17 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.975 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -98.69 2.65 47.34 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.408 ' O ' ' HD3' ' A' ' 65' ' ' ARG . . . 164.71 91.94 0.08 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 118.297 -1.906 . . . . 0.0 115.241 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -157.27 -62.02 0.09 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.569 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 41.2 t80 -90.48 114.05 26.14 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.39 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -118.41 114.36 22.78 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.465 173.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.03 -70.64 1.21 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.359 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.78 -17.74 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.654 -0.273 . . . . 0.0 112.765 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.66 141.79 15.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 117.072 0.436 . . . . 0.0 109.961 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 57.5 mt -111.3 123.76 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 94.9 m -92.85 143.96 25.76 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.7 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 3.7 t -76.29 -85.44 0.05 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 116.2 -2.2 . . . . 0.0 107.74 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 23.9 tpt180 -178.81 -34.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.065 0.848 . . . . 0.0 112.522 164.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' N ' ' S1 ' ' A' ' 113' ' ' FES . . . -98.63 -39.62 8.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.491 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 6.6 p-80 -84.92 178.73 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.431 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -53.41 -70.61 0.09 Allowed 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.494 ' O ' ' HA ' ' A' ' 63' ' ' THR 0.255 98.0 m95 -129.18 -93.71 0.43 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -173.162 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 32.6 p -101.6 146.17 28.05 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 117.333 2.345 . . . . 0.0 117.333 -160.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.458 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 45.8 t80 -135.96 143.08 44.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 168.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -119.11 128.17 54.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 120.507 1.503 . . . . 0.0 113.685 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.624 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 10.5 p-10 -79.44 -40.68 29.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.943 -175.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.02 47.24 2.22 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 121.141 0.301 . . . . 0.0 112.91 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -163.46 -45.34 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 85' ' ' CYS . . . 104.86 -65.36 0.3 Allowed Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.485 ' HA ' ' O ' ' A' ' 84' ' ' CYS . 44.1 m80 -73.73 132.47 42.69 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.664 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -82.97 177.14 53.3 Favored Glycine 0 C--N 1.299 -1.508 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.976 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.435 HD13 ' N ' ' A' ' 79' ' ' ILE . 2.4 mp -84.39 -34.99 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.458 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 23.7 t-20 -142.73 109.86 5.63 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.0 Cg_exo -80.08 147.83 77.36 Favored 'Cis proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.429 -3.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.664 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.6 p30 -77.61 -21.75 51.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.93 -8.38 58.78 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.913 0.387 . . . . 0.0 110.377 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 67.8 m -103.62 152.4 21.81 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 121.605 0.717 . . . . 0.0 111.842 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 4.3 p -132.0 178.77 6.53 Favored 'General case' 0 C--N 1.273 -2.743 0 C-N-CA 125.496 1.518 . . . . 0.0 110.139 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -131.32 35.75 3.86 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.539 ' HA ' ' OD1' ' A' ' 108' ' ' ASN . . . 46.3 102.46 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.849 1.26 . . . . 0.0 114.398 -177.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.99 112.25 23.6 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 110.941 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB2' ' HB1' ' A' ' 40' ' ' ALA . 93.6 m-85 -102.51 130.64 23.63 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.468 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -72.16 139.47 32.5 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.053 1.835 . . . . 0.0 111.271 177.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.58 140.07 49.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.685 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -130.43 137.24 49.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 110.537 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.26 129.22 64.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.795 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.455 ' HE3' ' CB ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -125.3 95.24 4.4 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.314 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.49 4.07 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.519 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -101.93 -2.87 28.84 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.544 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.455 ' CB ' ' HE3' ' A' ' 94' ' ' LYS . 20.7 m-20 -111.75 148.91 32.49 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.3 mt -126.39 131.99 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -99.49 148.48 24.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.538 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.67 137.31 52.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 2' ' ' SER . 43.7 t -90.58 113.73 25.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.8 p -138.29 -26.46 0.91 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.236 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -74.44 99.51 3.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.401 0.62 . . . . 0.0 109.725 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.92 -8.21 16.64 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.837 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.11 115.64 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.999 0.428 . . . . 0.0 110.456 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.83 144.29 31.41 Favored Pre-proline 0 N--CA 1.412 -2.351 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.76 128.58 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.96 1.773 . . . . 0.0 111.141 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.3 p-10 -85.28 122.0 28.82 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.136 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.5 tptt 67.72 160.93 0.17 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.92 1.387 . . . . 0.0 111.029 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 74.03 -67.92 0.24 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.919 1.288 . . . . 0.0 112.64 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -88.79 -4.56 58.47 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.478 0.656 . . . . 0.0 109.749 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.432 -1.363 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.139 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.7 ' S1 ' ' HB3' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.767 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.504 ' N ' ' SD ' ' A' ' 1' ' ' MET . 22.7 t 78.65 -44.81 0.38 Allowed 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.334 1.454 . . . . 0.0 110.16 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 68.2 m-85 -75.51 97.79 3.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -107.13 144.95 33.11 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -77.28 124.28 27.64 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -98.21 -45.92 12.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.734 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.1 p -157.79 -172.18 3.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.372 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -125.74 152.7 45.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.597 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.516 ' O ' HD21 ' A' ' 9' ' ' LEU . 5.5 tt -61.57 -26.03 67.7 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.26 -10.76 56.91 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.918 -0.489 . . . . 0.0 111.378 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -93.76 -53.4 4.04 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 42.2 pt -111.4 110.86 33.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 122.462 1.125 . . . . 0.0 111.757 178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.97 170.23 16.96 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.251 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.458 ' CG2' ' HB2' ' A' ' 34' ' ' GLU . 7.1 p -57.71 112.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-O 121.874 0.845 . . . . 0.0 111.276 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.21 58.95 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.558 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -102.83 152.48 21.22 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.168 0.508 . . . . 0.0 111.072 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.44 ' HB3' HG23 ' A' ' 31' ' ' VAL . 25.3 ptt? -149.95 145.23 26.36 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.895 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.8 pt-20 -157.8 154.73 28.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 73.5 m -71.99 130.26 40.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.017 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -128.09 157.01 41.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 173.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -106.24 135.68 47.29 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -83.39 173.71 11.29 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 m -73.89 -12.24 60.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.493 0.663 . . . . 0.0 110.993 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.2 -12.22 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.659 0.742 . . . . 0.0 109.111 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 20.71 24.91 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.629 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.9 m -91.34 130.27 37.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -88.04 124.39 33.7 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.8 t -138.7 145.68 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.407 HD23 ' HB2' ' A' ' 17' ' ' MET . 5.7 tt -97.3 112.32 24.18 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mm -97.6 119.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.456 ' CG1' ' HB2' ' A' ' 39' ' ' LYS . 10.1 p -116.52 134.1 61.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.411 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -108.86 104.31 13.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.3 m -101.19 143.9 30.72 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -76.57 -51.31 11.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.3 -46.58 22.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.317 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -92.75 2.62 56.64 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.199 0.523 . . . . 0.0 111.361 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.92 177.06 35.3 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.719 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.2 125.63 39.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 9.8 mmpt? -127.81 145.19 51.01 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.123 0.569 . . . . 0.0 109.97 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -125.56 112.13 15.83 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.467 ' HH ' HD13 ' A' ' 62' ' ' ILE . 13.9 p90 -137.53 140.94 41.39 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 119.553 -0.26 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.447 HE21 ' HA ' ' A' ' 86' ' ' LEU . 38.3 mt-30 -42.91 137.36 2.38 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.938 0.774 . . . . 0.0 111.953 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -102.46 78.7 1.75 Allowed 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.467 0.651 . . . . 0.0 110.157 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.408 ' HB2' ' HB2' ' A' ' 110' ' ' ALA 0.286 10.9 mmt -123.75 135.7 53.99 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.87 90.67 0.47 Allowed Pre-proline 0 C--N 1.311 -1.067 0 C-N-CA 127.594 2.357 . . . . 0.0 107.873 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -85.33 27.76 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.54 2.16 . . . . 0.0 111.063 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -85.18 -52.95 5.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.15 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -138.0 -72.02 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -98.83 115.69 29.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.31 -28.86 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.185 0.928 . . . . 0.0 110.515 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.7 mt -79.02 98.13 6.35 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.429 ' O ' HD21 ' A' ' 52' ' ' LEU . 3.2 tt -56.95 -28.9 62.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.53 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 67.5 p -58.04 -21.72 46.65 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.713 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -88.59 8.71 27.0 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.968 0.413 . . . . 0.0 112.009 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.49 -124.57 1.21 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 173.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.6 t -157.29 150.04 23.29 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 110.263 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.441 ' CD1' HD11 ' A' ' 62' ' ' ILE . 6.8 t80 -130.89 115.91 17.18 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.293 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -116.15 104.15 11.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.02 -73.89 0.13 Allowed Glycine 0 CA--C 1.52 0.364 0 O-C-N 123.715 0.634 . . . . 0.0 112.845 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.68 25.09 1.19 Allowed Glycine 0 C--N 1.295 -1.7 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.52 120.99 62.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.467 HD13 ' HH ' ' A' ' 41' ' ' TYR . 35.4 mm -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 m -127.2 129.05 47.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.933 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 0.1 OUTLIER -69.92 -155.2 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.045 0 C-N-CA 123.442 0.697 . . . . 0.0 111.411 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.431 ' N ' ' S1 ' ' A' ' 113' ' ' FES . 19.6 tpt180 -113.1 95.09 5.2 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.762 -0.586 . . . . 0.0 110.654 -169.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.69 21.81 10.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.798 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 2.7 t-160 -97.72 -17.02 19.66 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.21 -48.69 0.69 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -74.4 177.24 6.07 Favored 'General case' 0 CA--C 1.577 2.017 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.766 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -103.08 156.92 17.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -166.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.466 ' CZ ' ' HG ' ' A' ' 86' ' ' LEU . 6.3 t80 -134.07 146.26 50.15 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -118.57 112.84 20.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.905 0.775 . . . . 0.0 112.976 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.59 -34.36 58.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.515 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.84 -40.16 89.33 Favored Glycine 0 CA--C 1.508 -0.369 0 O-C-N 123.342 0.402 . . . . 0.0 113.486 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -101.1 -12.75 18.56 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.644 0.735 . . . . 0.0 109.41 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.35 38.68 38.19 Favored Glycine 0 C--O 1.219 -0.821 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.777 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -140.74 141.32 34.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -85.73 139.75 17.42 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.922 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.63 -35.97 17.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -141.47 137.47 16.52 Favored Pre-proline 0 N--CA 1.417 -2.114 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -66.76 -13.56 8.08 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 CA-C-N 119.383 0.815 . . . . 0.0 113.44 -0.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.575 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 11.2 t70 90.14 -39.35 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 126.928 2.091 . . . . 0.0 110.0 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -56.46 -34.28 66.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.325 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 51.6 m -93.7 141.84 28.03 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.853 0.835 . . . . 0.0 108.885 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.3 m -144.52 166.6 24.69 Favored 'General case' 0 C--N 1.254 -3.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.466 ' HG ' ' CZ ' ' A' ' 71' ' ' PHE . 72.5 mt -128.98 179.69 5.6 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -175.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.92 117.62 17.9 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -85.66 101.22 12.55 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -81.11 141.87 50.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.415 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -58.37 118.55 5.45 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.764 1.643 . . . . 0.0 110.537 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.0 p -133.5 137.79 52.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -133.64 140.19 46.94 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.365 0.602 . . . . 0.0 111.062 -176.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.8 127.97 57.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.43 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.53 91.3 3.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.37 -106.0 1.22 Allowed Glycine 0 C--N 1.3 -1.439 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.418 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.9 -10.86 22.27 Favored 'General case' 0 C--O 1.186 -2.283 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.16 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.87 140.36 35.27 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.774 0.321 . . . . 0.0 111.406 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.7 mt -127.14 122.06 59.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.831 0.825 . . . . 0.0 111.664 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 39.7 m-85 -115.12 144.41 43.7 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.937 -176.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.54 145.37 29.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.04 0.448 . . . . 0.0 110.911 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 2' ' ' SER . 51.5 m -111.45 116.26 30.6 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.441 ' HA ' ' CG2' ' A' ' 105' ' ' ILE . 10.0 t -134.26 -10.66 2.54 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.913 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -85.44 97.11 9.83 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.857 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.86 -32.85 2.47 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 102' ' ' THR . 13.3 tt -86.83 136.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.21 123.53 79.32 Favored Pre-proline 0 N--CA 1.426 -1.672 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.441 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 23.0 Cg_exo -68.25 129.7 19.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.605 2.87 . . . . 0.0 108.511 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -81.16 174.39 11.61 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.659 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -52.81 104.6 0.09 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.813 1.292 . . . . 0.0 114.158 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 44' ' ' MET . . . 175.0 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 111.237 -2.711 . . . . 0.0 104.406 -174.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -144.9 161.55 39.05 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 113.056 -1.884 . . . . 0.0 106.414 170.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 CA--C 1.54 0.59 0 O-C-N 124.233 0.958 . . . . 0.0 111.37 177.135 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.933 ' S1 ' ' HB3' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 101' ' ' SER . 49.3 m 60.33 -80.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.765 1.226 . . . . 0.0 114.153 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.439 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 95.6 m-85 -86.09 124.82 32.94 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -120.23 145.1 47.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 118.24 23.38 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -118.23 -40.72 2.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.379 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 p -146.27 -175.15 4.65 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.577 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.57 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.6 m -131.57 150.6 52.09 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.221 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -71.47 -25.26 62.21 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.422 ' HB2' ' HB3' ' A' ' 96' ' ' ASP . 23.8 t70 -72.19 -17.68 61.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.316 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.25 -53.43 4.7 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 12' ' ' ILE . 43.3 pt -108.37 110.13 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 122.433 1.111 . . . . 0.0 110.523 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.481 ' HB2' ' OE2' ' A' ' 16' ' ' GLU . 37.3 m95 -80.38 170.07 16.88 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.119 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.43 127.13 14.99 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.036 0.446 . . . . 0.0 110.015 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.65 -1.72 79.13 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' OE2' ' HB2' ' A' ' 13' ' ' TRP . 44.8 mt-10 -110.34 149.94 29.5 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.38 0.61 . . . . 0.0 112.239 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.408 ' HE2' ' H ' ' A' ' 56' ' ' SER . 20.3 ptt? -150.39 152.2 33.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.485 -171.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -157.24 151.91 25.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 123.613 0.571 . . . . 0.0 109.472 177.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 99.1 m -89.49 121.01 31.31 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 97.6 m-85 -119.2 155.77 31.08 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.88 143.42 39.8 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.1 p -83.06 165.76 19.32 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 m -67.0 -13.13 61.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.142 0.496 . . . . 0.0 111.213 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.85 -13.11 49.01 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 109.489 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 22.39 16.42 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.794 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.545 ' CG2' HE22 ' A' ' 42' ' ' GLN . 31.5 m -97.72 130.03 44.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.764 -0.257 . . . . 0.0 111.168 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.64 126.85 35.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.571 0.701 . . . . 0.0 111.589 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.19 148.78 27.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.8 tp -100.29 111.1 23.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.94 117.45 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 66.2 t -118.05 125.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.839 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -88.09 104.22 16.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -101.59 145.75 28.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.144 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.82 -48.98 19.37 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.483 0.659 . . . . 0.0 109.574 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.29 -41.33 61.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.723 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -100.78 2.48 41.27 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.77 -170.68 46.1 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.1 t -78.43 119.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.09 144.77 44.29 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.655 0.264 . . . . 0.0 110.914 -176.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.97 119.99 31.18 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.438 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 2.0 p90 -143.23 140.19 30.58 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.394 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.545 HE22 ' CG2' ' A' ' 26' ' ' THR . 14.7 mm100 -44.66 138.21 3.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.25 59.21 4.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.425 1.107 . . . . 0.0 109.877 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.559 ' HE1' ' HA ' ' A' ' 44' ' ' MET . 19.0 mmt -66.07 94.1 0.23 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 113.618 -1.628 . . . . 0.0 114.262 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.945 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 3.7 m -166.47 93.84 0.76 Allowed Pre-proline 0 C--N 1.31 -1.148 0 C-N-CA 125.445 1.498 . . . . 0.0 110.403 175.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.98 30.27 0.47 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.206 2.604 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 30.38 3.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -47.91 124.02 6.89 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.244 2.218 . . . . 0.0 114.817 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 41.7 mm-40 -92.55 -62.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 173.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 tp -151.16 172.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 110.71 2.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 118.985 0.811 . . . . 0.0 109.67 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -62.16 -20.01 63.66 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.893 1.277 . . . . 0.0 112.409 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.596 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 59.3 p -55.0 -21.86 13.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -166.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.46 8.59 44.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.36 0.6 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.68 81.3 0.12 Allowed Glycine 0 C--N 1.318 -0.426 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.499 ' HB3' HG21 ' A' ' 62' ' ' ILE . 66.3 m -138.53 -77.86 0.36 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -90.23 114.23 26.2 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.508 -169.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.4 105.24 11.93 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.657 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.85 -64.07 1.55 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 123.207 0.317 . . . . 0.0 113.028 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.1 -2.62 0.06 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.88 140.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.508 ' HB ' ' HB2' ' A' ' 71' ' ' PHE . 36.4 mt -113.4 121.06 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 0.0 112.044 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.4 m -92.94 148.46 21.99 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 125.67 1.588 . . . . 0.0 110.432 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.566 ' C ' ' H ' ' A' ' 66' ' ' ALA . 44.6 t -156.21 34.7 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 72.32 -22.91 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.694 1.198 . . . . 0.0 109.83 -170.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.566 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . 71.17 100.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 125.367 1.467 . . . . 0.0 111.576 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.411 ' CE1' ' HG2' ' A' ' 49' ' ' GLU . 52.7 m80 -99.83 -0.17 40.27 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.499 174.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -147.55 -55.1 0.22 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.016 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -170.62 -143.78 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.511 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 32.8 p -134.39 167.68 20.3 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.363 1.465 . . . . 0.0 108.981 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.508 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 54.2 m-85 -98.69 138.39 35.93 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -107.46 112.54 25.37 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 173.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.405 4.6 p-10 52.77 63.19 2.33 Favored 'General case' 0 CA--C 1.476 -1.883 0 CA-C-O 123.333 1.539 . . . . 0.0 111.342 -167.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' HA3' HD13 ' A' ' 62' ' ' ILE . . . -73.26 64.47 1.67 Allowed Glycine 0 CA--C 1.474 -2.491 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.257 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.2 m -139.85 -46.64 0.44 Allowed 'General case' 1 C--N 1.242 -4.09 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.96 -3.53 6.3 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 119.171 -1.49 . . . . 0.0 113.399 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -144.12 142.95 30.89 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.326 0.563 . . . . 0.0 110.801 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.45 129.05 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.699 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 70' ' ' THR . 51.1 mt -88.3 -22.93 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 173.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.475 ' ND2' ' S2 ' ' A' ' 113' ' ' FES . 23.7 t30 -143.8 113.44 5.44 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.895 168.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -76.11 129.16 18.08 Favored 'Cis proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.706 -1.789 . . . . 0.0 110.914 -2.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.21 -11.84 59.96 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.739 0.78 . . . . 0.0 109.886 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.84 -19.78 61.25 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.712 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' A' ' 111' ' ' HIS . 79.3 m -155.11 161.67 41.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 122.327 1.06 . . . . 0.0 113.196 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 p -94.06 -167.56 1.7 Allowed 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 84.6 mt -117.38 142.72 46.77 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.843 177.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.22 86.38 5.01 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.569 176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 123.58 24.57 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.105 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' CD2' HG23 ' A' ' 105' ' ' ILE 0.251 5.4 p90 -124.08 160.32 52.69 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.58 133.67 43.77 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.68 2.92 . . . . 0.0 115.012 -172.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.3 t -116.3 143.56 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-N 113.713 -1.585 . . . . 0.0 107.498 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.9 132.38 47.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.52 130.49 48.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.63 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -125.04 90.6 3.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 176.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.64 -113.55 5.96 Favored Glycine 0 C--N 1.31 -0.889 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.604 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.57 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.2 m-20 -91.93 -8.2 46.96 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 123.365 0.666 . . . . 0.0 110.671 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -111.65 157.61 20.24 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.2 mm -126.93 135.93 62.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 16.6 m-85 -106.54 145.99 31.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 167.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.32 151.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 2' ' ' SER . 20.8 m -87.47 113.08 22.85 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.1 p -124.51 -38.28 2.42 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.4 tpmt? -107.32 91.19 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.07 -39.08 0.73 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.617 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 28.1 mm -85.49 143.25 11.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 170.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.0 tp -96.86 100.75 7.9 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.451 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 105' ' ' ILE . 2.9 Cg_exo -78.41 136.98 14.49 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 123.084 2.523 . . . . 0.0 109.872 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -80.53 117.01 20.87 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.252 0.548 . . . . 0.0 110.385 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.436 ' O ' ' HE2' ' A' ' 44' ' ' MET . 40.8 ttmt -71.83 -24.13 61.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.704 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.45 ' HA ' ' SD ' ' A' ' 44' ' ' MET . . . -174.17 103.16 0.1 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.912 175.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.566 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 26.0 t-80 77.98 -70.59 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 C--N 1.288 -2.088 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -178.143 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.945 ' S1 ' ' HB3' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttm . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 121.027 0.441 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t 178.57 133.78 0.08 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 52.46 87.82 0.03 OUTLIER 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.151 0.977 . . . . 0.0 111.342 -174.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -105.3 142.48 34.99 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -65.8 117.52 8.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.278 0.561 . . . . 0.0 110.128 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 tt -104.3 -56.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.57 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.846 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.3 m -157.92 -177.14 6.35 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 123.058 0.543 . . . . 0.0 111.064 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 p -103.62 150.17 24.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.488 ' O ' HD22 ' A' ' 9' ' ' LEU . 5.0 tt -72.85 -24.77 60.92 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.4 -25.97 68.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.215 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.54 -48.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.6 pt -100.91 110.79 28.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 CA-C-O 122.802 1.287 . . . . 0.0 112.27 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -79.2 169.78 17.63 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 113.514 -1.676 . . . . 0.0 112.227 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.1 116.71 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.703 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.34 2.12 59.08 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.383 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -104.18 145.04 30.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.21 0.528 . . . . 0.0 110.679 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -142.36 143.73 32.85 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 tp10 -152.86 149.76 28.62 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 69.5 m -89.08 123.06 33.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.001 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -127.57 162.51 26.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.765 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -102.0 141.54 34.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -83.97 170.59 13.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -64.02 -13.68 48.5 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.758 0.423 . . . . 0.0 111.66 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.52 -13.24 24.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.283 0.563 . . . . 0.0 110.373 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.2 18.58 23.82 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.978 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -97.09 139.12 33.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -89.65 135.45 33.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 19' ' ' THR . 99.2 t -134.94 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -104.08 110.29 22.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.4 mp -101.3 123.19 54.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.3 p -111.96 125.58 69.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -101.86 102.01 12.54 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 117.941 -1.504 . . . . 0.0 108.456 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.9 m -103.6 139.08 39.38 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.64 -38.62 54.36 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.412 0.625 . . . . 0.0 109.706 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -92.93 -46.89 7.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.68 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -79.74 -12.3 59.8 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.111 0.481 . . . . 0.0 110.41 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.76 159.13 31.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.988 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.464 HG11 ' HB ' ' A' ' 93' ' ' VAL . 7.2 p -72.94 124.01 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -127.06 138.59 53.24 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.24 0.543 . . . . 0.0 112.38 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.7 112.33 16.62 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.015 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -136.82 147.08 46.37 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.676 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -47.33 137.79 8.02 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.896 0.855 . . . . 0.0 113.02 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 44' ' ' MET . . . -83.99 101.09 11.48 Favored 'General case' 0 N--CA 1.396 -3.141 0 CA-C-N 114.474 -1.239 . . . . 0.0 113.198 -172.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 26.1 ptt? 64.07 179.42 0.17 Allowed 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 111.32 -2.673 . . . . 0.0 116.306 163.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.61 116.64 66.83 Favored Pre-proline 0 N--CA 1.416 -2.169 0 CA-C-N 112.238 -2.256 . . . . 0.0 107.202 171.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.435 ' HG3' ' HB2' ' A' ' 111' ' ' HIS . 25.4 Cg_endo -85.8 37.26 0.55 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 122.742 2.295 . . . . 0.0 113.347 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.626 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 26.4 m80 -85.13 -59.69 2.26 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 176.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.15 115.11 29.71 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.603 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -75.13 82.97 2.32 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 122.359 1.076 . . . . 0.0 111.164 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.0 tt -71.99 -37.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.93 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 60.61 69.49 0.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.428 HD23 ' SD ' ' A' ' 44' ' ' MET . 1.5 pt? -77.5 -19.33 56.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.323 -2.217 . . . . 0.0 114.074 -169.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.478 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.9 p -54.88 -23.12 17.11 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -163.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.49 -9.24 58.53 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 119.083 0.856 . . . . 0.0 110.182 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.6 83.18 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.428 ' OG ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 m -125.31 -57.68 1.47 Allowed 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 122.411 1.1 . . . . 0.0 109.107 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -91.21 113.52 25.81 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.403 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.36 105.52 11.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 -53.82 2.1 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.606 -0.331 . . . . 0.0 113.585 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.55 -12.28 0.02 OUTLIER Glycine 0 C--N 1.306 -1.107 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.7 141.55 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 51.5 mm -106.83 128.35 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 123.956 0.902 . . . . 0.0 108.954 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.4 m -85.74 125.25 33.08 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 5.4 t -105.79 155.57 19.16 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.39 117.77 29.96 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.303 0.241 . . . . 0.0 110.957 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.05 -38.34 0.39 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 36.0 m170 -71.2 114.71 9.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 118.266 0.485 . . . . 0.0 111.38 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.473 ' HB3' ' CG ' ' A' ' 80' ' ' ASN . 2.1 tm? 49.24 -97.49 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.438 1.495 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -166.98 -44.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 p -138.34 134.93 34.85 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -160.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.406 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 48.3 t80 -116.23 138.53 51.21 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 101.868 -3.382 . . . . 0.0 101.868 168.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -123.35 117.34 24.99 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.873 1.67 . . . . 0.0 115.156 -168.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.48 -33.46 42.23 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.256 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -48.47 -54.58 12.74 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.757 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.7 m -88.94 -36.78 15.7 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.087 0.47 . . . . 0.0 110.223 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.509 ' O ' HD13 ' A' ' 86' ' ' LEU . . . 114.37 -33.55 5.35 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.471 ' HD2' ' SG ' ' A' ' 85' ' ' CYS . 29.8 t-80 -82.72 137.97 34.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.79 144.22 17.17 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.92 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.56 -42.42 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.473 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 3.5 p-10 -135.32 118.89 12.97 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -81.11 131.76 21.39 Favored 'Cis proline' 0 C--O 1.243 0.757 0 C-N-CA 123.797 -1.335 . . . . 0.0 111.397 -1.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.0 p30 -71.5 -12.69 61.51 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.059 0.457 . . . . 0.0 111.101 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.41 -17.53 62.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.39 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 25.5 p -138.58 178.78 6.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 111.951 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.471 ' SG ' ' HD2' ' A' ' 77' ' ' HIS . 62.3 m -133.61 176.12 8.83 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 76' ' ' GLY 0.313 0.0 OUTLIER -101.02 127.06 47.7 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.646 175.466 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.83 114.2 10.71 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 -179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -87.32 116.89 25.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 101' ' ' SER . 65.4 m-85 -95.69 152.54 39.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . 0.445 ' HD3' HD11 ' A' ' 105' ' ' ILE . 14.2 Cg_exo -70.76 120.55 7.16 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.186 1.924 . . . . 0.0 110.058 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.74 138.27 52.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.468 0.652 . . . . 0.0 110.667 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -115.24 132.06 56.73 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.464 ' HB ' HG11 ' A' ' 38' ' ' VAL . 8.8 p -106.57 122.21 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.324 -175.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.457 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -125.89 143.93 50.88 Favored 'General case' 0 N--CA 1.394 -3.234 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.312 176.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -33.62 -53.75 0.63 Allowed Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 117.531 1.772 . . . . 0.0 117.531 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.56 -0.73 13.58 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.457 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 9.3 m-20 -146.89 134.82 21.37 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.67 129.77 73.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-O 121.354 0.597 . . . . 0.0 111.088 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -113.73 141.49 47.2 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.027 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.76 147.94 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 120.946 0.403 . . . . 0.0 111.082 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.428 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 51.3 m -104.79 115.22 29.93 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.969 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -101.01 -18.43 16.28 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -81.73 108.38 15.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.147 176.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.55 -34.32 2.43 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.445 HD11 ' HD3' ' A' ' 90' ' ' PRO . 33.7 mt -119.02 127.64 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.06 128.07 61.69 Favored Pre-proline 0 N--CA 1.404 -2.732 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.09 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.42 148.87 91.87 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.36 2.04 . . . . 0.0 110.362 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -80.18 166.88 21.0 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -78.56 74.14 5.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.975 1.369 . . . . 0.0 114.139 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.95 -65.61 1.16 Allowed 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 46' ' ' PRO . 13.1 t-80 -139.33 121.65 15.99 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.418 -2.052 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.379 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.626 ' S1 ' ' HB2' ' A' ' 47' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.503 -0.837 0 N-CA-C 110.848 -0.056 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.6 m 58.08 -161.25 0.24 Allowed 'General case' 0 C--O 1.243 0.727 0 O-C-N 124.186 0.929 . . . . 0.0 110.868 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.515 ' CD2' ' HB2' ' A' ' 101' ' ' SER . 92.2 m-85 -76.07 97.72 4.14 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.76 143.81 35.79 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 120.908 0.385 . . . . 0.0 110.284 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 86.1 tttt -79.54 123.66 27.78 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.415 HG21 ' SG ' ' A' ' 7' ' ' CYS . 39.7 mm -94.87 -53.55 8.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.333 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.415 ' SG ' HG21 ' A' ' 6' ' ' ILE . 93.4 m -158.31 -172.56 3.93 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.465 0.65 . . . . 0.0 111.921 -173.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 41.2 t -104.74 153.22 21.57 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.959 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.518 ' O ' HD22 ' A' ' 9' ' ' LEU . 6.4 tt -61.73 -21.8 64.82 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.99 -19.6 66.08 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.186 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -94.98 -42.95 8.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.6 tp -114.49 110.83 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.056 0.931 . . . . 0.0 112.65 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -102.59 169.04 8.89 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.327 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.42 124.76 27.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.684 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.52 66.0 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -105.14 153.27 21.75 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.083 -0.559 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.411 ' HE2' ' O ' ' A' ' 52' ' ' LEU . 23.5 ptt? -151.27 143.92 24.34 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.512 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.01 155.44 31.25 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.3 m -73.38 136.21 44.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.064 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -135.33 160.5 38.22 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.11 136.98 44.83 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.9 p -84.62 175.64 9.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.9 m -66.12 -20.72 66.24 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.046 0.45 . . . . 0.0 111.368 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.44 5.12 52.42 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.588 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.05 33.67 54.17 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.104 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 m -97.98 134.95 40.39 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.68 122.67 33.01 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.13 141.98 45.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.215 0.531 . . . . 0.0 110.267 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.489 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 53.5 tp -100.04 111.91 24.21 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 124.512 1.125 . . . . 0.0 108.191 177.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.7 114.33 32.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.39 124.55 64.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.3 t30 -109.31 106.46 16.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.5 m -98.37 157.3 16.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.686 0.755 . . . . 0.0 112.518 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -75.26 -48.96 20.88 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.543 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.12 -33.77 10.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -91.45 3.28 55.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.15 -166.37 41.23 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.392 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 10.6 p -90.92 128.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.523 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -132.3 158.16 42.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.336 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.31 128.02 48.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.523 ' CZ ' ' HG2' ' A' ' 39' ' ' LYS . 95.0 m-85 -134.97 163.56 29.59 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -55.38 138.93 44.72 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.206 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.47 -39.3 74.32 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.493 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 66.6 mtt -103.19 120.61 41.03 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.516 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 29.8 p -70.7 171.88 7.34 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 123.362 0.413 . . . . 0.0 110.429 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.476 ' N ' ' HA ' ' A' ' 110' ' ' ALA . 31.8 Cg_exo -60.62 -18.84 57.26 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.672 2.248 . . . . 0.0 111.661 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -100.01 -22.69 15.14 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.369 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.548 ' HG3' ' H ' ' A' ' 49' ' ' GLU 0.375 11.8 pt20 47.9 -102.98 0.09 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.02 0.928 . . . . 0.0 113.433 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 44.4 mt-10 58.5 -75.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.796 1.238 . . . . 0.0 113.505 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -109.27 141.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.62 99.34 5.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.942 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.474 HD22 ' H ' ' A' ' 52' ' ' LEU . 1.5 pt? -60.33 -24.97 65.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.3 p -63.58 -27.82 69.51 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 123.982 0.913 . . . . 0.0 110.305 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -113.84 21.19 15.17 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.37 -110.47 2.62 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.8 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 m -148.27 157.84 43.73 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.546 0.689 . . . . 0.0 111.495 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -125.24 127.47 46.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.327 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -114.96 163.88 14.95 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 175.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.26 -34.85 48.6 Favored Glycine 0 C--N 1.317 -0.479 0 CA-C-N 118.535 0.607 . . . . 0.0 113.288 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.06 7.14 5.11 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.527 -1.32 . . . . 0.0 113.058 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 64.3 t -124.79 125.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 122.002 -0.705 . . . . 0.0 111.43 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.469 ' HB ' ' CD2' ' A' ' 71' ' ' PHE . 51.4 mm -89.99 130.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.3 m -91.93 113.73 26.08 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.059 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.458 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 39.8 m -87.02 -45.55 10.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.786 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.517 ' O ' ' HD3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER 71.76 -36.28 0.35 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.71 1.204 . . . . 0.0 110.822 -177.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.597 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . . . -56.16 -61.06 2.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -75.8 -19.29 59.08 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.134 -1.426 . . . . 0.0 112.079 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.0 tp 179.87 -77.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 73.7 t90 177.32 -27.69 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.503 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.4 ' HB ' HD12 ' A' ' 79' ' ' ILE . 34.1 p -100.77 140.58 34.84 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' CD2' ' HB ' ' A' ' 62' ' ' ILE . 42.7 t80 -134.39 139.93 45.94 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 126.311 1.844 . . . . 0.0 107.107 173.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -106.47 113.03 26.31 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.955 0.407 . . . . 0.0 110.704 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.94 -50.91 72.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -42.7 -45.32 5.67 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.574 ' HB ' ' CD2' ' A' ' 77' ' ' HIS . 10.7 m -116.31 12.17 15.26 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 122.123 -0.634 . . . . 0.0 110.634 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.56 51.42 52.15 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.396 -0.431 . . . . 0.0 112.258 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.574 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -146.46 157.24 43.73 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.536 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.56 173.79 54.9 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 119.346 -1.406 . . . . 0.0 109.998 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 79' ' ' ILE . 1.8 mp -87.71 -27.77 5.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.07 107.13 2.82 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.558 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.87 158.07 98.36 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.123 -1.615 . . . . 0.0 111.175 -2.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.2 p-10 -104.22 -4.61 22.83 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -173.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.49 -55.44 18.92 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.236 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 85.9 m -167.46 170.63 11.16 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.619 0.768 . . . . 0.0 109.895 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.571 ' CB ' ' HA ' ' A' ' 77' ' ' HIS . 42.1 t -145.39 -79.42 0.18 Allowed 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.312 1.053 . . . . 0.0 110.756 169.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HG ' ' SG ' ' A' ' 85' ' ' CYS . 87.5 mt -114.0 167.14 10.92 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.824 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -97.51 137.7 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -95.67 113.88 25.57 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -106.03 142.74 25.47 Favored Pre-proline 0 C--O 1.245 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.048 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.89 131.97 32.99 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.963 2.442 . . . . 0.0 111.074 176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -133.15 146.78 31.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.508 -178.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 50.6 mt-10 -131.74 132.61 43.99 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.28 118.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.202 0.525 . . . . 0.0 110.427 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.491 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -120.7 91.97 3.66 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.34 -99.52 0.52 Allowed Glycine 0 CA--C 1.498 -0.989 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.583 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 8' ' ' SER . 10.6 m-20 -104.85 -9.78 17.79 Favored 'General case' 0 C--O 1.174 -2.886 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.956 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.8 128.39 45.9 Favored 'General case' 0 C--N 1.273 -2.722 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.551 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -119.73 121.9 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.409 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 20.3 m-85 -114.08 142.37 46.28 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.251 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.5 m -128.56 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.564 ' HA ' ' O ' ' A' ' 2' ' ' SER . 32.1 t -105.45 120.03 40.58 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.163 0.506 . . . . 0.0 110.074 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.2 t -102.49 12.75 36.03 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.784 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -100.82 144.33 29.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 -41.66 2.65 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.43 136.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.26 140.75 23.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.23 138.78 28.76 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.073 2.515 . . . . 0.0 113.688 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -80.86 -177.34 6.32 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -14.74 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 124.118 0.967 . . . . 0.0 112.8 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . -49.48 146.54 3.96 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.453 1.501 . . . . 0.0 111.242 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 66.54 74.76 0.34 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.654 0.782 . . . . 0.0 110.812 -176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--N 1.299 -1.597 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.912 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.597 ' S1 ' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 C--O 1.235 0.292 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -162.17 -163.98 1.0 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -59.54 102.88 0.16 Allowed 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.302 0.572 . . . . 0.0 110.049 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -117.71 150.28 39.34 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.659 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -77.38 115.29 17.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.291 0.567 . . . . 0.0 110.083 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.8 tp -96.4 -35.28 5.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.791 -177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.9 p -162.3 -166.58 1.42 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.981 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.697 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.2 m -127.96 149.1 50.49 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.147 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.95 -34.72 78.62 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 123.495 0.718 . . . . 0.0 109.395 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.45 -23.08 66.83 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.36 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.45 -46.47 12.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.572 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 47.0 pt -100.65 114.75 40.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.353 1.073 . . . . 0.0 112.124 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.442 ' O ' ' HB2' ' A' ' 16' ' ' GLU . 15.0 m95 -82.25 168.52 17.53 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.196 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.08 122.06 11.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.67 0.748 . . . . 0.0 110.001 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 57' ' ' TYR . . . 94.18 1.11 65.05 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.223 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 13' ' ' TRP . 24.2 mm-40 -102.69 137.83 40.4 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.3 0.572 . . . . 0.0 109.747 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.408 ' CB ' HG22 ' A' ' 31' ' ' VAL . 23.1 ptm -137.23 143.14 42.11 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.902 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.584 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 12.2 tp10 -156.54 154.66 30.65 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 176.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.636 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 89.1 m -100.93 130.94 47.0 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.19 0.519 . . . . 0.0 109.912 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -123.11 152.19 41.33 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.08 138.47 51.6 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.18 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.2 p -83.92 172.71 11.84 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 p -64.43 -26.54 68.49 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.177 0.591 . . . . 0.0 110.944 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.55 -12.22 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.212 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.52 18.07 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.443 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.6 m -90.28 117.0 28.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.72 123.72 33.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' THR . 62.1 t -127.33 137.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.163 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.511 ' O ' HD12 ' A' ' 29' ' ' LEU . 4.3 pp -93.3 123.3 36.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -109.44 114.55 47.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' CB ' ' A' ' 17' ' ' MET . 46.6 t -119.19 125.84 74.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.355 -177.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -87.82 106.21 17.92 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 22.8 m -99.53 149.35 23.33 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -75.28 -50.04 17.34 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.177 0.513 . . . . 0.0 111.063 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.7 -45.04 9.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.803 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.4 ' NE2' ' HE3' ' A' ' 39' ' ' LYS . 21.3 t-160 -84.25 -15.02 48.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.86 0.362 . . . . 0.0 111.949 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 85.59 -171.5 45.48 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.003 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.4 t -77.72 123.35 34.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.4 ' HE3' ' NE2' ' A' ' 36' ' ' HIS . 74.3 mmtt -128.25 150.44 50.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.23 119.24 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.329 -179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -128.69 158.61 38.11 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -60.19 138.23 57.96 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HB1' ' N ' ' A' ' 29' ' ' LEU . . . -106.35 -5.75 18.83 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.01 17.49 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.434 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 89.3 m -80.45 111.79 25.7 Favored Pre-proline 0 N--CA 1.443 -0.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 168.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.07 39.05 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.626 2.218 . . . . 0.0 111.845 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -102.25 -77.03 0.56 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -170.15 131.78 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.407 ' HB2' ' HB1' ' A' ' 66' ' ' ALA . 43.1 mt-10 64.54 86.44 0.13 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.778 0.799 . . . . 0.0 112.164 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tt -93.88 106.46 18.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.729 0.776 . . . . 0.0 111.836 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HB3' ' HG2' ' A' ' 65' ' ' ARG . 36.1 tp -154.38 48.92 0.61 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.451 ' C ' HD12 ' A' ' 52' ' ' LEU . 1.6 tm? -56.16 -38.78 71.36 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.276 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.636 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 94.0 p -68.56 -29.47 68.02 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.382 0.611 . . . . 0.0 112.331 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -83.87 17.15 2.46 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 124.265 1.026 . . . . 0.0 110.815 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.01 -125.01 1.15 Allowed Glycine 0 N--CA 1.412 -2.914 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.4 m -152.69 151.46 30.57 Favored 'General case' 0 N--CA 1.424 -1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.905 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.519 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 20.8 t80 -120.75 116.25 24.87 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.162 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -117.18 170.82 8.37 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 69.61 0.04 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.01 1.75 39.08 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.14 127.21 72.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.8 mm -122.72 132.94 70.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.39 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.4 m -101.76 137.39 40.12 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 25.9 p -78.09 -73.86 0.29 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.558 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.452 ' HG2' ' HB3' ' A' ' 51' ' ' LEU . 29.7 tpt180 174.72 -69.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 49' ' ' GLU . . . -66.51 -57.96 6.23 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.443 ' C ' ' H ' ' A' ' 69' ' ' TRP . 8.6 m170 -70.59 116.11 10.53 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.836 167.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.93 17.63 3.39 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.53 1.157 . . . . 0.0 108.603 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.443 ' H ' ' C ' ' A' ' 67' ' ' HIS . 87.7 m95 -93.47 177.41 6.04 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.164 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -129.8 140.81 50.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.474 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 53.5 p90 -105.67 154.02 21.02 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -93.7 116.57 29.07 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.983 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.46 -30.49 67.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.159 0.584 . . . . 0.0 111.3 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.77 31.51 4.25 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.3 m -156.7 -44.2 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.784 0.834 . . . . 0.0 109.305 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.59 -9.72 66.65 Favored Glycine 0 C--O 1.215 -1.049 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.911 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.12 148.29 28.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.474 ' HA2' ' CB ' ' A' ' 71' ' ' PHE . . . -72.56 137.73 25.08 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.645 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.41 -43.72 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -160.84 124.31 1.93 Allowed Pre-proline 0 N--CA 1.425 -1.721 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.503 ' HD2' ' SG ' ' A' ' 84' ' ' CYS . 12.7 Cg_exo -71.92 166.21 79.85 Favored 'Cis proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.79 0.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.41 -11.54 34.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.18 -10.75 59.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.503 ' SG ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 p -110.32 133.98 52.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 122.334 1.064 . . . . 0.0 111.96 176.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.52 157.69 43.3 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.3 mt -131.75 179.47 6.05 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -141.07 139.66 34.08 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.25 104.09 16.49 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.235 0.541 . . . . 0.0 109.933 176.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -89.96 163.51 31.88 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.88 119.57 6.81 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.656 2.237 . . . . 0.0 114.018 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.1 p -129.9 127.47 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.629 176.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.459 0.647 . . . . 0.0 110.028 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.83 129.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.062 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -122.61 146.85 47.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.07 101.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.07 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.741 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.697 ' O ' ' HB3' ' A' ' 8' ' ' SER . 8.0 m-20 76.27 -13.82 0.87 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.28 2.232 . . . . 0.0 114.716 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -120.62 155.46 33.72 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-N 119.965 1.257 . . . . 0.0 110.849 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . 0.251 45.8 mt -131.26 133.92 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -119.44 144.38 46.98 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.495 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.3 m -135.52 144.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -132.39 118.09 18.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -92.92 6.08 49.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.156 0.503 . . . . 0.0 109.96 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -72.13 109.76 6.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.719 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.02 25.4 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.62 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.8 119.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 110.031 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 148.05 34.03 Favored Pre-proline 0 N--CA 1.409 -2.496 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.83 134.13 57.61 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.887 2.391 . . . . 0.0 111.251 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 54.3 t30 -79.91 157.29 26.95 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.1 106.01 0.24 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -171.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 174.52 -69.86 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.614 -2.539 . . . . 0.0 106.34 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 39.29 -90.65 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.745 2.018 . . . . 0.0 115.005 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.429 -1.511 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 -173.66 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' FES . . . . . 0.434 ' S1 ' ' HB3' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.5 t . . . . . 0 C--O 1.243 0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.8 m-85 -90.11 105.62 17.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.177 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -106.3 146.23 30.65 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -76.09 116.78 17.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -98.55 -30.89 3.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.523 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.0 p -167.35 -171.73 1.78 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.082 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 56.7 p -130.5 152.8 49.48 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.588 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.7 mt -67.9 -15.36 63.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.858 0.837 . . . . 0.0 109.325 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.4 -23.58 63.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.047 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -83.6 -64.55 1.15 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.7 pt -103.16 134.57 43.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.48 1.133 . . . . 0.0 113.604 -174.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 30.6 m95 -93.1 170.02 9.96 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.179 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.5 118.3 6.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.36 56.88 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -112.22 151.28 29.76 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.859 0.362 . . . . 0.0 110.539 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.516 ' SD ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -148.39 146.61 28.56 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 178.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.6 pt-20 -158.36 156.77 31.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.514 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.9 t -94.19 141.7 28.25 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.064 0.459 . . . . 0.0 110.039 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 92.7 m-85 -131.57 155.63 47.15 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.45 138.34 35.81 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -82.86 173.7 11.6 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -66.39 -15.48 63.33 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.155 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -93.59 -13.9 27.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.222 0.534 . . . . 0.0 110.204 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 -3.4 38.78 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.671 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 m -76.89 133.09 39.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.81 123.01 42.77 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.99 0.9 . . . . 0.0 109.149 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -122.62 143.83 34.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.449 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 2.8 tm? -94.24 120.48 34.54 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.4 113.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 7.7 p -112.84 128.53 69.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.123 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.9 t30 -111.06 102.3 10.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 169.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.4 p -103.64 157.81 16.8 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.885 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -76.46 -33.67 58.71 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.403 175.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -94.69 -46.14 7.05 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -97.28 -4.74 38.19 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.976 -0.453 . . . . 0.0 111.468 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.52 -163.12 48.09 Favored Glycine 0 C--O 1.248 0.995 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -93.36 118.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-O 121.716 0.77 . . . . 0.0 109.352 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -129.99 146.69 51.69 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.896 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.86 112.6 16.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.604 ' HB2' HD11 ' A' ' 86' ' ' LEU . 5.1 p90 -138.95 163.33 32.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -51.52 137.13 24.92 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.53 0.519 . . . . 0.0 110.377 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -111.66 -37.89 5.05 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -84.1 79.92 9.35 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -167.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -100.72 -28.41 0.23 Allowed Pre-proline 0 C--O 1.174 -2.921 0 CA-C-O 116.748 -1.596 . . . . 0.0 110.786 167.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 10.2 Cg_endo -50.06 105.44 0.1 OUTLIER 'Trans proline' 1 C--N 1.424 4.547 0 CA-C-N 122.683 1.994 . . . . 0.0 112.288 -177.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 68.0 m80 -82.61 9.46 9.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.032 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.74 116.9 20.93 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 103.358 -2.83 . . . . 0.0 103.358 170.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.0 OUTLIER -50.78 111.7 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -173.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 tp -155.27 163.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.14 100.25 9.99 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.066 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.436 HD11 HG22 ' A' ' 62' ' ' ILE . 6.0 tt -56.64 -32.83 65.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.624 1.169 . . . . 0.0 112.897 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 31.8 p -72.36 -22.48 61.14 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.495 0.664 . . . . 0.0 111.517 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -103.64 12.65 34.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.17 -103.08 2.85 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.817 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.549 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 22.6 t -144.74 145.42 31.68 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 123.372 1.558 . . . . 0.0 114.26 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -131.82 114.43 14.69 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 110.874 -2.875 . . . . 0.0 104.389 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -116.59 103.29 10.24 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.069 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.28 -72.77 0.43 Allowed Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.239 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.24 3.11 0.54 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.68 124.68 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.488 0.661 . . . . 0.0 109.363 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 52' ' ' LEU . 67.6 mt -93.66 139.13 18.82 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.549 ' OG1' ' HB3' ' A' ' 56' ' ' SER . 35.8 m -80.78 115.39 20.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.556 1.169 . . . . 0.0 112.873 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 37.1 t -93.06 141.07 28.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 173.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 65' ' ' ARG . 21.8 ttt180 -118.76 -42.53 2.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 117.237 -1.785 . . . . 0.0 114.691 -168.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . . . -93.45 -6.33 47.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.222 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 72.9 m80 -116.75 -174.21 2.53 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.425 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 69' ' ' TRP . 2.6 tm? -77.76 73.56 4.33 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.405 ' CD1' HD13 ' A' ' 68' ' ' LEU 0.343 17.9 p-90 35.94 -31.91 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 131.095 3.758 . . . . 0.0 120.841 172.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -102.19 127.29 49.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.402 ' CE2' HD13 ' A' ' 86' ' ' LEU . 37.1 t80 -135.33 136.15 41.33 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 171.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -123.59 133.32 53.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 117.773 -1.571 . . . . 0.0 114.16 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.17 -42.43 72.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.921 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.18 98.52 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.58 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -80.46 -27.46 37.88 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.21 26.7 73.88 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 16.9 t-160 -157.56 154.91 29.3 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -173.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.02 137.49 23.16 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.54 -41.83 20.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 51.0 t-20 -160.68 113.96 1.35 Allowed Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 67' ' ' HIS . 2.0 Cg_endo -81.44 -179.54 25.0 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.963 4.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.44 -19.51 29.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.838 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.35 -33.33 74.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.423 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.5 p -90.69 142.44 27.75 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-O 122.112 0.958 . . . . 0.0 112.078 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 108' ' ' ASN . 1.6 p -139.38 159.83 41.25 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.275 -1.329 . . . . 0.0 111.399 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 41' ' ' TYR . 34.4 tp -111.61 129.83 55.95 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.046 0.45 . . . . 0.0 110.997 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -110.8 111.62 22.9 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.06 148.73 22.71 Favored 'General case' 0 N--CA 1.421 -1.894 0 O-C-N 123.618 0.574 . . . . 0.0 110.499 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 101' ' ' SER . 97.6 m-85 -108.7 149.8 39.94 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.624 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.8 121.83 9.29 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.7 2.267 . . . . 0.0 110.755 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.69 138.32 32.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.865 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 119.07 35.43 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.12 120.24 59.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.289 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' ' 94' ' ' LYS 0.282 0.0 OUTLIER -126.54 145.72 50.41 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.946 174.985 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -25.29 -45.75 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 119.763 2.665 . . . . 0.0 119.763 -171.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 8' ' ' SER . 26.6 m-20 -116.46 -13.59 10.96 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 117.808 0.804 . . . . 0.0 111.795 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 94' ' ' LYS . 5.0 m-20 -121.62 148.9 43.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.612 0.72 . . . . 0.0 112.887 -169.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -126.14 111.57 27.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.309 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -108.98 144.29 37.15 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.781 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 8.8 p -140.32 145.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 2' ' ' SER . 38.5 t -87.84 114.21 24.24 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -134.36 15.87 3.75 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.416 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -108.36 118.19 36.11 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.265 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 -3.82 86.73 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.175 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.6 mt -90.39 130.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 120.778 0.323 . . . . 0.0 110.444 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 61.6 tp -78.48 119.98 79.33 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.103 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 37.0 Cg_endo -69.11 145.93 62.55 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.842 2.361 . . . . 0.0 111.052 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.69 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 10.1 m120 -88.91 179.14 6.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.853 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.506 ' HD2' ' N ' ' A' ' 109' ' ' LYS . 11.0 mptt -67.8 101.38 1.06 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.74 1.257 . . . . 0.0 112.582 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.262 -3.239 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 -178.58 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.433 -1.282 0 CA-C-O 120.675 0.274 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' A' ' 92' ' ' GLU . 96.4 m-85 58.28 97.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.3 150.26 50.15 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.106 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 88.4 tttt -68.72 137.83 54.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.013 0.435 . . . . 0.0 111.602 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.457 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -127.25 -40.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' HG23 ' A' ' 6' ' ' ILE . 19.8 p -155.08 -172.11 4.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.305 0.574 . . . . 0.0 112.122 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p -131.45 150.01 52.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.646 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.7 tt -69.65 -25.66 64.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.05 -24.93 68.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.977 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.38 -55.11 3.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.683 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 12' ' ' ILE . 40.4 pt -100.82 110.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 122.541 1.162 . . . . 0.0 111.085 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -83.75 170.15 14.49 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.749 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -56.89 118.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.012 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 -2.27 61.25 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.64 142.3 34.56 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.97 142.11 32.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.189 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.737 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -148.16 133.8 18.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.232 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 89.4 m -79.03 123.08 26.97 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -119.23 155.04 32.44 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.508 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -102.65 134.66 45.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.819 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -83.55 167.36 17.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -63.14 -13.31 35.29 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -88.48 -12.27 43.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.25 30.87 11.45 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -97.62 133.59 41.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.64 126.83 35.78 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.176 0.512 . . . . 0.0 110.068 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 19' ' ' THR . 42.0 t -131.67 140.15 48.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -97.34 108.13 20.79 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.8 mp -99.36 115.85 41.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.37 125.11 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 42.5 t30 -97.26 105.08 17.16 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.306 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -101.4 148.58 25.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -76.64 -50.72 13.06 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.505 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.54 -38.5 14.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.81 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -79.72 -9.66 59.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.65 169.51 38.52 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.337 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -76.01 122.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.47 142.95 50.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.57 137.5 49.33 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 96.4 m-85 -130.35 149.77 51.88 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB3' ' H ' ' A' ' 87' ' ' ALA . 33.7 tt0 -52.02 136.31 29.39 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.86 19.61 18.91 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.65 0.738 . . . . 0.0 110.511 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.2 mmm -78.55 87.5 4.52 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.575 ' SG ' HD11 ' A' ' 52' ' ' LEU . 9.1 p -115.89 94.09 40.07 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 165.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.47 42.25 1.2 Allowed 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.993 2.462 . . . . 0.0 113.89 -170.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -96.26 -67.0 0.87 Allowed 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.884 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -161.7 -35.62 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.009 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 2.7 mp0 -99.74 100.65 11.64 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.873 0.844 . . . . 0.0 110.913 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.4 tp -92.51 0.49 9.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 122.734 1.254 . . . . 0.0 108.565 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.26 41.85 1.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.369 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.575 HD11 ' SG ' ' A' ' 45' ' ' CYS . 4.5 mp -56.66 -32.55 65.49 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.414 0.686 . . . . 0.0 111.248 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.737 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 80.7 p -72.23 -28.05 62.92 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.609 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -99.73 17.5 20.49 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 64' ' ' CYS . . . -86.68 -109.21 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 t -149.67 148.77 29.68 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.131 0.967 . . . . 0.0 111.883 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -129.89 121.11 26.02 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.109 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 44.2 mt-10 -115.4 168.13 10.26 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.35 64.48 2.47 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 120.802 -0.714 . . . . 0.0 113.128 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.09 -12.7 3.08 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 70.6 t -123.5 131.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 120.778 0.323 . . . . 0.0 110.382 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mm -111.47 135.58 50.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.0 m -128.06 129.16 46.2 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 43.1 t -63.85 -72.11 0.15 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 25.8 ttt180 161.05 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.65 1.58 . . . . 0.0 107.263 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.59 11.85 7.02 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.552 1.167 . . . . 0.0 108.668 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -146.57 145.61 30.17 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 127.464 2.306 . . . . 0.0 107.473 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.479 ' HB3' ' H ' ' A' ' 64' ' ' CYS . 43.3 tp 58.15 82.74 0.13 Allowed 'General case' 0 C--N 1.32 -0.677 0 O-C-N 124.965 1.416 . . . . 0.0 109.68 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -74.55 -45.76 43.39 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.421 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 p -133.69 129.11 36.33 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.665 0.745 . . . . 0.0 111.275 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 74.1 t80 -135.1 138.62 43.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -103.85 112.8 25.92 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.461 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.13 -22.26 66.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.58 1.152 . . . . 0.0 111.502 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 16.79 57.31 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.954 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.1 m -148.78 -47.98 0.15 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.201 -0.587 . . . . 0.0 111.14 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.46 -3.62 34.76 Favored Glycine 0 C--O 1.211 -1.337 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.794 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -104.17 147.5 27.38 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.997 -0.707 . . . . 0.0 110.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.48 133.71 11.95 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.2 mp -82.09 -43.15 19.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 27.2 t-20 -140.31 113.02 7.34 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.032 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 96.8 Cg_endo -85.68 163.86 57.51 Favored 'Cis proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.26 -1.558 . . . . 0.0 111.468 -1.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -82.5 -11.73 58.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.128 0.966 . . . . 0.0 108.463 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.08 -26.21 25.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.212 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 73.3 m -139.47 158.17 44.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.087 0.946 . . . . 0.0 111.631 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.2 m -153.06 169.09 23.78 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 42' ' ' GLN . 51.2 mt -126.79 163.92 22.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.755 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -118.32 153.66 33.61 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.21 131.8 47.45 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.301 1.0 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.529 ' CE1' ' HB ' ' A' ' 100' ' ' VAL . 1.7 t80 -126.44 106.54 23.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.79 125.13 16.14 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.844 3.03 . . . . 0.0 113.751 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.06 145.19 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.766 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.518 ' HG3' ' CE1' ' A' ' 3' ' ' PHE . 42.1 mt-10 -127.78 134.24 49.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.317 0.647 . . . . 0.0 110.345 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.1 117.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.79 108.91 11.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.251 178.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 55.92 54.68 33.53 Favored Glycine 0 CA--C 1.5 -0.865 0 C-N-CA 121.361 -0.447 . . . . 0.0 113.026 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 72.23 -6.4 1.55 Allowed 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 125.141 1.377 . . . . 0.0 113.842 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -100.89 138.86 37.37 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -126.37 125.51 67.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 5' ' ' LYS . 3.2 m-85 -112.83 141.63 46.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.738 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 89' ' ' TYR . 27.0 m -129.8 143.23 41.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.115 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 26.7 t -116.23 129.69 56.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.578 0.228 . . . . 0.0 111.32 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 2.9 m -86.38 -15.15 41.28 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -88.6 123.58 33.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.36 23.23 8.56 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 64.1 mt -100.12 129.44 50.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.977 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -106.44 102.12 39.22 Favored Pre-proline 0 N--CA 1.426 -1.655 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.02 132.68 23.41 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.276 1.984 . . . . 0.0 110.002 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.755 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 18.6 t30 -115.08 115.68 27.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.623 -172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 8.7 tmtt? 64.1 -53.32 0.26 Allowed 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 127.534 2.334 . . . . 0.0 111.239 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 C--N 1.284 -2.27 0 C-N-CA 124.23 1.012 . . . . 0.0 109.113 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 68.7 103.41 0.05 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.925 0.869 . . . . 0.0 111.382 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.25 143.16 37.46 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.539 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -69.41 119.28 13.43 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.506 0.722 . . . . 0.0 109.504 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -115.97 -47.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.471 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.3 p -157.57 -168.08 2.46 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-O 121.452 0.644 . . . . 0.0 112.096 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.2 p -129.56 152.36 49.17 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.402 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 9' ' ' LEU . 1.6 tm? -67.23 -16.2 64.15 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.46 -29.9 70.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.786 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.82 -60.35 2.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.038 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -111.56 118.17 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 122.356 1.074 . . . . 0.0 113.227 -176.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -99.15 171.83 7.76 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.237 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 34' ' ' GLU . 7.2 p -51.11 111.73 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 CA-C-O 121.567 0.699 . . . . 0.0 111.443 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.75 7.68 56.41 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.38 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -109.45 151.59 26.5 Favored 'General case' 0 C--O 1.246 0.914 0 O-C-N 122.37 -0.488 . . . . 0.0 110.219 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -150.46 137.48 19.3 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.1 mt-10 -149.66 153.48 37.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.0 t -92.87 138.15 31.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.236 0.541 . . . . 0.0 110.565 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 148.82 52.43 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 42.6 tt0 -98.22 146.0 26.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.939 0.399 . . . . 0.0 111.544 -171.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -83.26 178.72 7.95 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 m -70.57 -11.9 61.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.46 0.648 . . . . 0.0 110.592 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -91.49 -14.36 30.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.044 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.08 15.57 51.21 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.501 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.1 m -97.34 128.4 44.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.381 -0.482 . . . . 0.0 109.844 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 40.3 mt-10 -90.05 128.07 36.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.445 0.64 . . . . 0.0 111.036 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' THR . 94.3 t -117.99 141.54 36.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.53 -175.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.5 117.11 29.79 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.2 mp -100.11 112.79 33.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.59 130.55 68.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.75 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -105.52 106.91 17.63 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 t -79.36 146.49 32.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 124.451 1.1 . . . . 0.0 110.769 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.495 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 mp0 -53.94 -50.19 67.0 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.365 1.066 . . . . 0.0 111.904 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -110.4 -36.87 5.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.589 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -79.96 -28.51 39.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.482 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.78 -149.97 17.39 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.881 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -86.39 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.712 0.768 . . . . 0.0 111.652 -171.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -129.26 130.0 45.65 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.316 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.54 111.5 15.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.032 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -144.56 154.52 42.95 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.53 137.06 19.97 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.644 0.59 . . . . 0.0 109.652 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.87 -54.03 9.85 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -88.27 160.94 17.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.777 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' A' ' 64' ' ' CYS . 13.5 p -89.62 86.44 0.17 Allowed Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 45' ' ' CYS . 19.9 Cg_exo -1.44 42.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.95 1 C-N-CA 128.156 5.904 . . . . 0.0 119.476 -162.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -149.71 129.93 13.67 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 68.31 123.7 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 114.796 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -85.77 103.27 14.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.304 176.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tp -153.07 154.68 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.36 80.51 4.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.198 0.999 . . . . 0.0 110.233 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -73.22 -19.17 61.14 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.679 -176.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 30.5 p -56.31 -19.72 15.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -84.42 -9.67 58.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.378 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.13 75.41 0.28 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.1 m -130.76 -73.29 0.55 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.311 0.577 . . . . 0.0 110.841 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.569 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 64.8 t80 -91.26 112.74 24.78 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.332 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -118.89 104.05 10.17 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.21 -73.11 0.41 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-O 121.28 0.378 . . . . 0.0 112.643 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.73 12.3 0.46 Allowed Glycine 0 C--N 1.301 -1.4 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.66 134.48 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 40.0 mm -100.15 139.41 21.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 m -83.56 115.08 21.95 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 111.72 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.686 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 5.6 t -81.02 119.33 23.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.424 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -60.57 -60.24 4.12 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.94 -39.05 4.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 10.6 m80 -58.09 -45.6 86.92 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -157.56 -95.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.425 ' CD1' HG23 ' A' ' 70' ' ' THR . 18.4 p90 172.96 -16.46 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 124.387 1.075 . . . . 0.0 110.376 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 69' ' ' TRP . 35.1 p -101.78 128.82 47.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.158 0.504 . . . . 0.0 111.802 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.634 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 43.7 t80 -137.5 138.98 40.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 171.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.02 111.15 22.15 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.05 -33.38 63.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 111.713 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.73 88.69 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -94.99 -28.48 15.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.309 0.576 . . . . 0.0 109.612 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.72 18.83 64.9 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -136.54 137.6 40.42 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.82 137.73 20.48 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.398 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.84 -44.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -154.04 109.2 2.48 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.1 148.85 91.95 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.167 -1.597 . . . . 0.0 113.213 3.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 14.2 t70 -86.2 -24.69 26.0 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.869 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.91 -37.83 86.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.0 m -94.72 151.32 19.37 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 123.077 1.418 . . . . 0.0 112.715 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.73 140.04 20.4 Favored 'General case' 0 C--N 1.262 -3.232 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.681 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.634 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 7.6 mp -110.97 100.98 9.58 Favored 'General case' 0 C--N 1.259 -3.368 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.617 -175.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.26 127.73 33.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.604 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.2 160.77 25.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 124.003 0.814 . . . . 0.0 110.014 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.12 148.41 43.56 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 105' ' ' ILE . 26.6 Cg_exo -62.94 121.16 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.017 1.812 . . . . 0.0 109.248 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.11 133.67 68.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.426 0.632 . . . . 0.0 111.765 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 47.3 mt-10 -122.76 135.05 54.44 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.15 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.98 120.82 63.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.115 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -121.66 91.33 3.49 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.93 -99.19 0.18 Allowed Glycine 0 N--CA 1.437 -1.271 0 O-C-N 123.793 0.683 . . . . 0.0 113.869 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -90.55 -18.55 25.05 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.828 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -110.91 147.47 34.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 12' ' ' ILE . 78.6 mt -127.32 129.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.577 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -119.22 136.9 53.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.68 137.53 55.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -97.35 114.69 26.52 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.012 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.5 m -100.27 -40.53 7.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -53.86 111.0 0.66 Allowed 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.686 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.82 -25.28 9.64 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.343 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.426 ' CD1' ' HD3' ' A' ' 90' ' ' PRO . 67.3 mt -103.73 133.16 48.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 120.939 0.4 . . . . 0.0 110.119 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.89 124.05 55.71 Favored Pre-proline 0 N--CA 1.403 -2.799 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.464 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 149.29 85.78 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 121.865 1.71 . . . . 0.0 108.712 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -91.49 113.54 25.83 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm 49.66 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 124.71 1.256 . . . . 0.0 110.241 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 125.856 1.662 . . . . 0.0 111.299 176.469 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 39.9 t . . . . . 0 N--CA 1.428 -1.568 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 81.0 m-85 -80.15 97.9 7.08 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.157 0.503 . . . . 0.0 109.701 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -106.23 143.75 33.91 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -75.0 124.05 26.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -83.18 -54.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.8 m -171.98 -173.79 1.19 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 126.001 1.72 . . . . 0.0 108.052 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.702 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 15.5 p -101.11 151.47 21.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 96' ' ' ASP . 53.1 tp -60.13 -17.85 43.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.257 1.027 . . . . 0.0 108.971 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.86 -25.74 68.3 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.164 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -93.11 -43.8 8.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.303 0.573 . . . . 0.0 109.824 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 tp -100.28 117.21 45.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.984 0.897 . . . . 0.0 111.868 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -105.86 168.97 8.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.298 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.58 123.68 26.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.143 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.72 65.29 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -104.01 162.13 13.4 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.04 0.447 . . . . 0.0 110.377 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 53' ' ' SER . 26.7 ptt? -150.15 136.84 19.16 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.642 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.3 tp10 -147.39 152.93 38.97 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.622 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.571 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 97.2 m -97.33 129.19 44.63 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.85 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -139.74 157.97 44.87 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.5 tt0 -108.01 143.78 36.23 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.159 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 p -83.07 168.61 16.75 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -68.18 -18.62 64.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.442 0.639 . . . . 0.0 109.664 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.44 -13.33 52.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.84 14.26 37.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.201 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 m -97.37 126.39 42.58 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 35.6 tt0 -89.2 123.69 33.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.405 HG11 ' HB1' ' A' ' 40' ' ' ALA . 58.9 t -127.47 146.01 33.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.7 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.53 111.92 24.42 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.4 mp -95.95 119.22 43.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 17' ' ' MET . 7.6 p -110.08 123.82 66.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -114.51 104.15 11.74 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.376 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 36' ' ' HIS . 58.9 p -102.32 148.77 25.06 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.13 -37.96 66.46 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.315 0.578 . . . . 0.0 110.27 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -86.13 -30.2 22.7 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.811 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.452 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 12.0 m170 -106.84 -23.58 12.34 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.82 -170.96 17.56 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.448 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -98.25 121.45 48.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.495 0.664 . . . . 0.0 111.459 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -117.77 148.15 42.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.195 177.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -124.18 113.19 17.99 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -131.72 163.6 27.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -50.71 138.14 18.82 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.707 0.63 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.09 8.74 32.38 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.2 tpt -75.57 88.4 2.7 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.217 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' A' ' 48' ' ' GLN . 44.8 t -159.25 85.57 2.25 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.918 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.62 5.62 6.28 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.315 2.01 . . . . 0.0 108.947 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -86.51 -18.91 30.38 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.74 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.719 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 53.6 tt0 -69.24 147.06 51.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.421 -1.263 . . . . 0.0 113.383 -171.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.16 100.05 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.046 1.738 . . . . 0.0 112.953 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mm 63.75 -79.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 125.049 1.339 . . . . 0.0 114.017 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -118.65 119.99 36.12 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -174.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.9 pt? -63.93 -49.08 74.0 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.642 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 77.4 p -73.74 -31.34 63.31 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.499 0.666 . . . . 0.0 112.446 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' H ' HD12 ' A' ' 51' ' ' LEU . 43.4 mt-10 -95.11 22.06 7.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.78 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.0 -95.41 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.655 0.597 . . . . 0.0 113.373 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.7 m -155.53 127.5 7.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.899 0.857 . . . . 0.0 111.903 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -130.44 120.62 24.47 Favored 'General case' 0 C--N 1.261 -3.273 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.707 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 45.9 mt-10 -110.21 168.17 9.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -37.01 -58.45 1.22 Allowed Glycine 0 N--CA 1.48 1.575 0 O-C-N 124.236 0.96 . . . . 0.0 114.782 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.26 24.59 4.7 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.771 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 64.5 t -124.15 122.07 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 120.944 0.402 . . . . 0.0 110.484 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.658 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 47.8 mm -95.72 138.08 22.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 m -127.22 115.69 19.45 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.18 -1.408 . . . . 0.0 111.112 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.417 ' HB3' HD12 ' A' ' 68' ' ' LEU . 4.1 t -64.86 -21.78 66.87 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.542 ' H ' HD11 ' A' ' 68' ' ' LEU 0.343 71.6 ttt180 46.39 80.95 0.04 OUTLIER 'General case' 0 C--O 1.248 1.009 0 C-N-CA 129.505 3.122 . . . . 0.0 117.792 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 174.02 -45.4 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 125.352 1.657 . . . . 0.0 109.464 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -123.31 8.84 9.11 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -119.82 162.75 18.57 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.547 -1.261 . . . . 0.0 112.759 -177.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 75.6 t-105 -96.71 -69.45 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 p -135.01 141.96 46.32 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 121.497 0.665 . . . . 0.0 111.686 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.658 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 21.3 t80 -135.45 138.29 43.04 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -98.81 127.22 44.68 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.2 -56.59 17.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.157 0.983 . . . . 0.0 113.446 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.33 -50.43 62.42 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.202 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.2 m -81.17 -32.51 33.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.165 0.507 . . . . 0.0 110.402 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.97 71.65 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.64 ' HE1' ' OD1' ' A' ' 82' ' ' ASP . 55.2 t60 -102.65 138.61 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.543 1.137 . . . . 0.0 109.567 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.1 140.79 15.66 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.8 -48.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 48.6 t30 -149.17 112.18 3.52 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.052 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.6 Cg_exo -76.8 160.68 94.73 Favored 'Cis proline' 0 C--O 1.241 0.663 0 C-N-CA 123.127 -1.614 . . . . 0.0 111.817 -0.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' HE1' ' A' ' 77' ' ' HIS . 17.4 t70 -72.38 -40.88 66.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.742 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -89.44 26.28 1.73 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.194 0.521 . . . . 0.0 111.719 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 71' ' ' PHE . 18.5 t -101.27 6.22 42.79 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.581 0.705 . . . . 0.0 109.428 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 38.0 m -51.53 155.91 1.43 Allowed 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.127 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 pp -101.53 -177.86 3.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.27 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.58 113.55 15.59 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.5 120.33 32.87 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.638 0.733 . . . . 0.0 110.904 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -91.61 129.65 41.92 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.21 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.49 120.89 8.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.693 2.929 . . . . 0.0 112.04 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.01 131.74 56.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.233 0.54 . . . . 0.0 111.114 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -109.38 110.56 21.74 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.2 115.81 50.72 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.49 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -126.01 147.02 49.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -38.91 124.45 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.602 0.564 . . . . 0.0 113.628 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.702 ' O ' ' HB2' ' A' ' 8' ' ' SER . 19.5 m-20 78.92 -19.53 0.44 Allowed 'General case' 0 C--O 1.2 -1.535 0 C-N-CA 126.281 1.832 . . . . 0.0 114.928 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 34.4 t70 -145.77 143.64 29.82 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.673 1.579 . . . . 0.0 114.266 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.94 127.15 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.38 151.3 38.72 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.364 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.87 144.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 121.388 0.613 . . . . 0.0 111.627 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 37.3 t -95.28 124.85 39.54 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.094 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -111.07 15.41 21.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 63.8 tttp -66.35 110.18 2.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.789 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.53 7.11 78.5 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.256 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.04 108.8 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.22 155.66 38.63 Favored Pre-proline 0 N--CA 1.411 -2.412 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 138.19 53.63 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.918 1.745 . . . . 0.0 109.632 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.12 169.8 17.62 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -52.65 -23.1 5.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.061 1.344 . . . . 0.0 113.782 -171.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.286 -2.164 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.96 178.79 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 24.6 m . . . . . 0 CA--C 1.554 1.113 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 77.1 m-85 -95.65 107.54 19.75 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -114.12 150.31 34.29 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.04 117.72 9.48 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 tp -111.33 -39.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.945 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.5 m -147.94 172.26 14.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.363 0.601 . . . . 0.0 110.717 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 27.2 m -118.86 152.38 36.36 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 170.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.57 -17.15 12.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.524 0.678 . . . . 0.0 112.398 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.69 -22.15 54.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.92 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.54 -35.73 24.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.888 0.852 . . . . 0.0 109.305 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 30' ' ' ILE . 3.2 tp -125.07 113.95 38.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.165 -173.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -104.28 168.39 9.13 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.829 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 122.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.308 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.88 65.36 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -103.84 159.91 15.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 121.405 0.621 . . . . 0.0 112.07 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 26.8 ptt? -151.35 140.89 21.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.07 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 43.8 tt0 -154.53 155.04 34.1 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.831 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 85.1 m -90.39 132.01 35.84 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.634 0.731 . . . . 0.0 110.677 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -128.37 153.49 47.0 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.11 137.44 45.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.565 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 p -83.89 -178.33 6.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.611 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -70.24 -30.75 67.88 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.69 -13.01 57.15 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.46 20.28 13.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.222 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.9 m -87.14 123.67 32.43 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.57 123.01 33.88 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.9 t -133.09 146.0 33.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 120.778 0.323 . . . . 0.0 110.269 -174.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD23 ' CE1' ' A' ' 41' ' ' TYR . 66.3 tp -96.17 114.81 26.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.1 mp -96.53 116.76 39.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 17' ' ' MET . 43.5 t -112.84 128.64 69.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 42.4 t30 -110.91 107.14 16.5 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -96.62 149.39 21.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.856 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -50.3 49.55 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -89.1 -37.57 14.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.898 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -94.35 1.42 55.88 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 -161.51 54.24 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.704 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 22.2 t -89.22 122.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -122.31 136.44 54.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.37 127.31 47.39 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.438 ' CE1' HD23 ' A' ' 29' ' ' LEU . 40.3 p90 -143.68 163.7 32.53 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.393 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -44.3 137.38 3.58 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.897 0.748 . . . . 0.0 110.101 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.78 -36.03 7.17 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.32 121.54 29.04 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.931 -0.707 . . . . 0.0 112.309 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.3 t -97.11 118.66 64.5 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HG3' ' HA ' ' A' ' 110' ' ' ALA . 41.7 Cg_endo -90.78 10.55 2.84 Favored 'Trans proline' 0 CA--C 1.502 -1.114 0 C-N-CA 123.129 2.553 . . . . 0.0 111.151 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -72.02 -56.06 6.3 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -140.95 -63.89 0.46 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -125.6 157.86 36.11 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.411 HG13 ' CD2' ' A' ' 51' ' ' LEU . 38.1 pt -108.42 -161.57 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.039 0.936 . . . . 0.0 109.336 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.411 ' CD2' HG13 ' A' ' 50' ' ' ILE . 4.3 mm? 74.6 29.01 1.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.884 0.85 . . . . 0.0 110.587 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 64' ' ' CYS . 53.8 tp -59.08 -29.69 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.478 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.499 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 51.0 p -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.279 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -109.95 22.47 15.59 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.89 -129.38 1.37 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 t -137.26 151.99 49.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.148 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -129.87 129.25 43.7 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.87 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.48 169.48 9.13 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.25 -46.62 5.43 Favored Glycine 0 N--CA 1.476 1.305 0 O-C-N 123.964 0.79 . . . . 0.0 114.239 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.58 14.95 3.4 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.786 -1.197 . . . . 0.0 113.073 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.93 140.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.6 ' HB ' ' CB ' ' A' ' 71' ' ' PHE . 29.3 mm -112.27 140.34 32.47 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.639 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 68' ' ' LEU . 49.9 m -100.47 117.55 34.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.823 -0.548 . . . . 0.0 110.674 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.497 ' HA ' HD13 ' A' ' 52' ' ' LEU . 43.0 t -66.25 135.72 54.85 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -49.82 107.0 0.13 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.082 0.553 . . . . 0.0 111.917 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.26 13.94 9.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.472 1.109 . . . . 0.0 113.177 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -129.53 98.12 4.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.628 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 69' ' ' TRP . 4.4 mm? 64.95 -170.34 0.19 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.422 ' H ' ' HB3' ' A' ' 68' ' ' LEU . 50.4 p-90 -128.66 11.61 6.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.645 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -120.05 130.8 54.86 Favored 'General case' 0 C--O 1.167 -3.271 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.6 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 45.4 t80 -139.74 159.43 42.19 Favored 'General case' 0 CA--C 1.469 -2.142 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 166.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.48 ' CB ' ' HA3' ' A' ' 78' ' ' GLY . 51.0 t30 -115.73 99.08 7.05 Favored 'General case' 0 N--CA 1.391 -3.398 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.024 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.46 -60.16 3.45 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.775 -173.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.48 32.71 4.62 Favored Glycine 0 C--N 1.304 -1.213 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.777 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.479 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 26.0 m -151.4 -38.62 0.12 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.282 0.541 . . . . 0.0 111.318 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.76 -55.84 0.52 Allowed Glycine 0 C--O 1.223 -0.575 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.829 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 85' ' ' CYS . 16.2 p80 -85.1 135.24 34.07 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 72' ' ' ASN . . . 157.14 38.0 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.385 0 N-CA-C 119.815 2.686 . . . . 0.0 119.815 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.731 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 mp -107.11 -56.11 5.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 116.901 -1.92 . . . . 0.0 111.775 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 24.6 t-20 159.34 105.49 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.389 1.476 . . . . 0.0 107.909 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 5.7 Cg_exo -78.83 -170.86 9.15 Favored 'Cis proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.812 -1.745 . . . . 0.0 110.909 1.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 7.0 m-20 -61.15 -18.17 56.69 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.72 -32.8 70.87 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.062 1.345 . . . . 0.0 113.121 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.731 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 17.9 p -81.74 133.12 35.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.124 -1.031 . . . . 0.0 112.311 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 77' ' ' HIS . 12.9 p -142.02 170.1 16.35 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.603 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -146.13 125.83 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.576 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.73 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -60.25 129.0 39.5 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -96.26 131.17 43.03 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.789 0.681 . . . . 0.0 109.556 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 101' ' ' SER . 47.4 m-85 -116.08 138.56 24.24 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -59.97 135.12 60.86 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 C-N-CA 123.15 2.566 . . . . 0.0 112.037 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.87 130.78 74.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -109.92 112.7 24.89 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.88 106.73 21.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 122.07 0.938 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -129.64 117.32 20.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.342 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.16 -115.14 7.63 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.302 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 8' ' ' SER . 7.1 m-20 -95.76 -10.78 28.23 Favored 'General case' 0 C--O 1.195 -1.791 0 O-C-N 123.64 0.259 . . . . 0.0 110.784 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -104.21 138.66 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.2 mt -124.74 115.33 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.463 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-85 -109.52 145.08 36.89 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.881 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 60.2 t -134.11 145.56 32.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 32.8 t -87.86 113.69 23.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 t -126.2 -11.34 6.41 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.203 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' SER . 59.1 tttp -122.87 126.42 47.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.38 -39.86 2.46 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.2 mt -102.07 106.21 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 5.5 tt -85.79 130.42 50.78 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 7.1 Cg_exo -42.08 128.78 4.27 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 124.056 3.17 . . . . 0.0 112.02 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.73 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -94.22 116.69 29.12 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.983 0.421 . . . . 0.0 111.04 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.549 ' HD3' ' SG ' ' A' ' 85' ' ' CYS . 89.0 tttt 57.0 -169.16 0.1 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.282 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.53 ' H ' ' HG2' ' A' ' 109' ' ' LYS . . . . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 101' ' ' SER . 57.5 m . . . . . 0 N--CA 1.437 -1.089 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -88.56 131.77 34.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.007 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.67 149.17 38.52 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 6.7 ttpm? -68.7 127.1 31.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 7.6 tp -83.75 -50.31 15.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' N ' HG23 ' A' ' 6' ' ' ILE . 95.7 m -164.64 -175.24 3.74 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 125.094 1.357 . . . . 0.0 108.416 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 6.9 m -111.16 154.98 23.58 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.07 -16.41 7.31 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.429 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 5.1 p-10 -79.99 -20.2 46.02 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.657 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.05 -54.56 4.76 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 98' ' ' ILE . 4.0 tp -108.05 110.54 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.071 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB2' ' CG ' ' A' ' 16' ' ' GLU . 20.8 m95 -86.37 163.03 17.88 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.227 -1.352 . . . . 0.0 111.163 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.65 121.88 26.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.235 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.5 59.81 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 13' ' ' TRP . 24.4 mm-40 -107.66 162.42 13.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.937 0.399 . . . . 0.0 110.964 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.658 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 26.1 ptt? -144.3 135.57 25.49 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.179 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 53' ' ' SER 0.319 10.1 pt-20 -157.18 155.12 30.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 71.9 m -83.52 127.05 33.42 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.681 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 76.6 m-85 -126.81 150.5 49.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -97.55 143.81 27.87 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.534 0.683 . . . . 0.0 111.457 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -83.55 176.98 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.518 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -74.39 -8.78 57.42 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.2 0.524 . . . . 0.0 111.241 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.9 -6.16 51.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.405 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.81 17.67 57.7 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.019 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 m -94.47 127.32 40.3 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.24 124.29 34.25 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.652 0.739 . . . . 0.0 110.602 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' THR . 48.7 t -125.42 146.5 31.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.93 -175.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 65.4 tp -89.35 111.21 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.81 114.21 31.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.78 123.72 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.9 t30 -106.46 104.7 14.45 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.592 ' CB ' ' HB3' ' A' ' 36' ' ' HIS . 19.6 m -100.33 157.34 16.69 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.1 -51.41 13.54 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -108.55 -25.21 11.02 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.954 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.592 ' HB3' ' CB ' ' A' ' 33' ' ' SER . 43.6 t-80 -79.17 -7.61 58.35 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.785 0.803 . . . . 0.0 109.166 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.73 173.19 17.77 Favored Glycine 0 CA--C 1.5 -0.86 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.591 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.1 p -84.64 117.58 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.27 176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -130.07 149.14 51.92 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.319 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -123.71 132.35 53.81 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.6 154.84 51.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.583 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 15.7 mm100 -53.98 137.02 40.41 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.567 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -101.13 -11.35 19.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.873 0.844 . . . . 0.0 109.739 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.9 mmt -93.98 108.77 20.55 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.054 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 110' ' ' ALA . 24.0 p -105.79 172.57 3.86 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 73.2 Cg_endo -76.15 21.78 0.52 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 121.89 1.727 . . . . 0.0 111.605 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 32.0 m80 -144.45 135.35 25.04 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 125.336 1.454 . . . . 0.0 107.649 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 60.11 -172.11 0.13 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.512 0.672 . . . . 0.0 112.394 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.66 -48.88 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.3 pt -94.66 178.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp 79.67 -25.88 0.18 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.463 1.105 . . . . 0.0 112.368 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 43' ' ' ALA . 4.0 mm? -56.8 -40.89 76.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.535 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 90.5 p -80.31 -15.6 56.53 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.369 0.604 . . . . 0.0 110.888 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -92.0 -9.13 44.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.949 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 126.65 0.89 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.589 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.7 t 178.28 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.658 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 66.3 t80 -91.85 113.11 25.29 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.109 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -115.91 105.34 12.56 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.452 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 -69.24 1.69 Allowed Glycine 0 C--O 1.241 0.567 0 O-C-N 123.215 0.322 . . . . 0.0 112.313 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.68 26.39 0.16 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.62 133.8 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 42.9 mm -96.51 117.16 40.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.003 0.906 . . . . 0.0 109.525 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.7 m -102.0 121.33 41.95 Favored 'General case' 0 C--N 1.259 -3.333 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.194 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.24 -177.02 3.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.374 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 2.8 mmp_? -119.33 -42.44 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.165 -1.014 . . . . 0.0 113.153 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -98.17 -20.57 17.21 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.606 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -116.51 137.33 52.26 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 117.969 -1.493 . . . . 0.0 109.314 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 68' ' ' LEU . 2.9 tm? -63.26 -36.47 83.76 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 124.28 1.032 . . . . 0.0 113.119 -170.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 13.5 m-90 -62.26 174.36 0.95 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -103.37 161.22 14.02 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.644 0.735 . . . . 0.0 112.6 -169.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.526 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 48.7 t80 -132.43 141.41 48.83 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.24 119.8 31.25 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -73.47 -22.31 60.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.48 -54.49 10.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.6 m -73.9 -34.65 64.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.844 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.8 -4.26 49.73 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.751 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -125.27 161.74 26.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 122.84 0.456 . . . . 0.0 110.381 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -77.98 144.07 28.28 Favored Glycine 0 N--CA 1.416 -2.65 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.83 -30.68 29.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 27.4 t-20 -143.61 125.83 8.53 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.356 172.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 80' ' ' ASN . 22.0 Cg_exo -67.37 -63.79 0.03 OUTLIER 'Cis proline' 0 C--N 1.354 0.824 0 C-N-CA 123.847 -1.314 . . . . 0.0 113.783 0.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 21.4 t70 164.91 -35.06 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 125.122 1.369 . . . . 0.0 109.569 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.16 -26.91 69.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.845 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.31 142.36 39.46 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 121.744 0.783 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.33 150.93 31.09 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.834 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 86' ' ' LEU . 1.6 pt? -114.44 141.34 47.8 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.267 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -88.12 124.05 33.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.379 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -96.74 110.85 23.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 33.9 m-85 -79.24 139.79 56.44 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.662 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.27 120.22 7.4 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.227 1.952 . . . . 0.0 109.114 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.57 HG22 HG23 ' A' ' 100' ' ' VAL . 20.9 t -132.38 140.84 46.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -136.37 150.32 48.76 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.977 0.418 . . . . 0.0 110.982 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.02 117.28 55.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.283 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -125.94 100.73 6.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.603 0.716 . . . . 0.0 110.243 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.94 -112.16 3.95 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.083 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' SER . 19.5 m-20 -102.24 -1.82 30.42 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.729 -0.235 . . . . 0.0 111.115 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 26.1 m-20 -121.82 155.85 34.47 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.84 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 12' ' ' ILE . 75.1 mt -127.58 129.04 70.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 5' ' ' LYS . 54.5 p90 -112.72 143.14 44.45 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.926 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 91' ' ' VAL . 5.9 p -132.85 143.39 39.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.806 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 2' ' ' SER . 33.5 t -91.58 113.94 26.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.0 p -109.99 -41.25 4.52 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.339 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -70.65 112.17 6.68 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.136 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.3 -27.32 7.03 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.5 mm -99.78 117.73 45.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 tt -99.27 136.38 20.48 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.583 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 50.5 Cg_exo -55.72 127.78 27.58 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.309 2.006 . . . . 0.0 111.534 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 33.9 t-20 -84.45 177.33 8.17 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.462 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -74.27 60.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 124.248 1.019 . . . . 0.0 113.354 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' CYS . . . . . . . . 0 C--N 1.273 -2.748 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 74.17 96.77 0.07 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -166.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -119.79 150.06 41.02 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.99 109.51 5.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -92.04 -40.91 12.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.853 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . 63.7 m -155.09 175.85 13.3 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.473 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 m -120.88 154.79 35.37 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.21 -25.28 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.203 0.525 . . . . 0.0 111.062 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.49 -20.61 62.84 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.258 0.551 . . . . 0.0 110.777 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 17.4 m-20 -88.51 -36.88 16.17 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.938 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 tp -130.71 116.14 33.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.158 0.98 . . . . 0.0 111.736 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -104.72 167.15 9.91 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.029 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.57 130.47 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.245 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 10.09 70.61 Favored Glycine 0 C--N 1.309 -0.942 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.61 147.68 48.34 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 120.814 0.34 . . . . 0.0 111.108 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.8 mtp -130.74 133.74 46.29 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 33.4 mt-10 -146.17 140.43 26.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.861 0.363 . . . . 0.0 111.349 172.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.1 m -73.78 132.48 42.65 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -128.4 162.22 27.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -106.18 137.06 44.78 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.413 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -83.54 171.87 12.93 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 m -67.8 -17.99 64.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.056 0.455 . . . . 0.0 111.729 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.56 4.8 51.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.8 29.36 35.29 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.597 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -98.68 136.72 38.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.386 -0.479 . . . . 0.0 110.177 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.49 124.94 34.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 41' ' ' TYR . 97.3 t -133.6 147.01 31.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -96.41 117.21 30.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -100.78 116.97 45.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.3 122.83 68.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.453 ' OD1' ' HB ' ' A' ' 38' ' ' VAL . 49.3 t30 -113.87 106.8 14.88 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.432 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -99.99 150.78 22.08 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -51.38 12.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.58 -45.86 12.13 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -79.01 -12.95 60.04 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.025 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -175.75 50.83 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.139 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' OD1' ' A' ' 32' ' ' ASN . 6.6 p -105.4 125.26 60.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.524 0.678 . . . . 0.0 111.115 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -129.92 150.98 50.96 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.595 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.07 128.44 49.33 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 2.6 m-85 -131.08 163.08 28.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.68 ' HB2' HD11 ' A' ' 86' ' ' LEU . 15.7 mm100 -53.12 138.95 30.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.19 -28.24 1.2 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 -169.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.502 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -162.28 -178.15 6.15 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -169.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.419 ' C ' ' H ' ' A' ' 47' ' ' HIS . 86.9 m -87.02 163.75 39.16 Favored Pre-proline 0 C--N 1.361 1.091 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 169.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 45' ' ' CYS . 49.4 Cg_endo -69.58 24.31 0.17 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.276 1.984 . . . . 0.0 113.037 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.419 ' H ' ' C ' ' A' ' 45' ' ' CYS . 32.2 m170 -111.96 -52.25 2.8 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.414 ' OE1' ' HG2' ' A' ' 44' ' ' MET . 19.9 tp60 63.33 108.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 167.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 55.0 mm-40 -124.5 170.74 10.59 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 165.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 pt -87.18 167.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 118.429 0.559 . . . . 0.0 111.092 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.7 mt 70.73 28.84 3.35 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.533 1.133 . . . . 0.0 111.449 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.707 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.7 pt? -75.24 -42.17 55.84 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.659 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 96.1 p -72.93 -21.97 60.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.924 0.869 . . . . 0.0 109.503 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.66 15.86 5.26 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.293 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.2 -124.93 1.93 Allowed Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.4 m -142.79 157.09 44.97 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-O 122.167 0.984 . . . . 0.0 113.009 -174.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.06 116.79 19.84 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.27 -1.787 . . . . 0.0 108.222 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -115.15 104.55 11.96 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.87 -74.87 0.46 Allowed Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.648 0.582 . . . . 0.0 111.905 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.0 0.51 0.34 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.69 143.33 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.507 HG12 ' H ' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -117.89 117.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.389 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.5 m -108.86 132.15 54.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.255 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.767 ' HB2' ' H ' ' A' ' 68' ' ' LEU . 1.7 p -85.02 -13.91 49.02 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 64.47 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.973 0.909 . . . . 0.0 112.649 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.49 27.74 8.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 109.775 -175.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.608 ' C ' HD12 ' A' ' 68' ' ' LEU 0.276 96.2 m-70 84.01 97.24 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.767 ' H ' ' HB2' ' A' ' 64' ' ' CYS . 7.2 mp -149.51 -80.04 0.13 Allowed 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 127.906 2.482 . . . . 0.0 108.954 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.646 ' N ' ' HB3' ' A' ' 64' ' ' CYS . 0.9 OUTLIER -146.8 135.22 21.89 Favored 'General case' 0 CA--C 1.594 2.641 0 O-C-N 121.955 -0.466 . . . . 0.0 111.221 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -139.69 132.4 29.0 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.541 -0.725 . . . . 0.0 112.721 174.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.507 ' H ' HG12 ' A' ' 62' ' ' ILE . 75.2 t80 -138.15 150.43 46.8 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.353 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.611 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . 45.8 t-20 -105.98 100.46 10.01 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.01 -36.71 50.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.13 -3.3 60.38 Favored Glycine 0 C--N 1.311 -0.832 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.857 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.3 m -139.74 -14.55 1.07 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.089 0.944 . . . . 0.0 112.98 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.49 -59.17 4.99 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 96.3 m-70 -63.44 102.29 0.4 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 72' ' ' ASN . . . -161.06 19.06 0.2 Allowed Glycine 0 CA--C 1.469 -2.823 0 C-N-CA 119.985 -1.102 . . . . 0.0 114.284 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 86' ' ' LEU . 1.5 mp -98.77 -12.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.106 0 CA-C-N 115.126 -0.537 . . . . 0.0 111.131 -169.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 73.7 m-20 77.28 115.06 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.721 0 C-N-CA 125.293 1.437 . . . . 0.0 112.111 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 14.1 Cg_exo -71.35 -174.14 10.74 Favored 'Cis proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.039 -1.65 . . . . 0.0 112.012 -0.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 77' ' ' HIS . 9.2 p-10 -68.99 2.76 2.43 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.714 0.769 . . . . 0.0 111.248 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.55 -21.14 42.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.965 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.507 ' SG ' ' HE2' ' A' ' 109' ' ' LYS . 37.3 m -102.42 141.38 35.34 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.424 0.631 . . . . 0.0 111.507 -172.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.3 p -122.15 178.09 5.07 Favored 'General case' 0 C--N 1.273 -2.754 0 C-N-CA 125.176 1.391 . . . . 0.0 109.899 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 42' ' ' GLN . 52.1 tp -141.25 156.28 45.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.37 124.28 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.902 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.68 125.09 38.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.518 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 98.6 m-85 -100.27 132.36 22.69 Favored Pre-proline 0 C--N 1.28 -2.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.917 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.5 120.78 8.16 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.109 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.492 HG13 HG22 ' A' ' 100' ' ' VAL . 45.1 t -109.47 134.47 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.3 131.98 56.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -108.41 118.1 55.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.781 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.76 91.57 3.37 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.59 -107.3 1.33 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.77 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -101.87 -0.97 33.15 Favored 'General case' 0 C--O 1.193 -1.872 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.332 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.401 ' O ' HD13 ' A' ' 98' ' ' ILE . 25.6 m-20 -106.52 139.51 40.87 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.441 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.401 HD13 ' O ' ' A' ' 97' ' ' ASP . 38.5 mm -127.06 122.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.204 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -118.82 142.78 47.41 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.962 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 91' ' ' VAL . 39.2 t -134.31 139.14 48.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 t -95.31 114.29 26.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.518 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 24.5 p -118.52 -47.01 2.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.668 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -78.48 105.02 9.46 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.558 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.44 -35.57 1.72 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -96.19 128.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.21 133.09 72.22 Favored Pre-proline 0 N--CA 1.417 -2.076 0 CA-C-O 120.671 0.272 . . . . 0.0 111.722 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.494 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 18.4 Cg_endo -61.22 134.72 53.95 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.307 2.671 . . . . 0.0 111.135 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -104.57 123.52 47.69 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.507 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 52.0 tptt 58.88 178.87 0.07 Allowed 'General case' 0 CA--C 1.568 1.662 0 O-C-N 125.467 1.729 . . . . 0.0 111.349 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.47 ' H ' ' HG3' ' A' ' 109' ' ' LYS . . . . . . . . 0 CA--C 1.514 -0.414 0 C-N-CA 125.185 1.394 . . . . 0.0 114.217 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 68.54 84.79 0.15 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.06 0.85 . . . . 0.0 109.846 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.74 144.09 40.23 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.181 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.13 119.27 20.59 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.313 0.578 . . . . 0.0 110.933 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.6 -44.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.747 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.95 -172.83 4.07 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.3 m -118.89 152.65 35.9 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.189 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -61.46 -22.06 64.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.292 0.637 . . . . 0.0 110.372 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 2.5 p-10 -77.27 -11.19 59.8 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.705 -0.622 . . . . 0.0 109.81 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -84.68 -45.04 12.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.8 pt -114.37 109.84 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 122.468 1.127 . . . . 0.0 109.777 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -75.25 170.43 16.07 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.747 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.59 115.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.173 0.511 . . . . 0.0 110.672 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.13 10.79 59.33 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.213 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.13 149.52 24.19 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -150.5 142.09 23.55 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 pt-20 -155.01 144.78 21.52 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.205 0.526 . . . . 0.0 112.291 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 90.1 m -79.96 138.85 37.17 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.588 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -129.65 162.33 28.56 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.32 134.93 54.36 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.079 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -83.15 168.46 16.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.0 m -68.0 -17.27 64.37 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.043 0.449 . . . . 0.0 110.767 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.52 -12.83 59.85 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.321 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.42 37.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.0 m -96.13 131.58 42.42 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 122.181 0.193 . . . . 0.0 111.088 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.94 124.45 36.06 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.541 0.686 . . . . 0.0 109.353 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' THR . 58.1 t -125.84 136.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 52' ' ' LEU . 1.3 tt -95.56 112.21 23.97 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 18' ' ' GLU . 9.9 tp -95.8 117.22 39.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.52 125.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -113.13 104.58 12.5 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.138 174.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -102.0 158.54 16.07 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.432 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -75.54 -50.72 14.79 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.641 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.69 -46.46 17.07 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -84.44 -11.32 56.42 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.605 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.72 -157.44 34.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.967 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.65 123.22 53.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 16.7 tppt? -128.59 145.34 51.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.39 113.94 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.555 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.462 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 22.5 m-85 -116.32 147.72 41.28 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.425 ' CG ' HD22 ' A' ' 86' ' ' LEU . 11.3 pt20 -64.36 138.71 58.57 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.99 -68.37 0.69 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.489 0.661 . . . . 0.0 111.043 -175.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.497 ' HA ' ' CE ' ' A' ' 44' ' ' MET 0.265 0.1 OUTLIER 62.73 -100.21 0.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -178.86 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.4 t 49.56 96.36 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.824 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.58 36.96 0.48 Allowed 'Trans proline' 0 N--CA 1.48 0.69 0 C-N-CA 123.099 2.532 . . . . 0.0 112.149 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.484 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 37.2 m80 -150.39 -179.77 7.48 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 123.936 0.894 . . . . 0.0 109.578 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.7 pt20 62.78 142.33 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.523 2.329 . . . . 0.0 114.505 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.21 85.36 2.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 tp 169.83 167.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.48 138.04 36.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.928 0.394 . . . . 0.0 111.529 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.1 tt -67.07 -32.47 73.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.646 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.5 p -63.7 -14.02 48.44 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.314 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -100.68 13.27 35.36 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.702 0.763 . . . . 0.0 109.267 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.76 -109.91 0.64 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.414 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 20.8 p -155.78 146.8 22.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.407 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 87.3 t80 -125.83 116.67 21.93 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.911 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 2.4 mp0 -99.37 170.12 8.86 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.24 67.45 0.37 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 -1.51 21.56 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.5 t -124.02 136.64 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.462 HD11 ' CZ ' ' A' ' 41' ' ' TYR . 52.2 mt -119.57 129.99 74.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.414 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 53.8 m -110.5 123.66 50.34 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 52' ' ' LEU . 10.4 p -57.75 -30.6 65.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 169.24 -48.57 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.241 1.816 . . . . 0.0 107.501 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.69 -87.41 0.09 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.559 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 52.87 -85.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.161 1.384 . . . . 0.0 111.489 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.6 tp -174.16 -60.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.32 0.648 . . . . 0.0 109.47 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -99.11 -176.47 3.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.341 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 65.9 p -135.05 165.33 25.62 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.57 0.748 . . . . 0.0 111.316 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -103.22 147.75 26.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -118.22 126.12 51.54 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.997 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.71 -56.69 16.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.245 1.018 . . . . 0.0 111.243 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.49 50.02 4.27 Favored Glycine 0 CA--C 1.509 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.673 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.2 m -152.95 -44.83 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.24 -34.51 3.78 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . 21.3 t-80 -90.32 146.29 24.31 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.61 140.58 14.92 Favored Glycine 0 CA--C 1.483 -1.925 0 C-N-CA 118.705 -1.712 . . . . 0.0 112.391 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 70' ' ' THR . 2.0 mp -73.52 -31.41 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -109.97 129.4 23.97 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.632 169.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.37 -41.73 0.95 Allowed 'Cis proline' 0 CA--C 1.498 -1.283 0 C-N-CA 123.658 -1.393 . . . . 0.0 110.456 -4.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.3 t70 152.54 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.445 2.298 . . . . 0.0 107.326 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.45 -21.01 49.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.001 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.0 m -96.09 150.57 20.35 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-O 122.893 1.33 . . . . 0.0 112.721 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 77' ' ' HIS . 1.7 p -140.0 148.62 42.13 Favored 'General case' 0 C--N 1.253 -3.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 106.904 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.425 HD22 ' CG ' ' A' ' 42' ' ' GLN . 51.2 mt -112.83 175.94 5.23 Favored 'General case' 0 C--N 1.266 -3.043 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.022 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -126.36 142.99 51.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.187 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.05 118.26 35.41 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.81 148.07 39.0 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.754 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 101' ' ' SER . 11.9 Cg_exo -68.04 119.73 6.73 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.508 1.472 . . . . 0.0 111.002 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.6 p -127.95 134.84 64.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.128 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -127.32 126.51 42.7 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.497 0.665 . . . . 0.0 109.952 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.7 124.5 68.5 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.502 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.6 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.81 96.97 4.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.492 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.43 -104.87 1.52 Allowed Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.05 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 8' ' ' SER . 21.8 m-20 -109.37 4.11 22.19 Favored 'General case' 0 C--O 1.19 -2.027 0 CA-C-N 115.525 -0.337 . . . . 0.0 110.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.64 139.59 43.21 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 120.63 0.252 . . . . 0.0 111.155 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -127.1 119.64 53.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.495 0.664 . . . . 0.0 111.303 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -112.58 137.87 50.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.755 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.4 m -127.33 148.53 32.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.51 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 32.2 t -127.77 146.6 50.54 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.5 m -125.74 2.06 7.47 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -91.33 130.78 37.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.458 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.16 -45.8 1.26 Allowed Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.9 mt -108.05 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.456 HD12 ' HD2' ' A' ' 107' ' ' PRO . 33.6 tp -82.46 139.09 44.47 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.968 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD2' HD12 ' A' ' 106' ' ' LEU . 96.0 Cg_exo -50.61 128.99 25.41 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 122.547 2.165 . . . . 0.0 111.014 174.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 55.4 t-20 -86.99 143.57 27.28 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.687 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.43 -76.09 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.08 2.552 . . . . 0.0 113.768 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.424 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.075 -176.555 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.223 -0.318 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.85 148.04 35.73 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -142.46 144.84 33.21 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -73.16 129.54 38.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.241 0.543 . . . . 0.0 110.758 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.537 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -100.43 -42.61 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.044 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' HG23 ' A' ' 6' ' ' ILE . 7.7 p -165.76 -176.69 3.97 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.22 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 14.9 m -123.57 150.42 44.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.296 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.4 tt -60.1 -24.62 64.79 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.222 1.409 . . . . 0.0 110.287 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.28 -23.49 64.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.21 -45.4 4.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.342 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 5.6 tp -100.68 110.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 122.298 1.047 . . . . 0.0 111.972 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -101.64 162.84 12.6 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.249 -1.342 . . . . 0.0 113.073 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.27 124.23 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.714 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.39 64.15 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -119.75 158.24 26.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -151.21 148.62 28.45 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.784 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.8 pt-20 -156.52 151.25 25.86 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.111 171.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -73.0 133.32 44.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.389 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.35 154.23 47.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -104.87 142.65 34.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.7 p -83.41 179.17 7.74 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -76.05 -17.65 59.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.169 0.509 . . . . 0.0 110.683 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.37 -12.49 49.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.607 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.15 21.73 19.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -95.81 120.59 36.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.02 122.61 33.82 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.153 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.8 142.6 42.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.125 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.5 tt -93.93 114.28 26.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.35 112.95 28.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.9 t -110.35 124.75 67.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.527 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -100.13 107.19 19.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -98.29 148.83 23.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.7 -36.71 65.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -111.15 -38.09 5.14 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.153 0.501 . . . . 0.0 111.082 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -81.97 -3.51 54.55 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.321 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.74 -178.67 47.95 Favored Glycine 0 CA--C 1.51 -0.281 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.671 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -78.2 129.55 37.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -129.32 141.77 51.0 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.52 115.1 20.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.765 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 47.7 p90 -143.62 157.32 44.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -50.25 138.03 17.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -106.86 -78.17 0.59 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.584 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.6 tpt 53.26 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.488 ' SG ' ' HG ' ' A' ' 52' ' ' LEU . 69.2 m 55.49 84.77 0.2 Allowed Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 121.119 0.485 . . . . 0.0 112.237 -168.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -90.87 21.13 0.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.93 1.753 . . . . 0.0 110.867 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -103.68 -78.6 0.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.05 -39.29 7.36 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 69.42 -89.42 0.03 OUTLIER 'General case' 0 C--O 1.243 0.745 0 O-C-N 124.465 1.103 . . . . 0.0 112.918 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.0 mt 58.24 -81.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 124.799 1.24 . . . . 0.0 109.212 -171.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -167.03 92.06 0.42 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 128.158 2.583 . . . . 0.0 104.306 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.488 ' HG ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -67.21 -21.82 65.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.419 0.628 . . . . 0.0 111.828 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 10.6 p -75.58 -10.67 59.64 Favored 'General case' 0 N--CA 1.414 -2.225 0 C-N-CA 124.805 1.242 . . . . 0.0 111.434 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -94.78 11.0 33.0 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.48 -128.18 1.39 Allowed Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.938 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -150.85 156.99 42.36 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.932 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -130.37 128.99 42.52 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.756 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 61' ' ' VAL . 1.8 tm-20 -115.65 158.13 23.19 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.84 -30.31 21.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.119 0.407 . . . . 0.0 114.119 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.57 -4.08 5.86 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.163 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 61.7 t -124.04 125.0 70.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-N 117.343 0.572 . . . . 0.0 110.717 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 46.6 mt -103.17 136.09 37.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 69' ' ' TRP . 99.3 m -117.51 116.02 26.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.31 144.49 57.11 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -50.98 -55.23 18.34 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.815 0.697 . . . . 0.0 109.639 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.6 91.66 2.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.274 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -167.94 -76.37 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 69' ' ' TRP . 5.2 tt -144.56 143.63 30.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.487 ' HA ' HG23 ' A' ' 63' ' ' THR . 40.8 p90 -89.82 -19.57 24.51 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -169.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.424 ' H ' HD23 ' A' ' 68' ' ' LEU . 41.2 p -103.93 126.32 50.97 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.719 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 90.7 t80 -138.71 144.73 39.67 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -99.08 104.81 16.85 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 118.466 0.575 . . . . 0.0 111.146 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.38 -39.54 94.81 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.378 0.671 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.4 94.42 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.731 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 m -80.11 -35.41 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.864 0.364 . . . . 0.0 111.32 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.61 3.61 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.539 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 52.8 t60 -92.71 132.53 36.84 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 173.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.69 146.41 22.34 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.98 -36.26 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 47.7 t30 -164.24 110.79 0.9 Allowed Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.38 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.574 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 2.5 Cg_endo -87.97 172.11 32.48 Favored 'Cis proline' 0 CA--C 1.554 1.502 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.222 1.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.539 ' OD1' ' CE1' ' A' ' 77' ' ' HIS . 7.1 m-20 -94.92 -11.39 28.73 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.29 12.92 34.87 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.987 0.898 . . . . 0.0 110.881 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.574 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 77.7 m -112.81 9.46 19.02 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.231 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 57.5 m -58.3 156.3 10.23 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.678 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 2.8 pp -117.85 169.09 9.9 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.207 -174.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB2' ' CB ' ' A' ' 108' ' ' ASN . . . -130.88 122.18 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.89 127.36 32.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.172 0.51 . . . . 0.0 112.015 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.9 143.45 26.74 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.394 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.78 127.64 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.183 1.922 . . . . 0.0 110.53 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.78 143.74 39.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.04 138.08 52.43 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 120.938 0.399 . . . . 0.0 110.551 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.38 126.25 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.287 1.041 . . . . 0.0 111.474 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -119.52 146.92 45.03 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.41 100.66 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 8' ' ' SER . 38.1 t70 84.86 -33.46 0.06 Allowed 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 126.797 2.039 . . . . 0.0 114.476 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -99.37 131.2 45.55 Favored 'General case' 0 C--N 1.282 -2.353 0 O-C-N 120.639 -1.288 . . . . 0.0 111.206 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.15 123.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.837 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -112.74 145.61 40.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.985 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.4 144.51 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.4 t -105.1 115.22 29.9 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.4 m -106.44 -33.54 7.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.428 0.633 . . . . 0.0 109.486 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 103' ' ' LYS . 1.3 tpmt? -74.02 107.98 6.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.666 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.29 -4.04 8.9 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.9 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.2 mm -119.17 140.69 42.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.44 120.79 55.29 Favored Pre-proline 0 N--CA 1.42 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.91 133.08 53.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.726 2.284 . . . . 0.0 111.996 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.425 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 51.2 t30 -89.53 176.24 6.97 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.571 -176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.31 104.65 0.52 Allowed 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.198 0.999 . . . . 0.0 111.679 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.318 0 CA-C-N 112.278 -2.237 . . . . 0.0 105.649 -176.47 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.424 ' OG ' ' HE3' ' A' ' 103' ' ' LYS . 31.3 t . . . . . 0 N--CA 1.413 -2.301 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.591 ' H ' ' HA ' ' A' ' 101' ' ' SER . 96.7 m-85 72.46 93.53 0.08 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.425 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 8.4 tp10 -106.81 138.27 43.29 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 4.1 tmmm? -80.94 105.14 11.93 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -85.94 -49.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.826 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.061 -176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.5 m -145.65 177.58 8.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.709 0.766 . . . . 0.0 111.317 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.7 p -110.56 152.76 26.02 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.051 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.38 -20.04 58.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.014 0.911 . . . . 0.0 109.918 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.35 -20.88 58.77 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.363 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.22 -32.09 12.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.232 0.539 . . . . 0.0 110.556 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 16' ' ' GLU . 3.2 tp -124.11 111.87 30.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.921 0.867 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -105.06 163.96 12.17 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.406 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.57 124.98 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.422 0.63 . . . . 0.0 111.32 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.37 59.8 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.542 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' HB3' HD12 ' A' ' 12' ' ' ILE . 8.8 tp10 -103.76 152.16 22.18 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.508 ' HG3' ' HB2' ' A' ' 56' ' ' SER . 0.0 OUTLIER -150.75 139.1 20.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 120.883 0.373 . . . . 0.0 110.156 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.0 tt0 -158.05 155.22 28.91 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.2 t -89.16 132.61 34.75 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.027 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.34 151.7 42.22 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.05 133.78 47.59 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -83.01 178.79 7.99 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -69.11 -21.53 64.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.463 0.649 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.94 -13.36 58.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.696 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.01 23.06 33.61 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -92.85 115.6 28.26 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.99 123.75 34.16 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' CG1' ' HB1' ' A' ' 40' ' ' ALA . 46.6 t -130.64 144.53 37.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.505 ' N ' ' HB2' ' A' ' 43' ' ' ALA . 62.2 tp -88.32 111.86 22.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.09 118.65 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 17' ' ' MET . 46.5 t -119.36 125.19 74.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.849 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 46.6 t-20 -92.32 106.99 18.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.0 m -99.02 152.96 19.24 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.8 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.51 -50.28 16.15 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.07 -22.19 18.67 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -99.23 -4.27 32.38 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.128 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.89 -170.67 51.42 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.908 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 46.2 t -80.55 120.74 32.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.06 150.74 50.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.147 0.498 . . . . 0.0 110.802 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -124.74 131.69 53.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 59.8 m-85 -130.21 162.21 29.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 119.562 -0.256 . . . . 0.0 110.478 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -50.18 136.31 19.73 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.505 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -118.05 -11.51 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.462 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 47.3 tpp -69.2 108.91 3.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 47' ' ' HIS . 17.4 t -108.69 107.27 59.95 Favored Pre-proline 0 N--CA 1.413 -2.29 0 CA-C-O 121.233 0.54 . . . . 0.0 111.452 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -96.87 17.08 0.65 Allowed 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.677 2.251 . . . . 0.0 109.422 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.591 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 16.5 t-160 -94.71 -38.9 10.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.44 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 178.57 110.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.28 1.832 . . . . 0.0 107.704 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -155.94 134.71 11.86 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.127 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -114.57 -63.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 162.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 68.9 mt -154.06 110.82 3.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 165.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -68.59 -25.35 64.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.918 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 47.7 p -62.57 -19.65 63.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -170.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp0 -84.88 -9.16 58.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.105 0.479 . . . . 0.0 110.818 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.57 81.07 0.27 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 63' ' ' THR . 66.9 m -143.26 -33.76 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.402 ' CZ ' ' HA2' ' A' ' 60' ' ' GLY . 69.2 t80 -129.0 113.49 15.23 Favored 'General case' 0 C--N 1.264 -3.114 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.348 -174.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -116.97 112.26 20.75 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.227 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 -73.8 1.04 Allowed Glycine 0 CA--C 1.5 -0.871 0 O-C-N 123.582 0.551 . . . . 0.0 111.938 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.402 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . -161.26 13.64 0.15 Allowed Glycine 0 C--N 1.298 -1.56 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.74 143.6 23.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 O-C-N 122.531 -0.394 . . . . 0.0 110.273 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' SER . 48.4 mm -89.92 133.41 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.634 0.73 . . . . 0.0 111.934 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' ' 56' ' ' SER . 32.4 m -128.29 152.27 48.32 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 124.327 1.051 . . . . 0.0 108.253 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.1 t -119.82 89.03 3.05 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.453 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' NE ' ' HA ' ' A' ' 65' ' ' ARG . 5.0 tpm_? 54.64 21.31 3.36 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.093 0.957 . . . . 0.0 111.001 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' H ' HG22 ' A' ' 63' ' ' THR . . . 62.8 100.18 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 111.894 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 68' ' ' LEU 0.271 1.5 p-80 -107.69 -13.06 15.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 1.7 tm? 171.36 -63.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 28.7 t-105 -141.05 -155.57 0.6 Allowed 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 28.3 p -101.3 163.54 12.23 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -171.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -110.49 148.05 32.87 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -111.56 108.07 17.45 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 62' ' ' ILE . 5.6 p-10 -76.8 -29.79 56.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.04 73.22 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.9 m -90.52 -52.0 5.12 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.18 -42.16 1.46 Allowed Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.386 -0.912 . . . . 0.0 112.398 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.94 158.81 18.57 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 120.828 0.347 . . . . 0.0 110.611 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.75 157.26 52.23 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.874 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 70' ' ' THR . 69.5 mt -84.6 -51.42 13.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 117.635 0.718 . . . . 0.0 109.478 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 63.7 t30 -160.73 108.47 1.31 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.122 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 6.9 Cg_exo -75.57 -174.86 15.08 Favored 'Cis proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.539 -1.859 . . . . 0.0 110.278 -3.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.82 -43.57 58.37 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . 0.326 4.4 p30 38.76 31.53 0.04 OUTLIER 'General case' 0 C--N 1.369 1.424 0 C-N-CA 127.106 2.162 . . . . 0.0 113.828 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 64.5 m 79.13 148.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.654 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.7 p -72.9 172.68 10.43 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.224 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 pp -96.86 -171.1 2.17 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.633 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -130.18 119.24 22.64 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.27 134.02 38.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.005 0.431 . . . . 0.0 110.941 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 12.0 m-85 -102.9 145.67 31.0 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 123.616 0.766 . . . . 0.0 109.535 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.99 120.29 6.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.51 2.14 . . . . 0.0 110.413 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.01 141.0 42.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.53 137.57 53.94 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.83 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.609 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -125.22 99.13 5.94 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.37 5.47 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.674 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.19 -10.05 34.35 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.216 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -109.68 143.13 39.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 12' ' ' ILE . 59.5 mt -122.37 120.47 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.953 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 26.9 m-85 -113.58 149.47 34.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.249 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 7.4 p -135.45 138.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.591 ' HA ' ' H ' ' A' ' 3' ' ' PHE . 35.3 t -97.99 133.58 42.27 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.826 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -122.3 16.37 10.6 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.157 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HE3' ' OG ' ' A' ' 2' ' ' SER . 37.7 ttmt -58.47 -76.31 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.748 0.785 . . . . 0.0 112.839 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.42 20.79 45.39 Favored Glycine 0 C--N 1.263 -3.528 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.04 120.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.502 0.668 . . . . 0.0 111.693 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 tp -110.07 124.01 34.58 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -65.67 137.75 51.21 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -80.03 175.78 10.33 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -57.15 138.55 54.42 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 p . . . . . 0 N--CA 1.429 -1.525 0 CA-C-O 121.327 0.584 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 99.4 m-85 -90.81 125.47 35.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.889 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -112.72 144.98 41.32 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 37.5 ttpt -87.07 128.08 35.11 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.842 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.484 HG12 ' CD1' ' A' ' 20' ' ' PHE . 6.5 tp -115.16 -45.05 4.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.227 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.7 p -139.71 -173.47 3.64 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.573 0.701 . . . . 0.0 111.915 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -129.61 150.12 51.08 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.558 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -72.61 -22.91 60.89 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.72 -21.76 65.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.457 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.59 -49.97 5.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.193 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 12' ' ' ILE . 47.4 pt -110.85 116.88 53.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-O 122.135 0.969 . . . . 0.0 111.107 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -90.36 169.24 11.25 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.758 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.19 117.79 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.353 0.597 . . . . 0.0 110.844 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.46 62.15 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -103.1 140.47 37.28 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.281 0.632 . . . . 0.0 110.188 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.455 ' HB3' HG23 ' A' ' 31' ' ' VAL . 26.9 ptt? -151.03 156.3 40.82 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.874 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -157.5 156.58 32.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.593 0.558 . . . . 0.0 109.517 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.2 t -88.87 137.09 32.63 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 121.218 0.532 . . . . 0.0 110.051 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.484 ' CD1' HG12 ' A' ' 6' ' ' ILE . 52.4 p90 -119.94 156.41 30.86 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 22' ' ' THR . 44.7 tt0 -100.35 135.31 41.98 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 77.7 p -82.58 171.29 14.23 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -73.36 -15.49 61.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.68 0.752 . . . . 0.0 109.252 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -84.55 -12.59 53.83 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.6 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.99 36.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.827 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 84.8 m -97.08 137.43 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.142 -0.622 . . . . 0.0 111.989 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -88.85 126.55 35.41 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.499 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' THR . 60.6 t -130.25 137.7 55.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.186 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.416 HD21 ' SD ' ' A' ' 17' ' ' MET . 45.5 tp -87.28 114.65 24.08 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 10.0 tp -97.74 112.7 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 17' ' ' MET . 8.2 p -114.12 127.9 71.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.5 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.447 ' ND2' ' HG ' ' A' ' 9' ' ' LEU . 51.2 t-20 -95.45 104.15 16.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 21.5 m -102.77 150.79 23.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.197 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -76.46 -50.27 14.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.242 0.544 . . . . 0.0 110.591 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.68 -46.7 16.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.921 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 50.8 m80 -79.11 -21.19 47.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.923 0.392 . . . . 0.0 111.185 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.72 -168.68 47.88 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 45.7 t -81.49 120.02 32.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.722 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -118.63 149.33 41.56 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.602 0.761 . . . . 0.0 111.201 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.91 112.69 16.91 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.458 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 88' ' ' GLU . 49.7 m-85 -125.57 159.84 31.08 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 110' ' ' ALA . 35.4 tt0 -53.77 138.33 35.87 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.92 -12.39 59.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -167.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.445 ' HB3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.8 166.79 31.15 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.152 -1.419 . . . . 0.0 114.086 -175.054 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.9 m -88.79 166.52 22.06 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.07 31.41 0.52 Allowed 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 121.73 1.62 . . . . 0.0 112.723 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.481 ' CE1' ' HG3' ' A' ' 81' ' ' PRO . 14.1 m170 -120.34 -75.34 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.191 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -93.96 -177.62 4.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 0.0 112.622 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.32 163.24 28.04 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.114 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 44' ' ' MET . 29.8 mt -74.94 87.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.44 0.638 . . . . 0.0 110.438 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.434 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 85.0 mt -106.39 1.49 25.73 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.516 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.8 tt -76.23 -41.72 48.32 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.925 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -67.75 -7.39 26.92 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.48 -9.19 50.99 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.24 115.37 1.33 Allowed Glycine 0 CA--C 1.495 -1.167 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 63' ' ' THR . 72.0 m -161.41 -25.02 0.05 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.907 0.861 . . . . 0.0 110.867 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 94.5 t80 -89.05 115.53 26.66 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.181 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -116.15 104.5 11.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.681 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.91 -72.85 0.53 Allowed Glycine 0 C--N 1.316 -0.53 0 O-C-N 123.899 0.749 . . . . 0.0 113.504 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.16 17.43 1.18 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 62.9 t -123.11 132.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -98.1 129.17 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 36.3 m -106.74 151.79 24.67 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' ALA . 8.0 t -75.15 -40.31 59.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.22 172.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 63' ' ' THR . 1.1 tmt_? 75.93 -21.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.495 1.118 . . . . 0.0 110.939 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . -96.56 -23.45 16.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.927 173.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -146.88 152.46 38.74 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.305 0.642 . . . . 0.0 112.069 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.412 ' HB3' ' CG ' ' A' ' 80' ' ' ASN 0.278 2.2 tm? 36.94 -107.21 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.85 2.46 . . . . 0.0 113.602 175.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 63' ' ' THR . 94.9 m95 -163.7 -51.36 0.03 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.6 p -107.71 130.64 54.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -160.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -134.1 137.49 44.63 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -122.98 114.84 20.96 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.961 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.64 -29.67 70.28 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.11 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.91 -3.6 74.74 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.894 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.4 m -124.22 1.26 8.47 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.666 0.746 . . . . 0.0 109.66 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -49.06 1.08 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.536 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 25.8 p80 -88.84 160.91 17.01 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.219 0.533 . . . . 0.0 111.719 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.13 169.99 35.49 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.923 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.61 -31.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 3.2 p-10 -127.27 101.92 24.5 Favored Pre-proline 0 N--CA 1.42 -1.939 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.883 173.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 22.7 Cg_endo -89.62 155.23 31.62 Favored 'Cis proline' 0 C--N 1.362 1.282 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.864 -4.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.9 p-10 -74.4 -19.26 60.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.83 -22.07 24.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.248 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.523 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 65.3 m -95.82 150.91 19.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-O 121.79 0.805 . . . . 0.0 110.577 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 77' ' ' HIS . 17.6 p -142.08 167.85 21.14 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.941 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.462 HD22 ' HB3' ' A' ' 42' ' ' GLN . 81.2 mt -120.98 129.18 53.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . . . -88.87 136.51 32.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -104.42 158.52 16.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.277 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.499 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 19.1 p90 -135.39 157.73 75.95 Favored Pre-proline 0 C--N 1.273 -2.751 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.508 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 89' ' ' TYR . 37.5 Cg_endo -61.27 138.58 78.11 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 122.545 2.163 . . . . 0.0 114.03 -174.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.14 128.99 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.54 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -109.98 131.66 54.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.99 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.1 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -122.75 91.34 3.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.95 -112.11 4.68 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.573 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.26 -5.44 33.13 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.714 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -103.21 137.05 41.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -127.61 123.4 61.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 5.0 m-85 -112.01 142.08 44.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.834 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.96 154.71 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -127.9 114.6 17.39 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.345 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -108.76 -8.05 15.44 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.63 102.51 5.36 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.72 -29.28 4.99 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.6 mt -120.63 108.35 22.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.447 0.641 . . . . 0.0 110.319 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.0 pp -89.08 147.92 39.73 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 12.6 Cg_exo -69.78 140.96 43.87 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.059 1.84 . . . . 0.0 112.298 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -88.31 133.05 34.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.3 -176.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.484 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 125.255 1.422 . . . . 0.0 113.069 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 p . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 69.9 m-85 73.54 108.21 0.07 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 -168.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -106.57 137.36 44.72 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -73.84 121.32 20.71 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.876 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tp -97.51 -48.52 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.357 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.7 m -159.23 -174.55 4.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.386 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -129.77 152.67 49.01 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 12' ' ' ILE . 27.5 tp -56.66 -21.22 25.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.184 1.393 . . . . 0.0 110.624 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.76 -30.97 71.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.261 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -100.18 -40.87 7.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.388 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.4 tp -104.96 115.43 46.83 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-O 121.533 0.682 . . . . 0.0 110.934 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -102.99 164.75 11.43 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.469 -172.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.67 127.57 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.491 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.64 -0.81 68.1 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.92 154.13 29.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -146.15 131.06 18.14 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.727 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 44.1 mt-10 -144.22 150.52 38.09 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 93.7 m -74.42 130.97 40.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.993 0.425 . . . . 0.0 111.124 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -140.71 149.8 42.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.25 146.88 34.87 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.642 0.258 . . . . 0.0 110.359 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -83.72 165.29 19.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.9 m -65.59 -14.03 60.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.89 -12.48 41.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.444 0.64 . . . . 0.0 110.137 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.75 23.41 13.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.902 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -97.09 127.92 43.53 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -88.07 123.28 32.6 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.09 143.75 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.378 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 60.0 tp -93.01 112.86 24.96 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' MET . 49.6 mm -94.73 112.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 17' ' ' MET . 41.9 t -112.66 124.75 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 54.0 t30 -103.83 104.93 14.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 14.0 m -83.77 143.21 30.13 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.454 -172.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -47.08 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -83.14 -44.13 15.42 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -101.88 2.92 38.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 86.73 -176.95 48.09 Favored Glycine 0 C--O 1.201 -1.937 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.931 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 9.3 p -72.39 134.65 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 118.274 1.037 . . . . 0.0 111.553 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -125.7 139.01 53.9 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.774 0.83 . . . . 0.0 110.501 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.06 115.25 20.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.415 ' OH ' HG12 ' A' ' 62' ' ' ILE . 18.6 p90 -143.27 165.11 28.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.082 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -41.19 137.4 1.37 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.756 0.66 . . . . 0.0 111.818 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 19' ' ' THR . . . -71.29 -46.77 60.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.287 0.565 . . . . 0.0 112.524 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 69.8 mtm -94.25 147.07 23.55 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.17 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.508 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 28.9 p -94.82 161.87 27.18 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.777 0.673 . . . . 0.0 111.258 -175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 57.0 Cg_endo -71.2 -4.75 15.54 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.499 2.132 . . . . 0.0 111.914 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -88.74 -96.9 0.09 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -179.3 104.59 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 117.911 0.323 . . . . 0.0 110.579 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 6.5 tp10 -171.97 145.8 1.9 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 111.375 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.8 pt -118.58 141.67 37.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 tp 65.77 24.03 11.45 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.672 1.225 . . . . 0.0 109.129 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.2 pt? -62.04 -20.54 64.06 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.141 -1.391 . . . . 0.0 111.289 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 36.0 p -56.92 -32.53 66.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 125.965 1.706 . . . . 0.0 113.832 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -100.66 23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.989 -0.445 . . . . 0.0 110.962 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.75 -83.61 0.04 OUTLIER Glycine 0 C--N 1.346 1.113 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.431 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 19.0 p -173.49 146.89 1.4 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -129.75 115.62 17.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.98 105.8 12.72 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.489 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.89 0.44 Allowed Glycine 0 N--CA 1.462 0.429 0 O-C-N 123.489 0.493 . . . . 0.0 114.206 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 73' ' ' ASP . . . -153.21 17.95 0.7 Allowed Glycine 0 C--N 1.301 -1.366 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.1 t -125.12 124.92 68.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.789 0.436 . . . . 0.0 110.05 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.415 HG12 ' OH ' ' A' ' 41' ' ' TYR . 2.0 pp -92.76 140.26 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.431 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 89.9 m -116.44 127.05 54.25 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.19 156.31 39.71 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.469 ' HD3' ' O ' ' A' ' 65' ' ' ARG . 1.8 tmt_? -73.34 -33.08 64.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.783 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . . . -83.08 -72.32 0.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.308 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.479 ' CD2' ' HB2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -82.66 110.26 17.56 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.132 175.106 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.08 84.83 7.57 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.356 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 86.9 m95 -144.3 -166.55 2.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 p -101.66 136.65 41.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 121.955 0.883 . . . . 0.0 112.268 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 47.4 t80 -134.06 143.19 47.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.99 111.87 19.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.348 0.594 . . . . 0.0 111.33 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 16.3 t70 -71.41 -11.81 61.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.418 1.487 . . . . 0.0 112.012 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.51 -33.76 6.06 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.717 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.6 p -107.24 -26.14 11.19 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.436 0.618 . . . . 0.0 112.638 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.87 65.32 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -106.76 146.39 30.91 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -76.64 153.25 42.17 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.517 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.95 -49.25 12.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 8.2 t30 -146.55 111.71 4.26 Favored Pre-proline 0 N--CA 1.436 -1.153 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.415 174.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 4.8 Cg_exo -78.74 141.61 64.64 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.962 -1.683 . . . . 0.0 111.004 -1.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.1 p30 -74.66 -12.48 60.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.407 0.622 . . . . 0.0 109.627 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.87 -28.53 68.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.736 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 36.9 m -92.72 152.15 19.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-O 121.563 0.696 . . . . 0.0 111.002 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.454 ' C ' HD12 ' A' ' 86' ' ' LEU . 5.9 p -163.27 156.13 18.75 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.045 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.481 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 7.3 mp -129.45 135.16 48.31 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.289 1.436 . . . . 0.0 107.868 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.9 123.92 29.85 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.726 0.411 . . . . 0.0 109.972 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -86.64 143.94 27.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.086 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 101' ' ' SER . 46.2 m-85 -102.37 143.32 26.37 Favored Pre-proline 0 N--CA 1.428 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.04 123.01 12.56 Favored 'Trans proline' 0 C--O 1.253 1.242 0 C-N-CA 122.329 2.019 . . . . 0.0 110.264 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.87 132.96 70.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -112.57 117.21 31.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.447 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.56 107.56 23.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 122.026 0.917 . . . . 0.0 109.69 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.69 118.16 23.3 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.01 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.43 -119.93 9.75 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.96 -4.45 16.71 Favored 'General case' 0 C--O 1.17 -3.086 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 94' ' ' LYS . 17.0 t70 -100.03 139.28 35.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.697 -0.627 . . . . 0.0 110.089 -170.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.2 mt -127.63 119.12 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 63.4 m-85 -102.72 146.23 28.52 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.71 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.63 137.23 54.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 20.4 t -107.35 113.26 26.52 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.446 -1.702 . . . . 0.0 109.296 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.4 p -95.96 -36.43 11.07 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.93 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -66.3 113.26 4.47 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.112 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.26 -36.14 2.78 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 105' ' ' ILE . 2.7 mp -100.89 120.82 50.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.436 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 3.5 tt -79.92 124.1 83.35 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 9.4 Cg_endo -52.96 145.58 40.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.006 2.471 . . . . 0.0 111.994 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -80.43 177.61 8.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.69 -11.89 2.5 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.468 ' CB ' ' HG ' ' A' ' 86' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.472 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.996 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 75.0 m-85 67.22 100.25 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.464 -169.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -106.9 130.53 54.55 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.815 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -70.17 115.64 9.6 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.62 -59.59 3.06 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.194 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 11' ' ' ASP . 85.6 m -152.21 -177.29 6.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.353 -175.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 8.7 p -101.02 153.52 19.47 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.588 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.43 -17.52 21.33 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.847 0.832 . . . . 0.0 110.673 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.4 -10.84 58.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.583 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 33.2 t70 -97.7 -41.46 8.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.687 -0.633 . . . . 0.0 109.358 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 98' ' ' ILE . 2.3 tp -109.95 114.13 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.415 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -101.05 166.96 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.503 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.44 128.83 35.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.496 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.89 66.7 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -103.87 144.14 31.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.172 -0.514 . . . . 0.0 110.127 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.4 134.0 39.24 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 9.2 pt-20 -157.63 156.21 31.41 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 15.1 t -90.51 137.7 32.14 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 77.3 m-85 -126.41 155.94 41.37 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' THR . 40.9 tt0 -113.95 141.49 47.32 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -83.18 172.76 12.3 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -68.86 -20.17 64.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.131 0.491 . . . . 0.0 110.424 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.97 -12.25 55.6 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 109.526 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.95 14.82 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.109 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.5 m -92.19 124.31 36.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.77 128.97 35.64 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' THR . 40.0 t -133.03 141.2 45.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.18 116.43 28.83 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.58 122.83 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 122.327 0.251 . . . . 0.0 110.355 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.99 123.61 70.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 50.7 t30 -103.12 106.41 16.92 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.837 173.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -98.81 148.67 23.67 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.511 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.95 -48.85 77.1 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 122.957 0.503 . . . . 0.0 111.8 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.26 -40.33 8.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.95 0.405 . . . . 0.0 111.979 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -79.69 -11.42 59.85 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -167.33 42.47 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.042 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 6.7 p -99.05 118.05 45.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.535 0.683 . . . . 0.0 109.333 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -131.98 151.16 51.9 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.162 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.05 143.27 45.7 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.569 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 63.9 m-85 -133.28 157.6 45.04 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 110' ' ' ALA . 19.8 pt20 -59.11 139.22 57.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.187 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.21 -7.29 58.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.336 0.589 . . . . 0.0 110.252 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -92.79 99.76 12.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.618 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' HIS . 59.0 m -76.71 158.8 80.33 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.92 20.78 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.718 1.612 . . . . 0.0 108.883 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.475 ' H ' ' C ' ' A' ' 45' ' ' CYS . 54.6 m-70 -120.1 -175.12 2.92 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.778 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -65.98 103.72 0.99 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.265 0.353 . . . . 0.0 111.039 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.73 156.6 22.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.633 0.73 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.647 HG13 ' H ' ' A' ' 51' ' ' LEU . 9.8 tp -179.99 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 -174.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.647 ' H ' HG13 ' A' ' 50' ' ' ILE . 2.9 mm? -78.01 91.68 4.27 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 121.118 1.781 . . . . 0.0 109.738 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.582 HD22 ' O ' ' A' ' 50' ' ' ILE . 2.0 mm? -73.36 -20.98 60.64 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.776 1.274 . . . . 0.0 108.156 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.669 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 60.0 p -63.4 -19.49 64.72 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.921 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.62 12.24 36.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.742 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 -108.41 0.03 OUTLIER Glycine 0 C--O 1.241 0.566 0 O-C-N 123.324 0.39 . . . . 0.0 113.033 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.3 t -146.14 154.07 41.39 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.915 0.864 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -128.78 114.63 16.81 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.153 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 42.4 mt-10 -118.14 169.9 9.31 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.27 74.39 0.14 Allowed Glycine 0 C--N 1.309 -0.932 0 O-C-N 123.309 0.381 . . . . 0.0 113.799 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.18 38.68 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.7 t -123.96 119.27 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 71' ' ' PHE . 42.6 mm -112.58 138.26 42.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.4 m -118.08 115.72 25.41 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -72.71 0.41 Allowed 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.887 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -149.02 -63.42 0.23 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.597 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.36 27.96 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.42 ' HB3' ' NE2' ' A' ' 47' ' ' HIS . 13.5 p-80 162.32 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.931 2.092 . . . . 0.0 107.575 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.6 tp 172.59 -71.7 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.569 1.548 . . . . 0.0 108.983 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -176.92 -49.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.059 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p -103.53 136.48 43.17 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -169.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 22.5 p90 -135.16 142.7 46.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 159.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -86.84 122.87 31.32 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.322 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.25 -38.41 90.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.793 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.18 26.58 3.83 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.002 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -155.33 -51.28 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.819 0.31 . . . . 0.0 110.816 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.64 40.05 Favored Glycine 0 C--O 1.218 -0.844 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -85.75 139.16 31.57 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 108.887 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -68.53 140.34 35.02 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 176.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.0 mt -81.16 -51.65 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 50.3 t-20 -150.23 113.88 3.32 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.6 Cg_exo -81.3 179.25 28.66 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.858 -1.726 . . . . 0.0 111.412 -3.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -95.93 12.23 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.401 ' O ' ' HE3' ' A' ' 109' ' ' LYS . 34.8 t70 -67.73 -14.66 63.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.397 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 23.6 p -136.89 152.21 49.97 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.543 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 31.1 m -152.17 146.11 25.22 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 mp -102.79 153.67 19.94 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-O 120.984 0.421 . . . . 0.0 110.784 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -88.19 119.54 28.69 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.738 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.48 129.98 34.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.732 0.645 . . . . 0.0 109.537 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.11 136.25 20.12 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 101' ' ' SER . 37.3 Cg_endo -68.37 124.3 11.5 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.548 2.165 . . . . 0.0 112.304 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.86 138.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -119.58 135.82 54.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 178.415 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.426 ' C ' ' HE2' ' A' ' 94' ' ' LYS . 58.7 t -106.21 122.52 60.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -167.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.626 ' HD3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -111.36 146.35 37.28 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 173.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.71 -35.6 17.16 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 115.61 1.004 . . . . 0.0 115.61 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' SER . 25.4 t70 -113.7 -22.7 10.1 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.778 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -114.87 147.65 39.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.136 0.969 . . . . 0.0 113.422 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 12' ' ' ILE . 62.7 mt -121.71 118.16 54.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.788 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.626 ' CD1' ' HD3' ' A' ' 94' ' ' LYS . 4.5 m-85 -112.2 144.11 42.14 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.96 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.78 141.31 39.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 21.4 t -104.15 128.17 51.8 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.518 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.2 p -120.56 5.55 10.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -74.99 118.39 17.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.734 -174.86 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.03 16.09 79.64 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.142 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.26 119.51 57.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.255 0.55 . . . . 0.0 110.957 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.88 142.68 36.82 Favored Pre-proline 0 N--CA 1.411 -2.387 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.363 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.38 150.08 88.93 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.468 2.112 . . . . 0.0 111.166 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.638 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 34.9 t-20 -81.41 -179.77 7.51 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 83' ' ' ASP . 39.2 ttpt -62.42 93.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.41 1.1 . . . . 0.0 111.521 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . . . . . . . . 0 C--N 1.267 -3.019 0 C-N-CA 128.274 2.63 . . . . 0.0 104.471 -174.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.427 -1.588 0 CA-C-O 121.126 0.489 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -156.95 97.81 1.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 125.979 1.712 . . . . 0.0 107.252 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.87 133.47 52.18 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.41 127.39 32.11 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.22 -40.94 5.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.721 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.9 p -160.34 -170.88 2.96 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.768 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 7.2 m -120.15 153.07 36.74 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.348 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -61.58 -21.4 64.28 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.846 0.831 . . . . 0.0 108.924 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.86 -29.63 69.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.266 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.96 -47.55 65.35 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.607 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.83 112.27 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.734 1.254 . . . . 0.0 113.529 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -79.16 170.54 16.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.786 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.34 118.79 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 CA-C-O 121.602 0.715 . . . . 0.0 110.451 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.97 56.9 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.682 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -103.22 150.45 23.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.563 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.8 ptt? -150.12 137.92 20.06 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 34.7 mt-10 -144.2 155.11 43.75 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 m -91.42 123.97 35.25 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.01 154.32 34.72 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -113.54 137.35 51.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -83.0 173.3 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 m -71.94 -9.35 58.23 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.159 0.505 . . . . 0.0 111.669 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.74 -4.74 46.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.36 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.17 44.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.628 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.9 m -89.86 114.79 26.61 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -91.58 123.83 35.28 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' A' ' 40' ' ' ALA . 58.7 t -136.49 142.49 38.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.027 -172.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 32.9 tp -83.61 117.62 23.28 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -107.87 113.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.87 137.31 43.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.711 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -109.97 107.8 17.82 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.3 t -99.2 148.51 24.03 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.031 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -74.99 -36.16 62.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.24 -46.75 6.62 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.793 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -88.51 -7.01 57.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.73 -164.9 52.22 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.202 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.8 t -82.82 128.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -127.9 141.52 51.53 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.483 0.713 . . . . 0.0 111.197 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -125.07 121.26 33.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.913 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.434 ' CD1' HD22 ' A' ' 86' ' ' LEU . 53.6 m-85 -133.04 152.1 51.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -48.96 138.06 12.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.615 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -141.17 19.12 2.26 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -172.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 86.3 mtp -68.97 -30.56 69.01 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.811 ' SG ' ' N ' ' A' ' 65' ' ' ARG . 3.5 t -76.48 124.09 87.88 Favored Pre-proline 0 CA--C 1.619 3.603 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.711 ' C ' ' HA ' ' A' ' 65' ' ' ARG . 12.6 Cg_endo -108.71 104.83 0.02 OUTLIER 'Trans proline' 2 C--N 1.421 4.375 0 C-N-CA 123.922 3.081 . . . . 0.0 113.145 163.585 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.938 ' CE1' ' H ' ' A' ' 67' ' ' HIS . 6.4 t60 -81.26 -25.8 36.3 Favored 'General case' 0 N--CA 1.523 3.212 0 O-C-N 121.363 -0.835 . . . . 0.0 109.882 -173.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -105.32 111.94 24.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.306 10.9 pt-20 -74.14 83.46 1.82 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.791 1.282 . . . . 0.0 114.256 -174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.618 HG12 ' H ' ' A' ' 51' ' ' LEU . 15.1 tt -152.74 -159.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 102.388 -3.189 . . . . 0.0 102.388 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.618 ' H ' HG12 ' A' ' 50' ' ' ILE . 84.9 mt -64.06 122.55 16.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 120.752 1.615 . . . . 0.0 109.301 175.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 43' ' ' ALA . 1.4 pt? -56.0 -44.76 78.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.409 1.084 . . . . 0.0 113.713 -172.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.588 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 38.2 p -63.54 -24.26 67.73 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.422 0.689 . . . . 0.0 112.516 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -84.31 3.16 36.89 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -139.85 36.64 1.8 Allowed Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.737 -1.22 . . . . 0.0 113.066 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.456 ' H ' ' HE1' ' A' ' 17' ' ' MET . 19.3 m -107.14 -80.39 0.57 Allowed 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.351 0.596 . . . . 0.0 111.425 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 80.7 t80 -90.39 112.73 24.44 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-O 121.84 0.829 . . . . 0.0 110.684 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.51 105.41 11.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.524 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.08 -77.28 0.56 Allowed Glycine 0 N--CA 1.45 -0.395 0 O-C-N 123.384 0.427 . . . . 0.0 112.424 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.22 6.56 0.82 Allowed Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.66 135.16 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 69.1 mt -105.68 129.95 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 121.347 0.594 . . . . 0.0 109.763 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 9.1 m -111.2 152.5 27.01 Favored 'General case' 0 N--CA 1.38 -3.951 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 1.555 ' CA ' ' CB ' ' A' ' 64' ' ' CYS 0.473 15.0 p -118.32 -112.49 0.34 Allowed 'General case' 2 CA--C 1.789 10.154 0 C-N-CA 128.179 2.591 . . . . 0.0 106.829 179.1 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.836 ' HA ' ' N ' ' A' ' 47' ' ' HIS . 37.2 ttm105 -122.29 -161.89 0.96 Allowed 'General case' 3 N--CA 1.652 9.667 1 C-N-CA 137.532 6.333 . . . . 0.0 107.513 170.359 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.748 ' H ' ' HG2' ' A' ' 65' ' ' ARG . . . -55.95 100.38 0.04 OUTLIER 'General case' 2 N--CA 1.557 4.891 1 N-CA-C 122.168 4.136 . . . . 0.0 122.168 -166.922 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.938 ' H ' ' CE1' ' A' ' 47' ' ' HIS 0.373 53.7 m80 -96.1 -170.47 2.12 Favored 'General case' 1 N--CA 1.543 4.186 0 C-N-CA 129.863 3.265 . . . . 0.0 106.597 170.21 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -145.06 8.94 1.25 Allowed 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.735 ' H ' ' HB3' ' A' ' 67' ' ' HIS . 28.8 m-90 -146.32 -159.96 1.09 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.7 2.0 . . . . 0.0 107.822 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -124.26 161.98 24.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 11.8 t80 -119.48 142.47 48.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -119.33 140.61 50.04 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.656 -1.218 . . . . 0.0 114.214 -172.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.488 ' HB2' HG13 ' A' ' 62' ' ' ILE . 7.0 t70 -75.28 -53.91 7.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.647 1.179 . . . . 0.0 112.463 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.54 95.73 Favored Glycine 0 CA--C 1.503 -0.658 0 O-C-N 123.702 0.626 . . . . 0.0 112.789 -175.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -79.46 -30.86 42.34 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 66.8 41.84 93.37 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 78' ' ' GLY . 12.1 t60 -160.03 150.52 18.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -174.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 77' ' ' HIS . . . -77.88 133.75 13.47 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 119.225 -1.465 . . . . 0.0 110.251 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.89 -37.51 54.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 69' ' ' TRP . 25.0 t-20 -146.81 119.98 4.98 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.87 154.63 54.85 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.62 -1.408 . . . . 0.0 112.895 0.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.12 -15.68 57.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.942 0.877 . . . . 0.0 109.235 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.9 -32.87 61.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.218 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 109' ' ' LYS . 71.9 m -134.4 161.43 35.02 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 122.229 1.014 . . . . 0.0 112.317 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 24.5 p -138.21 -171.88 3.14 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.597 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 86' ' ' LEU . 2.0 pp -97.41 145.71 25.9 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.983 0.42 . . . . 0.0 111.226 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.24 113.74 26.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.43 118.51 22.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 O-C-N 123.452 0.47 . . . . 0.0 109.779 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -90.74 124.47 62.19 Favored Pre-proline 0 C--N 1.278 -2.536 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -60.2 120.05 7.6 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.966 1.778 . . . . 0.0 110.45 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.37 130.31 72.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.411 0.624 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.619 ' HG2' ' HD2' ' A' ' 94' ' ' LYS . 35.7 tt0 -115.42 131.51 56.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.161 -174.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.28 117.34 55.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.001 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.619 ' HD2' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -125.96 98.5 5.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.21 -107.07 2.12 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 8' ' ' SER . 31.2 t70 -109.98 -5.24 15.51 Favored 'General case' 0 C--O 1.177 -2.758 0 CA-C-O 121.051 0.453 . . . . 0.0 109.962 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.64 133.18 44.35 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.294 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.7 mt -123.88 119.54 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.875 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.586 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 10.9 m-85 -112.68 144.49 42.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.098 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.55 142.32 39.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.42 0.629 . . . . 0.0 111.098 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t -106.71 128.97 54.65 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.113 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -120.84 -8.32 9.43 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.252 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -78.01 121.83 24.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.07 -32.52 6.63 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.569 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.432 HD12 ' HD3' ' A' ' 90' ' ' PRO . 73.1 mt -120.14 108.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.504 0.668 . . . . 0.0 109.963 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -94.02 155.06 40.55 Favored Pre-proline 0 N--CA 1.41 -2.459 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.339 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.59 144.1 99.51 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.448 2.098 . . . . 0.0 109.86 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -79.58 166.03 22.32 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 52.8 mtmt -38.04 -51.26 1.38 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.472 1.509 . . . . 0.0 115.073 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.225 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -175.412 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' SER . 46.5 t . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 73.5 m-85 -79.89 115.72 19.63 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 170.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.29 144.97 49.68 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -74.08 125.43 28.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.101 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -106.68 -42.25 6.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.488 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.3 m -148.08 -179.32 6.83 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.338 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 12' ' ' ILE . 13.2 p -130.69 152.7 49.77 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 125.211 1.405 . . . . 0.0 108.881 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 9' ' ' LEU . 2.8 tm? -56.41 -23.76 40.5 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.12 -30.33 71.4 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.668 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.8 -8.39 13.19 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 8' ' ' SER . 3.7 tp -127.65 110.4 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 0.0 110.081 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.37 164.63 11.57 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.513 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.48 124.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.065 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.09 -8.17 62.83 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -102.81 153.25 20.36 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.447 0.641 . . . . 0.0 111.142 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.581 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -149.55 137.72 20.57 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.121 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 20' ' ' PHE . 12.0 pt-20 -157.41 155.36 30.35 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.402 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -93.81 141.36 28.59 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 112.047 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.77 148.75 52.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.491 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.73 139.72 37.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -83.56 168.37 16.46 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 m -70.05 -12.4 61.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.084 0.469 . . . . 0.0 110.845 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -90.22 -2.9 58.09 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.374 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.41 12.91 60.69 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.392 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -87.01 123.34 32.0 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.35 123.6 33.68 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.16 135.64 60.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.446 0.641 . . . . 0.0 110.892 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -89.53 113.97 25.44 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 124.454 1.101 . . . . 0.0 109.277 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.19 113.6 30.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.44 124.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 43.5 t30 -108.17 104.57 14.01 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.766 -1.173 . . . . 0.0 108.323 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 48.0 t -101.36 149.26 24.23 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.506 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -77.46 -32.32 54.38 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.292 0.568 . . . . 0.0 109.576 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -93.43 -47.13 7.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.699 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 65.7 m80 -83.28 -19.96 35.34 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.781 0.324 . . . . 0.0 111.309 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.37 -174.29 48.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -87.52 118.15 32.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.679 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -131.68 157.74 42.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.007 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -124.7 134.96 52.67 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 73' ' ' ASP . 69.2 m-85 -134.11 163.63 29.14 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 10.2 pt20 -66.57 144.23 56.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.77 8.19 33.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.43 0.633 . . . . 0.0 111.305 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.2 tpp -99.4 143.37 29.74 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.876 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -116.76 152.73 48.82 Favored Pre-proline 0 N--CA 1.426 -1.663 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.925 177.325 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.72 -39.39 13.51 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 123.564 2.843 . . . . 0.0 112.558 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -64.77 -86.14 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 168.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -153.22 173.85 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.74 129.82 36.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 50' ' ' ILE . 13.0 tt -156.74 24.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 122.82 1.295 . . . . 0.0 108.714 -174.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt 69.31 84.38 0.15 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 113.524 -1.671 . . . . 0.0 113.687 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.2 mp -70.14 -30.65 67.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.456 1.122 . . . . 0.0 108.26 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 11.6 p -61.41 -29.81 70.17 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.975 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -98.69 2.65 47.34 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 65' ' ' ARG . . . 164.71 91.94 0.08 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 118.297 -1.906 . . . . 0.0 115.241 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -157.27 -62.02 0.09 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.581 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 41.2 t80 -90.48 114.05 26.14 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.39 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -118.41 114.36 22.78 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.465 173.765 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.03 -70.64 1.21 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.359 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.78 -17.74 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.654 -0.273 . . . . 0.0 112.765 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.66 141.79 15.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 117.072 0.436 . . . . 0.0 109.961 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 57.5 mt -111.3 123.76 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 94.9 m -92.85 143.96 25.76 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 3.7 t -76.29 -85.44 0.05 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 116.2 -2.2 . . . . 0.0 107.74 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 23.9 tpt180 -178.81 -34.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.065 0.848 . . . . 0.0 112.522 164.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.63 -39.62 8.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -84.92 178.73 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.431 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -53.41 -70.61 0.09 Allowed 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' A' ' 63' ' ' THR 0.255 98.0 m95 -129.18 -93.71 0.43 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -173.162 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 32.6 p -101.6 146.17 28.05 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 117.333 2.345 . . . . 0.0 117.333 -160.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 45.8 t80 -135.96 143.08 44.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 168.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -119.11 128.17 54.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 120.507 1.503 . . . . 0.0 113.685 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 10.5 p-10 -79.44 -40.68 29.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.943 -175.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.02 47.24 2.22 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 121.141 0.301 . . . . 0.0 112.91 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -163.46 -45.34 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 85' ' ' CYS . . . 104.86 -65.36 0.3 Allowed Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' CYS . 44.1 m80 -73.73 132.47 42.69 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -82.97 177.14 53.3 Favored Glycine 0 C--N 1.299 -1.508 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.976 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.4 mp -84.39 -34.99 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 23.7 t-20 -142.73 109.86 5.63 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.0 Cg_exo -80.08 147.83 77.36 Favored 'Cis proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.429 -3.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.675 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.6 p30 -77.61 -21.75 51.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.93 -8.38 58.78 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.913 0.387 . . . . 0.0 110.377 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 67.8 m -103.62 152.4 21.81 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 121.605 0.717 . . . . 0.0 111.842 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 4.3 p -132.0 178.77 6.53 Favored 'General case' 0 C--N 1.273 -2.743 0 C-N-CA 125.496 1.518 . . . . 0.0 110.139 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -131.32 35.75 3.86 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . . . 46.3 102.46 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.849 1.26 . . . . 0.0 114.398 -177.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.99 112.25 23.6 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 110.941 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 93.6 m-85 -102.51 130.64 23.63 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.468 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 101' ' ' SER . 14.5 Cg_endo -72.16 139.47 32.5 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.053 1.835 . . . . 0.0 111.271 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 100' ' ' VAL . 57.8 t -126.58 140.07 49.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.685 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -130.43 137.24 49.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 110.537 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.26 129.22 64.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.795 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -125.3 95.24 4.4 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.314 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.49 4.07 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.519 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -101.93 -2.87 28.84 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.544 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.494 ' HB2' ' HE3' ' A' ' 94' ' ' LYS . 20.7 m-20 -111.75 148.91 32.49 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.3 mt -126.39 131.99 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -99.49 148.48 24.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.538 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 91' ' ' VAL . 35.9 m -133.67 137.31 52.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 2' ' ' SER . 43.7 t -90.58 113.73 25.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.8 p -138.29 -26.46 0.91 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.236 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -74.44 99.51 3.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.401 0.62 . . . . 0.0 109.725 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.92 -8.21 16.64 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.837 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.11 115.64 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.999 0.428 . . . . 0.0 110.456 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.83 144.29 31.41 Favored Pre-proline 0 N--CA 1.412 -2.351 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.76 128.58 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.96 1.773 . . . . 0.0 111.141 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.3 p-10 -85.28 122.0 28.82 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.136 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.425 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 55.5 tptt 67.72 160.93 0.17 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.92 1.387 . . . . 0.0 111.029 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 124.919 1.288 . . . . 0.0 112.64 176.162 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 101' ' ' SER . 22.7 t . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 68.2 m-85 -75.51 97.79 3.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -107.13 144.95 33.11 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -77.28 124.28 27.64 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -98.21 -45.92 12.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.734 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.1 p -157.79 -172.18 3.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.372 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -125.74 152.7 45.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.597 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.5 tt -61.57 -26.03 67.7 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.26 -10.76 56.91 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.918 -0.489 . . . . 0.0 111.378 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -93.76 -53.4 4.04 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 12' ' ' ILE . 42.2 pt -111.4 110.86 33.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 122.462 1.125 . . . . 0.0 111.757 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.97 170.23 16.96 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.251 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 34' ' ' GLU . 7.1 p -57.71 112.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-O 121.874 0.845 . . . . 0.0 111.276 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.21 58.95 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.558 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -102.83 152.48 21.22 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.168 0.508 . . . . 0.0 111.072 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.559 ' HB2' HD21 ' A' ' 29' ' ' LEU . 25.3 ptt? -149.95 145.23 26.36 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.895 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.8 pt-20 -157.8 154.73 28.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 73.5 m -71.99 130.26 40.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.017 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 97.6 m-85 -128.09 157.01 41.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -106.24 135.68 47.29 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -83.39 173.71 11.29 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 m -73.89 -12.24 60.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.493 0.663 . . . . 0.0 110.993 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.2 -12.22 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.659 0.742 . . . . 0.0 109.111 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 20.71 24.91 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.629 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.9 m -91.34 130.27 37.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -88.04 124.39 33.7 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.8 t -138.7 145.68 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 17' ' ' MET . 5.7 tt -97.3 112.32 24.18 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mm -97.6 119.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 17' ' ' MET . 10.1 p -116.52 134.1 61.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.411 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -108.86 104.31 13.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.3 m -101.19 143.9 30.72 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -76.57 -51.31 11.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.3 -46.58 22.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.317 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -92.75 2.62 56.64 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.199 0.523 . . . . 0.0 111.361 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.92 177.06 35.3 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.719 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.2 125.63 39.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 9.8 mmpt? -127.81 145.19 51.01 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.123 0.569 . . . . 0.0 109.97 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -125.56 112.13 15.83 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' C ' HG13 ' A' ' 28' ' ' VAL . 13.9 p90 -137.53 140.94 41.39 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 119.553 -0.26 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.515 ' HB2' HD22 ' A' ' 86' ' ' LEU . 38.3 mt-30 -42.91 137.36 2.38 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.938 0.774 . . . . 0.0 111.953 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.46 78.7 1.75 Allowed 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.467 0.651 . . . . 0.0 110.157 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.488 ' HB2' ' HB1' ' A' ' 110' ' ' ALA 0.286 10.9 mmt -123.75 135.7 53.99 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.87 90.67 0.47 Allowed Pre-proline 0 C--N 1.311 -1.067 0 C-N-CA 127.594 2.357 . . . . 0.0 107.873 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -85.33 27.76 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.54 2.16 . . . . 0.0 111.063 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.18 -52.95 5.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.15 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -138.0 -72.02 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -98.83 115.69 29.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.31 -28.86 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.185 0.928 . . . . 0.0 110.515 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.7 mt -79.02 98.13 6.35 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.426 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.2 tt -56.95 -28.9 62.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.488 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 67.5 p -58.04 -21.72 46.65 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.713 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -88.59 8.71 27.0 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.968 0.413 . . . . 0.0 112.009 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.49 -124.57 1.21 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 173.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.6 t -157.29 150.04 23.29 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 110.263 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CD1' HD13 ' A' ' 62' ' ' ILE . 6.8 t80 -130.89 115.91 17.18 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.293 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -116.15 104.15 11.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.02 -73.89 0.13 Allowed Glycine 0 CA--C 1.52 0.364 0 O-C-N 123.715 0.634 . . . . 0.0 112.845 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.68 25.09 1.19 Allowed Glycine 0 C--N 1.295 -1.7 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.52 120.99 62.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 35.4 mm -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 m -127.2 129.05 47.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -155.2 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.045 0 C-N-CA 123.442 0.697 . . . . 0.0 111.411 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -113.1 95.09 5.2 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.762 -0.586 . . . . 0.0 110.654 -169.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.69 21.81 10.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -97.72 -17.02 19.66 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.21 -48.69 0.69 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -74.4 177.24 6.07 Favored 'General case' 0 CA--C 1.577 2.017 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.766 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -103.08 156.92 17.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -166.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.515 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 6.3 t80 -134.07 146.26 50.15 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -118.57 112.84 20.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.905 0.775 . . . . 0.0 112.976 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.59 -34.36 58.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.515 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.84 -40.16 89.33 Favored Glycine 0 CA--C 1.508 -0.369 0 O-C-N 123.342 0.402 . . . . 0.0 113.486 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -101.1 -12.75 18.56 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.644 0.735 . . . . 0.0 109.41 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.35 38.68 38.19 Favored Glycine 0 C--O 1.219 -0.821 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.777 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -140.74 141.32 34.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -85.73 139.75 17.42 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.922 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.63 -35.97 17.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -141.47 137.47 16.52 Favored Pre-proline 0 N--CA 1.417 -2.114 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -66.76 -13.56 8.08 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 CA-C-N 119.383 0.815 . . . . 0.0 113.44 -0.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 11.2 t70 90.14 -39.35 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 126.928 2.091 . . . . 0.0 110.0 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -56.46 -34.28 66.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.325 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 51.6 m -93.7 141.84 28.03 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.853 0.835 . . . . 0.0 108.885 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.3 m -144.52 166.6 24.69 Favored 'General case' 0 C--N 1.254 -3.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 42' ' ' GLN . 72.5 mt -128.98 179.69 5.6 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -175.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.92 117.62 17.9 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -85.66 101.22 12.55 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -81.11 141.87 50.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.415 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -58.37 118.55 5.45 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.764 1.643 . . . . 0.0 110.537 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.0 p -133.5 137.79 52.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -133.64 140.19 46.94 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.365 0.602 . . . . 0.0 111.062 -176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.8 127.97 57.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.43 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.53 91.3 3.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.37 -106.0 1.22 Allowed Glycine 0 C--N 1.3 -1.439 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.418 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.9 -10.86 22.27 Favored 'General case' 0 C--O 1.186 -2.283 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.16 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.87 140.36 35.27 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.774 0.321 . . . . 0.0 111.406 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.7 mt -127.14 122.06 59.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.831 0.825 . . . . 0.0 111.664 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 39.7 m-85 -115.12 144.41 43.7 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.937 -176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.54 145.37 29.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.04 0.448 . . . . 0.0 110.911 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.424 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 51.5 m -111.45 116.26 30.6 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.437 ' HA ' ' CG2' ' A' ' 105' ' ' ILE . 10.0 t -134.26 -10.66 2.54 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.913 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -85.44 97.11 9.83 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.857 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.86 -32.85 2.47 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 102' ' ' THR . 13.3 tt -86.83 136.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.21 123.53 79.32 Favored Pre-proline 0 N--CA 1.426 -1.672 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.457 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 23.0 Cg_exo -68.25 129.7 19.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.605 2.87 . . . . 0.0 108.511 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -81.16 174.39 11.61 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.659 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 109' ' ' LYS . 75.3 mmtt -52.81 104.6 0.09 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.813 1.292 . . . . 0.0 114.158 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.279 -2.492 0 CA-C-N 111.237 -2.711 . . . . 0.0 104.406 -174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 101' ' ' SER . 49.3 m . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.482 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 95.6 m-85 -86.09 124.82 32.94 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -120.23 145.1 47.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 118.24 23.38 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -118.23 -40.72 2.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.379 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 p -146.27 -175.15 4.65 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.577 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.574 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.6 m -131.57 150.6 52.09 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.221 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -71.47 -25.26 62.21 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 96' ' ' ASP . 23.8 t70 -72.19 -17.68 61.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.316 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.25 -53.43 4.7 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 12' ' ' ILE . 43.3 pt -108.37 110.13 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 122.433 1.111 . . . . 0.0 110.523 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.492 ' HB2' ' OE2' ' A' ' 16' ' ' GLU . 37.3 m95 -80.38 170.07 16.88 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.119 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.43 127.13 14.99 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.036 0.446 . . . . 0.0 110.015 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.65 -1.72 79.13 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 13' ' ' TRP . 44.8 mt-10 -110.34 149.94 29.5 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.38 0.61 . . . . 0.0 112.239 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 53' ' ' SER . 20.3 ptt? -150.39 152.2 33.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.485 -171.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -157.24 151.91 25.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 123.613 0.571 . . . . 0.0 109.472 177.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.638 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 99.1 m -89.49 121.01 31.31 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 97.6 m-85 -119.2 155.77 31.08 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' THR . 36.1 tt0 -109.88 143.42 39.8 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.1 p -83.06 165.76 19.32 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 m -67.0 -13.13 61.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.142 0.496 . . . . 0.0 111.213 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.85 -13.11 49.01 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 109.489 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 22.39 16.42 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.794 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.587 ' CG2' HE22 ' A' ' 42' ' ' GLN . 31.5 m -97.72 130.03 44.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.764 -0.257 . . . . 0.0 111.168 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -89.64 126.85 35.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.571 0.701 . . . . 0.0 111.589 175.694 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.19 148.78 27.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.8 tp -100.29 111.1 23.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.3 mp -102.94 117.45 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 17' ' ' MET . 66.2 t -118.05 125.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.839 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -88.09 104.22 16.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -101.59 145.75 28.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.144 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.82 -48.98 19.37 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.483 0.659 . . . . 0.0 109.574 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.29 -41.33 61.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.723 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -100.78 2.48 41.27 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.77 -170.68 46.1 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.1 t -78.43 119.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.09 144.77 44.29 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.655 0.264 . . . . 0.0 110.914 -176.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.97 119.99 31.18 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.535 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 2.0 p90 -143.23 140.19 30.58 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.394 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.587 HE22 ' CG2' ' A' ' 26' ' ' THR . 14.7 mm100 -44.66 138.21 3.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.25 59.21 4.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.425 1.107 . . . . 0.0 109.877 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 19.0 mmt -66.07 94.1 0.23 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 113.618 -1.628 . . . . 0.0 114.262 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 m -166.47 93.84 0.76 Allowed Pre-proline 0 C--N 1.31 -1.148 0 C-N-CA 125.445 1.498 . . . . 0.0 110.403 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.98 30.27 0.47 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.206 2.604 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 30.38 3.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -47.91 124.02 6.89 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.244 2.218 . . . . 0.0 114.817 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 41.7 mm-40 -92.55 -62.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 173.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 tp -151.16 172.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 110.71 2.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 118.985 0.811 . . . . 0.0 109.67 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.2 pt? -62.16 -20.01 63.66 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.893 1.277 . . . . 0.0 112.409 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.638 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 59.3 p -55.0 -21.86 13.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -166.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.46 8.59 44.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.36 0.6 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.68 81.3 0.12 Allowed Glycine 0 C--N 1.318 -0.426 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.602 ' HB3' HG23 ' A' ' 62' ' ' ILE . 66.3 m -138.53 -77.86 0.36 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -90.23 114.23 26.2 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.508 -169.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.4 105.24 11.93 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.657 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.85 -64.07 1.55 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 123.207 0.317 . . . . 0.0 113.028 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.1 -2.62 0.06 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.88 140.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 56' ' ' SER . 36.4 mt -113.4 121.06 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 0.0 112.044 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.4 m -92.94 148.46 21.99 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 125.67 1.588 . . . . 0.0 110.432 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.549 ' C ' ' H ' ' A' ' 66' ' ' ALA . 44.6 t -156.21 34.7 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 72.32 -22.91 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.694 1.198 . . . . 0.0 109.83 -170.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . 71.17 100.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 125.367 1.467 . . . . 0.0 111.576 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.452 ' CE1' ' HG2' ' A' ' 49' ' ' GLU . 52.7 m80 -99.83 -0.17 40.27 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.499 174.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -147.55 -55.1 0.22 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.016 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -170.62 -143.78 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 32.8 p -134.39 167.68 20.3 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.363 1.465 . . . . 0.0 108.981 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 54.2 m-85 -98.69 138.39 35.93 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -107.46 112.54 25.37 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 173.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.405 4.6 p-10 52.77 63.19 2.33 Favored 'General case' 0 CA--C 1.476 -1.883 0 CA-C-O 123.333 1.539 . . . . 0.0 111.342 -167.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.506 ' HA3' HD12 ' A' ' 62' ' ' ILE . . . -73.26 64.47 1.67 Allowed Glycine 0 CA--C 1.474 -2.491 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.257 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.2 m -139.85 -46.64 0.44 Allowed 'General case' 1 C--N 1.242 -4.09 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.96 -3.53 6.3 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 119.171 -1.49 . . . . 0.0 113.399 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -144.12 142.95 30.89 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.326 0.563 . . . . 0.0 110.801 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.45 129.05 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.699 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 70' ' ' THR . 51.1 mt -88.3 -22.93 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 173.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 23.7 t30 -143.8 113.44 5.44 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.895 168.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 6.9 Cg_exo -76.11 129.16 18.08 Favored 'Cis proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.706 -1.789 . . . . 0.0 110.914 -2.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.21 -11.84 59.96 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.739 0.78 . . . . 0.0 109.886 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.84 -19.78 61.25 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.712 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 79.3 m -155.11 161.67 41.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 122.327 1.06 . . . . 0.0 113.196 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 p -94.06 -167.56 1.7 Allowed 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 84.6 mt -117.38 142.72 46.77 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.843 177.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.22 86.38 5.01 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.569 176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 123.58 24.57 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.105 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.52 ' CD2' HG21 ' A' ' 105' ' ' ILE 0.251 5.4 p90 -124.08 160.32 52.69 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.58 133.67 43.77 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.68 2.92 . . . . 0.0 115.012 -172.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.3 t -116.3 143.56 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-N 113.713 -1.585 . . . . 0.0 107.498 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.9 132.38 47.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.52 130.49 48.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.63 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 90.6 3.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 176.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.64 -113.55 5.96 Favored Glycine 0 C--N 1.31 -0.889 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.604 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.2 m-20 -91.93 -8.2 46.96 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 123.365 0.666 . . . . 0.0 110.671 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 17.4 m-20 -111.65 157.61 20.24 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.2 mm -126.93 135.93 62.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 16.6 m-85 -106.54 145.99 31.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 167.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.32 151.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 2' ' ' SER . 20.8 m -87.47 113.08 22.85 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.1 p -124.51 -38.28 2.42 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 103' ' ' LYS . 1.4 tpmt? -107.32 91.19 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.07 -39.08 0.73 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.614 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 28.1 mm -85.49 143.25 11.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 170.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.0 tp -96.86 100.75 7.9 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.451 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 105' ' ' ILE . 2.9 Cg_exo -78.41 136.98 14.49 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 123.084 2.523 . . . . 0.0 109.872 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.53 117.01 20.87 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.252 0.548 . . . . 0.0 110.385 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -71.83 -24.13 61.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.704 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HA ' ' SD ' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.301 -1.504 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.912 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 CA--C 1.506 -0.726 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 52.46 87.82 0.03 OUTLIER 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.151 0.977 . . . . 0.0 111.342 -174.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -105.3 142.48 34.99 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -65.8 117.52 8.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.278 0.561 . . . . 0.0 110.128 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 tt -104.3 -56.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.57 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.846 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.3 m -157.92 -177.14 6.35 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 123.058 0.543 . . . . 0.0 111.064 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 p -103.62 150.17 24.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.0 tt -72.85 -24.77 60.92 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.4 -25.97 68.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.215 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.54 -48.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.6 pt -100.91 110.79 28.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 CA-C-O 122.802 1.287 . . . . 0.0 112.27 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -79.2 169.78 17.63 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 113.514 -1.676 . . . . 0.0 112.227 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.1 116.71 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.703 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.34 2.12 59.08 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.383 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -104.18 145.04 30.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.21 0.528 . . . . 0.0 110.679 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -142.36 143.73 32.85 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 tp10 -152.86 149.76 28.62 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 69.5 m -89.08 123.06 33.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.001 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -127.57 162.51 26.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.765 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -102.0 141.54 34.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -83.97 170.59 13.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -64.02 -13.68 48.5 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.758 0.423 . . . . 0.0 111.66 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.52 -13.24 24.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.283 0.563 . . . . 0.0 110.373 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.2 18.58 23.82 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.978 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -97.09 139.12 33.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -89.65 135.45 33.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' THR . 99.2 t -134.94 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -104.08 110.29 22.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.4 mp -101.3 123.19 54.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 17' ' ' MET . 9.3 p -111.96 125.58 69.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -101.86 102.01 12.54 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 117.941 -1.504 . . . . 0.0 108.456 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.9 m -103.6 139.08 39.38 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.64 -38.62 54.36 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.412 0.625 . . . . 0.0 109.706 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -92.93 -46.89 7.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.68 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -79.74 -12.3 59.8 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.111 0.481 . . . . 0.0 110.41 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.76 159.13 31.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.988 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 93' ' ' VAL . 7.2 p -72.94 124.01 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -127.06 138.59 53.24 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.24 0.543 . . . . 0.0 112.38 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.7 112.33 16.62 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.015 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 25.3 p90 -136.82 147.08 46.37 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.676 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -47.33 137.79 8.02 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.896 0.855 . . . . 0.0 113.02 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . . . -83.99 101.09 11.48 Favored 'General case' 0 N--CA 1.396 -3.141 0 CA-C-N 114.474 -1.239 . . . . 0.0 113.198 -172.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 26.1 ptt? 64.07 179.42 0.17 Allowed 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 111.32 -2.673 . . . . 0.0 116.306 163.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.61 116.64 66.83 Favored Pre-proline 0 N--CA 1.416 -2.169 0 CA-C-N 112.238 -2.256 . . . . 0.0 107.202 171.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -85.8 37.26 0.55 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 122.742 2.295 . . . . 0.0 113.347 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -85.13 -59.69 2.26 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.15 115.11 29.71 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.603 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -75.13 82.97 2.32 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 122.359 1.076 . . . . 0.0 111.164 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.0 tt -71.99 -37.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.93 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 60.61 69.49 0.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' H ' ' CD2' ' A' ' 52' ' ' LEU . 1.5 pt? -77.5 -19.33 56.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.323 -2.217 . . . . 0.0 114.074 -169.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.9 p -54.88 -23.12 17.11 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -163.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.49 -9.24 58.53 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 119.083 0.856 . . . . 0.0 110.182 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.6 83.18 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 m -125.31 -57.68 1.47 Allowed 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 122.411 1.1 . . . . 0.0 109.107 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -91.21 113.52 25.81 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.403 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.36 105.52 11.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 -53.82 2.1 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.606 -0.331 . . . . 0.0 113.585 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.55 -12.28 0.02 OUTLIER Glycine 0 C--N 1.306 -1.107 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.7 141.55 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 51.5 mm -106.83 128.35 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 123.956 0.902 . . . . 0.0 108.954 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.4 m -85.74 125.25 33.08 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 5.4 t -105.79 155.57 19.16 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.39 117.77 29.96 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.303 0.241 . . . . 0.0 110.957 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.05 -38.34 0.39 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 36.0 m170 -71.2 114.71 9.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 118.266 0.485 . . . . 0.0 111.38 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.477 ' HB3' ' CG ' ' A' ' 80' ' ' ASN . 2.1 tm? 49.24 -97.49 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.438 1.495 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -166.98 -44.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 p -138.34 134.93 34.85 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -160.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 48.3 t80 -116.23 138.53 51.21 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 101.868 -3.382 . . . . 0.0 101.868 168.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.421 ' H ' ' HA2' ' A' ' 78' ' ' GLY . 54.7 t30 -123.35 117.34 24.99 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.873 1.67 . . . . 0.0 115.156 -168.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.48 -33.46 42.23 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.256 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -48.47 -54.58 12.74 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.757 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.7 m -88.94 -36.78 15.7 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.087 0.47 . . . . 0.0 110.223 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.508 ' O ' HD13 ' A' ' 86' ' ' LEU . . . 114.37 -33.55 5.35 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.456 ' HD2' ' SG ' ' A' ' 85' ' ' CYS . 29.8 t-80 -82.72 137.97 34.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.79 144.22 17.17 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.92 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.56 -42.42 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.477 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 3.5 p-10 -135.32 118.89 12.97 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.0 Cg_endo -81.11 131.76 21.39 Favored 'Cis proline' 0 C--O 1.243 0.757 0 C-N-CA 123.797 -1.335 . . . . 0.0 111.397 -1.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.0 p30 -71.5 -12.69 61.51 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.059 0.457 . . . . 0.0 111.101 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.41 -17.53 62.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.39 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 25.5 p -138.58 178.78 6.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 111.951 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 77' ' ' HIS . 62.3 m -133.61 176.12 8.83 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 76' ' ' GLY 0.313 0.0 OUTLIER -101.02 127.06 47.7 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.646 175.466 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -72.83 114.2 10.71 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -87.32 116.89 25.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 101' ' ' SER . 65.4 m-85 -95.69 152.54 39.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HD3' HD12 ' A' ' 105' ' ' ILE . 14.2 Cg_exo -70.76 120.55 7.16 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.186 1.924 . . . . 0.0 110.058 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.74 138.27 52.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.468 0.652 . . . . 0.0 110.667 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -115.24 132.06 56.73 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.512 ' HB ' HG11 ' A' ' 38' ' ' VAL . 8.8 p -106.57 122.21 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.324 -175.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -125.89 143.93 50.88 Favored 'General case' 0 N--CA 1.394 -3.234 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.312 176.442 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -33.62 -53.75 0.63 Allowed Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 117.531 1.772 . . . . 0.0 117.531 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.56 -0.73 13.58 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.534 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 9.3 m-20 -146.89 134.82 21.37 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.67 129.77 73.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-O 121.354 0.597 . . . . 0.0 111.088 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -113.73 141.49 47.2 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.027 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.76 147.94 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 120.946 0.403 . . . . 0.0 111.082 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.456 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 51.3 m -104.79 115.22 29.93 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.969 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -101.01 -18.43 16.28 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.525 ' HE3' ' HA ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -81.73 108.38 15.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.147 176.475 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.55 -34.32 2.43 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.498 HD12 ' HD3' ' A' ' 90' ' ' PRO . 33.7 mt -119.02 127.64 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.06 128.07 61.69 Favored Pre-proline 0 N--CA 1.404 -2.732 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.09 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.42 148.87 91.87 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.36 2.04 . . . . 0.0 110.362 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -80.18 166.88 21.0 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -78.56 74.14 5.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.975 1.369 . . . . 0.0 114.139 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.26 -3.291 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.87 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.6 m . . . . . 0 C--O 1.243 0.727 0 CA-C-O 119.82 -0.133 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CD2' ' HB2' ' A' ' 101' ' ' SER . 92.2 m-85 -76.07 97.72 4.14 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.76 143.81 35.79 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 120.908 0.385 . . . . 0.0 110.284 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 86.1 tttt -79.54 123.66 27.78 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' ' 7' ' ' CYS . 39.7 mm -94.87 -53.55 8.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.333 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 6' ' ' ILE . 93.4 m -158.31 -172.56 3.93 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.465 0.65 . . . . 0.0 111.921 -173.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 41.2 t -104.74 153.22 21.57 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.959 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.4 tt -61.73 -21.8 64.82 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.99 -19.6 66.08 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.186 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -94.98 -42.95 8.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.6 tp -114.49 110.83 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.056 0.931 . . . . 0.0 112.65 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -102.59 169.04 8.89 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.327 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.42 124.76 27.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.684 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.52 66.0 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -105.14 153.27 21.75 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.083 -0.559 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -151.27 143.92 24.34 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.512 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.01 155.44 31.25 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.3 m -73.38 136.21 44.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.064 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -135.33 160.5 38.22 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.11 136.98 44.83 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.9 p -84.62 175.64 9.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.9 m -66.12 -20.72 66.24 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.046 0.45 . . . . 0.0 111.368 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.44 5.12 52.42 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.588 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.05 33.67 54.17 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.104 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 m -97.98 134.95 40.39 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.68 122.67 33.01 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.13 141.98 45.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.215 0.531 . . . . 0.0 110.267 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 53.5 tp -100.04 111.91 24.21 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 124.512 1.125 . . . . 0.0 108.191 177.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.7 114.33 32.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.39 124.55 64.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.3 t30 -109.31 106.46 16.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.5 m -98.37 157.3 16.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.686 0.755 . . . . 0.0 112.518 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -75.26 -48.96 20.88 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.543 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.12 -33.77 10.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -91.45 3.28 55.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.15 -166.37 41.23 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.392 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 10.6 p -90.92 128.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.548 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -132.3 158.16 42.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.336 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.31 128.02 48.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 39' ' ' LYS . 95.0 m-85 -134.97 163.56 29.59 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -55.38 138.93 44.72 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.206 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.47 -39.3 74.32 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.511 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 66.6 mtt -103.19 120.61 41.03 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.8 p -70.7 171.88 7.34 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 123.362 0.413 . . . . 0.0 110.429 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' N ' ' HA ' ' A' ' 110' ' ' ALA . 31.8 Cg_exo -60.62 -18.84 57.26 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.672 2.248 . . . . 0.0 111.661 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -100.01 -22.69 15.14 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.369 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.577 ' HG3' ' H ' ' A' ' 49' ' ' GLU 0.375 11.8 pt20 47.9 -102.98 0.09 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.02 0.928 . . . . 0.0 113.433 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.577 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 44.4 mt-10 58.5 -75.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.796 1.238 . . . . 0.0 113.505 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -109.27 141.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.62 99.34 5.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.942 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.5 pt? -60.33 -24.97 65.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.3 p -63.58 -27.82 69.51 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 123.982 0.913 . . . . 0.0 110.305 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -113.84 21.19 15.17 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.37 -110.47 2.62 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.8 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 m -148.27 157.84 43.73 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.546 0.689 . . . . 0.0 111.495 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -125.24 127.47 46.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.327 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 61' ' ' VAL . 1.6 tm-20 -114.96 163.88 14.95 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.26 -34.85 48.6 Favored Glycine 0 C--N 1.317 -0.479 0 CA-C-N 118.535 0.607 . . . . 0.0 113.288 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.06 7.14 5.11 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.527 -1.32 . . . . 0.0 113.058 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 58' ' ' GLU . 64.3 t -124.79 125.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 122.002 -0.705 . . . . 0.0 111.43 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 71' ' ' PHE . 51.4 mm -89.99 130.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.3 m -91.93 113.73 26.08 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.059 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.415 ' C ' ' H ' ' A' ' 66' ' ' ALA . 39.8 m -87.02 -45.55 10.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.786 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 65' ' ' ARG . 0.9 OUTLIER 71.76 -36.28 0.35 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.71 1.204 . . . . 0.0 110.822 -177.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . -56.16 -61.06 2.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -75.8 -19.29 59.08 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.134 -1.426 . . . . 0.0 112.079 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.0 tp 179.87 -77.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 73.7 t90 177.32 -27.69 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.503 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' HD13 ' A' ' 79' ' ' ILE . 34.1 p -100.77 140.58 34.84 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CD2' ' HB ' ' A' ' 62' ' ' ILE . 42.7 t80 -134.39 139.93 45.94 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 126.311 1.844 . . . . 0.0 107.107 173.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -106.47 113.03 26.31 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.955 0.407 . . . . 0.0 110.704 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.94 -50.91 72.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -42.7 -45.32 5.67 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.578 ' HB ' ' CD2' ' A' ' 77' ' ' HIS . 10.7 m -116.31 12.17 15.26 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 122.123 -0.634 . . . . 0.0 110.634 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.56 51.42 52.15 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.396 -0.431 . . . . 0.0 112.258 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.578 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -146.46 157.24 43.73 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.56 173.79 54.9 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 119.346 -1.406 . . . . 0.0 109.998 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.459 HD13 ' HB ' ' A' ' 70' ' ' THR . 1.8 mp -87.71 -27.77 5.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -152.07 107.13 2.82 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.558 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.87 158.07 98.36 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.123 -1.615 . . . . 0.0 111.175 -2.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.2 p-10 -104.22 -4.61 22.83 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -173.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.49 -55.44 18.92 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.236 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 85.9 m -167.46 170.63 11.16 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.619 0.768 . . . . 0.0 109.895 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.566 ' CB ' ' HA ' ' A' ' 77' ' ' HIS . 42.1 t -145.39 -79.42 0.18 Allowed 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.312 1.053 . . . . 0.0 110.756 169.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.509 ' HG ' ' SG ' ' A' ' 85' ' ' CYS . 87.5 mt -114.0 167.14 10.92 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.824 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -97.51 137.7 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -95.67 113.88 25.57 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 97.4 m-85 -106.03 142.74 25.47 Favored Pre-proline 0 C--O 1.245 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.048 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 89' ' ' TYR . 24.1 Cg_exo -63.89 131.97 32.99 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.963 2.442 . . . . 0.0 111.074 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 100' ' ' VAL . 7.3 p -133.15 146.78 31.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.508 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.528 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 50.6 mt-10 -131.74 132.61 43.99 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.28 118.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.202 0.525 . . . . 0.0 110.427 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.528 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -120.7 91.97 3.66 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.34 -99.52 0.52 Allowed Glycine 0 CA--C 1.498 -0.989 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.583 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.624 ' O ' ' HA ' ' A' ' 8' ' ' SER . 10.6 m-20 -104.85 -9.78 17.79 Favored 'General case' 0 C--O 1.174 -2.886 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.956 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.8 128.39 45.9 Favored 'General case' 0 C--N 1.273 -2.722 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.551 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -119.73 121.9 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.409 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 20.3 m-85 -114.08 142.37 46.28 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.251 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 91' ' ' VAL . 24.5 m -128.56 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 2' ' ' SER . 32.1 t -105.45 120.03 40.58 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.163 0.506 . . . . 0.0 110.074 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.2 t -102.49 12.75 36.03 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.784 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -100.82 144.33 29.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 -41.66 2.65 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.43 136.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.26 140.75 23.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.23 138.78 28.76 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.073 2.515 . . . . 0.0 113.688 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -80.86 -177.34 6.32 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -14.74 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 124.118 0.967 . . . . 0.0 112.8 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.314 -0.946 0 C-N-CA 125.453 1.501 . . . . 0.0 111.242 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -59.54 102.88 0.16 Allowed 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.302 0.572 . . . . 0.0 110.049 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -117.71 150.28 39.34 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.659 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 87.8 tttt -77.38 115.29 17.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.291 0.567 . . . . 0.0 110.083 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.403 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.8 tp -96.4 -35.28 5.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.791 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' A' ' 6' ' ' ILE . 21.9 p -162.3 -166.58 1.42 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.981 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.723 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.2 m -127.96 149.1 50.49 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.147 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.95 -34.72 78.62 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 123.495 0.718 . . . . 0.0 109.395 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.45 -23.08 66.83 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.36 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.45 -46.47 12.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.572 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 12' ' ' ILE . 47.0 pt -100.65 114.75 40.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.353 1.073 . . . . 0.0 112.124 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -82.25 168.52 17.53 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.196 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.08 122.06 11.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.67 0.748 . . . . 0.0 110.001 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' A' ' 57' ' ' TYR . . . 94.18 1.11 65.05 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.223 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -102.69 137.83 40.4 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.3 0.572 . . . . 0.0 109.747 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.422 ' CB ' HG22 ' A' ' 31' ' ' VAL . 23.1 ptm -137.23 143.14 42.11 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.902 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 12.2 tp10 -156.54 154.66 30.65 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 176.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 89.1 m -100.93 130.94 47.0 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.19 0.519 . . . . 0.0 109.912 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -123.11 152.19 41.33 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.08 138.47 51.6 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.18 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.2 p -83.92 172.71 11.84 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 p -64.43 -26.54 68.49 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.177 0.591 . . . . 0.0 110.944 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.55 -12.22 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.212 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.52 18.07 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.443 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.6 m -90.28 117.0 28.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.72 123.72 33.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' THR . 62.1 t -127.33 137.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.163 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 29' ' ' LEU . 4.3 pp -93.3 123.3 36.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -109.44 114.55 47.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 ' CB ' ' A' ' 17' ' ' MET . 46.6 t -119.19 125.84 74.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.355 -177.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -87.82 106.21 17.92 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 22.8 m -99.53 149.35 23.33 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -75.28 -50.04 17.34 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.177 0.513 . . . . 0.0 111.063 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.7 -45.04 9.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.803 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' NE2' ' HE3' ' A' ' 39' ' ' LYS . 21.3 t-160 -84.25 -15.02 48.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.86 0.362 . . . . 0.0 111.949 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 85.59 -171.5 45.48 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.003 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 98' ' ' ILE . 61.4 t -77.72 123.35 34.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HE3' ' NE2' ' A' ' 36' ' ' HIS . 74.3 mmtt -128.25 150.44 50.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.23 119.24 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.329 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -128.69 158.61 38.11 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -60.19 138.23 57.96 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -106.35 -5.75 18.83 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.01 17.49 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.3 m -80.45 111.79 25.7 Favored Pre-proline 0 N--CA 1.443 -0.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 168.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.07 39.05 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.626 2.218 . . . . 0.0 111.845 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -102.25 -77.03 0.56 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -170.15 131.78 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 43.1 mt-10 64.54 86.44 0.13 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.778 0.799 . . . . 0.0 112.164 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tt -93.88 106.46 18.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.729 0.776 . . . . 0.0 111.836 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB3' ' HG2' ' A' ' 65' ' ' ARG . 36.1 tp -154.38 48.92 0.61 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 29' ' ' LEU . 1.6 tm? -56.16 -38.78 71.36 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.276 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.653 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 94.0 p -68.56 -29.47 68.02 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.382 0.611 . . . . 0.0 112.331 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -83.87 17.15 2.46 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 124.265 1.026 . . . . 0.0 110.815 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.01 -125.01 1.15 Allowed Glycine 0 N--CA 1.412 -2.914 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.4 m -152.69 151.46 30.57 Favored 'General case' 0 N--CA 1.424 -1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.905 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.536 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 20.8 t80 -120.75 116.25 24.87 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.162 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -117.18 170.82 8.37 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 69.61 0.04 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.01 1.75 39.08 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.14 127.21 72.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.8 mm -122.72 132.94 70.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.39 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.4 m -101.76 137.39 40.12 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 25.9 p -78.09 -73.86 0.29 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.558 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 51' ' ' LEU . 29.7 tpt180 174.72 -69.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . . . -66.51 -57.96 6.23 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.413 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 8.6 m170 -70.59 116.11 10.53 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.836 167.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.93 17.63 3.39 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.53 1.157 . . . . 0.0 108.603 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' HIS . 87.7 m95 -93.47 177.41 6.04 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.164 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -129.8 140.81 50.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.495 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 53.5 p90 -105.67 154.02 21.02 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -93.7 116.57 29.07 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.983 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.46 -30.49 67.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.159 0.584 . . . . 0.0 111.3 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.77 31.51 4.25 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.3 m -156.7 -44.2 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.784 0.834 . . . . 0.0 109.305 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.59 -9.72 66.65 Favored Glycine 0 C--O 1.215 -1.049 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.911 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.12 148.29 28.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.495 ' HA2' ' CB ' ' A' ' 71' ' ' PHE . . . -72.56 137.73 25.08 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.645 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.41 -43.72 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -160.84 124.31 1.93 Allowed Pre-proline 0 N--CA 1.425 -1.721 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.496 ' HD2' ' SG ' ' A' ' 84' ' ' CYS . 12.7 Cg_exo -71.92 166.21 79.85 Favored 'Cis proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.79 0.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.41 -11.54 34.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.18 -10.75 59.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 p -110.32 133.98 52.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 122.334 1.064 . . . . 0.0 111.96 176.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.52 157.69 43.3 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.3 mt -131.75 179.47 6.05 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -141.07 139.66 34.08 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 8.6 pt-20 -92.25 104.09 16.49 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.235 0.541 . . . . 0.0 109.933 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -89.96 163.51 31.88 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.88 119.57 6.81 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.656 2.237 . . . . 0.0 114.018 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 100' ' ' VAL . 3.1 p -129.9 127.47 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.629 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.459 0.647 . . . . 0.0 110.028 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 98' ' ' ILE . 7.4 p -94.83 129.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.062 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -122.61 146.85 47.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.07 101.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.07 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.741 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.723 ' O ' ' HB3' ' A' ' 8' ' ' SER . 8.0 m-20 76.27 -13.82 0.87 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.28 2.232 . . . . 0.0 114.716 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -120.62 155.46 33.72 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-N 119.965 1.257 . . . . 0.0 110.849 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.478 HD13 HG11 ' A' ' 38' ' ' VAL 0.251 45.8 mt -131.26 133.92 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.634 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -119.44 144.38 46.98 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.495 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.424 HG12 HG23 ' A' ' 91' ' ' VAL . 35.3 m -135.52 144.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -132.39 118.09 18.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -92.92 6.08 49.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.156 0.503 . . . . 0.0 109.96 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -72.13 109.76 6.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.719 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.02 25.4 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.62 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.8 119.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 110.031 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 148.05 34.03 Favored Pre-proline 0 N--CA 1.409 -2.496 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.83 134.13 57.61 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.887 2.391 . . . . 0.0 111.251 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 54.3 t30 -79.91 157.29 26.95 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.1 106.01 0.24 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.826 0 CA-C-N 111.614 -2.539 . . . . 0.0 106.34 -179.402 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 C--O 1.237 0.436 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.5 t -92.35 -54.01 3.98 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.8 m-85 -90.11 105.62 17.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.177 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -106.3 146.23 30.65 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -76.09 116.78 17.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -98.55 -30.89 3.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.523 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.0 p -167.35 -171.73 1.78 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.082 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 56.7 p -130.5 152.8 49.48 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.588 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.7 mt -67.9 -15.36 63.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.858 0.837 . . . . 0.0 109.325 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.4 -23.58 63.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.047 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -83.6 -64.55 1.15 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.7 pt -103.16 134.57 43.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.48 1.133 . . . . 0.0 113.604 -174.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 30.6 m95 -93.1 170.02 9.96 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.179 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.5 118.3 6.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.36 56.88 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -112.22 151.28 29.76 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.859 0.362 . . . . 0.0 110.539 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.516 ' SD ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -148.39 146.61 28.56 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 178.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.6 pt-20 -158.36 156.77 31.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.514 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.9 t -94.19 141.7 28.25 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.064 0.459 . . . . 0.0 110.039 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 92.7 m-85 -131.57 155.63 47.15 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.45 138.34 35.81 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -82.86 173.7 11.6 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -66.39 -15.48 63.33 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.155 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -93.59 -13.9 27.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.222 0.534 . . . . 0.0 110.204 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 -3.4 38.78 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.671 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 m -76.89 133.09 39.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.81 123.01 42.77 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.99 0.9 . . . . 0.0 109.149 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -122.62 143.83 34.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.449 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 2.8 tm? -94.24 120.48 34.54 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.4 113.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 7.7 p -112.84 128.53 69.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.123 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.9 t30 -111.06 102.3 10.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 169.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.4 p -103.64 157.81 16.8 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.885 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -76.46 -33.67 58.71 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.403 175.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -94.69 -46.14 7.05 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -97.28 -4.74 38.19 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.976 -0.453 . . . . 0.0 111.468 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.52 -163.12 48.09 Favored Glycine 0 C--O 1.248 0.995 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -93.36 118.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-O 121.716 0.77 . . . . 0.0 109.352 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -129.99 146.69 51.69 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.896 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.86 112.6 16.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.604 ' HB2' HD11 ' A' ' 86' ' ' LEU . 5.1 p90 -138.95 163.33 32.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -51.52 137.13 24.92 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.53 0.519 . . . . 0.0 110.377 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -111.66 -37.89 5.05 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -84.1 79.92 9.35 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -167.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -100.72 -28.41 0.23 Allowed Pre-proline 0 C--O 1.174 -2.921 0 CA-C-O 116.748 -1.596 . . . . 0.0 110.786 167.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 10.2 Cg_endo -50.06 105.44 0.1 OUTLIER 'Trans proline' 1 C--N 1.424 4.547 0 CA-C-N 122.683 1.994 . . . . 0.0 112.288 -177.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 68.0 m80 -82.61 9.46 9.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.032 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.74 116.9 20.93 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 103.358 -2.83 . . . . 0.0 103.358 170.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 1.0 OUTLIER -50.78 111.7 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -173.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 tp -155.27 163.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.14 100.25 9.99 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.066 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.436 HD11 HG22 ' A' ' 62' ' ' ILE . 6.0 tt -56.64 -32.83 65.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.624 1.169 . . . . 0.0 112.897 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 31.8 p -72.36 -22.48 61.14 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.495 0.664 . . . . 0.0 111.517 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -103.64 12.65 34.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.17 -103.08 2.85 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.817 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.549 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 22.6 t -144.74 145.42 31.68 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 123.372 1.558 . . . . 0.0 114.26 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -131.82 114.43 14.69 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 110.874 -2.875 . . . . 0.0 104.389 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -116.59 103.29 10.24 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.069 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.28 -72.77 0.43 Allowed Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.239 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.24 3.11 0.54 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.68 124.68 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.488 0.661 . . . . 0.0 109.363 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 52' ' ' LEU . 67.6 mt -93.66 139.13 18.82 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.549 ' OG1' ' HB3' ' A' ' 56' ' ' SER . 35.8 m -80.78 115.39 20.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.556 1.169 . . . . 0.0 112.873 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 37.1 t -93.06 141.07 28.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 173.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 65' ' ' ARG . 21.8 ttt180 -118.76 -42.53 2.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 117.237 -1.785 . . . . 0.0 114.691 -168.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . . . -93.45 -6.33 47.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.222 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 72.9 m80 -116.75 -174.21 2.53 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.425 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 69' ' ' TRP . 2.6 tm? -77.76 73.56 4.33 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.405 ' CD1' HD13 ' A' ' 68' ' ' LEU 0.343 17.9 p-90 35.94 -31.91 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 131.095 3.758 . . . . 0.0 120.841 172.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -102.19 127.29 49.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.402 ' CE2' HD13 ' A' ' 86' ' ' LEU . 37.1 t80 -135.33 136.15 41.33 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 171.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -123.59 133.32 53.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 117.773 -1.571 . . . . 0.0 114.16 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.17 -42.43 72.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.921 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.18 98.52 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.58 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -80.46 -27.46 37.88 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.21 26.7 73.88 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 16.9 t-160 -157.56 154.91 29.3 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -173.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.02 137.49 23.16 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.54 -41.83 20.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 51.0 t-20 -160.68 113.96 1.35 Allowed Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 67' ' ' HIS . 2.0 Cg_endo -81.44 -179.54 25.0 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.963 4.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.44 -19.51 29.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.838 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.35 -33.33 74.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.423 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.5 p -90.69 142.44 27.75 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-O 122.112 0.958 . . . . 0.0 112.078 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 108' ' ' ASN . 1.6 p -139.38 159.83 41.25 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.275 -1.329 . . . . 0.0 111.399 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 41' ' ' TYR . 34.4 tp -111.61 129.83 55.95 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.046 0.45 . . . . 0.0 110.997 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -110.8 111.62 22.9 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.06 148.73 22.71 Favored 'General case' 0 N--CA 1.421 -1.894 0 O-C-N 123.618 0.574 . . . . 0.0 110.499 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 101' ' ' SER . 97.6 m-85 -108.7 149.8 39.94 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.624 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.8 121.83 9.29 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.7 2.267 . . . . 0.0 110.755 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.69 138.32 32.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.865 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 119.07 35.43 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.12 120.24 59.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.289 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' ' 94' ' ' LYS 0.282 0.0 OUTLIER -126.54 145.72 50.41 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.946 174.985 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -25.29 -45.75 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 119.763 2.665 . . . . 0.0 119.763 -171.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 8' ' ' SER . 26.6 m-20 -116.46 -13.59 10.96 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 117.808 0.804 . . . . 0.0 111.795 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 94' ' ' LYS . 5.0 m-20 -121.62 148.9 43.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.612 0.72 . . . . 0.0 112.887 -169.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -126.14 111.57 27.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.309 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -108.98 144.29 37.15 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.781 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 8.8 p -140.32 145.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 2' ' ' SER . 38.5 t -87.84 114.21 24.24 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -134.36 15.87 3.75 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.416 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -108.36 118.19 36.11 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.265 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 -3.82 86.73 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.175 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.6 mt -90.39 130.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 120.778 0.323 . . . . 0.0 110.444 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 61.6 tp -78.48 119.98 79.33 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.103 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 37.0 Cg_endo -69.11 145.93 62.55 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.842 2.361 . . . . 0.0 111.052 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.69 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 10.1 m120 -88.91 179.14 6.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.853 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.506 ' HD2' ' N ' ' A' ' 109' ' ' LYS . 11.0 mptt -67.8 101.38 1.06 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.74 1.257 . . . . 0.0 112.582 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 178.24 -63.78 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.239 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.422 ' CG ' ' H ' ' A' ' 112' ' ' SER . 23.0 t-80 56.23 -164.95 0.14 Allowed 'General case' 0 CA--C 1.562 1.409 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.918 169.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.422 ' H ' ' CG ' ' A' ' 111' ' ' HIS . 37.7 m . . . . . 0 N--CA 1.428 -1.561 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.477 ' S1 ' ' HA ' ' A' ' 46' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 C--O 1.24 0.602 0 CA-C-O 120.777 0.322 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -102.2 101.05 11.32 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.675 0.274 . . . . 0.0 111.265 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' A' ' 92' ' ' GLU . 96.4 m-85 58.28 97.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.3 150.26 50.15 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.106 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 88.4 tttt -68.72 137.83 54.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.013 0.435 . . . . 0.0 111.602 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.457 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -127.25 -40.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' HG23 ' A' ' 6' ' ' ILE . 19.8 p -155.08 -172.11 4.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.305 0.574 . . . . 0.0 112.122 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p -131.45 150.01 52.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.646 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.7 tt -69.65 -25.66 64.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.05 -24.93 68.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.977 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.38 -55.11 3.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.683 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 12' ' ' ILE . 40.4 pt -100.82 110.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 122.541 1.162 . . . . 0.0 111.085 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -83.75 170.15 14.49 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.749 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -56.89 118.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.012 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 -2.27 61.25 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.64 142.3 34.56 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.97 142.11 32.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.189 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.737 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -148.16 133.8 18.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.232 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 89.4 m -79.03 123.08 26.97 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -119.23 155.04 32.44 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.508 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -102.65 134.66 45.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.819 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -83.55 167.36 17.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -63.14 -13.31 35.29 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -88.48 -12.27 43.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.25 30.87 11.45 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -97.62 133.59 41.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.64 126.83 35.78 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.176 0.512 . . . . 0.0 110.068 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 19' ' ' THR . 42.0 t -131.67 140.15 48.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -97.34 108.13 20.79 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.8 mp -99.36 115.85 41.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.37 125.11 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 42.5 t30 -97.26 105.08 17.16 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.306 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -101.4 148.58 25.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -76.64 -50.72 13.06 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.505 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.54 -38.5 14.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.81 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -79.72 -9.66 59.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.65 169.51 38.52 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.337 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -76.01 122.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.47 142.95 50.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.57 137.5 49.33 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 96.4 m-85 -130.35 149.77 51.88 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB3' ' H ' ' A' ' 87' ' ' ALA . 33.7 tt0 -52.02 136.31 29.39 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.86 19.61 18.91 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.65 0.738 . . . . 0.0 110.511 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.2 mmm -78.55 87.5 4.52 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.575 ' SG ' HD11 ' A' ' 52' ' ' LEU . 9.1 p -115.89 94.09 40.07 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 165.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.47 42.25 1.2 Allowed 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.993 2.462 . . . . 0.0 113.89 -170.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.634 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 19.5 m80 -96.26 -67.0 0.87 Allowed 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.884 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -161.7 -35.62 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.009 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' N ' ' S1 ' ' A' ' 113' ' ' FES . 2.7 mp0 -99.74 100.65 11.64 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.873 0.844 . . . . 0.0 110.913 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.4 tp -92.51 0.49 9.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 122.734 1.254 . . . . 0.0 108.565 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.26 41.85 1.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.369 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.575 HD11 ' SG ' ' A' ' 45' ' ' CYS . 4.5 mp -56.66 -32.55 65.49 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.414 0.686 . . . . 0.0 111.248 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.737 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 80.7 p -72.23 -28.05 62.92 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.609 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -99.73 17.5 20.49 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 64' ' ' CYS . . . -86.68 -109.21 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 t -149.67 148.77 29.68 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.131 0.967 . . . . 0.0 111.883 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -129.89 121.11 26.02 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.109 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 44.2 mt-10 -115.4 168.13 10.26 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.35 64.48 2.47 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 120.802 -0.714 . . . . 0.0 113.128 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.09 -12.7 3.08 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 70.6 t -123.5 131.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 120.778 0.323 . . . . 0.0 110.382 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mm -111.47 135.58 50.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.0 m -128.06 129.16 46.2 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 43.1 t -63.85 -72.11 0.15 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 25.8 ttt180 161.05 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.65 1.58 . . . . 0.0 107.263 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.59 11.85 7.02 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.552 1.167 . . . . 0.0 108.668 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.83 ' HB3' ' S2 ' ' A' ' 113' ' ' FES . 8.9 m-70 -146.57 145.61 30.17 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 127.464 2.306 . . . . 0.0 107.473 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.479 ' HB3' ' H ' ' A' ' 64' ' ' CYS . 43.3 tp 58.15 82.74 0.13 Allowed 'General case' 0 C--N 1.32 -0.677 0 O-C-N 124.965 1.416 . . . . 0.0 109.68 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -74.55 -45.76 43.39 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.421 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 p -133.69 129.11 36.33 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.665 0.745 . . . . 0.0 111.275 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 74.1 t80 -135.1 138.62 43.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -103.85 112.8 25.92 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.461 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.13 -22.26 66.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.58 1.152 . . . . 0.0 111.502 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 16.79 57.31 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.954 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.1 m -148.78 -47.98 0.15 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.201 -0.587 . . . . 0.0 111.14 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.46 -3.62 34.76 Favored Glycine 0 C--O 1.211 -1.337 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.794 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -104.17 147.5 27.38 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.997 -0.707 . . . . 0.0 110.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.48 133.71 11.95 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.2 mp -82.09 -43.15 19.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 27.2 t-20 -140.31 113.02 7.34 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.032 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 96.8 Cg_endo -85.68 163.86 57.51 Favored 'Cis proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.26 -1.558 . . . . 0.0 111.468 -1.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -82.5 -11.73 58.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.128 0.966 . . . . 0.0 108.463 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.08 -26.21 25.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.212 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 73.3 m -139.47 158.17 44.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.087 0.946 . . . . 0.0 111.631 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.2 m -153.06 169.09 23.78 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 42' ' ' GLN . 51.2 mt -126.79 163.92 22.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.755 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -118.32 153.66 33.61 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.21 131.8 47.45 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.301 1.0 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.529 ' CE1' ' HB ' ' A' ' 100' ' ' VAL . 1.7 t80 -126.44 106.54 23.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.79 125.13 16.14 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.844 3.03 . . . . 0.0 113.751 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.06 145.19 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.766 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.518 ' HG3' ' CE1' ' A' ' 3' ' ' PHE . 42.1 mt-10 -127.78 134.24 49.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.317 0.647 . . . . 0.0 110.345 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.1 117.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.79 108.91 11.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.251 178.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 55.92 54.68 33.53 Favored Glycine 0 CA--C 1.5 -0.865 0 C-N-CA 121.361 -0.447 . . . . 0.0 113.026 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 72.23 -6.4 1.55 Allowed 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 125.141 1.377 . . . . 0.0 113.842 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -100.89 138.86 37.37 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -126.37 125.51 67.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 5' ' ' LYS . 3.2 m-85 -112.83 141.63 46.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.738 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 89' ' ' TYR . 27.0 m -129.8 143.23 41.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.115 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 26.7 t -116.23 129.69 56.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.578 0.228 . . . . 0.0 111.32 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 2.9 m -86.38 -15.15 41.28 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -88.6 123.58 33.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.36 23.23 8.56 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 64.1 mt -100.12 129.44 50.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.977 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -106.44 102.12 39.22 Favored Pre-proline 0 N--CA 1.426 -1.655 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.02 132.68 23.41 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.276 1.984 . . . . 0.0 110.002 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.755 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 18.6 t30 -115.08 115.68 27.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.623 -172.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 8.7 tmtt? 64.1 -53.32 0.26 Allowed 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 127.534 2.334 . . . . 0.0 111.239 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . -86.59 -156.8 0.33 Allowed 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 124.23 1.012 . . . . 0.0 109.113 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -158.8 157.67 32.06 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.497 -0.752 . . . . 0.0 111.853 -171.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.299 -1.629 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.09 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.83 ' S2 ' ' HB3' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 CA--C 1.512 -0.511 0 CA-C-O 120.824 0.345 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m -115.44 132.28 56.67 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 68.7 103.41 0.05 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.925 0.869 . . . . 0.0 111.382 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.25 143.16 37.46 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.539 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -69.41 119.28 13.43 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.506 0.722 . . . . 0.0 109.504 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -115.97 -47.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.471 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.3 p -157.57 -168.08 2.46 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-O 121.452 0.644 . . . . 0.0 112.096 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.2 p -129.56 152.36 49.17 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.402 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.48 HD13 ' O ' ' A' ' 9' ' ' LEU . 1.6 tm? -67.23 -16.2 64.15 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.46 -29.9 70.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.786 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.82 -60.35 2.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.038 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -111.56 118.17 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 122.356 1.074 . . . . 0.0 113.227 -176.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -99.15 171.83 7.76 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.237 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 34' ' ' GLU . 7.2 p -51.11 111.73 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 CA-C-O 121.567 0.699 . . . . 0.0 111.443 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.75 7.68 56.41 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.38 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -109.45 151.59 26.5 Favored 'General case' 0 C--O 1.246 0.914 0 O-C-N 122.37 -0.488 . . . . 0.0 110.219 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -150.46 137.48 19.3 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.1 mt-10 -149.66 153.48 37.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.0 t -92.87 138.15 31.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.236 0.541 . . . . 0.0 110.565 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 148.82 52.43 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 42.6 tt0 -98.22 146.0 26.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.939 0.399 . . . . 0.0 111.544 -171.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -83.26 178.72 7.95 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 m -70.57 -11.9 61.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.46 0.648 . . . . 0.0 110.592 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -91.49 -14.36 30.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.044 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.08 15.57 51.21 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.501 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.1 m -97.34 128.4 44.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.381 -0.482 . . . . 0.0 109.844 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 40.3 mt-10 -90.05 128.07 36.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.445 0.64 . . . . 0.0 111.036 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' THR . 94.3 t -117.99 141.54 36.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.53 -175.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.5 117.11 29.79 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.2 mp -100.11 112.79 33.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.59 130.55 68.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.75 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -105.52 106.91 17.63 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 t -79.36 146.49 32.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 124.451 1.1 . . . . 0.0 110.769 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.495 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 mp0 -53.94 -50.19 67.0 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.365 1.066 . . . . 0.0 111.904 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -110.4 -36.87 5.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.589 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -79.96 -28.51 39.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.482 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.78 -149.97 17.39 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.881 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -86.39 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.712 0.768 . . . . 0.0 111.652 -171.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -129.26 130.0 45.65 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.316 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.54 111.5 15.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.032 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -144.56 154.52 42.95 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.53 137.06 19.97 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.644 0.59 . . . . 0.0 109.652 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.87 -54.03 9.85 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -88.27 160.94 17.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.777 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' A' ' 64' ' ' CYS . 13.5 p -89.62 86.44 0.17 Allowed Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 45' ' ' CYS . 19.9 Cg_exo -1.44 42.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.95 1 C-N-CA 128.156 5.904 . . . . 0.0 119.476 -162.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -149.71 129.93 13.67 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 68.31 123.7 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 114.796 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -85.77 103.27 14.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.304 176.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tp -153.07 154.68 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.36 80.51 4.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.198 0.999 . . . . 0.0 110.233 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -73.22 -19.17 61.14 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.679 -176.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 30.5 p -56.31 -19.72 15.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -84.42 -9.67 58.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.378 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.13 75.41 0.28 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.1 m -130.76 -73.29 0.55 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.311 0.577 . . . . 0.0 110.841 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.569 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 64.8 t80 -91.26 112.74 24.78 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.332 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -118.89 104.05 10.17 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.21 -73.11 0.41 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-O 121.28 0.378 . . . . 0.0 112.643 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.73 12.3 0.46 Allowed Glycine 0 C--N 1.301 -1.4 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.66 134.48 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 40.0 mm -100.15 139.41 21.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 m -83.56 115.08 21.95 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 111.72 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.686 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 5.6 t -81.02 119.33 23.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.424 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -60.57 -60.24 4.12 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.94 -39.05 4.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 10.6 m80 -58.09 -45.6 86.92 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -157.56 -95.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.425 ' CD1' HG23 ' A' ' 70' ' ' THR . 18.4 p90 172.96 -16.46 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 124.387 1.075 . . . . 0.0 110.376 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 69' ' ' TRP . 35.1 p -101.78 128.82 47.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.158 0.504 . . . . 0.0 111.802 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.634 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 43.7 t80 -137.5 138.98 40.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 171.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.02 111.15 22.15 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.05 -33.38 63.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 111.713 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.73 88.69 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -94.99 -28.48 15.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.309 0.576 . . . . 0.0 109.612 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.72 18.83 64.9 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -136.54 137.6 40.42 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.82 137.73 20.48 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.398 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.84 -44.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -154.04 109.2 2.48 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.1 148.85 91.95 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.167 -1.597 . . . . 0.0 113.213 3.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 14.2 t70 -86.2 -24.69 26.0 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.869 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.91 -37.83 86.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.419 ' SG ' ' S2 ' ' A' ' 113' ' ' FES . 70.0 m -94.72 151.32 19.37 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 123.077 1.418 . . . . 0.0 112.715 -177.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.73 140.04 20.4 Favored 'General case' 0 C--N 1.262 -3.232 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.681 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.634 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 7.6 mp -110.97 100.98 9.58 Favored 'General case' 0 C--N 1.259 -3.368 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.617 -175.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.26 127.73 33.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.604 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.2 160.77 25.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 124.003 0.814 . . . . 0.0 110.014 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.12 148.41 43.56 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 105' ' ' ILE . 26.6 Cg_exo -62.94 121.16 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.017 1.812 . . . . 0.0 109.248 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.11 133.67 68.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.426 0.632 . . . . 0.0 111.765 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 47.3 mt-10 -122.76 135.05 54.44 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.15 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.98 120.82 63.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.115 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -121.66 91.33 3.49 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.93 -99.19 0.18 Allowed Glycine 0 N--CA 1.437 -1.271 0 O-C-N 123.793 0.683 . . . . 0.0 113.869 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -90.55 -18.55 25.05 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.828 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -110.91 147.47 34.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 12' ' ' ILE . 78.6 mt -127.32 129.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.577 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -119.22 136.9 53.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.68 137.53 55.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -97.35 114.69 26.52 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.012 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.5 m -100.27 -40.53 7.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -53.86 111.0 0.66 Allowed 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.686 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.82 -25.28 9.64 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.343 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.426 ' CD1' ' HD3' ' A' ' 90' ' ' PRO . 67.3 mt -103.73 133.16 48.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 120.939 0.4 . . . . 0.0 110.119 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.89 124.05 55.71 Favored Pre-proline 0 N--CA 1.403 -2.799 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.464 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 149.29 85.78 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 121.865 1.71 . . . . 0.0 108.712 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -91.49 113.54 25.83 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm 49.66 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 124.71 1.256 . . . . 0.0 110.241 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 44.99 -156.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.856 1.662 . . . . 0.0 111.299 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.5 t60 69.22 116.33 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.759 0.823 . . . . 0.0 110.3 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 C--O 1.246 0.871 0 C-N-CA 124.036 0.934 . . . . 0.0 111.266 -174.898 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.419 ' S2 ' ' SG ' ' A' ' 84' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.6 ttm . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 121.204 0.526 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 39.9 t -148.7 -145.93 0.18 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 81.0 m-85 -80.15 97.9 7.08 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.157 0.503 . . . . 0.0 109.701 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -106.23 143.75 33.91 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -75.0 124.05 26.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -83.18 -54.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.8 m -171.98 -173.79 1.19 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 126.001 1.72 . . . . 0.0 108.052 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.702 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 15.5 p -101.11 151.47 21.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 96' ' ' ASP . 53.1 tp -60.13 -17.85 43.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.257 1.027 . . . . 0.0 108.971 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.86 -25.74 68.3 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.164 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -93.11 -43.8 8.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.303 0.573 . . . . 0.0 109.824 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 tp -100.28 117.21 45.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.984 0.897 . . . . 0.0 111.868 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -105.86 168.97 8.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.298 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.58 123.68 26.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.143 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.72 65.29 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -104.01 162.13 13.4 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.04 0.447 . . . . 0.0 110.377 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 53' ' ' SER . 26.7 ptt? -150.15 136.84 19.16 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.642 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.3 tp10 -147.39 152.93 38.97 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.622 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.571 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 97.2 m -97.33 129.19 44.63 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.85 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -139.74 157.97 44.87 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.5 tt0 -108.01 143.78 36.23 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.159 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 p -83.07 168.61 16.75 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -68.18 -18.62 64.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.442 0.639 . . . . 0.0 109.664 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.44 -13.33 52.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.84 14.26 37.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.201 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 m -97.37 126.39 42.58 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 35.6 tt0 -89.2 123.69 33.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.405 HG11 ' HB1' ' A' ' 40' ' ' ALA . 58.9 t -127.47 146.01 33.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.7 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.53 111.92 24.42 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.4 mp -95.95 119.22 43.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 17' ' ' MET . 7.6 p -110.08 123.82 66.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -114.51 104.15 11.74 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.376 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 36' ' ' HIS . 58.9 p -102.32 148.77 25.06 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.13 -37.96 66.46 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.315 0.578 . . . . 0.0 110.27 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -86.13 -30.2 22.7 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.811 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.452 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 12.0 m170 -106.84 -23.58 12.34 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.82 -170.96 17.56 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.448 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -98.25 121.45 48.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.495 0.664 . . . . 0.0 111.459 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -117.77 148.15 42.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.195 177.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -124.18 113.19 17.99 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -131.72 163.6 27.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -50.71 138.14 18.82 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.707 0.63 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.09 8.74 32.38 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.2 tpt -75.57 88.4 2.7 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.217 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' A' ' 48' ' ' GLN . 44.8 t -159.25 85.57 2.25 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.918 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.62 5.62 6.28 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.315 2.01 . . . . 0.0 108.947 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.457 ' HE1' ' HB3' ' A' ' 67' ' ' HIS . 17.9 t-160 -86.51 -18.91 30.38 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.74 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.719 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 53.6 tt0 -69.24 147.06 51.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.421 -1.263 . . . . 0.0 113.383 -171.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.16 100.05 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.046 1.738 . . . . 0.0 112.953 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mm 63.75 -79.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 125.049 1.339 . . . . 0.0 114.017 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -118.65 119.99 36.12 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -174.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.9 pt? -63.93 -49.08 74.0 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.642 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 77.4 p -73.74 -31.34 63.31 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.499 0.666 . . . . 0.0 112.446 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' H ' HD12 ' A' ' 51' ' ' LEU . 43.4 mt-10 -95.11 22.06 7.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.78 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.0 -95.41 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.655 0.597 . . . . 0.0 113.373 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.7 m -155.53 127.5 7.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.899 0.857 . . . . 0.0 111.903 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -130.44 120.62 24.47 Favored 'General case' 0 C--N 1.261 -3.273 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.707 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 45.9 mt-10 -110.21 168.17 9.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -37.01 -58.45 1.22 Allowed Glycine 0 N--CA 1.48 1.575 0 O-C-N 124.236 0.96 . . . . 0.0 114.782 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.26 24.59 4.7 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.771 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 64.5 t -124.15 122.07 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 120.944 0.402 . . . . 0.0 110.484 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.658 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 47.8 mm -95.72 138.08 22.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 m -127.22 115.69 19.45 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.18 -1.408 . . . . 0.0 111.112 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.417 ' HB3' HD12 ' A' ' 68' ' ' LEU . 4.1 t -64.86 -21.78 66.87 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.542 ' H ' HD11 ' A' ' 68' ' ' LEU 0.343 71.6 ttt180 46.39 80.95 0.04 OUTLIER 'General case' 0 C--O 1.248 1.009 0 C-N-CA 129.505 3.122 . . . . 0.0 117.792 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.677 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . . . 174.02 -45.4 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 125.352 1.657 . . . . 0.0 109.464 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' HB3' ' HE1' ' A' ' 47' ' ' HIS . 4.7 p-80 -123.31 8.84 9.11 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -119.82 162.75 18.57 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.547 -1.261 . . . . 0.0 112.759 -177.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 75.6 t-105 -96.71 -69.45 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 p -135.01 141.96 46.32 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 121.497 0.665 . . . . 0.0 111.686 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.658 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 21.3 t80 -135.45 138.29 43.04 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -98.81 127.22 44.68 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.2 -56.59 17.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.157 0.983 . . . . 0.0 113.446 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.33 -50.43 62.42 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.202 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.2 m -81.17 -32.51 33.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.165 0.507 . . . . 0.0 110.402 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.97 71.65 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.64 ' HE1' ' OD1' ' A' ' 82' ' ' ASP . 55.2 t60 -102.65 138.61 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.543 1.137 . . . . 0.0 109.567 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.1 140.79 15.66 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.8 -48.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 48.6 t30 -149.17 112.18 3.52 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.052 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.6 Cg_exo -76.8 160.68 94.73 Favored 'Cis proline' 0 C--O 1.241 0.663 0 C-N-CA 123.127 -1.614 . . . . 0.0 111.817 -0.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' HE1' ' A' ' 77' ' ' HIS . 17.4 t70 -72.38 -40.88 66.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.742 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -89.44 26.28 1.73 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.194 0.521 . . . . 0.0 111.719 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 71' ' ' PHE . 18.5 t -101.27 6.22 42.79 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.581 0.705 . . . . 0.0 109.428 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 38.0 m -51.53 155.91 1.43 Allowed 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.127 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 pp -101.53 -177.86 3.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.27 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.58 113.55 15.59 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.5 120.33 32.87 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.638 0.733 . . . . 0.0 110.904 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -91.61 129.65 41.92 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.21 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.49 120.89 8.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.693 2.929 . . . . 0.0 112.04 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.01 131.74 56.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.233 0.54 . . . . 0.0 111.114 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -109.38 110.56 21.74 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.2 115.81 50.72 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.49 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -126.01 147.02 49.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -38.91 124.45 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.602 0.564 . . . . 0.0 113.628 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.702 ' O ' ' HB2' ' A' ' 8' ' ' SER . 19.5 m-20 78.92 -19.53 0.44 Allowed 'General case' 0 C--O 1.2 -1.535 0 C-N-CA 126.281 1.832 . . . . 0.0 114.928 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 34.4 t70 -145.77 143.64 29.82 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.673 1.579 . . . . 0.0 114.266 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.94 127.15 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.38 151.3 38.72 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.364 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.87 144.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 121.388 0.613 . . . . 0.0 111.627 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 37.3 t -95.28 124.85 39.54 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.094 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -111.07 15.41 21.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 63.8 tttp -66.35 110.18 2.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.789 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.53 7.11 78.5 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.256 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.04 108.8 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.22 155.66 38.63 Favored Pre-proline 0 N--CA 1.411 -2.412 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 138.19 53.63 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.918 1.745 . . . . 0.0 109.632 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.12 169.8 17.62 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -52.65 -23.1 5.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.061 1.344 . . . . 0.0 113.782 -171.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.0 -16.21 63.18 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.96 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -64.31 97.98 0.21 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.731 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 124.052 0.941 . . . . 0.0 110.577 177.122 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.677 ' S1 ' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 119.723 -0.179 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 24.6 m 60.63 -87.95 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.825 0.85 . . . . 0.0 111.929 -176.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 77.1 m-85 -95.65 107.54 19.75 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -114.12 150.31 34.29 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.04 117.72 9.48 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 tp -111.33 -39.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.945 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.5 m -147.94 172.26 14.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.363 0.601 . . . . 0.0 110.717 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 27.2 m -118.86 152.38 36.36 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 170.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.57 -17.15 12.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.524 0.678 . . . . 0.0 112.398 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.69 -22.15 54.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.92 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.54 -35.73 24.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.888 0.852 . . . . 0.0 109.305 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 30' ' ' ILE . 3.2 tp -125.07 113.95 38.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.165 -173.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -104.28 168.39 9.13 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.829 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 122.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.308 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.88 65.36 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -103.84 159.91 15.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 121.405 0.621 . . . . 0.0 112.07 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 26.8 ptt? -151.35 140.89 21.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.07 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 43.8 tt0 -154.53 155.04 34.1 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.831 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 85.1 m -90.39 132.01 35.84 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.634 0.731 . . . . 0.0 110.677 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -128.37 153.49 47.0 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.11 137.44 45.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.565 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 p -83.89 -178.33 6.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.611 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -70.24 -30.75 67.88 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.69 -13.01 57.15 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.46 20.28 13.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.222 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.9 m -87.14 123.67 32.43 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.57 123.01 33.88 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.9 t -133.09 146.0 33.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 120.778 0.323 . . . . 0.0 110.269 -174.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD23 ' CE1' ' A' ' 41' ' ' TYR . 66.3 tp -96.17 114.81 26.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.1 mp -96.53 116.76 39.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 17' ' ' MET . 43.5 t -112.84 128.64 69.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 42.4 t30 -110.91 107.14 16.5 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -96.62 149.39 21.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.856 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -50.3 49.55 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -89.1 -37.57 14.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.898 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -94.35 1.42 55.88 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 -161.51 54.24 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.704 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 22.2 t -89.22 122.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -122.31 136.44 54.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.37 127.31 47.39 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.438 ' CE1' HD23 ' A' ' 29' ' ' LEU . 40.3 p90 -143.68 163.7 32.53 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.393 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 111' ' ' HIS . 6.1 tp-100 -44.3 137.38 3.58 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.897 0.748 . . . . 0.0 110.101 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.78 -36.03 7.17 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.563 ' HB3' ' H ' ' A' ' 112' ' ' SER . 0.6 OUTLIER -86.32 121.54 29.04 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.931 -0.707 . . . . 0.0 112.309 -177.249 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.3 t -97.11 118.66 64.5 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HG3' ' HA ' ' A' ' 110' ' ' ALA . 41.7 Cg_endo -90.78 10.55 2.84 Favored 'Trans proline' 0 CA--C 1.502 -1.114 0 C-N-CA 123.129 2.553 . . . . 0.0 111.151 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.657 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 11.3 t-160 -72.02 -56.06 6.3 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -140.95 -63.89 0.46 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -125.6 157.86 36.11 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.411 HG13 ' CD2' ' A' ' 51' ' ' LEU . 38.1 pt -108.42 -161.57 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.039 0.936 . . . . 0.0 109.336 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.411 ' CD2' HG13 ' A' ' 50' ' ' ILE . 4.3 mm? 74.6 29.01 1.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.884 0.85 . . . . 0.0 110.587 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 64' ' ' CYS . 53.8 tp -59.08 -29.69 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.478 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.499 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 51.0 p -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.279 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -109.95 22.47 15.59 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.89 -129.38 1.37 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 t -137.26 151.99 49.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.148 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -129.87 129.25 43.7 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.87 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.48 169.48 9.13 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.25 -46.62 5.43 Favored Glycine 0 N--CA 1.476 1.305 0 O-C-N 123.964 0.79 . . . . 0.0 114.239 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.58 14.95 3.4 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.786 -1.197 . . . . 0.0 113.073 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.93 140.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.6 ' HB ' ' CB ' ' A' ' 71' ' ' PHE . 29.3 mm -112.27 140.34 32.47 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.639 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 68' ' ' LEU . 49.9 m -100.47 117.55 34.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.823 -0.548 . . . . 0.0 110.674 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.497 ' HA ' HD13 ' A' ' 52' ' ' LEU . 43.0 t -66.25 135.72 54.85 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -49.82 107.0 0.13 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.082 0.553 . . . . 0.0 111.917 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.26 13.94 9.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.472 1.109 . . . . 0.0 113.177 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -129.53 98.12 4.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.628 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 69' ' ' TRP . 4.4 mm? 64.95 -170.34 0.19 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.422 ' H ' ' HB3' ' A' ' 68' ' ' LEU . 50.4 p-90 -128.66 11.61 6.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.645 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -120.05 130.8 54.86 Favored 'General case' 0 C--O 1.167 -3.271 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.6 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 45.4 t80 -139.74 159.43 42.19 Favored 'General case' 0 CA--C 1.469 -2.142 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 166.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.48 ' CB ' ' HA3' ' A' ' 78' ' ' GLY . 51.0 t30 -115.73 99.08 7.05 Favored 'General case' 0 N--CA 1.391 -3.398 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.024 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.46 -60.16 3.45 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.775 -173.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.48 32.71 4.62 Favored Glycine 0 C--N 1.304 -1.213 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.777 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.479 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 26.0 m -151.4 -38.62 0.12 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.282 0.541 . . . . 0.0 111.318 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.76 -55.84 0.52 Allowed Glycine 0 C--O 1.223 -0.575 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.829 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 85' ' ' CYS . 16.2 p80 -85.1 135.24 34.07 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 72' ' ' ASN . . . 157.14 38.0 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.385 0 N-CA-C 119.815 2.686 . . . . 0.0 119.815 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.731 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 mp -107.11 -56.11 5.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 116.901 -1.92 . . . . 0.0 111.775 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 24.6 t-20 159.34 105.49 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.389 1.476 . . . . 0.0 107.909 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 5.7 Cg_exo -78.83 -170.86 9.15 Favored 'Cis proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.812 -1.745 . . . . 0.0 110.909 1.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 7.0 m-20 -61.15 -18.17 56.69 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.72 -32.8 70.87 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.062 1.345 . . . . 0.0 113.121 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.731 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 17.9 p -81.74 133.12 35.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.124 -1.031 . . . . 0.0 112.311 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 77' ' ' HIS . 12.9 p -142.02 170.1 16.35 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.603 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -146.13 125.83 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.576 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.73 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -60.25 129.0 39.5 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -96.26 131.17 43.03 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.789 0.681 . . . . 0.0 109.556 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 101' ' ' SER . 47.4 m-85 -116.08 138.56 24.24 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -59.97 135.12 60.86 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 C-N-CA 123.15 2.566 . . . . 0.0 112.037 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.87 130.78 74.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -109.92 112.7 24.89 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.88 106.73 21.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 122.07 0.938 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -129.64 117.32 20.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.342 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.16 -115.14 7.63 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.302 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 8' ' ' SER . 7.1 m-20 -95.76 -10.78 28.23 Favored 'General case' 0 C--O 1.195 -1.791 0 O-C-N 123.64 0.259 . . . . 0.0 110.784 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -104.21 138.66 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.2 mt -124.74 115.33 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.463 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-85 -109.52 145.08 36.89 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.881 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 60.2 t -134.11 145.56 32.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 32.8 t -87.86 113.69 23.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 t -126.2 -11.34 6.41 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.203 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' SER . 59.1 tttp -122.87 126.42 47.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.38 -39.86 2.46 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.2 mt -102.07 106.21 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 5.5 tt -85.79 130.42 50.78 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 7.1 Cg_exo -42.08 128.78 4.27 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 124.056 3.17 . . . . 0.0 112.02 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.73 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -94.22 116.69 29.12 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.983 0.421 . . . . 0.0 111.04 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.549 ' HD3' ' SG ' ' A' ' 85' ' ' CYS . 89.0 tttt 57.0 -169.16 0.1 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.282 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.53 ' H ' ' HG2' ' A' ' 109' ' ' LYS . . . 65.4 -167.53 0.22 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.413 ' HB2' ' NE2' ' A' ' 42' ' ' GLN . 51.0 t-80 74.12 116.09 0.06 Allowed 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 126.185 1.794 . . . . 0.0 111.345 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.563 ' H ' ' HB3' ' A' ' 44' ' ' MET . 15.8 t . . . . . 0 C--N 1.3 -1.557 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.657 ' S1 ' ' HB3' ' A' ' 47' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ptp . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 121.31 0.576 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 101' ' ' SER . 57.5 m -159.13 -60.49 0.07 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -88.56 131.77 34.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.007 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.67 149.17 38.52 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 6.7 ttpm? -68.7 127.1 31.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 7.6 tp -83.75 -50.31 15.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' N ' HG23 ' A' ' 6' ' ' ILE . 95.7 m -164.64 -175.24 3.74 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 125.094 1.357 . . . . 0.0 108.416 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 6.9 m -111.16 154.98 23.58 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.07 -16.41 7.31 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.429 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 5.1 p-10 -79.99 -20.2 46.02 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.657 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.05 -54.56 4.76 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 98' ' ' ILE . 4.0 tp -108.05 110.54 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.071 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB2' ' CG ' ' A' ' 16' ' ' GLU . 20.8 m95 -86.37 163.03 17.88 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.227 -1.352 . . . . 0.0 111.163 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.65 121.88 26.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.235 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.5 59.81 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 13' ' ' TRP . 24.4 mm-40 -107.66 162.42 13.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.937 0.399 . . . . 0.0 110.964 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.658 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 26.1 ptt? -144.3 135.57 25.49 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.179 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 53' ' ' SER 0.319 10.1 pt-20 -157.18 155.12 30.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 71.9 m -83.52 127.05 33.42 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.681 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 76.6 m-85 -126.81 150.5 49.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' CD ' ' H ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -97.55 143.81 27.87 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.534 0.683 . . . . 0.0 111.457 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -83.55 176.98 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.518 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -74.39 -8.78 57.42 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.2 0.524 . . . . 0.0 111.241 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.9 -6.16 51.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.405 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.81 17.67 57.7 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.019 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 m -94.47 127.32 40.3 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.24 124.29 34.25 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.652 0.739 . . . . 0.0 110.602 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' THR . 48.7 t -125.42 146.5 31.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.93 -175.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 65.4 tp -89.35 111.21 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.81 114.21 31.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.78 123.72 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.9 t30 -106.46 104.7 14.45 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.592 ' CB ' ' HB3' ' A' ' 36' ' ' HIS . 19.6 m -100.33 157.34 16.69 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.1 -51.41 13.54 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -108.55 -25.21 11.02 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.954 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.592 ' HB3' ' CB ' ' A' ' 33' ' ' SER . 43.6 t-80 -79.17 -7.61 58.35 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.785 0.803 . . . . 0.0 109.166 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.73 173.19 17.77 Favored Glycine 0 CA--C 1.5 -0.86 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.591 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.1 p -84.64 117.58 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.27 176.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -130.07 149.14 51.92 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.319 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -123.71 132.35 53.81 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.6 154.84 51.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.583 ' NE2' ' HB3' ' A' ' 107' ' ' PRO . 15.7 mm100 -53.98 137.02 40.41 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.567 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -101.13 -11.35 19.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.873 0.844 . . . . 0.0 109.739 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.9 mmt -93.98 108.77 20.55 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.054 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 110' ' ' ALA . 24.0 p -105.79 172.57 3.86 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.811 ' HD2' ' S2 ' ' A' ' 113' ' ' FES . 73.2 Cg_endo -76.15 21.78 0.52 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 121.89 1.727 . . . . 0.0 111.605 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 32.0 m80 -144.45 135.35 25.04 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 125.336 1.454 . . . . 0.0 107.649 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 60.11 -172.11 0.13 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.512 0.672 . . . . 0.0 112.394 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.66 -48.88 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.3 pt -94.66 178.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp 79.67 -25.88 0.18 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.463 1.105 . . . . 0.0 112.368 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 43' ' ' ALA . 4.0 mm? -56.8 -40.89 76.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.535 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 90.5 p -80.31 -15.6 56.53 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.369 0.604 . . . . 0.0 110.888 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -92.0 -9.13 44.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.949 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 126.65 0.89 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.589 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.7 t 178.28 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.658 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 66.3 t80 -91.85 113.11 25.29 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.109 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -115.91 105.34 12.56 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.452 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 -69.24 1.69 Allowed Glycine 0 C--O 1.241 0.567 0 O-C-N 123.215 0.322 . . . . 0.0 112.313 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.68 26.39 0.16 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.62 133.8 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 42.9 mm -96.51 117.16 40.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.003 0.906 . . . . 0.0 109.525 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.7 m -102.0 121.33 41.95 Favored 'General case' 0 C--N 1.259 -3.333 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.194 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.976 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 1.2 m -75.24 -177.02 3.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.374 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 2.8 mmp_? -119.33 -42.44 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.165 -1.014 . . . . 0.0 113.153 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -98.17 -20.57 17.21 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.606 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -116.51 137.33 52.26 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 117.969 -1.493 . . . . 0.0 109.314 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 68' ' ' LEU . 2.9 tm? -63.26 -36.47 83.76 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 124.28 1.032 . . . . 0.0 113.119 -170.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 13.5 m-90 -62.26 174.36 0.95 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -103.37 161.22 14.02 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.644 0.735 . . . . 0.0 112.6 -169.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.526 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 48.7 t80 -132.43 141.41 48.83 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.24 119.8 31.25 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -73.47 -22.31 60.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.48 -54.49 10.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.6 m -73.9 -34.65 64.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.844 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.8 -4.26 49.73 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.751 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -125.27 161.74 26.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 122.84 0.456 . . . . 0.0 110.381 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -77.98 144.07 28.28 Favored Glycine 0 N--CA 1.416 -2.65 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.83 -30.68 29.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 27.4 t-20 -143.61 125.83 8.53 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.356 172.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 80' ' ' ASN . 22.0 Cg_exo -67.37 -63.79 0.03 OUTLIER 'Cis proline' 0 C--N 1.354 0.824 0 C-N-CA 123.847 -1.314 . . . . 0.0 113.783 0.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 21.4 t70 164.91 -35.06 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 125.122 1.369 . . . . 0.0 109.569 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.16 -26.91 69.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.845 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.31 142.36 39.46 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 121.744 0.783 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.33 150.93 31.09 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.834 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.613 ' H ' HD23 ' A' ' 86' ' ' LEU . 1.6 pt? -114.44 141.34 47.8 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.267 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -88.12 124.05 33.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.379 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -96.74 110.85 23.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 33.9 m-85 -79.24 139.79 56.44 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.662 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.27 120.22 7.4 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.227 1.952 . . . . 0.0 109.114 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.57 HG22 HG23 ' A' ' 100' ' ' VAL . 20.9 t -132.38 140.84 46.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -136.37 150.32 48.76 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.977 0.418 . . . . 0.0 110.982 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.02 117.28 55.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.283 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -125.94 100.73 6.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.603 0.716 . . . . 0.0 110.243 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.94 -112.16 3.95 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.083 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' SER . 19.5 m-20 -102.24 -1.82 30.42 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.729 -0.235 . . . . 0.0 111.115 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 26.1 m-20 -121.82 155.85 34.47 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.84 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 12' ' ' ILE . 75.1 mt -127.58 129.04 70.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 5' ' ' LYS . 54.5 p90 -112.72 143.14 44.45 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.926 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 91' ' ' VAL . 5.9 p -132.85 143.39 39.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.806 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 2' ' ' SER . 33.5 t -91.58 113.94 26.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.0 p -109.99 -41.25 4.52 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.339 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -70.65 112.17 6.68 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.136 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.3 -27.32 7.03 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.5 mm -99.78 117.73 45.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 tt -99.27 136.38 20.48 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.583 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 50.5 Cg_exo -55.72 127.78 27.58 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.309 2.006 . . . . 0.0 111.534 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 33.9 t-20 -84.45 177.33 8.17 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.462 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -74.27 60.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 124.248 1.019 . . . . 0.0 113.354 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' CYS . . . -84.98 -20.08 31.08 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 26.9 p80 -141.65 155.74 45.69 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--N 1.287 -2.121 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.371 178.547 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.976 ' S1 ' ' HB3' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 m 55.77 91.42 0.03 OUTLIER 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -170.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 74.17 96.77 0.07 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -166.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -119.79 150.06 41.02 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.99 109.51 5.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -92.04 -40.91 12.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.853 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . 63.7 m -155.09 175.85 13.3 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.473 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 m -120.88 154.79 35.37 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.21 -25.28 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.203 0.525 . . . . 0.0 111.062 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.49 -20.61 62.84 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.258 0.551 . . . . 0.0 110.777 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 17.4 m-20 -88.51 -36.88 16.17 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.938 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 tp -130.71 116.14 33.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.158 0.98 . . . . 0.0 111.736 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -104.72 167.15 9.91 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.029 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.57 130.47 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.245 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 10.09 70.61 Favored Glycine 0 C--N 1.309 -0.942 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.61 147.68 48.34 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 120.814 0.34 . . . . 0.0 111.108 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.8 mtp -130.74 133.74 46.29 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 33.4 mt-10 -146.17 140.43 26.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.861 0.363 . . . . 0.0 111.349 172.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.1 m -73.78 132.48 42.65 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -128.4 162.22 27.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -106.18 137.06 44.78 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.413 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -83.54 171.87 12.93 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 m -67.8 -17.99 64.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.056 0.455 . . . . 0.0 111.729 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.56 4.8 51.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.8 29.36 35.29 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.597 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -98.68 136.72 38.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.386 -0.479 . . . . 0.0 110.177 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.49 124.94 34.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 41' ' ' TYR . 97.3 t -133.6 147.01 31.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -96.41 117.21 30.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -100.78 116.97 45.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.3 122.83 68.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.453 ' OD1' ' HB ' ' A' ' 38' ' ' VAL . 49.3 t30 -113.87 106.8 14.88 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.432 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -99.99 150.78 22.08 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -51.38 12.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.58 -45.86 12.13 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -79.01 -12.95 60.04 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.025 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -175.75 50.83 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.139 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' OD1' ' A' ' 32' ' ' ASN . 6.6 p -105.4 125.26 60.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.524 0.678 . . . . 0.0 111.115 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -129.92 150.98 50.96 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.595 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.07 128.44 49.33 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 2.6 m-85 -131.08 163.08 28.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.68 ' HB2' HD11 ' A' ' 86' ' ' LEU . 15.7 mm100 -53.12 138.95 30.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.19 -28.24 1.2 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 -169.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.502 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -162.28 -178.15 6.15 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -169.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 86.9 m -87.02 163.75 39.16 Favored Pre-proline 0 C--N 1.361 1.091 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 169.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 45' ' ' CYS . 49.4 Cg_endo -69.58 24.31 0.17 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.276 1.984 . . . . 0.0 113.037 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.474 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 32.2 m170 -111.96 -52.25 2.8 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.414 ' OE1' ' HG2' ' A' ' 44' ' ' MET . 19.9 tp60 63.33 108.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 167.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 55.0 mm-40 -124.5 170.74 10.59 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 165.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 pt -87.18 167.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 118.429 0.559 . . . . 0.0 111.092 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.7 mt 70.73 28.84 3.35 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.533 1.133 . . . . 0.0 111.449 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.707 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.7 pt? -75.24 -42.17 55.84 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.659 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 96.1 p -72.93 -21.97 60.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.924 0.869 . . . . 0.0 109.503 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.66 15.86 5.26 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.293 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.2 -124.93 1.93 Allowed Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.4 m -142.79 157.09 44.97 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-O 122.167 0.984 . . . . 0.0 113.009 -174.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.06 116.79 19.84 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.27 -1.787 . . . . 0.0 108.222 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -115.15 104.55 11.96 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.87 -74.87 0.46 Allowed Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.648 0.582 . . . . 0.0 111.905 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.0 0.51 0.34 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.69 143.33 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.507 HG12 ' H ' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -117.89 117.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.389 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.5 m -108.86 132.15 54.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.255 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.767 ' HB2' ' H ' ' A' ' 68' ' ' LEU . 1.7 p -85.02 -13.91 49.02 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 64.47 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.973 0.909 . . . . 0.0 112.649 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.49 27.74 8.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 109.775 -175.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.673 ' HA ' ' S1 ' ' A' ' 113' ' ' FES 0.276 96.2 m-70 84.01 97.24 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.767 ' H ' ' HB2' ' A' ' 64' ' ' CYS . 7.2 mp -149.51 -80.04 0.13 Allowed 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 127.906 2.482 . . . . 0.0 108.954 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.646 ' N ' ' HB3' ' A' ' 64' ' ' CYS . 0.9 OUTLIER -146.8 135.22 21.89 Favored 'General case' 0 CA--C 1.594 2.641 0 O-C-N 121.955 -0.466 . . . . 0.0 111.221 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -139.69 132.4 29.0 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.541 -0.725 . . . . 0.0 112.721 174.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.507 ' H ' HG12 ' A' ' 62' ' ' ILE . 75.2 t80 -138.15 150.43 46.8 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.353 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.611 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . 45.8 t-20 -105.98 100.46 10.01 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.01 -36.71 50.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.13 -3.3 60.38 Favored Glycine 0 C--N 1.311 -0.832 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.857 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.3 m -139.74 -14.55 1.07 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.089 0.944 . . . . 0.0 112.98 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.49 -59.17 4.99 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 96.3 m-70 -63.44 102.29 0.4 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 72' ' ' ASN . . . -161.06 19.06 0.2 Allowed Glycine 0 CA--C 1.469 -2.823 0 C-N-CA 119.985 -1.102 . . . . 0.0 114.284 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 86' ' ' LEU . 1.5 mp -98.77 -12.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.106 0 CA-C-N 115.126 -0.537 . . . . 0.0 111.131 -169.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.565 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 73.7 m-20 77.28 115.06 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.721 0 C-N-CA 125.293 1.437 . . . . 0.0 112.111 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 14.1 Cg_exo -71.35 -174.14 10.74 Favored 'Cis proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.039 -1.65 . . . . 0.0 112.012 -0.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 77' ' ' HIS . 9.2 p-10 -68.99 2.76 2.43 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.714 0.769 . . . . 0.0 111.248 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.55 -21.14 42.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.965 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.507 ' SG ' ' HE2' ' A' ' 109' ' ' LYS . 37.3 m -102.42 141.38 35.34 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.424 0.631 . . . . 0.0 111.507 -172.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.3 p -122.15 178.09 5.07 Favored 'General case' 0 C--N 1.273 -2.754 0 C-N-CA 125.176 1.391 . . . . 0.0 109.899 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 42' ' ' GLN . 52.1 tp -141.25 156.28 45.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.37 124.28 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.902 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.68 125.09 38.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.518 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 98.6 m-85 -100.27 132.36 22.69 Favored Pre-proline 0 C--N 1.28 -2.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.917 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.5 120.78 8.16 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.109 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.492 HG13 HG22 ' A' ' 100' ' ' VAL . 45.1 t -109.47 134.47 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.3 131.98 56.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -108.41 118.1 55.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.781 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.76 91.57 3.37 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.59 -107.3 1.33 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.77 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -101.87 -0.97 33.15 Favored 'General case' 0 C--O 1.193 -1.872 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.332 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.401 ' O ' HD13 ' A' ' 98' ' ' ILE . 25.6 m-20 -106.52 139.51 40.87 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.441 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.401 HD13 ' O ' ' A' ' 97' ' ' ASP . 38.5 mm -127.06 122.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.204 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -118.82 142.78 47.41 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.962 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 91' ' ' VAL . 39.2 t -134.31 139.14 48.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 t -95.31 114.29 26.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.518 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 24.5 p -118.52 -47.01 2.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.668 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -78.48 105.02 9.46 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.558 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.44 -35.57 1.72 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -96.19 128.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.21 133.09 72.22 Favored Pre-proline 0 N--CA 1.417 -2.076 0 CA-C-O 120.671 0.272 . . . . 0.0 111.722 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.494 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 18.4 Cg_endo -61.22 134.72 53.95 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.307 2.671 . . . . 0.0 111.135 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -104.57 123.52 47.69 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.507 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 52.0 tptt 58.88 178.87 0.07 Allowed 'General case' 0 CA--C 1.568 1.662 0 O-C-N 125.467 1.729 . . . . 0.0 111.349 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.47 ' H ' ' HG3' ' A' ' 109' ' ' LYS . . . 65.6 -78.1 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.185 1.394 . . . . 0.0 114.217 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -133.54 105.33 6.83 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 C--N 1.282 -2.344 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.659 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.673 ' S1 ' ' HA ' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -136.8 130.51 31.99 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 68.54 84.79 0.15 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.06 0.85 . . . . 0.0 109.846 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.74 144.09 40.23 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.181 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.13 119.27 20.59 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.313 0.578 . . . . 0.0 110.933 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.6 -44.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.747 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.95 -172.83 4.07 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.3 m -118.89 152.65 35.9 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.189 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -61.46 -22.06 64.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.292 0.637 . . . . 0.0 110.372 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 2.5 p-10 -77.27 -11.19 59.8 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.705 -0.622 . . . . 0.0 109.81 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -84.68 -45.04 12.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.8 pt -114.37 109.84 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 122.468 1.127 . . . . 0.0 109.777 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -75.25 170.43 16.07 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.747 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.59 115.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.173 0.511 . . . . 0.0 110.672 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.13 10.79 59.33 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.213 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.13 149.52 24.19 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -150.5 142.09 23.55 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 pt-20 -155.01 144.78 21.52 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.205 0.526 . . . . 0.0 112.291 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 90.1 m -79.96 138.85 37.17 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.588 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -129.65 162.33 28.56 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.32 134.93 54.36 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.079 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -83.15 168.46 16.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.0 m -68.0 -17.27 64.37 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.043 0.449 . . . . 0.0 110.767 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.52 -12.83 59.85 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.321 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.42 37.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.0 m -96.13 131.58 42.42 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 122.181 0.193 . . . . 0.0 111.088 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.94 124.45 36.06 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.541 0.686 . . . . 0.0 109.353 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' THR . 58.1 t -125.84 136.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 52' ' ' LEU . 1.3 tt -95.56 112.21 23.97 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 18' ' ' GLU . 9.9 tp -95.8 117.22 39.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.52 125.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -113.13 104.58 12.5 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.138 174.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -102.0 158.54 16.07 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.432 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -75.54 -50.72 14.79 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.641 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.69 -46.46 17.07 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -84.44 -11.32 56.42 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.605 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.72 -157.44 34.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.967 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.65 123.22 53.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 16.7 tppt? -128.59 145.34 51.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.39 113.94 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.555 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.462 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 22.5 m-85 -116.32 147.72 41.28 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.425 ' CG ' HD22 ' A' ' 86' ' ' LEU . 11.3 pt20 -64.36 138.71 58.57 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.99 -68.37 0.69 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.489 0.661 . . . . 0.0 111.043 -175.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.497 ' HA ' ' CE ' ' A' ' 44' ' ' MET 0.265 0.1 OUTLIER 62.73 -100.21 0.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -178.86 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.4 t 49.56 96.36 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.824 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.451 ' HD2' ' S2 ' ' A' ' 113' ' ' FES . 71.6 Cg_endo -75.58 36.96 0.48 Allowed 'Trans proline' 0 N--CA 1.48 0.69 0 C-N-CA 123.099 2.532 . . . . 0.0 112.149 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.484 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 37.2 m80 -150.39 -179.77 7.48 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 123.936 0.894 . . . . 0.0 109.578 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.7 pt20 62.78 142.33 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.523 2.329 . . . . 0.0 114.505 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.21 85.36 2.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 tp 169.83 167.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.48 138.04 36.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.928 0.394 . . . . 0.0 111.529 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.1 tt -67.07 -32.47 73.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.646 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.5 p -63.7 -14.02 48.44 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.314 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -100.68 13.27 35.36 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.702 0.763 . . . . 0.0 109.267 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.76 -109.91 0.64 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.414 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 20.8 p -155.78 146.8 22.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.407 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 87.3 t80 -125.83 116.67 21.93 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.911 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 2.4 mp0 -99.37 170.12 8.86 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.24 67.45 0.37 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 -1.51 21.56 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.5 t -124.02 136.64 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.462 HD11 ' CZ ' ' A' ' 41' ' ' TYR . 52.2 mt -119.57 129.99 74.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 53.8 m -110.5 123.66 50.34 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 52' ' ' LEU . 10.4 p -57.75 -30.6 65.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 169.24 -48.57 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.241 1.816 . . . . 0.0 107.501 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.69 -87.41 0.09 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.559 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.68 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 3.6 t-160 52.87 -85.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.161 1.384 . . . . 0.0 111.489 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.6 tp -174.16 -60.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.32 0.648 . . . . 0.0 109.47 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -99.11 -176.47 3.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.341 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 65.9 p -135.05 165.33 25.62 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.57 0.748 . . . . 0.0 111.316 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -103.22 147.75 26.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -118.22 126.12 51.54 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.997 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.71 -56.69 16.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.245 1.018 . . . . 0.0 111.243 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.49 50.02 4.27 Favored Glycine 0 CA--C 1.509 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.673 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.2 m -152.95 -44.83 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.24 -34.51 3.78 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . 21.3 t-80 -90.32 146.29 24.31 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.61 140.58 14.92 Favored Glycine 0 CA--C 1.483 -1.925 0 C-N-CA 118.705 -1.712 . . . . 0.0 112.391 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 70' ' ' THR . 2.0 mp -73.52 -31.41 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -109.97 129.4 23.97 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.632 169.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.37 -41.73 0.95 Allowed 'Cis proline' 0 CA--C 1.498 -1.283 0 C-N-CA 123.658 -1.393 . . . . 0.0 110.456 -4.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.3 t70 152.54 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.445 2.298 . . . . 0.0 107.326 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.45 -21.01 49.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.001 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.0 m -96.09 150.57 20.35 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-O 122.893 1.33 . . . . 0.0 112.721 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 77' ' ' HIS . 1.7 p -140.0 148.62 42.13 Favored 'General case' 0 C--N 1.253 -3.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 106.904 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.425 HD22 ' CG ' ' A' ' 42' ' ' GLN . 51.2 mt -112.83 175.94 5.23 Favored 'General case' 0 C--N 1.266 -3.043 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.022 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -126.36 142.99 51.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.187 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.05 118.26 35.41 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.81 148.07 39.0 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.754 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 101' ' ' SER . 11.9 Cg_exo -68.04 119.73 6.73 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.508 1.472 . . . . 0.0 111.002 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.6 p -127.95 134.84 64.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.128 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -127.32 126.51 42.7 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.497 0.665 . . . . 0.0 109.952 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.7 124.5 68.5 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.502 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.6 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.81 96.97 4.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.492 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.43 -104.87 1.52 Allowed Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.05 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 8' ' ' SER . 21.8 m-20 -109.37 4.11 22.19 Favored 'General case' 0 C--O 1.19 -2.027 0 CA-C-N 115.525 -0.337 . . . . 0.0 110.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.64 139.59 43.21 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 120.63 0.252 . . . . 0.0 111.155 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -127.1 119.64 53.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.495 0.664 . . . . 0.0 111.303 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -112.58 137.87 50.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.755 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.4 m -127.33 148.53 32.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.51 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 32.2 t -127.77 146.6 50.54 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.5 m -125.74 2.06 7.47 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -91.33 130.78 37.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.458 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.16 -45.8 1.26 Allowed Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.9 mt -108.05 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.456 HD12 ' HD2' ' A' ' 107' ' ' PRO . 33.6 tp -82.46 139.09 44.47 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.968 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD2' HD12 ' A' ' 106' ' ' LEU . 96.0 Cg_exo -50.61 128.99 25.41 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 122.547 2.165 . . . . 0.0 111.014 174.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 55.4 t-20 -86.99 143.57 27.28 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.687 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.43 -76.09 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.08 2.552 . . . . 0.0 113.768 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.86 -61.62 2.28 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.075 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 107' ' ' PRO . 46.6 t-80 61.02 92.38 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.202 0.939 . . . . 0.0 112.551 175.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.0 p . . . . . 0 C--N 1.288 -2.101 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.6 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.68 ' S1 ' ' HB2' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -57.93 -51.33 70.06 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.85 148.04 35.73 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -142.46 144.84 33.21 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -73.16 129.54 38.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.241 0.543 . . . . 0.0 110.758 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.537 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -100.43 -42.61 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.044 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' HG23 ' A' ' 6' ' ' ILE . 7.7 p -165.76 -176.69 3.97 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.22 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 14.9 m -123.57 150.42 44.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.296 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.4 tt -60.1 -24.62 64.79 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.222 1.409 . . . . 0.0 110.287 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.28 -23.49 64.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.21 -45.4 4.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.342 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 5.6 tp -100.68 110.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 122.298 1.047 . . . . 0.0 111.972 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -101.64 162.84 12.6 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.249 -1.342 . . . . 0.0 113.073 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.27 124.23 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.714 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.39 64.15 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -119.75 158.24 26.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -151.21 148.62 28.45 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.784 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.8 pt-20 -156.52 151.25 25.86 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.111 171.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -73.0 133.32 44.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.389 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.35 154.23 47.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -104.87 142.65 34.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.7 p -83.41 179.17 7.74 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -76.05 -17.65 59.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.169 0.509 . . . . 0.0 110.683 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.37 -12.49 49.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.607 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.15 21.73 19.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -95.81 120.59 36.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.02 122.61 33.82 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.153 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.8 142.6 42.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.125 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.5 tt -93.93 114.28 26.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.35 112.95 28.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.9 t -110.35 124.75 67.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.527 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -100.13 107.19 19.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -98.29 148.83 23.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.7 -36.71 65.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -111.15 -38.09 5.14 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.153 0.501 . . . . 0.0 111.082 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -81.97 -3.51 54.55 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.321 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.74 -178.67 47.95 Favored Glycine 0 CA--C 1.51 -0.281 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.671 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -78.2 129.55 37.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -129.32 141.77 51.0 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.52 115.1 20.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.765 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 47.7 p90 -143.62 157.32 44.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -50.25 138.03 17.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -106.86 -78.17 0.59 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.584 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.6 tpt 53.26 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 69.2 m 55.49 84.77 0.2 Allowed Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 121.119 0.485 . . . . 0.0 112.237 -168.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -90.87 21.13 0.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.93 1.753 . . . . 0.0 110.867 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.502 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 8.8 m80 -103.68 -78.6 0.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.05 -39.29 7.36 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 69.42 -89.42 0.03 OUTLIER 'General case' 0 C--O 1.243 0.745 0 O-C-N 124.465 1.103 . . . . 0.0 112.918 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.0 mt 58.24 -81.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 124.799 1.24 . . . . 0.0 109.212 -171.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -167.03 92.06 0.42 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 128.158 2.583 . . . . 0.0 104.306 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.488 ' HG ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -67.21 -21.82 65.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.419 0.628 . . . . 0.0 111.828 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 10.6 p -75.58 -10.67 59.64 Favored 'General case' 0 N--CA 1.414 -2.225 0 C-N-CA 124.805 1.242 . . . . 0.0 111.434 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -94.78 11.0 33.0 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.48 -128.18 1.39 Allowed Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.938 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -150.85 156.99 42.36 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.932 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -130.37 128.99 42.52 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.756 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 61' ' ' VAL . 1.8 tm-20 -115.65 158.13 23.19 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.84 -30.31 21.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.119 0.407 . . . . 0.0 114.119 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.57 -4.08 5.86 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.163 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 61.7 t -124.04 125.0 70.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-N 117.343 0.572 . . . . 0.0 110.717 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 46.6 mt -103.17 136.09 37.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 69' ' ' TRP . 99.3 m -117.51 116.02 26.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.31 144.49 57.11 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -50.98 -55.23 18.34 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.815 0.697 . . . . 0.0 109.639 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.6 91.66 2.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.274 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -167.94 -76.37 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 69' ' ' TRP . 5.2 tt -144.56 143.63 30.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.487 ' HA ' HG23 ' A' ' 63' ' ' THR . 40.8 p90 -89.82 -19.57 24.51 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -169.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.424 ' H ' HD23 ' A' ' 68' ' ' LEU . 41.2 p -103.93 126.32 50.97 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.719 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 90.7 t80 -138.71 144.73 39.67 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -99.08 104.81 16.85 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 118.466 0.575 . . . . 0.0 111.146 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.38 -39.54 94.81 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.378 0.671 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.4 94.42 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.731 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 m -80.11 -35.41 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.864 0.364 . . . . 0.0 111.32 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.61 3.61 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.539 ' CE1' ' OD1' ' A' ' 82' ' ' ASP . 52.8 t60 -92.71 132.53 36.84 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 173.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.69 146.41 22.34 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.98 -36.26 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 47.7 t30 -164.24 110.79 0.9 Allowed Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.38 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.574 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 2.5 Cg_endo -87.97 172.11 32.48 Favored 'Cis proline' 0 CA--C 1.554 1.502 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.222 1.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.539 ' OD1' ' CE1' ' A' ' 77' ' ' HIS . 7.1 m-20 -94.92 -11.39 28.73 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.29 12.92 34.87 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.987 0.898 . . . . 0.0 110.881 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.574 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 77.7 m -112.81 9.46 19.02 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.231 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 57.5 m -58.3 156.3 10.23 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.678 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 2.8 pp -117.85 169.09 9.9 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.207 -174.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB2' ' CB ' ' A' ' 108' ' ' ASN . . . -130.88 122.18 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.89 127.36 32.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.172 0.51 . . . . 0.0 112.015 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.9 143.45 26.74 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.394 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.78 127.64 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.183 1.922 . . . . 0.0 110.53 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.78 143.74 39.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.04 138.08 52.43 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 120.938 0.399 . . . . 0.0 110.551 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.38 126.25 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.287 1.041 . . . . 0.0 111.474 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -119.52 146.92 45.03 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.41 100.66 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 8' ' ' SER . 38.1 t70 84.86 -33.46 0.06 Allowed 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 126.797 2.039 . . . . 0.0 114.476 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -99.37 131.2 45.55 Favored 'General case' 0 C--N 1.282 -2.353 0 O-C-N 120.639 -1.288 . . . . 0.0 111.206 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.15 123.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.837 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -112.74 145.61 40.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.985 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.4 144.51 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.4 t -105.1 115.22 29.9 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.4 m -106.44 -33.54 7.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.428 0.633 . . . . 0.0 109.486 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 103' ' ' LYS . 1.3 tpmt? -74.02 107.98 6.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.666 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.29 -4.04 8.9 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.9 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.2 mm -119.17 140.69 42.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.44 120.79 55.29 Favored Pre-proline 0 N--CA 1.42 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.91 133.08 53.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.726 2.284 . . . . 0.0 111.996 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.425 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 51.2 t30 -89.53 176.24 6.97 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.571 -176.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.31 104.65 0.52 Allowed 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.198 0.999 . . . . 0.0 111.679 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -176.13 -38.64 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 112.278 -2.237 . . . . 0.0 105.649 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -129.32 92.87 3.44 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.308 172.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.167 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.613 ' S1 ' ' HB3' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 CA--C 1.502 -0.879 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.424 ' OG ' ' HE3' ' A' ' 103' ' ' LYS . 31.3 t -75.38 111.39 10.6 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.591 ' H ' ' HA ' ' A' ' 101' ' ' SER . 96.7 m-85 72.46 93.53 0.08 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.425 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 8.4 tp10 -106.81 138.27 43.29 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 4.1 tmmm? -80.94 105.14 11.93 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -85.94 -49.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.826 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.061 -176.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.5 m -145.65 177.58 8.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.709 0.766 . . . . 0.0 111.317 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.7 p -110.56 152.76 26.02 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.051 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.38 -20.04 58.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.014 0.911 . . . . 0.0 109.918 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.35 -20.88 58.77 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.363 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.22 -32.09 12.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.232 0.539 . . . . 0.0 110.556 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 16' ' ' GLU . 3.2 tp -124.11 111.87 30.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.921 0.867 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -105.06 163.96 12.17 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.406 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.57 124.98 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.422 0.63 . . . . 0.0 111.32 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.37 59.8 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.542 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' HB3' HD12 ' A' ' 12' ' ' ILE . 8.8 tp10 -103.76 152.16 22.18 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.508 ' HG3' ' HB2' ' A' ' 56' ' ' SER . 0.0 OUTLIER -150.75 139.1 20.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 120.883 0.373 . . . . 0.0 110.156 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.0 tt0 -158.05 155.22 28.91 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.2 t -89.16 132.61 34.75 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.027 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.34 151.7 42.22 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.05 133.78 47.59 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -83.01 178.79 7.99 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -69.11 -21.53 64.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.463 0.649 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.94 -13.36 58.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.696 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.01 23.06 33.61 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -92.85 115.6 28.26 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.99 123.75 34.16 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' CG1' ' HB1' ' A' ' 40' ' ' ALA . 46.6 t -130.64 144.53 37.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.505 ' N ' ' HB2' ' A' ' 43' ' ' ALA . 62.2 tp -88.32 111.86 22.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.09 118.65 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 17' ' ' MET . 46.5 t -119.36 125.19 74.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.849 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 46.6 t-20 -92.32 106.99 18.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.0 m -99.02 152.96 19.24 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.8 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.51 -50.28 16.15 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.07 -22.19 18.67 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -99.23 -4.27 32.38 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.128 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.89 -170.67 51.42 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.908 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 46.2 t -80.55 120.74 32.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.06 150.74 50.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.147 0.498 . . . . 0.0 110.802 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -124.74 131.69 53.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 59.8 m-85 -130.21 162.21 29.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 119.562 -0.256 . . . . 0.0 110.478 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.5 tp60 -50.18 136.31 19.73 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.505 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -118.05 -11.51 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.462 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 47.3 tpp -69.2 108.91 3.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 47' ' ' HIS . 17.4 t -108.69 107.27 59.95 Favored Pre-proline 0 N--CA 1.413 -2.29 0 CA-C-O 121.233 0.54 . . . . 0.0 111.452 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -96.87 17.08 0.65 Allowed 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.677 2.251 . . . . 0.0 109.422 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.591 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 16.5 t-160 -94.71 -38.9 10.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.44 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.65 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 20.4 tt0 178.57 110.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.28 1.832 . . . . 0.0 107.704 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -155.94 134.71 11.86 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.127 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -114.57 -63.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 162.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 68.9 mt -154.06 110.82 3.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 165.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -68.59 -25.35 64.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.918 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 47.7 p -62.57 -19.65 63.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -170.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp0 -84.88 -9.16 58.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.105 0.479 . . . . 0.0 110.818 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.57 81.07 0.27 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 63' ' ' THR . 66.9 m -143.26 -33.76 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.402 ' CZ ' ' HA2' ' A' ' 60' ' ' GLY . 69.2 t80 -129.0 113.49 15.23 Favored 'General case' 0 C--N 1.264 -3.114 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.348 -174.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -116.97 112.26 20.75 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.227 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 -73.8 1.04 Allowed Glycine 0 CA--C 1.5 -0.871 0 O-C-N 123.582 0.551 . . . . 0.0 111.938 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.402 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . -161.26 13.64 0.15 Allowed Glycine 0 C--N 1.298 -1.56 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.74 143.6 23.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 O-C-N 122.531 -0.394 . . . . 0.0 110.273 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' SER . 48.4 mm -89.92 133.41 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.634 0.73 . . . . 0.0 111.934 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' ' 56' ' ' SER . 32.4 m -128.29 152.27 48.32 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 124.327 1.051 . . . . 0.0 108.253 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.1 t -119.82 89.03 3.05 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.453 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' NE ' ' HA ' ' A' ' 65' ' ' ARG . 5.0 tpm_? 54.64 21.31 3.36 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.093 0.957 . . . . 0.0 111.001 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' H ' HG22 ' A' ' 63' ' ' THR . . . 62.8 100.18 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 111.894 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.558 ' HB3' ' S1 ' ' A' ' 113' ' ' FES 0.271 1.5 p-80 -107.69 -13.06 15.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 1.7 tm? 171.36 -63.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 28.7 t-105 -141.05 -155.57 0.6 Allowed 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 28.3 p -101.3 163.54 12.23 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -171.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -110.49 148.05 32.87 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -111.56 108.07 17.45 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 62' ' ' ILE . 5.6 p-10 -76.8 -29.79 56.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.04 73.22 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.9 m -90.52 -52.0 5.12 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.18 -42.16 1.46 Allowed Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.386 -0.912 . . . . 0.0 112.398 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -87.94 158.81 18.57 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 120.828 0.347 . . . . 0.0 110.611 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.75 157.26 52.23 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.874 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 70' ' ' THR . 69.5 mt -84.6 -51.42 13.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 117.635 0.718 . . . . 0.0 109.478 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 63.7 t30 -160.73 108.47 1.31 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.122 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 6.9 Cg_exo -75.57 -174.86 15.08 Favored 'Cis proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.539 -1.859 . . . . 0.0 110.278 -3.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.82 -43.57 58.37 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . 0.326 4.4 p30 38.76 31.53 0.04 OUTLIER 'General case' 0 C--N 1.369 1.424 0 C-N-CA 127.106 2.162 . . . . 0.0 113.828 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 64.5 m 79.13 148.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.654 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.7 p -72.9 172.68 10.43 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.224 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 pp -96.86 -171.1 2.17 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.633 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -130.18 119.24 22.64 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.27 134.02 38.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.005 0.431 . . . . 0.0 110.941 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 12.0 m-85 -102.9 145.67 31.0 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 123.616 0.766 . . . . 0.0 109.535 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.99 120.29 6.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.51 2.14 . . . . 0.0 110.413 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.01 141.0 42.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.53 137.57 53.94 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.83 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.609 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -125.22 99.13 5.94 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.37 5.47 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.674 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.19 -10.05 34.35 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.216 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -109.68 143.13 39.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 12' ' ' ILE . 59.5 mt -122.37 120.47 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.953 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 26.9 m-85 -113.58 149.47 34.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.249 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 7.4 p -135.45 138.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.591 ' HA ' ' H ' ' A' ' 3' ' ' PHE . 35.3 t -97.99 133.58 42.27 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.826 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -122.3 16.37 10.6 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.157 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HE3' ' OG ' ' A' ' 2' ' ' SER . 37.7 ttmt -58.47 -76.31 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.748 0.785 . . . . 0.0 112.839 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.42 20.79 45.39 Favored Glycine 0 C--N 1.263 -3.528 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.04 120.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.502 0.668 . . . . 0.0 111.693 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 tp -110.07 124.01 34.58 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -65.67 137.75 51.21 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -80.03 175.78 10.33 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -57.15 138.55 54.42 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . -71.26 83.35 0.75 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.601 ' NE2' ' S2 ' ' A' ' 113' ' ' FES . 81.3 m-70 56.42 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.348 -1.297 . . . . 0.0 112.913 -172.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 C--N 1.292 -1.893 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.823 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.65 ' S1 ' ' HB3' ' A' ' 48' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 p -79.34 106.05 11.1 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.327 0.584 . . . . 0.0 110.766 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 99.4 m-85 -90.81 125.47 35.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.889 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -112.72 144.98 41.32 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 37.5 ttpt -87.07 128.08 35.11 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.842 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.484 HG12 ' CD1' ' A' ' 20' ' ' PHE . 6.5 tp -115.16 -45.05 4.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.227 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.7 p -139.71 -173.47 3.64 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.573 0.701 . . . . 0.0 111.915 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -129.61 150.12 51.08 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.558 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -72.61 -22.91 60.89 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.72 -21.76 65.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.457 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.59 -49.97 5.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.193 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 12' ' ' ILE . 47.4 pt -110.85 116.88 53.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-O 122.135 0.969 . . . . 0.0 111.107 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -90.36 169.24 11.25 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.758 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.19 117.79 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.353 0.597 . . . . 0.0 110.844 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.46 62.15 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -103.1 140.47 37.28 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.281 0.632 . . . . 0.0 110.188 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.455 ' HB3' HG23 ' A' ' 31' ' ' VAL . 26.9 ptt? -151.03 156.3 40.82 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.874 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -157.5 156.58 32.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.593 0.558 . . . . 0.0 109.517 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.2 t -88.87 137.09 32.63 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 121.218 0.532 . . . . 0.0 110.051 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.484 ' CD1' HG12 ' A' ' 6' ' ' ILE . 52.4 p90 -119.94 156.41 30.86 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 22' ' ' THR . 44.7 tt0 -100.35 135.31 41.98 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 77.7 p -82.58 171.29 14.23 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -73.36 -15.49 61.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.68 0.752 . . . . 0.0 109.252 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -84.55 -12.59 53.83 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.6 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.99 36.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.827 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 84.8 m -97.08 137.43 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.142 -0.622 . . . . 0.0 111.989 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -88.85 126.55 35.41 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.499 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' THR . 60.6 t -130.25 137.7 55.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.186 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.416 HD21 ' SD ' ' A' ' 17' ' ' MET . 45.5 tp -87.28 114.65 24.08 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 10.0 tp -97.74 112.7 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 17' ' ' MET . 8.2 p -114.12 127.9 71.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.5 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.447 ' ND2' ' HG ' ' A' ' 9' ' ' LEU . 51.2 t-20 -95.45 104.15 16.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 21.5 m -102.77 150.79 23.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.197 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -76.46 -50.27 14.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.242 0.544 . . . . 0.0 110.591 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.68 -46.7 16.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.921 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 50.8 m80 -79.11 -21.19 47.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.923 0.392 . . . . 0.0 111.185 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.72 -168.68 47.88 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 45.7 t -81.49 120.02 32.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.722 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -118.63 149.33 41.56 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.602 0.761 . . . . 0.0 111.201 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.91 112.69 16.91 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.458 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 88' ' ' GLU . 49.7 m-85 -125.57 159.84 31.08 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 110' ' ' ALA . 35.4 tt0 -53.77 138.33 35.87 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.92 -12.39 59.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -167.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.445 ' HB3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.8 166.79 31.15 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.152 -1.419 . . . . 0.0 114.086 -175.054 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.708 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 18.9 m -88.79 166.52 22.06 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.07 31.41 0.52 Allowed 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 121.73 1.62 . . . . 0.0 112.723 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.674 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 14.1 m170 -120.34 -75.34 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.191 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.477 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 15.5 mm100 -93.96 -177.62 4.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 0.0 112.622 -174.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.32 163.24 28.04 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.114 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 44' ' ' MET . 29.8 mt -74.94 87.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.44 0.638 . . . . 0.0 110.438 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.434 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 85.0 mt -106.39 1.49 25.73 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.516 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.8 tt -76.23 -41.72 48.32 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.925 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -67.75 -7.39 26.92 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.48 -9.19 50.99 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.24 115.37 1.33 Allowed Glycine 0 CA--C 1.495 -1.167 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 63' ' ' THR . 72.0 m -161.41 -25.02 0.05 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.907 0.861 . . . . 0.0 110.867 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 94.5 t80 -89.05 115.53 26.66 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.181 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -116.15 104.5 11.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.681 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.91 -72.85 0.53 Allowed Glycine 0 C--N 1.316 -0.53 0 O-C-N 123.899 0.749 . . . . 0.0 113.504 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.16 17.43 1.18 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 62.9 t -123.11 132.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -98.1 129.17 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 36.3 m -106.74 151.79 24.67 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' ALA . 8.0 t -75.15 -40.31 59.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.22 172.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 63' ' ' THR . 1.1 tmt_? 75.93 -21.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.495 1.118 . . . . 0.0 110.939 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . -96.56 -23.45 16.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.927 173.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.801 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 22.3 m170 -146.88 152.46 38.74 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.305 0.642 . . . . 0.0 112.069 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.412 ' HB3' ' CG ' ' A' ' 80' ' ' ASN 0.278 2.2 tm? 36.94 -107.21 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.85 2.46 . . . . 0.0 113.602 175.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 63' ' ' THR . 94.9 m95 -163.7 -51.36 0.03 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.6 p -107.71 130.64 54.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -160.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -134.1 137.49 44.63 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -122.98 114.84 20.96 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.961 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.64 -29.67 70.28 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.11 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.91 -3.6 74.74 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.894 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.4 m -124.22 1.26 8.47 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.666 0.746 . . . . 0.0 109.66 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -49.06 1.08 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.536 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 25.8 p80 -88.84 160.91 17.01 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.219 0.533 . . . . 0.0 111.719 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.13 169.99 35.49 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.923 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.61 -31.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 3.2 p-10 -127.27 101.92 24.5 Favored Pre-proline 0 N--CA 1.42 -1.939 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.883 173.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 22.7 Cg_endo -89.62 155.23 31.62 Favored 'Cis proline' 0 C--N 1.362 1.282 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.864 -4.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.9 p-10 -74.4 -19.26 60.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.83 -22.07 24.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.248 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.523 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 65.3 m -95.82 150.91 19.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-O 121.79 0.805 . . . . 0.0 110.577 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 77' ' ' HIS . 17.6 p -142.08 167.85 21.14 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.941 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.462 HD22 ' HB3' ' A' ' 42' ' ' GLN . 81.2 mt -120.98 129.18 53.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . . . -88.87 136.51 32.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -104.42 158.52 16.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.277 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.499 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 19.1 p90 -135.39 157.73 75.95 Favored Pre-proline 0 C--N 1.273 -2.751 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.508 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 89' ' ' TYR . 37.5 Cg_endo -61.27 138.58 78.11 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 122.545 2.163 . . . . 0.0 114.03 -174.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.14 128.99 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.54 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -109.98 131.66 54.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.99 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.1 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -122.75 91.34 3.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.95 -112.11 4.68 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.573 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.26 -5.44 33.13 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.714 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -103.21 137.05 41.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -127.61 123.4 61.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 5.0 m-85 -112.01 142.08 44.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.834 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.96 154.71 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -127.9 114.6 17.39 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.345 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -108.76 -8.05 15.44 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.63 102.51 5.36 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.72 -29.28 4.99 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.6 mt -120.63 108.35 22.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.447 0.641 . . . . 0.0 110.319 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.0 pp -89.08 147.92 39.73 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 12.6 Cg_exo -69.78 140.96 43.87 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.059 1.84 . . . . 0.0 112.298 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -88.31 133.05 34.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.3 -176.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.484 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . 57.53 -82.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.255 1.422 . . . . 0.0 113.069 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -138.18 103.28 4.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.422 -1.842 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.145 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.801 ' S2 ' ' HB2' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 CA--C 1.515 -0.382 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 p -95.18 -52.92 3.99 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -171.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 69.9 m-85 73.54 108.21 0.07 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 -168.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -106.57 137.36 44.72 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -73.84 121.32 20.71 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.876 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tp -97.51 -48.52 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.357 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.7 m -159.23 -174.55 4.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.386 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -129.77 152.67 49.01 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 12' ' ' ILE . 27.5 tp -56.66 -21.22 25.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.184 1.393 . . . . 0.0 110.624 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.76 -30.97 71.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.261 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -100.18 -40.87 7.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.388 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.4 tp -104.96 115.43 46.83 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-O 121.533 0.682 . . . . 0.0 110.934 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -102.99 164.75 11.43 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.469 -172.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.67 127.57 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.491 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.64 -0.81 68.1 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.92 154.13 29.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -146.15 131.06 18.14 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.727 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 44.1 mt-10 -144.22 150.52 38.09 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 93.7 m -74.42 130.97 40.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.993 0.425 . . . . 0.0 111.124 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -140.71 149.8 42.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.25 146.88 34.87 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.642 0.258 . . . . 0.0 110.359 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -83.72 165.29 19.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.9 m -65.59 -14.03 60.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.89 -12.48 41.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.444 0.64 . . . . 0.0 110.137 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.75 23.41 13.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.902 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -97.09 127.92 43.53 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -88.07 123.28 32.6 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.09 143.75 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.378 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 60.0 tp -93.01 112.86 24.96 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' MET . 49.6 mm -94.73 112.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 17' ' ' MET . 41.9 t -112.66 124.75 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 54.0 t30 -103.83 104.93 14.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 14.0 m -83.77 143.21 30.13 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.454 -172.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -47.08 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -83.14 -44.13 15.42 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -101.88 2.92 38.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 86.73 -176.95 48.09 Favored Glycine 0 C--O 1.201 -1.937 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.931 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 9.3 p -72.39 134.65 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 118.274 1.037 . . . . 0.0 111.553 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -125.7 139.01 53.9 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.774 0.83 . . . . 0.0 110.501 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.06 115.25 20.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.415 ' OH ' HG12 ' A' ' 62' ' ' ILE . 18.6 p90 -143.27 165.11 28.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.082 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -41.19 137.4 1.37 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.756 0.66 . . . . 0.0 111.818 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 19' ' ' THR . . . -71.29 -46.77 60.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.287 0.565 . . . . 0.0 112.524 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 69.8 mtm -94.25 147.07 23.55 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.17 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.557 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 28.9 p -94.82 161.87 27.18 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.777 0.673 . . . . 0.0 111.258 -175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 57.0 Cg_endo -71.2 -4.75 15.54 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.499 2.132 . . . . 0.0 111.914 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.446 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 36.3 m80 -88.74 -96.9 0.09 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -179.3 104.59 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 117.911 0.323 . . . . 0.0 110.579 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 6.5 tp10 -171.97 145.8 1.9 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 111.375 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.8 pt -118.58 141.67 37.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 tp 65.77 24.03 11.45 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.672 1.225 . . . . 0.0 109.129 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.2 pt? -62.04 -20.54 64.06 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.141 -1.391 . . . . 0.0 111.289 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 36.0 p -56.92 -32.53 66.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 125.965 1.706 . . . . 0.0 113.832 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -100.66 23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.989 -0.445 . . . . 0.0 110.962 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.75 -83.61 0.04 OUTLIER Glycine 0 C--N 1.346 1.113 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.431 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 19.0 p -173.49 146.89 1.4 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -129.75 115.62 17.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.98 105.8 12.72 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.489 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.89 0.44 Allowed Glycine 0 N--CA 1.462 0.429 0 O-C-N 123.489 0.493 . . . . 0.0 114.206 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 73' ' ' ASP . . . -153.21 17.95 0.7 Allowed Glycine 0 C--N 1.301 -1.366 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.1 t -125.12 124.92 68.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.789 0.436 . . . . 0.0 110.05 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.415 HG12 ' OH ' ' A' ' 41' ' ' TYR . 2.0 pp -92.76 140.26 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 89.9 m -116.44 127.05 54.25 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.19 156.31 39.71 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' HD3' ' O ' ' A' ' 65' ' ' ARG . 1.8 tmt_? -73.34 -33.08 64.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.783 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.677 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . . . -83.08 -72.32 0.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.308 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.479 ' CD2' ' HB2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -82.66 110.26 17.56 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.132 175.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.08 84.83 7.57 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.356 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 86.9 m95 -144.3 -166.55 2.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 p -101.66 136.65 41.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 121.955 0.883 . . . . 0.0 112.268 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 47.4 t80 -134.06 143.19 47.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.99 111.87 19.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.348 0.594 . . . . 0.0 111.33 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 16.3 t70 -71.41 -11.81 61.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.418 1.487 . . . . 0.0 112.012 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.51 -33.76 6.06 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.717 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.6 p -107.24 -26.14 11.19 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.436 0.618 . . . . 0.0 112.638 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.87 65.32 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -106.76 146.39 30.91 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -76.64 153.25 42.17 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.517 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.95 -49.25 12.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 8.2 t30 -146.55 111.71 4.26 Favored Pre-proline 0 N--CA 1.436 -1.153 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.415 174.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 4.8 Cg_exo -78.74 141.61 64.64 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.962 -1.683 . . . . 0.0 111.004 -1.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.1 p30 -74.66 -12.48 60.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.407 0.622 . . . . 0.0 109.627 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.87 -28.53 68.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.736 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 36.9 m -92.72 152.15 19.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-O 121.563 0.696 . . . . 0.0 111.002 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.454 ' C ' HD12 ' A' ' 86' ' ' LEU . 5.9 p -163.27 156.13 18.75 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.045 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.481 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 7.3 mp -129.45 135.16 48.31 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.289 1.436 . . . . 0.0 107.868 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.9 123.92 29.85 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.726 0.411 . . . . 0.0 109.972 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -86.64 143.94 27.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.086 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 101' ' ' SER . 46.2 m-85 -102.37 143.32 26.37 Favored Pre-proline 0 N--CA 1.428 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.04 123.01 12.56 Favored 'Trans proline' 0 C--O 1.253 1.242 0 C-N-CA 122.329 2.019 . . . . 0.0 110.264 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.87 132.96 70.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -112.57 117.21 31.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.447 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.56 107.56 23.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 122.026 0.917 . . . . 0.0 109.69 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.69 118.16 23.3 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.01 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.43 -119.93 9.75 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.96 -4.45 16.71 Favored 'General case' 0 C--O 1.17 -3.086 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 94' ' ' LYS . 17.0 t70 -100.03 139.28 35.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.697 -0.627 . . . . 0.0 110.089 -170.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.2 mt -127.63 119.12 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 63.4 m-85 -102.72 146.23 28.52 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.71 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.63 137.23 54.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 20.4 t -107.35 113.26 26.52 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.446 -1.702 . . . . 0.0 109.296 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.4 p -95.96 -36.43 11.07 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.93 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -66.3 113.26 4.47 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.112 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.26 -36.14 2.78 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 105' ' ' ILE . 2.7 mp -100.89 120.82 50.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.436 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 3.5 tt -79.92 124.1 83.35 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 9.4 Cg_endo -52.96 145.58 40.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.006 2.471 . . . . 0.0 111.994 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -80.43 177.61 8.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.69 -11.89 2.5 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.468 ' CB ' ' HG ' ' A' ' 86' ' ' LEU . . . -57.37 -36.19 70.91 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.996 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -108.64 102.83 11.85 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.863 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.704 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.677 ' S1 ' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m 59.24 84.76 0.11 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.404 0.682 . . . . 0.0 109.232 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 75.0 m-85 67.22 100.25 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.464 -169.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -106.9 130.53 54.55 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.815 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -70.17 115.64 9.6 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.62 -59.59 3.06 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.194 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 11' ' ' ASP . 85.6 m -152.21 -177.29 6.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.353 -175.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 8.7 p -101.02 153.52 19.47 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.588 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.43 -17.52 21.33 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.847 0.832 . . . . 0.0 110.673 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.4 -10.84 58.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.583 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 33.2 t70 -97.7 -41.46 8.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.687 -0.633 . . . . 0.0 109.358 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 98' ' ' ILE . 2.3 tp -109.95 114.13 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.415 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -101.05 166.96 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.503 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.44 128.83 35.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.496 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.89 66.7 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -103.87 144.14 31.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.172 -0.514 . . . . 0.0 110.127 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.4 134.0 39.24 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 9.2 pt-20 -157.63 156.21 31.41 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 15.1 t -90.51 137.7 32.14 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 77.3 m-85 -126.41 155.94 41.37 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' THR . 40.9 tt0 -113.95 141.49 47.32 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -83.18 172.76 12.3 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -68.86 -20.17 64.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.131 0.491 . . . . 0.0 110.424 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.97 -12.25 55.6 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 109.526 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.95 14.82 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.109 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.5 m -92.19 124.31 36.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.77 128.97 35.64 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' THR . 40.0 t -133.03 141.2 45.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.18 116.43 28.83 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.58 122.83 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 122.327 0.251 . . . . 0.0 110.355 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.99 123.61 70.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 50.7 t30 -103.12 106.41 16.92 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.837 173.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -98.81 148.67 23.67 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.511 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.95 -48.85 77.1 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 122.957 0.503 . . . . 0.0 111.8 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.26 -40.33 8.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.95 0.405 . . . . 0.0 111.979 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -79.69 -11.42 59.85 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -167.33 42.47 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.042 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 6.7 p -99.05 118.05 45.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.535 0.683 . . . . 0.0 109.333 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -131.98 151.16 51.9 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.162 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.05 143.27 45.7 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.569 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 63.9 m-85 -133.28 157.6 45.04 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.406 ' NE2' ' HB3' ' A' ' 110' ' ' ALA . 19.8 pt20 -59.11 139.22 57.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.187 175.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.21 -7.29 58.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.336 0.589 . . . . 0.0 110.252 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -92.79 99.76 12.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.618 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' HIS . 59.0 m -76.71 158.8 80.33 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.517 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 92.8 Cg_endo -82.92 20.78 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.718 1.612 . . . . 0.0 108.883 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 36.9 m80 -120.1 -175.12 2.92 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.778 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -65.98 103.72 0.99 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.265 0.353 . . . . 0.0 111.039 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.73 156.6 22.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.633 0.73 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.647 HG13 ' H ' ' A' ' 51' ' ' LEU . 9.8 tp -179.99 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 -174.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.647 ' H ' HG13 ' A' ' 50' ' ' ILE . 2.9 mm? -78.01 91.68 4.27 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 121.118 1.781 . . . . 0.0 109.738 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.582 HD22 ' O ' ' A' ' 50' ' ' ILE . 2.0 mm? -73.36 -20.98 60.64 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.776 1.274 . . . . 0.0 108.156 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.669 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 60.0 p -63.4 -19.49 64.72 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.921 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.62 12.24 36.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.742 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 -108.41 0.03 OUTLIER Glycine 0 C--O 1.241 0.566 0 O-C-N 123.324 0.39 . . . . 0.0 113.033 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.3 t -146.14 154.07 41.39 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.915 0.864 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -128.78 114.63 16.81 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.153 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 42.4 mt-10 -118.14 169.9 9.31 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.27 74.39 0.14 Allowed Glycine 0 C--N 1.309 -0.932 0 O-C-N 123.309 0.381 . . . . 0.0 113.799 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.18 38.68 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.7 t -123.96 119.27 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 71' ' ' PHE . 42.6 mm -112.58 138.26 42.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.4 m -118.08 115.72 25.41 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -72.71 0.41 Allowed 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.887 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -149.02 -63.42 0.23 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.597 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' N ' ' S1 ' ' A' ' 113' ' ' FES . . . -144.66 139.36 27.96 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 13.5 p-80 162.32 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.931 2.092 . . . . 0.0 107.575 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.6 tp 172.59 -71.7 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.569 1.548 . . . . 0.0 108.983 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -176.92 -49.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.059 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p -103.53 136.48 43.17 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -169.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 22.5 p90 -135.16 142.7 46.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 159.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -86.84 122.87 31.32 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.322 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.25 -38.41 90.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.793 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.18 26.58 3.83 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.002 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -155.33 -51.28 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.819 0.31 . . . . 0.0 110.816 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.64 40.05 Favored Glycine 0 C--O 1.218 -0.844 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -85.75 139.16 31.57 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 108.887 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -68.53 140.34 35.02 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 176.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.0 mt -81.16 -51.65 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 50.3 t-20 -150.23 113.88 3.32 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.6 Cg_exo -81.3 179.25 28.66 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.858 -1.726 . . . . 0.0 111.412 -3.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -95.93 12.23 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.401 ' O ' ' HE3' ' A' ' 109' ' ' LYS . 34.8 t70 -67.73 -14.66 63.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.397 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.442 ' SG ' ' S2 ' ' A' ' 113' ' ' FES . 23.6 p -136.89 152.21 49.97 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.543 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 31.1 m -152.17 146.11 25.22 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 mp -102.79 153.67 19.94 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-O 120.984 0.421 . . . . 0.0 110.784 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -88.19 119.54 28.69 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.738 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.48 129.98 34.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.732 0.645 . . . . 0.0 109.537 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.11 136.25 20.12 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 101' ' ' SER . 37.3 Cg_endo -68.37 124.3 11.5 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.548 2.165 . . . . 0.0 112.304 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.86 138.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -119.58 135.82 54.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 178.415 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.426 ' C ' ' HE2' ' A' ' 94' ' ' LYS . 58.7 t -106.21 122.52 60.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -167.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.626 ' HD3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -111.36 146.35 37.28 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 173.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.71 -35.6 17.16 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 115.61 1.004 . . . . 0.0 115.61 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' SER . 25.4 t70 -113.7 -22.7 10.1 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.778 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -114.87 147.65 39.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.136 0.969 . . . . 0.0 113.422 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 12' ' ' ILE . 62.7 mt -121.71 118.16 54.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.788 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.626 ' CD1' ' HD3' ' A' ' 94' ' ' LYS . 4.5 m-85 -112.2 144.11 42.14 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.96 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.78 141.31 39.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 21.4 t -104.15 128.17 51.8 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.518 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.2 p -120.56 5.55 10.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -74.99 118.39 17.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.734 -174.86 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.03 16.09 79.64 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.142 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.26 119.51 57.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.255 0.55 . . . . 0.0 110.957 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.88 142.68 36.82 Favored Pre-proline 0 N--CA 1.411 -2.387 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.363 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.38 150.08 88.93 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.468 2.112 . . . . 0.0 111.166 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.638 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 34.9 t-20 -81.41 -179.77 7.51 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 83' ' ' ASP . 39.2 ttpt -62.42 93.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.41 1.1 . . . . 0.0 111.521 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . . . 174.44 -149.46 0.01 OUTLIER 'General case' 0 C--N 1.267 -3.019 0 C-N-CA 128.274 2.63 . . . . 0.0 104.471 -174.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 51.66 88.15 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.898 0.772 . . . . 0.0 112.32 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.517 ' OG ' ' HA ' ' A' ' 46' ' ' PRO . 24.7 p . . . . . 0 C--N 1.298 -1.67 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.676 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.483 ' S1 ' ' N ' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 120.631 0.253 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -80.06 85.17 5.67 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.126 0.489 . . . . 0.0 109.95 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -156.95 97.81 1.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 125.979 1.712 . . . . 0.0 107.252 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.87 133.47 52.18 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.41 127.39 32.11 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.22 -40.94 5.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.721 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.9 p -160.34 -170.88 2.96 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.768 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 7.2 m -120.15 153.07 36.74 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.348 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -61.58 -21.4 64.28 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.846 0.831 . . . . 0.0 108.924 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.86 -29.63 69.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.266 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.96 -47.55 65.35 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.607 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.83 112.27 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.734 1.254 . . . . 0.0 113.529 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -79.16 170.54 16.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.786 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.34 118.79 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 CA-C-O 121.602 0.715 . . . . 0.0 110.451 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.97 56.9 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.682 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -103.22 150.45 23.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.563 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.8 ptt? -150.12 137.92 20.06 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 34.7 mt-10 -144.2 155.11 43.75 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 m -91.42 123.97 35.25 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.01 154.32 34.72 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -113.54 137.35 51.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -83.0 173.3 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 m -71.94 -9.35 58.23 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.159 0.505 . . . . 0.0 111.669 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.74 -4.74 46.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.36 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.17 44.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.628 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.9 m -89.86 114.79 26.61 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -91.58 123.83 35.28 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' A' ' 40' ' ' ALA . 58.7 t -136.49 142.49 38.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.027 -172.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 32.9 tp -83.61 117.62 23.28 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -107.87 113.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.87 137.31 43.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.711 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -109.97 107.8 17.82 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.3 t -99.2 148.51 24.03 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.031 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -74.99 -36.16 62.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.24 -46.75 6.62 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.793 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -88.51 -7.01 57.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.73 -164.9 52.22 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.202 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.8 t -82.82 128.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -127.9 141.52 51.53 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.483 0.713 . . . . 0.0 111.197 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -125.07 121.26 33.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.913 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.434 ' CD1' HD22 ' A' ' 86' ' ' LEU . 53.6 m-85 -133.04 152.1 51.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -48.96 138.06 12.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.615 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -141.17 19.12 2.26 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -172.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 86.3 mtp -68.97 -30.56 69.01 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.811 ' SG ' ' N ' ' A' ' 65' ' ' ARG . 3.5 t -76.48 124.09 87.88 Favored Pre-proline 0 CA--C 1.619 3.603 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.711 ' C ' ' HA ' ' A' ' 65' ' ' ARG . 12.6 Cg_endo -108.71 104.83 0.02 OUTLIER 'Trans proline' 2 C--N 1.421 4.375 0 C-N-CA 123.922 3.081 . . . . 0.0 113.145 163.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.938 ' CE1' ' H ' ' A' ' 67' ' ' HIS . 6.4 t60 -81.26 -25.8 36.3 Favored 'General case' 0 N--CA 1.523 3.212 0 O-C-N 121.363 -0.835 . . . . 0.0 109.882 -173.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -105.32 111.94 24.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.306 10.9 pt-20 -74.14 83.46 1.82 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.791 1.282 . . . . 0.0 114.256 -174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.618 HG12 ' H ' ' A' ' 51' ' ' LEU . 15.1 tt -152.74 -159.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 102.388 -3.189 . . . . 0.0 102.388 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.618 ' H ' HG12 ' A' ' 50' ' ' ILE . 84.9 mt -64.06 122.55 16.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 120.752 1.615 . . . . 0.0 109.301 175.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 43' ' ' ALA . 1.4 pt? -56.0 -44.76 78.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.409 1.084 . . . . 0.0 113.713 -172.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.588 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 38.2 p -63.54 -24.26 67.73 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.422 0.689 . . . . 0.0 112.516 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -84.31 3.16 36.89 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -139.85 36.64 1.8 Allowed Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.737 -1.22 . . . . 0.0 113.066 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.456 ' H ' ' HE1' ' A' ' 17' ' ' MET . 19.3 m -107.14 -80.39 0.57 Allowed 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.351 0.596 . . . . 0.0 111.425 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 80.7 t80 -90.39 112.73 24.44 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-O 121.84 0.829 . . . . 0.0 110.684 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.51 105.41 11.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.524 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.08 -77.28 0.56 Allowed Glycine 0 N--CA 1.45 -0.395 0 O-C-N 123.384 0.427 . . . . 0.0 112.424 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.22 6.56 0.82 Allowed Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.66 135.16 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 69.1 mt -105.68 129.95 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 121.347 0.594 . . . . 0.0 109.763 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 9.1 m -111.2 152.5 27.01 Favored 'General case' 0 N--CA 1.38 -3.951 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 1.555 ' CA ' ' CB ' ' A' ' 64' ' ' CYS 0.473 15.0 p -118.32 -112.49 0.34 Allowed 'General case' 2 CA--C 1.789 10.154 0 C-N-CA 128.179 2.591 . . . . 0.0 106.829 179.1 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.836 ' HA ' ' N ' ' A' ' 47' ' ' HIS . 37.2 ttm105 -122.29 -161.89 0.96 Allowed 'General case' 3 N--CA 1.652 9.667 1 C-N-CA 137.532 6.333 . . . . 0.0 107.513 170.359 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.748 ' H ' ' HG2' ' A' ' 65' ' ' ARG . . . -55.95 100.38 0.04 OUTLIER 'General case' 2 N--CA 1.557 4.891 1 N-CA-C 122.168 4.136 . . . . 0.0 122.168 -166.922 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.938 ' H ' ' CE1' ' A' ' 47' ' ' HIS 0.373 53.7 m80 -96.1 -170.47 2.12 Favored 'General case' 1 N--CA 1.543 4.186 0 C-N-CA 129.863 3.265 . . . . 0.0 106.597 170.21 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -145.06 8.94 1.25 Allowed 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.735 ' H ' ' HB3' ' A' ' 67' ' ' HIS . 28.8 m-90 -146.32 -159.96 1.09 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.7 2.0 . . . . 0.0 107.822 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -124.26 161.98 24.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.706 ' HB2' ' HE2' ' A' ' 67' ' ' HIS . 11.8 t80 -119.48 142.47 48.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -119.33 140.61 50.04 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.656 -1.218 . . . . 0.0 114.214 -172.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.488 ' HB2' HG13 ' A' ' 62' ' ' ILE . 7.0 t70 -75.28 -53.91 7.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.647 1.179 . . . . 0.0 112.463 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.54 95.73 Favored Glycine 0 CA--C 1.503 -0.658 0 O-C-N 123.702 0.626 . . . . 0.0 112.789 -175.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -79.46 -30.86 42.34 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 66.8 41.84 93.37 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 78' ' ' GLY . 12.1 t60 -160.03 150.52 18.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -174.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 77' ' ' HIS . . . -77.88 133.75 13.47 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 119.225 -1.465 . . . . 0.0 110.251 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.89 -37.51 54.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 69' ' ' TRP . 25.0 t-20 -146.81 119.98 4.98 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.87 154.63 54.85 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.62 -1.408 . . . . 0.0 112.895 0.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.12 -15.68 57.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.942 0.877 . . . . 0.0 109.235 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.9 -32.87 61.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.218 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 109' ' ' LYS . 71.9 m -134.4 161.43 35.02 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 122.229 1.014 . . . . 0.0 112.317 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 24.5 p -138.21 -171.88 3.14 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.597 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 86' ' ' LEU . 2.0 pp -97.41 145.71 25.9 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.983 0.42 . . . . 0.0 111.226 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.24 113.74 26.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.43 118.51 22.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 O-C-N 123.452 0.47 . . . . 0.0 109.779 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -90.74 124.47 62.19 Favored Pre-proline 0 C--N 1.278 -2.536 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -60.2 120.05 7.6 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.966 1.778 . . . . 0.0 110.45 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.37 130.31 72.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.411 0.624 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.619 ' HG2' ' HD2' ' A' ' 94' ' ' LYS . 35.7 tt0 -115.42 131.51 56.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.161 -174.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.28 117.34 55.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.001 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.619 ' HD2' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -125.96 98.5 5.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.21 -107.07 2.12 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 8' ' ' SER . 31.2 t70 -109.98 -5.24 15.51 Favored 'General case' 0 C--O 1.177 -2.758 0 CA-C-O 121.051 0.453 . . . . 0.0 109.962 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.64 133.18 44.35 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.294 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.7 mt -123.88 119.54 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.875 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.586 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 10.9 m-85 -112.68 144.49 42.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.098 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.55 142.32 39.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.42 0.629 . . . . 0.0 111.098 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t -106.71 128.97 54.65 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.113 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -120.84 -8.32 9.43 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.252 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -78.01 121.83 24.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.07 -32.52 6.63 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.569 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.432 HD12 ' HD3' ' A' ' 90' ' ' PRO . 73.1 mt -120.14 108.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.504 0.668 . . . . 0.0 109.963 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -94.02 155.06 40.55 Favored Pre-proline 0 N--CA 1.41 -2.459 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.339 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.59 144.1 99.51 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.448 2.098 . . . . 0.0 109.86 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -79.58 166.03 22.32 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 52.8 mtmt -38.04 -51.26 1.38 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.472 1.509 . . . . 0.0 115.073 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 112' ' ' SER . . . -63.87 -32.75 74.37 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -175.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 75.91 -36.52 0.29 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.51 1.124 . . . . 0.0 110.554 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.574 ' C ' ' HB2' ' A' ' 45' ' ' CYS . 32.5 p . . . . . 0 N--CA 1.429 -1.523 0 O-C-N 125.332 1.645 . . . . 0.0 110.713 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.76 ' S1 ' ' N ' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 CA--C 1.501 -0.933 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' SER . 46.5 t 67.01 -69.7 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -167.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 73.5 m-85 -79.89 115.72 19.63 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 170.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.29 144.97 49.68 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -74.08 125.43 28.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.101 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -106.68 -42.25 6.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.488 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.3 m -148.08 -179.32 6.83 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.338 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 12' ' ' ILE . 13.2 p -130.69 152.7 49.77 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 125.211 1.405 . . . . 0.0 108.881 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.494 HD13 ' O ' ' A' ' 9' ' ' LEU . 2.8 tm? -56.41 -23.76 40.5 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.12 -30.33 71.4 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.668 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.8 -8.39 13.19 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 8' ' ' SER . 3.7 tp -127.65 110.4 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 0.0 110.081 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.37 164.63 11.57 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.513 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.48 124.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.065 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.09 -8.17 62.83 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -102.81 153.25 20.36 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.447 0.641 . . . . 0.0 111.142 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.581 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -149.55 137.72 20.57 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.121 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 20' ' ' PHE . 12.0 pt-20 -157.41 155.36 30.35 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.402 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -93.81 141.36 28.59 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 112.047 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.77 148.75 52.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.491 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.73 139.72 37.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -83.56 168.37 16.46 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 m -70.05 -12.4 61.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.084 0.469 . . . . 0.0 110.845 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -90.22 -2.9 58.09 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.374 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.41 12.91 60.69 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.392 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -87.01 123.34 32.0 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.35 123.6 33.68 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.16 135.64 60.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.446 0.641 . . . . 0.0 110.892 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -89.53 113.97 25.44 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 124.454 1.101 . . . . 0.0 109.277 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.19 113.6 30.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.44 124.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 43.5 t30 -108.17 104.57 14.01 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.766 -1.173 . . . . 0.0 108.323 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 48.0 t -101.36 149.26 24.23 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.506 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -77.46 -32.32 54.38 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.292 0.568 . . . . 0.0 109.576 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -93.43 -47.13 7.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.699 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 65.7 m80 -83.28 -19.96 35.34 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.781 0.324 . . . . 0.0 111.309 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.37 -174.29 48.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -87.52 118.15 32.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.679 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -131.68 157.74 42.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.007 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -124.7 134.96 52.67 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 73' ' ' ASP . 69.2 m-85 -134.11 163.63 29.14 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 10.2 pt20 -66.57 144.23 56.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.77 8.19 33.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.43 0.633 . . . . 0.0 111.305 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.2 tpp -99.4 143.37 29.74 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.876 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -116.76 152.73 48.82 Favored Pre-proline 0 N--CA 1.426 -1.663 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.925 177.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.72 -39.39 13.51 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 123.564 2.843 . . . . 0.0 112.558 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.5 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 8.8 m80 -64.77 -86.14 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 168.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -153.22 173.85 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.74 129.82 36.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 50' ' ' ILE . 13.0 tt -156.74 24.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 122.82 1.295 . . . . 0.0 108.714 -174.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt 69.31 84.38 0.15 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 113.524 -1.671 . . . . 0.0 113.687 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.2 mp -70.14 -30.65 67.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.456 1.122 . . . . 0.0 108.26 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 11.6 p -61.41 -29.81 70.17 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.975 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -98.69 2.65 47.34 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 65' ' ' ARG . . . 164.71 91.94 0.08 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 118.297 -1.906 . . . . 0.0 115.241 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -157.27 -62.02 0.09 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.581 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 41.2 t80 -90.48 114.05 26.14 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.39 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -118.41 114.36 22.78 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.465 173.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.03 -70.64 1.21 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.359 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.78 -17.74 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.654 -0.273 . . . . 0.0 112.765 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.66 141.79 15.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 117.072 0.436 . . . . 0.0 109.961 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 57.5 mt -111.3 123.76 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 94.9 m -92.85 143.96 25.76 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.69 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 3.7 t -76.29 -85.44 0.05 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 116.2 -2.2 . . . . 0.0 107.74 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 23.9 tpt180 -178.81 -34.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.065 0.848 . . . . 0.0 112.522 164.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' N ' ' S1 ' ' A' ' 113' ' ' FES . . . -98.63 -39.62 8.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 6.6 p-80 -84.92 178.73 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.431 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -53.41 -70.61 0.09 Allowed 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' A' ' 63' ' ' THR 0.255 98.0 m95 -129.18 -93.71 0.43 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -173.162 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 32.6 p -101.6 146.17 28.05 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 117.333 2.345 . . . . 0.0 117.333 -160.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 45.8 t80 -135.96 143.08 44.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 168.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -119.11 128.17 54.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 120.507 1.503 . . . . 0.0 113.685 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 10.5 p-10 -79.44 -40.68 29.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.943 -175.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.02 47.24 2.22 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 121.141 0.301 . . . . 0.0 112.91 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -163.46 -45.34 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 85' ' ' CYS . . . 104.86 -65.36 0.3 Allowed Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' CYS . 44.1 m80 -73.73 132.47 42.69 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -82.97 177.14 53.3 Favored Glycine 0 C--N 1.299 -1.508 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.976 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.4 mp -84.39 -34.99 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 23.7 t-20 -142.73 109.86 5.63 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.0 Cg_exo -80.08 147.83 77.36 Favored 'Cis proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.429 -3.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.675 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.6 p30 -77.61 -21.75 51.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.93 -8.38 58.78 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.913 0.387 . . . . 0.0 110.377 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 67.8 m -103.62 152.4 21.81 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 121.605 0.717 . . . . 0.0 111.842 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 4.3 p -132.0 178.77 6.53 Favored 'General case' 0 C--N 1.273 -2.743 0 C-N-CA 125.496 1.518 . . . . 0.0 110.139 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -131.32 35.75 3.86 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . . . 46.3 102.46 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.849 1.26 . . . . 0.0 114.398 -177.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.99 112.25 23.6 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 110.941 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 93.6 m-85 -102.51 130.64 23.63 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.468 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 101' ' ' SER . 14.5 Cg_endo -72.16 139.47 32.5 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.053 1.835 . . . . 0.0 111.271 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 100' ' ' VAL . 57.8 t -126.58 140.07 49.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.685 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -130.43 137.24 49.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 110.537 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.26 129.22 64.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.795 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -125.3 95.24 4.4 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.314 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.49 4.07 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.519 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -101.93 -2.87 28.84 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.544 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.494 ' HB2' ' HE3' ' A' ' 94' ' ' LYS . 20.7 m-20 -111.75 148.91 32.49 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.3 mt -126.39 131.99 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -99.49 148.48 24.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.538 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 91' ' ' VAL . 35.9 m -133.67 137.31 52.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 2' ' ' SER . 43.7 t -90.58 113.73 25.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.8 p -138.29 -26.46 0.91 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.236 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -74.44 99.51 3.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.401 0.62 . . . . 0.0 109.725 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.92 -8.21 16.64 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.837 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.11 115.64 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.999 0.428 . . . . 0.0 110.456 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.83 144.29 31.41 Favored Pre-proline 0 N--CA 1.412 -2.351 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.76 128.58 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.96 1.773 . . . . 0.0 111.141 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.3 p-10 -85.28 122.0 28.82 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.136 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.425 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 55.5 tptt 67.72 160.93 0.17 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.92 1.387 . . . . 0.0 111.029 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 74.03 -67.92 0.24 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.919 1.288 . . . . 0.0 112.64 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -88.79 -4.56 58.47 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.478 0.656 . . . . 0.0 109.749 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.432 -1.363 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.139 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.69 ' S1 ' ' HB3' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.767 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.504 ' N ' ' SD ' ' A' ' 1' ' ' MET . 22.7 t 78.65 -44.81 0.38 Allowed 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.334 1.454 . . . . 0.0 110.16 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 68.2 m-85 -75.51 97.79 3.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -107.13 144.95 33.11 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -77.28 124.28 27.64 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -98.21 -45.92 12.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.734 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.1 p -157.79 -172.18 3.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.372 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -125.74 152.7 45.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.597 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.5 tt -61.57 -26.03 67.7 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.26 -10.76 56.91 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.918 -0.489 . . . . 0.0 111.378 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -93.76 -53.4 4.04 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 12' ' ' ILE . 42.2 pt -111.4 110.86 33.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 122.462 1.125 . . . . 0.0 111.757 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.97 170.23 16.96 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.251 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 34' ' ' GLU . 7.1 p -57.71 112.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-O 121.874 0.845 . . . . 0.0 111.276 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.21 58.95 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.558 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -102.83 152.48 21.22 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.168 0.508 . . . . 0.0 111.072 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.559 ' HB2' HD21 ' A' ' 29' ' ' LEU . 25.3 ptt? -149.95 145.23 26.36 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.895 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.8 pt-20 -157.8 154.73 28.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 73.5 m -71.99 130.26 40.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.017 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 97.6 m-85 -128.09 157.01 41.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -106.24 135.68 47.29 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -83.39 173.71 11.29 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 m -73.89 -12.24 60.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.493 0.663 . . . . 0.0 110.993 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.2 -12.22 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.659 0.742 . . . . 0.0 109.111 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 20.71 24.91 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.629 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.9 m -91.34 130.27 37.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -88.04 124.39 33.7 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.8 t -138.7 145.68 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 17' ' ' MET . 5.7 tt -97.3 112.32 24.18 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mm -97.6 119.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 17' ' ' MET . 10.1 p -116.52 134.1 61.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.411 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -108.86 104.31 13.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.3 m -101.19 143.9 30.72 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -76.57 -51.31 11.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.3 -46.58 22.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.317 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -92.75 2.62 56.64 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.199 0.523 . . . . 0.0 111.361 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.92 177.06 35.3 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.719 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.2 125.63 39.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 9.8 mmpt? -127.81 145.19 51.01 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.123 0.569 . . . . 0.0 109.97 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -125.56 112.13 15.83 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' C ' HG13 ' A' ' 28' ' ' VAL . 13.9 p90 -137.53 140.94 41.39 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 119.553 -0.26 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.515 ' HB2' HD22 ' A' ' 86' ' ' LEU . 38.3 mt-30 -42.91 137.36 2.38 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.938 0.774 . . . . 0.0 111.953 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.46 78.7 1.75 Allowed 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.467 0.651 . . . . 0.0 110.157 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.488 ' HB2' ' HB1' ' A' ' 110' ' ' ALA 0.286 10.9 mmt -123.75 135.7 53.99 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.87 90.67 0.47 Allowed Pre-proline 0 C--N 1.311 -1.067 0 C-N-CA 127.594 2.357 . . . . 0.0 107.873 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -85.33 27.76 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.54 2.16 . . . . 0.0 111.063 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -85.18 -52.95 5.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.15 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -138.0 -72.02 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -98.83 115.69 29.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.31 -28.86 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.185 0.928 . . . . 0.0 110.515 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.7 mt -79.02 98.13 6.35 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.426 ' O ' HD23 ' A' ' 52' ' ' LEU . 3.2 tt -56.95 -28.9 62.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.488 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 67.5 p -58.04 -21.72 46.65 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.713 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -88.59 8.71 27.0 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.968 0.413 . . . . 0.0 112.009 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.49 -124.57 1.21 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 173.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.6 t -157.29 150.04 23.29 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 110.263 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CD1' HD13 ' A' ' 62' ' ' ILE . 6.8 t80 -130.89 115.91 17.18 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.293 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -116.15 104.15 11.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.02 -73.89 0.13 Allowed Glycine 0 CA--C 1.52 0.364 0 O-C-N 123.715 0.634 . . . . 0.0 112.845 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.68 25.09 1.19 Allowed Glycine 0 C--N 1.295 -1.7 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.52 120.99 62.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 35.4 mm -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 m -127.2 129.05 47.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.935 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 0.1 OUTLIER -69.92 -155.2 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.045 0 C-N-CA 123.442 0.697 . . . . 0.0 111.411 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.479 ' N ' ' S1 ' ' A' ' 113' ' ' FES . 19.6 tpt180 -113.1 95.09 5.2 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.762 -0.586 . . . . 0.0 110.654 -169.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.69 21.81 10.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.812 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 2.7 t-160 -97.72 -17.02 19.66 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.21 -48.69 0.69 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -74.4 177.24 6.07 Favored 'General case' 0 CA--C 1.577 2.017 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.766 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -103.08 156.92 17.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -166.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.515 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 6.3 t80 -134.07 146.26 50.15 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -118.57 112.84 20.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.905 0.775 . . . . 0.0 112.976 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.59 -34.36 58.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.515 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.84 -40.16 89.33 Favored Glycine 0 CA--C 1.508 -0.369 0 O-C-N 123.342 0.402 . . . . 0.0 113.486 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -101.1 -12.75 18.56 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.644 0.735 . . . . 0.0 109.41 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.35 38.68 38.19 Favored Glycine 0 C--O 1.219 -0.821 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.777 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -140.74 141.32 34.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -85.73 139.75 17.42 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.922 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.63 -35.97 17.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -141.47 137.47 16.52 Favored Pre-proline 0 N--CA 1.417 -2.114 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -66.76 -13.56 8.08 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 CA-C-N 119.383 0.815 . . . . 0.0 113.44 -0.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 11.2 t70 90.14 -39.35 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 126.928 2.091 . . . . 0.0 110.0 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -56.46 -34.28 66.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.325 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 51.6 m -93.7 141.84 28.03 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.853 0.835 . . . . 0.0 108.885 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.3 m -144.52 166.6 24.69 Favored 'General case' 0 C--N 1.254 -3.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 42' ' ' GLN . 72.5 mt -128.98 179.69 5.6 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -175.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.92 117.62 17.9 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -85.66 101.22 12.55 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -81.11 141.87 50.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.415 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -58.37 118.55 5.45 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.764 1.643 . . . . 0.0 110.537 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.0 p -133.5 137.79 52.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -133.64 140.19 46.94 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.365 0.602 . . . . 0.0 111.062 -176.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.8 127.97 57.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.43 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.53 91.3 3.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.37 -106.0 1.22 Allowed Glycine 0 C--N 1.3 -1.439 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.418 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.9 -10.86 22.27 Favored 'General case' 0 C--O 1.186 -2.283 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.16 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.87 140.36 35.27 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.774 0.321 . . . . 0.0 111.406 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.7 mt -127.14 122.06 59.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.831 0.825 . . . . 0.0 111.664 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 39.7 m-85 -115.12 144.41 43.7 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.937 -176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.54 145.37 29.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.04 0.448 . . . . 0.0 110.911 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.424 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 51.5 m -111.45 116.26 30.6 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.437 ' HA ' ' CG2' ' A' ' 105' ' ' ILE . 10.0 t -134.26 -10.66 2.54 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.913 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -85.44 97.11 9.83 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.857 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.86 -32.85 2.47 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 102' ' ' THR . 13.3 tt -86.83 136.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.21 123.53 79.32 Favored Pre-proline 0 N--CA 1.426 -1.672 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 23.0 Cg_exo -68.25 129.7 19.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.605 2.87 . . . . 0.0 108.511 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -81.16 174.39 11.61 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.659 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 109' ' ' LYS . 75.3 mmtt -52.81 104.6 0.09 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.813 1.292 . . . . 0.0 114.158 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 44' ' ' MET . . . 175.0 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 111.237 -2.711 . . . . 0.0 104.406 -174.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -144.9 161.55 39.05 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 113.056 -1.884 . . . . 0.0 106.414 170.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 CA--C 1.54 0.59 0 O-C-N 124.233 0.958 . . . . 0.0 111.37 177.135 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.935 ' S1 ' ' HB3' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 101' ' ' SER . 49.3 m 60.33 -80.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.765 1.226 . . . . 0.0 114.153 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.482 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 95.6 m-85 -86.09 124.82 32.94 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -120.23 145.1 47.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 118.24 23.38 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -118.23 -40.72 2.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.379 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 p -146.27 -175.15 4.65 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.577 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.574 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.6 m -131.57 150.6 52.09 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.221 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -71.47 -25.26 62.21 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 96' ' ' ASP . 23.8 t70 -72.19 -17.68 61.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.316 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.25 -53.43 4.7 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 12' ' ' ILE . 43.3 pt -108.37 110.13 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 122.433 1.111 . . . . 0.0 110.523 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.492 ' HB2' ' OE2' ' A' ' 16' ' ' GLU . 37.3 m95 -80.38 170.07 16.88 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.119 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.43 127.13 14.99 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.036 0.446 . . . . 0.0 110.015 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.65 -1.72 79.13 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 13' ' ' TRP . 44.8 mt-10 -110.34 149.94 29.5 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.38 0.61 . . . . 0.0 112.239 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 53' ' ' SER . 20.3 ptt? -150.39 152.2 33.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.485 -171.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -157.24 151.91 25.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 123.613 0.571 . . . . 0.0 109.472 177.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.638 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 99.1 m -89.49 121.01 31.31 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 97.6 m-85 -119.2 155.77 31.08 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' THR . 36.1 tt0 -109.88 143.42 39.8 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.1 p -83.06 165.76 19.32 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 m -67.0 -13.13 61.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.142 0.496 . . . . 0.0 111.213 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.85 -13.11 49.01 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 109.489 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 22.39 16.42 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.794 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.587 ' CG2' HE22 ' A' ' 42' ' ' GLN . 31.5 m -97.72 130.03 44.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.764 -0.257 . . . . 0.0 111.168 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -89.64 126.85 35.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.571 0.701 . . . . 0.0 111.589 175.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.19 148.78 27.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.8 tp -100.29 111.1 23.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.3 mp -102.94 117.45 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 17' ' ' MET . 66.2 t -118.05 125.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.839 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -88.09 104.22 16.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -101.59 145.75 28.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.144 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.82 -48.98 19.37 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.483 0.659 . . . . 0.0 109.574 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.29 -41.33 61.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.723 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -100.78 2.48 41.27 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.77 -170.68 46.1 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.1 t -78.43 119.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.09 144.77 44.29 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.655 0.264 . . . . 0.0 110.914 -176.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.97 119.99 31.18 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.535 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 2.0 p90 -143.23 140.19 30.58 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.394 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.587 HE22 ' CG2' ' A' ' 26' ' ' THR . 14.7 mm100 -44.66 138.21 3.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.25 59.21 4.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.425 1.107 . . . . 0.0 109.877 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 19.0 mmt -66.07 94.1 0.23 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 113.618 -1.628 . . . . 0.0 114.262 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.951 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 3.7 m -166.47 93.84 0.76 Allowed Pre-proline 0 C--N 1.31 -1.148 0 C-N-CA 125.445 1.498 . . . . 0.0 110.403 175.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.98 30.27 0.47 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.206 2.604 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 30.38 3.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -47.91 124.02 6.89 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.244 2.218 . . . . 0.0 114.817 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 41.7 mm-40 -92.55 -62.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 173.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 tp -151.16 172.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 110.71 2.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 118.985 0.811 . . . . 0.0 109.67 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.2 pt? -62.16 -20.01 63.66 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.893 1.277 . . . . 0.0 112.409 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.638 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 59.3 p -55.0 -21.86 13.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -166.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.46 8.59 44.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.36 0.6 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.68 81.3 0.12 Allowed Glycine 0 C--N 1.318 -0.426 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.602 ' HB3' HG23 ' A' ' 62' ' ' ILE . 66.3 m -138.53 -77.86 0.36 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -90.23 114.23 26.2 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.508 -169.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.4 105.24 11.93 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.657 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.85 -64.07 1.55 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 123.207 0.317 . . . . 0.0 113.028 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.1 -2.62 0.06 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.88 140.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 56' ' ' SER . 36.4 mt -113.4 121.06 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 0.0 112.044 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.4 m -92.94 148.46 21.99 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 125.67 1.588 . . . . 0.0 110.432 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.549 ' C ' ' H ' ' A' ' 66' ' ' ALA . 44.6 t -156.21 34.7 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 72.32 -22.91 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.694 1.198 . . . . 0.0 109.83 -170.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . 71.17 100.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 125.367 1.467 . . . . 0.0 111.576 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.452 ' CE1' ' HG2' ' A' ' 49' ' ' GLU . 52.7 m80 -99.83 -0.17 40.27 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.499 174.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -147.55 -55.1 0.22 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.016 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -170.62 -143.78 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 32.8 p -134.39 167.68 20.3 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.363 1.465 . . . . 0.0 108.981 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 54.2 m-85 -98.69 138.39 35.93 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -107.46 112.54 25.37 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 173.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.405 4.6 p-10 52.77 63.19 2.33 Favored 'General case' 0 CA--C 1.476 -1.883 0 CA-C-O 123.333 1.539 . . . . 0.0 111.342 -167.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.506 ' HA3' HD12 ' A' ' 62' ' ' ILE . . . -73.26 64.47 1.67 Allowed Glycine 0 CA--C 1.474 -2.491 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.257 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.2 m -139.85 -46.64 0.44 Allowed 'General case' 1 C--N 1.242 -4.09 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.96 -3.53 6.3 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 119.171 -1.49 . . . . 0.0 113.399 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -144.12 142.95 30.89 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.326 0.563 . . . . 0.0 110.801 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.45 129.05 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.699 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 70' ' ' THR . 51.1 mt -88.3 -22.93 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 173.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.52 ' ND2' ' S2 ' ' A' ' 113' ' ' FES . 23.7 t30 -143.8 113.44 5.44 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.895 168.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 6.9 Cg_exo -76.11 129.16 18.08 Favored 'Cis proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.706 -1.789 . . . . 0.0 110.914 -2.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.21 -11.84 59.96 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.739 0.78 . . . . 0.0 109.886 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.84 -19.78 61.25 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.712 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 111' ' ' HIS . 79.3 m -155.11 161.67 41.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 122.327 1.06 . . . . 0.0 113.196 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 p -94.06 -167.56 1.7 Allowed 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 84.6 mt -117.38 142.72 46.77 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.843 177.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.22 86.38 5.01 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.569 176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 123.58 24.57 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.105 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.52 ' CD2' HG21 ' A' ' 105' ' ' ILE 0.251 5.4 p90 -124.08 160.32 52.69 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.58 133.67 43.77 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.68 2.92 . . . . 0.0 115.012 -172.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.3 t -116.3 143.56 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-N 113.713 -1.585 . . . . 0.0 107.498 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.9 132.38 47.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.52 130.49 48.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.63 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 90.6 3.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 176.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.64 -113.55 5.96 Favored Glycine 0 C--N 1.31 -0.889 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.604 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.2 m-20 -91.93 -8.2 46.96 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 123.365 0.666 . . . . 0.0 110.671 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 17.4 m-20 -111.65 157.61 20.24 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.2 mm -126.93 135.93 62.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 16.6 m-85 -106.54 145.99 31.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 167.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.32 151.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 2' ' ' SER . 20.8 m -87.47 113.08 22.85 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.1 p -124.51 -38.28 2.42 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HE3' ' HA ' ' A' ' 103' ' ' LYS . 1.4 tpmt? -107.32 91.19 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.07 -39.08 0.73 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.614 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 28.1 mm -85.49 143.25 11.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 170.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.0 tp -96.86 100.75 7.9 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.451 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 105' ' ' ILE . 2.9 Cg_exo -78.41 136.98 14.49 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 123.084 2.523 . . . . 0.0 109.872 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.53 117.01 20.87 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.252 0.548 . . . . 0.0 110.385 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -71.83 -24.13 61.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.704 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HA ' ' SD ' ' A' ' 44' ' ' MET . . . -174.17 103.16 0.1 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.912 175.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.586 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 73.9 t60 77.98 -70.59 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 C--N 1.288 -2.088 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -178.143 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.951 ' S1 ' ' HB3' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttm . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 121.027 0.441 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t 178.57 133.78 0.08 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 52.46 87.82 0.03 OUTLIER 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.151 0.977 . . . . 0.0 111.342 -174.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -105.3 142.48 34.99 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -65.8 117.52 8.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.278 0.561 . . . . 0.0 110.128 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 tt -104.3 -56.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.57 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.846 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.3 m -157.92 -177.14 6.35 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 123.058 0.543 . . . . 0.0 111.064 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 p -103.62 150.17 24.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.0 tt -72.85 -24.77 60.92 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.4 -25.97 68.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.215 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.54 -48.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.6 pt -100.91 110.79 28.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 CA-C-O 122.802 1.287 . . . . 0.0 112.27 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -79.2 169.78 17.63 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 113.514 -1.676 . . . . 0.0 112.227 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.1 116.71 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.703 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.34 2.12 59.08 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.383 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -104.18 145.04 30.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.21 0.528 . . . . 0.0 110.679 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -142.36 143.73 32.85 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 tp10 -152.86 149.76 28.62 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 69.5 m -89.08 123.06 33.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.001 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -127.57 162.51 26.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.765 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -102.0 141.54 34.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -83.97 170.59 13.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -64.02 -13.68 48.5 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.758 0.423 . . . . 0.0 111.66 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.52 -13.24 24.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.283 0.563 . . . . 0.0 110.373 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.2 18.58 23.82 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.978 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -97.09 139.12 33.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -89.65 135.45 33.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' THR . 99.2 t -134.94 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -104.08 110.29 22.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 30' ' ' ILE . 2.4 mp -101.3 123.19 54.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 17' ' ' MET . 9.3 p -111.96 125.58 69.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -101.86 102.01 12.54 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 117.941 -1.504 . . . . 0.0 108.456 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.9 m -103.6 139.08 39.38 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.64 -38.62 54.36 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.412 0.625 . . . . 0.0 109.706 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -92.93 -46.89 7.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.68 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -79.74 -12.3 59.8 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.111 0.481 . . . . 0.0 110.41 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.76 159.13 31.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.988 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 93' ' ' VAL . 7.2 p -72.94 124.01 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -127.06 138.59 53.24 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.24 0.543 . . . . 0.0 112.38 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.7 112.33 16.62 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.015 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 25.3 p90 -136.82 147.08 46.37 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.676 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -47.33 137.79 8.02 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.896 0.855 . . . . 0.0 113.02 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . . . -83.99 101.09 11.48 Favored 'General case' 0 N--CA 1.396 -3.141 0 CA-C-N 114.474 -1.239 . . . . 0.0 113.198 -172.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 26.1 ptt? 64.07 179.42 0.17 Allowed 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 111.32 -2.673 . . . . 0.0 116.306 163.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.61 116.64 66.83 Favored Pre-proline 0 N--CA 1.416 -2.169 0 CA-C-N 112.238 -2.256 . . . . 0.0 107.202 171.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HG3' ' HB2' ' A' ' 111' ' ' HIS . 25.4 Cg_endo -85.8 37.26 0.55 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 122.742 2.295 . . . . 0.0 113.347 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.624 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 26.4 m80 -85.13 -59.69 2.26 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 176.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.15 115.11 29.71 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.603 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -75.13 82.97 2.32 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 122.359 1.076 . . . . 0.0 111.164 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.0 tt -71.99 -37.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.93 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 60.61 69.49 0.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' H ' ' CD2' ' A' ' 52' ' ' LEU . 1.5 pt? -77.5 -19.33 56.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.323 -2.217 . . . . 0.0 114.074 -169.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.9 p -54.88 -23.12 17.11 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -163.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.49 -9.24 58.53 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 119.083 0.856 . . . . 0.0 110.182 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.6 83.18 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 m -125.31 -57.68 1.47 Allowed 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 122.411 1.1 . . . . 0.0 109.107 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -91.21 113.52 25.81 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.403 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.36 105.52 11.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 -53.82 2.1 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.606 -0.331 . . . . 0.0 113.585 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.55 -12.28 0.02 OUTLIER Glycine 0 C--N 1.306 -1.107 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.7 141.55 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 51.5 mm -106.83 128.35 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 123.956 0.902 . . . . 0.0 108.954 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.4 m -85.74 125.25 33.08 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 5.4 t -105.79 155.57 19.16 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.39 117.77 29.96 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.303 0.241 . . . . 0.0 110.957 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.05 -38.34 0.39 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 36.0 m170 -71.2 114.71 9.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 118.266 0.485 . . . . 0.0 111.38 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' HB3' ' CG ' ' A' ' 80' ' ' ASN . 2.1 tm? 49.24 -97.49 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.438 1.495 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -166.98 -44.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 p -138.34 134.93 34.85 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -160.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 48.3 t80 -116.23 138.53 51.21 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 101.868 -3.382 . . . . 0.0 101.868 168.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.421 ' H ' ' HA2' ' A' ' 78' ' ' GLY . 54.7 t30 -123.35 117.34 24.99 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.873 1.67 . . . . 0.0 115.156 -168.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.48 -33.46 42.23 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.256 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -48.47 -54.58 12.74 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.757 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.7 m -88.94 -36.78 15.7 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.087 0.47 . . . . 0.0 110.223 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.508 ' O ' HD13 ' A' ' 86' ' ' LEU . . . 114.37 -33.55 5.35 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.456 ' HD2' ' SG ' ' A' ' 85' ' ' CYS . 29.8 t-80 -82.72 137.97 34.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.79 144.22 17.17 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.92 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.56 -42.42 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.477 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 3.5 p-10 -135.32 118.89 12.97 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.0 Cg_endo -81.11 131.76 21.39 Favored 'Cis proline' 0 C--O 1.243 0.757 0 C-N-CA 123.797 -1.335 . . . . 0.0 111.397 -1.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.0 p30 -71.5 -12.69 61.51 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.059 0.457 . . . . 0.0 111.101 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.41 -17.53 62.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.39 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 25.5 p -138.58 178.78 6.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 111.951 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 77' ' ' HIS . 62.3 m -133.61 176.12 8.83 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 76' ' ' GLY 0.313 0.0 OUTLIER -101.02 127.06 47.7 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.646 175.466 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -72.83 114.2 10.71 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -87.32 116.89 25.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 101' ' ' SER . 65.4 m-85 -95.69 152.54 39.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HD3' HD12 ' A' ' 105' ' ' ILE . 14.2 Cg_exo -70.76 120.55 7.16 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.186 1.924 . . . . 0.0 110.058 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.74 138.27 52.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.468 0.652 . . . . 0.0 110.667 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -115.24 132.06 56.73 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.512 ' HB ' HG11 ' A' ' 38' ' ' VAL . 8.8 p -106.57 122.21 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.324 -175.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -125.89 143.93 50.88 Favored 'General case' 0 N--CA 1.394 -3.234 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.312 176.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -33.62 -53.75 0.63 Allowed Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 117.531 1.772 . . . . 0.0 117.531 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.56 -0.73 13.58 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 9.3 m-20 -146.89 134.82 21.37 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.67 129.77 73.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-O 121.354 0.597 . . . . 0.0 111.088 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -113.73 141.49 47.2 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.027 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.76 147.94 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 120.946 0.403 . . . . 0.0 111.082 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.456 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 51.3 m -104.79 115.22 29.93 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.969 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -101.01 -18.43 16.28 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.525 ' HE3' ' HA ' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -81.73 108.38 15.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.147 176.475 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.55 -34.32 2.43 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.498 HD12 ' HD3' ' A' ' 90' ' ' PRO . 33.7 mt -119.02 127.64 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.06 128.07 61.69 Favored Pre-proline 0 N--CA 1.404 -2.732 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.09 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.42 148.87 91.87 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.36 2.04 . . . . 0.0 110.362 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -80.18 166.88 21.0 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -78.56 74.14 5.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.975 1.369 . . . . 0.0 114.139 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.95 -65.61 1.16 Allowed 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 46' ' ' PRO . 13.1 t-80 -139.33 121.65 15.99 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.418 -2.052 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.379 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.624 ' S1 ' ' HB2' ' A' ' 47' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.503 -0.837 0 N-CA-C 110.848 -0.056 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.6 m 58.08 -161.25 0.24 Allowed 'General case' 0 C--O 1.243 0.727 0 O-C-N 124.186 0.929 . . . . 0.0 110.868 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CD2' ' HB2' ' A' ' 101' ' ' SER . 92.2 m-85 -76.07 97.72 4.14 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.76 143.81 35.79 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 120.908 0.385 . . . . 0.0 110.284 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 86.1 tttt -79.54 123.66 27.78 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' ' 7' ' ' CYS . 39.7 mm -94.87 -53.55 8.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.333 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 6' ' ' ILE . 93.4 m -158.31 -172.56 3.93 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.465 0.65 . . . . 0.0 111.921 -173.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 41.2 t -104.74 153.22 21.57 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.959 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.4 tt -61.73 -21.8 64.82 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.99 -19.6 66.08 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.186 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -94.98 -42.95 8.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.6 tp -114.49 110.83 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.056 0.931 . . . . 0.0 112.65 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -102.59 169.04 8.89 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.327 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.42 124.76 27.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.684 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.52 66.0 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -105.14 153.27 21.75 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.083 -0.559 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -151.27 143.92 24.34 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.512 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.01 155.44 31.25 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.3 m -73.38 136.21 44.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.064 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -135.33 160.5 38.22 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.11 136.98 44.83 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.9 p -84.62 175.64 9.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.9 m -66.12 -20.72 66.24 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.046 0.45 . . . . 0.0 111.368 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.44 5.12 52.42 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.588 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.05 33.67 54.17 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.104 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 m -97.98 134.95 40.39 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.68 122.67 33.01 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.13 141.98 45.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.215 0.531 . . . . 0.0 110.267 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 53.5 tp -100.04 111.91 24.21 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 124.512 1.125 . . . . 0.0 108.191 177.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.7 114.33 32.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.39 124.55 64.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.3 t30 -109.31 106.46 16.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.5 m -98.37 157.3 16.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.686 0.755 . . . . 0.0 112.518 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -75.26 -48.96 20.88 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.543 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.12 -33.77 10.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -91.45 3.28 55.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.15 -166.37 41.23 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.392 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 10.6 p -90.92 128.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.548 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -132.3 158.16 42.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.336 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.31 128.02 48.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 39' ' ' LYS . 95.0 m-85 -134.97 163.56 29.59 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -55.38 138.93 44.72 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.206 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.47 -39.3 74.32 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.511 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 66.6 mtt -103.19 120.61 41.03 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.507 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 29.8 p -70.7 171.88 7.34 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 123.362 0.413 . . . . 0.0 110.429 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' N ' ' HA ' ' A' ' 110' ' ' ALA . 31.8 Cg_exo -60.62 -18.84 57.26 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.672 2.248 . . . . 0.0 111.661 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -100.01 -22.69 15.14 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.369 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.577 ' HG3' ' H ' ' A' ' 49' ' ' GLU 0.375 11.8 pt20 47.9 -102.98 0.09 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.02 0.928 . . . . 0.0 113.433 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.577 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 44.4 mt-10 58.5 -75.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.796 1.238 . . . . 0.0 113.505 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -109.27 141.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.62 99.34 5.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.942 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.5 pt? -60.33 -24.97 65.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.3 p -63.58 -27.82 69.51 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 123.982 0.913 . . . . 0.0 110.305 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -113.84 21.19 15.17 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.37 -110.47 2.62 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.8 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 m -148.27 157.84 43.73 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.546 0.689 . . . . 0.0 111.495 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -125.24 127.47 46.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.327 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 61' ' ' VAL . 1.6 tm-20 -114.96 163.88 14.95 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.26 -34.85 48.6 Favored Glycine 0 C--N 1.317 -0.479 0 CA-C-N 118.535 0.607 . . . . 0.0 113.288 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.06 7.14 5.11 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.527 -1.32 . . . . 0.0 113.058 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 58' ' ' GLU . 64.3 t -124.79 125.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 122.002 -0.705 . . . . 0.0 111.43 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 71' ' ' PHE . 51.4 mm -89.99 130.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.3 m -91.93 113.73 26.08 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.059 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.447 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 39.8 m -87.02 -45.55 10.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.786 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.525 ' HD3' ' O ' ' A' ' 65' ' ' ARG . 0.9 OUTLIER 71.76 -36.28 0.35 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.71 1.204 . . . . 0.0 110.822 -177.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.564 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . . . -56.16 -61.06 2.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -75.8 -19.29 59.08 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.134 -1.426 . . . . 0.0 112.079 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.0 tp 179.87 -77.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 73.7 t90 177.32 -27.69 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.503 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' HD13 ' A' ' 79' ' ' ILE . 34.1 p -100.77 140.58 34.84 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CD2' ' HB ' ' A' ' 62' ' ' ILE . 42.7 t80 -134.39 139.93 45.94 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 126.311 1.844 . . . . 0.0 107.107 173.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -106.47 113.03 26.31 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.955 0.407 . . . . 0.0 110.704 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.94 -50.91 72.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -42.7 -45.32 5.67 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.578 ' HB ' ' CD2' ' A' ' 77' ' ' HIS . 10.7 m -116.31 12.17 15.26 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 122.123 -0.634 . . . . 0.0 110.634 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.56 51.42 52.15 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.396 -0.431 . . . . 0.0 112.258 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.578 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -146.46 157.24 43.73 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.56 173.79 54.9 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 119.346 -1.406 . . . . 0.0 109.998 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.459 HD13 ' HB ' ' A' ' 70' ' ' THR . 1.8 mp -87.71 -27.77 5.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -152.07 107.13 2.82 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.558 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.87 158.07 98.36 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.123 -1.615 . . . . 0.0 111.175 -2.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.2 p-10 -104.22 -4.61 22.83 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -173.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.49 -55.44 18.92 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.236 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 85.9 m -167.46 170.63 11.16 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.619 0.768 . . . . 0.0 109.895 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.566 ' CB ' ' HA ' ' A' ' 77' ' ' HIS . 42.1 t -145.39 -79.42 0.18 Allowed 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.312 1.053 . . . . 0.0 110.756 169.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.509 ' HG ' ' SG ' ' A' ' 85' ' ' CYS . 87.5 mt -114.0 167.14 10.92 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.824 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -97.51 137.7 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -95.67 113.88 25.57 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 97.4 m-85 -106.03 142.74 25.47 Favored Pre-proline 0 C--O 1.245 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.048 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 89' ' ' TYR . 24.1 Cg_exo -63.89 131.97 32.99 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.963 2.442 . . . . 0.0 111.074 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 100' ' ' VAL . 7.3 p -133.15 146.78 31.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.508 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.528 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 50.6 mt-10 -131.74 132.61 43.99 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.28 118.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.202 0.525 . . . . 0.0 110.427 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.528 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -120.7 91.97 3.66 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.34 -99.52 0.52 Allowed Glycine 0 CA--C 1.498 -0.989 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.583 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.624 ' O ' ' HA ' ' A' ' 8' ' ' SER . 10.6 m-20 -104.85 -9.78 17.79 Favored 'General case' 0 C--O 1.174 -2.886 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.956 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.8 128.39 45.9 Favored 'General case' 0 C--N 1.273 -2.722 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.551 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -119.73 121.9 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.409 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 20.3 m-85 -114.08 142.37 46.28 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.251 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 91' ' ' VAL . 24.5 m -128.56 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 2' ' ' SER . 32.1 t -105.45 120.03 40.58 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.163 0.506 . . . . 0.0 110.074 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.2 t -102.49 12.75 36.03 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.784 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HB2' ' H ' ' A' ' 2' ' ' SER . 63.0 tttm -100.82 144.33 29.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 -41.66 2.65 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.43 136.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.26 140.75 23.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.23 138.78 28.76 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.073 2.515 . . . . 0.0 113.688 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -80.86 -177.34 6.32 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -14.74 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 124.118 0.967 . . . . 0.0 112.8 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . -49.48 146.54 3.96 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.453 1.501 . . . . 0.0 111.242 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 66.54 74.76 0.34 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.654 0.782 . . . . 0.0 110.812 -176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--N 1.299 -1.597 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.912 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.564 ' S1 ' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 C--O 1.235 0.292 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -162.17 -163.98 1.0 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -59.54 102.88 0.16 Allowed 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.302 0.572 . . . . 0.0 110.049 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -117.71 150.28 39.34 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.659 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 87.8 tttt -77.38 115.29 17.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.291 0.567 . . . . 0.0 110.083 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.8 tp -96.4 -35.28 5.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.791 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' A' ' 6' ' ' ILE . 21.9 p -162.3 -166.58 1.42 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.981 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.723 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.2 m -127.96 149.1 50.49 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.147 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.95 -34.72 78.62 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 123.495 0.718 . . . . 0.0 109.395 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.45 -23.08 66.83 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.36 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.45 -46.47 12.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.572 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 12' ' ' ILE . 47.0 pt -100.65 114.75 40.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.353 1.073 . . . . 0.0 112.124 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -82.25 168.52 17.53 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.196 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.08 122.06 11.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.67 0.748 . . . . 0.0 110.001 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' A' ' 57' ' ' TYR . . . 94.18 1.11 65.05 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.223 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -102.69 137.83 40.4 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.3 0.572 . . . . 0.0 109.747 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.422 ' CB ' HG22 ' A' ' 31' ' ' VAL . 23.1 ptm -137.23 143.14 42.11 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.902 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 12.2 tp10 -156.54 154.66 30.65 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 176.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 89.1 m -100.93 130.94 47.0 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.19 0.519 . . . . 0.0 109.912 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -123.11 152.19 41.33 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.08 138.47 51.6 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.18 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.2 p -83.92 172.71 11.84 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 p -64.43 -26.54 68.49 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.177 0.591 . . . . 0.0 110.944 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.55 -12.22 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.212 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.52 18.07 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.443 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.6 m -90.28 117.0 28.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.72 123.72 33.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' THR . 62.1 t -127.33 137.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.163 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 29' ' ' LEU . 4.3 pp -93.3 123.3 36.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -109.44 114.55 47.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 ' CB ' ' A' ' 17' ' ' MET . 46.6 t -119.19 125.84 74.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.355 -177.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -87.82 106.21 17.92 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 22.8 m -99.53 149.35 23.33 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -75.28 -50.04 17.34 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.177 0.513 . . . . 0.0 111.063 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.7 -45.04 9.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.803 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' NE2' ' HE3' ' A' ' 39' ' ' LYS . 21.3 t-160 -84.25 -15.02 48.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.86 0.362 . . . . 0.0 111.949 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 85.59 -171.5 45.48 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.003 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 98' ' ' ILE . 61.4 t -77.72 123.35 34.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HE3' ' NE2' ' A' ' 36' ' ' HIS . 74.3 mmtt -128.25 150.44 50.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.23 119.24 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.329 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -128.69 158.61 38.11 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.7 mm-40 -60.19 138.23 57.96 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -106.35 -5.75 18.83 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.01 17.49 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.435 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 89.3 m -80.45 111.79 25.7 Favored Pre-proline 0 N--CA 1.443 -0.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 168.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 112' ' ' SER . 63.2 Cg_endo -85.07 39.05 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.626 2.218 . . . . 0.0 111.845 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -102.25 -77.03 0.56 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -170.15 131.78 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 43.1 mt-10 64.54 86.44 0.13 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.778 0.799 . . . . 0.0 112.164 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tt -93.88 106.46 18.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.729 0.776 . . . . 0.0 111.836 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB3' ' HG2' ' A' ' 65' ' ' ARG . 36.1 tp -154.38 48.92 0.61 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 29' ' ' LEU . 1.6 tm? -56.16 -38.78 71.36 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.276 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.653 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 94.0 p -68.56 -29.47 68.02 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.382 0.611 . . . . 0.0 112.331 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -83.87 17.15 2.46 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 124.265 1.026 . . . . 0.0 110.815 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.01 -125.01 1.15 Allowed Glycine 0 N--CA 1.412 -2.914 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.4 m -152.69 151.46 30.57 Favored 'General case' 0 N--CA 1.424 -1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.905 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.536 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 20.8 t80 -120.75 116.25 24.87 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.162 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -117.18 170.82 8.37 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 69.61 0.04 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.01 1.75 39.08 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.14 127.21 72.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.8 mm -122.72 132.94 70.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.39 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.4 m -101.76 137.39 40.12 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 25.9 p -78.09 -73.86 0.29 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.558 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 51' ' ' LEU . 29.7 tpt180 174.72 -69.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . . . -66.51 -57.96 6.23 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.413 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 8.6 m170 -70.59 116.11 10.53 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.836 167.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.93 17.63 3.39 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.53 1.157 . . . . 0.0 108.603 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' HIS . 87.7 m95 -93.47 177.41 6.04 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.164 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -129.8 140.81 50.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.495 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 53.5 p90 -105.67 154.02 21.02 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -93.7 116.57 29.07 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.983 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.46 -30.49 67.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.159 0.584 . . . . 0.0 111.3 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.77 31.51 4.25 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.3 m -156.7 -44.2 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.784 0.834 . . . . 0.0 109.305 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.59 -9.72 66.65 Favored Glycine 0 C--O 1.215 -1.049 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.911 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.12 148.29 28.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.495 ' HA2' ' CB ' ' A' ' 71' ' ' PHE . . . -72.56 137.73 25.08 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.645 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.41 -43.72 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -160.84 124.31 1.93 Allowed Pre-proline 0 N--CA 1.425 -1.721 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.496 ' HD2' ' SG ' ' A' ' 84' ' ' CYS . 12.7 Cg_exo -71.92 166.21 79.85 Favored 'Cis proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.79 0.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.41 -11.54 34.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.18 -10.75 59.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 p -110.32 133.98 52.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 122.334 1.064 . . . . 0.0 111.96 176.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.52 157.69 43.3 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.3 mt -131.75 179.47 6.05 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -141.07 139.66 34.08 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 8.6 pt-20 -92.25 104.09 16.49 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.235 0.541 . . . . 0.0 109.933 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -89.96 163.51 31.88 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.88 119.57 6.81 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.656 2.237 . . . . 0.0 114.018 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 100' ' ' VAL . 3.1 p -129.9 127.47 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.629 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.459 0.647 . . . . 0.0 110.028 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 98' ' ' ILE . 7.4 p -94.83 129.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.062 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -122.61 146.85 47.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.07 101.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.07 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.741 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.723 ' O ' ' HB3' ' A' ' 8' ' ' SER . 8.0 m-20 76.27 -13.82 0.87 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.28 2.232 . . . . 0.0 114.716 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -120.62 155.46 33.72 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-N 119.965 1.257 . . . . 0.0 110.849 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.478 HD13 HG11 ' A' ' 38' ' ' VAL 0.251 45.8 mt -131.26 133.92 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.634 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -119.44 144.38 46.98 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.495 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.424 HG12 HG23 ' A' ' 91' ' ' VAL . 35.3 m -135.52 144.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -132.39 118.09 18.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -92.92 6.08 49.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.156 0.503 . . . . 0.0 109.96 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -72.13 109.76 6.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.719 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.02 25.4 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.62 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.8 119.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 110.031 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 148.05 34.03 Favored Pre-proline 0 N--CA 1.409 -2.496 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.83 134.13 57.61 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.887 2.391 . . . . 0.0 111.251 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 54.3 t30 -79.91 157.29 26.95 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.1 106.01 0.24 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -171.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 174.52 -69.86 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.614 -2.539 . . . . 0.0 106.34 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 39.29 -90.65 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.745 2.018 . . . . 0.0 115.005 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 46' ' ' PRO . 27.4 t . . . . . 0 N--CA 1.429 -1.511 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 -173.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' FES . . . . . 0.435 ' S1 ' ' HB3' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.5 t . . . . . 0 C--O 1.243 0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.8 m-85 -90.11 105.62 17.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.177 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -106.3 146.23 30.65 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -76.09 116.78 17.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -98.55 -30.89 3.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.523 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.0 p -167.35 -171.73 1.78 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.082 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 56.7 p -130.5 152.8 49.48 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.588 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.7 mt -67.9 -15.36 63.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.858 0.837 . . . . 0.0 109.325 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.4 -23.58 63.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.047 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -83.6 -64.55 1.15 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.7 pt -103.16 134.57 43.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.48 1.133 . . . . 0.0 113.604 -174.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 30.6 m95 -93.1 170.02 9.96 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.179 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.5 118.3 6.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.36 56.88 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -112.22 151.28 29.76 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.859 0.362 . . . . 0.0 110.539 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.516 ' SD ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -148.39 146.61 28.56 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 178.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.6 pt-20 -158.36 156.77 31.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.514 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.9 t -94.19 141.7 28.25 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.064 0.459 . . . . 0.0 110.039 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 92.7 m-85 -131.57 155.63 47.15 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.45 138.34 35.81 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -82.86 173.7 11.6 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -66.39 -15.48 63.33 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.155 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -93.59 -13.9 27.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.222 0.534 . . . . 0.0 110.204 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 -3.4 38.78 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.671 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 m -76.89 133.09 39.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.81 123.01 42.77 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.99 0.9 . . . . 0.0 109.149 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -122.62 143.83 34.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.449 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 2.8 tm? -94.24 120.48 34.54 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.4 113.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 7.7 p -112.84 128.53 69.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.123 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.9 t30 -111.06 102.3 10.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 169.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.4 p -103.64 157.81 16.8 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.885 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -76.46 -33.67 58.71 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.403 175.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -94.69 -46.14 7.05 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -97.28 -4.74 38.19 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.976 -0.453 . . . . 0.0 111.468 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.52 -163.12 48.09 Favored Glycine 0 C--O 1.248 0.995 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -93.36 118.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-O 121.716 0.77 . . . . 0.0 109.352 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -129.99 146.69 51.69 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.896 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.86 112.6 16.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.604 ' HB2' HD11 ' A' ' 86' ' ' LEU . 5.1 p90 -138.95 163.33 32.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -51.52 137.13 24.92 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.53 0.519 . . . . 0.0 110.377 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -111.66 -37.89 5.05 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -84.1 79.92 9.35 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -167.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -100.72 -28.41 0.23 Allowed Pre-proline 0 C--O 1.174 -2.921 0 CA-C-O 116.748 -1.596 . . . . 0.0 110.786 167.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 10.2 Cg_endo -50.06 105.44 0.1 OUTLIER 'Trans proline' 1 C--N 1.424 4.547 0 CA-C-N 122.683 1.994 . . . . 0.0 112.288 -177.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 68.0 m80 -82.61 9.46 9.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.032 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.74 116.9 20.93 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 103.358 -2.83 . . . . 0.0 103.358 170.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.0 OUTLIER -50.78 111.7 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -173.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 tp -155.27 163.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.14 100.25 9.99 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.066 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.436 HD11 HG22 ' A' ' 62' ' ' ILE . 6.0 tt -56.64 -32.83 65.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.624 1.169 . . . . 0.0 112.897 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 31.8 p -72.36 -22.48 61.14 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.495 0.664 . . . . 0.0 111.517 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -103.64 12.65 34.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.17 -103.08 2.85 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.817 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.549 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 22.6 t -144.74 145.42 31.68 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 123.372 1.558 . . . . 0.0 114.26 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -131.82 114.43 14.69 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 110.874 -2.875 . . . . 0.0 104.389 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -116.59 103.29 10.24 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.069 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.28 -72.77 0.43 Allowed Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.239 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.24 3.11 0.54 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.68 124.68 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.488 0.661 . . . . 0.0 109.363 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 52' ' ' LEU . 67.6 mt -93.66 139.13 18.82 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.549 ' OG1' ' HB3' ' A' ' 56' ' ' SER . 35.8 m -80.78 115.39 20.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.556 1.169 . . . . 0.0 112.873 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 37.1 t -93.06 141.07 28.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 173.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 65' ' ' ARG . 21.8 ttt180 -118.76 -42.53 2.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 117.237 -1.785 . . . . 0.0 114.691 -168.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . . . -93.45 -6.33 47.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.222 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 72.9 m80 -116.75 -174.21 2.53 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.425 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 69' ' ' TRP . 2.6 tm? -77.76 73.56 4.33 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.405 ' CD1' HD13 ' A' ' 68' ' ' LEU 0.343 17.9 p-90 35.94 -31.91 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 131.095 3.758 . . . . 0.0 120.841 172.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -102.19 127.29 49.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.402 ' CE2' HD13 ' A' ' 86' ' ' LEU . 37.1 t80 -135.33 136.15 41.33 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 171.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -123.59 133.32 53.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 117.773 -1.571 . . . . 0.0 114.16 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.17 -42.43 72.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.921 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.18 98.52 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.58 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -80.46 -27.46 37.88 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.21 26.7 73.88 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 16.9 t-160 -157.56 154.91 29.3 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -173.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.02 137.49 23.16 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.54 -41.83 20.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 51.0 t-20 -160.68 113.96 1.35 Allowed Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 67' ' ' HIS . 2.0 Cg_endo -81.44 -179.54 25.0 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.963 4.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.44 -19.51 29.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.838 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.35 -33.33 74.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.423 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.5 p -90.69 142.44 27.75 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-O 122.112 0.958 . . . . 0.0 112.078 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 108' ' ' ASN . 1.6 p -139.38 159.83 41.25 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.275 -1.329 . . . . 0.0 111.399 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 41' ' ' TYR . 34.4 tp -111.61 129.83 55.95 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.046 0.45 . . . . 0.0 110.997 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 108' ' ' ASN . . . -110.8 111.62 22.9 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.06 148.73 22.71 Favored 'General case' 0 N--CA 1.421 -1.894 0 O-C-N 123.618 0.574 . . . . 0.0 110.499 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 101' ' ' SER . 97.6 m-85 -108.7 149.8 39.94 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.624 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.8 121.83 9.29 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.7 2.267 . . . . 0.0 110.755 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.69 138.32 32.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.865 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 119.07 35.43 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.12 120.24 59.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.289 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' ' 94' ' ' LYS 0.282 0.0 OUTLIER -126.54 145.72 50.41 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.946 174.985 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -25.29 -45.75 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 119.763 2.665 . . . . 0.0 119.763 -171.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 8' ' ' SER . 26.6 m-20 -116.46 -13.59 10.96 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 117.808 0.804 . . . . 0.0 111.795 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 94' ' ' LYS . 5.0 m-20 -121.62 148.9 43.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.612 0.72 . . . . 0.0 112.887 -169.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -126.14 111.57 27.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.309 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -108.98 144.29 37.15 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.781 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 8.8 p -140.32 145.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 2' ' ' SER . 38.5 t -87.84 114.21 24.24 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -134.36 15.87 3.75 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.416 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -108.36 118.19 36.11 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.265 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 -3.82 86.73 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.175 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.6 mt -90.39 130.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 120.778 0.323 . . . . 0.0 110.444 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 61.6 tp -78.48 119.98 79.33 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.103 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 37.0 Cg_endo -69.11 145.93 62.55 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.842 2.361 . . . . 0.0 111.052 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.69 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 30.9 m-80 -88.91 179.14 6.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.853 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 11.0 mptt -67.8 101.38 1.06 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.74 1.257 . . . . 0.0 112.582 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.262 -3.239 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 -178.58 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.433 -1.282 0 CA-C-O 120.675 0.274 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' A' ' 92' ' ' GLU . 96.4 m-85 58.28 97.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.3 150.26 50.15 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.106 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 88.4 tttt -68.72 137.83 54.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.013 0.435 . . . . 0.0 111.602 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.457 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -127.25 -40.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' HG23 ' A' ' 6' ' ' ILE . 19.8 p -155.08 -172.11 4.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.305 0.574 . . . . 0.0 112.122 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p -131.45 150.01 52.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.646 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.7 tt -69.65 -25.66 64.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.05 -24.93 68.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.977 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.38 -55.11 3.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.683 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 12' ' ' ILE . 40.4 pt -100.82 110.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 122.541 1.162 . . . . 0.0 111.085 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -83.75 170.15 14.49 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.749 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -56.89 118.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.012 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 -2.27 61.25 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.64 142.3 34.56 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.97 142.11 32.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.189 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.737 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -148.16 133.8 18.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.232 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 89.4 m -79.03 123.08 26.97 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -119.23 155.04 32.44 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.508 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -102.65 134.66 45.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.819 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -83.55 167.36 17.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -63.14 -13.31 35.29 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -88.48 -12.27 43.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.25 30.87 11.45 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -97.62 133.59 41.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.64 126.83 35.78 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.176 0.512 . . . . 0.0 110.068 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 19' ' ' THR . 42.0 t -131.67 140.15 48.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -97.34 108.13 20.79 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.8 mp -99.36 115.85 41.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.37 125.11 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 42.5 t30 -97.26 105.08 17.16 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.306 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -101.4 148.58 25.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -76.64 -50.72 13.06 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.505 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.54 -38.5 14.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.81 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -79.72 -9.66 59.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.65 169.51 38.52 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.337 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -76.01 122.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.47 142.95 50.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.57 137.5 49.33 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 96.4 m-85 -130.35 149.77 51.88 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB3' ' H ' ' A' ' 87' ' ' ALA . 33.7 tt0 -52.02 136.31 29.39 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.86 19.61 18.91 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.65 0.738 . . . . 0.0 110.511 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.2 mmm -78.55 87.5 4.52 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.575 ' SG ' HD11 ' A' ' 52' ' ' LEU . 9.1 p -115.89 94.09 40.07 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 165.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.47 42.25 1.2 Allowed 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.993 2.462 . . . . 0.0 113.89 -170.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -96.26 -67.0 0.87 Allowed 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.884 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -161.7 -35.62 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.009 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.411 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 2.7 mp0 -99.74 100.65 11.64 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.873 0.844 . . . . 0.0 110.913 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.4 tp -92.51 0.49 9.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 122.734 1.254 . . . . 0.0 108.565 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.26 41.85 1.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.369 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.575 HD11 ' SG ' ' A' ' 45' ' ' CYS . 4.5 mp -56.66 -32.55 65.49 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.414 0.686 . . . . 0.0 111.248 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.737 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 80.7 p -72.23 -28.05 62.92 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.609 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -99.73 17.5 20.49 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 64' ' ' CYS . . . -86.68 -109.21 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 t -149.67 148.77 29.68 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.131 0.967 . . . . 0.0 111.883 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -129.89 121.11 26.02 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.109 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 44.2 mt-10 -115.4 168.13 10.26 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.35 64.48 2.47 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 120.802 -0.714 . . . . 0.0 113.128 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.09 -12.7 3.08 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 70.6 t -123.5 131.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 120.778 0.323 . . . . 0.0 110.382 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mm -111.47 135.58 50.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.0 m -128.06 129.16 46.2 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 43.1 t -63.85 -72.11 0.15 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 25.8 ttt180 161.05 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.65 1.58 . . . . 0.0 107.263 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.59 11.85 7.02 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.552 1.167 . . . . 0.0 108.668 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -146.57 145.61 30.17 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 127.464 2.306 . . . . 0.0 107.473 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.479 ' HB3' ' H ' ' A' ' 64' ' ' CYS . 43.3 tp 58.15 82.74 0.13 Allowed 'General case' 0 C--N 1.32 -0.677 0 O-C-N 124.965 1.416 . . . . 0.0 109.68 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -74.55 -45.76 43.39 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.421 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 p -133.69 129.11 36.33 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.665 0.745 . . . . 0.0 111.275 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 74.1 t80 -135.1 138.62 43.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -103.85 112.8 25.92 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.461 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.13 -22.26 66.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.58 1.152 . . . . 0.0 111.502 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 16.79 57.31 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.954 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.1 m -148.78 -47.98 0.15 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.201 -0.587 . . . . 0.0 111.14 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.46 -3.62 34.76 Favored Glycine 0 C--O 1.211 -1.337 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.794 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -104.17 147.5 27.38 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.997 -0.707 . . . . 0.0 110.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.48 133.71 11.95 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.2 mp -82.09 -43.15 19.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 27.2 t-20 -140.31 113.02 7.34 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.032 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 96.8 Cg_endo -85.68 163.86 57.51 Favored 'Cis proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.26 -1.558 . . . . 0.0 111.468 -1.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -82.5 -11.73 58.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.128 0.966 . . . . 0.0 108.463 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.08 -26.21 25.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.212 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 73.3 m -139.47 158.17 44.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.087 0.946 . . . . 0.0 111.631 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.2 m -153.06 169.09 23.78 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 42' ' ' GLN . 51.2 mt -126.79 163.92 22.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.755 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -118.32 153.66 33.61 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.21 131.8 47.45 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.301 1.0 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.529 ' CE1' ' HB ' ' A' ' 100' ' ' VAL . 1.7 t80 -126.44 106.54 23.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.79 125.13 16.14 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.844 3.03 . . . . 0.0 113.751 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.06 145.19 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.766 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.518 ' HG3' ' CE1' ' A' ' 3' ' ' PHE . 42.1 mt-10 -127.78 134.24 49.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.317 0.647 . . . . 0.0 110.345 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.1 117.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.524 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.79 108.91 11.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.251 178.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 55.92 54.68 33.53 Favored Glycine 0 CA--C 1.5 -0.865 0 C-N-CA 121.361 -0.447 . . . . 0.0 113.026 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 72.23 -6.4 1.55 Allowed 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 125.141 1.377 . . . . 0.0 113.842 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -100.89 138.86 37.37 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -126.37 125.51 67.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 5' ' ' LYS . 3.2 m-85 -112.83 141.63 46.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.738 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 89' ' ' TYR . 27.0 m -129.8 143.23 41.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.115 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 26.7 t -116.23 129.69 56.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.578 0.228 . . . . 0.0 111.32 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 2.9 m -86.38 -15.15 41.28 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -88.6 123.58 33.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.36 23.23 8.56 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 64.1 mt -100.12 129.44 50.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.977 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -106.44 102.12 39.22 Favored Pre-proline 0 N--CA 1.426 -1.655 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.02 132.68 23.41 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.276 1.984 . . . . 0.0 110.002 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.755 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 18.6 t30 -115.08 115.68 27.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.623 -172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 8.7 tmtt? 64.1 -53.32 0.26 Allowed 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 127.534 2.334 . . . . 0.0 111.239 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 C--N 1.284 -2.27 0 C-N-CA 124.23 1.012 . . . . 0.0 109.113 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 68.7 103.41 0.05 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.925 0.869 . . . . 0.0 111.382 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.25 143.16 37.46 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.539 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -69.41 119.28 13.43 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.506 0.722 . . . . 0.0 109.504 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -115.97 -47.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.471 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.3 p -157.57 -168.08 2.46 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-O 121.452 0.644 . . . . 0.0 112.096 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.2 p -129.56 152.36 49.17 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.402 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.48 ' O ' HD13 ' A' ' 9' ' ' LEU . 1.6 tm? -67.23 -16.2 64.15 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.46 -29.9 70.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.786 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.82 -60.35 2.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.038 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -111.56 118.17 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 122.356 1.074 . . . . 0.0 113.227 -176.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -99.15 171.83 7.76 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.237 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 34' ' ' GLU . 7.2 p -51.11 111.73 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 CA-C-O 121.567 0.699 . . . . 0.0 111.443 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.75 7.68 56.41 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.38 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -109.45 151.59 26.5 Favored 'General case' 0 C--O 1.246 0.914 0 O-C-N 122.37 -0.488 . . . . 0.0 110.219 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -150.46 137.48 19.3 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.1 mt-10 -149.66 153.48 37.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.0 t -92.87 138.15 31.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.236 0.541 . . . . 0.0 110.565 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 148.82 52.43 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 42.6 tt0 -98.22 146.0 26.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.939 0.399 . . . . 0.0 111.544 -171.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -83.26 178.72 7.95 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 m -70.57 -11.9 61.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.46 0.648 . . . . 0.0 110.592 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -91.49 -14.36 30.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.044 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.08 15.57 51.21 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.501 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.1 m -97.34 128.4 44.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.381 -0.482 . . . . 0.0 109.844 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 40.3 mt-10 -90.05 128.07 36.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.445 0.64 . . . . 0.0 111.036 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' THR . 94.3 t -117.99 141.54 36.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.53 -175.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.5 117.11 29.79 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.2 mp -100.11 112.79 33.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.59 130.55 68.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.75 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -105.52 106.91 17.63 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 t -79.36 146.49 32.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 124.451 1.1 . . . . 0.0 110.769 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.495 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 mp0 -53.94 -50.19 67.0 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.365 1.066 . . . . 0.0 111.904 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -110.4 -36.87 5.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.589 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -79.96 -28.51 39.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.482 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.78 -149.97 17.39 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.881 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -86.39 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.712 0.768 . . . . 0.0 111.652 -171.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -129.26 130.0 45.65 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.316 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.54 111.5 15.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.032 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -144.56 154.52 42.95 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.53 137.06 19.97 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.644 0.59 . . . . 0.0 109.652 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.87 -54.03 9.85 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -88.27 160.94 17.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.777 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' A' ' 64' ' ' CYS . 13.5 p -89.62 86.44 0.17 Allowed Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 45' ' ' CYS . 19.9 Cg_exo -1.44 42.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.95 1 C-N-CA 128.156 5.904 . . . . 0.0 119.476 -162.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -149.71 129.93 13.67 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 68.31 123.7 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 114.796 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -85.77 103.27 14.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.304 176.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tp -153.07 154.68 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.36 80.51 4.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.198 0.999 . . . . 0.0 110.233 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -73.22 -19.17 61.14 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.679 -176.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 30.5 p -56.31 -19.72 15.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -84.42 -9.67 58.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.378 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.13 75.41 0.28 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.1 m -130.76 -73.29 0.55 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.311 0.577 . . . . 0.0 110.841 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.569 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 64.8 t80 -91.26 112.74 24.78 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.332 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -118.89 104.05 10.17 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.21 -73.11 0.41 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-O 121.28 0.378 . . . . 0.0 112.643 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.73 12.3 0.46 Allowed Glycine 0 C--N 1.301 -1.4 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.66 134.48 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 40.0 mm -100.15 139.41 21.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 m -83.56 115.08 21.95 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 111.72 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.686 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 5.6 t -81.02 119.33 23.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.424 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -60.57 -60.24 4.12 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.94 -39.05 4.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 10.6 m80 -58.09 -45.6 86.92 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -157.56 -95.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.425 ' CD1' HG23 ' A' ' 70' ' ' THR . 18.4 p90 172.96 -16.46 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 124.387 1.075 . . . . 0.0 110.376 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 69' ' ' TRP . 35.1 p -101.78 128.82 47.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.158 0.504 . . . . 0.0 111.802 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.634 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 43.7 t80 -137.5 138.98 40.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 171.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.02 111.15 22.15 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.05 -33.38 63.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 111.713 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.73 88.69 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -94.99 -28.48 15.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.309 0.576 . . . . 0.0 109.612 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.72 18.83 64.9 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -136.54 137.6 40.42 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.82 137.73 20.48 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.398 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.84 -44.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -154.04 109.2 2.48 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.1 148.85 91.95 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.167 -1.597 . . . . 0.0 113.213 3.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 14.2 t70 -86.2 -24.69 26.0 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.869 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.91 -37.83 86.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.0 m -94.72 151.32 19.37 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 123.077 1.418 . . . . 0.0 112.715 -177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.73 140.04 20.4 Favored 'General case' 0 C--N 1.262 -3.232 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.681 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.634 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 7.6 mp -110.97 100.98 9.58 Favored 'General case' 0 C--N 1.259 -3.368 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.617 -175.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.26 127.73 33.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.604 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.2 160.77 25.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 124.003 0.814 . . . . 0.0 110.014 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.12 148.41 43.56 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 105' ' ' ILE . 26.6 Cg_exo -62.94 121.16 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.017 1.812 . . . . 0.0 109.248 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.11 133.67 68.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.426 0.632 . . . . 0.0 111.765 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.439 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 47.3 mt-10 -122.76 135.05 54.44 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.15 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.98 120.82 63.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.115 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -121.66 91.33 3.49 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.93 -99.19 0.18 Allowed Glycine 0 N--CA 1.437 -1.271 0 O-C-N 123.793 0.683 . . . . 0.0 113.869 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -90.55 -18.55 25.05 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.828 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -110.91 147.47 34.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 12' ' ' ILE . 78.6 mt -127.32 129.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.577 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -119.22 136.9 53.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.68 137.53 55.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -97.35 114.69 26.52 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.012 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.5 m -100.27 -40.53 7.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -53.86 111.0 0.66 Allowed 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.686 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.82 -25.28 9.64 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.343 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.426 ' CD1' ' HD3' ' A' ' 90' ' ' PRO . 67.3 mt -103.73 133.16 48.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 120.939 0.4 . . . . 0.0 110.119 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.89 124.05 55.71 Favored Pre-proline 0 N--CA 1.403 -2.799 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.464 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 149.29 85.78 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 121.865 1.71 . . . . 0.0 108.712 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -91.49 113.54 25.83 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm 49.66 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 124.71 1.256 . . . . 0.0 110.241 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 C-N-CA 125.856 1.662 . . . . 0.0 111.299 176.469 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 39.9 t . . . . . 0 N--CA 1.428 -1.568 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 81.0 m-85 -80.15 97.9 7.08 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.157 0.503 . . . . 0.0 109.701 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -106.23 143.75 33.91 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -75.0 124.05 26.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -83.18 -54.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.8 m -171.98 -173.79 1.19 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 126.001 1.72 . . . . 0.0 108.052 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.702 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 15.5 p -101.11 151.47 21.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 96' ' ' ASP . 53.1 tp -60.13 -17.85 43.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.257 1.027 . . . . 0.0 108.971 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.86 -25.74 68.3 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.164 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -93.11 -43.8 8.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.303 0.573 . . . . 0.0 109.824 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 tp -100.28 117.21 45.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.984 0.897 . . . . 0.0 111.868 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -105.86 168.97 8.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.298 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.58 123.68 26.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.143 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.72 65.29 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -104.01 162.13 13.4 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.04 0.447 . . . . 0.0 110.377 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 53' ' ' SER . 26.7 ptt? -150.15 136.84 19.16 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.642 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.3 tp10 -147.39 152.93 38.97 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.622 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.571 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 97.2 m -97.33 129.19 44.63 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.85 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -139.74 157.97 44.87 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.5 tt0 -108.01 143.78 36.23 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.159 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 p -83.07 168.61 16.75 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -68.18 -18.62 64.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.442 0.639 . . . . 0.0 109.664 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.44 -13.33 52.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.84 14.26 37.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.201 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 m -97.37 126.39 42.58 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 35.6 tt0 -89.2 123.69 33.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.405 HG11 ' HB1' ' A' ' 40' ' ' ALA . 58.9 t -127.47 146.01 33.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.7 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.53 111.92 24.42 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.4 mp -95.95 119.22 43.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 17' ' ' MET . 7.6 p -110.08 123.82 66.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -114.51 104.15 11.74 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.376 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 36' ' ' HIS . 58.9 p -102.32 148.77 25.06 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.13 -37.96 66.46 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.315 0.578 . . . . 0.0 110.27 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -86.13 -30.2 22.7 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.811 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.452 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 12.0 m170 -106.84 -23.58 12.34 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.82 -170.96 17.56 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.448 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -98.25 121.45 48.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.495 0.664 . . . . 0.0 111.459 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -117.77 148.15 42.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.195 177.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -124.18 113.19 17.99 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -131.72 163.6 27.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -50.71 138.14 18.82 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.707 0.63 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.09 8.74 32.38 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.2 tpt -75.57 88.4 2.7 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.217 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' A' ' 48' ' ' GLN . 44.8 t -159.25 85.57 2.25 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.918 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.62 5.62 6.28 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.315 2.01 . . . . 0.0 108.947 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.457 ' HE1' ' HB3' ' A' ' 67' ' ' HIS . 17.9 t-160 -86.51 -18.91 30.38 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.74 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.719 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 53.6 tt0 -69.24 147.06 51.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.421 -1.263 . . . . 0.0 113.383 -171.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.16 100.05 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.046 1.738 . . . . 0.0 112.953 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mm 63.75 -79.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 125.049 1.339 . . . . 0.0 114.017 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -118.65 119.99 36.12 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -174.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.9 pt? -63.93 -49.08 74.0 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.642 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 77.4 p -73.74 -31.34 63.31 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.499 0.666 . . . . 0.0 112.446 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' H ' HD12 ' A' ' 51' ' ' LEU . 43.4 mt-10 -95.11 22.06 7.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.78 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.0 -95.41 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.655 0.597 . . . . 0.0 113.373 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.7 m -155.53 127.5 7.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.899 0.857 . . . . 0.0 111.903 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -130.44 120.62 24.47 Favored 'General case' 0 C--N 1.261 -3.273 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.707 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 45.9 mt-10 -110.21 168.17 9.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -37.01 -58.45 1.22 Allowed Glycine 0 N--CA 1.48 1.575 0 O-C-N 124.236 0.96 . . . . 0.0 114.782 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.26 24.59 4.7 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.771 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 64.5 t -124.15 122.07 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 120.944 0.402 . . . . 0.0 110.484 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.658 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 47.8 mm -95.72 138.08 22.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 m -127.22 115.69 19.45 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.18 -1.408 . . . . 0.0 111.112 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.417 ' HB3' HD12 ' A' ' 68' ' ' LEU . 4.1 t -64.86 -21.78 66.87 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.542 ' H ' HD11 ' A' ' 68' ' ' LEU 0.343 71.6 ttt180 46.39 80.95 0.04 OUTLIER 'General case' 0 C--O 1.248 1.009 0 C-N-CA 129.505 3.122 . . . . 0.0 117.792 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 174.02 -45.4 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 125.352 1.657 . . . . 0.0 109.464 173.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.457 ' HB3' ' HE1' ' A' ' 47' ' ' HIS . 4.7 p-80 -123.31 8.84 9.11 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -119.82 162.75 18.57 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.547 -1.261 . . . . 0.0 112.759 -177.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 75.6 t-105 -96.71 -69.45 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 p -135.01 141.96 46.32 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 121.497 0.665 . . . . 0.0 111.686 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.658 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 21.3 t80 -135.45 138.29 43.04 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -98.81 127.22 44.68 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.2 -56.59 17.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.157 0.983 . . . . 0.0 113.446 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.33 -50.43 62.42 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.202 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.2 m -81.17 -32.51 33.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.165 0.507 . . . . 0.0 110.402 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.97 71.65 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.631 ' HA ' ' SG ' ' A' ' 85' ' ' CYS . 14.2 t-80 -102.65 138.61 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.543 1.137 . . . . 0.0 109.567 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.1 140.79 15.66 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.8 -48.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 48.6 t30 -149.17 112.18 3.52 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.052 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.6 Cg_exo -76.8 160.68 94.73 Favored 'Cis proline' 0 C--O 1.241 0.663 0 C-N-CA 123.127 -1.614 . . . . 0.0 111.817 -0.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.38 -40.88 66.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.742 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -89.44 26.28 1.73 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.194 0.521 . . . . 0.0 111.719 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 71' ' ' PHE . 18.5 t -101.27 6.22 42.79 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.581 0.705 . . . . 0.0 109.428 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 38.0 m -51.53 155.91 1.43 Allowed 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.127 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 pp -101.53 -177.86 3.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.27 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.58 113.55 15.59 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.5 120.33 32.87 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.638 0.733 . . . . 0.0 110.904 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -91.61 129.65 41.92 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.21 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.49 120.89 8.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.693 2.929 . . . . 0.0 112.04 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.01 131.74 56.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.233 0.54 . . . . 0.0 111.114 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -109.38 110.56 21.74 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.2 115.81 50.72 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.49 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -126.01 147.02 49.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -38.91 124.45 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.602 0.564 . . . . 0.0 113.628 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.702 ' O ' ' HB2' ' A' ' 8' ' ' SER . 19.5 m-20 78.92 -19.53 0.44 Allowed 'General case' 0 C--O 1.2 -1.535 0 C-N-CA 126.281 1.832 . . . . 0.0 114.928 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 34.4 t70 -145.77 143.64 29.82 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.673 1.579 . . . . 0.0 114.266 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.94 127.15 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.38 151.3 38.72 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.364 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.87 144.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 121.388 0.613 . . . . 0.0 111.627 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 37.3 t -95.28 124.85 39.54 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.094 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -111.07 15.41 21.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 63.8 tttp -66.35 110.18 2.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.789 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.53 7.11 78.5 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.256 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.04 108.8 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.22 155.66 38.63 Favored Pre-proline 0 N--CA 1.411 -2.412 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 138.19 53.63 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.918 1.745 . . . . 0.0 109.632 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.12 169.8 17.62 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -52.65 -23.1 5.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.061 1.344 . . . . 0.0 113.782 -171.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.286 -2.164 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.96 178.79 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 24.6 m . . . . . 0 CA--C 1.554 1.113 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 77.1 m-85 -95.65 107.54 19.75 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -114.12 150.31 34.29 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.04 117.72 9.48 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 tp -111.33 -39.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.945 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.5 m -147.94 172.26 14.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.363 0.601 . . . . 0.0 110.717 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 27.2 m -118.86 152.38 36.36 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 170.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.57 -17.15 12.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.524 0.678 . . . . 0.0 112.398 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.69 -22.15 54.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.92 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.54 -35.73 24.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.888 0.852 . . . . 0.0 109.305 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 30' ' ' ILE . 3.2 tp -125.07 113.95 38.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.165 -173.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -104.28 168.39 9.13 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.829 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 122.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.308 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.88 65.36 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -103.84 159.91 15.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 121.405 0.621 . . . . 0.0 112.07 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 26.8 ptt? -151.35 140.89 21.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.07 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 43.8 tt0 -154.53 155.04 34.1 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.831 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 85.1 m -90.39 132.01 35.84 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.634 0.731 . . . . 0.0 110.677 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -128.37 153.49 47.0 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.11 137.44 45.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.565 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 p -83.89 -178.33 6.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.611 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -70.24 -30.75 67.88 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.69 -13.01 57.15 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.46 20.28 13.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.222 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.9 m -87.14 123.67 32.43 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.57 123.01 33.88 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.9 t -133.09 146.0 33.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 120.778 0.323 . . . . 0.0 110.269 -174.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD23 ' CE1' ' A' ' 41' ' ' TYR . 66.3 tp -96.17 114.81 26.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.1 mp -96.53 116.76 39.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 17' ' ' MET . 43.5 t -112.84 128.64 69.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 42.4 t30 -110.91 107.14 16.5 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -96.62 149.39 21.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.856 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -50.3 49.55 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -89.1 -37.57 14.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.898 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -94.35 1.42 55.88 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 -161.51 54.24 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.704 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 22.2 t -89.22 122.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -122.31 136.44 54.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.37 127.31 47.39 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.438 ' CE1' HD23 ' A' ' 29' ' ' LEU . 40.3 p90 -143.68 163.7 32.53 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.393 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -44.3 137.38 3.58 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.897 0.748 . . . . 0.0 110.101 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.78 -36.03 7.17 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.32 121.54 29.04 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.931 -0.707 . . . . 0.0 112.309 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.3 t -97.11 118.66 64.5 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HG3' ' HA ' ' A' ' 110' ' ' ALA . 41.7 Cg_endo -90.78 10.55 2.84 Favored 'Trans proline' 0 CA--C 1.502 -1.114 0 C-N-CA 123.129 2.553 . . . . 0.0 111.151 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.3 t-160 -72.02 -56.06 6.3 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -140.95 -63.89 0.46 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -125.6 157.86 36.11 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.411 HG13 ' CD2' ' A' ' 51' ' ' LEU . 38.1 pt -108.42 -161.57 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.039 0.936 . . . . 0.0 109.336 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.411 ' CD2' HG13 ' A' ' 50' ' ' ILE . 4.3 mm? 74.6 29.01 1.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.884 0.85 . . . . 0.0 110.587 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 64' ' ' CYS . 53.8 tp -59.08 -29.69 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.478 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.499 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 51.0 p -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.279 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -109.95 22.47 15.59 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.89 -129.38 1.37 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 t -137.26 151.99 49.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.148 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -129.87 129.25 43.7 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.87 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.48 169.48 9.13 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.25 -46.62 5.43 Favored Glycine 0 N--CA 1.476 1.305 0 O-C-N 123.964 0.79 . . . . 0.0 114.239 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.58 14.95 3.4 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.786 -1.197 . . . . 0.0 113.073 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.93 140.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.6 ' HB ' ' CB ' ' A' ' 71' ' ' PHE . 29.3 mm -112.27 140.34 32.47 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.639 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 68' ' ' LEU . 49.9 m -100.47 117.55 34.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.823 -0.548 . . . . 0.0 110.674 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.497 ' HA ' HD13 ' A' ' 52' ' ' LEU . 43.0 t -66.25 135.72 54.85 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -49.82 107.0 0.13 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.082 0.553 . . . . 0.0 111.917 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.26 13.94 9.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.472 1.109 . . . . 0.0 113.177 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -129.53 98.12 4.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.628 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 69' ' ' TRP . 4.4 mm? 64.95 -170.34 0.19 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.422 ' H ' ' HB3' ' A' ' 68' ' ' LEU . 50.4 p-90 -128.66 11.61 6.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.645 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -120.05 130.8 54.86 Favored 'General case' 0 C--O 1.167 -3.271 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.6 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 45.4 t80 -139.74 159.43 42.19 Favored 'General case' 0 CA--C 1.469 -2.142 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 166.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.48 ' CB ' ' HA3' ' A' ' 78' ' ' GLY . 51.0 t30 -115.73 99.08 7.05 Favored 'General case' 0 N--CA 1.391 -3.398 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.024 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.46 -60.16 3.45 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.775 -173.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.48 32.71 4.62 Favored Glycine 0 C--N 1.304 -1.213 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.777 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.479 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 26.0 m -151.4 -38.62 0.12 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.282 0.541 . . . . 0.0 111.318 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.76 -55.84 0.52 Allowed Glycine 0 C--O 1.223 -0.575 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.829 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 85' ' ' CYS . 16.2 p80 -85.1 135.24 34.07 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 72' ' ' ASN . . . 157.14 38.0 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.385 0 N-CA-C 119.815 2.686 . . . . 0.0 119.815 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.731 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 mp -107.11 -56.11 5.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 116.901 -1.92 . . . . 0.0 111.775 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 24.6 t-20 159.34 105.49 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.389 1.476 . . . . 0.0 107.909 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 5.7 Cg_exo -78.83 -170.86 9.15 Favored 'Cis proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.812 -1.745 . . . . 0.0 110.909 1.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 7.0 m-20 -61.15 -18.17 56.69 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.72 -32.8 70.87 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.062 1.345 . . . . 0.0 113.121 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.731 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 17.9 p -81.74 133.12 35.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.124 -1.031 . . . . 0.0 112.311 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 77' ' ' HIS . 12.9 p -142.02 170.1 16.35 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.603 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -146.13 125.83 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.576 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.73 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -60.25 129.0 39.5 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -96.26 131.17 43.03 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.789 0.681 . . . . 0.0 109.556 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 101' ' ' SER . 47.4 m-85 -116.08 138.56 24.24 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -59.97 135.12 60.86 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 C-N-CA 123.15 2.566 . . . . 0.0 112.037 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.87 130.78 74.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -109.92 112.7 24.89 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.88 106.73 21.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 122.07 0.938 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.534 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -129.64 117.32 20.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.342 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.16 -115.14 7.63 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.302 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 8' ' ' SER . 7.1 m-20 -95.76 -10.78 28.23 Favored 'General case' 0 C--O 1.195 -1.791 0 O-C-N 123.64 0.259 . . . . 0.0 110.784 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -104.21 138.66 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.2 mt -124.74 115.33 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.463 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-85 -109.52 145.08 36.89 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.881 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 60.2 t -134.11 145.56 32.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 32.8 t -87.86 113.69 23.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 t -126.2 -11.34 6.41 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.203 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' SER . 59.1 tttp -122.87 126.42 47.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.38 -39.86 2.46 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.2 mt -102.07 106.21 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 5.5 tt -85.79 130.42 50.78 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 7.1 Cg_exo -42.08 128.78 4.27 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 124.056 3.17 . . . . 0.0 112.02 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.73 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -94.22 116.69 29.12 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.983 0.421 . . . . 0.0 111.04 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.549 ' HD3' ' SG ' ' A' ' 85' ' ' CYS . 89.0 tttt 57.0 -169.16 0.1 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.282 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.53 ' H ' ' HG2' ' A' ' 109' ' ' LYS . . . . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 101' ' ' SER . 57.5 m . . . . . 0 N--CA 1.437 -1.089 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -88.56 131.77 34.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.007 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.67 149.17 38.52 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 6.7 ttpm? -68.7 127.1 31.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 7.6 tp -83.75 -50.31 15.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' N ' HG23 ' A' ' 6' ' ' ILE . 95.7 m -164.64 -175.24 3.74 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 125.094 1.357 . . . . 0.0 108.416 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 6.9 m -111.16 154.98 23.58 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.07 -16.41 7.31 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.429 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 5.1 p-10 -79.99 -20.2 46.02 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.657 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.05 -54.56 4.76 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 98' ' ' ILE . 4.0 tp -108.05 110.54 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.071 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB2' ' CG ' ' A' ' 16' ' ' GLU . 20.8 m95 -86.37 163.03 17.88 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.227 -1.352 . . . . 0.0 111.163 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.65 121.88 26.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.235 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.5 59.81 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 13' ' ' TRP . 24.4 mm-40 -107.66 162.42 13.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.937 0.399 . . . . 0.0 110.964 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.658 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 26.1 ptt? -144.3 135.57 25.49 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.179 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 53' ' ' SER 0.319 10.1 pt-20 -157.18 155.12 30.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 71.9 m -83.52 127.05 33.42 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.681 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 76.6 m-85 -126.81 150.5 49.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -97.55 143.81 27.87 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.534 0.683 . . . . 0.0 111.457 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -83.55 176.98 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.518 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -74.39 -8.78 57.42 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.2 0.524 . . . . 0.0 111.241 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.9 -6.16 51.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.405 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.81 17.67 57.7 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.019 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 m -94.47 127.32 40.3 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.24 124.29 34.25 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.652 0.739 . . . . 0.0 110.602 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' THR . 48.7 t -125.42 146.5 31.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.93 -175.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 65.4 tp -89.35 111.21 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.81 114.21 31.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.78 123.72 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.9 t30 -106.46 104.7 14.45 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.592 ' CB ' ' HB3' ' A' ' 36' ' ' HIS . 19.6 m -100.33 157.34 16.69 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.1 -51.41 13.54 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -108.55 -25.21 11.02 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.954 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.592 ' HB3' ' CB ' ' A' ' 33' ' ' SER . 43.6 t-80 -79.17 -7.61 58.35 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.785 0.803 . . . . 0.0 109.166 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.73 173.19 17.77 Favored Glycine 0 CA--C 1.5 -0.86 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.591 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.1 p -84.64 117.58 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.27 176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -130.07 149.14 51.92 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.319 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -123.71 132.35 53.81 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.6 154.84 51.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.433 ' OE1' ' HB3' ' A' ' 107' ' ' PRO . 26.6 mm-40 -53.98 137.02 40.41 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.567 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -101.13 -11.35 19.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.873 0.844 . . . . 0.0 109.739 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.9 mmt -93.98 108.77 20.55 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.054 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 110' ' ' ALA . 24.0 p -105.79 172.57 3.86 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 73.2 Cg_endo -76.15 21.78 0.52 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 121.89 1.727 . . . . 0.0 111.605 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 32.0 m80 -144.45 135.35 25.04 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 125.336 1.454 . . . . 0.0 107.649 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 60.11 -172.11 0.13 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.512 0.672 . . . . 0.0 112.394 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.66 -48.88 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.3 pt -94.66 178.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp 79.67 -25.88 0.18 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.463 1.105 . . . . 0.0 112.368 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 43' ' ' ALA . 4.0 mm? -56.8 -40.89 76.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.535 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 90.5 p -80.31 -15.6 56.53 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.369 0.604 . . . . 0.0 110.888 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -92.0 -9.13 44.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.949 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 126.65 0.89 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.589 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.7 t 178.28 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.658 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 66.3 t80 -91.85 113.11 25.29 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.109 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -115.91 105.34 12.56 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.452 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 -69.24 1.69 Allowed Glycine 0 C--O 1.241 0.567 0 O-C-N 123.215 0.322 . . . . 0.0 112.313 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.68 26.39 0.16 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.62 133.8 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 42.9 mm -96.51 117.16 40.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.003 0.906 . . . . 0.0 109.525 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.7 m -102.0 121.33 41.95 Favored 'General case' 0 C--N 1.259 -3.333 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.194 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 1.2 m -75.24 -177.02 3.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.374 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 2.8 mmp_? -119.33 -42.44 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.165 -1.014 . . . . 0.0 113.153 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -98.17 -20.57 17.21 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.606 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -116.51 137.33 52.26 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 117.969 -1.493 . . . . 0.0 109.314 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 68' ' ' LEU . 2.9 tm? -63.26 -36.47 83.76 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 124.28 1.032 . . . . 0.0 113.119 -170.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 13.5 m-90 -62.26 174.36 0.95 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -103.37 161.22 14.02 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.644 0.735 . . . . 0.0 112.6 -169.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.526 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 48.7 t80 -132.43 141.41 48.83 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.24 119.8 31.25 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -73.47 -22.31 60.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.48 -54.49 10.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.6 m -73.9 -34.65 64.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.844 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.8 -4.26 49.73 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.751 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -125.27 161.74 26.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 122.84 0.456 . . . . 0.0 110.381 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -77.98 144.07 28.28 Favored Glycine 0 N--CA 1.416 -2.65 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.83 -30.68 29.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 27.4 t-20 -143.61 125.83 8.53 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.356 172.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 80' ' ' ASN . 22.0 Cg_exo -67.37 -63.79 0.03 OUTLIER 'Cis proline' 0 C--N 1.354 0.824 0 C-N-CA 123.847 -1.314 . . . . 0.0 113.783 0.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 21.4 t70 164.91 -35.06 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 125.122 1.369 . . . . 0.0 109.569 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.16 -26.91 69.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.845 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.31 142.36 39.46 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 121.744 0.783 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.33 150.93 31.09 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.834 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 86' ' ' LEU . 1.6 pt? -114.44 141.34 47.8 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.267 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -88.12 124.05 33.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.379 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -96.74 110.85 23.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 33.9 m-85 -79.24 139.79 56.44 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.662 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.27 120.22 7.4 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.227 1.952 . . . . 0.0 109.114 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.57 HG22 HG23 ' A' ' 100' ' ' VAL . 20.9 t -132.38 140.84 46.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -136.37 150.32 48.76 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.977 0.418 . . . . 0.0 110.982 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.02 117.28 55.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.283 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -125.94 100.73 6.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.603 0.716 . . . . 0.0 110.243 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.94 -112.16 3.95 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.083 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' SER . 19.5 m-20 -102.24 -1.82 30.42 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.729 -0.235 . . . . 0.0 111.115 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 26.1 m-20 -121.82 155.85 34.47 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.84 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 12' ' ' ILE . 75.1 mt -127.58 129.04 70.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 5' ' ' LYS . 54.5 p90 -112.72 143.14 44.45 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.926 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 91' ' ' VAL . 5.9 p -132.85 143.39 39.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.806 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 2' ' ' SER . 33.5 t -91.58 113.94 26.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.0 p -109.99 -41.25 4.52 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.339 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -70.65 112.17 6.68 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.136 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.3 -27.32 7.03 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.5 mm -99.78 117.73 45.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 tt -99.27 136.38 20.48 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.433 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 50.5 Cg_exo -55.72 127.78 27.58 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.309 2.006 . . . . 0.0 111.534 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 33.9 t-20 -84.45 177.33 8.17 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.462 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -74.27 60.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 124.248 1.019 . . . . 0.0 113.354 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' CYS . . . . . . . . 0 C--N 1.273 -2.748 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 74.17 96.77 0.07 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -166.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -119.79 150.06 41.02 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.99 109.51 5.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -92.04 -40.91 12.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.853 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . 63.7 m -155.09 175.85 13.3 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.473 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 m -120.88 154.79 35.37 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.21 -25.28 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.203 0.525 . . . . 0.0 111.062 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.49 -20.61 62.84 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.258 0.551 . . . . 0.0 110.777 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 17.4 m-20 -88.51 -36.88 16.17 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.938 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 tp -130.71 116.14 33.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.158 0.98 . . . . 0.0 111.736 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -104.72 167.15 9.91 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.029 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.57 130.47 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.245 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 10.09 70.61 Favored Glycine 0 C--N 1.309 -0.942 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.61 147.68 48.34 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 120.814 0.34 . . . . 0.0 111.108 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.8 mtp -130.74 133.74 46.29 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 33.4 mt-10 -146.17 140.43 26.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.861 0.363 . . . . 0.0 111.349 172.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.1 m -73.78 132.48 42.65 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -128.4 162.22 27.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -106.18 137.06 44.78 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.413 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -83.54 171.87 12.93 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 m -67.8 -17.99 64.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.056 0.455 . . . . 0.0 111.729 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.56 4.8 51.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.8 29.36 35.29 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.597 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -98.68 136.72 38.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.386 -0.479 . . . . 0.0 110.177 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.49 124.94 34.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 41' ' ' TYR . 97.3 t -133.6 147.01 31.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -96.41 117.21 30.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -100.78 116.97 45.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.3 122.83 68.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.453 ' OD1' ' HB ' ' A' ' 38' ' ' VAL . 49.3 t30 -113.87 106.8 14.88 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.432 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -99.99 150.78 22.08 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -51.38 12.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.58 -45.86 12.13 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -79.01 -12.95 60.04 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.025 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -175.75 50.83 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.139 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' OD1' ' A' ' 32' ' ' ASN . 6.6 p -105.4 125.26 60.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.524 0.678 . . . . 0.0 111.115 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -129.92 150.98 50.96 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.595 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.07 128.44 49.33 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 2.6 m-85 -131.08 163.08 28.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.68 ' HB2' HD11 ' A' ' 86' ' ' LEU . 15.7 mm100 -53.12 138.95 30.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.19 -28.24 1.2 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 -169.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.502 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -162.28 -178.15 6.15 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -169.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.419 ' C ' ' H ' ' A' ' 47' ' ' HIS . 86.9 m -87.02 163.75 39.16 Favored Pre-proline 0 C--N 1.361 1.091 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 169.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 45' ' ' CYS . 49.4 Cg_endo -69.58 24.31 0.17 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.276 1.984 . . . . 0.0 113.037 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.419 ' H ' ' C ' ' A' ' 45' ' ' CYS . 32.2 m170 -111.96 -52.25 2.8 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.414 ' OE1' ' HG2' ' A' ' 44' ' ' MET . 19.9 tp60 63.33 108.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 167.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 55.0 mm-40 -124.5 170.74 10.59 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 165.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 pt -87.18 167.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 118.429 0.559 . . . . 0.0 111.092 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.7 mt 70.73 28.84 3.35 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.533 1.133 . . . . 0.0 111.449 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.707 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.7 pt? -75.24 -42.17 55.84 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.659 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 96.1 p -72.93 -21.97 60.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.924 0.869 . . . . 0.0 109.503 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.66 15.86 5.26 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.293 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.2 -124.93 1.93 Allowed Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.4 m -142.79 157.09 44.97 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-O 122.167 0.984 . . . . 0.0 113.009 -174.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.06 116.79 19.84 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.27 -1.787 . . . . 0.0 108.222 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -115.15 104.55 11.96 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.87 -74.87 0.46 Allowed Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.648 0.582 . . . . 0.0 111.905 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.0 0.51 0.34 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.69 143.33 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.507 HG12 ' H ' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -117.89 117.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.389 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.5 m -108.86 132.15 54.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.255 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.767 ' HB2' ' H ' ' A' ' 68' ' ' LEU . 1.7 p -85.02 -13.91 49.02 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 64.47 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.973 0.909 . . . . 0.0 112.649 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.49 27.74 8.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 109.775 -175.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.608 ' C ' HD12 ' A' ' 68' ' ' LEU 0.276 96.2 m-70 84.01 97.24 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.767 ' H ' ' HB2' ' A' ' 64' ' ' CYS . 7.2 mp -149.51 -80.04 0.13 Allowed 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 127.906 2.482 . . . . 0.0 108.954 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.646 ' N ' ' HB3' ' A' ' 64' ' ' CYS . 0.9 OUTLIER -146.8 135.22 21.89 Favored 'General case' 0 CA--C 1.594 2.641 0 O-C-N 121.955 -0.466 . . . . 0.0 111.221 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -139.69 132.4 29.0 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.541 -0.725 . . . . 0.0 112.721 174.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.507 ' H ' HG12 ' A' ' 62' ' ' ILE . 75.2 t80 -138.15 150.43 46.8 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.353 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.611 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . 45.8 t-20 -105.98 100.46 10.01 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.01 -36.71 50.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.13 -3.3 60.38 Favored Glycine 0 C--N 1.311 -0.832 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.857 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.3 m -139.74 -14.55 1.07 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.089 0.944 . . . . 0.0 112.98 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.49 -59.17 4.99 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 42.0 m80 -63.44 102.29 0.4 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 72' ' ' ASN . . . -161.06 19.06 0.2 Allowed Glycine 0 CA--C 1.469 -2.823 0 C-N-CA 119.985 -1.102 . . . . 0.0 114.284 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 86' ' ' LEU . 1.5 mp -98.77 -12.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.106 0 CA-C-N 115.126 -0.537 . . . . 0.0 111.131 -169.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 73.7 m-20 77.28 115.06 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.721 0 C-N-CA 125.293 1.437 . . . . 0.0 112.111 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 14.1 Cg_exo -71.35 -174.14 10.74 Favored 'Cis proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.039 -1.65 . . . . 0.0 112.012 -0.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 77' ' ' HIS . 9.2 p-10 -68.99 2.76 2.43 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.714 0.769 . . . . 0.0 111.248 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.55 -21.14 42.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.965 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.507 ' SG ' ' HE2' ' A' ' 109' ' ' LYS . 37.3 m -102.42 141.38 35.34 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.424 0.631 . . . . 0.0 111.507 -172.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.3 p -122.15 178.09 5.07 Favored 'General case' 0 C--N 1.273 -2.754 0 C-N-CA 125.176 1.391 . . . . 0.0 109.899 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 42' ' ' GLN . 52.1 tp -141.25 156.28 45.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.37 124.28 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.902 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.68 125.09 38.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.518 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 98.6 m-85 -100.27 132.36 22.69 Favored Pre-proline 0 C--N 1.28 -2.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.917 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.5 120.78 8.16 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.109 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.492 HG13 HG22 ' A' ' 100' ' ' VAL . 45.1 t -109.47 134.47 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.3 131.98 56.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -108.41 118.1 55.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.781 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.76 91.57 3.37 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.59 -107.3 1.33 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.77 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -101.87 -0.97 33.15 Favored 'General case' 0 C--O 1.193 -1.872 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.332 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.401 ' O ' HD13 ' A' ' 98' ' ' ILE . 25.6 m-20 -106.52 139.51 40.87 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.441 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.401 HD13 ' O ' ' A' ' 97' ' ' ASP . 38.5 mm -127.06 122.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.204 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -118.82 142.78 47.41 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.962 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 91' ' ' VAL . 39.2 t -134.31 139.14 48.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 t -95.31 114.29 26.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.518 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 24.5 p -118.52 -47.01 2.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.668 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -78.48 105.02 9.46 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.558 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.44 -35.57 1.72 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -96.19 128.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.21 133.09 72.22 Favored Pre-proline 0 N--CA 1.417 -2.076 0 CA-C-O 120.671 0.272 . . . . 0.0 111.722 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.494 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 18.4 Cg_endo -61.22 134.72 53.95 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.307 2.671 . . . . 0.0 111.135 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.57 123.52 47.69 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.507 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 52.0 tptt 58.88 178.87 0.07 Allowed 'General case' 0 CA--C 1.568 1.662 0 O-C-N 125.467 1.729 . . . . 0.0 111.349 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.47 ' H ' ' HG3' ' A' ' 109' ' ' LYS . . . . . . . . 0 CA--C 1.514 -0.414 0 C-N-CA 125.185 1.394 . . . . 0.0 114.217 171.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.436 -1.143 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 68.54 84.79 0.15 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.06 0.85 . . . . 0.0 109.846 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.74 144.09 40.23 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.181 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.13 119.27 20.59 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.313 0.578 . . . . 0.0 110.933 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.6 -44.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.747 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.95 -172.83 4.07 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.3 m -118.89 152.65 35.9 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.189 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -61.46 -22.06 64.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.292 0.637 . . . . 0.0 110.372 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 2.5 p-10 -77.27 -11.19 59.8 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.705 -0.622 . . . . 0.0 109.81 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -84.68 -45.04 12.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.8 pt -114.37 109.84 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 122.468 1.127 . . . . 0.0 109.777 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -75.25 170.43 16.07 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.747 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.59 115.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.173 0.511 . . . . 0.0 110.672 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.13 10.79 59.33 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.213 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.13 149.52 24.19 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -150.5 142.09 23.55 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 pt-20 -155.01 144.78 21.52 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.205 0.526 . . . . 0.0 112.291 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 90.1 m -79.96 138.85 37.17 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.588 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -129.65 162.33 28.56 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.32 134.93 54.36 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.079 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -83.15 168.46 16.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.0 m -68.0 -17.27 64.37 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.043 0.449 . . . . 0.0 110.767 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.52 -12.83 59.85 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.321 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.42 37.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.0 m -96.13 131.58 42.42 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 122.181 0.193 . . . . 0.0 111.088 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.94 124.45 36.06 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.541 0.686 . . . . 0.0 109.353 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' THR . 58.1 t -125.84 136.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 52' ' ' LEU . 1.3 tt -95.56 112.21 23.97 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 18' ' ' GLU . 9.9 tp -95.8 117.22 39.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.52 125.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -113.13 104.58 12.5 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.138 174.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -102.0 158.54 16.07 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.432 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -75.54 -50.72 14.79 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.641 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.69 -46.46 17.07 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -84.44 -11.32 56.42 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.605 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.72 -157.44 34.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.967 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.65 123.22 53.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 16.7 tppt? -128.59 145.34 51.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.39 113.94 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.555 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.462 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 22.5 m-85 -116.32 147.72 41.28 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.425 ' CG ' HD22 ' A' ' 86' ' ' LEU . 11.3 pt20 -64.36 138.71 58.57 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.99 -68.37 0.69 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.489 0.661 . . . . 0.0 111.043 -175.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.497 ' CE ' ' HA ' ' A' ' 44' ' ' MET 0.265 0.1 OUTLIER 62.73 -100.21 0.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -178.86 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.4 t 49.56 96.36 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.824 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.58 36.96 0.48 Allowed 'Trans proline' 0 N--CA 1.48 0.69 0 C-N-CA 123.099 2.532 . . . . 0.0 112.149 -176.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.484 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 37.2 m80 -150.39 -179.77 7.48 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 123.936 0.894 . . . . 0.0 109.578 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.7 pt20 62.78 142.33 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.523 2.329 . . . . 0.0 114.505 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.21 85.36 2.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 tp 169.83 167.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.48 138.04 36.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.928 0.394 . . . . 0.0 111.529 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 52' ' ' LEU . 4.1 tt -67.07 -32.47 73.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.646 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.5 p -63.7 -14.02 48.44 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.314 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -100.68 13.27 35.36 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.702 0.763 . . . . 0.0 109.267 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.76 -109.91 0.64 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.414 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 20.8 p -155.78 146.8 22.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.407 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 87.3 t80 -125.83 116.67 21.93 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.911 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 2.4 mp0 -99.37 170.12 8.86 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.24 67.45 0.37 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 -1.51 21.56 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.5 t -124.02 136.64 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.462 HD11 ' CZ ' ' A' ' 41' ' ' TYR . 52.2 mt -119.57 129.99 74.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.414 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 53.8 m -110.5 123.66 50.34 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 52' ' ' LEU . 10.4 p -57.75 -30.6 65.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 169.24 -48.57 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.241 1.816 . . . . 0.0 107.501 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.69 -87.41 0.09 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.559 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 52.87 -85.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.161 1.384 . . . . 0.0 111.489 -175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.6 tp -174.16 -60.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.32 0.648 . . . . 0.0 109.47 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -99.11 -176.47 3.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.341 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 65.9 p -135.05 165.33 25.62 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.57 0.748 . . . . 0.0 111.316 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -103.22 147.75 26.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -118.22 126.12 51.54 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.997 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.71 -56.69 16.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.245 1.018 . . . . 0.0 111.243 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.49 50.02 4.27 Favored Glycine 0 CA--C 1.509 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.673 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.2 m -152.95 -44.83 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.24 -34.51 3.78 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . 21.3 t-80 -90.32 146.29 24.31 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.61 140.58 14.92 Favored Glycine 0 CA--C 1.483 -1.925 0 C-N-CA 118.705 -1.712 . . . . 0.0 112.391 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 70' ' ' THR . 2.0 mp -73.52 -31.41 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -109.97 129.4 23.97 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.632 169.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.37 -41.73 0.95 Allowed 'Cis proline' 0 CA--C 1.498 -1.283 0 C-N-CA 123.658 -1.393 . . . . 0.0 110.456 -4.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.3 t70 152.54 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.445 2.298 . . . . 0.0 107.326 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.45 -21.01 49.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.001 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.0 m -96.09 150.57 20.35 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-O 122.893 1.33 . . . . 0.0 112.721 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 77' ' ' HIS . 1.7 p -140.0 148.62 42.13 Favored 'General case' 0 C--N 1.253 -3.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 106.904 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.425 HD22 ' CG ' ' A' ' 42' ' ' GLN . 51.2 mt -112.83 175.94 5.23 Favored 'General case' 0 C--N 1.266 -3.043 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.022 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -126.36 142.99 51.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.187 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.05 118.26 35.41 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.81 148.07 39.0 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.754 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 101' ' ' SER . 11.9 Cg_exo -68.04 119.73 6.73 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.508 1.472 . . . . 0.0 111.002 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.6 p -127.95 134.84 64.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.128 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -127.32 126.51 42.7 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.497 0.665 . . . . 0.0 109.952 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.7 124.5 68.5 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.502 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.6 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.81 96.97 4.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.492 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.43 -104.87 1.52 Allowed Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.05 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 8' ' ' SER . 21.8 m-20 -109.37 4.11 22.19 Favored 'General case' 0 C--O 1.19 -2.027 0 CA-C-N 115.525 -0.337 . . . . 0.0 110.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.64 139.59 43.21 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 120.63 0.252 . . . . 0.0 111.155 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -127.1 119.64 53.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.495 0.664 . . . . 0.0 111.303 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -112.58 137.87 50.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.755 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.4 m -127.33 148.53 32.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.51 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 32.2 t -127.77 146.6 50.54 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.5 m -125.74 2.06 7.47 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -91.33 130.78 37.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.458 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.16 -45.8 1.26 Allowed Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.9 mt -108.05 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.456 HD12 ' HD2' ' A' ' 107' ' ' PRO . 33.6 tp -82.46 139.09 44.47 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.968 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD2' HD12 ' A' ' 106' ' ' LEU . 96.0 Cg_exo -50.61 128.99 25.41 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 122.547 2.165 . . . . 0.0 111.014 174.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 55.4 t-20 -86.99 143.57 27.28 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.687 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.43 -76.09 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.08 2.552 . . . . 0.0 113.768 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.424 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.075 -176.555 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.223 -0.318 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.85 148.04 35.73 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -142.46 144.84 33.21 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -73.16 129.54 38.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.241 0.543 . . . . 0.0 110.758 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.537 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -100.43 -42.61 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.044 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' HG23 ' A' ' 6' ' ' ILE . 7.7 p -165.76 -176.69 3.97 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.22 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 14.9 m -123.57 150.42 44.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.296 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.4 tt -60.1 -24.62 64.79 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.222 1.409 . . . . 0.0 110.287 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.28 -23.49 64.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.21 -45.4 4.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.342 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 5.6 tp -100.68 110.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 122.298 1.047 . . . . 0.0 111.972 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -101.64 162.84 12.6 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.249 -1.342 . . . . 0.0 113.073 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.27 124.23 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.714 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.39 64.15 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -119.75 158.24 26.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -151.21 148.62 28.45 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.784 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.8 pt-20 -156.52 151.25 25.86 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.111 171.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -73.0 133.32 44.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.389 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.35 154.23 47.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -104.87 142.65 34.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.7 p -83.41 179.17 7.74 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -76.05 -17.65 59.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.169 0.509 . . . . 0.0 110.683 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.37 -12.49 49.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.607 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.15 21.73 19.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -95.81 120.59 36.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.02 122.61 33.82 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.153 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.8 142.6 42.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.125 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.5 tt -93.93 114.28 26.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.35 112.95 28.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.9 t -110.35 124.75 67.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.527 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -100.13 107.19 19.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -98.29 148.83 23.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.7 -36.71 65.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -111.15 -38.09 5.14 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.153 0.501 . . . . 0.0 111.082 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -81.97 -3.51 54.55 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.321 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.74 -178.67 47.95 Favored Glycine 0 CA--C 1.51 -0.281 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.671 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -78.2 129.55 37.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -129.32 141.77 51.0 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.52 115.1 20.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.765 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 47.7 p90 -143.62 157.32 44.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -50.25 138.03 17.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -106.86 -78.17 0.59 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.584 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 15.6 tpt 53.26 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.488 ' SG ' ' HG ' ' A' ' 52' ' ' LEU . 69.2 m 55.49 84.77 0.2 Allowed Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 121.119 0.485 . . . . 0.0 112.237 -168.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -90.87 21.13 0.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.93 1.753 . . . . 0.0 110.867 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -103.68 -78.6 0.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.05 -39.29 7.36 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 69.42 -89.42 0.03 OUTLIER 'General case' 0 C--O 1.243 0.745 0 O-C-N 124.465 1.103 . . . . 0.0 112.918 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.0 mt 58.24 -81.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 124.799 1.24 . . . . 0.0 109.212 -171.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -167.03 92.06 0.42 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 128.158 2.583 . . . . 0.0 104.306 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.488 ' HG ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -67.21 -21.82 65.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.419 0.628 . . . . 0.0 111.828 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 10.6 p -75.58 -10.67 59.64 Favored 'General case' 0 N--CA 1.414 -2.225 0 C-N-CA 124.805 1.242 . . . . 0.0 111.434 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -94.78 11.0 33.0 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.48 -128.18 1.39 Allowed Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.938 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -150.85 156.99 42.36 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.932 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -130.37 128.99 42.52 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.756 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 61' ' ' VAL . 1.8 tm-20 -115.65 158.13 23.19 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.84 -30.31 21.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.119 0.407 . . . . 0.0 114.119 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.57 -4.08 5.86 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.163 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 61.7 t -124.04 125.0 70.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-N 117.343 0.572 . . . . 0.0 110.717 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 46.6 mt -103.17 136.09 37.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 69' ' ' TRP . 99.3 m -117.51 116.02 26.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.31 144.49 57.11 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -50.98 -55.23 18.34 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.815 0.697 . . . . 0.0 109.639 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.6 91.66 2.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.274 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -167.94 -76.37 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 69' ' ' TRP . 5.2 tt -144.56 143.63 30.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.487 ' HA ' HG23 ' A' ' 63' ' ' THR . 40.8 p90 -89.82 -19.57 24.51 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -169.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.424 ' H ' HD23 ' A' ' 68' ' ' LEU . 41.2 p -103.93 126.32 50.97 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.719 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 90.7 t80 -138.71 144.73 39.67 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -99.08 104.81 16.85 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 118.466 0.575 . . . . 0.0 111.146 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.38 -39.54 94.81 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.378 0.671 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.4 94.42 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.731 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 m -80.11 -35.41 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.864 0.364 . . . . 0.0 111.32 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.61 3.61 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.483 ' HA ' ' SG ' ' A' ' 85' ' ' CYS . 14.8 t-80 -92.71 132.53 36.84 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 173.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.69 146.41 22.34 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.98 -36.26 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 47.7 t30 -164.24 110.79 0.9 Allowed Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.38 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.574 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 2.5 Cg_endo -87.97 172.11 32.48 Favored 'Cis proline' 0 CA--C 1.554 1.502 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.222 1.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.92 -11.39 28.73 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.29 12.92 34.87 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.987 0.898 . . . . 0.0 110.881 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.574 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 77.7 m -112.81 9.46 19.02 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.231 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 57.5 m -58.3 156.3 10.23 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.678 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 2.8 pp -117.85 169.09 9.9 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.207 -174.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB2' ' CB ' ' A' ' 108' ' ' ASN . . . -130.88 122.18 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.89 127.36 32.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.172 0.51 . . . . 0.0 112.015 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.9 143.45 26.74 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.394 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.78 127.64 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.183 1.922 . . . . 0.0 110.53 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.78 143.74 39.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.04 138.08 52.43 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 120.938 0.399 . . . . 0.0 110.551 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.38 126.25 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.287 1.041 . . . . 0.0 111.474 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -119.52 146.92 45.03 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.41 100.66 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 8' ' ' SER . 38.1 t70 84.86 -33.46 0.06 Allowed 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 126.797 2.039 . . . . 0.0 114.476 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -99.37 131.2 45.55 Favored 'General case' 0 C--N 1.282 -2.353 0 O-C-N 120.639 -1.288 . . . . 0.0 111.206 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.15 123.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.837 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -112.74 145.61 40.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.985 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.4 144.51 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.4 t -105.1 115.22 29.9 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.4 m -106.44 -33.54 7.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.428 0.633 . . . . 0.0 109.486 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.3 tpmt? -74.02 107.98 6.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.666 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.29 -4.04 8.9 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.9 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.2 mm -119.17 140.69 42.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.44 120.79 55.29 Favored Pre-proline 0 N--CA 1.42 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.91 133.08 53.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.726 2.284 . . . . 0.0 111.996 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.425 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 51.2 t30 -89.53 176.24 6.97 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.571 -176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.31 104.65 0.52 Allowed 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.198 0.999 . . . . 0.0 111.679 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.283 -2.318 0 CA-C-N 112.278 -2.237 . . . . 0.0 105.649 -176.47 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.424 ' OG ' ' HE3' ' A' ' 103' ' ' LYS . 31.3 t . . . . . 0 N--CA 1.413 -2.301 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.591 ' H ' ' HA ' ' A' ' 101' ' ' SER . 96.7 m-85 72.46 93.53 0.08 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.425 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 8.4 tp10 -106.81 138.27 43.29 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 4.1 tmmm? -80.94 105.14 11.93 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -85.94 -49.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.826 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.061 -176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.5 m -145.65 177.58 8.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.709 0.766 . . . . 0.0 111.317 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.7 p -110.56 152.76 26.02 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.051 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.38 -20.04 58.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.014 0.911 . . . . 0.0 109.918 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.35 -20.88 58.77 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.363 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.22 -32.09 12.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.232 0.539 . . . . 0.0 110.556 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 16' ' ' GLU . 3.2 tp -124.11 111.87 30.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.921 0.867 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -105.06 163.96 12.17 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.406 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.57 124.98 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.422 0.63 . . . . 0.0 111.32 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.37 59.8 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.542 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' HB3' HD12 ' A' ' 12' ' ' ILE . 8.8 tp10 -103.76 152.16 22.18 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.508 ' HG3' ' HB2' ' A' ' 56' ' ' SER . 0.0 OUTLIER -150.75 139.1 20.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 120.883 0.373 . . . . 0.0 110.156 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.0 tt0 -158.05 155.22 28.91 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.2 t -89.16 132.61 34.75 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.027 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.34 151.7 42.22 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.05 133.78 47.59 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -83.01 178.79 7.99 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -69.11 -21.53 64.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.463 0.649 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.94 -13.36 58.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.696 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.01 23.06 33.61 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -92.85 115.6 28.26 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.99 123.75 34.16 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.429 ' CG1' ' HB1' ' A' ' 40' ' ' ALA . 46.6 t -130.64 144.53 37.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.505 ' N ' ' HB2' ' A' ' 43' ' ' ALA . 62.2 tp -88.32 111.86 22.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.09 118.65 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 17' ' ' MET . 46.5 t -119.36 125.19 74.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.849 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 46.6 t-20 -92.32 106.99 18.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.0 m -99.02 152.96 19.24 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.8 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.51 -50.28 16.15 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.07 -22.19 18.67 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -99.23 -4.27 32.38 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.128 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.89 -170.67 51.42 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.908 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 46.2 t -80.55 120.74 32.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.06 150.74 50.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.147 0.498 . . . . 0.0 110.802 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -124.74 131.69 53.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 59.8 m-85 -130.21 162.21 29.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 119.562 -0.256 . . . . 0.0 110.478 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.657 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -50.18 136.31 19.73 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.505 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -118.05 -11.51 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.462 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 47.3 tpp -69.2 108.91 3.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 47' ' ' HIS . 17.4 t -108.69 107.27 59.95 Favored Pre-proline 0 N--CA 1.413 -2.29 0 CA-C-O 121.233 0.54 . . . . 0.0 111.452 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -96.87 17.08 0.65 Allowed 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.677 2.251 . . . . 0.0 109.422 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.591 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 16.5 t-160 -94.71 -38.9 10.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.44 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 178.57 110.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.28 1.832 . . . . 0.0 107.704 -177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -155.94 134.71 11.86 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.127 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -114.57 -63.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 162.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 68.9 mt -154.06 110.82 3.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 165.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -68.59 -25.35 64.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.918 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 47.7 p -62.57 -19.65 63.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -170.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp0 -84.88 -9.16 58.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.105 0.479 . . . . 0.0 110.818 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.57 81.07 0.27 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 63' ' ' THR . 66.9 m -143.26 -33.76 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.402 ' CZ ' ' HA2' ' A' ' 60' ' ' GLY . 69.2 t80 -129.0 113.49 15.23 Favored 'General case' 0 C--N 1.264 -3.114 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.348 -174.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -116.97 112.26 20.75 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.227 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 -73.8 1.04 Allowed Glycine 0 CA--C 1.5 -0.871 0 O-C-N 123.582 0.551 . . . . 0.0 111.938 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.402 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . -161.26 13.64 0.15 Allowed Glycine 0 C--N 1.298 -1.56 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.74 143.6 23.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 O-C-N 122.531 -0.394 . . . . 0.0 110.273 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' SER . 48.4 mm -89.92 133.41 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.634 0.73 . . . . 0.0 111.934 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' ' 56' ' ' SER . 32.4 m -128.29 152.27 48.32 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 124.327 1.051 . . . . 0.0 108.253 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.1 t -119.82 89.03 3.05 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.453 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' HA ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 tpm_? 54.64 21.31 3.36 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.093 0.957 . . . . 0.0 111.001 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' H ' HG22 ' A' ' 63' ' ' THR . . . 62.8 100.18 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 111.894 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 68' ' ' LEU 0.271 1.5 p-80 -107.69 -13.06 15.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 1.7 tm? 171.36 -63.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 28.7 t-105 -141.05 -155.57 0.6 Allowed 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 28.3 p -101.3 163.54 12.23 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -171.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -110.49 148.05 32.87 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -111.56 108.07 17.45 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 62' ' ' ILE . 5.6 p-10 -76.8 -29.79 56.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.04 73.22 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.9 m -90.52 -52.0 5.12 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.18 -42.16 1.46 Allowed Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.386 -0.912 . . . . 0.0 112.398 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CD2' ' HB3' ' A' ' 85' ' ' CYS . 43.1 m80 -87.94 158.81 18.57 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 120.828 0.347 . . . . 0.0 110.611 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.75 157.26 52.23 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.874 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 70' ' ' THR . 69.5 mt -84.6 -51.42 13.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 117.635 0.718 . . . . 0.0 109.478 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 63.7 t30 -160.73 108.47 1.31 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.122 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 6.9 Cg_exo -75.57 -174.86 15.08 Favored 'Cis proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.539 -1.859 . . . . 0.0 110.278 -3.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.82 -43.57 58.37 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . 0.326 4.4 p30 38.76 31.53 0.04 OUTLIER 'General case' 0 C--N 1.369 1.424 0 C-N-CA 127.106 2.162 . . . . 0.0 113.828 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 64.5 m 79.13 148.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.654 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.4 ' HB3' ' CD2' ' A' ' 77' ' ' HIS . 17.7 p -72.9 172.68 10.43 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.224 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 pp -96.86 -171.1 2.17 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.633 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -130.18 119.24 22.64 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.27 134.02 38.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.005 0.431 . . . . 0.0 110.941 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 12.0 m-85 -102.9 145.67 31.0 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 123.616 0.766 . . . . 0.0 109.535 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.99 120.29 6.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.51 2.14 . . . . 0.0 110.413 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.01 141.0 42.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.53 137.57 53.94 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.83 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.609 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -125.22 99.13 5.94 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.37 5.47 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.674 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.19 -10.05 34.35 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.216 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -109.68 143.13 39.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 12' ' ' ILE . 59.5 mt -122.37 120.47 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.953 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 26.9 m-85 -113.58 149.47 34.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.249 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 7.4 p -135.45 138.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.591 ' HA ' ' H ' ' A' ' 3' ' ' PHE . 35.3 t -97.99 133.58 42.27 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.826 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -122.3 16.37 10.6 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.157 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HE3' ' OG ' ' A' ' 2' ' ' SER . 37.7 ttmt -58.47 -76.31 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.748 0.785 . . . . 0.0 112.839 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.42 20.79 45.39 Favored Glycine 0 C--N 1.263 -3.528 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.04 120.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.502 0.668 . . . . 0.0 111.693 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 tp -110.07 124.01 34.58 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -65.67 137.75 51.21 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -80.03 175.78 10.33 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -57.15 138.55 54.42 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.299 -1.623 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 p . . . . . 0 N--CA 1.429 -1.525 0 CA-C-O 121.327 0.584 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 99.4 m-85 -90.81 125.47 35.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.889 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -112.72 144.98 41.32 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 37.5 ttpt -87.07 128.08 35.11 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.842 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.484 HG12 ' CD1' ' A' ' 20' ' ' PHE . 6.5 tp -115.16 -45.05 4.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.227 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.7 p -139.71 -173.47 3.64 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.573 0.701 . . . . 0.0 111.915 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -129.61 150.12 51.08 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.558 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -72.61 -22.91 60.89 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.72 -21.76 65.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.457 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.59 -49.97 5.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.193 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 12' ' ' ILE . 47.4 pt -110.85 116.88 53.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-O 122.135 0.969 . . . . 0.0 111.107 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -90.36 169.24 11.25 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.758 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.19 117.79 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.353 0.597 . . . . 0.0 110.844 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.46 62.15 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -103.1 140.47 37.28 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.281 0.632 . . . . 0.0 110.188 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.455 ' HB3' HG23 ' A' ' 31' ' ' VAL . 26.9 ptt? -151.03 156.3 40.82 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.874 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -157.5 156.58 32.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.593 0.558 . . . . 0.0 109.517 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.2 t -88.87 137.09 32.63 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 121.218 0.532 . . . . 0.0 110.051 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.484 ' CD1' HG12 ' A' ' 6' ' ' ILE . 52.4 p90 -119.94 156.41 30.86 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 22' ' ' THR . 44.7 tt0 -100.35 135.31 41.98 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 77.7 p -82.58 171.29 14.23 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -73.36 -15.49 61.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.68 0.752 . . . . 0.0 109.252 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -84.55 -12.59 53.83 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.6 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.99 36.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.827 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 84.8 m -97.08 137.43 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.142 -0.622 . . . . 0.0 111.989 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -88.85 126.55 35.41 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.499 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' THR . 60.6 t -130.25 137.7 55.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.186 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.416 HD21 ' SD ' ' A' ' 17' ' ' MET . 45.5 tp -87.28 114.65 24.08 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 10.0 tp -97.74 112.7 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 17' ' ' MET . 8.2 p -114.12 127.9 71.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.5 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.447 ' ND2' ' HG ' ' A' ' 9' ' ' LEU . 51.2 t-20 -95.45 104.15 16.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 21.5 m -102.77 150.79 23.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.197 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -76.46 -50.27 14.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.242 0.544 . . . . 0.0 110.591 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.68 -46.7 16.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.921 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 50.8 m80 -79.11 -21.19 47.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.923 0.392 . . . . 0.0 111.185 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.72 -168.68 47.88 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 45.7 t -81.49 120.02 32.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.722 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -118.63 149.33 41.56 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.602 0.761 . . . . 0.0 111.201 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.91 112.69 16.91 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.458 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 88' ' ' GLU . 49.7 m-85 -125.57 159.84 31.08 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 110' ' ' ALA . 35.4 tt0 -53.77 138.33 35.87 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.92 -12.39 59.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -167.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.445 ' HB3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.8 166.79 31.15 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.152 -1.419 . . . . 0.0 114.086 -175.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 18.9 m -88.79 166.52 22.06 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 176.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.07 31.41 0.52 Allowed 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 121.73 1.62 . . . . 0.0 112.723 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.481 ' CE1' ' HG3' ' A' ' 81' ' ' PRO . 14.1 m170 -120.34 -75.34 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.191 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.477 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 15.5 mm100 -93.96 -177.62 4.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 0.0 112.622 -174.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.32 163.24 28.04 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.114 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 44' ' ' MET . 29.8 mt -74.94 87.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.44 0.638 . . . . 0.0 110.438 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.434 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 85.0 mt -106.39 1.49 25.73 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.516 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.8 tt -76.23 -41.72 48.32 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.925 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -67.75 -7.39 26.92 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.48 -9.19 50.99 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.24 115.37 1.33 Allowed Glycine 0 CA--C 1.495 -1.167 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 63' ' ' THR . 72.0 m -161.41 -25.02 0.05 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.907 0.861 . . . . 0.0 110.867 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 94.5 t80 -89.05 115.53 26.66 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.181 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -116.15 104.5 11.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.681 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.91 -72.85 0.53 Allowed Glycine 0 C--N 1.316 -0.53 0 O-C-N 123.899 0.749 . . . . 0.0 113.504 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.16 17.43 1.18 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 62.9 t -123.11 132.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -98.1 129.17 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 36.3 m -106.74 151.79 24.67 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' ALA . 8.0 t -75.15 -40.31 59.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.22 172.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 63' ' ' THR . 1.1 tmt_? 75.93 -21.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.495 1.118 . . . . 0.0 110.939 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . -96.56 -23.45 16.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.927 173.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.477 ' CE1' ' HG2' ' A' ' 48' ' ' GLN . 22.3 m170 -146.88 152.46 38.74 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.305 0.642 . . . . 0.0 112.069 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.412 ' HB3' ' CG ' ' A' ' 80' ' ' ASN 0.278 2.2 tm? 36.94 -107.21 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.85 2.46 . . . . 0.0 113.602 175.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 63' ' ' THR . 94.9 m95 -163.7 -51.36 0.03 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.6 p -107.71 130.64 54.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -160.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -134.1 137.49 44.63 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -122.98 114.84 20.96 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.961 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.64 -29.67 70.28 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.11 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.91 -3.6 74.74 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.894 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.4 m -124.22 1.26 8.47 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.666 0.746 . . . . 0.0 109.66 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -49.06 1.08 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.536 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 25.8 p80 -88.84 160.91 17.01 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.219 0.533 . . . . 0.0 111.719 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.13 169.99 35.49 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.923 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.61 -31.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 3.2 p-10 -127.27 101.92 24.5 Favored Pre-proline 0 N--CA 1.42 -1.939 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.883 173.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 22.7 Cg_endo -89.62 155.23 31.62 Favored 'Cis proline' 0 C--N 1.362 1.282 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.864 -4.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.9 p-10 -74.4 -19.26 60.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.83 -22.07 24.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.248 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.523 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 65.3 m -95.82 150.91 19.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-O 121.79 0.805 . . . . 0.0 110.577 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 77' ' ' HIS . 17.6 p -142.08 167.85 21.14 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.941 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.462 HD22 ' HB3' ' A' ' 42' ' ' GLN . 81.2 mt -120.98 129.18 53.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . . . -88.87 136.51 32.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -104.42 158.52 16.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.277 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.499 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 19.1 p90 -135.39 157.73 75.95 Favored Pre-proline 0 C--N 1.273 -2.751 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.508 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 89' ' ' TYR . 37.5 Cg_endo -61.27 138.58 78.11 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 122.545 2.163 . . . . 0.0 114.03 -174.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.14 128.99 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.54 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -109.98 131.66 54.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.99 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.1 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -122.75 91.34 3.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.95 -112.11 4.68 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.573 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.26 -5.44 33.13 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.714 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -103.21 137.05 41.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -127.61 123.4 61.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 5.0 m-85 -112.01 142.08 44.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.834 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.96 154.71 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -127.9 114.6 17.39 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.345 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -108.76 -8.05 15.44 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.63 102.51 5.36 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.72 -29.28 4.99 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.6 mt -120.63 108.35 22.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.447 0.641 . . . . 0.0 110.319 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.0 pp -89.08 147.92 39.73 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 12.6 Cg_exo -69.78 140.96 43.87 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.059 1.84 . . . . 0.0 112.298 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -88.31 133.05 34.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.3 -176.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.484 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . . . . . . 0 N--CA 1.473 0.701 0 C-N-CA 125.255 1.422 . . . . 0.0 113.069 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 p . . . . . 0 N--CA 1.443 -0.778 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 69.9 m-85 73.54 108.21 0.07 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 -168.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -106.57 137.36 44.72 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -73.84 121.32 20.71 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.876 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tp -97.51 -48.52 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.357 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.7 m -159.23 -174.55 4.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.386 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -129.77 152.67 49.01 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 12' ' ' ILE . 27.5 tp -56.66 -21.22 25.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.184 1.393 . . . . 0.0 110.624 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.76 -30.97 71.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.261 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -100.18 -40.87 7.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.388 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.4 tp -104.96 115.43 46.83 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-O 121.533 0.682 . . . . 0.0 110.934 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -102.99 164.75 11.43 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.469 -172.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.67 127.57 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.491 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.64 -0.81 68.1 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.92 154.13 29.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -146.15 131.06 18.14 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.727 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 44.1 mt-10 -144.22 150.52 38.09 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 93.7 m -74.42 130.97 40.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.993 0.425 . . . . 0.0 111.124 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -140.71 149.8 42.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.25 146.88 34.87 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.642 0.258 . . . . 0.0 110.359 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -83.72 165.29 19.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.9 m -65.59 -14.03 60.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.89 -12.48 41.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.444 0.64 . . . . 0.0 110.137 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.75 23.41 13.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.902 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -97.09 127.92 43.53 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -88.07 123.28 32.6 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.09 143.75 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.378 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 60.0 tp -93.01 112.86 24.96 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' MET . 49.6 mm -94.73 112.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 17' ' ' MET . 41.9 t -112.66 124.75 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 54.0 t30 -103.83 104.93 14.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 14.0 m -83.77 143.21 30.13 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.454 -172.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -47.08 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -83.14 -44.13 15.42 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -101.88 2.92 38.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 86.73 -176.95 48.09 Favored Glycine 0 C--O 1.201 -1.937 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.931 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 9.3 p -72.39 134.65 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 118.274 1.037 . . . . 0.0 111.553 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -125.7 139.01 53.9 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.774 0.83 . . . . 0.0 110.501 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.06 115.25 20.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.415 ' OH ' HG12 ' A' ' 62' ' ' ILE . 18.6 p90 -143.27 165.11 28.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.082 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -41.19 137.4 1.37 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.756 0.66 . . . . 0.0 111.818 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 19' ' ' THR . . . -71.29 -46.77 60.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.287 0.565 . . . . 0.0 112.524 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 69.8 mtm -94.25 147.07 23.55 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.17 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.508 ' HB2' ' HD2' ' A' ' 46' ' ' PRO . 28.9 p -94.82 161.87 27.18 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.777 0.673 . . . . 0.0 111.258 -175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 57.0 Cg_endo -71.2 -4.75 15.54 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.499 2.132 . . . . 0.0 111.914 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -88.74 -96.9 0.09 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -179.3 104.59 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 117.911 0.323 . . . . 0.0 110.579 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 6.5 tp10 -171.97 145.8 1.9 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 111.375 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.8 pt -118.58 141.67 37.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 tp 65.77 24.03 11.45 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.672 1.225 . . . . 0.0 109.129 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.2 pt? -62.04 -20.54 64.06 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.141 -1.391 . . . . 0.0 111.289 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 36.0 p -56.92 -32.53 66.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 125.965 1.706 . . . . 0.0 113.832 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -100.66 23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.989 -0.445 . . . . 0.0 110.962 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.75 -83.61 0.04 OUTLIER Glycine 0 C--N 1.346 1.113 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.431 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 19.0 p -173.49 146.89 1.4 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -129.75 115.62 17.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.98 105.8 12.72 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.489 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.89 0.44 Allowed Glycine 0 N--CA 1.462 0.429 0 O-C-N 123.489 0.493 . . . . 0.0 114.206 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 73' ' ' ASP . . . -153.21 17.95 0.7 Allowed Glycine 0 C--N 1.301 -1.366 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.1 t -125.12 124.92 68.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.789 0.436 . . . . 0.0 110.05 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.415 HG12 ' OH ' ' A' ' 41' ' ' TYR . 2.0 pp -92.76 140.26 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.431 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 89.9 m -116.44 127.05 54.25 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.19 156.31 39.71 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.469 ' O ' ' HD3' ' A' ' 65' ' ' ARG . 1.8 tmt_? -73.34 -33.08 64.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.783 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . . . -83.08 -72.32 0.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.308 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.479 ' CD2' ' HB2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -82.66 110.26 17.56 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.132 175.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.08 84.83 7.57 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.356 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 86.9 m95 -144.3 -166.55 2.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 p -101.66 136.65 41.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 121.955 0.883 . . . . 0.0 112.268 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 47.4 t80 -134.06 143.19 47.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.99 111.87 19.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.348 0.594 . . . . 0.0 111.33 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 16.3 t70 -71.41 -11.81 61.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.418 1.487 . . . . 0.0 112.012 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.51 -33.76 6.06 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.717 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.6 p -107.24 -26.14 11.19 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.436 0.618 . . . . 0.0 112.638 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.87 65.32 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -106.76 146.39 30.91 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -76.64 153.25 42.17 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.517 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.95 -49.25 12.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 8.2 t30 -146.55 111.71 4.26 Favored Pre-proline 0 N--CA 1.436 -1.153 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.415 174.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 4.8 Cg_exo -78.74 141.61 64.64 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.962 -1.683 . . . . 0.0 111.004 -1.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.1 p30 -74.66 -12.48 60.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.407 0.622 . . . . 0.0 109.627 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.87 -28.53 68.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.736 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 36.9 m -92.72 152.15 19.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-O 121.563 0.696 . . . . 0.0 111.002 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.454 ' C ' HD12 ' A' ' 86' ' ' LEU . 5.9 p -163.27 156.13 18.75 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.045 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.481 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 7.3 mp -129.45 135.16 48.31 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.289 1.436 . . . . 0.0 107.868 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.9 123.92 29.85 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.726 0.411 . . . . 0.0 109.972 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -86.64 143.94 27.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.086 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 101' ' ' SER . 46.2 m-85 -102.37 143.32 26.37 Favored Pre-proline 0 N--CA 1.428 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.04 123.01 12.56 Favored 'Trans proline' 0 C--O 1.253 1.242 0 C-N-CA 122.329 2.019 . . . . 0.0 110.264 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.87 132.96 70.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -112.57 117.21 31.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.447 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.56 107.56 23.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 122.026 0.917 . . . . 0.0 109.69 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.545 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.69 118.16 23.3 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.43 -119.93 9.75 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.96 -4.45 16.71 Favored 'General case' 0 C--O 1.17 -3.086 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 94' ' ' LYS . 17.0 t70 -100.03 139.28 35.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.697 -0.627 . . . . 0.0 110.089 -170.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.2 mt -127.63 119.12 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 63.4 m-85 -102.72 146.23 28.52 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.71 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.63 137.23 54.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 20.4 t -107.35 113.26 26.52 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.446 -1.702 . . . . 0.0 109.296 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.4 p -95.96 -36.43 11.07 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.93 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -66.3 113.26 4.47 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.112 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.26 -36.14 2.78 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 105' ' ' ILE . 2.7 mp -100.89 120.82 50.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.436 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 3.5 tt -79.92 124.1 83.35 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 9.4 Cg_endo -52.96 145.58 40.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.006 2.471 . . . . 0.0 111.994 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -80.43 177.61 8.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.69 -11.89 2.5 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.468 ' CB ' ' HG ' ' A' ' 86' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.472 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.996 177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 75.0 m-85 67.22 100.25 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.464 -169.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -106.9 130.53 54.55 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.815 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -70.17 115.64 9.6 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.62 -59.59 3.06 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.194 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 11' ' ' ASP . 85.6 m -152.21 -177.29 6.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.353 -175.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 8.7 p -101.02 153.52 19.47 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.588 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.43 -17.52 21.33 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.847 0.832 . . . . 0.0 110.673 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.4 -10.84 58.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.583 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 33.2 t70 -97.7 -41.46 8.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.687 -0.633 . . . . 0.0 109.358 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 98' ' ' ILE . 2.3 tp -109.95 114.13 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.415 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -101.05 166.96 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.503 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.44 128.83 35.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.496 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.89 66.7 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -103.87 144.14 31.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.172 -0.514 . . . . 0.0 110.127 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.4 134.0 39.24 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 9.2 pt-20 -157.63 156.21 31.41 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 15.1 t -90.51 137.7 32.14 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 77.3 m-85 -126.41 155.94 41.37 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' THR . 40.9 tt0 -113.95 141.49 47.32 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -83.18 172.76 12.3 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -68.86 -20.17 64.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.131 0.491 . . . . 0.0 110.424 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.97 -12.25 55.6 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 109.526 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.95 14.82 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.109 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.5 m -92.19 124.31 36.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.77 128.97 35.64 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' THR . 40.0 t -133.03 141.2 45.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.18 116.43 28.83 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.58 122.83 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 122.327 0.251 . . . . 0.0 110.355 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.99 123.61 70.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 50.7 t30 -103.12 106.41 16.92 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.837 173.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -98.81 148.67 23.67 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.511 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.95 -48.85 77.1 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 122.957 0.503 . . . . 0.0 111.8 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.26 -40.33 8.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.95 0.405 . . . . 0.0 111.979 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -79.69 -11.42 59.85 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -167.33 42.47 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.042 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 6.7 p -99.05 118.05 45.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.535 0.683 . . . . 0.0 109.333 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -131.98 151.16 51.9 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.162 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.05 143.27 45.7 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.569 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 63.9 m-85 -133.28 157.6 45.04 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -59.11 139.22 57.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.187 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.21 -7.29 58.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.336 0.589 . . . . 0.0 110.252 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -92.79 99.76 12.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.618 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' HIS . 59.0 m -76.71 158.8 80.33 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -82.92 20.78 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.718 1.612 . . . . 0.0 108.883 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 36.9 m80 -120.1 -175.12 2.92 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.778 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -65.98 103.72 0.99 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.265 0.353 . . . . 0.0 111.039 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.73 156.6 22.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.633 0.73 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.647 HG13 ' H ' ' A' ' 51' ' ' LEU . 9.8 tp -179.99 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 -174.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.647 ' H ' HG13 ' A' ' 50' ' ' ILE . 2.9 mm? -78.01 91.68 4.27 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 121.118 1.781 . . . . 0.0 109.738 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.582 HD22 ' O ' ' A' ' 50' ' ' ILE . 2.0 mm? -73.36 -20.98 60.64 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.776 1.274 . . . . 0.0 108.156 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.669 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 60.0 p -63.4 -19.49 64.72 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.921 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.62 12.24 36.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.742 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 -108.41 0.03 OUTLIER Glycine 0 C--O 1.241 0.566 0 O-C-N 123.324 0.39 . . . . 0.0 113.033 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.3 t -146.14 154.07 41.39 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.915 0.864 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -128.78 114.63 16.81 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.153 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 42.4 mt-10 -118.14 169.9 9.31 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.27 74.39 0.14 Allowed Glycine 0 C--N 1.309 -0.932 0 O-C-N 123.309 0.381 . . . . 0.0 113.799 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.18 38.68 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.7 t -123.96 119.27 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 71' ' ' PHE . 42.6 mm -112.58 138.26 42.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.4 m -118.08 115.72 25.41 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -72.71 0.41 Allowed 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.887 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -149.02 -63.42 0.23 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.597 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.66 139.36 27.96 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 13.5 p-80 162.32 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.931 2.092 . . . . 0.0 107.575 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.6 tp 172.59 -71.7 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.569 1.548 . . . . 0.0 108.983 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -176.92 -49.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.059 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p -103.53 136.48 43.17 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -169.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 22.5 p90 -135.16 142.7 46.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 159.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -86.84 122.87 31.32 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.322 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.25 -38.41 90.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.793 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.18 26.58 3.83 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.002 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -155.33 -51.28 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.819 0.31 . . . . 0.0 110.816 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.64 40.05 Favored Glycine 0 C--O 1.218 -0.844 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -85.75 139.16 31.57 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 108.887 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -68.53 140.34 35.02 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 176.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.0 mt -81.16 -51.65 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 50.3 t-20 -150.23 113.88 3.32 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.6 Cg_exo -81.3 179.25 28.66 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.858 -1.726 . . . . 0.0 111.412 -3.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -95.93 12.23 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.401 ' O ' ' HE3' ' A' ' 109' ' ' LYS . 34.8 t70 -67.73 -14.66 63.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.397 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 23.6 p -136.89 152.21 49.97 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.543 176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 31.1 m -152.17 146.11 25.22 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 mp -102.79 153.67 19.94 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-O 120.984 0.421 . . . . 0.0 110.784 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -88.19 119.54 28.69 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.738 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.48 129.98 34.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.732 0.645 . . . . 0.0 109.537 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.11 136.25 20.12 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 101' ' ' SER . 37.3 Cg_endo -68.37 124.3 11.5 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.548 2.165 . . . . 0.0 112.304 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.86 138.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -119.58 135.82 54.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 178.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.426 ' C ' ' HE2' ' A' ' 94' ' ' LYS . 58.7 t -106.21 122.52 60.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -167.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.626 ' HD3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -111.36 146.35 37.28 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 173.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.71 -35.6 17.16 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 115.61 1.004 . . . . 0.0 115.61 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' SER . 25.4 t70 -113.7 -22.7 10.1 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.778 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -114.87 147.65 39.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.136 0.969 . . . . 0.0 113.422 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 12' ' ' ILE . 62.7 mt -121.71 118.16 54.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.788 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.626 ' CD1' ' HD3' ' A' ' 94' ' ' LYS . 4.5 m-85 -112.2 144.11 42.14 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.96 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.78 141.31 39.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 21.4 t -104.15 128.17 51.8 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.518 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.2 p -120.56 5.55 10.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -74.99 118.39 17.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.734 -174.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.03 16.09 79.64 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.142 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.26 119.51 57.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.255 0.55 . . . . 0.0 110.957 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.88 142.68 36.82 Favored Pre-proline 0 N--CA 1.411 -2.387 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.363 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.38 150.08 88.93 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.468 2.112 . . . . 0.0 111.166 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.638 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 34.9 t-20 -81.41 -179.77 7.51 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 83' ' ' ASP . 39.2 ttpt -62.42 93.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.41 1.1 . . . . 0.0 111.521 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.267 -3.019 0 C-N-CA 128.274 2.63 . . . . 0.0 104.471 -174.749 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t . . . . . 0 N--CA 1.427 -1.588 0 CA-C-O 121.126 0.489 . . . . 0.0 109.95 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -156.95 97.81 1.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 125.979 1.712 . . . . 0.0 107.252 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.87 133.47 52.18 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.41 127.39 32.11 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.22 -40.94 5.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.721 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.9 p -160.34 -170.88 2.96 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.768 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 7.2 m -120.15 153.07 36.74 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.348 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -61.58 -21.4 64.28 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.846 0.831 . . . . 0.0 108.924 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.86 -29.63 69.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.266 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.96 -47.55 65.35 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.607 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.83 112.27 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.734 1.254 . . . . 0.0 113.529 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -79.16 170.54 16.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.786 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.34 118.79 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 CA-C-O 121.602 0.715 . . . . 0.0 110.451 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.97 56.9 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.682 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -103.22 150.45 23.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.563 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.8 ptt? -150.12 137.92 20.06 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 34.7 mt-10 -144.2 155.11 43.75 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 m -91.42 123.97 35.25 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.01 154.32 34.72 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -113.54 137.35 51.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -83.0 173.3 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 m -71.94 -9.35 58.23 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.159 0.505 . . . . 0.0 111.669 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.74 -4.74 46.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.36 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.17 44.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.628 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.9 m -89.86 114.79 26.61 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -91.58 123.83 35.28 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' A' ' 40' ' ' ALA . 58.7 t -136.49 142.49 38.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.027 -172.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 32.9 tp -83.61 117.62 23.28 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -107.87 113.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.87 137.31 43.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.711 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -109.97 107.8 17.82 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.3 t -99.2 148.51 24.03 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.031 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -74.99 -36.16 62.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.24 -46.75 6.62 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.793 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -88.51 -7.01 57.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.73 -164.9 52.22 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.202 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.8 t -82.82 128.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -127.9 141.52 51.53 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.483 0.713 . . . . 0.0 111.197 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -125.07 121.26 33.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.913 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.434 ' CD1' HD22 ' A' ' 86' ' ' LEU . 53.6 m-85 -133.04 152.1 51.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -48.96 138.06 12.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.615 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -141.17 19.12 2.26 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -172.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 86.3 mtp -68.97 -30.56 69.01 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.811 ' SG ' ' N ' ' A' ' 65' ' ' ARG . 3.5 t -76.48 124.09 87.88 Favored Pre-proline 0 CA--C 1.619 3.603 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.711 ' C ' ' HA ' ' A' ' 65' ' ' ARG . 12.6 Cg_endo -108.71 104.83 0.02 OUTLIER 'Trans proline' 2 C--N 1.421 4.375 0 C-N-CA 123.922 3.081 . . . . 0.0 113.145 163.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.938 ' CE1' ' H ' ' A' ' 67' ' ' HIS . 6.4 t60 -81.26 -25.8 36.3 Favored 'General case' 0 N--CA 1.523 3.212 0 O-C-N 121.363 -0.835 . . . . 0.0 109.882 -173.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -105.32 111.94 24.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.306 10.9 pt-20 -74.14 83.46 1.82 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.791 1.282 . . . . 0.0 114.256 -174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.618 HG12 ' H ' ' A' ' 51' ' ' LEU . 15.1 tt -152.74 -159.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 102.388 -3.189 . . . . 0.0 102.388 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.618 ' H ' HG12 ' A' ' 50' ' ' ILE . 84.9 mt -64.06 122.55 16.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 120.752 1.615 . . . . 0.0 109.301 175.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 43' ' ' ALA . 1.4 pt? -56.0 -44.76 78.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.409 1.084 . . . . 0.0 113.713 -172.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.588 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 38.2 p -63.54 -24.26 67.73 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.422 0.689 . . . . 0.0 112.516 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -84.31 3.16 36.89 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -139.85 36.64 1.8 Allowed Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.737 -1.22 . . . . 0.0 113.066 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.456 ' H ' ' HE1' ' A' ' 17' ' ' MET . 19.3 m -107.14 -80.39 0.57 Allowed 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.351 0.596 . . . . 0.0 111.425 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 80.7 t80 -90.39 112.73 24.44 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-O 121.84 0.829 . . . . 0.0 110.684 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.51 105.41 11.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.524 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.08 -77.28 0.56 Allowed Glycine 0 N--CA 1.45 -0.395 0 O-C-N 123.384 0.427 . . . . 0.0 112.424 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.22 6.56 0.82 Allowed Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.66 135.16 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 69.1 mt -105.68 129.95 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 121.347 0.594 . . . . 0.0 109.763 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 9.1 m -111.2 152.5 27.01 Favored 'General case' 0 N--CA 1.38 -3.951 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 1.555 ' CA ' ' CB ' ' A' ' 64' ' ' CYS 0.473 15.0 p -118.32 -112.49 0.34 Allowed 'General case' 2 CA--C 1.789 10.154 0 C-N-CA 128.179 2.591 . . . . 0.0 106.829 179.1 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.836 ' HA ' ' N ' ' A' ' 47' ' ' HIS . 37.2 ttm105 -122.29 -161.89 0.96 Allowed 'General case' 3 N--CA 1.652 9.667 1 C-N-CA 137.532 6.333 . . . . 0.0 107.513 170.359 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.748 ' H ' ' HG2' ' A' ' 65' ' ' ARG . . . -55.95 100.38 0.04 OUTLIER 'General case' 2 N--CA 1.557 4.891 1 N-CA-C 122.168 4.136 . . . . 0.0 122.168 -166.922 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.938 ' H ' ' CE1' ' A' ' 47' ' ' HIS 0.373 53.7 m80 -96.1 -170.47 2.12 Favored 'General case' 1 N--CA 1.543 4.186 0 C-N-CA 129.863 3.265 . . . . 0.0 106.597 170.21 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -145.06 8.94 1.25 Allowed 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.735 ' H ' ' HB3' ' A' ' 67' ' ' HIS . 28.8 m-90 -146.32 -159.96 1.09 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.7 2.0 . . . . 0.0 107.822 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -124.26 161.98 24.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.489 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 11.8 t80 -119.48 142.47 48.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -119.33 140.61 50.04 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.656 -1.218 . . . . 0.0 114.214 -172.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.488 ' HB2' HG13 ' A' ' 62' ' ' ILE . 7.0 t70 -75.28 -53.91 7.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.647 1.179 . . . . 0.0 112.463 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.54 95.73 Favored Glycine 0 CA--C 1.503 -0.658 0 O-C-N 123.702 0.626 . . . . 0.0 112.789 -175.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -79.46 -30.86 42.34 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 66.8 41.84 93.37 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 78' ' ' GLY . 12.1 t60 -160.03 150.52 18.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -174.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 77' ' ' HIS . . . -77.88 133.75 13.47 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 119.225 -1.465 . . . . 0.0 110.251 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.89 -37.51 54.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 69' ' ' TRP . 25.0 t-20 -146.81 119.98 4.98 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.87 154.63 54.85 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.62 -1.408 . . . . 0.0 112.895 0.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.12 -15.68 57.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.942 0.877 . . . . 0.0 109.235 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.9 -32.87 61.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.218 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 109' ' ' LYS . 71.9 m -134.4 161.43 35.02 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 122.229 1.014 . . . . 0.0 112.317 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 24.5 p -138.21 -171.88 3.14 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.597 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 86' ' ' LEU . 2.0 pp -97.41 145.71 25.9 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.983 0.42 . . . . 0.0 111.226 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.24 113.74 26.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.43 118.51 22.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 O-C-N 123.452 0.47 . . . . 0.0 109.779 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -90.74 124.47 62.19 Favored Pre-proline 0 C--N 1.278 -2.536 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -60.2 120.05 7.6 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.966 1.778 . . . . 0.0 110.45 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.37 130.31 72.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.411 0.624 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.619 ' HG2' ' HD2' ' A' ' 94' ' ' LYS . 35.7 tt0 -115.42 131.51 56.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.161 -174.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.28 117.34 55.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.001 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.619 ' HD2' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -125.96 98.5 5.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.21 -107.07 2.12 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 8' ' ' SER . 31.2 t70 -109.98 -5.24 15.51 Favored 'General case' 0 C--O 1.177 -2.758 0 CA-C-O 121.051 0.453 . . . . 0.0 109.962 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.64 133.18 44.35 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.294 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.7 mt -123.88 119.54 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.875 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.586 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 10.9 m-85 -112.68 144.49 42.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.098 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.55 142.32 39.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.42 0.629 . . . . 0.0 111.098 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t -106.71 128.97 54.65 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.113 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -120.84 -8.32 9.43 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.252 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -78.01 121.83 24.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.07 -32.52 6.63 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.569 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.432 HD12 ' HD3' ' A' ' 90' ' ' PRO . 73.1 mt -120.14 108.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.504 0.668 . . . . 0.0 109.963 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -94.02 155.06 40.55 Favored Pre-proline 0 N--CA 1.41 -2.459 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.339 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.59 144.1 99.51 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.448 2.098 . . . . 0.0 109.86 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -79.58 166.03 22.32 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 52.8 mtmt -38.04 -51.26 1.38 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.472 1.509 . . . . 0.0 115.073 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.285 -2.225 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -175.412 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' SER . 46.5 t . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 73.5 m-85 -79.89 115.72 19.63 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 170.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.29 144.97 49.68 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -74.08 125.43 28.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.101 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -106.68 -42.25 6.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.488 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.3 m -148.08 -179.32 6.83 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.338 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 12' ' ' ILE . 13.2 p -130.69 152.7 49.77 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 125.211 1.405 . . . . 0.0 108.881 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.494 ' O ' HD13 ' A' ' 9' ' ' LEU . 2.8 tm? -56.41 -23.76 40.5 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.12 -30.33 71.4 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.668 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.8 -8.39 13.19 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 8' ' ' SER . 3.7 tp -127.65 110.4 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 0.0 110.081 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.37 164.63 11.57 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.513 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.48 124.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.065 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.09 -8.17 62.83 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -102.81 153.25 20.36 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.447 0.641 . . . . 0.0 111.142 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.581 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -149.55 137.72 20.57 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.121 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 20' ' ' PHE . 12.0 pt-20 -157.41 155.36 30.35 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.402 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -93.81 141.36 28.59 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 112.047 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.77 148.75 52.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.491 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.73 139.72 37.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -83.56 168.37 16.46 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 m -70.05 -12.4 61.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.084 0.469 . . . . 0.0 110.845 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -90.22 -2.9 58.09 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.374 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.41 12.91 60.69 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.392 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -87.01 123.34 32.0 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.35 123.6 33.68 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.16 135.64 60.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.446 0.641 . . . . 0.0 110.892 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -89.53 113.97 25.44 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 124.454 1.101 . . . . 0.0 109.277 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.19 113.6 30.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.44 124.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 43.5 t30 -108.17 104.57 14.01 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.766 -1.173 . . . . 0.0 108.323 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 48.0 t -101.36 149.26 24.23 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.506 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -77.46 -32.32 54.38 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.292 0.568 . . . . 0.0 109.576 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -93.43 -47.13 7.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.699 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 65.7 m80 -83.28 -19.96 35.34 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.781 0.324 . . . . 0.0 111.309 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.37 -174.29 48.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -87.52 118.15 32.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.679 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -131.68 157.74 42.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.007 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -124.7 134.96 52.67 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 73' ' ' ASP . 69.2 m-85 -134.11 163.63 29.14 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 10.2 pt20 -66.57 144.23 56.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.77 8.19 33.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.43 0.633 . . . . 0.0 111.305 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.2 tpp -99.4 143.37 29.74 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.876 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.49 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -116.76 152.73 48.82 Favored Pre-proline 0 N--CA 1.426 -1.663 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.925 177.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.72 -39.39 13.51 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 123.564 2.843 . . . . 0.0 112.558 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.5 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 8.8 m80 -64.77 -86.14 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 168.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -153.22 173.85 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.74 129.82 36.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 50' ' ' ILE . 13.0 tt -156.74 24.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 122.82 1.295 . . . . 0.0 108.714 -174.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt 69.31 84.38 0.15 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 113.524 -1.671 . . . . 0.0 113.687 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.2 mp -70.14 -30.65 67.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.456 1.122 . . . . 0.0 108.26 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 11.6 p -61.41 -29.81 70.17 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.975 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -98.69 2.65 47.34 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 65' ' ' ARG . . . 164.71 91.94 0.08 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 118.297 -1.906 . . . . 0.0 115.241 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -157.27 -62.02 0.09 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.581 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 41.2 t80 -90.48 114.05 26.14 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.39 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -118.41 114.36 22.78 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.465 173.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.03 -70.64 1.21 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.359 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.78 -17.74 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.654 -0.273 . . . . 0.0 112.765 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.66 141.79 15.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 117.072 0.436 . . . . 0.0 109.961 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 57.5 mt -111.3 123.76 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 94.9 m -92.85 143.96 25.76 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 3.7 t -76.29 -85.44 0.05 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 116.2 -2.2 . . . . 0.0 107.74 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 23.9 tpt180 -178.81 -34.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.065 0.848 . . . . 0.0 112.522 164.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.63 -39.62 8.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 6.6 p-80 -84.92 178.73 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.431 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -53.41 -70.61 0.09 Allowed 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' A' ' 63' ' ' THR 0.255 98.0 m95 -129.18 -93.71 0.43 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -173.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 32.6 p -101.6 146.17 28.05 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 117.333 2.345 . . . . 0.0 117.333 -160.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 45.8 t80 -135.96 143.08 44.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 168.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -119.11 128.17 54.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 120.507 1.503 . . . . 0.0 113.685 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 10.5 p-10 -79.44 -40.68 29.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.943 -175.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.02 47.24 2.22 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 121.141 0.301 . . . . 0.0 112.91 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -163.46 -45.34 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 85' ' ' CYS . . . 104.86 -65.36 0.3 Allowed Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' CYS . 44.1 m80 -73.73 132.47 42.69 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -82.97 177.14 53.3 Favored Glycine 0 C--N 1.299 -1.508 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.976 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.4 mp -84.39 -34.99 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 23.7 t-20 -142.73 109.86 5.63 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.0 Cg_exo -80.08 147.83 77.36 Favored 'Cis proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.429 -3.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.675 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.6 p30 -77.61 -21.75 51.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.93 -8.38 58.78 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.913 0.387 . . . . 0.0 110.377 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 67.8 m -103.62 152.4 21.81 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 121.605 0.717 . . . . 0.0 111.842 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 4.3 p -132.0 178.77 6.53 Favored 'General case' 0 C--N 1.273 -2.743 0 C-N-CA 125.496 1.518 . . . . 0.0 110.139 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -131.32 35.75 3.86 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . . . 46.3 102.46 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.849 1.26 . . . . 0.0 114.398 -177.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.99 112.25 23.6 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 110.941 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 93.6 m-85 -102.51 130.64 23.63 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.468 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 101' ' ' SER . 14.5 Cg_endo -72.16 139.47 32.5 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.053 1.835 . . . . 0.0 111.271 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 100' ' ' VAL . 57.8 t -126.58 140.07 49.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.685 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -130.43 137.24 49.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 110.537 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.26 129.22 64.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.795 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -125.3 95.24 4.4 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.49 4.07 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.519 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -101.93 -2.87 28.84 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.544 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.494 ' HB2' ' HE3' ' A' ' 94' ' ' LYS . 20.7 m-20 -111.75 148.91 32.49 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.3 mt -126.39 131.99 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -99.49 148.48 24.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.538 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 91' ' ' VAL . 35.9 m -133.67 137.31 52.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 2' ' ' SER . 43.7 t -90.58 113.73 25.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.8 p -138.29 -26.46 0.91 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.236 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -74.44 99.51 3.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.401 0.62 . . . . 0.0 109.725 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.92 -8.21 16.64 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.837 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.11 115.64 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.999 0.428 . . . . 0.0 110.456 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.83 144.29 31.41 Favored Pre-proline 0 N--CA 1.412 -2.351 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.76 128.58 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.96 1.773 . . . . 0.0 111.141 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.3 p-10 -85.28 122.0 28.82 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.136 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.425 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 55.5 tptt 67.72 160.93 0.17 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.92 1.387 . . . . 0.0 111.029 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 124.919 1.288 . . . . 0.0 112.64 176.162 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 101' ' ' SER . 22.7 t . . . . . 0 N--CA 1.463 0.187 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 68.2 m-85 -75.51 97.79 3.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -107.13 144.95 33.11 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -77.28 124.28 27.64 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -98.21 -45.92 12.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.734 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.1 p -157.79 -172.18 3.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.372 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -125.74 152.7 45.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.597 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.5 tt -61.57 -26.03 67.7 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.26 -10.76 56.91 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.918 -0.489 . . . . 0.0 111.378 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -93.76 -53.4 4.04 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 12' ' ' ILE . 42.2 pt -111.4 110.86 33.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 122.462 1.125 . . . . 0.0 111.757 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.97 170.23 16.96 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.251 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 34' ' ' GLU . 7.1 p -57.71 112.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-O 121.874 0.845 . . . . 0.0 111.276 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.21 58.95 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.558 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -102.83 152.48 21.22 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.168 0.508 . . . . 0.0 111.072 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.559 ' HB2' HD21 ' A' ' 29' ' ' LEU . 25.3 ptt? -149.95 145.23 26.36 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.895 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.8 pt-20 -157.8 154.73 28.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 73.5 m -71.99 130.26 40.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.017 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 97.6 m-85 -128.09 157.01 41.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -106.24 135.68 47.29 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -83.39 173.71 11.29 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 m -73.89 -12.24 60.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.493 0.663 . . . . 0.0 110.993 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.2 -12.22 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.659 0.742 . . . . 0.0 109.111 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 20.71 24.91 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.629 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.9 m -91.34 130.27 37.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -88.04 124.39 33.7 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.8 t -138.7 145.68 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 17' ' ' MET . 5.7 tt -97.3 112.32 24.18 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mm -97.6 119.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 17' ' ' MET . 10.1 p -116.52 134.1 61.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.411 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -108.86 104.31 13.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.3 m -101.19 143.9 30.72 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -76.57 -51.31 11.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.3 -46.58 22.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.317 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -92.75 2.62 56.64 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.199 0.523 . . . . 0.0 111.361 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.92 177.06 35.3 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.719 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.2 125.63 39.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 9.8 mmpt? -127.81 145.19 51.01 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.123 0.569 . . . . 0.0 109.97 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -125.56 112.13 15.83 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.403 ' C ' HG13 ' A' ' 28' ' ' VAL . 13.9 p90 -137.53 140.94 41.39 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 119.553 -0.26 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.515 ' HB2' HD22 ' A' ' 86' ' ' LEU . 38.3 mt-30 -42.91 137.36 2.38 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.938 0.774 . . . . 0.0 111.953 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.46 78.7 1.75 Allowed 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.467 0.651 . . . . 0.0 110.157 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.488 ' HB2' ' HB1' ' A' ' 110' ' ' ALA 0.286 10.9 mmt -123.75 135.7 53.99 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.87 90.67 0.47 Allowed Pre-proline 0 C--N 1.311 -1.067 0 C-N-CA 127.594 2.357 . . . . 0.0 107.873 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -85.33 27.76 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.54 2.16 . . . . 0.0 111.063 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -85.18 -52.95 5.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.15 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -138.0 -72.02 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -98.83 115.69 29.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.31 -28.86 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.185 0.928 . . . . 0.0 110.515 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.7 mt -79.02 98.13 6.35 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 52' ' ' LEU . 3.2 tt -56.95 -28.9 62.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.488 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 67.5 p -58.04 -21.72 46.65 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.713 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -88.59 8.71 27.0 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.968 0.413 . . . . 0.0 112.009 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.49 -124.57 1.21 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 173.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.6 t -157.29 150.04 23.29 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 110.263 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CD1' HD13 ' A' ' 62' ' ' ILE . 6.8 t80 -130.89 115.91 17.18 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.293 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -116.15 104.15 11.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.02 -73.89 0.13 Allowed Glycine 0 CA--C 1.52 0.364 0 O-C-N 123.715 0.634 . . . . 0.0 112.845 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.68 25.09 1.19 Allowed Glycine 0 C--N 1.295 -1.7 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.52 120.99 62.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 35.4 mm -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 m -127.2 129.05 47.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 -155.2 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.045 0 C-N-CA 123.442 0.697 . . . . 0.0 111.411 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.6 tpt180 -113.1 95.09 5.2 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.762 -0.586 . . . . 0.0 110.654 -169.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.69 21.81 10.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -97.72 -17.02 19.66 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.21 -48.69 0.69 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -74.4 177.24 6.07 Favored 'General case' 0 CA--C 1.577 2.017 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.766 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -103.08 156.92 17.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -166.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.515 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 6.3 t80 -134.07 146.26 50.15 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -118.57 112.84 20.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.905 0.775 . . . . 0.0 112.976 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.59 -34.36 58.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.515 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.84 -40.16 89.33 Favored Glycine 0 CA--C 1.508 -0.369 0 O-C-N 123.342 0.402 . . . . 0.0 113.486 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -101.1 -12.75 18.56 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.644 0.735 . . . . 0.0 109.41 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.35 38.68 38.19 Favored Glycine 0 C--O 1.219 -0.821 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.777 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -140.74 141.32 34.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -85.73 139.75 17.42 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.922 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.63 -35.97 17.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -141.47 137.47 16.52 Favored Pre-proline 0 N--CA 1.417 -2.114 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -66.76 -13.56 8.08 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 CA-C-N 119.383 0.815 . . . . 0.0 113.44 -0.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 11.2 t70 90.14 -39.35 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 126.928 2.091 . . . . 0.0 110.0 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -56.46 -34.28 66.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.325 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 51.6 m -93.7 141.84 28.03 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.853 0.835 . . . . 0.0 108.885 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.3 m -144.52 166.6 24.69 Favored 'General case' 0 C--N 1.254 -3.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 42' ' ' GLN . 72.5 mt -128.98 179.69 5.6 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -175.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.92 117.62 17.9 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -85.66 101.22 12.55 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -81.11 141.87 50.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.415 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -58.37 118.55 5.45 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.764 1.643 . . . . 0.0 110.537 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.0 p -133.5 137.79 52.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -133.64 140.19 46.94 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.365 0.602 . . . . 0.0 111.062 -176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.8 127.97 57.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.43 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.53 91.3 3.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.37 -106.0 1.22 Allowed Glycine 0 C--N 1.3 -1.439 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.418 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.9 -10.86 22.27 Favored 'General case' 0 C--O 1.186 -2.283 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.16 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.87 140.36 35.27 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.774 0.321 . . . . 0.0 111.406 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.7 mt -127.14 122.06 59.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.831 0.825 . . . . 0.0 111.664 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 39.7 m-85 -115.12 144.41 43.7 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.937 -176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.54 145.37 29.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.04 0.448 . . . . 0.0 110.911 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 2' ' ' SER . 51.5 m -111.45 116.26 30.6 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.437 ' HA ' ' CG2' ' A' ' 105' ' ' ILE . 10.0 t -134.26 -10.66 2.54 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.913 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -85.44 97.11 9.83 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.857 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.86 -32.85 2.47 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 102' ' ' THR . 13.3 tt -86.83 136.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.21 123.53 79.32 Favored Pre-proline 0 N--CA 1.426 -1.672 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.457 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 23.0 Cg_exo -68.25 129.7 19.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.605 2.87 . . . . 0.0 108.511 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -81.16 174.39 11.61 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.659 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 109' ' ' LYS . 75.3 mmtt -52.81 104.6 0.09 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.813 1.292 . . . . 0.0 114.158 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.279 -2.492 0 CA-C-N 111.237 -2.711 . . . . 0.0 104.406 -174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 101' ' ' SER . 49.3 m . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.482 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 95.6 m-85 -86.09 124.82 32.94 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -120.23 145.1 47.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 118.24 23.38 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -118.23 -40.72 2.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.379 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 p -146.27 -175.15 4.65 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.577 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.574 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.6 m -131.57 150.6 52.09 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.221 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -71.47 -25.26 62.21 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 96' ' ' ASP . 23.8 t70 -72.19 -17.68 61.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.316 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.25 -53.43 4.7 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 12' ' ' ILE . 43.3 pt -108.37 110.13 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 122.433 1.111 . . . . 0.0 110.523 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.492 ' HB2' ' OE2' ' A' ' 16' ' ' GLU . 37.3 m95 -80.38 170.07 16.88 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.119 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.43 127.13 14.99 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.036 0.446 . . . . 0.0 110.015 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.65 -1.72 79.13 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 13' ' ' TRP . 44.8 mt-10 -110.34 149.94 29.5 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.38 0.61 . . . . 0.0 112.239 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 53' ' ' SER . 20.3 ptt? -150.39 152.2 33.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.485 -171.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -157.24 151.91 25.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 123.613 0.571 . . . . 0.0 109.472 177.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.638 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 99.1 m -89.49 121.01 31.31 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 97.6 m-85 -119.2 155.77 31.08 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' THR . 36.1 tt0 -109.88 143.42 39.8 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.1 p -83.06 165.76 19.32 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 m -67.0 -13.13 61.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.142 0.496 . . . . 0.0 111.213 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.85 -13.11 49.01 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 109.489 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 22.39 16.42 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.794 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.587 ' CG2' HE22 ' A' ' 42' ' ' GLN . 31.5 m -97.72 130.03 44.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.764 -0.257 . . . . 0.0 111.168 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -89.64 126.85 35.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.571 0.701 . . . . 0.0 111.589 175.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.19 148.78 27.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.8 tp -100.29 111.1 23.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.3 mp -102.94 117.45 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 17' ' ' MET . 66.2 t -118.05 125.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.839 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -88.09 104.22 16.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -101.59 145.75 28.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.144 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.82 -48.98 19.37 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.483 0.659 . . . . 0.0 109.574 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.29 -41.33 61.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.723 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -100.78 2.48 41.27 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.77 -170.68 46.1 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.1 t -78.43 119.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.09 144.77 44.29 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.655 0.264 . . . . 0.0 110.914 -176.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.97 119.99 31.18 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.535 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 2.0 p90 -143.23 140.19 30.58 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.394 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.587 HE22 ' CG2' ' A' ' 26' ' ' THR . 14.7 mm100 -44.66 138.21 3.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.25 59.21 4.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.425 1.107 . . . . 0.0 109.877 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 19.0 mmt -66.07 94.1 0.23 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 113.618 -1.628 . . . . 0.0 114.262 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 3.7 m -166.47 93.84 0.76 Allowed Pre-proline 0 C--N 1.31 -1.148 0 C-N-CA 125.445 1.498 . . . . 0.0 110.403 175.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.98 30.27 0.47 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.206 2.604 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 30.38 3.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -47.91 124.02 6.89 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.244 2.218 . . . . 0.0 114.817 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 41.7 mm-40 -92.55 -62.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 173.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 tp -151.16 172.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 110.71 2.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 118.985 0.811 . . . . 0.0 109.67 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.2 pt? -62.16 -20.01 63.66 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.893 1.277 . . . . 0.0 112.409 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.638 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 59.3 p -55.0 -21.86 13.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -166.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.46 8.59 44.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.36 0.6 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.68 81.3 0.12 Allowed Glycine 0 C--N 1.318 -0.426 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.602 ' HB3' HG23 ' A' ' 62' ' ' ILE . 66.3 m -138.53 -77.86 0.36 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -90.23 114.23 26.2 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.508 -169.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.4 105.24 11.93 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.657 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.85 -64.07 1.55 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 123.207 0.317 . . . . 0.0 113.028 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.1 -2.62 0.06 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.88 140.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 56' ' ' SER . 36.4 mt -113.4 121.06 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 0.0 112.044 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.4 m -92.94 148.46 21.99 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 125.67 1.588 . . . . 0.0 110.432 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.549 ' C ' ' H ' ' A' ' 66' ' ' ALA . 44.6 t -156.21 34.7 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 72.32 -22.91 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.694 1.198 . . . . 0.0 109.83 -170.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . 71.17 100.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 125.367 1.467 . . . . 0.0 111.576 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.452 ' CE1' ' HG2' ' A' ' 49' ' ' GLU . 52.7 m80 -99.83 -0.17 40.27 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.499 174.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -147.55 -55.1 0.22 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.016 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -170.62 -143.78 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 32.8 p -134.39 167.68 20.3 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.363 1.465 . . . . 0.0 108.981 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 54.2 m-85 -98.69 138.39 35.93 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -107.46 112.54 25.37 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 173.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.405 4.6 p-10 52.77 63.19 2.33 Favored 'General case' 0 CA--C 1.476 -1.883 0 CA-C-O 123.333 1.539 . . . . 0.0 111.342 -167.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.506 ' HA3' HD12 ' A' ' 62' ' ' ILE . . . -73.26 64.47 1.67 Allowed Glycine 0 CA--C 1.474 -2.491 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.257 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.2 m -139.85 -46.64 0.44 Allowed 'General case' 1 C--N 1.242 -4.09 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.96 -3.53 6.3 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 119.171 -1.49 . . . . 0.0 113.399 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -144.12 142.95 30.89 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.326 0.563 . . . . 0.0 110.801 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.45 129.05 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.699 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 70' ' ' THR . 51.1 mt -88.3 -22.93 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 173.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 23.7 t30 -143.8 113.44 5.44 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.895 168.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 6.9 Cg_exo -76.11 129.16 18.08 Favored 'Cis proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.706 -1.789 . . . . 0.0 110.914 -2.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.21 -11.84 59.96 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.739 0.78 . . . . 0.0 109.886 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.84 -19.78 61.25 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.712 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 79.3 m -155.11 161.67 41.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 122.327 1.06 . . . . 0.0 113.196 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 p -94.06 -167.56 1.7 Allowed 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 84.6 mt -117.38 142.72 46.77 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.843 177.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.22 86.38 5.01 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.569 176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 123.58 24.57 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.105 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.52 ' CD2' HG21 ' A' ' 105' ' ' ILE 0.251 5.4 p90 -124.08 160.32 52.69 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.58 133.67 43.77 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.68 2.92 . . . . 0.0 115.012 -172.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.3 t -116.3 143.56 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-N 113.713 -1.585 . . . . 0.0 107.498 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.9 132.38 47.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.52 130.49 48.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.63 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 90.6 3.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 176.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.64 -113.55 5.96 Favored Glycine 0 C--N 1.31 -0.889 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.604 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.2 m-20 -91.93 -8.2 46.96 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 123.365 0.666 . . . . 0.0 110.671 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 17.4 m-20 -111.65 157.61 20.24 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.2 mm -126.93 135.93 62.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 16.6 m-85 -106.54 145.99 31.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 167.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.32 151.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 2' ' ' SER . 20.8 m -87.47 113.08 22.85 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.1 p -124.51 -38.28 2.42 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.4 tpmt? -107.32 91.19 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.07 -39.08 0.73 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.614 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 28.1 mm -85.49 143.25 11.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 170.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.0 tp -96.86 100.75 7.9 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.451 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 105' ' ' ILE . 2.9 Cg_exo -78.41 136.98 14.49 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 123.084 2.523 . . . . 0.0 109.872 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -80.53 117.01 20.87 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.252 0.548 . . . . 0.0 110.385 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -71.83 -24.13 61.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.704 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HA ' ' SD ' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.301 -1.504 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.912 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 CA--C 1.506 -0.726 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 52.46 87.82 0.03 OUTLIER 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.151 0.977 . . . . 0.0 111.342 -174.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -105.3 142.48 34.99 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -65.8 117.52 8.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.278 0.561 . . . . 0.0 110.128 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 tt -104.3 -56.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.57 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.846 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.3 m -157.92 -177.14 6.35 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 123.058 0.543 . . . . 0.0 111.064 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 p -103.62 150.17 24.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.0 tt -72.85 -24.77 60.92 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.4 -25.97 68.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.215 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.54 -48.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.6 pt -100.91 110.79 28.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 CA-C-O 122.802 1.287 . . . . 0.0 112.27 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -79.2 169.78 17.63 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 113.514 -1.676 . . . . 0.0 112.227 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.1 116.71 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.703 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.34 2.12 59.08 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.383 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -104.18 145.04 30.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.21 0.528 . . . . 0.0 110.679 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -142.36 143.73 32.85 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 tp10 -152.86 149.76 28.62 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 69.5 m -89.08 123.06 33.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.001 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -127.57 162.51 26.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.765 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -102.0 141.54 34.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -83.97 170.59 13.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -64.02 -13.68 48.5 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.758 0.423 . . . . 0.0 111.66 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.52 -13.24 24.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.283 0.563 . . . . 0.0 110.373 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.2 18.58 23.82 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.978 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -97.09 139.12 33.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -89.65 135.45 33.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' THR . 99.2 t -134.94 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -104.08 110.29 22.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.455 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.4 mp -101.3 123.19 54.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 17' ' ' MET . 9.3 p -111.96 125.58 69.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -101.86 102.01 12.54 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 117.941 -1.504 . . . . 0.0 108.456 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.9 m -103.6 139.08 39.38 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.64 -38.62 54.36 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.412 0.625 . . . . 0.0 109.706 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -92.93 -46.89 7.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.68 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -79.74 -12.3 59.8 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.111 0.481 . . . . 0.0 110.41 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.76 159.13 31.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.988 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 93' ' ' VAL . 7.2 p -72.94 124.01 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -127.06 138.59 53.24 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.24 0.543 . . . . 0.0 112.38 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.7 112.33 16.62 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.015 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 25.3 p90 -136.82 147.08 46.37 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.676 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -47.33 137.79 8.02 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.896 0.855 . . . . 0.0 113.02 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . . . -83.99 101.09 11.48 Favored 'General case' 0 N--CA 1.396 -3.141 0 CA-C-N 114.474 -1.239 . . . . 0.0 113.198 -172.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 26.1 ptt? 64.07 179.42 0.17 Allowed 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 111.32 -2.673 . . . . 0.0 116.306 163.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.61 116.64 66.83 Favored Pre-proline 0 N--CA 1.416 -2.169 0 CA-C-N 112.238 -2.256 . . . . 0.0 107.202 171.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -85.8 37.26 0.55 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 122.742 2.295 . . . . 0.0 113.347 -175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.4 m80 -85.13 -59.69 2.26 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 176.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.15 115.11 29.71 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.603 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -75.13 82.97 2.32 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 122.359 1.076 . . . . 0.0 111.164 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.0 tt -71.99 -37.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.93 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 60.61 69.49 0.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.454 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 1.5 pt? -77.5 -19.33 56.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.323 -2.217 . . . . 0.0 114.074 -169.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.9 p -54.88 -23.12 17.11 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -163.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.49 -9.24 58.53 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 119.083 0.856 . . . . 0.0 110.182 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.6 83.18 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 m -125.31 -57.68 1.47 Allowed 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 122.411 1.1 . . . . 0.0 109.107 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -91.21 113.52 25.81 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.403 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.36 105.52 11.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 -53.82 2.1 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.606 -0.331 . . . . 0.0 113.585 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.55 -12.28 0.02 OUTLIER Glycine 0 C--N 1.306 -1.107 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.7 141.55 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 51.5 mm -106.83 128.35 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 123.956 0.902 . . . . 0.0 108.954 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.4 m -85.74 125.25 33.08 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 5.4 t -105.79 155.57 19.16 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.39 117.77 29.96 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.303 0.241 . . . . 0.0 110.957 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.05 -38.34 0.39 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 36.0 m170 -71.2 114.71 9.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 118.266 0.485 . . . . 0.0 111.38 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.477 ' HB3' ' CG ' ' A' ' 80' ' ' ASN . 2.1 tm? 49.24 -97.49 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.438 1.495 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -166.98 -44.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 p -138.34 134.93 34.85 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -160.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 48.3 t80 -116.23 138.53 51.21 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 101.868 -3.382 . . . . 0.0 101.868 168.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.421 ' H ' ' HA2' ' A' ' 78' ' ' GLY . 54.7 t30 -123.35 117.34 24.99 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.873 1.67 . . . . 0.0 115.156 -168.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.48 -33.46 42.23 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.256 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -48.47 -54.58 12.74 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.757 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.7 m -88.94 -36.78 15.7 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.087 0.47 . . . . 0.0 110.223 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.508 ' O ' HD13 ' A' ' 86' ' ' LEU . . . 114.37 -33.55 5.35 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.456 ' HD2' ' SG ' ' A' ' 85' ' ' CYS . 29.8 t-80 -82.72 137.97 34.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.79 144.22 17.17 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.92 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.56 -42.42 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.477 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 3.5 p-10 -135.32 118.89 12.97 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.0 Cg_endo -81.11 131.76 21.39 Favored 'Cis proline' 0 C--O 1.243 0.757 0 C-N-CA 123.797 -1.335 . . . . 0.0 111.397 -1.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.0 p30 -71.5 -12.69 61.51 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.059 0.457 . . . . 0.0 111.101 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.41 -17.53 62.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.39 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 25.5 p -138.58 178.78 6.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 111.951 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 77' ' ' HIS . 62.3 m -133.61 176.12 8.83 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 76' ' ' GLY 0.313 0.0 OUTLIER -101.02 127.06 47.7 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.646 175.466 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -72.83 114.2 10.71 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -87.32 116.89 25.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 101' ' ' SER . 65.4 m-85 -95.69 152.54 39.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HD3' HD12 ' A' ' 105' ' ' ILE . 14.2 Cg_exo -70.76 120.55 7.16 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.186 1.924 . . . . 0.0 110.058 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.74 138.27 52.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.468 0.652 . . . . 0.0 110.667 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -115.24 132.06 56.73 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.512 ' HB ' HG11 ' A' ' 38' ' ' VAL . 8.8 p -106.57 122.21 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.324 -175.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -125.89 143.93 50.88 Favored 'General case' 0 N--CA 1.394 -3.234 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.312 176.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -33.62 -53.75 0.63 Allowed Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 117.531 1.772 . . . . 0.0 117.531 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.56 -0.73 13.58 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.534 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 9.3 m-20 -146.89 134.82 21.37 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.67 129.77 73.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-O 121.354 0.597 . . . . 0.0 111.088 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -113.73 141.49 47.2 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.027 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.76 147.94 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 120.946 0.403 . . . . 0.0 111.082 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.456 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 51.3 m -104.79 115.22 29.93 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.969 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -101.01 -18.43 16.28 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -81.73 108.38 15.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.147 176.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.55 -34.32 2.43 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.498 HD12 ' HD3' ' A' ' 90' ' ' PRO . 33.7 mt -119.02 127.64 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.06 128.07 61.69 Favored Pre-proline 0 N--CA 1.404 -2.732 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.09 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.42 148.87 91.87 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.36 2.04 . . . . 0.0 110.362 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -80.18 166.88 21.0 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -78.56 74.14 5.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.975 1.369 . . . . 0.0 114.139 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.26 -3.291 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.87 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.6 m . . . . . 0 C--O 1.243 0.727 0 CA-C-O 119.82 -0.133 . . . . 0.0 110.868 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CD2' ' HB2' ' A' ' 101' ' ' SER . 92.2 m-85 -76.07 97.72 4.14 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.76 143.81 35.79 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 120.908 0.385 . . . . 0.0 110.284 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 86.1 tttt -79.54 123.66 27.78 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' ' 7' ' ' CYS . 39.7 mm -94.87 -53.55 8.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.333 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 6' ' ' ILE . 93.4 m -158.31 -172.56 3.93 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.465 0.65 . . . . 0.0 111.921 -173.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 41.2 t -104.74 153.22 21.57 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.959 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.4 tt -61.73 -21.8 64.82 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.99 -19.6 66.08 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.186 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -94.98 -42.95 8.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.6 tp -114.49 110.83 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.056 0.931 . . . . 0.0 112.65 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -102.59 169.04 8.89 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.327 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.42 124.76 27.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.684 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.52 66.0 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -105.14 153.27 21.75 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.083 -0.559 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -151.27 143.92 24.34 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.512 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.01 155.44 31.25 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.3 m -73.38 136.21 44.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.064 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -135.33 160.5 38.22 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.11 136.98 44.83 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.9 p -84.62 175.64 9.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.9 m -66.12 -20.72 66.24 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.046 0.45 . . . . 0.0 111.368 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.44 5.12 52.42 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.588 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.05 33.67 54.17 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.104 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 m -97.98 134.95 40.39 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.68 122.67 33.01 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.13 141.98 45.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.215 0.531 . . . . 0.0 110.267 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 53.5 tp -100.04 111.91 24.21 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 124.512 1.125 . . . . 0.0 108.191 177.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.7 114.33 32.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.39 124.55 64.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.3 t30 -109.31 106.46 16.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.5 m -98.37 157.3 16.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.686 0.755 . . . . 0.0 112.518 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -75.26 -48.96 20.88 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.543 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.12 -33.77 10.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -91.45 3.28 55.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.15 -166.37 41.23 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.392 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 10.6 p -90.92 128.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.548 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -132.3 158.16 42.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.336 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.31 128.02 48.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 39' ' ' LYS . 95.0 m-85 -134.97 163.56 29.59 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -55.38 138.93 44.72 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.206 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.47 -39.3 74.32 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.511 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 66.6 mtt -103.19 120.61 41.03 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 29.8 p -70.7 171.88 7.34 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 123.362 0.413 . . . . 0.0 110.429 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.479 ' N ' ' HA ' ' A' ' 110' ' ' ALA . 31.8 Cg_exo -60.62 -18.84 57.26 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.672 2.248 . . . . 0.0 111.661 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -100.01 -22.69 15.14 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.369 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.577 ' HG3' ' H ' ' A' ' 49' ' ' GLU 0.375 11.8 pt20 47.9 -102.98 0.09 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.02 0.928 . . . . 0.0 113.433 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.577 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 44.4 mt-10 58.5 -75.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.796 1.238 . . . . 0.0 113.505 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -109.27 141.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.62 99.34 5.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.942 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.5 pt? -60.33 -24.97 65.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.3 p -63.58 -27.82 69.51 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 123.982 0.913 . . . . 0.0 110.305 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -113.84 21.19 15.17 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.37 -110.47 2.62 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.8 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 m -148.27 157.84 43.73 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.546 0.689 . . . . 0.0 111.495 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -125.24 127.47 46.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.327 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 61' ' ' VAL . 1.6 tm-20 -114.96 163.88 14.95 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.26 -34.85 48.6 Favored Glycine 0 C--N 1.317 -0.479 0 CA-C-N 118.535 0.607 . . . . 0.0 113.288 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.06 7.14 5.11 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.527 -1.32 . . . . 0.0 113.058 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 58' ' ' GLU . 64.3 t -124.79 125.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 122.002 -0.705 . . . . 0.0 111.43 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 71' ' ' PHE . 51.4 mm -89.99 130.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.3 m -91.93 113.73 26.08 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.059 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.415 ' C ' ' H ' ' A' ' 66' ' ' ALA . 39.8 m -87.02 -45.55 10.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.786 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.525 ' O ' ' HD3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER 71.76 -36.28 0.35 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.71 1.204 . . . . 0.0 110.822 -177.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . -56.16 -61.06 2.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -75.8 -19.29 59.08 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.134 -1.426 . . . . 0.0 112.079 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.0 tp 179.87 -77.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 73.7 t90 177.32 -27.69 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.503 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' HD13 ' A' ' 79' ' ' ILE . 34.1 p -100.77 140.58 34.84 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CD2' ' HB ' ' A' ' 62' ' ' ILE . 42.7 t80 -134.39 139.93 45.94 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 126.311 1.844 . . . . 0.0 107.107 173.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -106.47 113.03 26.31 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.955 0.407 . . . . 0.0 110.704 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.94 -50.91 72.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -42.7 -45.32 5.67 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.578 ' HB ' ' CD2' ' A' ' 77' ' ' HIS . 10.7 m -116.31 12.17 15.26 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 122.123 -0.634 . . . . 0.0 110.634 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.56 51.42 52.15 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.396 -0.431 . . . . 0.0 112.258 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.578 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -146.46 157.24 43.73 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.56 173.79 54.9 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 119.346 -1.406 . . . . 0.0 109.998 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.459 HD13 ' HB ' ' A' ' 70' ' ' THR . 1.8 mp -87.71 -27.77 5.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.07 107.13 2.82 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.558 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.87 158.07 98.36 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.123 -1.615 . . . . 0.0 111.175 -2.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.2 p-10 -104.22 -4.61 22.83 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -173.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.49 -55.44 18.92 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.236 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 85.9 m -167.46 170.63 11.16 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.619 0.768 . . . . 0.0 109.895 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.566 ' CB ' ' HA ' ' A' ' 77' ' ' HIS . 42.1 t -145.39 -79.42 0.18 Allowed 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.312 1.053 . . . . 0.0 110.756 169.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.509 ' HG ' ' SG ' ' A' ' 85' ' ' CYS . 87.5 mt -114.0 167.14 10.92 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.824 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -97.51 137.7 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -95.67 113.88 25.57 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 97.4 m-85 -106.03 142.74 25.47 Favored Pre-proline 0 C--O 1.245 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.048 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 89' ' ' TYR . 24.1 Cg_exo -63.89 131.97 32.99 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.963 2.442 . . . . 0.0 111.074 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 100' ' ' VAL . 7.3 p -133.15 146.78 31.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.508 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.528 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 50.6 mt-10 -131.74 132.61 43.99 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.28 118.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.202 0.525 . . . . 0.0 110.427 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.528 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -120.7 91.97 3.66 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.34 -99.52 0.52 Allowed Glycine 0 CA--C 1.498 -0.989 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.583 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.624 ' O ' ' HA ' ' A' ' 8' ' ' SER . 10.6 m-20 -104.85 -9.78 17.79 Favored 'General case' 0 C--O 1.174 -2.886 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.956 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.8 128.39 45.9 Favored 'General case' 0 C--N 1.273 -2.722 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.551 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -119.73 121.9 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.409 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 20.3 m-85 -114.08 142.37 46.28 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.251 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 91' ' ' VAL . 24.5 m -128.56 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 2' ' ' SER . 32.1 t -105.45 120.03 40.58 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.163 0.506 . . . . 0.0 110.074 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.2 t -102.49 12.75 36.03 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.784 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -100.82 144.33 29.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 -41.66 2.65 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.43 136.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.26 140.75 23.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.23 138.78 28.76 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.073 2.515 . . . . 0.0 113.688 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -80.86 -177.34 6.32 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -14.74 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 124.118 0.967 . . . . 0.0 112.8 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . . . . . . 0 C--N 1.314 -0.946 0 C-N-CA 125.453 1.501 . . . . 0.0 111.242 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.442 -0.834 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -59.54 102.88 0.16 Allowed 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.302 0.572 . . . . 0.0 110.049 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -117.71 150.28 39.34 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.659 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 87.8 tttt -77.38 115.29 17.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.291 0.567 . . . . 0.0 110.083 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.403 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.8 tp -96.4 -35.28 5.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.791 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' A' ' 6' ' ' ILE . 21.9 p -162.3 -166.58 1.42 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.981 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.723 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.2 m -127.96 149.1 50.49 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.147 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.95 -34.72 78.62 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 123.495 0.718 . . . . 0.0 109.395 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.45 -23.08 66.83 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.36 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.45 -46.47 12.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.572 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 12' ' ' ILE . 47.0 pt -100.65 114.75 40.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.353 1.073 . . . . 0.0 112.124 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -82.25 168.52 17.53 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.196 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.08 122.06 11.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.67 0.748 . . . . 0.0 110.001 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' A' ' 57' ' ' TYR . . . 94.18 1.11 65.05 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.223 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -102.69 137.83 40.4 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.3 0.572 . . . . 0.0 109.747 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.422 ' CB ' HG22 ' A' ' 31' ' ' VAL . 23.1 ptm -137.23 143.14 42.11 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.902 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 12.2 tp10 -156.54 154.66 30.65 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 176.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 89.1 m -100.93 130.94 47.0 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.19 0.519 . . . . 0.0 109.912 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -123.11 152.19 41.33 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.08 138.47 51.6 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.18 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.2 p -83.92 172.71 11.84 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 p -64.43 -26.54 68.49 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.177 0.591 . . . . 0.0 110.944 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.55 -12.22 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.212 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.52 18.07 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.443 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.6 m -90.28 117.0 28.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.72 123.72 33.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' THR . 62.1 t -127.33 137.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.163 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 29' ' ' LEU . 4.3 pp -93.3 123.3 36.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -109.44 114.55 47.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 ' CB ' ' A' ' 17' ' ' MET . 46.6 t -119.19 125.84 74.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.355 -177.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -87.82 106.21 17.92 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 22.8 m -99.53 149.35 23.33 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -75.28 -50.04 17.34 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.177 0.513 . . . . 0.0 111.063 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.7 -45.04 9.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.803 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' NE2' ' HE3' ' A' ' 39' ' ' LYS . 21.3 t-160 -84.25 -15.02 48.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.86 0.362 . . . . 0.0 111.949 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 85.59 -171.5 45.48 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.003 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 98' ' ' ILE . 61.4 t -77.72 123.35 34.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HE3' ' NE2' ' A' ' 36' ' ' HIS . 74.3 mmtt -128.25 150.44 50.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.23 119.24 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.329 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -128.69 158.61 38.11 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -60.19 138.23 57.96 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -106.35 -5.75 18.83 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.01 17.49 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.3 m -80.45 111.79 25.7 Favored Pre-proline 0 N--CA 1.443 -0.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 168.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -85.07 39.05 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.626 2.218 . . . . 0.0 111.845 -176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -102.25 -77.03 0.56 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -170.15 131.78 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 43.1 mt-10 64.54 86.44 0.13 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.778 0.799 . . . . 0.0 112.164 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tt -93.88 106.46 18.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.729 0.776 . . . . 0.0 111.836 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB3' ' HG2' ' A' ' 65' ' ' ARG . 36.1 tp -154.38 48.92 0.61 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 29' ' ' LEU . 1.6 tm? -56.16 -38.78 71.36 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.276 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.653 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 94.0 p -68.56 -29.47 68.02 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.382 0.611 . . . . 0.0 112.331 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -83.87 17.15 2.46 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 124.265 1.026 . . . . 0.0 110.815 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.01 -125.01 1.15 Allowed Glycine 0 N--CA 1.412 -2.914 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.4 m -152.69 151.46 30.57 Favored 'General case' 0 N--CA 1.424 -1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.905 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.536 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 20.8 t80 -120.75 116.25 24.87 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.162 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -117.18 170.82 8.37 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 69.61 0.04 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.01 1.75 39.08 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.14 127.21 72.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.8 mm -122.72 132.94 70.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.39 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.4 m -101.76 137.39 40.12 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 25.9 p -78.09 -73.86 0.29 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.558 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 51' ' ' LEU . 29.7 tpt180 174.72 -69.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . . . -66.51 -57.96 6.23 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.413 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 8.6 m170 -70.59 116.11 10.53 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.836 167.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.93 17.63 3.39 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.53 1.157 . . . . 0.0 108.603 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' HIS . 87.7 m95 -93.47 177.41 6.04 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.164 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -129.8 140.81 50.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.495 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 53.5 p90 -105.67 154.02 21.02 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -93.7 116.57 29.07 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.983 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.46 -30.49 67.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.159 0.584 . . . . 0.0 111.3 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.77 31.51 4.25 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.3 m -156.7 -44.2 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.784 0.834 . . . . 0.0 109.305 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.59 -9.72 66.65 Favored Glycine 0 C--O 1.215 -1.049 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.911 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.12 148.29 28.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.495 ' HA2' ' CB ' ' A' ' 71' ' ' PHE . . . -72.56 137.73 25.08 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.645 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.41 -43.72 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -160.84 124.31 1.93 Allowed Pre-proline 0 N--CA 1.425 -1.721 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.496 ' HD2' ' SG ' ' A' ' 84' ' ' CYS . 12.7 Cg_exo -71.92 166.21 79.85 Favored 'Cis proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.79 0.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.41 -11.54 34.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.18 -10.75 59.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 p -110.32 133.98 52.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 122.334 1.064 . . . . 0.0 111.96 176.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.52 157.69 43.3 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.3 mt -131.75 179.47 6.05 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -141.07 139.66 34.08 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 8.6 pt-20 -92.25 104.09 16.49 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.235 0.541 . . . . 0.0 109.933 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -89.96 163.51 31.88 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.88 119.57 6.81 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.656 2.237 . . . . 0.0 114.018 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 100' ' ' VAL . 3.1 p -129.9 127.47 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.629 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.459 0.647 . . . . 0.0 110.028 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 98' ' ' ILE . 7.4 p -94.83 129.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.062 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -122.61 146.85 47.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.07 101.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.07 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.741 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.723 ' O ' ' HB3' ' A' ' 8' ' ' SER . 8.0 m-20 76.27 -13.82 0.87 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.28 2.232 . . . . 0.0 114.716 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -120.62 155.46 33.72 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-N 119.965 1.257 . . . . 0.0 110.849 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.478 HD13 HG11 ' A' ' 38' ' ' VAL 0.251 45.8 mt -131.26 133.92 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -119.44 144.38 46.98 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.495 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.424 HG12 HG23 ' A' ' 91' ' ' VAL . 35.3 m -135.52 144.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -132.39 118.09 18.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -92.92 6.08 49.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.156 0.503 . . . . 0.0 109.96 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -72.13 109.76 6.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.719 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.02 25.4 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.62 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.8 119.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 110.031 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 148.05 34.03 Favored Pre-proline 0 N--CA 1.409 -2.496 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.83 134.13 57.61 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.887 2.391 . . . . 0.0 111.251 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 54.3 t30 -79.91 157.29 26.95 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.1 106.01 0.24 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.294 -1.826 0 CA-C-N 111.614 -2.539 . . . . 0.0 106.34 -179.402 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 C--O 1.237 0.436 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.5 t -92.35 -54.01 3.98 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.443 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 46.8 m-85 -90.11 105.62 17.93 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.177 177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -106.3 146.23 30.65 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -76.09 116.78 17.12 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -98.55 -30.89 3.58 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.035 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.523 -176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 20.0 p -167.35 -171.73 1.78 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.082 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 56.7 p -130.5 152.8 49.48 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.588 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.7 mt -67.9 -15.36 63.58 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-O 121.858 0.837 . . . . 0.0 109.325 173.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -69.4 -23.58 63.74 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.047 172.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -83.6 -64.55 1.15 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.7 pt -103.16 134.57 43.92 Favored 'Isoleucine or valine' 0 C--O 1.242 0.664 0 CA-C-O 122.48 1.133 . . . . 0.0 113.604 -174.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 30.6 m95 -93.1 170.02 9.96 Favored 'General case' 0 C--N 1.279 -2.468 0 CA-C-N 113.726 -1.579 . . . . 0.0 112.179 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.0 t -64.5 118.3 6.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 5.36 56.88 Favored Glycine 0 N--CA 1.432 -1.577 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -112.22 151.28 29.76 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.859 0.362 . . . . 0.0 110.539 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.516 ' SD ' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -148.39 146.61 28.56 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 178.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.6 pt-20 -158.36 156.77 31.11 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.514 174.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 13.9 t -94.19 141.7 28.25 Favored 'General case' 0 N--CA 1.428 -1.534 0 CA-C-O 121.064 0.459 . . . . 0.0 110.039 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 92.7 m-85 -131.57 155.63 47.15 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 174.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -98.45 138.34 35.81 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -82.86 173.7 11.6 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.2 m -66.39 -15.48 63.33 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.155 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -93.59 -13.9 27.14 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.222 0.534 . . . . 0.0 110.204 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 105.86 -3.4 38.78 Favored Glycine 0 CA--C 1.506 -0.519 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.671 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.0 m -76.89 133.09 39.39 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -98.81 123.01 42.77 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-O 121.99 0.9 . . . . 0.0 109.149 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.1 t -122.62 143.83 34.11 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 CA-C-N 114.163 -1.38 . . . . 0.0 109.449 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.537 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 2.8 tm? -94.24 120.48 34.54 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 179.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.0 mp -104.4 113.24 40.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 38' ' ' VAL . 7.7 p -112.84 128.53 69.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.123 -177.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.9 t30 -111.06 102.3 10.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 169.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.4 p -103.64 157.81 16.8 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.885 -178.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -76.46 -33.67 58.71 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.403 175.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -94.69 -46.14 7.05 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.914 -176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -97.28 -4.74 38.19 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.976 -0.453 . . . . 0.0 111.468 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.52 -163.12 48.09 Favored Glycine 0 C--O 1.248 0.995 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -93.36 118.91 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-O 121.716 0.77 . . . . 0.0 109.352 178.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -129.99 146.69 51.69 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.896 -176.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.86 112.6 16.85 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.604 ' HB2' HD11 ' A' ' 86' ' ' LEU . 5.1 p90 -138.95 163.33 32.63 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -178.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -51.52 137.13 24.92 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 123.53 0.519 . . . . 0.0 110.377 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -111.66 -37.89 5.05 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.8 mmt -84.1 79.92 9.35 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 -167.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.622 ' N ' ' HD2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -100.72 -28.41 0.23 Allowed Pre-proline 0 C--O 1.174 -2.921 0 CA-C-O 116.748 -1.596 . . . . 0.0 110.786 167.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 45' ' ' CYS . 10.2 Cg_endo -50.06 105.44 0.1 OUTLIER 'Trans proline' 1 C--N 1.424 4.547 0 CA-C-N 122.683 1.994 . . . . 0.0 112.288 -177.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 66' ' ' ALA . 68.0 m80 -82.61 9.46 9.43 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.032 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.74 116.9 20.93 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 103.358 -2.83 . . . . 0.0 103.358 170.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 1.0 OUTLIER -50.78 111.7 0.59 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 115.254 1.576 . . . . 0.0 115.254 -173.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.9 tp -155.27 163.41 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 104.599 -2.371 . . . . 0.0 104.599 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.4 tp -104.14 100.25 9.99 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.066 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.436 HD11 HG22 ' A' ' 62' ' ' ILE . 6.0 tt -56.64 -32.83 65.72 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.624 1.169 . . . . 0.0 112.897 -173.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.453 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 31.8 p -72.36 -22.48 61.14 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.495 0.664 . . . . 0.0 111.517 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -103.64 12.65 34.59 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.17 -103.08 2.85 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.817 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.549 ' HB3' ' OG1' ' A' ' 63' ' ' THR . 22.6 t -144.74 145.42 31.68 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-O 123.372 1.558 . . . . 0.0 114.26 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -131.82 114.43 14.69 Favored 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 110.874 -2.875 . . . . 0.0 104.389 168.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -116.59 103.29 10.24 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 118.905 -1.118 . . . . 0.0 111.069 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.28 -72.77 0.43 Allowed Glycine 0 C--N 1.321 -0.271 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.239 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.24 3.11 0.54 Allowed Glycine 0 C--N 1.293 -1.835 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 176.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.68 124.68 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.635 0 CA-C-O 121.488 0.661 . . . . 0.0 109.363 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 52' ' ' LEU . 67.6 mt -93.66 139.13 18.82 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.549 ' OG1' ' HB3' ' A' ' 56' ' ' SER . 35.8 m -80.78 115.39 20.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.556 1.169 . . . . 0.0 112.873 -175.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 37.1 t -93.06 141.07 28.82 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 173.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 65' ' ' ARG . 21.8 ttt180 -118.76 -42.53 2.72 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 117.237 -1.785 . . . . 0.0 114.691 -168.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 47' ' ' HIS . . . -93.45 -6.33 47.25 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.222 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.645 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 72.9 m80 -116.75 -174.21 2.53 Favored 'General case' 0 N--CA 1.422 -1.849 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.425 178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 69' ' ' TRP . 2.6 tm? -77.76 73.56 4.33 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -170.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.405 ' CD1' HD13 ' A' ' 68' ' ' LEU 0.343 17.9 p-90 35.94 -31.91 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.523 0 C-N-CA 131.095 3.758 . . . . 0.0 120.841 172.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 33.2 p -102.19 127.29 49.2 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.402 ' CE2' HD13 ' A' ' 86' ' ' LEU . 37.1 t80 -135.33 136.15 41.33 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 101.958 -3.349 . . . . 0.0 101.958 171.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -123.59 133.32 53.98 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 117.773 -1.571 . . . . 0.0 114.16 -170.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -70.17 -42.43 72.46 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.921 175.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.18 98.52 Favored Glycine 0 C--N 1.331 0.253 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.58 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -80.46 -27.46 37.88 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 70.21 26.7 73.88 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 16.9 t-160 -157.56 154.91 29.3 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -173.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.02 137.49 23.16 Favored Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.54 -41.83 20.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 51.0 t-20 -160.68 113.96 1.35 Allowed Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.433 ' HD3' ' HB3' ' A' ' 67' ' ' HIS . 2.0 Cg_endo -81.44 -179.54 25.0 Favored 'Cis proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.963 4.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -86.44 -19.51 29.52 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.838 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -62.35 -33.33 74.49 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.423 -175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.5 p -90.69 142.44 27.75 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-O 122.112 0.958 . . . . 0.0 112.078 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.69 ' SG ' ' HB3' ' A' ' 108' ' ' ASN . 1.6 p -139.38 159.83 41.25 Favored 'General case' 0 C--N 1.276 -2.623 0 CA-C-N 114.275 -1.329 . . . . 0.0 111.399 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 41' ' ' TYR . 34.4 tp -111.61 129.83 55.95 Favored 'General case' 0 N--CA 1.419 -2.024 0 CA-C-O 121.046 0.45 . . . . 0.0 110.997 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 108' ' ' ASN . . . -110.8 111.62 22.9 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.06 148.73 22.71 Favored 'General case' 0 N--CA 1.421 -1.894 0 O-C-N 123.618 0.574 . . . . 0.0 110.499 176.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' A' ' 101' ' ' SER . 97.6 m-85 -108.7 149.8 39.94 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.624 -178.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.8 121.83 9.29 Favored 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.7 2.267 . . . . 0.0 110.755 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.69 138.32 32.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.865 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 119.07 35.43 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.12 120.24 59.12 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.769 0 CA-C-N 114.8 -1.091 . . . . 0.0 113.289 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' ' 94' ' ' LYS 0.282 0.0 OUTLIER -126.54 145.72 50.41 Favored 'General case' 0 C--O 1.199 -1.603 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.946 174.985 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -25.29 -45.75 0.02 OUTLIER Glycine 0 N--CA 1.485 1.966 0 N-CA-C 119.763 2.665 . . . . 0.0 119.763 -171.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 8' ' ' SER . 26.6 m-20 -116.46 -13.59 10.96 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 117.808 0.804 . . . . 0.0 111.795 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.43 ' HB2' ' HG2' ' A' ' 94' ' ' LYS . 5.0 m-20 -121.62 148.9 43.94 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.612 0.72 . . . . 0.0 112.887 -169.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.2 mt -126.14 111.57 27.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.309 177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -108.98 144.29 37.15 Favored 'General case' 0 CA--C 1.488 -1.431 0 CA-C-N 115.371 -0.831 . . . . 0.0 108.781 177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 8.8 p -140.32 145.56 25.84 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.615 0 CA-C-O 120.863 0.363 . . . . 0.0 110.172 -178.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 2' ' ' SER . 38.5 t -87.84 114.21 24.24 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -134.36 15.87 3.75 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.416 -175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -108.36 118.19 36.11 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.265 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 86.75 -3.82 86.73 Favored Glycine 0 C--N 1.317 -0.525 0 CA-C-N 115.99 -0.55 . . . . 0.0 113.175 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.6 mt -90.39 130.51 39.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-O 120.778 0.323 . . . . 0.0 110.444 -178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 61.6 tp -78.48 119.98 79.33 Favored Pre-proline 0 C--N 1.312 -1.051 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.103 -175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 37.0 Cg_endo -69.11 145.93 62.55 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.842 2.361 . . . . 0.0 111.052 172.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.69 ' HB3' ' SG ' ' A' ' 85' ' ' CYS . 30.9 m-80 -88.91 179.14 6.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.853 175.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 109' ' ' LYS . 11.0 mptt -67.8 101.38 1.06 Allowed 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.74 1.257 . . . . 0.0 112.582 -175.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 178.24 -63.78 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.239 0 N-CA-C 102.792 -3.04 . . . . 0.0 102.792 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.422 ' CG ' ' H ' ' A' ' 112' ' ' SER . 23.0 t-80 56.23 -164.95 0.14 Allowed 'General case' 0 CA--C 1.562 1.409 0 CA-C-N 113.831 -1.531 . . . . 0.0 110.918 169.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.422 ' H ' ' CG ' ' A' ' 111' ' ' HIS . 37.7 m . . . . . 0 N--CA 1.428 -1.561 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 175.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.477 ' S1 ' ' HA ' ' A' ' 46' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 pmm? . . . . . 0 C--O 1.24 0.602 0 CA-C-O 120.777 0.322 . . . . 0.0 111.649 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -102.2 101.05 11.32 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 120.675 0.274 . . . . 0.0 111.265 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' A' ' 92' ' ' GLU . 96.4 m-85 58.28 97.97 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 177.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -128.3 150.26 50.15 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.106 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 99' ' ' TYR . 88.4 tttt -68.72 137.83 54.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.013 0.435 . . . . 0.0 111.602 -176.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.457 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -127.25 -40.37 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.135 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.457 ' SG ' HG23 ' A' ' 6' ' ' ILE . 19.8 p -155.08 -172.11 4.07 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.305 0.574 . . . . 0.0 112.122 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.2 p -131.45 150.01 52.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.646 176.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.519 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.7 tt -69.65 -25.66 64.03 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -63.05 -24.93 68.14 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.977 176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -92.38 -55.11 3.53 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.683 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 12' ' ' ILE . 40.4 pt -100.82 110.69 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 122.541 1.162 . . . . 0.0 111.085 177.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -83.75 170.15 14.49 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.749 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.3 t -56.89 118.59 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.012 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 -2.27 61.25 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -103.64 142.3 34.56 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.97 142.11 32.95 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.189 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.737 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -148.16 133.8 18.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.176 -0.61 . . . . 0.0 111.232 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 89.4 m -79.03 123.08 26.97 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 176.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -119.23 155.04 32.44 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.508 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -102.65 134.66 45.64 Favored 'General case' 0 N--CA 1.426 -1.667 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.819 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.4 p -83.55 167.36 17.43 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.1 m -63.14 -13.31 35.29 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -88.48 -12.27 43.46 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 177.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.25 30.87 11.45 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -176.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.1 m -97.62 133.59 41.96 Favored 'General case' 0 N--CA 1.437 -1.084 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -89.64 126.83 35.78 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.176 0.512 . . . . 0.0 110.068 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 19' ' ' THR . 42.0 t -131.67 140.15 48.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 58.8 tp -97.34 108.13 20.79 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.8 mp -99.36 115.85 41.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -114.37 125.11 71.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 42.5 t30 -97.26 105.08 17.16 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 119.098 -1.041 . . . . 0.0 110.306 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.4 m -101.4 148.58 25.0 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -76.64 -50.72 13.06 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 119.179 -1.008 . . . . 0.0 113.505 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -88.54 -38.5 14.87 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.528 -0.469 . . . . 0.0 111.81 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -79.72 -9.66 59.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 79.65 169.51 38.52 Favored Glycine 0 N--CA 1.436 -1.358 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.337 177.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -76.01 122.02 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -129.47 142.95 50.66 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.57 137.5 49.33 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 96.4 m-85 -130.35 149.77 51.88 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' HB3' ' H ' ' A' ' 87' ' ' ALA . 33.7 tt0 -52.02 136.31 29.39 Favored 'General case' 0 C--O 1.209 -1.045 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 171.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -109.86 19.61 18.91 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 121.65 0.738 . . . . 0.0 110.511 -176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 94.2 mmm -78.55 87.5 4.52 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 116.595 2.072 . . . . 0.0 116.595 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.575 ' SG ' HD11 ' A' ' 52' ' ' LEU . 9.1 p -115.89 94.09 40.07 Favored Pre-proline 0 C--N 1.308 -1.2 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 165.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.47 42.25 1.2 Allowed 'Trans proline' 0 N--CA 1.475 0.436 0 C-N-CA 122.993 2.462 . . . . 0.0 113.89 -170.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.634 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 19.5 m80 -96.26 -67.0 0.87 Allowed 'General case' 0 CA--C 1.494 -1.188 0 C-N-CA 118.918 -1.113 . . . . 0.0 108.884 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.3 tt0 -161.7 -35.62 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 119.623 -0.831 . . . . 0.0 112.009 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.498 ' N ' ' S1 ' ' A' ' 113' ' ' FES . 2.7 mp0 -99.74 100.65 11.64 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.873 0.844 . . . . 0.0 110.913 -176.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.4 tp -92.51 0.49 9.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 122.734 1.254 . . . . 0.0 108.565 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.1 mp -89.26 41.85 1.06 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.369 -177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.575 HD11 ' SG ' ' A' ' 45' ' ' CYS . 4.5 mp -56.66 -32.55 65.49 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 123.414 0.686 . . . . 0.0 111.248 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.737 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 80.7 p -72.23 -28.05 62.92 Favored 'General case' 0 N--CA 1.408 -2.552 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.609 -174.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -99.73 17.5 20.49 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 64' ' ' CYS . . . -86.68 -109.21 0.83 Allowed Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 175.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.1 t -149.67 148.77 29.68 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 122.131 0.967 . . . . 0.0 111.883 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -129.89 121.11 26.02 Favored 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 113.181 -1.827 . . . . 0.0 111.109 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 44.2 mt-10 -115.4 168.13 10.26 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 171.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.35 64.48 2.47 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 120.802 -0.714 . . . . 0.0 113.128 -177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.09 -12.7 3.08 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 70.6 t -123.5 131.81 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 120.778 0.323 . . . . 0.0 110.382 -177.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.1 mm -111.47 135.58 50.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.0 m -128.06 129.16 46.2 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 43.1 t -63.85 -72.11 0.15 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 25.8 ttt180 161.05 104.85 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.65 1.58 . . . . 0.0 107.263 174.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 64.59 11.85 7.02 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.552 1.167 . . . . 0.0 108.668 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.83 ' HB3' ' S2 ' ' A' ' 113' ' ' FES . 8.9 m-70 -146.57 145.61 30.17 Favored 'General case' 0 CA--C 1.486 -1.49 0 C-N-CA 127.464 2.306 . . . . 0.0 107.473 -175.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.479 ' HB3' ' H ' ' A' ' 64' ' ' CYS . 43.3 tp 58.15 82.74 0.13 Allowed 'General case' 0 C--N 1.32 -0.677 0 O-C-N 124.965 1.416 . . . . 0.0 109.68 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 65.8 t-105 -74.55 -45.76 43.39 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.421 -173.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 p -133.69 129.11 36.33 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.665 0.745 . . . . 0.0 111.275 177.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 74.1 t80 -135.1 138.62 43.98 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -103.85 112.8 25.92 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.391 -0.924 . . . . 0.0 111.461 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.13 -22.26 66.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.58 1.152 . . . . 0.0 111.502 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.71 16.79 57.31 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.954 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 90.1 m -148.78 -47.98 0.15 Allowed 'General case' 0 C--N 1.317 -0.845 0 O-C-N 122.201 -0.587 . . . . 0.0 111.14 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 107.46 -3.62 34.76 Favored Glycine 0 C--O 1.211 -1.337 0 C-N-CA 119.898 -1.144 . . . . 0.0 112.794 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -104.17 147.5 27.38 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.997 -0.707 . . . . 0.0 110.365 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.48 133.71 11.95 Favored Glycine 0 N--CA 1.435 -1.396 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.424 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.2 mp -82.09 -43.15 19.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 27.2 t-20 -140.31 113.02 7.34 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.032 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 96.8 Cg_endo -85.68 163.86 57.51 Favored 'Cis proline' 0 N--CA 1.448 -1.15 0 C-N-CA 123.26 -1.558 . . . . 0.0 111.468 -1.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -82.5 -11.73 58.28 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 122.128 0.966 . . . . 0.0 108.463 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -54.08 -26.21 25.74 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 113.682 -1.599 . . . . 0.0 112.212 179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 73.3 m -139.47 158.17 44.6 Favored 'General case' 0 N--CA 1.427 -1.578 0 CA-C-O 122.087 0.946 . . . . 0.0 111.631 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 62.2 m -153.06 169.09 23.78 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD22 ' O ' ' A' ' 42' ' ' GLN . 51.2 mt -126.79 163.92 22.5 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.755 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -118.32 153.66 33.61 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -173.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.21 131.8 47.45 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.301 1.0 . . . . 0.0 109.944 175.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.529 ' CE1' ' HB ' ' A' ' 100' ' ' VAL . 1.7 t80 -126.44 106.54 23.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 174.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.79 125.13 16.14 Favored 'Trans proline' 0 C--N 1.36 1.134 0 C-N-CA 123.844 3.03 . . . . 0.0 113.751 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.7 p -134.06 145.19 33.55 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.766 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.518 ' HG3' ' CE1' ' A' ' 3' ' ' PHE . 42.1 mt-10 -127.78 134.24 49.48 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.317 0.647 . . . . 0.0 110.345 173.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -117.1 117.64 56.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.68 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.524 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.79 108.91 11.13 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.251 178.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 55.92 54.68 33.53 Favored Glycine 0 CA--C 1.5 -0.865 0 C-N-CA 121.361 -0.447 . . . . 0.0 113.026 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 72.23 -6.4 1.55 Allowed 'General case' 0 C--O 1.193 -1.894 0 C-N-CA 125.141 1.377 . . . . 0.0 113.842 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -100.89 138.86 37.37 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -177.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -126.37 125.51 67.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -171.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 5' ' ' LYS . 3.2 m-85 -112.83 141.63 46.41 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.738 176.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.529 ' HB ' ' CE1' ' A' ' 89' ' ' TYR . 27.0 m -129.8 143.23 41.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.115 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 26.7 t -116.23 129.69 56.42 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.578 0.228 . . . . 0.0 111.32 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.446 ' HA ' ' CD1' ' A' ' 105' ' ' ILE . 2.9 m -86.38 -15.15 41.28 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -88.6 123.58 33.22 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.36 23.23 8.56 Favored Glycine 0 C--N 1.316 -0.533 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -178.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.446 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 64.1 mt -100.12 129.44 50.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-N 115.402 -0.399 . . . . 0.0 110.977 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -106.44 102.12 39.22 Favored Pre-proline 0 N--CA 1.426 -1.655 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 172.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.02 132.68 23.41 Favored 'Trans proline' 0 C--O 1.242 0.7 0 C-N-CA 122.276 1.984 . . . . 0.0 110.002 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.755 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 18.6 t30 -115.08 115.68 27.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.623 -172.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.416 ' HD3' ' C ' ' A' ' 109' ' ' LYS . 8.7 tmtt? 64.1 -53.32 0.26 Allowed 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 127.534 2.334 . . . . 0.0 111.239 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.529 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . -86.59 -156.8 0.33 Allowed 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 124.23 1.012 . . . . 0.0 109.113 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -158.8 157.67 32.06 Favored 'General case' 0 C--N 1.318 -0.804 0 O-C-N 121.497 -0.752 . . . . 0.0 111.853 -171.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 C--N 1.299 -1.629 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.09 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.83 ' S2 ' ' HB3' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 CA--C 1.512 -0.511 0 CA-C-O 120.824 0.345 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.5 m -115.44 132.28 56.67 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 68.7 103.41 0.05 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.925 0.869 . . . . 0.0 111.382 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.25 143.16 37.46 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.539 -175.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.0 tptt -69.41 119.28 13.43 Favored 'General case' 0 C--N 1.316 -0.883 0 C-N-CA 123.506 0.722 . . . . 0.0 109.504 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -115.97 -47.49 4.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.471 -177.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.3 p -157.57 -168.08 2.46 Favored 'General case' 0 C--O 1.258 1.518 0 CA-C-O 121.452 0.644 . . . . 0.0 112.096 -176.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.2 p -129.56 152.36 49.17 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.402 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.48 ' O ' HD13 ' A' ' 9' ' ' LEU . 1.6 tm? -67.23 -16.2 64.15 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.46 -29.9 70.26 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.786 174.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -76.82 -60.35 2.39 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.038 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.579 ' H ' HD13 ' A' ' 12' ' ' ILE . 0.2 OUTLIER -111.56 118.17 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.094 0 CA-C-O 122.356 1.074 . . . . 0.0 113.227 -176.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -99.15 171.83 7.76 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 113.844 -1.525 . . . . 0.0 108.237 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 34' ' ' GLU . 7.2 p -51.11 111.73 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.746 0 CA-C-O 121.567 0.699 . . . . 0.0 111.443 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.75 7.68 56.41 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.38 -177.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -109.45 151.59 26.5 Favored 'General case' 0 C--O 1.246 0.914 0 O-C-N 122.37 -0.488 . . . . 0.0 110.219 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.569 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -150.46 137.48 19.3 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.012 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.1 mt-10 -149.66 153.48 37.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 174.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.0 t -92.87 138.15 31.74 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.236 0.541 . . . . 0.0 110.565 178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.39 148.82 52.43 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 42.6 tt0 -98.22 146.0 26.06 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.939 0.399 . . . . 0.0 111.544 -171.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -83.26 178.72 7.95 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.874 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.5 m -70.57 -11.9 61.23 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.46 0.648 . . . . 0.0 110.592 177.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -91.49 -14.36 30.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.044 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.08 15.57 51.21 Favored Glycine 0 N--CA 1.436 -1.314 0 C-N-CA 119.723 -1.227 . . . . 0.0 111.501 -176.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 74.1 m -97.34 128.4 44.14 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 122.381 -0.482 . . . . 0.0 109.844 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 40.3 mt-10 -90.05 128.07 36.21 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.445 0.64 . . . . 0.0 111.036 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' THR . 94.3 t -117.99 141.54 36.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 CA-C-N 114.609 -1.178 . . . . 0.0 109.53 -175.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 55.1 tp -95.5 117.11 29.79 Favored 'General case' 0 C--N 1.283 -2.292 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.2 mp -100.11 112.79 33.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 177.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.1 t -114.59 130.55 68.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.75 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -105.52 106.91 17.63 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 t -79.36 146.49 32.85 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 124.451 1.1 . . . . 0.0 110.769 -174.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.495 ' HA ' ' CG2' ' A' ' 14' ' ' VAL . 1.6 mp0 -53.94 -50.19 67.0 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 124.365 1.066 . . . . 0.0 111.904 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -110.4 -36.87 5.67 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.211 -0.595 . . . . 0.0 112.589 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -79.96 -28.51 39.61 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.482 -173.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.78 -149.97 17.39 Favored Glycine 0 C--N 1.299 -1.506 0 C-N-CA 119.27 -1.443 . . . . 0.0 112.881 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.9 p -86.39 135.41 25.14 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.712 0.768 . . . . 0.0 111.652 -171.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -129.26 130.0 45.65 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.595 -1.184 . . . . 0.0 108.316 178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.54 111.5 15.11 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.032 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -144.56 154.52 42.95 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -50.53 137.06 19.97 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 123.644 0.59 . . . . 0.0 109.652 178.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.87 -54.03 9.85 Favored 'General case' 0 C--N 1.315 -0.912 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 -166.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -88.27 160.94 17.45 Favored 'General case' 0 C--N 1.286 -2.163 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.777 -172.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' A' ' 64' ' ' CYS . 13.5 p -89.62 86.44 0.17 Allowed Pre-proline 0 C--O 1.217 -0.632 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 169.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 45' ' ' CYS . 19.9 Cg_exo -1.44 42.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.95 1 C-N-CA 128.156 5.904 . . . . 0.0 119.476 -162.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.4 m80 -149.71 129.93 13.67 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 68.31 123.7 0.03 OUTLIER 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 114.796 174.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.469 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -85.77 103.27 14.39 Favored 'General case' 0 N--CA 1.422 -1.843 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.304 176.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tp -153.07 154.68 7.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.4 mp -78.36 80.51 4.75 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.198 0.999 . . . . 0.0 110.233 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.546 HD13 ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -73.22 -19.17 61.14 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 113.895 -1.502 . . . . 0.0 113.679 -176.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.516 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 30.5 p -56.31 -19.72 15.61 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -84.42 -9.67 58.19 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.378 175.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.13 75.41 0.28 Allowed Glycine 0 N--CA 1.441 -1.013 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.1 m -130.76 -73.29 0.55 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 121.311 0.577 . . . . 0.0 110.841 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.569 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 64.8 t80 -91.26 112.74 24.78 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.332 -174.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -118.89 104.05 10.17 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.21 -73.11 0.41 Allowed Glycine 0 CA--C 1.524 0.608 0 CA-C-O 121.28 0.378 . . . . 0.0 112.643 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.73 12.3 0.46 Allowed Glycine 0 C--N 1.301 -1.4 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 55.6 t -112.66 134.48 55.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 40.0 mm -100.15 139.41 21.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 m -83.56 115.08 21.95 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-O 121.618 0.723 . . . . 0.0 111.72 -175.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.686 ' HA ' ' SG ' ' A' ' 45' ' ' CYS . 5.6 t -81.02 119.33 23.39 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.79 -1.096 . . . . 0.0 108.424 174.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.3 tpt180 -60.57 -60.24 4.12 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 -171.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.94 -39.05 4.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -173.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 10.6 m80 -58.09 -45.6 86.92 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -157.56 -95.25 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.425 ' CD1' HG23 ' A' ' 70' ' ' THR . 18.4 p90 172.96 -16.46 0.0 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 124.387 1.075 . . . . 0.0 110.376 175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 69' ' ' TRP . 35.1 p -101.78 128.82 47.96 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.158 0.504 . . . . 0.0 111.802 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.634 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 43.7 t80 -137.5 138.98 40.24 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 171.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -90.02 111.15 22.15 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -74.05 -33.38 63.69 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.108 0.563 . . . . 0.0 111.713 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.45 -41.73 88.69 Favored Glycine 0 C--O 1.225 -0.428 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.792 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.1 m -94.99 -28.48 15.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.309 0.576 . . . . 0.0 109.612 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 82.72 18.83 64.9 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -136.54 137.6 40.42 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.82 137.73 20.48 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 119.381 -1.39 . . . . 0.0 112.398 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.2 mt -82.84 -44.04 18.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -154.04 109.2 2.48 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.1 148.85 91.95 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.167 -1.597 . . . . 0.0 113.213 3.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.528 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 14.2 t70 -86.2 -24.69 26.0 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.201 -0.908 . . . . 0.0 110.869 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.91 -37.83 86.1 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.419 ' SG ' ' S2 ' ' A' ' 113' ' ' FES . 70.0 m -94.72 151.32 19.37 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 123.077 1.418 . . . . 0.0 112.715 -177.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.7 p -151.73 140.04 20.4 Favored 'General case' 0 C--N 1.262 -3.232 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.681 175.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.634 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 7.6 mp -110.97 100.98 9.58 Favored 'General case' 0 C--N 1.259 -3.368 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.617 -175.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.26 127.73 33.74 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.604 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.2 160.77 25.51 Favored 'General case' 0 N--CA 1.432 -1.373 0 O-C-N 124.003 0.814 . . . . 0.0 110.014 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.12 148.41 43.56 Favored Pre-proline 0 C--N 1.294 -1.846 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 105' ' ' ILE . 26.6 Cg_exo -62.94 121.16 8.94 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.017 1.812 . . . . 0.0 109.248 176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.11 133.67 68.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.426 0.632 . . . . 0.0 111.765 -175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.439 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 47.3 mt-10 -122.76 135.05 54.44 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.15 177.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.98 120.82 63.94 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.115 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -121.66 91.33 3.49 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.93 -99.19 0.18 Allowed Glycine 0 N--CA 1.437 -1.271 0 O-C-N 123.793 0.683 . . . . 0.0 113.869 178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -90.55 -18.55 25.05 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 114.858 -0.671 . . . . 0.0 111.828 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -110.91 147.47 34.56 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -172.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 12' ' ' ILE . 78.6 mt -127.32 129.57 70.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.577 176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -119.22 136.9 53.99 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.68 137.53 55.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.3 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -97.35 114.69 26.52 Favored 'General case' 0 C--N 1.276 -2.605 0 C-N-CA 118.571 -1.252 . . . . 0.0 109.012 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.5 m -100.27 -40.53 7.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 tptt -53.86 111.0 0.66 Allowed 'General case' 0 C--O 1.244 0.799 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.686 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.82 -25.28 9.64 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.343 177.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.426 ' CD1' ' HD3' ' A' ' 90' ' ' PRO . 67.3 mt -103.73 133.16 48.45 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 120.939 0.4 . . . . 0.0 110.119 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -94.89 124.05 55.71 Favored Pre-proline 0 N--CA 1.403 -2.799 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.464 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.12 149.29 85.78 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 121.865 1.71 . . . . 0.0 108.712 172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 65.6 m-20 -91.49 113.54 25.83 Favored 'General case' 0 CA--C 1.48 -1.712 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.5 tttm 49.66 -87.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.586 0 O-C-N 124.71 1.256 . . . . 0.0 110.241 -167.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 44.99 -156.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.856 1.662 . . . . 0.0 111.299 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 8.5 t60 69.22 116.33 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.759 0.823 . . . . 0.0 110.3 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 C--O 1.246 0.871 0 C-N-CA 124.036 0.934 . . . . 0.0 111.266 -174.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.419 ' S2 ' ' SG ' ' A' ' 84' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.6 ttm . . . . . 0 N--CA 1.464 0.265 0 CA-C-O 121.204 0.526 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.449 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 39.9 t -148.7 -145.93 0.18 Allowed 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -173.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 101' ' ' SER . 81.0 m-85 -80.15 97.9 7.08 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-O 121.157 0.503 . . . . 0.0 109.701 174.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -106.23 143.75 33.91 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -75.0 124.05 26.27 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.1 tp -83.18 -54.27 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.238 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 98.8 m -171.98 -173.79 1.19 Allowed 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 126.001 1.72 . . . . 0.0 108.052 -177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.702 ' HB2' ' O ' ' A' ' 96' ' ' ASP . 15.5 p -101.11 151.47 21.78 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.4 HD23 ' H ' ' A' ' 96' ' ' ASP . 53.1 tp -60.13 -17.85 43.25 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 122.257 1.027 . . . . 0.0 108.971 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -63.86 -25.74 68.3 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.164 173.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -93.11 -43.8 8.69 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.303 0.573 . . . . 0.0 109.824 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.1 tp -100.28 117.21 45.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-O 121.984 0.897 . . . . 0.0 111.868 -177.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 47.4 m95 -105.86 168.97 8.76 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.298 -174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.5 t -71.58 123.68 26.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.143 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.62 -6.72 65.29 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -104.01 162.13 13.4 Favored 'General case' 0 C--O 1.248 1.017 0 CA-C-O 121.04 0.447 . . . . 0.0 110.377 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 53' ' ' SER . 26.7 ptt? -150.15 136.84 19.16 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 173.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.642 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.3 tp10 -147.39 152.93 38.97 Favored 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.622 -175.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.571 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 97.2 m -97.33 129.19 44.63 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.85 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -139.74 157.97 44.87 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.5 tt0 -108.01 143.78 36.23 Favored 'General case' 0 C--N 1.298 -1.66 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.159 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 p -83.07 168.61 16.75 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -176.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.7 m -68.18 -18.62 64.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 121.442 0.639 . . . . 0.0 109.664 177.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -84.44 -13.33 52.39 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.918 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.84 14.26 37.56 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.77 -0.729 . . . . 0.0 113.201 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.5 m -97.37 126.39 42.58 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 21' ' ' GLU . 35.6 tt0 -89.2 123.69 33.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.405 HG11 ' HB1' ' A' ' 40' ' ' ALA . 58.9 t -127.47 146.01 33.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.7 -171.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.53 111.92 24.42 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.4 mp -95.95 119.22 43.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -177.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 17' ' ' MET . 7.6 p -110.08 123.82 66.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -114.51 104.15 11.74 Favored 'General case' 0 C--N 1.311 -1.103 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.376 174.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 36' ' ' HIS . 58.9 p -102.32 148.77 25.06 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.13 -37.96 66.46 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.315 0.578 . . . . 0.0 110.27 179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -86.13 -30.2 22.7 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.811 -173.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.452 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 12.0 m170 -106.84 -23.58 12.34 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.82 -170.96 17.56 Favored Glycine 0 C--N 1.305 -1.176 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.448 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 7.1 p -98.25 121.45 48.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 121.495 0.664 . . . . 0.0 111.459 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HB2' ' CG1' ' A' ' 31' ' ' VAL . 0.8 OUTLIER -117.77 148.15 42.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.195 177.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -124.18 113.19 17.99 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 174.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -131.72 163.6 27.8 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -50.71 138.14 18.82 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.707 0.63 . . . . 0.0 111.298 -178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -106.09 8.74 32.38 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.267 0.556 . . . . 0.0 109.772 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.2 tpt -75.57 88.4 2.7 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.217 -173.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.719 ' SG ' ' HB2' ' A' ' 48' ' ' GLN . 44.8 t -159.25 85.57 2.25 Favored Pre-proline 0 C--N 1.311 -1.07 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.918 172.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -82.62 5.62 6.28 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.315 2.01 . . . . 0.0 108.947 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.457 ' HE1' ' HB3' ' A' ' 67' ' ' HIS . 17.9 t-160 -86.51 -18.91 30.38 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 113.953 -1.476 . . . . 0.0 107.74 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.719 ' HB2' ' SG ' ' A' ' 45' ' ' CYS . 53.6 tt0 -69.24 147.06 51.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.421 -1.263 . . . . 0.0 113.383 -171.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.16 100.05 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 126.046 1.738 . . . . 0.0 112.953 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.1 mm 63.75 -79.84 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 125.049 1.339 . . . . 0.0 114.017 175.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 54' ' ' GLU . 0.5 OUTLIER -118.65 119.99 36.12 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 -174.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.9 pt? -63.93 -49.08 74.0 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -173.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.642 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 77.4 p -73.74 -31.34 63.31 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.499 0.666 . . . . 0.0 112.446 -174.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' H ' HD12 ' A' ' 51' ' ' LEU . 43.4 mt-10 -95.11 22.06 7.11 Favored 'General case' 0 C--N 1.294 -1.847 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.78 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.0 -95.41 0.01 OUTLIER Glycine 0 N--CA 1.434 -1.446 0 O-C-N 123.655 0.597 . . . . 0.0 113.373 -175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.7 m -155.53 127.5 7.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.899 0.857 . . . . 0.0 111.903 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -130.44 120.62 24.47 Favored 'General case' 0 C--N 1.261 -3.273 0 CA-C-N 113.344 -1.753 . . . . 0.0 108.707 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 45.9 mt-10 -110.21 168.17 9.64 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -37.01 -58.45 1.22 Allowed Glycine 0 N--CA 1.48 1.575 0 O-C-N 124.236 0.96 . . . . 0.0 114.782 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -129.26 24.59 4.7 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.556 -0.83 . . . . 0.0 111.771 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 64.5 t -124.15 122.07 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 CA-C-O 120.944 0.402 . . . . 0.0 110.484 -177.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.658 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 47.8 mm -95.72 138.08 22.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 177.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.4 m -127.22 115.69 19.45 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 118.18 -1.408 . . . . 0.0 111.112 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.417 ' HB3' HD12 ' A' ' 68' ' ' LEU . 4.1 t -64.86 -21.78 66.87 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 175.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.542 ' H ' HD11 ' A' ' 68' ' ' LEU 0.343 71.6 ttt180 46.39 80.95 0.04 OUTLIER 'General case' 0 C--O 1.248 1.009 0 C-N-CA 129.505 3.122 . . . . 0.0 117.792 175.584 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.677 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . . . 174.02 -45.4 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.069 0 O-C-N 125.352 1.657 . . . . 0.0 109.464 173.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' HB3' ' HE1' ' A' ' 47' ' ' HIS . 4.7 p-80 -123.31 8.84 9.11 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -119.82 162.75 18.57 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 118.547 -1.261 . . . . 0.0 112.759 -177.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 75.6 t-105 -96.71 -69.45 0.76 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.1 p -135.01 141.96 46.32 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-O 121.497 0.665 . . . . 0.0 111.686 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.658 ' HB3' ' O ' ' A' ' 62' ' ' ILE . 21.3 t80 -135.45 138.29 43.04 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -98.81 127.22 44.68 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -62.2 -56.59 17.15 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.157 0.983 . . . . 0.0 113.446 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.33 -50.43 62.42 Favored Glycine 0 CA--C 1.503 -0.706 0 CA-C-N 115.933 -0.576 . . . . 0.0 114.202 -174.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.2 m -81.17 -32.51 33.59 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.165 0.507 . . . . 0.0 110.402 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.72 16.97 71.65 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.631 ' HA ' ' SG ' ' A' ' 85' ' ' CYS . 14.2 t-80 -102.65 138.61 39.33 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 124.543 1.137 . . . . 0.0 109.567 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.1 140.79 15.66 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.8 -48.07 16.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 48.6 t30 -149.17 112.18 3.52 Favored Pre-proline 0 C--N 1.307 -1.267 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.052 176.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.6 Cg_exo -76.8 160.68 94.73 Favored 'Cis proline' 0 C--O 1.241 0.663 0 C-N-CA 123.127 -1.614 . . . . 0.0 111.817 -0.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -72.38 -40.88 66.94 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.742 -176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -89.44 26.28 1.73 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.194 0.521 . . . . 0.0 111.719 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.404 ' O ' ' HE2' ' A' ' 71' ' ' PHE . 18.5 t -101.27 6.22 42.79 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.581 0.705 . . . . 0.0 109.428 -177.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.631 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 38.0 m -51.53 155.91 1.43 Allowed 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 113.772 -1.558 . . . . 0.0 113.127 -177.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.4 pp -101.53 -177.86 3.56 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.27 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.58 113.55 15.59 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 175.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -92.5 120.33 32.87 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.638 0.733 . . . . 0.0 110.904 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -91.61 129.65 41.92 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.21 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -53.49 120.89 8.53 Favored 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 123.693 2.929 . . . . 0.0 112.04 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 55.3 t -107.01 131.74 56.2 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.233 0.54 . . . . 0.0 111.114 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -109.38 110.56 21.74 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.2 115.81 50.72 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.11 0 CA-C-N 114.507 -1.224 . . . . 0.0 112.49 -175.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.501 ' HE3' ' HB3' ' A' ' 97' ' ' ASP . 0.2 OUTLIER -126.01 147.02 49.65 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -38.91 124.45 1.68 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.602 0.564 . . . . 0.0 113.628 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.702 ' O ' ' HB2' ' A' ' 8' ' ' SER . 19.5 m-20 78.92 -19.53 0.44 Allowed 'General case' 0 C--O 1.2 -1.535 0 C-N-CA 126.281 1.832 . . . . 0.0 114.928 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 34.4 t70 -145.77 143.64 29.82 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.673 1.579 . . . . 0.0 114.266 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 54.4 mt -127.94 127.15 67.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -119.38 151.3 38.72 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.364 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.3 p -135.87 144.41 33.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-O 121.388 0.613 . . . . 0.0 111.627 -172.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 37.3 t -95.28 124.85 39.54 Favored 'General case' 0 C--N 1.291 -1.975 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.094 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.4 m -111.07 15.41 21.65 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 63.8 tttp -66.35 110.18 2.98 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 114.601 -1.181 . . . . 0.0 112.789 -175.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.53 7.11 78.5 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.659 -0.7 . . . . 0.0 113.256 175.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 55.1 mt -119.04 108.8 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.22 155.66 38.63 Favored Pre-proline 0 N--CA 1.411 -2.412 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.1 138.19 53.63 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 121.918 1.745 . . . . 0.0 109.632 173.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -79.12 169.8 17.62 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -52.65 -23.1 5.94 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 125.061 1.344 . . . . 0.0 113.782 -171.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.0 -16.21 63.18 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.96 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.8 p-80 -64.31 97.98 0.21 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 120.789 -0.364 . . . . 0.0 111.731 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 124.052 0.941 . . . . 0.0 110.577 177.122 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.677 ' S1 ' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.477 0.892 0 CA-C-O 119.723 -0.179 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' LYS . 24.6 m 60.63 -87.95 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.825 0.85 . . . . 0.0 111.929 -176.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 77.1 m-85 -95.65 107.54 19.75 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -114.12 150.31 34.29 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 120.912 0.387 . . . . 0.0 111.322 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -67.04 117.72 9.48 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.119 -1.438 . . . . 0.0 107.119 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.1 tp -111.33 -39.65 3.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.945 -176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.5 m -147.94 172.26 14.47 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.363 0.601 . . . . 0.0 110.717 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 27.2 m -118.86 152.38 36.36 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 170.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.57 -17.15 12.57 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.524 0.678 . . . . 0.0 112.398 -176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.69 -22.15 54.36 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.167 0.508 . . . . 0.0 110.92 175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.54 -35.73 24.57 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.888 0.852 . . . . 0.0 109.305 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.456 HG12 HG22 ' A' ' 30' ' ' ILE . 3.2 tp -125.07 113.95 38.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.165 -173.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -104.28 168.39 9.13 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.829 -174.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 122.95 21.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.308 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.05 -8.88 65.36 Favored Glycine 0 N--CA 1.44 -1.087 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -103.84 159.91 15.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 121.405 0.621 . . . . 0.0 112.07 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 26.8 ptt? -151.35 140.89 21.62 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.584 -1.189 . . . . 0.0 109.07 177.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.475 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 43.8 tt0 -154.53 155.04 34.1 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.831 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 85.1 m -90.39 132.01 35.84 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 121.634 0.731 . . . . 0.0 110.677 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -128.37 153.49 47.0 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -107.11 137.44 45.17 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.964 -0.694 . . . . 0.0 109.565 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.9 p -83.89 -178.33 6.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.611 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.2 m -70.24 -30.75 67.88 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 120.927 0.394 . . . . 0.0 111.846 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -82.69 -13.01 57.15 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.307 0.575 . . . . 0.0 109.934 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 101.46 20.28 13.86 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.222 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.9 m -87.14 123.67 32.43 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -90.57 123.01 33.88 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.9 t -133.09 146.0 33.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 120.778 0.323 . . . . 0.0 110.269 -174.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD23 ' CE1' ' A' ' 41' ' ' TYR . 66.3 tp -96.17 114.81 26.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 17' ' ' MET . 2.1 mp -96.53 116.76 39.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.409 HG22 ' HB2' ' A' ' 17' ' ' MET . 43.5 t -112.84 128.64 69.46 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 42.4 t30 -110.91 107.14 16.5 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 174.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.1 m -96.62 149.39 21.83 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.856 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.08 -50.3 49.55 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -89.1 -37.57 14.99 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.898 -176.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -94.35 1.42 55.88 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.42 -161.51 54.24 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.704 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 22.2 t -89.22 122.0 40.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -122.31 136.44 54.9 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.37 127.31 47.39 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.438 ' CE1' HD23 ' A' ' 29' ' ' LEU . 40.3 p90 -143.68 163.7 32.53 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.393 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 111' ' ' HIS . 6.1 tp-100 -44.3 137.38 3.58 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 123.897 0.748 . . . . 0.0 110.101 176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.78 -36.03 7.17 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.563 ' HB3' ' H ' ' A' ' 112' ' ' SER . 0.6 OUTLIER -86.32 121.54 29.04 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.931 -0.707 . . . . 0.0 112.309 -177.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 32.3 t -97.11 118.66 64.5 Favored Pre-proline 0 N--CA 1.439 -1.006 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.439 ' HG3' ' HA ' ' A' ' 110' ' ' ALA . 41.7 Cg_endo -90.78 10.55 2.84 Favored 'Trans proline' 0 CA--C 1.502 -1.114 0 C-N-CA 123.129 2.553 . . . . 0.0 111.151 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.657 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 11.3 t-160 -72.02 -56.06 6.3 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -140.95 -63.89 0.46 Allowed 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 168.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -125.6 157.86 36.11 Favored 'General case' 0 C--N 1.315 -0.919 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.411 HG13 ' CD2' ' A' ' 51' ' ' LEU . 38.1 pt -108.42 -161.57 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 124.039 0.936 . . . . 0.0 109.336 178.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.411 ' CD2' HG13 ' A' ' 50' ' ' ILE . 4.3 mm? 74.6 29.01 1.18 Allowed 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.884 0.85 . . . . 0.0 110.587 -175.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 64' ' ' CYS . 53.8 tp -59.08 -29.69 67.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.478 177.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.499 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 51.0 p -64.36 -28.47 69.72 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.279 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -109.95 22.47 15.59 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -82.89 -129.38 1.37 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.3 t -137.26 151.99 49.31 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.148 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -129.87 129.25 43.7 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.87 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -115.48 169.48 9.13 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 170.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -42.25 -46.62 5.43 Favored Glycine 0 N--CA 1.476 1.305 0 O-C-N 123.964 0.79 . . . . 0.0 114.239 -176.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.58 14.95 3.4 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 119.786 -1.197 . . . . 0.0 113.073 178.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.93 140.97 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 -178.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.6 ' HB ' ' CB ' ' A' ' 71' ' ' PHE . 29.3 mm -112.27 140.34 32.47 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.021 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.639 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 68' ' ' LEU . 49.9 m -100.47 117.55 34.86 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.823 -0.548 . . . . 0.0 110.674 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.497 ' HA ' HD13 ' A' ' 52' ' ' LEU . 43.0 t -66.25 135.72 54.85 Favored 'General case' 0 C--N 1.366 1.321 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.9 tpt180 -49.82 107.0 0.13 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.082 0.553 . . . . 0.0 111.917 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 65.26 13.94 9.09 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.472 1.109 . . . . 0.0 113.177 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 7.6 t-80 -129.53 98.12 4.75 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 119.801 -0.759 . . . . 0.0 110.628 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 69' ' ' TRP . 4.4 mm? 64.95 -170.34 0.19 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.422 ' H ' ' HB3' ' A' ' 68' ' ' LEU . 50.4 p-90 -128.66 11.61 6.24 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.645 -176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.651 ' O ' ' HA ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -120.05 130.8 54.86 Favored 'General case' 0 C--O 1.167 -3.271 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.6 ' CB ' ' HB ' ' A' ' 62' ' ' ILE . 45.4 t80 -139.74 159.43 42.19 Favored 'General case' 0 CA--C 1.469 -2.142 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 166.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.48 ' CB ' ' HA3' ' A' ' 78' ' ' GLY . 51.0 t30 -115.73 99.08 7.05 Favored 'General case' 0 N--CA 1.391 -3.398 0 C-N-CA 118.217 -1.393 . . . . 0.0 111.024 -178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -51.46 -60.16 3.45 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.775 -173.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.48 32.71 4.62 Favored Glycine 0 C--N 1.304 -1.213 0 C-N-CA 120.101 -1.047 . . . . 0.0 113.777 -173.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.479 ' HB ' ' ND2' ' A' ' 72' ' ' ASN . 26.0 m -151.4 -38.62 0.12 Allowed 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 117.282 0.541 . . . . 0.0 111.318 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.76 -55.84 0.52 Allowed Glycine 0 C--O 1.223 -0.575 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.829 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 85' ' ' CYS . 16.2 p80 -85.1 135.24 34.07 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 176.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.48 ' HA3' ' CB ' ' A' ' 72' ' ' ASN . . . 157.14 38.0 0.02 OUTLIER Glycine 0 CA--C 1.476 -2.385 0 N-CA-C 119.815 2.686 . . . . 0.0 119.815 -178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.731 ' HB ' ' SG ' ' A' ' 84' ' ' CYS . 1.8 mp -107.11 -56.11 5.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 C-N-CA 116.901 -1.92 . . . . 0.0 111.775 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 79' ' ' ILE . 24.6 t-20 159.34 105.49 0.0 OUTLIER Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.389 1.476 . . . . 0.0 107.909 176.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 5.7 Cg_exo -78.83 -170.86 9.15 Favored 'Cis proline' 0 N--CA 1.442 -1.551 0 C-N-CA 122.812 -1.745 . . . . 0.0 110.909 1.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 7.0 m-20 -61.15 -18.17 56.69 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 176.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.72 -32.8 70.87 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.062 1.345 . . . . 0.0 113.121 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.731 ' SG ' ' HB ' ' A' ' 79' ' ' ILE . 17.9 p -81.74 133.12 35.31 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.124 -1.031 . . . . 0.0 112.311 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 77' ' ' HIS . 12.9 p -142.02 170.1 16.35 Favored 'General case' 0 C--N 1.277 -2.578 0 CA-C-N 113.764 -1.562 . . . . 0.0 112.603 -175.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 91.6 mt -146.13 125.83 13.41 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.576 179.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.73 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -60.25 129.0 39.5 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -96.26 131.17 43.03 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.789 0.681 . . . . 0.0 109.556 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 101' ' ' SER . 47.4 m-85 -116.08 138.56 24.24 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -59.97 135.12 60.86 Favored 'Trans proline' 0 N--CA 1.486 1.045 0 C-N-CA 123.15 2.566 . . . . 0.0 112.037 176.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 53.1 t -122.87 130.78 74.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -109.92 112.7 24.89 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -112.88 106.73 21.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.395 0 CA-C-O 122.07 0.938 . . . . 0.0 110.7 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.534 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -129.64 117.32 20.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.342 -179.268 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.16 -115.14 7.63 Favored Glycine 0 C--N 1.311 -0.859 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.302 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.558 ' O ' ' HA ' ' A' ' 8' ' ' SER . 7.1 m-20 -95.76 -10.78 28.23 Favored 'General case' 0 C--O 1.195 -1.791 0 O-C-N 123.64 0.259 . . . . 0.0 110.784 178.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -104.21 138.66 40.35 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -171.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.2 mt -124.74 115.33 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.871 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.463 176.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.404 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 5.3 m-85 -109.52 145.08 36.89 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.881 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 60.2 t -134.11 145.56 32.88 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.465 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 32.8 t -87.86 113.69 23.76 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 176.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.3 t -126.2 -11.34 6.41 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.203 -174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' SER . 59.1 tttp -122.87 126.42 47.3 Favored 'General case' 0 N--CA 1.417 -2.122 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.38 -39.86 2.46 Favored Glycine 0 C--N 1.295 -1.732 0 N-CA-C 107.335 -2.306 . . . . 0.0 107.335 -172.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 64.2 mt -102.07 106.21 19.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 173.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 5.5 tt -85.79 130.42 50.78 Favored Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 7.1 Cg_exo -42.08 128.78 4.27 Favored 'Trans proline' 0 C--N 1.368 1.558 0 C-N-CA 124.056 3.17 . . . . 0.0 112.02 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.73 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 0.3 OUTLIER -94.22 116.69 29.12 Favored 'General case' 0 N--CA 1.407 -2.592 0 CA-C-O 120.983 0.421 . . . . 0.0 111.04 179.452 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.549 ' HD3' ' SG ' ' A' ' 85' ' ' CYS . 89.0 tttt 57.0 -169.16 0.1 Allowed 'General case' 0 CA--C 1.571 1.755 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.282 -178.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.53 ' H ' ' HG2' ' A' ' 109' ' ' LYS . . . 65.4 -167.53 0.22 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.413 ' HB2' ' NE2' ' A' ' 42' ' ' GLN . 51.0 t-80 74.12 116.09 0.06 Allowed 'General case' 0 C--O 1.22 -0.476 0 C-N-CA 126.185 1.794 . . . . 0.0 111.345 -176.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.563 ' H ' ' HB3' ' A' ' 44' ' ' MET . 15.8 t . . . . . 0 C--N 1.3 -1.557 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.657 ' S1 ' ' HB3' ' A' ' 47' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ptp . . . . . 0 CA--C 1.511 -0.554 0 CA-C-O 121.31 0.576 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.589 ' O ' ' HA ' ' A' ' 101' ' ' SER . 57.5 m -159.13 -60.49 0.07 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -88.56 131.77 34.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.007 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -142.67 149.17 38.52 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 6.7 ttpm? -68.7 127.1 31.84 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.423 ' HB ' ' CG1' ' A' ' 100' ' ' VAL . 7.6 tp -83.75 -50.31 15.47 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' N ' HG23 ' A' ' 6' ' ' ILE . 95.7 m -164.64 -175.24 3.74 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 125.094 1.357 . . . . 0.0 108.416 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 97' ' ' ASP . 6.9 m -111.16 154.98 23.58 Favored 'General case' 0 N--CA 1.419 -2.014 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.0 tp -57.07 -16.41 7.31 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 125.379 1.472 . . . . 0.0 112.429 -176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 5.1 p-10 -79.99 -20.2 46.02 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.657 175.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -84.05 -54.56 4.76 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.46 HG23 HD12 ' A' ' 98' ' ' ILE . 4.0 tp -108.05 110.54 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.071 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.449 ' HB2' ' CG ' ' A' ' 16' ' ' GLU . 20.8 m95 -86.37 163.03 17.88 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 114.227 -1.352 . . . . 0.0 111.163 -173.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -74.65 121.88 26.93 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-O 121.673 0.749 . . . . 0.0 110.235 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.77 -1.5 59.81 Favored Glycine 0 N--CA 1.439 -1.162 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -176.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' CG ' ' HB2' ' A' ' 13' ' ' TRP . 24.4 mm-40 -107.66 162.42 13.98 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-O 120.937 0.399 . . . . 0.0 110.964 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.658 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 26.1 ptt? -144.3 135.57 25.49 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.179 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.524 ' HA ' ' HB2' ' A' ' 53' ' ' SER 0.319 10.1 pt-20 -157.18 155.12 30.39 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 175.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.535 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 71.9 m -83.52 127.05 33.42 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.681 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.4 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 76.6 m-85 -126.81 150.5 49.14 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 0.2 OUTLIER -97.55 143.81 27.87 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.534 0.683 . . . . 0.0 111.457 -179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.6 p -83.55 176.98 8.63 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.518 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 71.0 m -74.39 -8.78 57.42 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.2 0.524 . . . . 0.0 111.241 177.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -91.9 -6.16 51.95 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.405 175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.81 17.67 57.7 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.019 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.0 m -94.47 127.32 40.3 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -89.24 124.29 34.25 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.652 0.739 . . . . 0.0 110.602 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' THR . 48.7 t -125.42 146.5 31.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.93 -175.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 65.4 tp -89.35 111.21 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.81 114.21 31.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.1 t -106.78 123.72 61.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 45.9 t30 -106.46 104.7 14.45 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.592 ' CB ' ' HB3' ' A' ' 36' ' ' HIS . 19.6 m -100.33 157.34 16.69 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.862 -177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -75.1 -51.41 13.54 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.289 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -108.55 -25.21 11.02 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.954 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.592 ' HB3' ' CB ' ' A' ' 33' ' ' SER . 43.6 t-80 -79.17 -7.61 58.35 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.785 0.803 . . . . 0.0 109.166 177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 71.73 173.19 17.77 Favored Glycine 0 CA--C 1.5 -0.86 0 CA-C-N 115.034 -0.985 . . . . 0.0 112.591 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.1 p -84.64 117.58 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.27 176.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 46.1 mmtm -130.07 149.14 51.92 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.319 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -123.71 132.35 53.81 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -134.6 154.84 51.3 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.433 ' OE1' ' HB3' ' A' ' 107' ' ' PRO . 26.6 mm-40 -53.98 137.02 40.41 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.567 175.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' O ' ' HG ' ' A' ' 52' ' ' LEU . . . -101.13 -11.35 19.65 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.873 0.844 . . . . 0.0 109.739 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 11.9 mmt -93.98 108.77 20.55 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.054 -175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 110' ' ' ALA . 24.0 p -105.79 172.57 3.86 Favored Pre-proline 0 N--CA 1.436 -1.15 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 173.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.811 ' HD2' ' S2 ' ' A' ' 113' ' ' FES . 73.2 Cg_endo -76.15 21.78 0.52 Allowed 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 121.89 1.727 . . . . 0.0 111.605 -178.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 66' ' ' ALA . 32.0 m80 -144.45 135.35 25.04 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 125.336 1.454 . . . . 0.0 107.649 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 60.11 -172.11 0.13 Allowed 'General case' 0 C--O 1.249 1.033 0 CA-C-O 121.512 0.672 . . . . 0.0 112.394 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -161.66 -48.88 0.04 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.3 pt -94.66 178.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.5 tp 79.67 -25.88 0.18 Allowed 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.463 1.105 . . . . 0.0 112.368 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 43' ' ' ALA . 4.0 mm? -56.8 -40.89 76.76 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.535 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 90.5 p -80.31 -15.6 56.53 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.369 0.604 . . . . 0.0 110.888 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -92.0 -9.13 44.0 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.949 178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.45 126.65 0.89 Allowed Glycine 0 N--CA 1.428 -1.888 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.589 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.7 t 178.28 -53.67 0.01 OUTLIER 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.658 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 66.3 t80 -91.85 113.11 25.29 Favored 'General case' 0 C--N 1.278 -2.532 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.109 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -115.91 105.34 12.56 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.452 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.32 -69.24 1.69 Allowed Glycine 0 C--O 1.241 0.567 0 O-C-N 123.215 0.322 . . . . 0.0 112.313 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -166.68 26.39 0.16 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 65.3 t -123.62 133.8 68.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.498 -0.926 . . . . 0.0 108.498 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 42.9 mm -96.51 117.16 40.35 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.003 0.906 . . . . 0.0 109.525 179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.7 m -102.0 121.33 41.95 Favored 'General case' 0 C--N 1.259 -3.333 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.194 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.976 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 1.2 m -75.24 -177.02 3.29 Favored 'General case' 0 N--CA 1.427 -1.583 0 C-N-CA 120.194 -0.602 . . . . 0.0 111.374 174.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.495 ' HA ' ' HE ' ' A' ' 65' ' ' ARG . 2.8 mmp_? -119.33 -42.44 2.67 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.165 -1.014 . . . . 0.0 113.153 -167.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 47' ' ' HIS . . . -98.17 -20.57 17.21 Favored 'General case' 0 CA--C 1.484 -1.589 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.606 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -116.51 137.33 52.26 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 117.969 -1.493 . . . . 0.0 109.314 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.453 ' O ' HD13 ' A' ' 68' ' ' LEU . 2.9 tm? -63.26 -36.47 83.76 Favored 'General case' 0 C--N 1.317 -0.832 0 C-N-CA 124.28 1.032 . . . . 0.0 113.119 -170.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 13.5 m-90 -62.26 174.36 0.95 Allowed 'General case' 0 CA--C 1.554 1.102 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -175.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.6 m -103.37 161.22 14.02 Favored 'General case' 0 C--O 1.246 0.874 0 CA-C-O 121.644 0.735 . . . . 0.0 112.6 -169.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.526 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 48.7 t80 -132.43 141.41 48.83 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -123.24 119.8 31.25 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -73.47 -22.31 60.2 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.669 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.48 -54.49 10.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.18 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.6 m -73.9 -34.65 64.48 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.012 0.434 . . . . 0.0 110.844 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 102.8 -4.26 49.73 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.751 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -125.27 161.74 26.27 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 122.84 0.456 . . . . 0.0 110.381 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.526 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -77.98 144.07 28.28 Favored Glycine 0 N--CA 1.416 -2.65 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 174.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.0 mt -73.83 -30.68 29.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 27.4 t-20 -143.61 125.83 8.53 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.356 172.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' C ' ' HA ' ' A' ' 80' ' ' ASN . 22.0 Cg_exo -67.37 -63.79 0.03 OUTLIER 'Cis proline' 0 C--N 1.354 0.824 0 C-N-CA 123.847 -1.314 . . . . 0.0 113.783 0.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 21.4 t70 164.91 -35.06 0.0 OUTLIER 'General case' 0 C--N 1.287 -2.15 0 C-N-CA 125.122 1.369 . . . . 0.0 109.569 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -63.16 -26.91 69.03 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.845 -174.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.0 p -77.31 142.36 39.46 Favored 'General case' 0 N--CA 1.399 -2.977 0 CA-C-O 121.744 0.783 . . . . 0.0 110.845 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.4 p -151.33 150.93 31.09 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.834 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 86' ' ' LEU . 1.6 pt? -114.44 141.34 47.8 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.267 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.472 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -88.12 124.05 33.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.379 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -96.74 110.85 23.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 33.9 m-85 -79.24 139.79 56.44 Favored Pre-proline 0 C--N 1.286 -2.19 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.662 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -65.27 120.22 7.4 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.227 1.952 . . . . 0.0 109.114 172.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.57 HG22 HG23 ' A' ' 100' ' ' VAL . 20.9 t -132.38 140.84 46.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -136.37 150.32 48.76 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.977 0.418 . . . . 0.0 110.982 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.02 117.28 55.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.283 178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.452 ' HD3' ' O ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -125.94 100.73 6.5 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.603 0.716 . . . . 0.0 110.243 -179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.94 -112.16 3.95 Favored Glycine 0 N--CA 1.432 -1.608 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.083 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' SER . 19.5 m-20 -102.24 -1.82 30.42 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 115.729 -0.235 . . . . 0.0 111.115 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 26.1 m-20 -121.82 155.85 34.47 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.84 -176.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 12' ' ' ILE . 75.1 mt -127.58 129.04 70.25 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.979 -178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 5' ' ' LYS . 54.5 p90 -112.72 143.14 44.45 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-O 120.878 0.371 . . . . 0.0 111.926 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 HG22 ' A' ' 91' ' ' VAL . 5.9 p -132.85 143.39 39.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.806 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 2' ' ' SER . 33.5 t -91.58 113.94 26.34 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 176.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.0 p -109.99 -41.25 4.52 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.339 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -70.65 112.17 6.68 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.136 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.3 -27.32 7.03 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.5 mm -99.78 117.73 45.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.3 tt -99.27 136.38 20.48 Favored Pre-proline 0 C--N 1.289 -2.051 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.433 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 50.5 Cg_exo -55.72 127.78 27.58 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.309 2.006 . . . . 0.0 111.534 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 33.9 t-20 -84.45 177.33 8.17 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.992 -1.004 . . . . 0.0 108.462 -174.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -74.27 60.04 0.8 Allowed 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 124.248 1.019 . . . . 0.0 113.354 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' CYS . . . -84.98 -20.08 31.08 Favored 'General case' 0 C--N 1.273 -2.748 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 170.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 46' ' ' PRO . 26.9 p80 -141.65 155.74 45.69 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 174.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--N 1.287 -2.121 0 CA-C-O 118.617 -0.706 . . . . 0.0 110.371 178.547 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.976 ' S1 ' ' HB3' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.6 m 55.77 91.42 0.03 OUTLIER 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -170.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 74.17 96.77 0.07 Allowed 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -166.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -119.79 150.06 41.02 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.99 109.51 5.14 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -92.04 -40.91 12.68 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.853 -178.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.475 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . 63.7 m -155.09 175.85 13.3 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.473 -177.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.0 m -120.88 154.79 35.37 Favored 'General case' 0 C--N 1.269 -2.926 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 174.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 30.4 tp -56.21 -25.28 46.6 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.203 0.525 . . . . 0.0 111.062 -176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.49 -20.61 62.84 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 121.258 0.551 . . . . 0.0 110.777 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 7' ' ' CYS . 17.4 m-20 -88.51 -36.88 16.17 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.938 177.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 6.5 tp -130.71 116.14 33.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.158 0.98 . . . . 0.0 111.736 -176.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -104.72 167.15 9.91 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.029 -174.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.1 m -72.57 130.47 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.021 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.245 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.7 10.09 70.61 Favored Glycine 0 C--N 1.309 -0.942 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -124.61 147.68 48.34 Favored 'General case' 0 N--CA 1.432 -1.353 0 CA-C-O 120.814 0.34 . . . . 0.0 111.108 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 53.8 mtp -130.74 133.74 46.29 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 -177.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.659 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 33.4 mt-10 -146.17 140.43 26.63 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 120.861 0.363 . . . . 0.0 111.349 172.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.1 m -73.78 132.48 42.65 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -128.4 162.22 27.63 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -106.18 137.06 44.78 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.413 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.8 p -83.54 171.87 12.93 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 109.425 -0.584 . . . . 0.0 109.425 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.0 m -67.8 -17.99 64.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.056 0.455 . . . . 0.0 111.729 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -96.56 4.8 51.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.8 29.36 35.29 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.207 -0.52 . . . . 0.0 113.597 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -98.68 136.72 38.34 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 122.386 -0.479 . . . . 0.0 110.177 177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -89.49 124.94 34.96 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 41' ' ' TYR . 97.3 t -133.6 147.01 31.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -96.41 117.21 30.39 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 -178.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -100.78 116.97 45.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.2 t -113.3 122.83 68.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.453 ' OD1' ' HB ' ' A' ' 38' ' ' VAL . 49.3 t30 -113.87 106.8 14.88 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.432 176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -99.99 150.78 22.08 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.92 -51.38 12.58 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -84.58 -45.86 12.13 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.325 0.583 . . . . 0.0 110.906 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -79.01 -12.95 60.04 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.338 -0.846 . . . . 0.0 112.025 -175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -175.75 50.83 Favored Glycine 0 N--CA 1.431 -1.654 0 C-N-CA 120.069 -1.062 . . . . 0.0 113.139 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.453 ' HB ' ' OD1' ' A' ' 32' ' ' ASN . 6.6 p -105.4 125.26 60.63 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 CA-C-O 121.524 0.678 . . . . 0.0 111.115 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -129.92 150.98 50.96 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.595 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.07 128.44 49.33 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' O ' HG13 ' A' ' 28' ' ' VAL . 2.6 m-85 -131.08 163.08 28.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.68 ' HB2' HD11 ' A' ' 86' ' ' LEU . 15.7 mm100 -53.12 138.95 30.02 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.58 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -46.19 -28.24 1.2 Allowed 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 116.358 1.984 . . . . 0.0 116.358 -169.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.502 ' HB3' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -162.28 -178.15 6.15 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 -169.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.574 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 86.9 m -87.02 163.75 39.16 Favored Pre-proline 0 C--N 1.361 1.091 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 169.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 45' ' ' CYS . 49.4 Cg_endo -69.58 24.31 0.17 Allowed 'Trans proline' 0 CA--C 1.553 1.458 0 C-N-CA 122.276 1.984 . . . . 0.0 113.037 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.474 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 32.2 m170 -111.96 -52.25 2.8 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.414 ' OE1' ' HG2' ' A' ' 44' ' ' MET . 19.9 tp60 63.33 108.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 116.845 2.165 . . . . 0.0 116.845 167.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 55.0 mm-40 -124.5 170.74 10.59 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 165.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 pt -87.18 167.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 118.429 0.559 . . . . 0.0 111.092 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.7 mt 70.73 28.84 3.35 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 124.533 1.133 . . . . 0.0 111.449 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.707 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.7 pt? -75.24 -42.17 55.84 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -177.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.659 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 96.1 p -72.93 -21.97 60.8 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.924 0.869 . . . . 0.0 109.503 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.66 15.86 5.26 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.293 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -87.2 -124.93 1.93 Allowed Glycine 0 N--CA 1.416 -2.662 0 N-CA-C 112.082 -0.407 . . . . 0.0 112.082 -176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.4 m -142.79 157.09 44.97 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-O 122.167 0.984 . . . . 0.0 113.009 -174.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -129.06 116.79 19.84 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 113.27 -1.787 . . . . 0.0 108.222 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -115.15 104.55 11.96 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.87 -74.87 0.46 Allowed Glycine 0 N--CA 1.467 0.733 0 CA-C-O 121.648 0.582 . . . . 0.0 111.905 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -151.0 0.51 0.34 Allowed Glycine 0 C--N 1.292 -1.879 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.9 t -99.69 143.33 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-O 121.358 0.599 . . . . 0.0 110.453 -174.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.507 HG12 ' H ' ' A' ' 71' ' ' PHE . 0.1 OUTLIER -117.89 117.82 56.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 CA-C-N 114.782 -1.099 . . . . 0.0 109.389 179.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 90.5 m -108.86 132.15 54.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.012 -0.995 . . . . 0.0 112.255 -170.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.767 ' HB2' ' H ' ' A' ' 68' ' ' LEU . 1.7 p -85.02 -13.91 49.02 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 64.47 -80.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.973 0.909 . . . . 0.0 112.649 175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.49 27.74 8.59 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.145 0.978 . . . . 0.0 109.775 -175.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.673 ' HA ' ' S1 ' ' A' ' 113' ' ' FES 0.276 96.2 m-70 84.01 97.24 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.767 ' H ' ' HB2' ' A' ' 64' ' ' CYS . 7.2 mp -149.51 -80.04 0.13 Allowed 'General case' 0 CA--C 1.583 2.244 0 C-N-CA 127.906 2.482 . . . . 0.0 108.954 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.646 ' N ' ' HB3' ' A' ' 64' ' ' CYS . 0.9 OUTLIER -146.8 135.22 21.89 Favored 'General case' 0 CA--C 1.594 2.641 0 O-C-N 121.955 -0.466 . . . . 0.0 111.221 178.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 78' ' ' GLY . 0.3 OUTLIER -139.69 132.4 29.0 Favored 'General case' 0 N--CA 1.482 1.165 0 O-C-N 121.541 -0.725 . . . . 0.0 112.721 174.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.507 ' H ' HG12 ' A' ' 62' ' ' ILE . 75.2 t80 -138.15 150.43 46.8 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.353 172.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.611 ' HB2' ' HA3' ' A' ' 78' ' ' GLY . 45.8 t-20 -105.98 100.46 10.01 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -52.01 -36.71 50.87 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.13 -3.3 60.38 Favored Glycine 0 C--N 1.311 -0.832 0 C-N-CA 119.651 -1.262 . . . . 0.0 114.857 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.3 m -139.74 -14.55 1.07 Allowed 'General case' 0 CA--C 1.558 1.272 0 CA-C-N 118.089 0.944 . . . . 0.0 112.98 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.49 -59.17 4.99 Favored Glycine 0 C--N 1.318 -0.426 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -176.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.503 ' HB3' ' O ' ' A' ' 82' ' ' ASP . 42.0 m80 -63.44 102.29 0.4 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 175.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.611 ' HA3' ' HB2' ' A' ' 72' ' ' ASN . . . -161.06 19.06 0.2 Allowed Glycine 0 CA--C 1.469 -2.823 0 C-N-CA 119.985 -1.102 . . . . 0.0 114.284 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 86' ' ' LEU . 1.5 mp -98.77 -12.91 8.24 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.106 0 CA-C-N 115.126 -0.537 . . . . 0.0 111.131 -169.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.565 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 73.7 m-20 77.28 115.06 0.03 OUTLIER Pre-proline 0 N--CA 1.445 -0.721 0 C-N-CA 125.293 1.437 . . . . 0.0 112.111 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 14.1 Cg_exo -71.35 -174.14 10.74 Favored 'Cis proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.039 -1.65 . . . . 0.0 112.012 -0.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 77' ' ' HIS . 9.2 p-10 -68.99 2.76 2.43 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 121.714 0.769 . . . . 0.0 111.248 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -80.55 -21.14 42.06 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.965 174.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.507 ' SG ' ' HE2' ' A' ' 109' ' ' LYS . 37.3 m -102.42 141.38 35.34 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.424 0.631 . . . . 0.0 111.507 -172.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 9.3 p -122.15 178.09 5.07 Favored 'General case' 0 C--N 1.273 -2.754 0 C-N-CA 125.176 1.391 . . . . 0.0 109.899 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.68 HD11 ' HB2' ' A' ' 42' ' ' GLN . 52.1 tp -141.25 156.28 45.91 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -92.37 124.28 36.31 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 121.017 -0.273 . . . . 0.0 110.902 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -93.68 125.09 38.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.518 ' CD1' ' HA ' ' A' ' 102' ' ' THR . 98.6 m-85 -100.27 132.36 22.69 Favored Pre-proline 0 C--N 1.28 -2.424 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.917 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -64.5 120.78 8.16 Favored 'Trans proline' 0 C--O 1.25 1.079 0 C-N-CA 122.733 2.289 . . . . 0.0 112.109 -178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.492 HG13 HG22 ' A' ' 100' ' ' VAL . 45.1 t -109.47 134.47 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.548 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -117.3 131.98 56.7 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.6 p -108.41 118.1 55.31 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.781 -177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.552 ' HD2' ' N ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.76 91.57 3.37 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.59 -107.3 1.33 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.293 -0.956 . . . . 0.0 112.77 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -101.87 -0.97 33.15 Favored 'General case' 0 C--O 1.193 -1.872 0 CA-C-N 115.55 -0.325 . . . . 0.0 111.332 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.401 ' O ' HD13 ' A' ' 98' ' ' ILE . 25.6 m-20 -106.52 139.51 40.87 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.441 -178.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.401 HD13 ' O ' ' A' ' 97' ' ' ASP . 38.5 mm -127.06 122.77 60.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.204 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -118.82 142.78 47.41 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.962 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 91' ' ' VAL . 39.2 t -134.31 139.14 48.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.2 t -95.31 114.29 26.06 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.518 ' HA ' ' CD1' ' A' ' 89' ' ' TYR . 24.5 p -118.52 -47.01 2.56 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.668 -177.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -78.48 105.02 9.46 Favored 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.558 -175.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.44 -35.57 1.72 Allowed Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 70.0 mt -96.19 128.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.6 mp -76.21 133.09 72.22 Favored Pre-proline 0 N--CA 1.417 -2.076 0 CA-C-O 120.671 0.272 . . . . 0.0 111.722 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.494 ' HB3' ' NE2' ' A' ' 42' ' ' GLN . 18.4 Cg_endo -61.22 134.72 53.95 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 123.307 2.671 . . . . 0.0 111.135 176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.57 123.52 47.69 Favored 'General case' 0 CA--C 1.471 -2.073 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.507 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 52.0 tptt 58.88 178.87 0.07 Allowed 'General case' 0 CA--C 1.568 1.662 0 O-C-N 125.467 1.729 . . . . 0.0 111.349 177.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.47 ' H ' ' HG3' ' A' ' 109' ' ' LYS . . . 65.6 -78.1 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 125.185 1.394 . . . . 0.0 114.217 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -133.54 105.33 6.83 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 C--N 1.282 -2.344 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -179.659 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.673 ' S1 ' ' HA ' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 CA--C 1.511 -0.546 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -136.8 130.51 31.99 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 68.54 84.79 0.15 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.06 0.85 . . . . 0.0 109.846 -175.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -110.74 144.09 40.23 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.181 -178.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -77.13 119.27 20.59 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.313 0.578 . . . . 0.0 110.933 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.7 tp -93.6 -44.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.217 -0.901 . . . . 0.0 108.747 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.9 p -157.95 -172.83 4.07 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.104 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.433 ' HB2' ' OD1' ' A' ' 10' ' ' ASP . 6.3 m -118.89 152.65 35.9 Favored 'General case' 0 C--N 1.282 -2.362 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.189 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.538 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -61.46 -22.06 64.72 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.292 0.637 . . . . 0.0 110.372 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 8' ' ' SER . 2.5 p-10 -77.27 -11.19 59.8 Favored 'General case' 0 C--N 1.312 -1.028 0 O-C-N 121.705 -0.622 . . . . 0.0 109.81 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -84.68 -45.04 12.85 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.8 pt -114.37 109.84 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 122.468 1.127 . . . . 0.0 109.777 175.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 32.4 m95 -75.25 170.43 16.07 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.747 -175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 p -52.59 115.11 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.173 0.511 . . . . 0.0 110.672 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.13 10.79 59.33 Favored Glycine 0 N--CA 1.437 -1.294 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.213 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -102.13 149.52 24.19 Favored 'General case' 0 C--O 1.246 0.917 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -150.5 142.09 23.55 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.848 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.646 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 pt-20 -155.01 144.78 21.52 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.205 0.526 . . . . 0.0 112.291 176.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 90.1 m -79.96 138.85 37.17 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.588 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -129.65 162.33 28.56 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 173.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -113.32 134.93 54.36 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.079 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -83.15 168.46 16.8 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.0 m -68.0 -17.27 64.37 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.043 0.449 . . . . 0.0 110.767 179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.52 -12.83 59.85 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.321 177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.94 18.42 37.36 Favored Glycine 0 N--CA 1.444 -0.809 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 -178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.0 m -96.13 131.58 42.42 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 122.181 0.193 . . . . 0.0 111.088 -177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -91.94 124.45 36.06 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.541 0.686 . . . . 0.0 109.353 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 19' ' ' THR . 58.1 t -125.84 136.87 59.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.461 HD12 HD22 ' A' ' 52' ' ' LEU . 1.3 tt -95.56 112.21 23.97 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 105.824 -1.917 . . . . 0.0 105.824 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 18' ' ' GLU . 9.9 tp -95.8 117.22 39.46 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.5 t -113.52 125.22 70.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -113.13 104.58 12.5 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.138 174.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.2 p -102.0 158.54 16.07 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.432 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -75.54 -50.72 14.79 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.641 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -79.69 -46.46 17.07 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -174.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -84.44 -11.32 56.42 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.605 -177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 83.72 -157.44 34.22 Favored Glycine 0 N--CA 1.439 -1.129 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.967 176.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -100.65 123.22 53.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 41' ' ' TYR . 16.7 tppt? -128.59 145.34 51.16 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.39 113.94 18.85 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.555 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.462 ' CZ ' HD11 ' A' ' 62' ' ' ILE . 22.5 m-85 -116.32 147.72 41.28 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.425 ' CG ' HD22 ' A' ' 86' ' ' LEU . 11.3 pt20 -64.36 138.71 58.57 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 170.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.99 -68.37 0.69 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-O 121.489 0.661 . . . . 0.0 111.043 -175.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.497 ' CE ' ' HA ' ' A' ' 44' ' ' MET 0.265 0.1 OUTLIER 62.73 -100.21 0.09 Allowed 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -178.86 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.4 t 49.56 96.36 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.824 0 CA-C-O 121.049 0.452 . . . . 0.0 110.141 -168.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.451 ' HD2' ' S2 ' ' A' ' 113' ' ' FES . 71.6 Cg_endo -75.58 36.96 0.48 Allowed 'Trans proline' 0 N--CA 1.48 0.69 0 C-N-CA 123.099 2.532 . . . . 0.0 112.149 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.484 ' O ' ' HG2' ' A' ' 48' ' ' GLN . 37.2 m80 -150.39 -179.77 7.48 Favored 'General case' 0 CA--C 1.495 -1.143 0 C-N-CA 123.936 0.894 . . . . 0.0 109.578 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.484 ' HG2' ' O ' ' A' ' 47' ' ' HIS . 24.7 pt20 62.78 142.33 0.02 OUTLIER 'General case' 0 C--O 1.241 0.61 0 C-N-CA 127.523 2.329 . . . . 0.0 114.505 173.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -107.21 85.36 2.12 Favored 'General case' 0 N--CA 1.425 -1.694 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.1 tp 169.83 167.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 N-CA-C 105.715 -1.958 . . . . 0.0 105.715 -178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -80.48 138.04 36.52 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.928 0.394 . . . . 0.0 111.529 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 52' ' ' LEU . 4.1 tt -67.07 -32.47 73.66 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.646 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.5 p -63.7 -14.02 48.44 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.314 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -100.68 13.27 35.36 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.702 0.763 . . . . 0.0 109.267 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.76 -109.91 0.64 Allowed Glycine 0 N--CA 1.439 -1.106 0 N-CA-C 110.901 -0.879 . . . . 0.0 110.901 178.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.414 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 20.8 p -155.78 146.8 22.36 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.407 ' HB2' ' SD ' ' A' ' 17' ' ' MET . 87.3 t80 -125.83 116.67 21.93 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.961 -1.472 . . . . 0.0 109.911 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.603 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 2.4 mp0 -99.37 170.12 8.86 Favored 'General case' 0 C--N 1.286 -2.178 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 176.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.24 67.45 0.37 Allowed Glycine 0 CA--C 1.528 0.855 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 115.77 -1.51 21.56 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.603 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.5 t -124.02 136.64 59.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -178.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.462 HD11 ' CZ ' ' A' ' 41' ' ' TYR . 52.2 mt -119.57 129.99 74.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -178.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 53.8 m -110.5 123.66 50.34 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 176.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.4 ' HA ' ' CD2' ' A' ' 52' ' ' LEU . 10.4 p -57.75 -30.6 65.73 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.9 ttp180 169.24 -48.57 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 126.241 1.816 . . . . 0.0 107.501 168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.69 -87.41 0.09 Allowed 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.559 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.68 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 3.6 t-160 52.87 -85.74 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.161 1.384 . . . . 0.0 111.489 -175.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 63.6 tp -174.16 -60.66 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 C-N-CA 123.32 0.648 . . . . 0.0 109.47 -177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 8.1 m0 -99.11 -176.47 3.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.341 -178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.45 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 65.9 p -135.05 165.33 25.62 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.57 0.748 . . . . 0.0 111.316 -174.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -103.22 147.75 26.65 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -118.22 126.12 51.54 Favored 'General case' 0 C--O 1.244 0.797 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.997 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -54.71 -56.69 16.5 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.245 1.018 . . . . 0.0 111.243 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.49 50.02 4.27 Favored Glycine 0 CA--C 1.509 -0.336 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.673 -176.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.2 m -152.95 -44.83 0.1 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 88.24 -34.51 3.78 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 85' ' ' CYS . 21.3 t-80 -90.32 146.29 24.31 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -102.61 140.58 14.92 Favored Glycine 0 CA--C 1.483 -1.925 0 C-N-CA 118.705 -1.712 . . . . 0.0 112.391 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 70' ' ' THR . 2.0 mp -73.52 -31.41 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -109.97 129.4 23.97 Favored Pre-proline 0 CA--C 1.517 -0.313 0 CA-C-N 114.331 -1.304 . . . . 0.0 107.632 169.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -73.37 -41.73 0.95 Allowed 'Cis proline' 0 CA--C 1.498 -1.283 0 C-N-CA 123.658 -1.393 . . . . 0.0 110.456 -4.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.3 t70 152.54 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 127.445 2.298 . . . . 0.0 107.326 176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -78.45 -21.01 49.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.001 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 61.0 m -96.09 150.57 20.35 Favored 'General case' 0 N--CA 1.406 -2.636 0 CA-C-O 122.893 1.33 . . . . 0.0 112.721 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.421 ' HB3' ' HA ' ' A' ' 77' ' ' HIS . 1.7 p -140.0 148.62 42.13 Favored 'General case' 0 C--N 1.253 -3.599 0 CA-C-N 111.969 -2.378 . . . . 0.0 106.904 173.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.425 HD22 ' CG ' ' A' ' 42' ' ' GLN . 51.2 mt -112.83 175.94 5.23 Favored 'General case' 0 C--N 1.266 -3.043 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.022 -172.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.446 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -126.36 142.99 51.33 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.187 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.05 118.26 35.41 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -89.81 148.07 39.0 Favored Pre-proline 0 C--N 1.306 -1.326 0 CA-C-N 116.809 -0.178 . . . . 0.0 110.754 -175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 101' ' ' SER . 11.9 Cg_exo -68.04 119.73 6.73 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.508 1.472 . . . . 0.0 111.002 -179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.6 p -127.95 134.84 64.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.128 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -127.32 126.51 42.7 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.497 0.665 . . . . 0.0 109.952 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.1 p -111.7 124.5 68.5 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.579 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.502 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.6 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -126.81 96.97 4.81 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.492 178.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.43 -104.87 1.52 Allowed Glycine 0 N--CA 1.435 -1.381 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.05 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 8' ' ' SER . 21.8 m-20 -109.37 4.11 22.19 Favored 'General case' 0 C--O 1.19 -2.027 0 CA-C-N 115.525 -0.337 . . . . 0.0 110.921 178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -108.64 139.59 43.21 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 120.63 0.252 . . . . 0.0 111.155 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 74.6 mt -127.1 119.64 53.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 121.495 0.664 . . . . 0.0 111.303 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -112.58 137.87 50.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.755 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.4 m -127.33 148.53 32.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.46 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.51 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 32.2 t -127.77 146.6 50.54 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.5 m -125.74 2.06 7.47 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -91.33 130.78 37.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.458 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.16 -45.8 1.26 Allowed Glycine 0 C--N 1.303 -1.259 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 56.9 mt -108.05 107.34 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.456 HD12 ' HD2' ' A' ' 107' ' ' PRO . 33.6 tp -82.46 139.09 44.47 Favored Pre-proline 0 C--N 1.304 -1.401 0 CA-C-N 115.016 -0.993 . . . . 0.0 108.968 -177.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD2' HD12 ' A' ' 106' ' ' LEU . 96.0 Cg_exo -50.61 128.99 25.41 Favored 'Trans proline' 0 C--N 1.365 1.427 0 C-N-CA 122.547 2.165 . . . . 0.0 111.014 174.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 55.4 t-20 -86.99 143.57 27.28 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-N 114.387 -1.279 . . . . 0.0 110.687 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 52.43 -76.09 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 128.08 2.552 . . . . 0.0 113.768 176.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.86 -61.62 2.28 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.294 -0.867 . . . . 0.0 110.075 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 107' ' ' PRO . 46.6 t-80 61.02 92.38 0.05 OUTLIER 'General case' 0 C--N 1.314 -0.959 0 O-C-N 124.202 0.939 . . . . 0.0 112.551 175.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 35.0 p . . . . . 0 C--N 1.288 -2.101 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.6 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.68 ' S1 ' ' HB2' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 119.757 -0.163 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -57.93 -51.33 70.06 Favored 'General case' 0 C--N 1.344 0.369 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 175.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -112.85 148.04 35.73 Favored 'General case' 0 N--CA 1.431 -1.39 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 170.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -142.46 144.84 33.21 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -73.16 129.54 38.29 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.241 0.543 . . . . 0.0 110.758 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.537 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.6 tp -100.43 -42.61 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.773 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.044 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' SG ' HG23 ' A' ' 6' ' ' ILE . 7.7 p -165.76 -176.69 3.97 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.22 -178.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 14.9 m -123.57 150.42 44.1 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.296 178.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.4 tt -60.1 -24.62 64.79 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 125.222 1.409 . . . . 0.0 110.287 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.28 -23.49 64.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.169 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -106.21 -45.4 4.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.342 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 9' ' ' LEU . 5.6 tp -100.68 110.88 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 122.298 1.047 . . . . 0.0 111.972 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.4 m95 -101.64 162.84 12.6 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 114.249 -1.342 . . . . 0.0 113.073 -172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -67.27 124.23 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.714 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.84 3.39 64.15 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -119.75 158.24 26.92 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 120.874 0.369 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -151.21 148.62 28.45 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.784 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.602 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 11.8 pt-20 -156.52 151.25 25.86 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.111 171.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 m -73.0 133.32 44.23 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.389 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.402 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.35 154.23 47.88 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -104.87 142.65 34.36 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.7 p -83.41 179.17 7.74 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.4 m -76.05 -17.65 59.56 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.169 0.509 . . . . 0.0 110.683 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -86.37 -12.49 49.11 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.607 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.15 21.73 19.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.211 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 18.9 m -95.81 120.59 36.34 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -91.02 122.61 33.82 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.153 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 48.8 t -126.8 142.6 42.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.125 -172.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.477 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 1.5 tt -93.93 114.28 26.47 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.35 112.95 28.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 45.9 t -110.35 124.75 67.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.527 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -100.13 107.19 19.01 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 171.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.9 m -98.29 148.83 23.24 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -73.7 -36.71 65.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -111.15 -38.09 5.14 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.153 0.501 . . . . 0.0 111.082 178.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -81.97 -3.51 54.55 Favored 'General case' 0 CA--C 1.551 1.016 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.321 -174.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.74 -178.67 47.95 Favored Glycine 0 CA--C 1.51 -0.281 0 C-N-CA 121.421 -0.419 . . . . 0.0 113.671 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.1 t -78.2 129.55 37.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -129.32 141.77 51.0 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.93 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.52 115.1 20.33 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.765 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 86' ' ' LEU . 47.7 p90 -143.62 157.32 44.5 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -50.25 138.03 17.19 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 29' ' ' LEU . . . -106.86 -78.17 0.59 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.849 -1.068 . . . . 0.0 109.584 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.497 ' SD ' ' HD2' ' A' ' 111' ' ' HIS . 15.6 tpt 53.26 -84.29 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 69.2 m 55.49 84.77 0.2 Allowed Pre-proline 0 C--O 1.212 -0.904 0 CA-C-O 121.119 0.485 . . . . 0.0 112.237 -168.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -90.87 21.13 0.86 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.93 1.753 . . . . 0.0 110.867 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.502 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 8.8 m80 -103.68 -78.6 0.55 Allowed 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.05 -39.29 7.36 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 69.42 -89.42 0.03 OUTLIER 'General case' 0 C--O 1.243 0.745 0 O-C-N 124.465 1.103 . . . . 0.0 112.918 174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 66.0 mt 58.24 -81.68 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 124.799 1.24 . . . . 0.0 109.212 -171.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -167.03 92.06 0.42 Allowed 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 128.158 2.583 . . . . 0.0 104.306 175.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.488 ' HG ' ' SG ' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -67.21 -21.82 65.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.419 0.628 . . . . 0.0 111.828 -175.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.602 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 10.6 p -75.58 -10.67 59.64 Favored 'General case' 0 N--CA 1.414 -2.225 0 C-N-CA 124.805 1.242 . . . . 0.0 111.434 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -94.78 11.0 33.0 Favored 'General case' 0 CA--C 1.556 1.182 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.48 -128.18 1.39 Allowed Glycine 0 N--CA 1.44 -1.048 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.938 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.6 t -150.85 156.99 42.36 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.932 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -130.37 128.99 42.52 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.756 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 61' ' ' VAL . 1.8 tm-20 -115.65 158.13 23.19 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -50.84 -30.31 21.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 114.119 0.407 . . . . 0.0 114.119 -177.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.57 -4.08 5.86 Favored Glycine 0 N--CA 1.439 -1.131 0 C-N-CA 119.708 -1.234 . . . . 0.0 113.163 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 71' ' ' PHE . 61.7 t -124.04 125.0 70.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.593 0 CA-C-N 117.343 0.572 . . . . 0.0 110.717 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 46.6 mt -103.17 136.09 37.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 69' ' ' TRP . 99.3 m -117.51 116.02 26.3 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 111.287 0.106 . . . . 0.0 111.287 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 28.0 t -64.31 144.49 57.11 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 172.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -50.98 -55.23 18.34 Favored 'General case' 0 N--CA 1.465 0.325 0 O-C-N 123.815 0.697 . . . . 0.0 109.639 -176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.6 91.66 2.27 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.274 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -167.94 -76.37 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 69' ' ' TRP . 5.2 tt -144.56 143.63 30.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.487 ' HA ' HG23 ' A' ' 63' ' ' THR . 40.8 p90 -89.82 -19.57 24.51 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -169.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.424 ' H ' HD23 ' A' ' 68' ' ' LEU . 41.2 p -103.93 126.32 50.97 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 118.572 -1.251 . . . . 0.0 112.719 -177.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.558 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 90.7 t80 -138.71 144.73 39.67 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 168.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.6 t-20 -99.08 104.81 16.85 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 118.466 0.575 . . . . 0.0 111.146 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -63.38 -39.54 94.81 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 123.378 0.671 . . . . 0.0 110.536 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.44 -46.4 94.42 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.094 -0.957 . . . . 0.0 113.731 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.3 m -80.11 -35.41 36.84 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.864 0.364 . . . . 0.0 111.32 -178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.61 3.61 Favored Glycine 0 CA--C 1.51 -0.235 0 N-CA-C 110.64 -0.984 . . . . 0.0 110.64 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.483 ' HA ' ' SG ' ' A' ' 85' ' ' CYS . 14.8 t-80 -92.71 132.53 36.84 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 173.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -84.69 146.41 22.34 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 120.027 -1.082 . . . . 0.0 111.339 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -81.98 -36.26 13.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 47.7 t30 -164.24 110.79 0.9 Allowed Pre-proline 0 C--N 1.308 -1.236 0 CA-C-N 114.198 -1.365 . . . . 0.0 107.38 177.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.574 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 2.5 Cg_endo -87.97 172.11 32.48 Favored 'Cis proline' 0 CA--C 1.554 1.502 0 C-N-CA 124.058 -1.226 . . . . 0.0 113.222 1.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -94.92 -11.39 28.73 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -99.29 12.92 34.87 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.987 0.898 . . . . 0.0 110.881 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.574 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 77.7 m -112.81 9.46 19.02 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.231 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 77' ' ' HIS . 57.5 m -58.3 156.3 10.23 Favored 'General case' 0 C--N 1.269 -2.901 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.678 -176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' A' ' 41' ' ' TYR . 2.8 pp -117.85 169.09 9.9 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.207 -174.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.425 ' HB2' ' CB ' ' A' ' 108' ' ' ASN . . . -130.88 122.18 26.57 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -80.89 127.36 32.46 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.172 0.51 . . . . 0.0 112.015 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.9 143.45 26.74 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.394 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -65.78 127.64 18.28 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.183 1.922 . . . . 0.0 110.53 176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.78 143.74 39.42 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -128.04 138.08 52.43 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-O 120.938 0.399 . . . . 0.0 110.551 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.38 126.25 66.48 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.501 0 CA-C-O 122.287 1.041 . . . . 0.0 111.474 -176.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -119.52 146.92 45.03 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -47.41 100.66 0.03 OUTLIER Glycine 0 CA--C 1.523 0.563 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.289 175.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 8' ' ' SER . 38.1 t70 84.86 -33.46 0.06 Allowed 'General case' 0 C--O 1.179 -2.633 0 C-N-CA 126.797 2.039 . . . . 0.0 114.476 -176.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -99.37 131.2 45.55 Favored 'General case' 0 C--N 1.282 -2.353 0 O-C-N 120.639 -1.288 . . . . 0.0 111.206 -174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.15 123.07 69.97 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.837 -179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -112.74 145.61 40.22 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.985 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 59.2 t -131.4 144.51 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.4 t -105.1 115.22 29.9 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.4 m -106.44 -33.54 7.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.428 0.633 . . . . 0.0 109.486 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.3 tpmt? -74.02 107.98 6.55 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.666 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.29 -4.04 8.9 Favored Glycine 0 N--CA 1.438 -1.219 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.9 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 45.2 mm -119.17 140.69 42.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -100.44 120.79 55.29 Favored Pre-proline 0 N--CA 1.42 -1.964 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.91 133.08 53.54 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.726 2.284 . . . . 0.0 111.996 178.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.425 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 51.2 t30 -89.53 176.24 6.97 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.571 -176.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.31 104.65 0.52 Allowed 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 122.198 0.999 . . . . 0.0 111.679 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -176.13 -38.64 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 112.278 -2.237 . . . . 0.0 105.649 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.497 ' HD2' ' SD ' ' A' ' 44' ' ' MET . 54.7 t-80 -129.32 92.87 3.44 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.775 -1.557 . . . . 0.0 107.308 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -179.167 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.613 ' S1 ' ' HB3' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 CA--C 1.502 -0.879 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.424 ' OG ' ' HE3' ' A' ' 103' ' ' LYS . 31.3 t -75.38 111.39 10.6 Favored 'General case' 0 N--CA 1.413 -2.301 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.591 ' H ' ' HA ' ' A' ' 101' ' ' SER . 96.7 m-85 72.46 93.53 0.08 Allowed 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.425 -177.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 99' ' ' TYR . 8.4 tp10 -106.81 138.27 43.29 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 4.1 tmmm? -80.94 105.14 11.93 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -85.94 -49.16 15.53 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.826 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.061 -176.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 92.5 m -145.65 177.58 8.77 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.709 0.766 . . . . 0.0 111.317 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.7 p -110.56 152.76 26.02 Favored 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 113.882 -1.508 . . . . 0.0 108.051 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.7 tp -60.38 -20.04 58.04 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 122.014 0.911 . . . . 0.0 109.918 178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -75.35 -20.88 58.77 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.054 -0.975 . . . . 0.0 111.363 175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -96.22 -32.09 12.62 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.232 0.539 . . . . 0.0 110.556 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.563 HD12 ' HB3' ' A' ' 16' ' ' GLU . 3.2 tp -124.11 111.87 30.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 CA-C-O 121.921 0.867 . . . . 0.0 111.558 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -105.06 163.96 12.17 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.406 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.57 124.98 15.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 CA-C-O 121.422 0.63 . . . . 0.0 111.32 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.24 0.37 59.8 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.542 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' HB3' HD12 ' A' ' 12' ' ' ILE . 8.8 tp10 -103.76 152.16 22.18 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.508 ' HG3' ' HB2' ' A' ' 56' ' ' SER . 0.0 OUTLIER -150.75 139.1 20.36 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 120.883 0.373 . . . . 0.0 110.156 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 40.0 tt0 -158.05 155.22 28.91 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 13.2 t -89.16 132.61 34.75 Favored 'General case' 0 N--CA 1.419 -2.006 0 C-N-CA 119.536 -0.866 . . . . 0.0 109.027 175.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 -123.34 151.7 42.22 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.05 133.78 47.59 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -83.01 178.79 7.99 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.0 m -69.11 -21.53 64.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.463 0.649 . . . . 0.0 110.602 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -80.94 -13.36 58.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.499 0.666 . . . . 0.0 110.696 178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.01 23.06 33.61 Favored Glycine 0 N--CA 1.433 -1.565 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.5 m -92.85 115.6 28.26 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -89.99 123.75 34.16 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.429 ' CG1' ' HB1' ' A' ' 40' ' ' ALA . 46.6 t -130.64 144.53 37.63 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 -172.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.505 ' N ' ' HB2' ' A' ' 43' ' ' ALA . 62.2 tp -88.32 111.86 22.18 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 mt -103.09 118.65 50.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.449 HG22 ' HB2' ' A' ' 17' ' ' MET . 46.5 t -119.36 125.19 74.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 108.849 -177.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 46.6 t-20 -92.32 106.99 18.88 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.0 m -99.02 152.96 19.24 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.8 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -75.51 -50.28 16.15 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.962 0.41 . . . . 0.0 111.043 -178.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -94.07 -22.19 18.67 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.144 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -99.23 -4.27 32.38 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.128 -177.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.89 -170.67 51.42 Favored Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.908 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 46.2 t -80.55 120.74 32.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -129.06 150.74 50.34 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.147 0.498 . . . . 0.0 110.802 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -124.74 131.69 53.43 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 59.8 m-85 -130.21 162.21 29.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 119.562 -0.256 . . . . 0.0 110.478 -176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.657 ' HA ' HE21 ' A' ' 42' ' ' GLN . 0.0 OUTLIER -50.18 136.31 19.73 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.505 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -118.05 -11.51 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.462 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 47.3 tpp -69.2 108.91 3.82 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.594 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 47' ' ' HIS . 17.4 t -108.69 107.27 59.95 Favored Pre-proline 0 N--CA 1.413 -2.29 0 CA-C-O 121.233 0.54 . . . . 0.0 111.452 176.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -96.87 17.08 0.65 Allowed 'Trans proline' 0 N--CA 1.445 -1.347 0 C-N-CA 122.677 2.251 . . . . 0.0 109.422 174.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.591 ' HB3' ' SG ' ' A' ' 45' ' ' CYS . 16.5 t-160 -94.71 -38.9 10.58 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.44 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.65 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 20.4 tt0 178.57 110.56 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 126.28 1.832 . . . . 0.0 107.704 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -155.94 134.71 11.86 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 118.461 -1.296 . . . . 0.0 114.127 -175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.1 mm -114.57 -63.36 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 162.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB2' ' OE1' ' A' ' 54' ' ' GLU . 68.9 mt -154.06 110.82 3.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 165.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -68.59 -25.35 64.84 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.918 -174.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 47.7 p -62.57 -19.65 63.91 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -170.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.485 ' OE1' ' HB2' ' A' ' 51' ' ' LEU . 1.9 mp0 -84.88 -9.16 58.4 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.105 0.479 . . . . 0.0 110.818 176.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -138.57 81.07 0.27 Allowed Glycine 0 CA--C 1.488 -1.635 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.648 ' HA ' ' O ' ' A' ' 63' ' ' THR . 66.9 m -143.26 -33.76 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 -172.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.402 ' CZ ' ' HA2' ' A' ' 60' ' ' GLY . 69.2 t80 -129.0 113.49 15.23 Favored 'General case' 0 C--N 1.264 -3.114 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.348 -174.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 6.9 mp0 -116.97 112.26 20.75 Favored 'General case' 0 CA--C 1.502 -0.881 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.227 173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.13 -73.8 1.04 Allowed Glycine 0 CA--C 1.5 -0.871 0 O-C-N 123.582 0.551 . . . . 0.0 111.938 178.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.402 ' HA2' ' CZ ' ' A' ' 57' ' ' TYR . . . -161.26 13.64 0.15 Allowed Glycine 0 C--N 1.298 -1.56 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 177.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.74 143.6 23.1 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 O-C-N 122.531 -0.394 . . . . 0.0 110.273 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' A' ' 56' ' ' SER . 48.4 mm -89.92 133.41 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 121.634 0.73 . . . . 0.0 111.934 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.648 ' O ' ' HA ' ' A' ' 56' ' ' SER . 32.4 m -128.29 152.27 48.32 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 124.327 1.051 . . . . 0.0 108.253 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 53.1 t -119.82 89.03 3.05 Favored 'General case' 0 CA--C 1.495 -1.158 0 C-N-CA 119.401 -0.92 . . . . 0.0 109.453 170.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' HA ' ' NE ' ' A' ' 65' ' ' ARG . 5.0 tpm_? 54.64 21.31 3.36 Favored 'General case' 0 CA--C 1.562 1.427 0 C-N-CA 124.093 0.957 . . . . 0.0 111.001 176.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' H ' HG22 ' A' ' 63' ' ' THR . . . 62.8 100.18 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 111.894 -176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.558 ' HB3' ' S1 ' ' A' ' 113' ' ' FES 0.271 1.5 p-80 -107.69 -13.06 15.12 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 67' ' ' HIS . 1.7 tm? 171.36 -63.26 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 80' ' ' ASN . 28.7 t-105 -141.05 -155.57 0.6 Allowed 'General case' 0 N--CA 1.421 -1.907 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.518 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 28.3 p -101.3 163.54 12.23 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -171.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -110.49 148.05 32.87 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -111.56 108.07 17.45 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.451 ' HB3' HG13 ' A' ' 62' ' ' ILE . 5.6 p-10 -76.8 -29.79 56.15 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.983 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.54 -31.04 73.22 Favored Glycine 0 CA--C 1.501 -0.785 0 N-CA-C 111.576 -0.61 . . . . 0.0 111.576 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 80.9 m -90.52 -52.0 5.12 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 177.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 129.18 -42.16 1.46 Allowed Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.386 -0.912 . . . . 0.0 112.398 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.4 ' CD2' ' HB3' ' A' ' 85' ' ' CYS . 43.1 m80 -87.94 158.81 18.57 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-O 120.828 0.347 . . . . 0.0 110.611 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.75 157.26 52.23 Favored Glycine 0 C--N 1.317 -0.479 0 C-N-CA 120.301 -0.952 . . . . 0.0 110.874 174.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.518 ' HB ' ' O ' ' A' ' 70' ' ' THR . 69.5 mt -84.6 -51.42 13.84 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 117.635 0.718 . . . . 0.0 109.478 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.476 ' HB3' ' HB3' ' A' ' 69' ' ' TRP . 63.7 t30 -160.73 108.47 1.31 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 120.542 -0.463 . . . . 0.0 111.122 178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 6.9 Cg_exo -75.57 -174.86 15.08 Favored 'Cis proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.539 -1.859 . . . . 0.0 110.278 -3.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -73.82 -43.57 58.37 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . 0.326 4.4 p30 38.76 31.53 0.04 OUTLIER 'General case' 0 C--N 1.369 1.424 0 C-N-CA 127.106 2.162 . . . . 0.0 113.828 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 64.5 m 79.13 148.6 0.1 Allowed 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.508 1.923 . . . . 0.0 113.654 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.4 ' HB3' ' CD2' ' A' ' 77' ' ' HIS . 17.7 p -72.9 172.68 10.43 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 114.062 -1.426 . . . . 0.0 113.224 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.2 pp -96.86 -171.1 2.17 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.178 -1.374 . . . . 0.0 111.633 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -130.18 119.24 22.64 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 174.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -95.27 134.02 38.5 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.005 0.431 . . . . 0.0 110.941 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.441 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 12.0 m-85 -102.9 145.67 31.0 Favored Pre-proline 0 C--N 1.305 -1.36 0 C-N-CA 123.616 0.766 . . . . 0.0 109.535 177.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -73.99 120.29 6.28 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.51 2.14 . . . . 0.0 110.413 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -120.01 141.0 42.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -125.53 137.57 53.94 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.9 t -116.83 110.04 30.01 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.609 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -125.22 99.13 5.94 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 121.697 0.76 . . . . 0.0 110.608 -178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.13 -114.37 5.47 Favored Glycine 0 N--CA 1.419 -2.469 0 CA-C-N 114.867 -1.061 . . . . 0.0 111.674 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -94.19 -10.05 34.35 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.216 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -109.68 143.13 39.87 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -173.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 12' ' ' ILE . 59.5 mt -122.37 120.47 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.264 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.953 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.471 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 26.9 m-85 -113.58 149.47 34.46 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.249 -177.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 3' ' ' PHE . 7.4 p -135.45 138.02 48.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.454 177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.591 ' HA ' ' H ' ' A' ' 3' ' ' PHE . 35.3 t -97.99 133.58 42.27 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.826 -177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.4 p -122.3 16.37 10.6 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.157 176.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HE3' ' OG ' ' A' ' 2' ' ' SER . 37.7 ttmt -58.47 -76.31 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.114 0 CA-C-O 121.748 0.785 . . . . 0.0 112.839 -175.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -101.42 20.79 45.39 Favored Glycine 0 C--N 1.263 -3.528 0 N-CA-C 110.213 -1.155 . . . . 0.0 110.213 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 51.0 mm -94.04 120.95 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 CA-C-O 121.502 0.668 . . . . 0.0 111.693 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 52.5 tp -110.07 124.01 34.58 Favored Pre-proline 0 N--CA 1.417 -2.083 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -65.67 137.75 51.21 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 N-CA-C 107.851 -1.634 . . . . 0.0 107.851 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -80.03 175.78 10.33 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -57.15 138.55 54.42 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . -71.26 83.35 0.75 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.601 ' NE2' ' S2 ' ' A' ' 113' ' ' FES . 81.3 m-70 56.42 -91.06 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 114.348 -1.297 . . . . 0.0 112.913 -172.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 38.1 m . . . . . 0 C--N 1.292 -1.893 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.823 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.65 ' S1 ' ' HB3' ' A' ' 48' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.5 -0.953 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 p -79.34 106.05 11.1 Favored 'General case' 0 N--CA 1.429 -1.525 0 CA-C-O 121.327 0.584 . . . . 0.0 110.766 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 99.4 m-85 -90.81 125.47 35.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.889 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -112.72 144.98 41.32 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 99' ' ' TYR . 37.5 ttpt -87.07 128.08 35.11 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 120.557 -0.457 . . . . 0.0 109.842 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.484 HG12 ' CD1' ' A' ' 20' ' ' PHE . 6.5 tp -115.16 -45.05 4.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.227 -178.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 21.7 p -139.71 -173.47 3.64 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-O 121.573 0.701 . . . . 0.0 111.915 -176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.1 m -129.61 150.12 51.08 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.558 -176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.543 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -72.61 -22.91 60.89 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 175.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.72 -21.76 65.29 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 114.499 -1.228 . . . . 0.0 109.457 173.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -93.59 -49.97 5.63 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.193 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 12' ' ' ILE . 47.4 pt -110.85 116.88 53.64 Favored 'Isoleucine or valine' 0 C--O 1.244 0.798 0 CA-C-O 122.135 0.969 . . . . 0.0 111.107 176.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 71.8 m95 -90.36 169.24 11.25 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.447 -1.252 . . . . 0.0 110.758 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.19 117.79 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 CA-C-O 121.353 0.597 . . . . 0.0 110.844 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.23 -7.46 62.15 Favored Glycine 0 C--N 1.313 -0.715 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -103.1 140.47 37.28 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 123.281 0.632 . . . . 0.0 110.188 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.455 ' HB3' HG23 ' A' ' 31' ' ' VAL . 26.9 ptt? -151.03 156.3 40.82 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.406 -0.815 . . . . 0.0 108.874 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -157.5 156.58 32.3 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 123.593 0.558 . . . . 0.0 109.517 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 9.2 t -88.87 137.09 32.63 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-O 121.218 0.532 . . . . 0.0 110.051 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.484 ' CD1' HG12 ' A' ' 6' ' ' ILE . 52.4 p90 -119.94 156.41 30.86 Favored 'General case' 0 N--CA 1.422 -1.875 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 22' ' ' THR . 44.7 tt0 -100.35 135.31 41.98 Favored 'General case' 0 C--N 1.276 -2.615 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.42 ' O ' ' HG2' ' A' ' 21' ' ' GLU . 77.7 p -82.58 171.29 14.23 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 176.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -73.36 -15.49 61.37 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.68 0.752 . . . . 0.0 109.252 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -84.55 -12.59 53.83 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.6 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.45 13.99 36.7 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.827 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 84.8 m -97.08 137.43 36.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 122.142 -0.622 . . . . 0.0 111.989 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -88.85 126.55 35.41 Favored 'General case' 0 C--O 1.25 1.108 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.499 175.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' THR . 60.6 t -130.25 137.7 55.7 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.186 -178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.416 HD21 ' SD ' ' A' ' 17' ' ' MET . 45.5 tp -87.28 114.65 24.08 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.885 -0.784 . . . . 0.0 108.885 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HB ' ' CE2' ' A' ' 20' ' ' PHE . 10.0 tp -97.74 112.7 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.203 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 175.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 17' ' ' MET . 8.2 p -114.12 127.9 71.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.5 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.447 ' ND2' ' HG ' ' A' ' 9' ' ' LEU . 51.2 t-20 -95.45 104.15 16.04 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 36' ' ' HIS . 21.5 m -102.77 150.79 23.12 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.197 176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -76.46 -50.27 14.5 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.242 0.544 . . . . 0.0 110.591 176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -79.68 -46.7 16.65 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.921 -177.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 50.8 m80 -79.11 -21.19 47.0 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.923 0.392 . . . . 0.0 111.185 -176.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.72 -168.68 47.88 Favored Glycine 0 N--CA 1.435 -1.423 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 45.7 t -81.49 120.02 32.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 C-N-CA 119.25 -0.98 . . . . 0.0 108.722 177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -118.63 149.33 41.56 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 123.602 0.761 . . . . 0.0 111.201 -176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.91 112.69 16.91 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.458 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 88' ' ' GLU . 49.7 m-85 -125.57 159.84 31.08 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.484 ' OE1' ' HB3' ' A' ' 110' ' ' ALA . 35.4 tt0 -53.77 138.33 35.87 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.92 -12.39 59.73 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 -167.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.445 ' HB3' HG12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.8 166.79 31.15 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 118.152 -1.419 . . . . 0.0 114.086 -175.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.708 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 18.9 m -88.79 166.52 22.06 Favored Pre-proline 0 N--CA 1.431 -1.403 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 176.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -82.07 31.41 0.52 Allowed 'Trans proline' 0 CA--C 1.554 1.48 0 C-N-CA 121.73 1.62 . . . . 0.0 112.723 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.674 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 14.1 m170 -120.34 -75.34 0.59 Allowed 'General case' 0 C--N 1.342 0.276 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.191 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.477 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 15.5 mm100 -93.96 -177.62 4.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.488 0.661 . . . . 0.0 112.622 -174.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -74.32 163.24 28.04 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.114 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 44' ' ' MET . 29.8 mt -74.94 87.29 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 121.44 0.638 . . . . 0.0 110.438 -176.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.434 ' HB3' ' NH1' ' A' ' 65' ' ' ARG . 85.0 mt -106.39 1.49 25.73 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.516 178.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.8 tt -76.23 -41.72 48.32 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.925 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.6 p -67.75 -7.39 26.92 Favored 'General case' 0 CA--C 1.55 0.98 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -174.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.48 -9.19 50.99 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 122.655 0.382 . . . . 0.0 111.536 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.24 115.37 1.33 Allowed Glycine 0 CA--C 1.495 -1.167 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 63' ' ' THR . 72.0 m -161.41 -25.02 0.05 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.907 0.861 . . . . 0.0 110.867 -175.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 94.5 t80 -89.05 115.53 26.66 Favored 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.181 -178.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -116.15 104.5 11.6 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.681 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.91 -72.85 0.53 Allowed Glycine 0 C--N 1.316 -0.53 0 O-C-N 123.899 0.749 . . . . 0.0 113.504 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.16 17.43 1.18 Allowed Glycine 0 N--CA 1.438 -1.22 0 N-CA-C 111.988 -0.445 . . . . 0.0 111.988 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 57' ' ' TYR . 62.9 t -123.11 132.01 72.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 62' ' ' ILE . 1.8 mp -98.1 129.17 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 36.3 m -106.74 151.79 24.67 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 66' ' ' ALA . 8.0 t -75.15 -40.31 59.73 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 119.135 -1.026 . . . . 0.0 109.22 172.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' H ' HG22 ' A' ' 63' ' ' THR . 1.1 tmt_? 75.93 -21.87 0.29 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.495 1.118 . . . . 0.0 110.939 178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . -96.56 -23.45 16.51 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 116.134 -0.484 . . . . 0.0 109.927 173.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.801 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 22.3 m170 -146.88 152.46 38.74 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 123.305 0.642 . . . . 0.0 112.069 176.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.412 ' HB3' ' CG ' ' A' ' 80' ' ' ASN 0.278 2.2 tm? 36.94 -107.21 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 127.85 2.46 . . . . 0.0 113.602 175.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.568 ' O ' ' HA ' ' A' ' 63' ' ' THR . 94.9 m95 -163.7 -51.36 0.03 OUTLIER 'General case' 0 C--O 1.205 -1.289 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -174.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.6 p -107.71 130.64 54.92 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 118.842 2.904 . . . . 0.0 118.842 -160.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -134.1 137.49 44.63 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 167.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -122.98 114.84 20.96 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.961 178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -65.64 -29.67 70.28 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.11 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.91 -3.6 74.74 Favored Glycine 0 C--O 1.221 -0.682 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.894 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 38.4 m -124.22 1.26 8.47 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.666 0.746 . . . . 0.0 109.66 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 71.83 -49.06 1.08 Allowed Glycine 0 C--N 1.344 1.003 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.536 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 85' ' ' CYS . 25.8 p80 -88.84 160.91 17.01 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 121.219 0.533 . . . . 0.0 111.719 -178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.526 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.13 169.99 35.49 Favored Glycine 0 N--CA 1.42 -2.375 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.923 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.0 mp -90.61 -31.34 5.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 3.2 p-10 -127.27 101.92 24.5 Favored Pre-proline 0 N--CA 1.42 -1.939 0 CA-C-N 113.716 -1.584 . . . . 0.0 108.883 173.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.523 ' HG2' ' SG ' ' A' ' 84' ' ' CYS . 22.7 Cg_endo -89.62 155.23 31.62 Favored 'Cis proline' 0 C--N 1.362 1.282 0 C-N-CA 124.576 -1.01 . . . . 0.0 110.864 -4.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.526 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.9 p-10 -74.4 -19.26 60.49 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -87.83 -22.07 24.69 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.248 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.523 ' SG ' ' HG2' ' A' ' 81' ' ' PRO . 65.3 m -95.82 150.91 19.89 Favored 'General case' 0 N--CA 1.414 -2.262 0 CA-C-O 121.79 0.805 . . . . 0.0 110.577 -175.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 77' ' ' HIS . 17.6 p -142.08 167.85 21.14 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.941 -177.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.462 HD22 ' HB3' ' A' ' 42' ' ' GLN . 81.2 mt -120.98 129.18 53.31 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 179.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.44 ' HB3' ' HA ' ' A' ' 107' ' ' PRO . . . -88.87 136.51 32.97 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -104.42 158.52 16.42 Favored 'General case' 0 N--CA 1.425 -1.676 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.277 175.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.499 ' HB2' ' HD2' ' A' ' 90' ' ' PRO . 19.1 p90 -135.39 157.73 75.95 Favored Pre-proline 0 C--N 1.273 -2.751 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.508 172.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 89' ' ' TYR . 37.5 Cg_endo -61.27 138.58 78.11 Favored 'Trans proline' 0 C--O 1.256 1.414 0 C-N-CA 122.545 2.163 . . . . 0.0 114.03 -174.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.14 128.99 70.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.831 0 CA-C-N 114.731 -1.122 . . . . 0.0 109.54 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -109.98 131.66 54.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.99 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.1 t -115.67 120.77 65.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.1 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -122.75 91.34 3.47 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.95 -112.11 4.68 Favored Glycine 0 N--CA 1.436 -1.359 0 C-N-CA 119.877 -1.154 . . . . 0.0 111.573 -177.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -98.26 -5.44 33.13 Favored 'General case' 0 C--O 1.186 -2.274 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.714 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -103.21 137.05 41.88 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.685 0.278 . . . . 0.0 110.569 -176.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 81.6 mt -127.61 123.4 61.29 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 -176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 5.0 m-85 -112.01 142.08 44.87 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.834 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.96 154.71 40.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 28.3 t -127.9 114.6 17.39 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.345 178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.8 t -108.76 -8.05 15.44 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -75.63 102.51 5.36 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.72 -29.28 4.99 Favored Glycine 0 N--CA 1.432 -1.607 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.6 mt -120.63 108.35 22.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 CA-C-O 121.447 0.641 . . . . 0.0 110.319 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 3.0 pp -89.08 147.92 39.73 Favored Pre-proline 0 N--CA 1.415 -2.209 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HA ' ' HB3' ' A' ' 87' ' ' ALA . 12.6 Cg_exo -69.78 140.96 43.87 Favored 'Trans proline' 0 C--O 1.243 0.745 0 C-N-CA 122.059 1.84 . . . . 0.0 112.298 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -88.31 133.05 34.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 50.3 -176.89 0.02 OUTLIER 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.484 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . . . 57.53 -82.35 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.255 1.422 . . . . 0.0 113.069 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -138.18 103.28 4.89 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.422 -1.842 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.145 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.801 ' S2 ' ' HB2' ' A' ' 67' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ttt . . . . . 0 CA--C 1.515 -0.382 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 65.3 p -95.18 -52.92 3.99 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 -171.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.422 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 69.9 m-85 73.54 108.21 0.07 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 121.505 0.669 . . . . 0.0 109.842 -168.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -106.57 137.36 44.72 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -73.84 121.32 20.71 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.532 -0.867 . . . . 0.0 108.876 173.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.3 tp -97.51 -48.52 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.488 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.357 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.7 m -159.23 -174.55 4.76 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.386 -177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -129.77 152.67 49.01 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.484 HD12 ' O ' ' A' ' 12' ' ' ILE . 27.5 tp -56.66 -21.22 25.95 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.184 1.393 . . . . 0.0 110.624 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -61.76 -30.97 71.14 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.261 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -100.18 -40.87 7.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.388 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.484 ' O ' HD12 ' A' ' 9' ' ' LEU . 3.4 tp -104.96 115.43 46.83 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.642 0 CA-C-O 121.533 0.682 . . . . 0.0 110.934 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 43.9 m95 -102.99 164.75 11.43 Favored 'General case' 0 C--N 1.299 -1.629 0 CA-C-N 114.986 -1.007 . . . . 0.0 112.469 -172.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.9 p -68.67 127.57 30.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.491 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.64 -0.81 68.1 Favored Glycine 0 N--CA 1.437 -1.256 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.92 154.13 29.27 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 25.7 ptt? -146.15 131.06 18.14 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.727 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.591 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 44.1 mt-10 -144.22 150.52 38.09 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.501 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 93.7 m -74.42 130.97 40.64 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.993 0.425 . . . . 0.0 111.124 177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -140.71 149.8 42.64 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.25 146.88 34.87 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-O 120.642 0.258 . . . . 0.0 110.359 178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.3 p -83.72 165.29 19.02 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 33.9 m -65.59 -14.03 60.29 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.006 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -88.89 -12.48 41.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.444 0.64 . . . . 0.0 110.137 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.75 23.41 13.76 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.902 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.5 m -97.09 127.92 43.53 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -88.07 123.28 32.6 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.1 t -134.09 143.75 37.4 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 121.165 0.507 . . . . 0.0 110.378 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.47 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 60.0 tp -93.01 112.86 24.96 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 174.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.515 ' O ' ' HA ' ' A' ' 17' ' ' MET . 49.6 mm -94.73 112.04 26.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -179.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.439 HG13 ' HB3' ' A' ' 17' ' ' MET . 41.9 t -112.66 124.75 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.094 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 -177.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 54.0 t30 -103.83 104.93 14.99 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 170.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 14.0 m -83.77 143.21 30.13 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.454 -172.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.3 -47.08 29.54 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -83.14 -44.13 15.42 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.1 m80 -101.88 2.92 38.67 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -169.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 86.73 -176.95 48.09 Favored Glycine 0 C--O 1.201 -1.937 0 C-N-CA 119.5 -1.333 . . . . 0.0 110.931 -178.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 9.3 p -72.39 134.65 29.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 118.274 1.037 . . . . 0.0 111.553 -178.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -125.7 139.01 53.9 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 123.774 0.83 . . . . 0.0 110.501 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.06 115.25 20.22 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 176.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.415 ' OH ' HG12 ' A' ' 62' ' ' ILE . 18.6 p90 -143.27 165.11 28.37 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 118.571 -0.728 . . . . 0.0 111.082 178.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -41.19 137.4 1.37 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 123.756 0.66 . . . . 0.0 111.818 -175.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HB1' HG23 ' A' ' 19' ' ' THR . . . -71.29 -46.77 60.04 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 121.287 0.565 . . . . 0.0 112.524 -176.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 69.8 mtm -94.25 147.07 23.55 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.17 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.557 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 28.9 p -94.82 161.87 27.18 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 123.777 0.673 . . . . 0.0 111.258 -175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' HB2' ' A' ' 45' ' ' CYS . 57.0 Cg_endo -71.2 -4.75 15.54 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.499 2.132 . . . . 0.0 111.914 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.446 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 36.3 m80 -88.74 -96.9 0.09 Allowed 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.312 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -179.3 104.59 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.404 0 CA-C-N 117.911 0.323 . . . . 0.0 110.579 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 6.5 tp10 -171.97 145.8 1.9 Allowed 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.177 0.513 . . . . 0.0 111.375 176.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.8 pt -118.58 141.67 37.04 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.4 tp 65.77 24.03 11.45 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 122.672 1.225 . . . . 0.0 109.129 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.2 pt? -62.04 -20.54 64.06 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 114.141 -1.391 . . . . 0.0 111.289 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 36.0 p -56.92 -32.53 66.05 Favored 'General case' 0 N--CA 1.415 -2.18 0 C-N-CA 125.965 1.706 . . . . 0.0 113.832 -173.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -100.66 23.12 10.86 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.989 -0.445 . . . . 0.0 110.962 -175.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -55.75 -83.61 0.04 OUTLIER Glycine 0 C--N 1.346 1.113 0 N-CA-C 111.917 -0.473 . . . . 0.0 111.917 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.431 ' OG ' ' HB ' ' A' ' 63' ' ' THR . 19.0 p -173.49 146.89 1.4 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -129.75 115.62 17.56 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.703 176.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -116.98 105.8 12.72 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.489 -178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 69.36 -72.89 0.44 Allowed Glycine 0 N--CA 1.462 0.429 0 O-C-N 123.489 0.493 . . . . 0.0 114.206 175.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 73' ' ' ASP . . . -153.21 17.95 0.7 Allowed Glycine 0 C--N 1.301 -1.366 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.1 t -125.12 124.92 68.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 C-N-CA 122.789 0.436 . . . . 0.0 110.05 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.415 HG12 ' OH ' ' A' ' 41' ' ' TYR . 2.0 pp -92.76 140.26 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HB ' ' OG ' ' A' ' 56' ' ' SER . 89.9 m -116.44 127.05 54.25 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 42.2 t -71.19 156.31 39.71 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.469 ' O ' ' HD3' ' A' ' 65' ' ' ARG . 1.8 tmt_? -73.34 -33.08 64.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.783 -176.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.677 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . . . -83.08 -72.32 0.46 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.308 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.479 ' CD2' ' HB2' ' A' ' 69' ' ' TRP . 0.5 OUTLIER -82.66 110.26 17.56 Favored 'General case' 0 CA--C 1.561 1.401 0 C-N-CA 118.802 -1.159 . . . . 0.0 109.132 175.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.5 mp -85.08 84.83 7.57 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.02 0.438 . . . . 0.0 111.356 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.479 ' HB2' ' CD2' ' A' ' 67' ' ' HIS . 86.9 m95 -144.3 -166.55 2.4 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 24.4 p -101.66 136.65 41.15 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-O 121.955 0.883 . . . . 0.0 112.268 -173.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.481 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 47.4 t80 -134.06 143.19 47.9 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -82.99 111.87 19.24 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.348 0.594 . . . . 0.0 111.33 -173.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 60' ' ' GLY . 16.3 t70 -71.41 -11.81 61.08 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.418 1.487 . . . . 0.0 112.012 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -96.51 -33.76 6.06 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.717 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 59.6 p -107.24 -26.14 11.19 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 117.436 0.618 . . . . 0.0 112.638 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.17 13.87 65.32 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 -175.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -106.76 146.39 30.91 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -76.64 153.25 42.17 Favored Glycine 0 C--N 1.308 -1.026 0 C-N-CA 119.96 -1.114 . . . . 0.0 112.517 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.95 -49.25 12.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 174.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 8.2 t30 -146.55 111.71 4.26 Favored Pre-proline 0 N--CA 1.436 -1.153 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.415 174.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 4.8 Cg_exo -78.74 141.61 64.64 Favored 'Cis proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.962 -1.683 . . . . 0.0 111.004 -1.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.1 p30 -74.66 -12.48 60.45 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.407 0.622 . . . . 0.0 109.627 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -60.87 -28.53 68.93 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.736 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 36.9 m -92.72 152.15 19.67 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-O 121.563 0.696 . . . . 0.0 111.002 -176.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.454 ' C ' HD12 ' A' ' 86' ' ' LEU . 5.9 p -163.27 156.13 18.75 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.045 176.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.481 HD13 ' CZ ' ' A' ' 71' ' ' PHE . 7.3 mp -129.45 135.16 48.31 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 125.289 1.436 . . . . 0.0 107.868 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.9 123.92 29.85 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 122.726 0.411 . . . . 0.0 109.972 -175.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -86.64 143.94 27.39 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.222 0.534 . . . . 0.0 111.086 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 101' ' ' SER . 46.2 m-85 -102.37 143.32 26.37 Favored Pre-proline 0 N--CA 1.428 -1.55 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -59.04 123.01 12.56 Favored 'Trans proline' 0 C--O 1.253 1.242 0 C-N-CA 122.329 2.019 . . . . 0.0 110.264 173.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.2 p -123.87 132.96 70.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.489 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -112.57 117.21 31.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.447 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -110.56 107.56 23.23 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-O 122.026 0.917 . . . . 0.0 109.69 175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.545 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -127.69 118.16 23.3 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.43 -119.93 9.75 Favored Glycine 0 N--CA 1.427 -1.965 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -175.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -108.96 -4.45 16.71 Favored 'General case' 0 C--O 1.17 -3.086 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 94' ' ' LYS . 17.0 t70 -100.03 139.28 35.92 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.697 -0.627 . . . . 0.0 110.089 -170.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.2 mt -127.63 119.12 51.07 Favored 'Isoleucine or valine' 0 C--O 1.251 1.173 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -174.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.422 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 63.4 m-85 -102.72 146.23 28.52 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.71 172.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.63 137.23 54.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.464 ' O ' ' HB3' ' A' ' 89' ' ' TYR . 20.4 t -107.35 113.26 26.52 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.446 -1.702 . . . . 0.0 109.296 178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.4 p -95.96 -36.43 11.07 Favored 'General case' 0 N--CA 1.417 -2.117 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.93 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -66.3 113.26 4.47 Favored 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.112 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 126.26 -36.14 2.78 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 105' ' ' ILE . 2.7 mp -100.89 120.82 50.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.436 ' HA ' ' HD2' ' A' ' 107' ' ' PRO . 3.5 tt -79.92 124.1 83.35 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 106' ' ' LEU . 9.4 Cg_endo -52.96 145.58 40.51 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 123.006 2.471 . . . . 0.0 111.994 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -80.43 177.61 8.87 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -57.69 -11.89 2.5 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -174.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.468 ' CB ' ' HG ' ' A' ' 86' ' ' LEU . . . -57.37 -36.19 70.91 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.996 177.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -108.64 102.83 11.85 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 120.569 -0.452 . . . . 0.0 109.863 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.29 -1.997 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 177.704 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.677 ' S1 ' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.274 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m 59.24 84.76 0.11 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.404 0.682 . . . . 0.0 109.232 -176.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.402 ' CE1' ' HB2' ' A' ' 92' ' ' GLU . 75.0 m-85 67.22 100.25 0.05 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.464 -169.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -106.9 130.53 54.55 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.815 -175.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 0.6 OUTLIER -70.17 115.64 9.6 Favored 'General case' 0 CA--C 1.475 -1.936 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.1 mm -95.62 -59.59 3.06 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.205 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.194 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 11' ' ' ASP . 85.6 m -152.21 -177.29 6.09 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.353 -175.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 8.7 p -101.02 153.52 19.47 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 114.304 -1.316 . . . . 0.0 109.588 175.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.43 -17.52 21.33 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.847 0.832 . . . . 0.0 110.673 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -82.4 -10.84 58.9 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.583 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 33.2 t70 -97.7 -41.46 8.09 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.687 -0.633 . . . . 0.0 109.358 177.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.44 HG23 HD12 ' A' ' 98' ' ' ILE . 2.3 tp -109.95 114.13 46.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.415 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -101.05 166.96 10.54 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.619 -1.173 . . . . 0.0 112.503 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.44 128.83 35.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.496 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.3 -7.89 66.7 Favored Glycine 0 N--CA 1.442 -0.965 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -103.87 144.14 31.9 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.172 -0.514 . . . . 0.0 110.127 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.4 134.0 39.24 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.669 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 9.2 pt-20 -157.63 156.21 31.41 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 15.1 t -90.51 137.7 32.14 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.415 ' CZ ' ' HG3' ' A' ' 18' ' ' GLU . 77.3 m-85 -126.41 155.94 41.37 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 26' ' ' THR . 40.9 tt0 -113.95 141.49 47.32 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -83.18 172.76 12.3 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 19.5 m -68.86 -20.17 64.27 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.131 0.491 . . . . 0.0 110.424 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -83.97 -12.25 55.6 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.479 0.657 . . . . 0.0 109.526 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.39 24.95 14.82 Favored Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.109 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' GLU . 14.5 m -92.19 124.31 36.17 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -88.77 128.97 35.64 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 175.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 19' ' ' THR . 40.0 t -133.03 141.2 45.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.031 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.18 116.43 28.83 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.8 mp -105.58 122.83 59.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 C-N-CA 122.327 0.251 . . . . 0.0 110.355 -178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -114.99 123.61 70.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.52 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 50.7 t30 -103.12 106.41 16.92 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.837 173.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -98.81 148.67 23.67 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.511 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -62.95 -48.85 77.1 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 122.957 0.503 . . . . 0.0 111.8 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -98.26 -40.33 8.4 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.95 0.405 . . . . 0.0 111.979 -175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -79.69 -11.42 59.85 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 120.888 0.375 . . . . 0.0 111.213 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 84.63 -167.33 42.47 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.042 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.52 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 6.7 p -99.05 118.05 45.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-O 121.535 0.683 . . . . 0.0 109.333 -178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -131.98 151.16 51.9 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.162 -176.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.05 143.27 45.7 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.569 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.609 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 63.9 m-85 -133.28 157.6 45.04 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -59.11 139.22 57.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.187 175.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.21 -7.29 58.07 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.336 0.589 . . . . 0.0 110.252 -179.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -92.79 99.76 12.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.618 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' HIS . 59.0 m -76.71 158.8 80.33 Favored Pre-proline 0 C--N 1.302 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.517 ' HA ' ' OG ' ' A' ' 112' ' ' SER . 92.8 Cg_endo -82.92 20.78 1.1 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 121.718 1.612 . . . . 0.0 108.883 172.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.62 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 36.9 m80 -120.1 -175.12 2.92 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.778 -175.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -65.98 103.72 0.99 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 123.265 0.353 . . . . 0.0 111.039 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -83.73 156.6 22.5 Favored 'General case' 0 N--CA 1.434 -1.227 0 CA-C-O 121.633 0.73 . . . . 0.0 111.807 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.647 HG13 ' H ' ' A' ' 51' ' ' LEU . 9.8 tp -179.99 -156.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 N-CA-C 101.297 -3.594 . . . . 0.0 101.297 -174.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.647 ' H ' HG13 ' A' ' 50' ' ' ILE . 2.9 mm? -78.01 91.68 4.27 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 121.118 1.781 . . . . 0.0 109.738 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.582 HD22 ' O ' ' A' ' 50' ' ' ILE . 2.0 mm? -73.36 -20.98 60.64 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.776 1.274 . . . . 0.0 108.156 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.669 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 60.0 p -63.4 -19.49 64.72 Favored 'General case' 0 N--CA 1.408 -2.542 0 CA-C-N 112.573 -2.103 . . . . 0.0 111.921 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -102.62 12.24 36.65 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.742 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.74 -108.41 0.03 OUTLIER Glycine 0 C--O 1.241 0.566 0 O-C-N 123.324 0.39 . . . . 0.0 113.033 -178.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.3 t -146.14 154.07 41.39 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-O 121.915 0.864 . . . . 0.0 112.299 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -128.78 114.63 16.81 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.205 -1.816 . . . . 0.0 108.153 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.503 ' HB2' ' HB ' ' A' ' 61' ' ' VAL . 42.4 mt-10 -118.14 169.9 9.31 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.27 74.39 0.14 Allowed Glycine 0 C--N 1.309 -0.932 0 O-C-N 123.309 0.381 . . . . 0.0 113.799 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.02 0.18 38.68 Favored Glycine 0 C--N 1.306 -1.117 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 177.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 58' ' ' GLU . 79.7 t -123.96 119.27 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -177.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' HB ' ' CZ ' ' A' ' 71' ' ' PHE . 42.6 mm -112.58 138.26 42.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 67.4 m -118.08 115.72 25.41 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.33 -72.71 0.41 Allowed 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.887 177.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -149.02 -63.42 0.23 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 119.0 -1.08 . . . . 0.0 113.597 172.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' N ' ' S1 ' ' A' ' 113' ' ' FES . . . -144.66 139.36 27.96 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -169.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 13.5 p-80 162.32 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.931 2.092 . . . . 0.0 107.575 174.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 51.6 tp 172.59 -71.7 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 125.569 1.548 . . . . 0.0 108.983 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 15.5 t90 -176.92 -49.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.059 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p -103.53 136.48 43.17 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 116.82 2.156 . . . . 0.0 116.82 -169.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.563 ' HA ' ' HA2' ' A' ' 78' ' ' GLY . 22.5 p90 -135.16 142.7 46.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 103.266 -2.865 . . . . 0.0 103.266 159.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -86.84 122.87 31.32 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 118.737 -1.185 . . . . 0.0 112.322 -171.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -65.25 -38.41 90.24 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.793 177.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.18 26.58 3.83 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.002 -178.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.0 m -155.33 -51.28 0.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.819 0.31 . . . . 0.0 110.816 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.82 -18.64 40.05 Favored Glycine 0 C--O 1.218 -0.844 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -85.75 139.16 31.57 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 124.835 1.254 . . . . 0.0 108.887 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.563 ' HA2' ' HA ' ' A' ' 71' ' ' PHE . . . -68.53 140.34 35.02 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 176.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 60.0 mt -81.16 -51.65 15.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -178.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 50.3 t-20 -150.23 113.88 3.32 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.6 Cg_exo -81.3 179.25 28.66 Favored 'Cis proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.858 -1.726 . . . . 0.0 111.412 -3.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -95.93 12.23 31.05 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.401 ' O ' ' HE3' ' A' ' 109' ' ' LYS . 34.8 t70 -67.73 -14.66 63.14 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.397 -178.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.442 ' SG ' ' S2 ' ' A' ' 113' ' ' FES . 23.6 p -136.89 152.21 49.97 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 121.5 0.667 . . . . 0.0 111.543 176.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 31.1 m -152.17 146.11 25.22 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 5.9 mp -102.79 153.67 19.94 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-O 120.984 0.421 . . . . 0.0 110.784 -176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.638 ' HB2' ' H ' ' A' ' 108' ' ' ASN . . . -88.19 119.54 28.69 Favored 'General case' 0 CA--C 1.477 -1.828 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.738 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -81.48 129.98 34.87 Favored 'General case' 0 C--N 1.293 -1.889 0 O-C-N 123.732 0.645 . . . . 0.0 109.537 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -109.11 136.25 20.12 Favored Pre-proline 0 C--N 1.296 -1.747 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.432 ' HG2' ' HB3' ' A' ' 101' ' ' SER . 37.3 Cg_endo -68.37 124.3 11.5 Favored 'Trans proline' 0 C--O 1.249 1.074 0 C-N-CA 122.548 2.165 . . . . 0.0 112.304 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 57.8 t -106.86 138.58 31.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' HB2' ' CE1' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -119.58 135.82 54.63 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 178.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.426 ' C ' ' HE2' ' A' ' 94' ' ' LYS . 58.7 t -106.21 122.52 60.04 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.483 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -167.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.626 ' HD3' ' CD1' ' A' ' 99' ' ' TYR . 0.0 OUTLIER -111.36 146.35 37.28 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.014 -2.217 . . . . 0.0 105.014 173.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -48.71 -35.6 17.16 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 115.61 1.004 . . . . 0.0 115.61 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' SER . 25.4 t70 -113.7 -22.7 10.1 Favored 'General case' 0 C--N 1.28 -2.454 0 C-N-CA 121.363 -0.135 . . . . 0.0 110.778 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -114.87 147.65 39.62 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.136 0.969 . . . . 0.0 113.422 -172.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.44 HD12 HG23 ' A' ' 12' ' ' ILE . 62.7 mt -121.71 118.16 54.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.788 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.626 ' CD1' ' HD3' ' A' ' 94' ' ' LYS . 4.5 m-85 -112.2 144.11 42.14 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.96 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -137.78 141.31 39.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 176.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 90' ' ' PRO . 21.4 t -104.15 128.17 51.8 Favored 'General case' 0 C--N 1.282 -2.341 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.518 -177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 22.2 p -120.56 5.55 10.6 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.116 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.423 ' HD3' ' C ' ' A' ' 103' ' ' LYS . 0.6 OUTLIER -74.99 118.39 17.89 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.734 -174.86 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 74.03 16.09 79.64 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.399 -0.819 . . . . 0.0 113.142 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 66.1 mt -108.26 119.51 57.97 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.255 0.55 . . . . 0.0 110.957 -176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 5.6 mp -85.88 142.68 36.82 Favored Pre-proline 0 N--CA 1.411 -2.387 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.363 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -64.38 150.08 88.93 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 122.468 2.112 . . . . 0.0 111.166 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.638 ' H ' ' HB2' ' A' ' 87' ' ' ALA . 34.9 t-20 -81.41 -179.77 7.51 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.401 ' HE3' ' O ' ' A' ' 83' ' ' ASP . 39.2 ttpt -62.42 93.91 0.05 Allowed 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 122.41 1.1 . . . . 0.0 111.521 -178.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 174.44 -149.46 0.01 OUTLIER 'General case' 0 C--N 1.267 -3.019 0 C-N-CA 128.274 2.63 . . . . 0.0 104.471 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 49.6 t-80 51.66 88.15 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 118.898 0.772 . . . . 0.0 112.32 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.517 ' OG ' ' HA ' ' A' ' 46' ' ' PRO . 24.7 p . . . . . 0 C--N 1.298 -1.67 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.676 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.483 ' S1 ' ' N ' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 120.631 0.253 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.1 t -80.06 85.17 5.67 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 121.126 0.489 . . . . 0.0 109.95 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -156.95 97.81 1.71 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 125.979 1.712 . . . . 0.0 107.252 176.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.87 133.47 52.18 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.41 127.39 32.11 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -108.22 -40.94 5.01 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.403 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.721 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 23.9 p -160.34 -170.88 2.96 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.768 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 7.2 m -120.15 153.07 36.74 Favored 'General case' 0 C--N 1.289 -2.038 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.348 178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.561 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.1 tt -61.58 -21.4 64.28 Favored 'General case' 0 CA--C 1.555 1.173 0 CA-C-O 121.846 0.831 . . . . 0.0 108.924 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -60.86 -29.63 69.64 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.266 174.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -68.96 -47.55 65.35 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.607 176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 25.5 pt -124.83 112.27 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 CA-C-O 122.734 1.254 . . . . 0.0 113.529 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.5 m95 -79.16 170.54 16.5 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.786 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.9 m -61.34 118.79 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 CA-C-O 121.602 0.715 . . . . 0.0 110.451 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.26 5.97 56.9 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.682 -176.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -103.22 150.45 23.69 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.563 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.8 ptt? -150.12 137.92 20.06 Favored 'General case' 0 CA--C 1.495 -1.139 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.588 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 34.7 mt-10 -144.2 155.11 43.75 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 175.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 m -91.42 123.97 35.25 Favored 'General case' 0 N--CA 1.419 -2.004 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -120.01 154.32 34.72 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -113.54 137.35 51.68 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -83.0 173.3 11.9 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 43.7 m -71.94 -9.35 58.23 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.159 0.505 . . . . 0.0 111.669 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -94.74 -4.74 46.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.36 176.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.94 18.17 44.81 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.628 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.9 m -89.86 114.79 26.61 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -91.58 123.83 35.28 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.409 HG11 ' HB1' ' A' ' 40' ' ' ALA . 58.7 t -136.49 142.49 38.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.027 -172.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . 32.9 tp -83.61 117.62 23.28 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -107.87 113.62 44.26 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.2 p -110.87 137.31 43.85 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.711 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 34.2 t30 -109.97 107.8 17.82 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 41.3 t -99.2 148.51 24.03 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.031 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -74.99 -36.16 62.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -95.24 -46.75 6.62 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.793 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 42.4 m-70 -88.51 -7.01 57.22 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.73 -164.9 52.22 Favored Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.202 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 36.8 t -82.82 128.99 38.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 71.8 mmtt -127.9 141.52 51.53 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 123.483 0.713 . . . . 0.0 111.197 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.409 ' HB1' HG11 ' A' ' 28' ' ' VAL . . . -125.07 121.26 33.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.913 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.434 ' CD1' HD22 ' A' ' 86' ' ' LEU . 53.6 m-85 -133.04 152.1 51.99 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -48.96 138.06 12.06 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.615 ' O ' HD12 ' A' ' 52' ' ' LEU . . . -141.17 19.12 2.26 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 -172.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 86.3 mtp -68.97 -30.56 69.01 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -174.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.811 ' SG ' ' N ' ' A' ' 65' ' ' ARG . 3.5 t -76.48 124.09 87.88 Favored Pre-proline 0 CA--C 1.619 3.603 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.711 ' C ' ' HA ' ' A' ' 65' ' ' ARG . 12.6 Cg_endo -108.71 104.83 0.02 OUTLIER 'Trans proline' 2 C--N 1.421 4.375 0 C-N-CA 123.922 3.081 . . . . 0.0 113.145 163.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.938 ' CE1' ' H ' ' A' ' 67' ' ' HIS . 6.4 t60 -81.26 -25.8 36.3 Favored 'General case' 0 N--CA 1.523 3.212 0 O-C-N 121.363 -0.835 . . . . 0.0 109.882 -173.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -105.32 111.94 24.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 168.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . 0.306 10.9 pt-20 -74.14 83.46 1.82 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 122.791 1.282 . . . . 0.0 114.256 -174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.618 HG12 ' H ' ' A' ' 51' ' ' LEU . 15.1 tt -152.74 -159.5 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 N-CA-C 102.388 -3.189 . . . . 0.0 102.388 178.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.618 ' H ' HG12 ' A' ' 50' ' ' ILE . 84.9 mt -64.06 122.55 16.82 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 120.752 1.615 . . . . 0.0 109.301 175.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.615 HD12 ' O ' ' A' ' 43' ' ' ALA . 1.4 pt? -56.0 -44.76 78.94 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 124.409 1.084 . . . . 0.0 113.713 -172.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.588 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 38.2 p -63.54 -24.26 67.73 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 123.422 0.689 . . . . 0.0 112.516 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -84.31 3.16 36.89 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 63' ' ' THR . . . -139.85 36.64 1.8 Allowed Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 119.737 -1.22 . . . . 0.0 113.066 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.456 ' H ' ' HE1' ' A' ' 17' ' ' MET . 19.3 m -107.14 -80.39 0.57 Allowed 'General case' 0 N--CA 1.418 -2.069 0 CA-C-O 121.351 0.596 . . . . 0.0 111.425 -178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.563 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 80.7 t80 -90.39 112.73 24.44 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-O 121.84 0.829 . . . . 0.0 110.684 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -118.51 105.41 11.62 Favored 'General case' 0 N--CA 1.433 -1.31 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.524 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.08 -77.28 0.56 Allowed Glycine 0 N--CA 1.45 -0.395 0 O-C-N 123.384 0.427 . . . . 0.0 112.424 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.22 6.56 0.82 Allowed Glycine 0 C--N 1.298 -1.546 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.7 t -109.66 135.16 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.489 ' O ' ' HB3' ' A' ' 71' ' ' PHE . 69.1 mt -105.68 129.95 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 CA-C-O 121.347 0.594 . . . . 0.0 109.763 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.467 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 9.1 m -111.2 152.5 27.01 Favored 'General case' 0 N--CA 1.38 -3.951 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 1.555 ' CA ' ' CB ' ' A' ' 64' ' ' CYS 0.473 15.0 p -118.32 -112.49 0.34 Allowed 'General case' 2 CA--C 1.789 10.154 0 C-N-CA 128.179 2.591 . . . . 0.0 106.829 179.1 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.836 ' HA ' ' N ' ' A' ' 47' ' ' HIS . 37.2 ttm105 -122.29 -161.89 0.96 Allowed 'General case' 3 N--CA 1.652 9.667 1 C-N-CA 137.532 6.333 . . . . 0.0 107.513 170.359 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.748 ' H ' ' HG2' ' A' ' 65' ' ' ARG . . . -55.95 100.38 0.04 OUTLIER 'General case' 2 N--CA 1.557 4.891 1 N-CA-C 122.168 4.136 . . . . 0.0 122.168 -166.922 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.938 ' H ' ' CE1' ' A' ' 47' ' ' HIS 0.373 53.7 m80 -96.1 -170.47 2.12 Favored 'General case' 1 N--CA 1.543 4.186 0 C-N-CA 129.863 3.265 . . . . 0.0 106.597 170.21 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.9 tt -145.06 8.94 1.25 Allowed 'General case' 0 CA--C 1.573 1.857 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 163.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.735 ' H ' ' HB3' ' A' ' 67' ' ' HIS . 28.8 m-90 -146.32 -159.96 1.09 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.7 2.0 . . . . 0.0 107.822 -176.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -124.26 161.98 24.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -175.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.706 ' HB2' ' HE2' ' A' ' 67' ' ' HIS . 11.8 t80 -119.48 142.47 48.25 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 176.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -119.33 140.61 50.04 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 118.656 -1.218 . . . . 0.0 114.214 -172.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.488 ' HB2' HG13 ' A' ' 62' ' ' ILE . 7.0 t70 -75.28 -53.91 7.98 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.647 1.179 . . . . 0.0 112.463 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.54 95.73 Favored Glycine 0 CA--C 1.503 -0.658 0 O-C-N 123.702 0.626 . . . . 0.0 112.789 -175.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.6 m -79.46 -30.86 42.34 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 85' ' ' CYS . . . 66.8 41.84 93.37 Favored Glycine 0 CA--C 1.488 -1.629 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -178.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.446 ' HD2' ' O ' ' A' ' 78' ' ' GLY . 12.1 t60 -160.03 150.52 18.73 Favored 'General case' 0 N--CA 1.417 -2.097 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -174.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.446 ' O ' ' HD2' ' A' ' 77' ' ' HIS . . . -77.88 133.75 13.47 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 119.225 -1.465 . . . . 0.0 110.251 176.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.2 mm -72.89 -37.51 54.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 69' ' ' TRP . 25.0 t-20 -146.81 119.98 4.98 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 171.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -85.87 154.63 54.85 Favored 'Cis proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.62 -1.408 . . . . 0.0 112.895 0.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.12 -15.68 57.79 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.942 0.877 . . . . 0.0 109.235 177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -54.9 -32.87 61.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.48 -1.236 . . . . 0.0 112.218 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 109' ' ' LYS . 71.9 m -134.4 161.43 35.02 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-O 122.229 1.014 . . . . 0.0 112.317 -178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 24.5 p -138.21 -171.88 3.14 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 114.328 -1.306 . . . . 0.0 108.597 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' O ' HD12 ' A' ' 86' ' ' LEU . 2.0 pp -97.41 145.71 25.9 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.983 0.42 . . . . 0.0 111.226 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -100.24 113.74 26.66 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.43 118.51 22.75 Favored 'General case' 0 CA--C 1.491 -1.303 0 O-C-N 123.452 0.47 . . . . 0.0 109.779 177.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -90.74 124.47 62.19 Favored Pre-proline 0 C--N 1.278 -2.536 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -60.2 120.05 7.6 Favored 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.966 1.778 . . . . 0.0 110.45 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.5 p -125.37 130.31 72.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-O 121.411 0.624 . . . . 0.0 110.203 -176.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.619 ' HG2' ' HD2' ' A' ' 94' ' ' LYS . 35.7 tt0 -115.42 131.51 56.91 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.161 -174.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.28 117.34 55.13 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.171 0 CA-C-N 114.893 -1.048 . . . . 0.0 111.001 -178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.619 ' HD2' ' HG2' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -125.96 98.5 5.54 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 73.21 -107.07 2.12 Favored Glycine 0 N--CA 1.43 -1.707 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 8' ' ' SER . 31.2 t70 -109.98 -5.24 15.51 Favored 'General case' 0 C--O 1.177 -2.758 0 CA-C-O 121.051 0.453 . . . . 0.0 109.962 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -99.64 133.18 44.35 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.294 -175.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.7 mt -123.88 119.54 57.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.875 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.586 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 10.9 m-85 -112.68 144.49 42.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.098 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.3 p -122.55 142.32 39.51 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-O 121.42 0.629 . . . . 0.0 111.098 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 25.6 t -106.71 128.97 54.65 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.113 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.3 p -120.84 -8.32 9.43 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.484 -0.486 . . . . 0.0 112.252 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -78.01 121.83 24.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.07 -32.52 6.63 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.569 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.432 HD12 ' HD3' ' A' ' 90' ' ' PRO . 73.1 mt -120.14 108.27 22.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.504 0.668 . . . . 0.0 109.963 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.0 mp -94.02 155.06 40.55 Favored Pre-proline 0 N--CA 1.41 -2.459 0 CA-C-N 114.914 -1.039 . . . . 0.0 109.339 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.59 144.1 99.51 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 122.448 2.098 . . . . 0.0 109.86 174.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -79.58 166.03 22.32 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.778 -177.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.491 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 52.8 mtmt -38.04 -51.26 1.38 Allowed 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.472 1.509 . . . . 0.0 115.073 -174.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 112' ' ' SER . . . -63.87 -32.75 74.37 Favored 'General case' 0 C--N 1.285 -2.225 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -175.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 75.91 -36.52 0.29 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.51 1.124 . . . . 0.0 110.554 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.574 ' C ' ' HB2' ' A' ' 45' ' ' CYS . 32.5 p . . . . . 0 N--CA 1.429 -1.523 0 O-C-N 125.332 1.645 . . . . 0.0 110.713 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.76 ' S1 ' ' N ' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 CA--C 1.501 -0.933 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' SER . 46.5 t 67.01 -69.7 0.12 Allowed 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -167.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 101' ' ' SER . 73.5 m-85 -79.89 115.72 19.63 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 170.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -124.29 144.97 49.68 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -74.08 125.43 28.3 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.101 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.2 tp -106.68 -42.25 6.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.293 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.488 178.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 71.3 m -148.08 -179.32 6.83 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.338 -173.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 12' ' ' ILE . 13.2 p -130.69 152.7 49.77 Favored 'General case' 0 N--CA 1.417 -2.094 0 C-N-CA 125.211 1.405 . . . . 0.0 108.881 175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.494 ' O ' HD13 ' A' ' 9' ' ' LEU . 2.8 tm? -56.41 -23.76 40.5 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -64.12 -30.33 71.4 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.668 176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.8 -8.39 13.19 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.4 HG22 ' O ' ' A' ' 8' ' ' SER . 3.7 tp -127.65 110.4 22.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 122.034 0.921 . . . . 0.0 110.081 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 44.1 m95 -102.37 164.63 11.57 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 114.193 -1.367 . . . . 0.0 111.513 -172.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.48 124.38 30.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.065 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.09 -8.17 62.83 Favored Glycine 0 N--CA 1.437 -1.273 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -102.81 153.25 20.36 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.447 0.641 . . . . 0.0 111.142 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.581 ' SD ' ' HB3' ' A' ' 57' ' ' TYR . 25.5 ptt? -149.55 137.72 20.57 Favored 'General case' 0 C--N 1.307 -1.283 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.121 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.464 ' HG3' ' CE2' ' A' ' 20' ' ' PHE . 12.0 pt-20 -157.41 155.36 30.35 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.402 176.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 t -93.81 141.36 28.59 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-O 121.58 0.705 . . . . 0.0 112.047 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.464 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 96.8 m-85 -130.77 148.75 52.59 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.491 175.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -102.73 139.72 37.94 Favored 'General case' 0 C--N 1.282 -2.337 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.5 p -83.56 168.37 16.46 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 m -70.05 -12.4 61.58 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.084 0.469 . . . . 0.0 110.845 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -90.22 -2.9 58.09 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.374 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.41 12.91 60.69 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.392 177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.3 m -87.01 123.34 32.0 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -89.35 123.6 33.68 Favored 'General case' 0 C--O 1.251 1.132 0 N-CA-C 106.223 -1.769 . . . . 0.0 106.223 178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.6 t -130.16 135.64 60.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.446 0.641 . . . . 0.0 110.892 -173.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 50.1 tp -89.53 113.97 25.44 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 124.454 1.101 . . . . 0.0 109.277 -179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.19 113.6 30.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 46.7 t -116.44 124.88 73.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 43.5 t30 -108.17 104.57 14.01 Favored 'General case' 0 C--N 1.31 -1.117 0 C-N-CA 118.766 -1.173 . . . . 0.0 108.323 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' HIS . 48.0 t -101.36 149.26 24.23 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.506 -177.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -77.46 -32.32 54.38 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-O 121.292 0.568 . . . . 0.0 109.576 173.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -93.43 -47.13 7.01 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.699 -177.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 65.7 m80 -83.28 -19.96 35.34 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 120.781 0.324 . . . . 0.0 111.309 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.37 -174.29 48.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 7.3 p -87.52 118.15 32.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 118.96 -1.096 . . . . 0.0 109.679 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -131.68 157.74 42.96 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.007 -178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB3' ' HB2' ' A' ' 89' ' ' TYR . . . -124.7 134.96 52.67 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.625 ' CZ ' ' HB2' ' A' ' 73' ' ' ASP . 69.2 m-85 -134.11 163.63 29.14 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -178.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 87' ' ' ALA . 10.2 pt20 -66.57 144.23 56.56 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.77 8.19 33.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.43 0.633 . . . . 0.0 111.305 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.2 tpp -99.4 143.37 29.74 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 115.456 -0.793 . . . . 0.0 108.876 176.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 0.6 OUTLIER -116.76 152.73 48.82 Favored Pre-proline 0 N--CA 1.426 -1.663 0 C-N-CA 118.75 -1.18 . . . . 0.0 107.925 177.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.72 -39.39 13.51 Favored 'Trans proline' 0 C--N 1.366 1.494 0 C-N-CA 123.564 2.843 . . . . 0.0 112.558 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.5 ' CE1' ' HB3' ' A' ' 67' ' ' HIS . 8.8 m80 -64.77 -86.14 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 168.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -153.22 173.85 15.02 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.74 129.82 36.79 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 173.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.42 ' O ' HG12 ' A' ' 50' ' ' ILE . 13.0 tt -156.74 24.93 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 122.82 1.295 . . . . 0.0 108.714 -174.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 89.3 mt 69.31 84.38 0.15 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-N 113.524 -1.671 . . . . 0.0 113.687 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 6.2 mp -70.14 -30.65 67.87 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-O 122.456 1.122 . . . . 0.0 108.26 174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.432 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 11.6 p -61.41 -29.81 70.17 Favored 'General case' 0 N--CA 1.414 -2.242 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.975 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -98.69 2.65 47.34 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 65' ' ' ARG . . . 164.71 91.94 0.08 OUTLIER Glycine 0 C--N 1.334 0.442 0 C-N-CA 118.297 -1.906 . . . . 0.0 115.241 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -157.27 -62.02 0.09 Allowed 'General case' 0 N--CA 1.427 -1.624 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.581 ' HB3' ' SD ' ' A' ' 17' ' ' MET . 41.2 t80 -90.48 114.05 26.14 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.39 -178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . 0.31 0.1 OUTLIER -118.41 114.36 22.78 Favored 'General case' 0 N--CA 1.423 -1.779 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.465 173.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.03 -70.64 1.21 Allowed Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.299 -0.477 . . . . 0.0 112.359 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.78 -17.74 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 115.654 -0.273 . . . . 0.0 112.765 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.3 t -96.66 141.79 15.0 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 117.072 0.436 . . . . 0.0 109.961 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.475 ' HB ' ' O ' ' A' ' 71' ' ' PHE . 57.5 mt -111.3 123.76 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 CA-C-O 121.581 0.705 . . . . 0.0 112.653 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 69' ' ' TRP . 94.9 m -92.85 143.96 25.76 Favored 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 103.074 -2.935 . . . . 0.0 103.074 168.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.69 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 3.7 t -76.29 -85.44 0.05 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 116.2 -2.2 . . . . 0.0 107.74 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 64' ' ' CYS . 23.9 tpt180 -178.81 -34.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.065 0.848 . . . . 0.0 112.522 164.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.521 ' N ' ' S1 ' ' A' ' 113' ' ' FES . . . -98.63 -39.62 8.6 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 47' ' ' HIS . 6.6 p-80 -84.92 178.73 7.49 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 118.949 -1.1 . . . . 0.0 111.431 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -53.41 -70.61 0.09 Allowed 'General case' 0 C--O 1.241 0.64 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -173.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.49 ' O ' ' HA ' ' A' ' 63' ' ' THR 0.255 98.0 m95 -129.18 -93.71 0.43 Allowed 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 118.091 2.626 . . . . 0.0 118.091 -173.162 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 32.6 p -101.6 146.17 28.05 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 117.333 2.345 . . . . 0.0 117.333 -160.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 45.8 t80 -135.96 143.08 44.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 102.36 -3.2 . . . . 0.0 102.36 168.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -119.11 128.17 54.05 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 120.507 1.503 . . . . 0.0 113.685 -172.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.625 ' HB2' ' CZ ' ' A' ' 41' ' ' TYR . 10.5 p-10 -79.44 -40.68 29.31 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.943 -175.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.02 47.24 2.22 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-O 121.141 0.301 . . . . 0.0 112.91 -178.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 89.2 m -163.46 -45.34 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 85' ' ' CYS . . . 104.86 -65.36 0.3 Allowed Glycine 0 CA--C 1.482 -2.018 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 -177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.493 ' HA ' ' O ' ' A' ' 84' ' ' CYS . 44.1 m80 -73.73 132.47 42.69 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -82.97 177.14 53.3 Favored Glycine 0 C--N 1.299 -1.508 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.976 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.43 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.4 mp -84.39 -34.99 10.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 176.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' PRO . 23.7 t-20 -142.73 109.86 5.63 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 3.0 Cg_exo -80.08 147.83 77.36 Favored 'Cis proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.474 -1.469 . . . . 0.0 110.429 -3.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.675 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.6 p30 -77.61 -21.75 51.84 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -174.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -84.93 -8.38 58.78 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 120.913 0.387 . . . . 0.0 110.377 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 77' ' ' HIS . 67.8 m -103.62 152.4 21.81 Favored 'General case' 0 N--CA 1.412 -2.359 0 CA-C-O 121.605 0.717 . . . . 0.0 111.842 -174.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 4.3 p -132.0 178.77 6.53 Favored 'General case' 0 C--N 1.273 -2.743 0 C-N-CA 125.496 1.518 . . . . 0.0 110.139 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -131.32 35.75 3.86 Favored 'General case' 0 C--O 1.201 -1.492 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 -172.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HB3' ' HB3' ' A' ' 42' ' ' GLN . . . 46.3 102.46 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.849 1.26 . . . . 0.0 114.398 -177.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -89.99 112.25 23.6 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.354 0.597 . . . . 0.0 110.941 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.547 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 93.6 m-85 -102.51 130.64 23.63 Favored Pre-proline 0 C--N 1.306 -1.309 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.468 178.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 101' ' ' SER . 14.5 Cg_endo -72.16 139.47 32.5 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.053 1.835 . . . . 0.0 111.271 177.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.425 HG22 HG12 ' A' ' 100' ' ' VAL . 57.8 t -126.58 140.07 49.92 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.685 -174.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -130.43 137.24 49.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.827 0.346 . . . . 0.0 110.537 177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.26 129.22 64.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.795 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.494 ' HE3' ' HB2' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -125.3 95.24 4.4 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.314 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 72.15 -112.49 4.07 Favored Glycine 0 N--CA 1.427 -1.92 0 C-N-CA 120.447 -0.883 . . . . 0.0 111.519 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -101.93 -2.87 28.84 Favored 'General case' 0 C--N 1.288 -2.078 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.544 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.494 ' HB2' ' HE3' ' A' ' 94' ' ' LYS . 20.7 m-20 -111.75 148.91 32.49 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.386 -175.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 85.3 mt -126.39 131.99 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.886 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -173.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -99.49 148.48 24.21 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.538 172.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.425 HG12 HG22 ' A' ' 91' ' ' VAL . 35.9 m -133.67 137.31 52.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 169.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 2' ' ' SER . 43.7 t -90.58 113.73 25.81 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.8 p -138.29 -26.46 0.91 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.236 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -74.44 99.51 3.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 121.401 0.62 . . . . 0.0 109.725 -175.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.92 -8.21 16.64 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.837 -177.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 58.7 mt -113.11 115.64 50.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-O 120.999 0.428 . . . . 0.0 110.456 -178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.1 mp -89.83 144.29 31.41 Favored Pre-proline 0 N--CA 1.412 -2.351 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -59.76 128.58 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 121.96 1.773 . . . . 0.0 111.141 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.539 ' OD1' ' HA ' ' A' ' 87' ' ' ALA . 2.3 p-10 -85.28 122.0 28.82 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.136 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.425 ' HE2' ' SG ' ' A' ' 84' ' ' CYS . 55.5 tptt 67.72 160.93 0.17 Allowed 'General case' 0 CA--C 1.551 0.997 0 O-C-N 124.92 1.387 . . . . 0.0 111.029 -178.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 74.03 -67.92 0.24 Allowed 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.919 1.288 . . . . 0.0 112.64 176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -88.79 -4.56 58.47 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 121.478 0.656 . . . . 0.0 109.749 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.432 -1.363 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.139 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.69 ' S1 ' ' HB3' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.504 ' SD ' ' N ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.767 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.504 ' N ' ' SD ' ' A' ' 1' ' ' MET . 22.7 t 78.65 -44.81 0.38 Allowed 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 125.334 1.454 . . . . 0.0 110.16 -178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.435 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 68.2 m-85 -75.51 97.79 3.8 Favored 'General case' 0 CA--C 1.502 -0.871 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 170.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -107.13 144.95 33.11 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 -176.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -77.28 124.28 27.64 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.127 -177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.0 tp -98.21 -45.92 12.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.734 179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.1 p -157.79 -172.18 3.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.372 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.9 m -125.74 152.7 45.0 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 114.943 -1.026 . . . . 0.0 108.597 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.517 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.5 tt -61.57 -26.03 67.7 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -68.26 -10.76 56.91 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.918 -0.489 . . . . 0.0 111.378 174.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -93.76 -53.4 4.04 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 12' ' ' ILE . 42.2 pt -111.4 110.86 33.74 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 CA-C-O 122.462 1.125 . . . . 0.0 111.757 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 67.3 m95 -77.97 170.23 16.96 Favored 'General case' 0 C--N 1.274 -2.705 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.251 -177.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 34' ' ' GLU . 7.1 p -57.71 112.16 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.265 0 CA-C-O 121.874 0.845 . . . . 0.0 111.276 178.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.17 3.21 58.95 Favored Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.558 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 mm-40 -102.83 152.48 21.22 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-O 121.168 0.508 . . . . 0.0 111.072 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.559 ' HB2' HD21 ' A' ' 29' ' ' LEU . 25.3 ptt? -149.95 145.23 26.36 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.895 -178.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.8 pt-20 -157.8 154.73 28.55 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 73.5 m -71.99 130.26 40.54 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.017 175.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.411 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 97.6 m-85 -128.09 157.01 41.9 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -106.24 135.68 47.29 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.6 p -83.39 173.71 11.29 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 38.6 m -73.89 -12.24 60.6 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.493 0.663 . . . . 0.0 110.993 179.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -90.2 -12.22 38.75 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.659 0.742 . . . . 0.0 109.111 177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.11 20.71 24.91 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.629 178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 9.9 m -91.34 130.27 37.21 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -179.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.1 mp0 -88.04 124.39 33.7 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 175.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' THR . 61.8 t -138.7 145.68 27.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 17' ' ' MET . 5.7 tt -97.3 112.32 24.18 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mm -97.6 119.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 17' ' ' MET . 10.1 p -116.52 134.1 61.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 120.846 0.355 . . . . 0.0 110.411 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -108.86 104.31 13.53 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 173.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 39.3 m -101.19 143.9 30.72 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HB2' ' CG2' ' A' ' 14' ' ' VAL . 0.8 OUTLIER -76.57 -51.31 11.87 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 175.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -77.3 -46.58 22.55 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.317 -175.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 56.8 t60 -92.75 2.62 56.64 Favored 'General case' 0 CA--C 1.557 1.231 0 CA-C-O 121.199 0.523 . . . . 0.0 111.361 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.92 177.06 35.3 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.719 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.2 125.63 39.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 177.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 39' ' ' LYS . 9.8 mmpt? -127.81 145.19 51.01 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.123 0.569 . . . . 0.0 109.97 -175.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -125.56 112.13 15.83 Favored 'General case' 0 C--O 1.203 -1.358 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 177.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.403 ' C ' HG13 ' A' ' 28' ' ' VAL . 13.9 p90 -137.53 140.94 41.39 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 119.553 -0.26 . . . . 0.0 111.03 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.515 ' HB2' HD22 ' A' ' 86' ' ' LEU . 38.3 mt-30 -42.91 137.36 2.38 Favored 'General case' 0 N--CA 1.483 1.188 0 O-C-N 123.938 0.774 . . . . 0.0 111.953 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.46 78.7 1.75 Allowed 'General case' 0 CA--C 1.481 -1.709 0 CA-C-O 121.467 0.651 . . . . 0.0 110.157 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.488 ' HB2' ' HB1' ' A' ' 110' ' ' ALA 0.286 10.9 mmt -123.75 135.7 53.99 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 177.547 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 5.7 t -170.87 90.67 0.47 Allowed Pre-proline 0 C--N 1.311 -1.067 0 C-N-CA 127.594 2.357 . . . . 0.0 107.873 172.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -85.33 27.76 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.54 2.16 . . . . 0.0 111.063 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -85.18 -52.95 5.57 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.15 -177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -138.0 -72.02 0.42 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -98.83 115.69 29.36 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 10.6 tt -61.31 -28.86 44.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.185 0.928 . . . . 0.0 110.515 -178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.7 mt -79.02 98.13 6.35 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 52' ' ' LEU . 3.2 tt -56.95 -28.9 62.69 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.488 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 67.5 p -58.04 -21.72 46.65 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.713 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -88.59 8.71 27.0 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-O 120.968 0.413 . . . . 0.0 112.009 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.49 -124.57 1.21 Allowed Glycine 0 N--CA 1.437 -1.26 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 173.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.6 t -157.29 150.04 23.29 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-O 121.622 0.725 . . . . 0.0 110.263 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CD1' HD13 ' A' ' 62' ' ' ILE . 6.8 t80 -130.89 115.91 17.18 Favored 'General case' 0 C--N 1.271 -2.821 0 CA-C-N 113.916 -1.493 . . . . 0.0 108.293 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -116.15 104.15 11.25 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.163 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 66.02 -73.89 0.13 Allowed Glycine 0 CA--C 1.52 0.364 0 O-C-N 123.715 0.634 . . . . 0.0 112.845 179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.68 25.09 1.19 Allowed Glycine 0 C--N 1.295 -1.7 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.52 120.99 62.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 35.4 mm -89.99 137.75 20.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.6 m -127.2 129.05 47.1 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.935 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 0.1 OUTLIER -69.92 -155.2 0.02 OUTLIER 'General case' 0 CA--C 1.578 2.045 0 C-N-CA 123.442 0.697 . . . . 0.0 111.411 -179.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.479 ' N ' ' S1 ' ' A' ' 113' ' ' FES . 19.6 tpt180 -113.1 95.09 5.2 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.762 -0.586 . . . . 0.0 110.654 -169.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 66.69 21.81 10.52 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.674 0.79 . . . . 0.0 110.909 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.812 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 2.7 t-160 -97.72 -17.02 19.66 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.21 -48.69 0.69 Allowed 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 175.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -74.4 177.24 6.07 Favored 'General case' 0 CA--C 1.577 2.017 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.766 -173.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 43.5 p -103.08 156.92 17.35 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 114.414 1.265 . . . . 0.0 114.414 -166.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.515 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 6.3 t80 -134.07 146.26 50.15 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 177.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -118.57 112.84 20.39 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.905 0.775 . . . . 0.0 112.976 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.59 -34.36 58.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.515 -175.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.84 -40.16 89.33 Favored Glycine 0 CA--C 1.508 -0.369 0 O-C-N 123.342 0.402 . . . . 0.0 113.486 -175.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.9 m -101.1 -12.75 18.56 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.644 0.735 . . . . 0.0 109.41 -179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.35 38.68 38.19 Favored Glycine 0 C--O 1.219 -0.821 0 CA-C-N 115.493 -0.776 . . . . 0.0 113.777 177.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -140.74 141.32 34.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.616 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -85.73 139.75 17.42 Favored Glycine 0 N--CA 1.416 -2.688 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.922 178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.63 -35.97 17.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 172.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -141.47 137.47 16.52 Favored Pre-proline 0 N--CA 1.417 -2.114 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 172.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -66.76 -13.56 8.08 Favored 'Cis proline' 0 N--CA 1.504 2.122 0 CA-C-N 119.383 0.815 . . . . 0.0 113.44 -0.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.616 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 11.2 t70 90.14 -39.35 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 126.928 2.091 . . . . 0.0 110.0 -178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -56.46 -34.28 66.72 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.325 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 51.6 m -93.7 141.84 28.03 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-O 121.853 0.835 . . . . 0.0 108.885 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 85.3 m -144.52 166.6 24.69 Favored 'General case' 0 C--N 1.254 -3.587 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.515 HD22 ' HB2' ' A' ' 42' ' ' GLN . 72.5 mt -128.98 179.69 5.6 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -175.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -132.92 117.62 17.9 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 176.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.461 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -85.66 101.22 12.55 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 106.932 -1.506 . . . . 0.0 106.932 -178.599 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -81.11 141.87 50.76 Favored Pre-proline 0 C--N 1.303 -1.413 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.415 -173.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 101' ' ' SER . 32.3 Cg_exo -58.37 118.55 5.45 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.764 1.643 . . . . 0.0 110.537 177.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.0 p -133.5 137.79 52.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -133.64 140.19 46.94 Favored 'General case' 0 N--CA 1.42 -1.97 0 CA-C-O 121.365 0.602 . . . . 0.0 111.062 -176.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.8 127.97 57.45 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.43 179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -121.53 91.3 3.49 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.895 -1.521 . . . . 0.0 106.895 178.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 63.37 -106.0 1.22 Allowed Glycine 0 C--N 1.3 -1.439 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.418 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.9 -10.86 22.27 Favored 'General case' 0 C--O 1.186 -2.283 0 CA-C-N 115.39 -0.405 . . . . 0.0 110.16 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -100.87 140.36 35.27 Favored 'General case' 0 C--N 1.292 -1.907 0 CA-C-O 120.774 0.321 . . . . 0.0 111.406 -174.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 84.7 mt -127.14 122.06 59.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.831 0.825 . . . . 0.0 111.664 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.435 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 39.7 m-85 -115.12 144.41 43.7 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.592 -1.185 . . . . 0.0 110.937 -176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.54 145.37 29.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-O 121.04 0.448 . . . . 0.0 110.911 -178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 2' ' ' SER . 51.5 m -111.45 116.26 30.6 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.283 176.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.437 ' HA ' ' CG2' ' A' ' 105' ' ' ILE . 10.0 t -134.26 -10.66 2.54 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.913 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -85.44 97.11 9.83 Favored 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.857 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.86 -32.85 2.47 Favored Glycine 0 C--N 1.298 -1.54 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 102' ' ' THR . 13.3 tt -86.83 136.12 23.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.9 mp -82.21 123.53 79.32 Favored Pre-proline 0 N--CA 1.426 -1.672 0 N-CA-C 113.815 1.042 . . . . 0.0 113.815 -173.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' HB3' ' OE1' ' A' ' 42' ' ' GLN . 23.0 Cg_exo -68.25 129.7 19.79 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 123.605 2.87 . . . . 0.0 108.511 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -81.16 174.39 11.61 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 119.44 -0.314 . . . . 0.0 110.659 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 109' ' ' LYS . 75.3 mmtt -52.81 104.6 0.09 Allowed 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 122.813 1.292 . . . . 0.0 114.158 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.488 ' HB1' ' HB2' ' A' ' 44' ' ' MET . . . 175.0 -30.64 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.492 0 CA-C-N 111.237 -2.711 . . . . 0.0 104.406 -174.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -144.9 161.55 39.05 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 113.056 -1.884 . . . . 0.0 106.414 170.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 CA--C 1.54 0.59 0 O-C-N 124.233 0.958 . . . . 0.0 111.37 177.135 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.935 ' S1 ' ' HB3' ' A' ' 64' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.52 -0.206 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.519 ' O ' ' HA ' ' A' ' 101' ' ' SER . 49.3 m 60.33 -80.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.765 1.226 . . . . 0.0 114.153 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.482 ' HB3' ' HB3' ' A' ' 99' ' ' TYR . 95.6 m-85 -86.09 124.82 32.94 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -172.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -120.23 145.1 47.34 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.03 118.24 23.38 Favored 'General case' 0 CA--C 1.5 -0.961 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.1 tt -118.23 -40.72 2.33 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.379 -176.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 11.1 p -146.27 -175.15 4.65 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.577 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.574 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.6 m -131.57 150.6 52.09 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.221 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.5 tt -71.47 -25.26 62.21 Favored 'General case' 0 C--O 1.212 -0.89 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 176.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 96' ' ' ASP . 23.8 t70 -72.19 -17.68 61.91 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.316 174.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -88.25 -53.43 4.7 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 176.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.508 HG13 ' O ' ' A' ' 12' ' ' ILE . 43.3 pt -108.37 110.13 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 CA-C-O 122.433 1.111 . . . . 0.0 110.523 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.492 ' HB2' ' OE2' ' A' ' 16' ' ' GLU . 37.3 m95 -80.38 170.07 16.88 Favored 'General case' 0 C--N 1.278 -2.542 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.119 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.0 p -56.43 127.13 14.99 Favored 'Isoleucine or valine' 0 C--O 1.247 0.938 0 CA-C-O 121.036 0.446 . . . . 0.0 110.015 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.65 -1.72 79.13 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 13' ' ' TRP . 44.8 mt-10 -110.34 149.94 29.5 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-O 121.38 0.61 . . . . 0.0 112.239 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 53' ' ' SER . 20.3 ptt? -150.39 152.2 33.99 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.485 -171.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.557 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.1 tp10 -157.24 151.91 25.48 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 123.613 0.571 . . . . 0.0 109.472 177.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.638 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 99.1 m -89.49 121.01 31.31 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 175.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 18' ' ' GLU . 97.6 m-85 -119.2 155.77 31.08 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 26' ' ' THR . 36.1 tt0 -109.88 143.42 39.8 Favored 'General case' 0 N--CA 1.407 -2.604 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.1 p -83.06 165.76 19.32 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.7 m -67.0 -13.13 61.61 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.142 0.496 . . . . 0.0 111.213 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -85.85 -13.11 49.01 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.328 0.585 . . . . 0.0 109.489 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.63 22.39 16.42 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.794 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.587 ' CG2' HE22 ' A' ' 42' ' ' GLN . 31.5 m -97.72 130.03 44.72 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 122.764 -0.257 . . . . 0.0 111.168 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -89.64 126.85 35.79 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.571 0.701 . . . . 0.0 111.589 175.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.2 t -136.19 148.78 27.35 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -174.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 45.8 tp -100.29 111.1 23.36 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 178.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.3 mp -102.94 117.45 48.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 17' ' ' MET . 66.2 t -118.05 125.64 74.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.839 -178.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -88.09 104.22 16.47 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 175.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -101.59 145.75 28.63 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.144 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -75.82 -48.98 19.37 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.483 0.659 . . . . 0.0 109.574 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -74.29 -41.33 61.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.723 -176.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -100.78 2.48 41.27 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -174.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.77 -170.68 46.1 Favored Glycine 0 CA--C 1.522 0.515 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.1 t -78.43 119.98 28.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.534 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -117.09 144.77 44.29 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.655 0.264 . . . . 0.0 110.914 -176.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.97 119.99 31.18 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.535 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 2.0 p90 -143.23 140.19 30.58 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.394 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.587 HE22 ' CG2' ' A' ' 26' ' ' THR . 14.7 mm100 -44.66 138.21 3.49 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -177.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.25 59.21 4.39 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 122.425 1.107 . . . . 0.0 109.877 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.432 ' SD ' ' HA ' ' A' ' 110' ' ' ALA . 19.0 mmt -66.07 94.1 0.23 Allowed 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 113.618 -1.628 . . . . 0.0 114.262 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.951 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 3.7 m -166.47 93.84 0.76 Allowed Pre-proline 0 C--N 1.31 -1.148 0 C-N-CA 125.445 1.498 . . . . 0.0 110.403 175.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.98 30.27 0.47 Allowed 'Trans proline' 0 CA--C 1.547 1.163 0 C-N-CA 123.206 2.604 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 30.38 3.69 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.5 tm0? -47.91 124.02 6.89 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.244 2.218 . . . . 0.0 114.817 -172.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.452 ' HG2' ' CE1' ' A' ' 67' ' ' HIS . 41.7 mm-40 -92.55 -62.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 107.805 -1.184 . . . . 0.0 107.805 173.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.9 tp -151.16 172.77 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.214 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 -178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -65.33 110.71 2.72 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 118.985 0.811 . . . . 0.0 109.67 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.481 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.2 pt? -62.16 -20.01 63.66 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 124.893 1.277 . . . . 0.0 112.409 -178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.638 ' HB3' ' OG1' ' A' ' 19' ' ' THR . 59.3 p -55.0 -21.86 13.4 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 116.241 1.941 . . . . 0.0 116.241 -166.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -97.46 8.59 44.32 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.36 0.6 . . . . 0.0 110.977 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -163.68 81.3 0.12 Allowed Glycine 0 C--N 1.318 -0.426 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 176.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.602 ' HB3' HG23 ' A' ' 62' ' ' ILE . 66.3 m -138.53 -77.86 0.36 Allowed 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -173.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -90.23 114.23 26.2 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.508 -169.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -117.4 105.24 11.93 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.657 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.85 -64.07 1.55 Allowed Glycine 0 CA--C 1.527 0.801 0 O-C-N 123.207 0.317 . . . . 0.0 113.028 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -160.1 -2.62 0.06 OUTLIER Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.883 -0.487 . . . . 0.0 111.883 178.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.88 140.54 23.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.602 HG23 ' HB3' ' A' ' 56' ' ' SER . 36.4 mt -113.4 121.06 64.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.342 0.591 . . . . 0.0 112.044 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 94.4 m -92.94 148.46 21.99 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 125.67 1.588 . . . . 0.0 110.432 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.549 ' C ' ' H ' ' A' ' 66' ' ' ALA . 44.6 t -156.21 34.7 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 72.32 -22.91 0.2 Allowed 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.694 1.198 . . . . 0.0 109.83 -170.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.549 ' H ' ' C ' ' A' ' 64' ' ' CYS . . . 71.17 100.84 0.06 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 125.367 1.467 . . . . 0.0 111.576 177.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.452 ' CE1' ' HG2' ' A' ' 49' ' ' GLU . 52.7 m80 -99.83 -0.17 40.27 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 119.3 -0.96 . . . . 0.0 109.499 174.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.2 mt -147.55 -55.1 0.22 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.016 175.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -170.62 -143.78 0.04 OUTLIER 'General case' 0 CA--C 1.557 1.233 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.522 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 32.8 p -134.39 167.68 20.3 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 125.363 1.465 . . . . 0.0 108.981 -174.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 62' ' ' ILE . 54.2 m-85 -98.69 138.39 35.93 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 176.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -107.46 112.54 25.37 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 103.645 -2.724 . . . . 0.0 103.645 173.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . 0.405 4.6 p-10 52.77 63.19 2.33 Favored 'General case' 0 CA--C 1.476 -1.883 0 CA-C-O 123.333 1.539 . . . . 0.0 111.342 -167.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.506 ' HA3' HD12 ' A' ' 62' ' ' ILE . . . -73.26 64.47 1.67 Allowed Glycine 0 CA--C 1.474 -2.491 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.257 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.2 m -139.85 -46.64 0.44 Allowed 'General case' 1 C--N 1.242 -4.09 0 N-CA-C 104.266 -2.494 . . . . 0.0 104.266 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -126.96 -3.53 6.3 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 119.171 -1.49 . . . . 0.0 113.399 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -144.12 142.95 30.89 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 117.326 0.563 . . . . 0.0 110.801 178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -131.45 129.05 5.57 Favored Glycine 0 N--CA 1.422 -2.296 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.699 172.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' O ' ' A' ' 70' ' ' THR . 51.1 mt -88.3 -22.93 6.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 173.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.52 ' ND2' ' S2 ' ' A' ' 113' ' ' FES . 23.7 t30 -143.8 113.44 5.44 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 113.563 -1.653 . . . . 0.0 106.895 168.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 6.9 Cg_exo -76.11 129.16 18.08 Favored 'Cis proline' 0 N--CA 1.442 -1.539 0 C-N-CA 122.706 -1.789 . . . . 0.0 110.914 -2.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -68.21 -11.84 59.96 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.739 0.78 . . . . 0.0 109.886 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.84 -19.78 61.25 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.186 -1.37 . . . . 0.0 111.712 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 111' ' ' HIS . 79.3 m -155.11 161.67 41.21 Favored 'General case' 0 CA--C 1.503 -0.844 0 CA-C-O 122.327 1.06 . . . . 0.0 113.196 -176.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.1 p -94.06 -167.56 1.7 Allowed 'General case' 0 N--CA 1.404 -2.744 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.535 ' HB3' ' HB2' ' A' ' 41' ' ' TYR . 84.6 mt -117.38 142.72 46.77 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.843 177.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.22 86.38 5.01 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.569 176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 123.58 24.57 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.105 174.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.52 ' CD2' HG21 ' A' ' 105' ' ' ILE 0.251 5.4 p90 -124.08 160.32 52.69 Favored Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -62.58 133.67 43.77 Favored 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.68 2.92 . . . . 0.0 115.012 -172.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 88.3 t -116.3 143.56 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.517 0 CA-C-N 113.713 -1.585 . . . . 0.0 107.498 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -128.9 132.38 47.68 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.52 130.49 48.46 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.63 -178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.04 90.6 3.27 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 176.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.64 -113.55 5.96 Favored Glycine 0 C--N 1.31 -0.889 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.604 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 8' ' ' SER . 10.2 m-20 -91.93 -8.2 46.96 Favored 'General case' 0 CA--C 1.489 -1.402 0 C-N-CA 123.365 0.666 . . . . 0.0 110.671 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' SER . 17.4 m-20 -111.65 157.61 20.24 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.2 mm -126.93 135.93 62.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.482 ' HB3' ' HB3' ' A' ' 3' ' ' PHE . 16.6 m-85 -106.54 145.99 31.17 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 167.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 99.0 t -135.32 151.0 29.7 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.774 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 2' ' ' SER . 20.8 m -87.47 113.08 22.85 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 61.1 p -124.51 -38.28 2.42 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.964 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.4 tpmt? -107.32 91.19 3.55 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.07 -39.08 0.73 Allowed Glycine 0 C--N 1.294 -1.783 0 N-CA-C 107.623 -2.191 . . . . 0.0 107.623 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.614 ' O ' ' HD3' ' A' ' 107' ' ' PRO . 28.1 mm -85.49 143.25 11.95 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.161 -2.163 . . . . 0.0 105.161 170.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.0 tp -96.86 100.75 7.9 Favored Pre-proline 0 C--N 1.297 -1.694 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.451 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.614 ' HD3' ' O ' ' A' ' 105' ' ' ILE . 2.9 Cg_exo -78.41 136.98 14.49 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 123.084 2.523 . . . . 0.0 109.872 179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -80.53 117.01 20.87 Favored 'General case' 0 N--CA 1.417 -2.097 0 CA-C-O 121.252 0.548 . . . . 0.0 110.385 176.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -71.83 -24.13 61.66 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.704 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.432 ' HA ' ' SD ' ' A' ' 44' ' ' MET . . . -174.17 103.16 0.1 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.912 175.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.586 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 26.0 t-80 77.98 -70.59 0.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 C--N 1.288 -2.088 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -178.143 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.951 ' S1 ' ' HB3' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.3 ttm . . . . . 0 N--CA 1.467 0.415 0 CA-C-O 121.027 0.441 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.4 t 178.57 133.78 0.08 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 52.46 87.82 0.03 OUTLIER 'General case' 0 C--O 1.244 0.766 0 CA-C-O 122.151 0.977 . . . . 0.0 111.342 -174.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -105.3 142.48 34.99 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -65.8 117.52 8.34 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-O 121.278 0.561 . . . . 0.0 110.128 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.1 tt -104.3 -56.48 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.57 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.846 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.3 m -157.92 -177.14 6.35 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 123.058 0.543 . . . . 0.0 111.064 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.5 p -103.62 150.17 24.23 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 9' ' ' LEU . 5.0 tt -72.85 -24.77 60.92 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 174.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -62.4 -25.97 68.23 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.215 177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -89.54 -48.35 7.37 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.6 pt -100.91 110.79 28.68 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 CA-C-O 122.802 1.287 . . . . 0.0 112.27 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -79.2 169.78 17.63 Favored 'General case' 0 C--N 1.27 -2.864 0 CA-C-N 113.514 -1.676 . . . . 0.0 112.227 -178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.3 t -58.1 116.71 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.703 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.34 2.12 59.08 Favored Glycine 0 N--CA 1.433 -1.536 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.383 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -104.18 145.04 30.78 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 121.21 0.528 . . . . 0.0 110.679 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -142.36 143.73 32.85 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.121 179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.531 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 10.7 tp10 -152.86 149.76 28.62 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.084 0.468 . . . . 0.0 110.475 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 69.5 m -89.08 123.06 33.01 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.001 177.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -127.57 162.51 26.29 Favored 'General case' 0 C--N 1.281 -2.404 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.765 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -102.0 141.54 34.69 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.9 p -83.97 170.59 13.81 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.3 m -64.02 -13.68 48.5 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 122.758 0.423 . . . . 0.0 111.66 177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -95.52 -13.24 24.65 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.283 0.563 . . . . 0.0 110.373 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 99.2 18.58 23.82 Favored Glycine 0 C--O 1.221 -0.677 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.978 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 19.1 m -97.09 139.12 33.55 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.49 ' HG2' ' HB3' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -89.65 135.45 33.61 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.043 175.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' THR . 99.2 t -134.94 144.68 33.91 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 4.7 tt -104.08 110.29 22.4 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.455 ' N ' HD12 ' A' ' 30' ' ' ILE . 2.4 mp -101.3 123.19 54.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -177.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 17' ' ' MET . 9.3 p -111.96 125.58 69.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -101.86 102.01 12.54 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 117.941 -1.504 . . . . 0.0 108.456 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.9 m -103.6 139.08 39.38 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -76.64 -38.62 54.36 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.412 0.625 . . . . 0.0 109.706 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -92.93 -46.89 7.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.68 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -79.74 -12.3 59.8 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 121.111 0.481 . . . . 0.0 110.41 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.76 159.13 31.6 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.988 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.512 HG11 ' HB ' ' A' ' 93' ' ' VAL . 7.2 p -72.94 124.01 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -127.06 138.59 53.24 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.24 0.543 . . . . 0.0 112.38 -177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.7 112.33 16.62 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.015 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 87' ' ' ALA . 25.3 p90 -136.82 147.08 46.37 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.676 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -47.33 137.79 8.02 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 121.896 0.855 . . . . 0.0 113.02 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB3' ' HG2' ' A' ' 27' ' ' GLU . . . -83.99 101.09 11.48 Favored 'General case' 0 N--CA 1.396 -3.141 0 CA-C-N 114.474 -1.239 . . . . 0.0 113.198 -172.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.487 ' HG2' ' O ' ' A' ' 43' ' ' ALA . 26.1 ptt? 64.07 179.42 0.17 Allowed 'General case' 0 C--N 1.279 -2.498 0 CA-C-N 111.32 -2.673 . . . . 0.0 116.306 163.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -92.61 116.64 66.83 Favored Pre-proline 0 N--CA 1.416 -2.169 0 CA-C-N 112.238 -2.256 . . . . 0.0 107.202 171.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.498 ' HG3' ' HB2' ' A' ' 111' ' ' HIS . 25.4 Cg_endo -85.8 37.26 0.55 Allowed 'Trans proline' 0 C--N 1.323 -0.764 0 C-N-CA 122.742 2.295 . . . . 0.0 113.347 -175.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.624 ' HB2' ' S1 ' ' A' ' 113' ' ' FES . 26.4 m80 -85.13 -59.69 2.26 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 176.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -105.15 115.11 29.71 Favored 'General case' 0 N--CA 1.42 -1.963 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.603 173.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' H ' ' CD ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -75.13 82.97 2.32 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 122.359 1.076 . . . . 0.0 111.164 179.759 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.0 tt -71.99 -37.01 59.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.93 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.5 tm? 60.61 69.49 0.68 Allowed 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 104.802 -2.295 . . . . 0.0 104.802 -170.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.454 ' CD2' ' H ' ' A' ' 52' ' ' LEU . 1.5 pt? -77.5 -19.33 56.04 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 112.323 -2.217 . . . . 0.0 114.074 -169.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.531 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 61.9 p -54.88 -23.12 17.11 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 -163.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -84.49 -9.24 58.53 Favored 'General case' 0 CA--C 1.556 1.202 0 CA-C-N 119.083 0.856 . . . . 0.0 110.182 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -162.6 83.18 0.12 Allowed Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.419 ' OG ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 m -125.31 -57.68 1.47 Allowed 'General case' 0 CA--C 1.485 -1.541 0 CA-C-O 122.411 1.1 . . . . 0.0 109.107 -177.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -91.21 113.52 25.81 Favored 'General case' 0 C--N 1.284 -2.246 0 CA-C-N 113.288 -1.778 . . . . 0.0 111.403 -171.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.36 105.52 11.38 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 73.82 -53.82 2.1 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 121.606 -0.331 . . . . 0.0 113.585 178.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.55 -12.28 0.02 OUTLIER Glycine 0 C--N 1.306 -1.107 0 N-CA-C 111.779 -0.528 . . . . 0.0 111.779 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 60.8 t -92.7 141.55 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HB ' ' HB3' ' A' ' 71' ' ' PHE . 51.5 mm -106.83 128.35 61.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 C-N-CA 123.956 0.902 . . . . 0.0 108.954 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.4 m -85.74 125.25 33.08 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -175.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 67' ' ' HIS . 5.4 t -105.79 155.57 19.16 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 169.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -91.39 117.77 29.96 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 122.303 0.241 . . . . 0.0 110.957 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 69.05 -38.34 0.39 Allowed 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 173.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.487 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 36.0 m170 -71.2 114.71 9.55 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-N 118.266 0.485 . . . . 0.0 111.38 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.477 ' HB3' ' CG ' ' A' ' 80' ' ' ASN . 2.1 tm? 49.24 -97.49 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.438 1.495 . . . . 0.0 110.392 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -166.98 -44.74 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.0 p -138.34 134.93 34.85 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 116.666 2.099 . . . . 0.0 116.666 -160.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.449 ' HB3' ' HB ' ' A' ' 62' ' ' ILE . 48.3 t80 -116.23 138.53 51.21 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 101.868 -3.382 . . . . 0.0 101.868 168.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.421 ' H ' ' HA2' ' A' ' 78' ' ' GLY . 54.7 t30 -123.35 117.34 24.99 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 120.873 1.67 . . . . 0.0 115.156 -168.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -79.48 -33.46 42.23 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.256 175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -48.47 -54.58 12.74 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.757 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.7 m -88.94 -36.78 15.7 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.087 0.47 . . . . 0.0 110.223 178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.508 ' O ' HD13 ' A' ' 86' ' ' LEU . . . 114.37 -33.55 5.35 Favored Glycine 0 CA--C 1.504 -0.604 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.456 ' HD2' ' SG ' ' A' ' 85' ' ' CYS . 29.8 t-80 -82.72 137.97 34.23 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -90.79 144.22 17.17 Favored Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.92 178.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.56 -42.42 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.477 ' CG ' ' HB3' ' A' ' 68' ' ' LEU . 3.5 p-10 -135.32 118.89 12.97 Favored Pre-proline 0 N--CA 1.42 -1.929 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 171.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 80' ' ' ASN . 2.0 Cg_endo -81.11 131.76 21.39 Favored 'Cis proline' 0 C--O 1.243 0.757 0 C-N-CA 123.797 -1.335 . . . . 0.0 111.397 -1.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 4.0 p30 -71.5 -12.69 61.51 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.059 0.457 . . . . 0.0 111.101 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -71.41 -17.53 62.39 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.39 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 25.5 p -138.58 178.78 6.89 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 121.671 0.748 . . . . 0.0 111.951 -176.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 77' ' ' HIS . 62.3 m -133.61 176.12 8.83 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 76' ' ' GLY 0.313 0.0 OUTLIER -101.02 127.06 47.7 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.375 -0.93 . . . . 0.0 111.646 175.466 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -72.83 114.2 10.71 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.395 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -87.32 116.89 25.72 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 101' ' ' SER . 65.4 m-85 -95.69 152.54 39.19 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -175.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.498 ' HD3' HD12 ' A' ' 105' ' ' ILE . 14.2 Cg_exo -70.76 120.55 7.16 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.186 1.924 . . . . 0.0 110.058 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.9 p -121.74 138.27 52.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-O 121.468 0.652 . . . . 0.0 110.667 -177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -115.24 132.06 56.73 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.512 ' HB ' HG11 ' A' ' 38' ' ' VAL . 8.8 p -106.57 122.21 60.19 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.324 -175.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.534 ' HD3' ' H ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -125.89 143.93 50.88 Favored 'General case' 0 N--CA 1.394 -3.234 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.312 176.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -33.62 -53.75 0.63 Allowed Glycine 0 CA--C 1.49 -1.494 0 N-CA-C 117.531 1.772 . . . . 0.0 117.531 -171.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -114.56 -0.73 13.58 Favored 'General case' 0 C--N 1.269 -2.909 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -178.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' H ' ' HD3' ' A' ' 94' ' ' LYS . 9.3 m-20 -146.89 134.82 21.37 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.67 129.77 73.59 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.485 0 CA-C-O 121.354 0.597 . . . . 0.0 111.088 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -113.73 141.49 47.2 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.027 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 8.9 p -139.76 147.94 23.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 120.946 0.403 . . . . 0.0 111.082 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.456 ' O ' ' HD2' ' A' ' 90' ' ' PRO . 51.3 m -104.79 115.22 29.93 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.969 178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.6 m -101.01 -18.43 16.28 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 172.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 103' ' ' LYS . 1.0 OUTLIER -81.73 108.38 15.23 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.147 176.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.55 -34.32 2.43 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.498 HD12 ' HD3' ' A' ' 90' ' ' PRO . 33.7 mt -119.02 127.64 75.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -85.06 128.07 61.69 Favored Pre-proline 0 N--CA 1.404 -2.732 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.09 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.42 148.87 91.87 Favored 'Trans proline' 0 C--O 1.246 0.895 0 C-N-CA 122.36 2.04 . . . . 0.0 110.362 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -80.18 166.88 21.0 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -78.56 74.14 5.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.975 1.369 . . . . 0.0 114.139 -175.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -111.95 -65.61 1.16 Allowed 'General case' 0 C--N 1.26 -3.291 0 N-CA-C 103.955 -2.609 . . . . 0.0 103.955 169.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 46' ' ' PRO . 13.1 t-80 -139.33 121.65 15.99 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 171.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.418 -2.052 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -178.379 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.624 ' S1 ' ' HB2' ' A' ' 47' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mtp . . . . . 0 CA--C 1.503 -0.837 0 N-CA-C 110.848 -0.056 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 101' ' ' SER . 34.6 m 58.08 -161.25 0.24 Allowed 'General case' 0 C--O 1.243 0.727 0 O-C-N 124.186 0.929 . . . . 0.0 110.868 177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.53 ' CD2' ' HB2' ' A' ' 101' ' ' SER . 92.2 m-85 -76.07 97.72 4.14 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -107.76 143.81 35.79 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 120.908 0.385 . . . . 0.0 110.284 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 99' ' ' TYR . 86.1 tttt -79.54 123.66 27.78 Favored 'General case' 0 CA--C 1.484 -1.579 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.782 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.429 HG22 ' SG ' ' A' ' 7' ' ' CYS . 39.7 mm -94.87 -53.55 8.18 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.268 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.333 177.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.429 ' SG ' HG22 ' A' ' 6' ' ' ILE . 93.4 m -158.31 -172.56 3.93 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.465 0.65 . . . . 0.0 111.921 -173.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.624 ' HA ' ' O ' ' A' ' 96' ' ' ASP . 41.2 t -104.74 153.22 21.57 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.297 -1.319 . . . . 0.0 109.959 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 9' ' ' LEU . 6.4 tt -61.73 -21.8 64.82 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.99 -19.6 66.08 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.186 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -94.98 -42.95 8.38 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 176.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.6 tp -114.49 110.83 33.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 122.056 0.931 . . . . 0.0 112.65 -176.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -102.59 169.04 8.89 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.284 -1.326 . . . . 0.0 113.327 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.42 124.76 27.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.631 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.684 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.96 -10.52 66.0 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 mm-40 -105.14 153.27 21.75 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 115.083 -0.559 . . . . 0.0 110.097 -177.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 23.5 ptt? -151.27 143.92 24.34 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.512 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -157.01 155.44 31.25 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 98.3 m -73.38 136.21 44.33 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.788 -1.096 . . . . 0.0 112.064 176.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -135.33 160.5 38.22 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 173.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -106.11 136.98 44.83 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.9 p -84.62 175.64 9.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.9 m -66.12 -20.72 66.24 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.046 0.45 . . . . 0.0 111.368 177.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -95.44 5.12 52.42 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.588 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 75.05 33.67 54.17 Favored Glycine 0 N--CA 1.439 -1.137 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.104 178.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 20.8 m -97.98 134.95 40.39 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -89.68 122.67 33.01 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.5 t -128.13 141.98 45.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-O 121.215 0.531 . . . . 0.0 110.267 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . 53.5 tp -100.04 111.91 24.21 Favored 'General case' 0 C--N 1.284 -2.256 0 C-N-CA 124.512 1.125 . . . . 0.0 108.191 177.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.0 mt -95.7 114.33 32.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 44.0 t -108.39 124.55 64.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 38' ' ' VAL . 51.3 t30 -109.31 106.46 16.29 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.5 m -98.37 157.3 16.28 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.686 0.755 . . . . 0.0 112.518 -173.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -75.26 -48.96 20.88 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.543 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -99.12 -33.77 10.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.164 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 17.4 m-70 -91.45 3.28 55.34 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 67.15 -166.37 41.23 Favored Glycine 0 C--O 1.225 -0.435 0 C-N-CA 121.288 -0.482 . . . . 0.0 112.392 179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 32' ' ' ASN . 10.6 p -90.92 128.3 42.82 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 179.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.548 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.9 OUTLIER -132.3 158.16 42.58 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.336 179.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.31 128.02 48.5 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 177.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 39' ' ' LYS . 95.0 m-85 -134.97 163.56 29.59 Favored 'General case' 0 C--O 1.208 -1.097 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -55.38 138.93 44.72 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.206 172.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 29' ' ' LEU . . . -70.47 -39.3 74.32 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.511 ' O ' ' HB1' ' A' ' 110' ' ' ALA . 66.6 mtt -103.19 120.61 41.03 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.507 ' HB2' ' S2 ' ' A' ' 113' ' ' FES . 29.8 p -70.7 171.88 7.34 Favored Pre-proline 0 CA--C 1.552 1.04 0 O-C-N 123.362 0.413 . . . . 0.0 110.429 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.479 ' N ' ' HA ' ' A' ' 110' ' ' ALA . 31.8 Cg_exo -60.62 -18.84 57.26 Favored 'Trans proline' 0 C--N 1.375 1.945 0 C-N-CA 122.672 2.248 . . . . 0.0 111.661 -178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -100.01 -22.69 15.14 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.369 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.577 ' HG3' ' H ' ' A' ' 49' ' ' GLU 0.375 11.8 pt20 47.9 -102.98 0.09 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.02 0.928 . . . . 0.0 113.433 -172.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.577 ' H ' ' HG3' ' A' ' 48' ' ' GLN . 44.4 mt-10 58.5 -75.49 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.796 1.238 . . . . 0.0 113.505 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 51.5 mt -109.27 141.84 23.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.0 mp -77.62 99.34 5.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 C-N-CA 120.553 -0.459 . . . . 0.0 109.942 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.631 ' H ' HD23 ' A' ' 52' ' ' LEU . 1.5 pt? -60.33 -24.97 65.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.31 177.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.3 p -63.58 -27.82 69.51 Favored 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 123.982 0.913 . . . . 0.0 110.305 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -113.84 21.19 15.17 Favored 'General case' 0 CA--C 1.56 1.361 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -96.37 -110.47 2.62 Favored Glycine 0 N--CA 1.425 -2.061 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.8 -176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 52.2 m -148.27 157.84 43.73 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-O 121.546 0.689 . . . . 0.0 111.495 -179.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -125.24 127.47 46.79 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.327 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.465 ' HB3' ' HB ' ' A' ' 61' ' ' VAL . 1.6 tm-20 -114.96 163.88 14.95 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 103.128 -2.916 . . . . 0.0 103.128 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -53.26 -34.85 48.6 Favored Glycine 0 C--N 1.317 -0.479 0 CA-C-N 118.535 0.607 . . . . 0.0 113.288 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -133.06 7.14 5.11 Favored Glycine 0 N--CA 1.434 -1.456 0 C-N-CA 119.527 -1.32 . . . . 0.0 113.058 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 58' ' ' GLU . 64.3 t -124.79 125.65 70.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 O-C-N 122.002 -0.705 . . . . 0.0 111.43 -176.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.478 ' HB ' ' CD2' ' A' ' 71' ' ' PHE . 51.4 mm -89.99 130.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 172.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 56.3 m -91.93 113.73 26.08 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.253 -0.979 . . . . 0.0 113.059 -173.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.447 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 39.8 m -87.02 -45.55 10.65 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 115.303 -0.862 . . . . 0.0 108.786 169.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.525 ' O ' ' HD3' ' A' ' 65' ' ' ARG . 0.9 OUTLIER 71.76 -36.28 0.35 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.71 1.204 . . . . 0.0 110.822 -177.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.564 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . . . -56.16 -61.06 2.64 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -75.8 -19.29 59.08 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.134 -1.426 . . . . 0.0 112.079 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.0 tp 179.87 -77.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 65' ' ' ARG . 73.7 t90 177.32 -27.69 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.503 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' HD13 ' A' ' 79' ' ' ILE . 34.1 p -100.77 140.58 34.84 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -170.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.478 ' CD2' ' HB ' ' A' ' 62' ' ' ILE . 42.7 t80 -134.39 139.93 45.94 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 126.311 1.844 . . . . 0.0 107.107 173.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -106.47 113.03 26.31 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-O 120.955 0.407 . . . . 0.0 110.704 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -58.94 -50.91 72.26 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -42.7 -45.32 5.67 Favored Glycine 0 N--CA 1.475 1.267 0 N-CA-C 116.126 1.21 . . . . 0.0 116.126 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.578 ' HB ' ' CD2' ' A' ' 77' ' ' HIS . 10.7 m -116.31 12.17 15.26 Favored 'General case' 0 CA--C 1.561 1.387 0 O-C-N 122.123 -0.634 . . . . 0.0 110.634 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 54.56 51.42 52.15 Favored Glycine 0 C--N 1.338 0.659 0 C-N-CA 121.396 -0.431 . . . . 0.0 112.258 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.578 ' CD2' ' HB ' ' A' ' 75' ' ' THR . 0.3 OUTLIER -146.46 157.24 43.73 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -175.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' ASP . . . -77.56 173.79 54.9 Favored Glycine 0 N--CA 1.431 -1.691 0 C-N-CA 119.346 -1.406 . . . . 0.0 109.998 174.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.459 HD13 ' HB ' ' A' ' 70' ' ' THR . 1.8 mp -87.71 -27.77 5.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -152.07 107.13 2.82 Favored Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-N 114.879 -1.055 . . . . 0.0 108.558 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.87 158.07 98.36 Favored 'Cis proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.123 -1.615 . . . . 0.0 111.175 -2.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 78' ' ' GLY . 5.2 p-10 -104.22 -4.61 22.83 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -173.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -51.49 -55.44 18.92 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.236 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 85.9 m -167.46 170.63 11.16 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 123.619 0.768 . . . . 0.0 109.895 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.566 ' CB ' ' HA ' ' A' ' 77' ' ' HIS . 42.1 t -145.39 -79.42 0.18 Allowed 'General case' 0 N--CA 1.422 -1.837 0 CA-C-O 122.312 1.053 . . . . 0.0 110.756 169.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.509 ' HG ' ' SG ' ' A' ' 85' ' ' CYS . 87.5 mt -114.0 167.14 10.92 Favored 'General case' 0 C--N 1.265 -3.092 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.824 -175.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 41' ' ' TYR . . . -97.51 137.7 36.07 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -95.67 113.88 25.57 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 90' ' ' PRO . 97.4 m-85 -106.03 142.74 25.47 Favored Pre-proline 0 C--O 1.245 0.859 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.048 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 89' ' ' TYR . 24.1 Cg_exo -63.89 131.97 32.99 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.963 2.442 . . . . 0.0 111.074 176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.4 HG23 HG12 ' A' ' 100' ' ' VAL . 7.3 p -133.15 146.78 31.86 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.056 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.508 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.528 ' HB3' ' HE2' ' A' ' 94' ' ' LYS . 50.6 mt-10 -131.74 132.61 43.99 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -115.28 118.42 58.74 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-O 121.202 0.525 . . . . 0.0 110.427 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.528 ' HE2' ' HB3' ' A' ' 92' ' ' GLU . 0.0 OUTLIER -120.7 91.97 3.66 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 179.543 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.34 -99.52 0.52 Allowed Glycine 0 CA--C 1.498 -0.989 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.583 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.624 ' O ' ' HA ' ' A' ' 8' ' ' SER . 10.6 m-20 -104.85 -9.78 17.79 Favored 'General case' 0 C--O 1.174 -2.886 0 CA-C-N 115.157 -0.522 . . . . 0.0 109.956 178.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -99.8 128.39 45.9 Favored 'General case' 0 C--N 1.273 -2.722 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.551 -173.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 61.5 mt -119.73 121.9 67.34 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.409 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.445 ' CZ ' ' HB2' ' A' ' 5' ' ' LYS . 20.3 m-85 -114.08 142.37 46.28 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.251 178.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.4 HG12 HG23 ' A' ' 91' ' ' VAL . 24.5 m -128.56 139.67 51.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 2' ' ' SER . 32.1 t -105.45 120.03 40.58 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.163 0.506 . . . . 0.0 110.074 179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.2 t -102.49 12.75 36.03 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.784 177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' HB2' ' H ' ' A' ' 2' ' ' SER . 63.0 tttm -100.82 144.33 29.91 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.47 -41.66 2.65 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 111.484 -0.646 . . . . 0.0 111.484 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -101.43 136.15 34.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.0 tt -112.26 140.75 23.98 Favored Pre-proline 0 C--N 1.302 -1.483 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -49.23 138.78 28.76 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.073 2.515 . . . . 0.0 113.688 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -80.86 -177.34 6.32 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -178.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -14.74 0.1 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 124.118 0.967 . . . . 0.0 112.8 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.511 ' HB1' ' O ' ' A' ' 44' ' ' MET . . . -49.48 146.54 3.96 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 125.453 1.501 . . . . 0.0 111.242 175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 66.54 74.76 0.34 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 123.654 0.782 . . . . 0.0 110.812 -176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.4 t . . . . . 0 C--N 1.299 -1.597 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.912 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.564 ' S1 ' ' HB3' ' A' ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 tpt . . . . . 0 C--O 1.235 0.292 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t -162.17 -163.98 1.0 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 105.853 -1.906 . . . . 0.0 105.853 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -59.54 102.88 0.16 Allowed 'General case' 0 C--O 1.25 1.082 0 CA-C-O 121.302 0.572 . . . . 0.0 110.049 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -117.71 150.28 39.34 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.659 -176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 87.8 tttt -77.38 115.29 17.03 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.291 0.567 . . . . 0.0 110.083 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.403 HG23 ' SG ' ' A' ' 7' ' ' CYS . 10.8 tp -96.4 -35.28 5.55 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.791 -177.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' SG ' HG23 ' A' ' 6' ' ' ILE . 21.9 p -162.3 -166.58 1.42 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.981 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.723 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 6.2 m -127.96 149.1 50.49 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.147 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.95 -34.72 78.62 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 123.495 0.718 . . . . 0.0 109.395 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -65.45 -23.08 66.83 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.36 177.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.45 -46.47 12.46 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.572 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 12' ' ' ILE . 47.0 pt -100.65 114.75 40.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-O 122.353 1.073 . . . . 0.0 112.124 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -82.25 168.52 17.53 Favored 'General case' 0 C--N 1.274 -2.682 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.196 179.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -62.08 122.06 11.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.67 0.748 . . . . 0.0 110.001 178.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' A' ' 57' ' ' TYR . . . 94.18 1.11 65.05 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.223 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -102.69 137.83 40.4 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.3 0.572 . . . . 0.0 109.747 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.422 ' CB ' HG22 ' A' ' 31' ' ' VAL . 23.1 ptm -137.23 143.14 42.11 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.902 -176.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' A' ' 53' ' ' SER . 12.2 tp10 -156.54 154.66 30.65 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.518 176.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 53' ' ' SER . 89.1 m -100.93 130.94 47.0 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.19 0.519 . . . . 0.0 109.912 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -123.11 152.19 41.33 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -117.08 138.47 51.6 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.18 -176.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.2 p -83.92 172.71 11.84 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.8 p -64.43 -26.54 68.49 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.177 0.591 . . . . 0.0 110.944 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.55 -12.22 58.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.212 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 96.76 22.52 18.07 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.443 179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.6 m -90.28 117.0 28.69 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -89.72 123.72 33.99 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' THR . 62.1 t -127.33 137.96 56.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.163 -175.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.532 ' O ' HD12 ' A' ' 29' ' ' LEU . 4.3 pp -93.3 123.3 36.49 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -109.44 114.55 47.24 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.355 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 ' CB ' ' A' ' 17' ' ' MET . 46.6 t -119.19 125.84 74.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.355 -177.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -87.82 106.21 17.92 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 22.8 m -99.53 149.35 23.33 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 120.751 0.31 . . . . 0.0 110.962 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -75.28 -50.04 17.34 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.177 0.513 . . . . 0.0 111.063 -178.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.7 -45.04 9.1 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.803 -176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' NE2' ' HE3' ' A' ' 39' ' ' LYS . 21.3 t-160 -84.25 -15.02 48.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-O 120.86 0.362 . . . . 0.0 111.949 -174.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 33' ' ' SER . . . 85.59 -171.5 45.48 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.003 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG11 HD13 ' A' ' 98' ' ' ILE . 61.4 t -77.72 123.35 34.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.413 ' HE3' ' NE2' ' A' ' 36' ' ' HIS . 74.3 mmtt -128.25 150.44 50.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.966 0.412 . . . . 0.0 111.84 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' GLU . . . -124.23 119.24 28.77 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.329 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -128.69 158.61 38.11 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -60.19 138.23 57.96 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 174.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HB2' ' N ' ' A' ' 29' ' ' LEU . . . -106.35 -5.75 18.83 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 113.612 0.967 . . . . 0.0 113.612 -172.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.94 105.01 17.49 Favored 'General case' 0 C--N 1.278 -2.512 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -174.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.435 ' HB3' ' S1 ' ' A' ' 113' ' ' FES . 89.3 m -80.45 111.79 25.7 Favored Pre-proline 0 N--CA 1.443 -0.806 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 168.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 112' ' ' SER . 63.2 Cg_endo -85.07 39.05 0.7 Allowed 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.626 2.218 . . . . 0.0 111.845 -176.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -102.25 -77.03 0.56 Allowed 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.957 -175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -170.15 131.78 1.02 Allowed 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.24 -1.392 . . . . 0.0 107.24 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 43.1 mt-10 64.54 86.44 0.13 Allowed 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.778 0.799 . . . . 0.0 112.164 -178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.3 tt -93.88 106.46 18.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-O 121.729 0.776 . . . . 0.0 111.836 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HB3' ' HG2' ' A' ' 65' ' ' ARG . 36.1 tp -154.38 48.92 0.61 Allowed 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 176.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.494 HD11 HD22 ' A' ' 29' ' ' LEU . 1.6 tm? -56.16 -38.78 71.36 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 112.768 -2.015 . . . . 0.0 113.276 -175.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.653 ' HB2' ' HA ' ' A' ' 18' ' ' GLU . 94.0 p -68.56 -29.47 68.02 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.382 0.611 . . . . 0.0 112.331 -172.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -83.87 17.15 2.46 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 124.265 1.026 . . . . 0.0 110.815 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.01 -125.01 1.15 Allowed Glycine 0 N--CA 1.412 -2.914 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.4 m -152.69 151.46 30.57 Favored 'General case' 0 N--CA 1.424 -1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 112.905 -177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.536 ' CD2' ' HA2' ' A' ' 15' ' ' GLY . 20.8 t80 -120.75 116.25 24.87 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.162 177.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -117.18 170.82 8.37 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.5 69.61 0.04 OUTLIER Glycine 0 CA--C 1.535 1.306 0 N-CA-C 114.857 0.703 . . . . 0.0 114.857 -175.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.01 1.75 39.08 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 176.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.5 t -125.14 127.21 72.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 36.8 mm -122.72 132.94 70.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 0.0 110.39 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.4 m -101.76 137.39 40.12 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 25.9 p -78.09 -73.86 0.29 Allowed 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 119.202 -0.999 . . . . 0.0 112.558 -178.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.485 ' HG2' ' HB3' ' A' ' 51' ' ' LEU . 29.7 tpt180 174.72 -69.23 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 49' ' ' GLU . . . -66.51 -57.96 6.23 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 179.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.413 ' HB2' ' SG ' ' A' ' 64' ' ' CYS . 8.6 m170 -70.59 116.11 10.53 Favored 'General case' 0 N--CA 1.42 -1.971 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.836 167.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 45.2 tp -85.93 17.63 3.39 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 122.53 1.157 . . . . 0.0 108.603 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.403 ' H ' ' C ' ' A' ' 67' ' ' HIS . 87.7 m95 -93.47 177.41 6.04 Favored 'General case' 0 N--CA 1.416 -2.159 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.164 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 44.3 p -129.8 140.81 50.96 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 -172.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.495 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 53.5 p90 -105.67 154.02 21.02 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -93.7 116.57 29.07 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.542 -0.463 . . . . 0.0 109.983 -173.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -70.46 -30.49 67.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 123.159 0.584 . . . . 0.0 111.3 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.77 31.51 4.25 Favored Glycine 0 C--N 1.31 -0.884 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 178.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.3 m -156.7 -44.2 0.07 Allowed 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 123.784 0.834 . . . . 0.0 109.305 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 96.59 -9.72 66.65 Favored Glycine 0 C--O 1.215 -1.049 0 C-N-CA 121.279 -0.486 . . . . 0.0 111.911 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -107.12 148.29 28.98 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.495 ' HA2' ' CB ' ' A' ' 71' ' ' PHE . . . -72.56 137.73 25.08 Favored Glycine 0 N--CA 1.435 -1.432 0 C-N-CA 120.917 -0.658 . . . . 0.0 111.645 178.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 63.5 mt -77.41 -43.72 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -160.84 124.31 1.93 Allowed Pre-proline 0 N--CA 1.425 -1.721 0 N-CA-C 105.58 -2.008 . . . . 0.0 105.58 174.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.496 ' HD2' ' SG ' ' A' ' 84' ' ' CYS . 12.7 Cg_exo -71.92 166.21 79.85 Favored 'Cis proline' 0 C--N 1.325 -0.69 0 C-N-CA 124.021 -1.241 . . . . 0.0 112.79 0.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -92.41 -11.54 34.58 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.476 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -82.18 -10.75 59.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.87 0.367 . . . . 0.0 110.88 -177.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.496 ' SG ' ' HD2' ' A' ' 81' ' ' PRO . 6.0 p -110.32 133.98 52.73 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 122.334 1.064 . . . . 0.0 111.96 176.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 57.6 m -150.52 157.69 43.3 Favored 'General case' 0 C--N 1.275 -2.668 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 176.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.3 mt -131.75 179.47 6.05 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 -176.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.508 ' HB2' ' HB2' ' A' ' 108' ' ' ASN . . . -141.07 139.66 34.08 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 40' ' ' ALA . 8.6 pt-20 -92.25 104.09 16.49 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.235 0.541 . . . . 0.0 109.933 176.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -89.96 163.51 31.88 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.88 119.57 6.81 Favored 'Trans proline' 0 C--N 1.363 1.3 0 C-N-CA 122.656 2.237 . . . . 0.0 114.018 -174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.424 HG23 HG12 ' A' ' 100' ' ' VAL . 3.1 p -129.9 127.47 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.936 0 CA-C-N 114.065 -1.425 . . . . 0.0 108.629 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -115.02 128.87 56.53 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.459 0.647 . . . . 0.0 110.028 -176.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.462 ' HA ' HG12 ' A' ' 98' ' ' ILE . 7.4 p -94.83 129.46 44.97 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.269 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.062 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -122.61 146.85 47.07 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -49.07 101.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.07 0 C-N-CA 120.516 -0.85 . . . . 0.0 111.741 174.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.723 ' O ' ' HB3' ' A' ' 8' ' ' SER . 8.0 m-20 76.27 -13.82 0.87 Allowed 'General case' 0 C--O 1.195 -1.805 0 C-N-CA 127.28 2.232 . . . . 0.0 114.716 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -120.62 155.46 33.72 Favored 'General case' 0 C--O 1.2 -1.539 0 CA-C-N 119.965 1.257 . . . . 0.0 110.849 -177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.478 HD13 HG11 ' A' ' 38' ' ' VAL 0.251 45.8 mt -131.26 133.92 61.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 176.634 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -119.44 144.38 46.98 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.495 177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.424 HG12 HG23 ' A' ' 91' ' ' VAL . 35.3 m -135.52 144.9 32.63 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.296 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -132.39 118.09 18.94 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 t -92.92 6.08 49.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.156 0.503 . . . . 0.0 109.96 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -72.13 109.76 6.13 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.719 -177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.3 -15.02 25.4 Favored Glycine 0 N--CA 1.435 -1.384 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.62 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.8 119.94 63.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 121.253 0.549 . . . . 0.0 110.031 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.2 mp -95.17 148.05 34.03 Favored Pre-proline 0 N--CA 1.409 -2.496 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 177.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -53.83 134.13 57.61 Favored 'Trans proline' 0 C--O 1.245 0.868 0 C-N-CA 122.887 2.391 . . . . 0.0 111.251 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 54.3 t30 -79.91 157.29 26.95 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -176.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -56.1 106.01 0.24 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 114.943 1.46 . . . . 0.0 114.943 -171.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . 174.52 -69.86 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.614 -2.539 . . . . 0.0 106.34 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 39.29 -90.65 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 126.745 2.018 . . . . 0.0 115.005 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.415 ' HA ' ' HB3' ' A' ' 46' ' ' PRO . 27.4 t . . . . . 0 N--CA 1.429 -1.511 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 -173.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' FES . . . . . 0.435 ' S1 ' ' HB3' ' A' ' 45' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_